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Chapter 1 
 
INTRODUCTION 
 
The present volume presents new 2017 findings from the U.S. national Monitoring the Future (MTF) 
follow-up study concerning substance use among the nation’s college students and adults from ages 
19 through 55. We report 2017 prevalence estimates on numerous illicit and licit substances, examine 
how substance use differs across this age span, and show how substance use and related behaviors and 
attitudes have changed over the past four decades. MTF, now in its 44th year, is a research program 
conducted at the University of Michigan’s Institute for Social Research under a series of investigator-
initiated, competing research grants from the National Institute on Drug Abuse – one of the National 
Institutes of Health. The integrated MTF study comprises several ongoing series of annual surveys of 
nationally representative samples of 8th and 10th grade students (begun in 1991), 12th grade students 
(begun in 1975), and high school graduates followed into adulthood (begun in 1976).  
 
We report the results of the repeated cross-sectional surveys of all high school graduating classes since 
1976 as we follow them into their adult years (as discussed in Chapter 3, these cross-sections come 
from longitudinal data). Segments of the general adult population represented in these follow-up 
surveys include: 
 
• U.S. college students, 
• their age-peers who are not attending college, sometimes called the “forgotten half,”1 
• all young adult high school graduates of modal ages 19 to 30 (or 19-28 for trend estimates), to 
whom we refer as the “young adult” sample, and  
• high school graduates at the specific later modal ages of 35, 40, 45, 50, and 55. 
 
This volume emphasizes historical and developmental changes in substance use and related attitudes 
and beliefs occurring at these age strata.  
 
The follow-up surveys have been conducted by mail on representative subsamples of the previous 
participants from each high school senior class. This volume presents data from the 1977 through 2017 
follow-up surveys of the graduating high school classes of 1976 through 2016, as these respondents 
have progressed into adulthood. The oldest MTF respondents, from the classes of 1976-80, have been 
surveyed through age 55 in 2013-2017, 37 years after their graduation.  
 
Other monographs in this series include the Overview of Key Findings,2 which presents early results 
from the secondary school surveys; Volume I,3 which provides an in-depth look at the secondary school 
                                                 
1 Halperin S. The forgotten half revisited: American youth and young families, 1988-2008. Washington DC: American Youth Policy Forum; 1998. 
http://www.aypf.org/resources/the-forgotten-half-revisited-american-youth-and-young-families-1988-2008/ 
2 Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2018). Monitoring the Future national 
survey results on drug use, 1975-2017: Overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University 
of Michigan. 
3 Miech, R. A., Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2018). Monitoring the Future national 
survey results on drug use, 1975–2017: Volume I, Secondary school students. Ann Arbor, MI: Institute for Social Research, The University of 
Michigan.  
1
secondary school survey results; and the HIV/AIDS monograph,4 drawn from the follow-up 
surveys of 21- to 40-year-olds, which focuses on risk and protective behaviors related to the 
transmission of HIV/AIDS. This year's Overview and Volume I are currently available on the MTF 
website5; the HIV/AIDS monograph will be published in mid-October, 2018. 
 
In this volume, we first set the stage by providing a summary (in Chapter 2) of key findings from 
the integrated MTF study, including 8th , 10th, and 12th graders, college students, and young adults. 
Chapter 3 (which also is Chapter 3 in Volume 1) outlines the integrated study’s design and 
procedures. Chapter 4 provides prevalence estimates, and Chapter 5 provides historical trends, for 
drug use at ages 18 through 55. Chapter 6 concerns prevalence and trends in attitudes and beliefs 
about drug use for young adults. Chapter 7 covers the social context of drug use in terms of peer 
norms and use, as well as perceived availability of drugs. Chapters 8 and 9 provide prevalence 
estimates and historical trends, respectively, for college students and their same age peers. Chapter 
10 (which also is Chapter 10 in Volume I) provides a summary of recent publications from the 
integrated MTF study. 
 
SURVEYS OF YOUNG ADULTS AND ADULTS AGES 35, 40, 45, 50, AND 55 
The current young adult sample consists of representative samples from each graduating class from 
2005 to 2016, all surveyed in 2017 and corresponding to modal ages 19 through 30. College 
students are included as part of this young adult sample. The MTF study design calls for annual 
follow-up surveys of each high school class cohort through modal age 30, based on high school 
seniors being assumed to be modal age 18. Each individual participates in a follow-up survey only 
every two years, but a representative sample of people in each individual’s graduating class is 
obtained every year because each cohort’s follow-up sample is split into two random samples that 
are surveyed in alternate years. Thus, participants at modal ages 19-30 are surveyed biennially. 
Subsequent surveys are conducted at five-year intervals starting at age 35. In 2017 the graduating 
classes of 2005-2016 received biennial young adult surveys, and the classes of 1980, 1985, 1990, 
1995, and 2000 were sent the age-55, age-50, age-45, age-40, and age-35 questionnaires, 
respectively. 
 
In this volume, we reweight respondent data to adjust for the effects of panel attrition on measures 
such as drug use, using post-stratification procedures described in Chapter 3 in the section on panel 
retention. We are less able to adjust for the absence of students who drop out of high school and 
who are not included in the original 12th grade sample. Because nearly all college students have 
completed high school, the omission of high school dropouts should have almost no effect on 
population estimates for the college students, but this omission does affect the estimates for entire 
age groups. Therefore, the reader is advised that the omission of about 7% to 15% of each cohort 
who have dropped out of high school likely means that drug use estimates given here for the 
various age bands are somewhat low for the age group as a whole. Fortunately, high school dropout 
rates continue to decline. US Census data indicate that dropout comprised approximately 15% of 
the class/age cohort through most of the life of the study, until about 2002. Since then, there has 
                                                 
4 Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., Patrick, M. E. & Miech R. A. (2017). HIV/AIDS: Risk & protective behaviors 
among adults ages 21 to 40 in the U.S., 2004–2016. Ann Arbor, MI: Institute for Social Research, The University of Michigan.  
5 Please visit http://monitoringthefuture.org/pubs.html#monographs to access the full text of these monographs. 
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been a gradual decline, dropping to a little over 7% in 2017.6 The proportional effect of missing 
dropouts may be greatest for use of dangerous drugs such as heroin, crack, and methamphetamine, 
as well as cigarettes – the latter being highly correlated with educational aspirations and 
attainment. Nevertheless, even with some underreporting of usage rates, the year-to-year trends 
observed should be little affected by the limitations in sample coverage. 
 
For purposes beyond this volume, we note that studies on substance use and related factors that 
follow young people into middle adulthood are rare in the field. Monitoring the Future (MTF) 
provides for exceptionally useful analyses of adult substance use as well as many other behaviors 
and attitudes. These national data make possible (1) analyses aimed at differentiating period-, age-
, and cohort-related change; (2) analyses demonstrating long-term connections between use of 
various substances at various stages in life and many important potential outcomes (including 
eventual substance use disorders, adverse health outcomes, and functioning in work and family 
roles); (3) tracking substance use involvement and how such involvement is affected by transitions 
into and out of social roles and social contexts across the life course; and (4) identifying the 
individual and contextual factors in adolescence and early adulthood that are predictive of later 
substance use and substance use disorders. These and other topics are covered in other publications 
by MTF. 
 
SURVEYS OF COLLEGE STUDENTS AND NONCOLLEGE PEERS 
As defined here, the college student population comprises all full-time students enrolled in a two- 
or four-year college one to four years after high school in March during the year of the survey. 
More is said about this sample definition in Chapter 3 on study design. Results on the prevalence 
of drug use in 2017 among college students and also among their noncollege peers are reported in 
Chapter 8, and results on trends in substance use among college students and their noncollege 
peers are reported in Chapter 9, covering the 37-year interval since 1980.  
 
The MTF follow-up samples have provided excellent coverage of the U.S. college student 
population for more than three and a half decades (1980–2017). College students tend to be a 
difficult population to study for a variety of reasons. For a number of years, they were generally 
not well covered in household surveys, which tended to exclude dormitories, fraternities, and 
sororities. Further, institution-based samples of college students must be quite large in order to 
attain accurate national representation because of the great heterogeneity in universities, colleges, 
and community colleges, and in the types of student populations they serve. Obtaining good 
samples within many institutions also poses difficulties, because the cooperation of each institution 
must be obtained, as well as reasonable samples of the student body.  
 
In contrast, MTF draws the college sample prospectively in senior year of high school, so it has 
considerable advantages for generating a broadly representative sample of college students who 
emerge from each graduating cohort; moreover, it does so at very low cost. In addition, the “before, 
during, and after college” design permits examination of the many changes associated with the 
college experience. Finally, the MTF design also generates comparable panel data on high school 
graduates who are not attending college, an important segment of the young adult population not 
                                                 
6 U.S. Census Bureau (various years). Current population reports, Series P-20, [various numbers]. Washington, DC: U.S. Government Printing 
Office. Available at http://www.census.gov/cps/data/cpstablecreator.html  
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only in its own right, but also as a comparison group for college students. This is a particularly 
valuable and rare feature of this research design. 
 
GENERAL PURPOSES OF THE RESEARCH 
MTF’s research purposes are extensive and are outlined here only briefly.7 One major purpose is 
to serve an epidemiological social indicator function to accurately characterize the levels and 
trends in selected behaviors, attitudes, beliefs, and relevant social context conditions in the various 
populations covered. Social indicators can have important agenda-setting functions for society, 
drawing attention to new threats to public health and estimating the extent of those threats as well 
as determining where they are concentrated in the population. They are especially useful for 
gauging progress toward national goals and indicating the impacts of major historical events, 
including social trends and policy changes. Another purpose of the study is to develop knowledge 
that increases our understanding of how and why historical changes in these behaviors, attitudes, 
beliefs, and environmental conditions are taking place. Such work is usually considered to be 
social epidemiology. These two broad purposes are addressed in the current series of volumes. 
 
Additional etiologic purposes of MTF include helping to discover risk and protective factors for, 
and consequences of, drug use; indicating what types of young people are at greatest risk for 
developing various patterns of drug abuse; gaining a better understanding of the belief and attitude 
orientations associated with various patterns of drug use; and monitoring how all of these are 
shifting over time. MTF data permit the investigation of the immediate and more general aspects 
of the social environment that are associated with drug use and abuse, and permit the assessment 
of how drug use is affected by major transitions into and out of social roles and contexts (such as 
military service, civilian employment, college, unemployment, marriage, pregnancy, parenthood, 
divorce, remarriage). MTF examines the life course of various drug-using behaviors during the 
transition to adulthood and through middle adulthood, including progression to substance use 
disorder. This knowledge allows MTF to distinguish such age effects from cohort and period 
effects that influence drug use and associated attitudes, to discover the effects of legislation and 
changing regulations on various types of substance use, and to understand consequences of the 
changing connotations of drug use and changing patterns of multiple drug use among youth. 
 
We believe that differentiating among age, period, and cohort effects on use of various types of 
substances and associated attitudes and beliefs has been a particularly important contribution of 
the project. The MTF cohort-sequential research design is well suited to discern changes with age 
common to all cohorts (age effects), differences among cohorts that tend to persist across time 
(cohort effects), and changes common to most or all ages in a given historical period (period 
effects).  
 
Knowing which type of change is occurring is important for at least three reasons. First, it can help 
to discover what types of causes account for the change. For example, age effects are often 
                                                 
7 Johnston, L. D., O'Malley, P. M., Schulenberg, J. E., Bachman, J. G., Miech, R. A., & Patrick, M. E. (2016). The objectives and theoretical 
foundation of the Monitoring the Future Study (Monitoring the Future Occasional Paper No. 84). Ann Arbor, MI: Institute for Social Research, 
University of Michigan. See also Bachman, J. G., Johnston, L. D., O'Malley, P. M., Schulenberg, J. E., & Miech, R. A. (2015). The Monitoring the 
Future project after four decades: Design and procedures (Monitoring the Future Occasional Paper No. 82). Ann Arbor, MI: Institute for Social 
Research, University of Michigan.  
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explained by maturation as well as by social role and context transitions associated with age, as 
this study has demonstrated.8,9,10,11,12,13,14,15,16,17,18,19 Such age effects, as we have shown, can vary 
historically, indicating the historical embeddedness of developmental course.20,21 Second, the type 
of change can indicate when in the life course the causes may have had their impact; in the case of 
cohort effects, it may well have been in an earlier point in the life course than the age at which the 
change is actually documented. For example, we know from historical context and MTF data on 
age of initiation that the decline in cigarette smoking observed among 12th graders in the late 1970s 
actually reflected a cohort effect that emerged when those teens were younger, in the early 1970s, 
which was shortly after cigarette advertising was removed from radio and television. So, although 
we documented a cohort effect at 12th grade, its origins were most likely due to earlier changes in 
social context. The third reason that knowing the type of change is important is that it can help in 
predicting future change more accurately. For example, the study has shown that perceived risk 
often is a leading indicator of change and also that cohort effects help to predict forthcoming 
changes at later ages. Needless to say, predicting change is extremely valuable to the policy, 
prevention, and treatment communities. This volume documents some well-established age 
effects, some important cohort differences that emerged in the 1990s, and recent period effects. 
 
Another important purpose of MTF, related to but distinct from the ones described so far, is to 
study risk and risk-reducing behaviors associated with HIV/AIDS. This purpose is addressed in 
the monograph HIV/AIDS: Risk & protective behaviors among adults ages 21 to 40 in the U.S., 
                                                 
8 Bachman, J. G., O'Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education-drug use 
connection: How successes and failures in school relate to adolescent smoking, drinking, drug use, and delinquency. New York: Lawrence Erlbaum 
Associates/Taylor & Francis. 
9 Bachman, J. G., O'Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in 
young adulthood: Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates. 
10 Bachman, J. G., Wadsworth, K. N., O'Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
11 Jang, B., Patrick, M. E., & Schuler, M. S. (2017). Substance use behaviors and the timing of family formation during young adulthood. Journal 
of Family Issues, 39(5), 1396-1418.  
12 Jang, B., Schuler, M. S., Evans-Polce, R. J., & Patrick, M. E. (in press). The association between young adult substance use and adult substance 
use disorder: Marriage as a causal pathway. 
13 Patrick, M. E., Schulenberg, J. E., & O'Malley, P. M. (2016). High school substance use as a predictor of college attendance, completion, and 
dropout: A national multicohort longitudinal study. Youth & Society, 48(3), 425-447.  
14 Miech, R. A., Patrick, M. E., O'Malley, P. M., & Johnston, L. D. (2017). E-cigarette use as a predictor of cigarette smoking: Results from a 1-
year follow-up of a national sample of 12th grade students. Tobacco Control, 26(e2), e106-e111.  
15 Miech, R. A., Patrick, M. E., O'Malley, P. M., & Johnston, L. D. (2017). The influence of college attendance on risk for marijuana initiation in 
the United States: 1977 to 2015. American Journal of Public Health, 107(6), 996-1002.  
16 Patrick, M. E., Schulenberg, J. E., O’Malley, P. M., Maggs, J. L., Kloska, D. D., Johnston, L. D., & Bachman, J. G. (2011). Age-related changes 
in reasons for using alcohol and marijuana from ages 18 to 30 in a national sample. Psychology of Addictive Behaviors, 25, 330-339.  
17 Staff, J., Schulenberg, J. E., Maslowsky, J., Bachman, J. G., O’Malley, P. M., Maggs, J. L., & Johnston, L. D. (2010). Substance use changes and 
social role transitions: Proximal developmental effects on ongoing trajectories from late adolescence through early adulthood. Development and 
Psychopathology, 22(Special issue: Developmental cascades: Part 2), 917-932.  
18 Terry-McElrath, Y. M., O'Malley, P. M., Johnston, L. D., Bray, B. C., Patrick, M. E., & Schulenberg, J. E. (2017). Longitudinal patterns of 
marijuana use across ages 18-50 in a US national sample: A descriptive examination of predictors and health correlates of repeated measures latent 
class membership. Drug and Alcohol Dependence, 171, 70-83.  
19 Veliz, P., Schulenberg, J. E., Patrick, M. E., Kloska, D. D., McCabe, S. E., & Zarrett, N. (2017). Competitive sports participation in high school 
and subsequent substance use in young adulthood: Assessing differences based on level of contact. International Review for the Sociology of Sport, 
52(2), 240-259.  
20 Jager, J., Schulenberg, J. E., O'Malley, P. M., & Bachman, J. G. (2013). Historical variation in drug use trajectories across the transition to 
adulthood: The trend toward lower intercepts and steeper, ascending slopes. Development and Psychopathology, 25(2), 527-543.  
21 Jager, J., Keyes, K. M., & Schulenberg, J. E. (2015). Historical variation in young adult binge drinking trajectories and its link to historical 
variation in social roles and minimum legal drinking age. Developmental Psychology, 51(7): 962-974. 
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2004-201622 Beginning in 2004, MTF panel surveys have included questions on the prevalence 
and interconnectedness of risk and risk-reduction behaviors related to the spread of the human 
immunodeficiency virus (HIV) which causes acquired immunodeficiency syndrome (AIDS). The 
questions include drug involvement in general, injection drug use, needle sharing, number of 
sexual partners, gender(s) of those partners, use of condoms, getting tested for HIV/AIDS, and 
obtaining the results of such HIV tests.  
 
Readers interested in publications dealing with any of these areas are invited to visit the MTF 
website at www.monitoringthefuture.org. 
                                                 
22 Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., Patrick, M. E., & Miech, R. A. (2017). HIV/AIDS: Risk & protective 
behaviors among adults ages 21 to 40 in the U.S., 2004–2016. Ann Arbor, MI: Institute for Social Research, The University of Michigan. 
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Chapter 2 
 
KEY FINDINGS 
AN OVERVIEW AND INTEGRATION 
ACROSS FIVE POPULATIONS 
 
Monitoring the Future, having completed its 44th year of data collection, has become one of the 
nation’s most relied-upon scientific sources of valid information on trends in use of licit and illicit 
psychoactive drugs by U.S. adolescents, college students, young adults, and adults up to age 55. 
During the last four decades, the study has tracked and reported on the use of an ever-growing 
array of such substances in these populations of adolescents and adults. 
 
The annual series of monographs, of which this is Volume II, is a primary mechanism through 
which the epidemiological findings from MTF are reported. Findings from the inception of the 
study in 1975 through 2017 are included – the results of 44 national in-school surveys and 42 
national follow-up surveys. 
 
MTF has conducted in-school surveys of nationally representative samples of (a) 12th grade 
students each year since 1975 and (b) 8th and 10th grade students each year since 1991. Annual 
findings for 8th, 10th, and 12th graders through 2017 are presented in Volume I (also see the 2017 
Overview volume). Beginning with the class of 1976, the study has conducted follow-up mail 
surveys on representative subsamples of the respondents from each previously participating 12th 
grade class. These follow-up surveys now continue well into adulthood, currently up to age 55. 
Annual findings from these follow-up surveys are presented in this volume. 
 
In this chapter, we summarize a number of important findings to provide the reader with an 
overview of the epidemiological results from the integrated MTF study that span modal ages 14 
through 28, a key developmental period for the onset, peak, and decline in the use of most 
substances. Because so many populations, drugs, and prevalence intervals are discussed here, a 
single integrative set of tables (Tables 2-1 through 2-4) shows the 1991–2017 trends for all drugs 
on five populations: 1) 8th grade students (modal age 14), 2) 10th grade students (modal age 16), 
3) 12th grade students (modal age 18), 4) full-time college students modal ages 19–22, and 5) all 
young adults modal ages 19–28 who are high school graduates. (Note that the young adult group 
includes the college student population.) Volume I and the Overview volume provide more 
emphasis on the in-school epidemiological findings. In this current volume, we provide more 
emphasis on the epidemiological findings from young adults and college students, as well as from 
those at modal ages 35, 40, 45, 50, and 55. 
 
TRENDS IN DRUG USE – THE ADVENT OF COHORT EFFECTS 
Before considering the trends in specific drugs across the five age groups presented in Table 2-1, 
we first provide a brief summary of the rises and falls of substance use during the past quarter-
century to illustrate the impact of attitudes in historical trends of use and how cohort effects work 
to sometimes shift developmental trends. Early in the 1990s, MTF reported an increase in use of 
several illicit drugs among secondary school students, and some important changes among the 
students in terms of certain key attitudes and beliefs related to drug use. In the volume reporting 
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1992 survey results, we noted the beginning of such reversals in both use and attitudes among 8th 
graders, the youngest respondents surveyed in this study, and also a reversal in attitudes among 
12th graders. Specifically, the proportions seeing great risk in using drugs began to decline, as did 
the proportions saying they disapproved of use. As we suggested then, those reversals indeed 
presaged “an end to the improvements in the drug situation that the nation may be taking for 
granted.”1 The use of illicit drugs rose sharply in all three grade levels after 1992, in what we refer 
to as the “relapse phase” in the larger epidemic of illicit drug use, as negative attitudes and beliefs 
about drug use continued to erode. This pattern continued into the mid-1990s, and beyond that for 
some drugs, especially prescription-type psychotherapeutics like narcotics, amphetamines, 
tranquilizers, and sedatives. 
 
Then in 1997, for the first time in six years, the overall level of illicit drug use finally showed a 
decline among 8th graders. Although marijuana use continued to rise that year among 10th and 12th 
graders, their use of several other drugs leveled off, and relevant attitudes and beliefs also began 
to reverse in many cases. In 1998, illicit drug use continued a gradual decline among 8th graders 
and also started to decline at 10th and 12th grades. In 1999 and 2000, the decline continued for 8th 
graders, while use held fairly level among 10th and 12th graders. In 2002 and 2003, use by 8th and 
10th graders decreased significantly, and use by 12th graders finally began to drop; declines then 
continued for all three grades in 2004 and for several years thereafter. But in 2008, illicit drug use 
increased once again among 8th and 12th graders, followed by some increase in 8th and 10th grades 
in 2009, signaling an end to the immediately preceding period of decline. In 2010, the overall level 
of illicit drug use increased for all grades, although the increase was significant only among 8th 
graders. In 2011, the increase continued among 10th and 12th graders and declined some at 8th 
grade. Publicity around legalizing medical, and in some cases recreational use, may have served 
to normalize use of marijuana, the most widely used of all illicit substances. 
 
As shown in Figure 2-1, levels of overall illicit drug use among teens have shown a slight 
downward trend for the past several years through 2016. (2013 is an exception and shows a slight 
increase that resulted from an expansion of the question on amphetamines to include more current 
examples of these drugs.) During this time period, marijuana prevalence decreased at a slower rate 
than it has for other substances such as cigarettes and alcohol, perhaps due in part to the ongoing 
changes in state laws on medical and recreational marijuana use. In 2017, we see some 
nonsignificant increases in overall illicit drug use among teens, due in part to increases in 
marijuana use and inhalants (as summarized below and described in detail in Volume I), suggesting 
a leveling of use if not a turnaround. Among college students and young adults overall (aged 19-
28), there has been a slow but steady rise since 2010 in overall illicit drug use (see Figure 2-1), 
with consistent increases in marijuana use across this time period. Whether marijuana use (or other 
drug use) will continue to increase in coming years among teens and young adults, as more states 
legalize recreational marijuana use, is a matter to be clarified with continued monitoring. 
 
As will be illustrated below in the discussion of specific drugs, the increase in use of many drugs 
during the 1990s among secondary school students, combined with fairly level use among college 
students and young adults, resulted in some unusual reversals in prevalence levels by age (see 
Figure 2-1 and Table 2-2). In the early 1990s (the early years of the epidemic), illicit drug use 
                                                 
1 Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (1993). National survey results on drug use from the Monitoring the Future study, 1975-
1992. Volume I: Secondary school students. (NIH Publication No. 93-3597). Rockville, MD: National Institute on Drug Abuse. 
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levels were higher in the college-age group than they were among secondary school students 
(especially 8th and 10th graders). This reflects a normative developmental trend showing that 
prevalence increases with age through adolescence into the early 20s. But by the late 1990s, the 
highest levels of active use (i.e., use within the prior year or prior 30 days) were found in the late 
secondary school years. In fact, in 1996 and 1997 both 10th and 12th graders actually had higher 
annual prevalence levels for illicit drug use (i.e., higher percentages reporting any use within the 
prior year) than either college students or all young adults. This changed somewhat after 2001 
(with 10th graders annual prevalence becoming lower than that for college students), as the earlier, 
heavier-using cohorts of adolescents began to comprise the college student and young adult 
populations, while at the same time use among the incoming secondary school students was 
declining. In the past few years, a more typical normative developmental trend has returned, with 
annual prevalence increasing with age across adolescence and the early 20s. 
 
As can be seen by the divergence of trends for the different age groups in what follows, something 
other than simple developmental or secular trends in drug use were taking place; important cohort 
differences were emerging such that all ages were not changing simultaneously and age differences 
were not constant across historical time. (A cohort refers to a group of people who were born in 
the same year [a birth cohort] or, in this case, are in the same graduating class [a class cohort]. A 
birth cohort and class cohort obviously are quite close but not identical. Developmental trends 
pertain to changes with age that tend to be constant across multiple cohorts. A secular trend is a 
trend across historical time that occurs simultaneously across multiple cohorts and multiple age 
groups.) 
 
Regarding 2017 prevalence levels, we note that the typical developmental trend of substance use 
increasing with age through the early twenties remains in place. In 2017, the rank order by age 
group for annual prevalence of using any illicit drug was college students (42%), all 19- to 28-
year-old young adults (41%), 12th graders (40%), 10th graders (28%), and 8th graders (13%) (see 
Figure 2-1 and Table 2-2). With respect to using any illicit drug other than marijuana in the past 
12 months, prevalence ranged from all 19- to 28-year-olds and college students specifically (20% 
and 18% respectively) to 12th graders (13%), 10th graders (9%), and finally 8th graders (6%) (see 
Table 2-2). 
 
We turn now to summarize historical and developmental trends in the use of individual substances 
across the past quarter-century. 
 
• From the early 1990s until 1997, marijuana use rose sharply among secondary school 
students, as did their use of a number of other illicit drugs, though more gradually. As 
previously stated, we have called this period a “relapse phase” in the longer-term epidemic. 
An increase in marijuana use also began to occur among college students, largely reflecting 
“generational replacement” (i.e., a cohort effect), wherein earlier class cohorts were 
replaced in the college population by more recent ones who were more drug-experienced 
before they left high school. This resurgence in illicit drug use spread up the age spectrum 
in a reversal of the way the epidemic spread several decades earlier. In the 1960s, the 
epidemic began on the nation’s college campuses, and then diffused downward in age to 
high school students and eventually to middle school students. This time the increases 
began in middle schools and radiated up the age spectrum. The graduating class cohorts in 
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the middle and late 1990s carried with them the pattern of heavier drug use that emerged 
while they were in secondary school in the early 1990s. 
 
Increases during the 1990s in use of any illicit drug (including use of marijuana and use 
of other illicit drugs treated as a class) were substantially larger, in both proportional and 
absolute terms, in the three secondary school grades than in either the college or young 
adult populations. Among college students and young adults, the annual prevalence of use 
of any illicit drug held remarkably stable from 1991 through 1997, at the same time use 
rose appreciably among adolescents (see Figure 2-1). We predicted that, as generational 
replacement continued to occur, we would likely see some increase in use of illicit drugs 
by the young adults. As would be expected given their younger age range (19–22), the 
increase happened sooner and more sharply among the college students than among the 
young adults in general (age range 19–28). Peak levels (since 1990) in annual prevalence 
of any illicit drug were reached in 1996 among 8th graders (24%), in 1997 among 10th and 
12th graders (39% and 42%, respectively), in 2001 among college students (38% before 
leveling for some years and increasing in recent years to a new peak of 43% in 2016), and 
in 2004 in the young adult segment (34% before leveling and increasing in recent years to 
a new peak of 41% in 2017). More recently, a different, more complex pattern of cohort 
effects has been operating. Specifically, since about 2010, there has been some divergence 
in the annual prevalence of any illicit drug across the five age groups, with declines among 
8th and 10th graders, slight decline and leveling among 12th graders, and increases among 
college students and young adults (see Figure 2-1). However, in 2017, we see what may be 
a leveling or turnaround in annual prevalence among secondary school students (with 
nonsignificant increases to 13%, 28%, and 40% among 8th, 10th, and 12th graders, 
respectively), a leveling among college students (with a slight nonsignificant decline to 
42%), and a continued increase among young adults (with a nonsignificant increase to 
41%); whether this is the advent of a more general secular trend awaits continued 
monitoring. 
 
Again, the earlier diverging trends across the different age strata clearly show that changes 
during the 1990s reflected the emergence of some important cohort effects rather than 
broad secular trends that would have appeared simultaneously in all of the age groups. 
During all of the previous years of the study, the use of most drugs moved in parallel across 
most age groups, indicating that secular change was prevailing then. 
 
• Similar to the use patterns for illicit drugs, the trend for cigarette smoking evidenced a 
generational replacement effect during the 1990s in that college students showed a sharp 
increase in smoking beginning in 1995, as the heavier smoking cohorts of secondary school 
students from the early to mid-1990s entered college. This has been a more typical pattern 
of change for cigarettes, however, since differences in cigarette smoking levels among 
class cohorts tend to remain through the life course and also tend to account for much of 
the overall change in use observed at any given age. 
 
In the early 1990s, cigarette smoking among 8th and 10th graders rose by about 50% – a 
particularly sharp and worrisome rise (based on 30-day prevalence levels shown in Table 
2-3, and daily and half-pack levels shown in Table 2-4); MTF was the first study to draw 
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national attention to this momentous development, a finding that was widely covered in 
the media and had substantial impact on national policies and policy-related developments 
that followed. Smoking also rose among 12th graders, beginning a year later. 
 
The increase in 30-day smoking ended among 8th and 10th graders in 1996, among 12th 
graders in 1997, and among college students in 1999. The nation then entered a period of 
appreciable decline in smoking levels that first began among 8th graders in 1997 and 
radiated up the age spectrum as those cohorts aged. (The 8th grade 30-day prevalence fell 
by about nine-tenths from 21% in 1996 to 1.9% in 2017.) Among the college and the young 
adult strata, the declines have been less sharp so far, but they are generally continuing. The 
30-day smoking prevalence for college students in 2017 (8.0%) was down more than 
seven-tenths from the recent peak of 31% in 1999, with the decline accelerating after 2005 
as the cohort effect worked its way up the age bands. Smoking among the young adult 
subgroup has dropped by more than one half (to 15% by 2017) since its recent peak of 31% 
in 1998. Among secondary school students smoking has steadily declined for the past two 
decades, including a significant decline in past 30-day smoking from 2016 to 2017 among 
8th grade students (from 2.6% to 1.9%). The smoking levels among secondary students are 
now at the lowest ever recorded, with declines from the peak years of 1996-97 of over 80% 
for 8th and 10th grade students and over 70% for 12th grade students, and from peak years 
of 1998-99 of over 70% and over 50%, respectively, for college students and young adults. 
In 2017, in addition to the significant decline just mentioned among 8th grade students, 
there was a leveling for 10th graders, a nonsignificant decline for 12th grade and college 
students, and a nonsignificant increase for young adults. 
 
• During the 1990s, in what we have called the “relapse period” in the drug epidemic, the 
annual prevalence of marijuana use tripled among 8th graders (from 6% in 1991 to 18% in 
1996), more than doubled among 10th graders (from 15% in 1992 to 35% in 1997), and 
nearly doubled among 12th graders (from 22% in 1992 to 39% in 1997). Among college 
students, however, the increase in marijuana use was much more gradual, presumably due 
to a generational replacement effect. Annual prevalence of use rose by about one third, 
from 27% in 1991 to 36% in 1998. Marijuana use began to decline in 1997 among 8th 
graders and then did the same in 1998 among 10th and 12th graders. The rate of decline was 
rather modest, however, perhaps due in part to effects of the public debates over medical 
use of marijuana during that period. In 2001, use remained level in all three grades, but 
between 2001 and 2004 all three grades showed significant declines in their annual 
prevalence of marijuana use, with the proportional decline greatest among 8th graders. 
Eighth graders exhibited the steadiest long-term decline from their recent peak in 1996, a 
decline of more than four-tenths by 2007. After 2007 use began to increase among 8th 
graders (see Figure 5-4a in Chapter 5). Declines among 10th and 12th graders started a year 
later and accelerated after about 2001; between approximately 1997 and 2008, annual 
prevalence levels fell by 31% and 18% for 10th and 12th graders, respectively. All three 
grades exhibited slight increases in annual prevalence after the mid-2000s, although the 
increases were uneven. From 2016 to 2017, all age groups showed nonsignificant increases 
except college students, who showed a nonsignificant decrease. 
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• Current daily marijuana use (defined as use on 20 or more occasions in the prior 30 days) 
rose substantially after 1992 in all five populations, reaching peak levels in a somewhat 
staggered fashion as that just described (see Table 2-4). Daily use began a slow decline 
after 1999 among 8th graders until 2007, after 2001 until 2009 among 10th graders, and after 
2003 until 2010 among 12th graders, consistent with a cohort effect pattern. Use at all three 
grade levels was fairly level after 2004. In 2010, daily use at all three grade levels increased 
significantly and it increased further in grades 10 and 12 in 2011 and 2012, while holding 
steady in 8th grade. In 2014, the prevalence of daily marijuana use declined in all three 
grades, with a significant decline in 10th grade; these levels remained essentially unchanged 
in 2017. The 2017 daily prevalence levels in grades 8, 10, and 12, respectively, were 0.8%, 
2.9%, and 5.9%. In other words, in 2017 about one in every seventeen high school seniors 
was a daily or near-daily marijuana user. College student and young adult prevalence of 
daily use showed an overall increase since 2007, from 3.5% to 4.4% in 2017 among college 
students and from 5.0% to 7.8% over that same interval among young adults. That is, in 
2017 about one in every thirteen young adults aged 19-28 was a daily or near daily 
marijuana user. The role of the many debates on legalizing marijuana for medical use, the 
actual legalization for recreational use by adults in some states, and the experiences those 
states have with the new laws likely will have an impact on present and future secular 
trends and possibly cohort effects in use. 
 
• Synthetic marijuana contains synthetic versions of some of the cannabinoids found in 
marijuana sprayed onto herbal materials that are then sold in small packets under such 
brand names as Spice and K-2. They have been readily available as over-the-counter drugs 
on the Internet and in venues like head shops and gas stations. While many of the most 
widely used chemicals were scheduled by the Drug Enforcement Administration in March 
of 2011, making their sale no longer legal, purveyors of these products have skirted the 
restrictions by making small changes in the chemical composition of the cannabinoids 
used. Use of these products was first measured in MTF in 2011 (see Table 2-2). Annual 
prevalence was found to be 11.4%, 8.5%, and 7.4%, respectively, among 12th graders, 
college students, and young adults (8th and 10th graders were first asked about use of these 
drugs in 2012, and their annual prevalence levels were 4.4% and 8.8%, respectively). These 
relatively high prevalence levels made synthetic marijuana among the most widely used 
illicit drugs. Use declined appreciably in 2013 and 2014 among all five populations, with 
most of the 1-year declines being significant. Efforts by the DEA and various states to 
make their sale illegal may well have had an impact. In 2017, prevalence was 2.0%, 2.7%, 
3.7%, 0.5%, and 0.9%, respectively, across the five age groups from youngest to oldest, 
reflecting a continued decline for all age groups, except for 12th graders (with a significant 
decline among 8th grade students). There is a relatively low level of perceived risk for trying 
synthetic marijuana once or twice, despite growing evidence of serious health problems 
resulting from the use of these drugs. 
 
• Among 12th graders, the proportions using any illicit drug other than marijuana in the 
past twelve months rose from a low of 15% in 1992 to a high of 21% in 1999 (see Table 
2-2); these levels were substantially below the 34% peak level reached two decades earlier, 
in 1981. All of the younger groups showed significant increases between 1992 and 1997, 
with use beginning to increase in 1992 among 8th graders, in 1993 among 10th and 12th 
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graders, and in 1995 among college students – reflecting strong evidence of a cohort effect. 
Use peaked in 1996 among 8th and 10th graders, in 1997 among 12th graders, around 2004 
for college students, and in 2008 for young adults. Since 1996, the 8th graders have shown 
a gradual but considerable decline of more than one-half in their use of illicit drugs other 
than marijuana, treated as a class (13.1% annual prevalence in 1996 to 5.8% in 2017). The 
decline among 10th graders paused from 1998 to 2001 with a net decline of about a third in 
annual prevalence from 18.4% in 1996 to 11.3% in 2008; use leveled again for several 
years and then declined further in 2011. It stood at 9.4% in 2017. Twelfth-grade use also 
showed some decline beginning after 2001 (21.6%) but stood just 8.3 percentage points 
lower (13.3%) in 2017. College students so far have shown little change over the course of 
the survey and have hovered between 18% and 21% since 2013 (when the questions were 
last updated); annual prevalence in 2017 was 18%, representing a nonsignificant decline 
from 2016. Use among all young adults varied between the narrow ranges of 17% to 21% 
from 2003 to 2017; 2017 annual prevalence was 20%. 
 
• Between 1989 and 1992, we noted an increase among 12th graders, college students, and 
young adults in their use of LSD, a drug quite popular in the late 1960s and early 1970s. 
In 1992, the newly added populations (8th and 10th graders) were also showing an increase 
in LSD use; for several more years, modest increases persisted in all five populations. Use 
of LSD peaked in 1995 among college students and young adults and in 1996 among 8th, 
10th, and 12th graders, after which LSD use gradually declined in all five populations until 
about 2005 (the relatively large declines for all age groups in 2001 corresponded to the 
closing of a major LSD lab that year by the Drug Enforcement Administration). Since 
2006, annual prevalence has remained at about 1% for 8th graders, ranged from 1.7% to 
2.1% for 10th graders, and increased slightly but steadily for the three older age groups 
from 1.7% to 3.3% for 12th graders, from 1.4% to 2.8% among college students, and from 
1.2% to 3.4% for young adults. Overall, the pattern for LSD use seems more consistent 
with secular change than a cohort effect. The different age groups moved in parallel for the 
most part, likely in response to historical events in the environment, including a sharp 
reduction in LSD availability after 2001. 
 
• Questions about the use of MDMA, which goes by the street names “ecstasy” and more 
recently “Molly,” have been included in the follow-up surveys of college students and 
young adults since 1989; however, because of our concern about stimulating interest in an 
attractive-sounding and little-known drug, these questions were not added to the secondary 
school surveys until 1996. From 1989 to 1994, the annual prevalence levels tended to be 
quite low in the older age groups for which we had data, but in 1995, these levels increased 
– from 0.5% in 1994 to 2.4% in 1995 among college students, and from 0.7% to 1.6% over 
the same time span among young adults generally. 
 
When usage data were first gathered on secondary school students in 1996, the 10th and 
12th graders actually showed higher levels of annual use (both 4.6%) than the college 
students (2.8%). MDMA use then fell steadily in all three grades between 1996 and 1998, 
though it did not fall in the older age groups (see Table 2-2). But between 1998 and 2001, 
use rose sharply in all five populations. In fact, annual prevalence more than doubled in 
that three-year period among 12th graders, college students, and young adults, and nearly 
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doubled in the lower grades. In 2000, even the 8th graders showed a significant increase in 
use. Since the peak highs in 2001, annual MDMA use has declined overall, with a slight 
increase around 2010 that proved fleeting. 
 
In 2017, annual prevalence of MDMA was 0.9%, 1.7%, 2.6%, 2.5%, and 3.6% among the 
five age groups, respectively. This annual prevalence remained level in 2017 among 8th, 
10th, and 12th graders (after declining significantly in 2016), and declined significantly 
among college students and young adults. These declines are based on measures that 
included “Molly” as an example street name of MDMA, measures that were introduced in 
the survey in 2014. (Molly is supposed to be a stronger form of MDMA than ecstasy.) Per 
our custom when introducing new question wording, in 2014 we included the newly 
worded question on a random half of the surveys and the other half served as a control with 
the old version of the MDMA question. All 2016 and 2017 MDMA questions include the 
“Molly” street name, and are compared to the 2014 and 2015 measures that also include 
the “Molly” wording. The substantial declines in annual prevalence across 2015 through 
2017 suggest that any new popularity to MDMA brought by its new branding appears to 
have been transitory. 
 
MDMA use has been moving fairly synchronously among all five populations since 1999, 
which suggests a secular trend (likely due to some changes in the social environment that 
affected everyone). An important change during this period was the increasing availability 
of information on the adverse effects of ecstasy use via stories in the popular media, 
dissemination of scientific evidence by the National Institute on Drug Abuse, and an anti-
ecstasy media campaign by the Partnership for a Drug-Free America and the Office of 
National Drug Control Policy, initiated in 2002. 
 
• Between 1982 and 1992, among 12th graders levels of amphetamine use in the past 12 
months (other than use that was ordered by a physician) fell by nearly two thirds, from 
20.3% to 7.1%. Levels among college students fell even more over the same interval, from 
21.1% to 3.6%. During the relapse phase in the drug epidemic in the 1990s, annual 
amphetamine use increased by about half among 8th and 10th graders between 1991 and 
1996, and also increased among 12th graders and college students between 1992 and 1996. 
After 1996, the age groups diverged. Among secondary school students levels of use 
declined gradually and steadily, and today’s levels are about half of what they were in 1996 
for students in 8th and 10th grade, and about 30% lower for students in 12th grade. In 
contrast, among young adults and college students levels of amphetamine use have 
gradually and steadily increased, with levels of use among college students nearly doubling 
to 9% in 2017. It is possible more college students are using amphetamines to help their 
academic work. Young adults, who include the college students, showed less of an increase 
over the same interval, from 4.2% in 1996 to 7.8% in 2017. Since the late 1990s, there has 
been a greater difference between use among 8th graders and use by older students, 
suggesting that an age effect has emerged, possibly due to the older students becoming 
more likely to use amphetamines to aid their academic performance. (“To help me study” 
was the highest endorsed reason 12th graders gave for amphetamine use in 2017.) 
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• Use of the stimulant drug Ritalin outside of medical supervision showed a distinct increase 
around 1997 – with annual prevalence among 12th graders going from 0.1% in 1992 to 
2.8% in 1997 – and then stayed level for a few years (see Appendix C, Table C-22 in 
Volume I). Because of its increasing importance, a differently structured question was 
introduced for Ritalin use in 2001 for grades 8, 10, and 12, and in 2002 for college students 
and young adults. This new question, which we prefer to the original, does not use a prior 
branching question and produced somewhat higher prevalence levels. Results from the new 
question suggest an ongoing decline in Ritalin use, with prevalence levels in 2017 less than 
half of what they were in 2001-2002 for all five population groups; annual prevalence in 
2017 was 0.4%, 0.8%, 1.3%,1.4%, and 1.2%, respectively. 
 
• Another stimulant used in the treatment of the symptoms of attention deficit hyperactivity 
disorder (ADHD) is the amphetamine drug Adderall. A new question on its nonmedical 
use was introduced in 2009; annual prevalence levels in 2009 through 2017 were higher 
than those for Ritalin in all five populations. This suggests that Adderall to some degree 
replaced the use of Ritalin and may help to account for the declines that we have been 
observing for the latter drug. Since the drug was first tracked in 2009, annual prevalence 
of nonmedical use of Adderall has been at about 10% for college students and 7% among 
young adults, which are fairly high levels. Among secondary students prevalence has 
hovered around 1.5% for 8th graders, 5% for 10th graders, and 6% for 12th graders. 
 
• Methamphetamine questions were introduced in 1999 because of rising concern about use 
of this drug; but an overall decline in use has been observed among all five populations in 
the years since then. In 2017, annual use in all five populations was very low – below 1%. 
These substantial declines occurred during a period in which there were many media 
reports suggesting that methamphetamine use was a growing problem – an example of the 
importance of having accurate epidemiological data. 
 
• Measures on the use of crystal methamphetamine or ice (a crystallized form of 
methamphetamine that can be smoked, much like crack) have been included in MTF since 
1990. The use of crystal methamphetamine increased between the early and late 1990s 
among the three populations asked about their use: 12th graders, college students, and 
young adults. However, use never reached very high levels. The estimates are less stable 
than usual due to the relatively small samples asked about this drug, but it appears that 
among 12th graders crystal methamphetamine use held fairly steady from 1999 through 
2005 (when it was 2.3%); since then it has declined by roughly two-thirds, to 0.8% in 2017. 
Use rose somewhat among college students and other young adults until 2005, before 
dropping substantially since then. After their peak levels were reached in 2005, college 
students and young adults generally showed substantial drops in annual prevalence to 1% 
or less by 2017; this is true despite the increase in 2017 for both groups (significant for 
young adults) (see Table 2-2). 
 
                                                 
2 As discussed in Appendix C of Volume I, the absolute prevalence rates for Ritalin are probably higher than the statistics indicate, but the trend 
story is likely quite accurate. See Table 2-2 for more accurate estimates of the absolute annual prevalence rates in recent years; these estimates are 
based on a new question that does not require the respondent to indicate some amphetamine use before being branched to a question about Ritalin 
use. 
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• Inhalants are defined as fumes or gases that are inhaled to get high, and they include 
common household substances such as glues, aerosols, butane, and solvents of various 
types. Among 12th graders, there was a long-term gradual increase in the use of inhalants 
(unadjusted for nitrite inhalants) from 1976 to 1987, followed by a leveling for a few years 
and then a further increase in the early 1990s. This troublesome increase in inhalant use 
also occurred among students in the lower grades, and was followed by a reversal in all 
three grades after 1995. After reaching a low point by 2002 or 2003 in grades 8, 10, and 
12, use of inhalants increased some in all grades, but then declined in all grades. Inhalant 
use has been much lower among college students and young adults over the years, and it 
has declined steadily over the past two decades. Annual prevalence is now at or near the 
lowest point in the history of the study for all five groups at 4.7%, 2.3%, 1.5%, 1.7%, and 
0.7%, respectively; annual prevalence rose significantly in 2017 for 8th graders and college 
students (see Table 2-2). 
 
• Crack cocaine use spread rapidly from the early to mid-1980s. Still, among 12th graders, 
the use of crack remained relatively low during this period (3.9% annual prevalence in 
1987). Clearly, crack had quickly attained a reputation as a dangerous drug, and by the 
time of our first measurement of perceived risk in 1987, it was seen as the most dangerous 
of all drugs. Annual prevalence dropped sharply in the next few years, reaching 1.5% by 
1991, where it remained through 1993. Perceived risk began a long and substantial decline 
after 1990 – again serving as a driver and leading indicator of use. (The decline in perceived 
risk in this period may well reflect generational forgetting of the dangers of this drug.) 
Annual prevalence among 12th graders rose gradually after 1993, from 1.5% to 2.7% by 
1999. It finally declined slightly in 2000 and then held level through 2007. Since then, 
some additional decline has occurred. In 2017, annual prevalence for crack cocaine among 
12th graders was at 1.0%. 
 
Among 8th and 10th graders, crack use rose gradually in the 1990s: from 0.7% in 1991 to 
2.1% by 1998 among 8th graders, and from 0.9% in 1992 to 2.5% in 1998 among 10th 
graders. And, as just discussed, use among 12th graders peaked in 1999 at 2.7% and among 
young adults at 1.4%. Since those peak years, crack use has declined appreciably— by 
more than half among 8th, 10th, and 12th graders – yet it held fairly steady among college 
students and young adults, at least until 2007, when use among college students finally 
began to decline. The 2017 prevalence levels for this drug were relatively low – 1% or less 
in all five groups. Twelfth graders had the highest prevalence. Annual crack prevalence 
among the college-bound has generally been considerably lower than among those not 
bound for college. Among 12th graders, the levels of use in 2017 were 0.7% for college-
bound and 2.1% for noncollege-bound. 
 
• Use of cocaine3 in general began to decline a year earlier than crack, probably because 
crack was still in the process of diffusing to new parts of the country, being still quite new. 
Between 1986 and 1987 the annual prevalence for cocaine dropped dramatically, by about 
one fifth in all three populations being studied at that time – 12th graders, college students, 
and young adults. The decline occurred when young people finally began to view 
                                                 
3 Unless otherwise specified, all references to cocaine concern the use of cocaine in any form, including crack. 
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experimental and occasional use – the type of use in which they thought they would be 
most likely to engage – as more dangerous. This change was probably influenced by the 
extensive media campaigns that began in the preceding year, but also almost surely by the 
highly publicized cocaine-related deaths in 1986 of sports stars Len Bias and Don Rogers. 
By 1992, the annual prevalence of cocaine use had fallen by about two thirds among the 
three populations for which long-term data are available (12th graders, college students, 
and young adults). 
 
During the resurgence of illicit drug use in the 1990s, however, cocaine use in all five 
populations increased once again, both beginning and ending in a staggered pattern by age, 
consistent with a cohort effect. Use rose among 8th graders from 1991 to 1998, among 10th 
and 12th graders from 1992 to 1999, among college students from 1994 to 2004, and among 
young adults from 1996 through 2004. As with crack, all five populations showed some 
decline in cocaine use in 2008 through 2011 and a levelling over the next two years. Since 
then through 2016, cocaine use showed a slight decline among secondary students – 
including a significant decline among 10th grade students in 2016; however, in 2017, 
nonsignificant increases occurred for 10th and 12th graders. For college students and young 
adults, annual prevalence has trended slightly upward since 2011, showing nonsignificant 
increases in 2017. Annual prevalence levels in 2017 were 0.8%, 1.4%, 2.7%, 4.8%, and 
5.3% for the five populations, respectively. For a few years (1996–1999), 12th graders had 
higher prevalence than did the young adults; but because of the staggered declines in use, 
young adults have had the highest prevalence in all years since then (see Table 2-2). 
 
• Use of PCP (phencyclidine, also known as angel dust) is measured and reported only for 
12th graders and young adults. Its use fell sharply among 12th graders between 1979 and 
1982, from an annual prevalence of 7.0% to 2.2%. It reached a low point of 1.2% in 1988, 
rose some in the 1990s during the relapse period in the drug epidemic, reaching 2.6% by 
1996, and since 2002 has hovered at about 1%. For young adults, annual prevalence has 
fluctuated between 0.1% and 0.6%, but has remained quite low in recent years, standing at 
0.1% in 2017. 
 
• The annual prevalence of heroin use among 12th graders fell by half between 1975 (1.0%) 
and 1979 (0.5%), then stabilized for 15 years, through 1994. Heroin use was also stable in 
the early 1990s among the other four populations covered here (see Table 2-2). Then, in 
1994 for 8th graders and in 1995 for all other groups, use suddenly increased, with 
prevalence doubling or tripling in one or two years for 12th graders, college students, and 
young adults, and then remaining at the new higher levels among all five populations for 
the rest of the decade. After the period 1999 to 2001, heroin use fell back to lower levels 
than were observed in the mid- to late-1990s. Most of that decline was in heroin use without 
a needle, which we believe was largely responsible for the increase in use in the first half 
of the 1990s. In sum, all age groups except for the young adults had annual levels of heroin 
use in 2017 that were well below recent peaks (by roughly one half to two thirds). Young 
adults have remained at peak levels (0.4–0.6% in 2008–2017). Twelfth graders did show a 
significant increase to 0.7% annual prevalence in 2010 for heroin use with a needle, though 
there was no evidence of such an increase in any of the other four populations, which left 
us cautious about that finding. However, the 2011 prevalence provided some confirmation 
17
Chapter 2: Key Findings
that an increase did occur – annual prevalence was at 0.6%, which, except for 2010, was 
higher than any level reported since 1995 when this question was first asked. There is little 
evidence of any ongoing trend at present – indeed, the 12th graders’ annual prevalence for 
heroin use with a needle was 0.2% in 2017, suggesting that if there was an increase in use, 
it was short-lived. All five populations showed annual prevalence levels at 0.4% or less in 
2017. 
 
Two factors very likely contributed to the upturn in heroin use in the 1990s. One is a long-
term decline in the perceived risk of harm, probably due to generational forgetting, because 
it had been a long time since the country had experienced a heroin epidemic along with 
accompanying publicity about its casualties. The second factor, not unrelated to the first, 
is that in the 1990s the greatly increased purity of heroin allowed it to be used by means 
other than injection. This may have lowered an important psychological barrier for some 
potential users, making heroin use less aversive and risky in general, because avoiding 
injection reduces the likelihood of transmission of HIV, hepatitis, or other serious blood-
borne diseases. The introduction of additional questions on heroin use in 1995 showed that 
significant proportions of past-year users in all five populations were indeed taking heroin 
by means other than injection at that point (see Table 2-2, and Chapter 4 here and in Volume 
I for details). 
 
• The use of narcotics other than heroin is reported only for 12th graders and older 
populations because we believe that younger students are not accurately discriminating 
among the drugs that should be included or excluded from this general class. Use declined 
gradually over most of the first half of the study in these three older groups. Twelfth graders 
had an annual prevalence in 1977 of 6.4%, which fell to 3.3% by 1992. But after about 
1992 or 1993, all of the older age groups showed continuing increases for a decade or more, 
through 2003 or 2004, before stabilizing. Updating the list of examples given in the 
question stem in 2002 (to include Vicodin and OxyContin) led to an increase in reported 
prevalence. After a considerable increase in use from 1992 through 2001, during the relapse 
phase of the general drug epidemic and going beyond it, the use of narcotics other than 
heroin remained relatively constant at high levels through 2010. Since 2012, levels of use 
have declined overall among 12th graders, college students, and young adults. In 2017, 
annual prevalence was 4.2%, 3.1%, and 4.0% among 12th graders, college students, and 
young adults, respectively; these levels reflect decreases from 2016, with the decrease 
being significant for young adults. 
 
• In 2002, specific questions were added for Vicodin and OxyContin. The observed 
prevalence levels suggest that these two drugs likely help to account for the upturn and 
declines in use of the general class of narcotics other than heroin. In 2003, Vicodin had 
attained surprisingly high prevalence levels in the five populations under study here – 
annual levels of 2.8% in 8th grade, 7.2% in 10th grade, 10.5% in 12th grade, 7.5% among 
college students, and 8.6% among young adults. In 2017, prevalence levels were down for 
all age groups and stood at 0.7%, 1.5%, 2.0%, 1.1%, and 2.7%, respectively. OxyContin 
started with lower annual prevalence levels than Vicodin across all age groups in 2002, but 
given the highly addictive nature of this narcotic drug, these levels were not 
inconsequential. 
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Annual prevalence for OxyContin increased in 2003 with slight further increases and 
leveling through 2011. Since then its use has declined overall, although the decline has not 
been smooth. Prevalence levels in 2017 were 0.8%, 2.2%, 2.7%, 1.7%, and 1.9% for 8th, 
10th, and 12th grades, college students, and young adults. Because OxyContin has received 
considerable adverse publicity in recent years, it is possible that perceived risk (which we 
did not measure for this drug until 2012) increased. But because its use appears to have 
originated in several fairly delimited geographic areas, it seems likely that OxyContin was 
diffusing to new communities for some time, which may have delayed the turnaround in 
its use. We believe a similar process happened earlier when crack use and ecstasy use were 
rising. 
 
• Annual prevalence of tranquilizer use among 12th graders saw a long and very substantial 
decline from 11% in 1977 to 2.8% in 1992. After 1992, use increased significantly among 
12th graders as did most drugs, reaching 7.7% in 2002 (but the question was revised slightly 
in 2001 to include Xanax as an example of a tranquilizer, so a small portion of the increase 
may be an artifact). Since then, annual prevalence has dropped to 4.7% in 2017. Reported 
tranquilizer use also increased modestly among 8th graders, from 1.8% in 1991 to 3.3% in 
1996, before declining to 2.6% in 1998. It remained between 2.4% and 2.8% until 2011, 
when it began a decline; it was at 2.0% in 2017. As with a number of other drugs, the 
downturn in use began considerably earlier among 8th graders compared to their older 
counterparts. Among 10th graders, annual prevalence remained stable between 1991 and 
1994 at around 3.3%, and then increased significantly to 7.3% by 2001 (possibly including 
some artifact, as noted above). Since 2001, tranquilizer use has declined very gradually in 
all three grades. After a period of stability, college student use showed an increase between 
1994 and 2003 (to 6.9%), more than tripling in that period. Since then there has been a 
gradual decline there as well, to 3.6% by 2017. For the young adult sample, after a long 
period of decline, annual prevalence more than doubled between 1997 and 2002 to 7.0%, 
with some overall decline thereafter to 4.7% in 2017. Thus, while there was a considerable 
increase in use in all five populations, which reflected in part a cohort effect that first began 
in the early 1990s among 8th graders, that increase is clearly over and there has been some 
downward correction in recent years. Most of the reported tranquilizer use in recent years 
has involved Valium, Xanax, and more recently Klonopin (see Table C3 in Appendix C 
in Volume I). 
 
• The long-term gradual decline in sedative (barbiturate) use among 12th graders, which had 
been observed since the start of the study in 1975, halted in 1992. (Data are not included 
here for 8th and 10th graders, again because we believe that these students have more 
problems with proper classification of the relevant drugs.) Use among 12th graders then 
rose considerably during the relapse phase in the drug epidemic, from 2.8% in 1992 to 
6.7% by 2002 – but still well below the peak level of 10.7% in 1975; use has shown a 
modest decline since 2002, and by 2017 it had declined to 2.9%. The 2017 annual 
prevalence of this class of drugs was highest among 12th graders (2.9%) as compared to 
young adults (2.2%) and college students (1.9%). Use among college students began to rise 
a few years later than it did among 12th graders, again likely reflecting a cohort effect, but 
by 2011 it was at its lowest point since 1998. There followed a small increase from 2012 
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to 2013. Among young adults, sedative (barbiturate) use increased since the early 1990s, 
rising from 1.6% in 1992 to 4.4% in 2004. It stood at 2.2% in 2017, after declining some 
in recent years. 
 
• Clearly, use of most of the several classes of psychotherapeutic drugs – sedatives 
(barbiturates), tranquilizers, and narcotics other than heroin – has become a larger part of 
the nation’s drug abuse problem. While the rise in use appears to have halted, most 
prevalence levels remain relatively high. During much of the 1990s and into the 2000s, we 
saw a virtually uninterrupted increase among 12th graders, college students, and young 
adults in the use of all of these drugs, which had fallen from favor from the mid-1970s 
through the early 1990s. These drugs continued to rise, even after the increase in use of 
most illegal drugs ended in the late 1990s and began to reverse. All three of these classes 
of psychotherapeutic drugs have shown gradual declines since about 2008 among 12th 
graders, college students, and young adults 
 
• For many years, five classes of illicitly used drugs – marijuana, amphetamines, cocaine, 
LSD, and inhalants – had an impact on appreciable proportions of young Americans in 
their late teens and 20s. In 2017, 12th graders showed annual prevalence levels for these 
drugs of 37.1%, 5.9%, 2.7%, 3.3%, and 1.5%, respectively, reflecting declines in most of 
them, especially cocaine and LSD. Among college students in 2017, the comparable annual 
prevalence levels were 38.3%, 8.6%, 4.8%, 2.8%, and 1.7%; for all young adults the levels 
were 37.5%, 7.8%, 5.3%, 3.4%, and 0.7%. Narcotics other than heroin became quite 
important due to the long-term rise in use that began in the 1990s (followed by declines in 
recent years). These narcotics now have annual prevalence levels of 3–4% among 12th 
graders, college students, and young adults. Tranquilizers have also become more 
important due to a similar rise in use (followed by recent declines), with prevalence levels 
in 2017 of about 3–5% across the same three populations, as have sedatives (barbiturates), 
with levels of 2.9%, 1.9%, and 2.2%, respectively. The misuse of prescription-type drugs 
clearly has become a more important part of the nation’s drug problem. 
 
• Several drugs have been added to MTF’s coverage over the years, including ketamine, 
GHB, and Rohypnol, which are so-called “club drugs” (in addition to LSD and ecstasy). 
In general, these drugs have low prevalence levels that have declined over the past several 
years among the five age groups. For that reason, GHB and ketamine were dropped from 
the 8th and 10th grade surveys in 2012 and GHB and Rohypnol from the young adult surveys 
in 2016. For 12th graders, the 2017 annual prevalence was 1.2% for ketamine and 0.4% for 
GHB. Annual prevalence of Rohypnol was 0.4% for 8th graders, 0.3% for 10th graders and 
0.8% for 12th graders in 2017. Annual prevalence of ketamine was 1.2%, 0.3%, and 0.5%, 
respectively, among 12th graders, college students, and young adults. 
 
• Bath salts, so-called because they are sold over the counter as apparently innocuous 
products like real bath salts but contain strong synthetic stimulants, were first included in 
the 2012 MTF survey, which we believe provided the first national survey data on their 
use. Fortunately, we found the annual prevalence in 2012 to be very low, at 0.8%, 0.6%, 
1.3%, 0.3%, and 0.5%, respectively, among the five age groups. In 2017, the prevalence 
levels remain less than 1% in all five age groups. 
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• Salvia divinorum is a psychoactive plant that is legally available in most states; questions
on salvia were added to the 12th grade and follow-up questionnaires in 2009 and were added
to the 8th and 10th grade questionnaires in 2010. In 2011, the prevalence levels were 1.6%
among 8th graders, 3.9% among 10th graders, 5.9% among 12th graders, 3.1% for college
students, and 2.2% for young adults (see Table 2-2). But by 2017, levels of salvia use had
declined in all five populations, suggesting that the popularity of this drug has peaked. Still,
0.4% of 8th graders, 0.9% of 10th graders, and 1.5% of 12th graders reported some past-year
use in 2017, but the college and young adult populations had prevalence levels at or below
0.5%. 
• Anabolic steroid use has occurred predominantly among males. In 2017, the annual
prevalence levels for males in 8th, 10th, and 12th grades were 0.6%, 0.8%, and 1.4%,
compared with 0.6%, 0.5%, and 0.5% for females. Between 1991 and 1998, the overall
annual prevalence levels were fairly stable among 8th and 10th graders, ranging between
0.9% and 1.2%. In 1999, however, use jumped from 1.2% to 1.7% in both grades. Almost
all of that increase occurred among males, from 1.6% in 1998 to 2.5% in 1999 in 8th grade
and from 1.9% to 2.8% in 10th grade. Thus, levels among males increased by about half in
a single year, which corresponded in time to stories in the news media about the use of
androstenedione, a steroid precursor, by baseball home-run king Mark McGwire. Since
then, among all 8th graders, anabolic steroid use has declined by more than two thirds to
0.6% in 2017. Among 10th graders, use continued to increase, reaching 2.2% in 2002,
suggesting a cohort effect, but then declined by more than two thirds to 0.7% by 2017.
Among 12th graders, annual prevalence rose significantly to 2.4% in 2001, but then
decreased to 1.1% by 2017. Use generally has been much lower among college students
and young adults, with annual prevalence being below 1% between 1991 and 2017.
Male–Female Differences in Illicit Drug Use 
• Regarding gender differences in the three older populations (12th graders, college students,
and young adults), males are more likely to use most illicit drugs, and the differences tend
to be largest at the higher frequency levels. For example, 2017 daily marijuana use levels
among 12th graders were more than twice as high at 7.8% for males versus 3.6% for
females.
• The 8th and 10th grade samples evidence fewer and smaller gender differences in the use of
drugs than do the older populations. There are no appreciable gender differences in 2017
among 8th graders in their use of marijuana, synthetic marijuana, hallucinogens, LSD,
hallucinogens other than LSD, MDMA, cocaine, crack, cocaine other than crack,
heroin, or methamphetamine. The levels of use of inhalants, Rohypnol, alcohol, flavored
alcoholic beverages, and the frequency of being drunk are slightly higher among females
in 8th grade. By 10th grade use among boys catches up and in some cases surpasses use
among girls on many of these drugs as use increases faster among boys than among girls
with age, such that by late adolescence and young adulthood, prevalence for most all drugs
is higher for males than females. (For greater detail on trends in these gender differences,
as well as in other demographic differences, see chapters 4 and 5. Occasional Paper 91 [for
young adults] and Occasional Paper 90 [for adolescents] graphically depict these trends.)
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TRENDS IN ALCOHOL USE 
• Several findings about alcohol use in these five population groups are noteworthy. First, 
despite the fact that it is illegal for virtually all secondary school students and many college 
students to purchase alcoholic beverages, they have had a substantial amount of experience 
with alcohol. Alcohol has been tried by 23% of 8th graders, 42% of 10th graders, 62% of 
12th graders, 79% of college students, and 85% of young adults (19 to 28 years old). Current 
use (use in past 30 days) is also widespread. Of particular importance, is the prevalence of 
five or more drinks in a row at least once in the prior two-week period (occasions of heavy 
or binge drinking), which in 2017 was reported by 4% of 8th graders, 10% of 10th graders, 
17% of 12th graders, 33% of college students, and 32% of young adults. 
 
As use of other illicit drugs decreased among 12th graders from the late 1970s to the early 
1990s, alcohol use did not increase, although it was common to hear such a “displacement 
hypothesis” asserted. MTF findings demonstrate that the opposite seems to be true. After 
1980, when illicit drug use was declining, the monthly prevalence of alcohol use among 
12th graders also declined gradually, but substantially, from 72% in 1980 to 51% in 1992. 
Daily alcohol use declined by half over the same interval, from a peak of 6.9% in 1979 to 
3.4% in 1992; the prevalence of drinking five or more drinks in a row during the prior 
two-week interval fell from 41% in 1983 to 28% in 1993 – nearly a one-third decline. When 
illicit drug use rose again in the 1990s, alcohol use (particularly binge drinking of five more 
drinks in a row) rose as well – albeit not as sharply as marijuana use. In the late 1990s, as 
illicit drug use leveled in secondary schools and began a gradual decline, similar trends 
were observed for alcohol. Therefore, long-term evidence indicates that alcohol use moves 
much more in concert with illicit drug use than counter to it, at least up to the year 2007. 
 
However, since 2007 a new trend has emerged that is consistent with the “displacement” 
hypothesis. From 2007 through 2017 alcohol use continued its long-term decline, reaching 
historic lows in the life of the study. Meanwhile, for most of this time period, marijuana 
use has stayed steady or increased for all age groups, consistent with the possibility that 
marijuana use has increasingly displaced alcohol use. For the first time, trends in alcohol 
and marijuana use are substantially diverging, suggesting that the historical relationship 
between these two drugs may be changing. 
 
Male–Female Differences in Alcohol Use 
• Given that the physiological impacts of five drinks are considerably greater for the typical 
young female versus the typical young male, it is not surprising that we find substantial 
gender differences in the prevalence of having five or more drinks in a row. Among 12th 
graders, the levels of prevalence in 2017 were 15% for females versus 19% for males. This 
difference has diminished substantially since MTF began; in 1975 there was a 23-
percentage-point difference, versus a 4-point difference in 2017. The proportions 
indicating in 2017 that they have been drunk in the prior 30 days were somewhat higher 
at 19% and 22% for females and males, respectively. As discussed in Chapters 4 and 5, the 
general pattern of heavy alcohol use being more common among men than women 
continues into young and middle adulthood; likewise, the reduction of gender differences 
over the past few decades is evident among adults. 
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TRENDS IN CIGARETTE SMOKING AND VAPING 
A number of very important findings about cigarette smoking among American adolescents and 
young adults have emerged during the life of the study, and we believe that one of the study’s more 
important contributions to the long-term health of the nation has been to document and call public 
attention to these trends, particularly the upsurge in adolescent smoking in the early 1990s. Despite 
the demonstrated health risks associated with smoking, young people have continued to establish 
regular cigarette habits during late adolescence in sizable proportions, and, during the first half of 
the 1990s, in rapidly growing proportions. Even as cigarette smoking among adolescents reaches 
historic lows today, it remains at or near the top of all psychoactive substances used on a daily 
basis. 
 
• During most of the 1980s, when smoking levels were falling steadily among adults, we 
reported that smoking among adolescents was not declining. Then the situation went from 
bad to worse. Among 8th and 10th graders, levels of current (past 30-day) smoking 
increased by about half between 1991 (when their use was first measured) and 1996; among 
12th graders, current smoking rose by nearly one third between 1992 and 1997. MTF played 
an important role in bringing these disturbing increases in adolescent smoking to public 
attention during those years, which was the historical period in which major social action 
was initiated in the White House, the Food & Drug Administration, the Congress, and 
eventually the state attorneys general, culminating in the 1998 Tobacco Master Settlement 
agreement between the tobacco industry and the states. 
 
Fortunately, there have been some important declines in current smoking since 1996 among 
8th and 10th graders, and since 1997 among 12th graders. In fact, the declines have more 
than offset the increases observed earlier in the 1990s. In 2017, 2% of 8th graders (down 
from 14% in 1991 and 21% in 1996) reported smoking one or more cigarettes in the prior 
30 days – a decline of nine-tenths from the 1996 peak level. Some 5% of 10th graders were 
current smokers in 2017 (down from 21% in 1991 and 30% in 1996), representing a drop 
of three quarters from the 1996 peak level. And among 2017 12th grade students 10% were 
current smokers (versus 28% in 1991 and 37% in 1997), representing a drop of more than 
two thirds from the 1997 peak. Monthly prevalence of use for all three grades is now at or 
near the lowest point in the history of the study, and significantly declined in 2017 for 8th 
grade students. 
 
Several of the important attitudinal changes that accompanied these declines in use ended 
some years ago (around 2007), leading us to conclude that further reductions in smoking 
levels will likely have to come from changes in the environment – for example, enacting 
such policies as tobacco tax increases, further reducing the places in which smoking is 
permitted, and providing effective quit-smoking programs. In 2009, federal taxes on 
tobacco products were in fact raised, which may well have contributed to the resumption 
of declines in use starting in 2011. Despite these very important improvements in the past 
decade and a half, about one in ten (10%) young Americans are current smokers by the 
time they complete high school. Other research consistently shows that smoking levels are 
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substantially higher among those who drop out before graduating, so the estimates here, 
based on high school seniors, are low for the age cohort as a whole.4 
 
Among college students, the peak level in current smoking (31%) was not reached until 
1999, reflecting a cohort effect, after which it has declined to 8% in 2017, a decline of 
almost three-quarters. Young adults 19 to 28 years old have also shown a decline between 
2001 (30%) and 2017 (15%), a decline of one half and also indicative of a cohort effect 
working its way up the age range. 
 
Male–Female Differences in Cigarette Smoking 
• In the 1970s, 12th grade females caught up to and passed 12th grade males in levels of 
current smoking. Both genders then showed a decline in use followed by a long, fairly 
level period, with use by females consistently higher, but with the gender difference 
diminishing. In the early 1990s, another crossover occurred among the 12th graders when 
levels rose more among males than females; thereafter, males have had consistently slightly 
higher levels of current smoking. In the lower grades, the genders have generally had 
similar smoking levels since their use was first measured in 1991. 
 
• Among college students, females had a slightly higher probability of being daily smokers 
from 1980 through 1994 – although this long-standing gender difference was not seen 
among their age peers who were not in college. However, a crossover occurred between 
1994 and 2001, with college males exceeding college females in daily smoking – an echo 
of the crossover among 12th graders in 1991. Between about 2001 and 2005 there was little 
consistent gender difference in smoking among college students, but since 2006, college 
males have usually had higher levels of daily smoking than college females (see Chapter 
9). 
 
Vaping 
• MTF first asked about e-cigarette use in 2014 and vaporizer use in 2015 and 2016. We 
found that overall vaporizer use had higher 30-day prevalence than all tobacco products, 
including regular cigarettes, among 8th, 10th, and 12th graders; among college students and 
young adults, vaporizer use was lower compared to use among 10th and 12th graders, as 
well as lower compared to cigarette use. In 2017, we expanded the vaping questions to get 
at specific substances being vaped including nicotine, marijuana, and just flavoring. In 
2017, the 30-day prevalence of vaping nicotine was 3.5%, 8.2%, 11.0%, 6.1%, and 6.5% 
across the five age groups respectively; these levels are higher than 30-day prevalence for 
cigarette use among 8th, 10th, and 12th graders, but not among college students and young 
adults. Part of the reason for the popularity of vaporizers among teens is their low perceived 
risk: for the specific vaporizer device of an e-cigarette, less than 22% of students in all 
grades see a “great risk” in regular vaporizer use, one of the lowest levels of perceived risk 
measured in the survey. Among teens, males are more likely to use vaporizers than females, 
                                                 
4 For an analysis showing much higher smoking rates among 8th graders who later dropped out before completing high school, see Bachman, J. G., 
O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use connection: How 
successes and failures in school relate to adolescent smoking, drug use, and delinquency. New York: Lawrence Erlbaum Associates/Taylor & 
Francis. See also Table A-1 in Appendix A of this Volume. 
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especially at the older grades, and in all grades use is higher among students who do not 
plan to go to college. 
 
DRUG USE BY 8th GRADE 
It is useful to focus specifically on the youngest age group in the study – the 8th graders, most of 
whom are 13 or 14 years old – in part because the worrisome levels of both licit and illicit drug 
use that they report help illustrate the nation’s urgent need to continue to address the substance 
abuse problems among its youth. Further, it is a well-established fact that the earlier young people 
start to use drugs, both licit and illicit, the more likely they are to experience adverse outcomes.5,6,7 
And because of the strong cohort effects by which 8th graders often carry forward their behaviors 
and attitudes regarding substance use as they age, considering today’s 8th graders gives us a sense 
of future substance use among young adults. 
 
• Among 8th graders in 2017, about one in four (23%) reported having tried alcohol (more 
than just a few sips), and about one in eleven (9%) indicated having already been drunk at 
least once. One eleventh of all 8th graders in 2017 (9%) have tried cigarettes, and almost 
one in fifty (1.9%) reported having smoked in the prior month. Shocking to many adults is 
the fact that only 62% of 8th graders recognize that there is great risk associated with 
smoking one or more packs of cigarettes per day. While an increasing proportion of youth 
will recognize the risk by 12th grade, for many this is too late because they will have 
developed a smoking habit by then. 
 
• Among 8th grade males in 2017, 8% tried smokeless tobacco, 2.2% used it in the past 
month, and 0.5% used it daily. Levels of use were much lower among females. 
 
• One 8th grader in eleven (9%) reported ever trying inhalants, and over one in 50 (2.1%) 
reported inhalant use in just the month prior to the 2017 survey. This is the only class of 
drugs for which use is substantially higher in 8th grade than in 10th or 12th grade. 
 
• Marijuana has been tried by one in every seven 8th graders (14%) and has been used in the 
prior month by about one in every 19 (5.5%). Some 0.6% used it on a daily or near-daily 
basis in 8th grade. 
 
• A surprisingly large number of 8th graders (5.7%) say they have tried prescription-type 
amphetamines without medical instruction; 1.7% say they have used them in the prior 30 
days. 
 
• For most of the other illicit drugs, relatively few 8th graders in 2017 say they have tried 
them. (This is consistent with the retrospective reports from 12th graders concerning the 
grades in which they first used the various drugs.) But the proportions having at least some 
                                                 
5 Merline, A. C., O’Malley, P. M., Schulenberg, J. E., Bachman, J. G., & Johnston, L. D. (2004). Substance use among adults 35 years of age: 
Prevalence, adulthood predictors, and impact of adolescent substance use. American Journal of Public Health, 94, 96-102. 
6 Zucker, R. A., Hicks, B. M., & Heitzeg, M. H. (2016). In D. Cicchetti (Ed.) Developmental Psychopathology, Volume 3, Maladaptation and 
Psychopathology, 3rd Edition (pp 793-833). Hoboken, NJ: John Wiley & Sons. 
7 Office of the Surgeon General. (2007). The Surgeon General’s call to action to prevent and reduce underage drinking. Rockville, MD: Department 
of Health and Human Services. 
25
Chapter 2: Key Findings
experience with them is not inconsequential. Even prevalence as low as 3% represents 
about one child in every 30-student classroom, on average. The 2017 eighth-grade 
proportions reporting any lifetime experience with the other illicit drugs were: 
tranquilizers (3.4%), ecstasy (1.7%), hallucinogens other than LSD (1.2%), cocaine 
other than crack (1.0%), LSD (1.3%), crack, Rohypnol, and steroids (all at 0.9%), heroin 
(0.7%), and methamphetamine (0.7%). In total, 23% of all 8th graders in 2017 have tried 
some illicit drug (including inhalants), while 9%, or one in eleven, have tried some illicit 
drug other than marijuana or inhalants. Put another way, in an average 30-student 
classroom of 8th graders, about six have used some illicit drug, including inhalants; and 
about three have used some illicit drug other than marijuana or inhalants. 
 
• The very large number of 8th graders who have already begun using the so-called “gateway 
drugs” (tobacco, alcohol, inhalants, and marijuana) suggests that a substantial number 
are also at risk of proceeding further to such drugs as LSD, cocaine, amphetamines, and 
heroin. 
 
SUMMARY AND CONCLUSIONS 
Over the past four decades, MTF has documented some good news, along with the worrisome 
news. From the late 1970s to the early 1990s – and again in the late 1990s – the use of a number 
of illicit drugs declined appreciably among 12th grade students, and declined even more among 
college students and young adults in the U.S. These substantial improvements – which seem 
largely explainable in terms of changes in attitudes about drug use, beliefs about the risks of drug 
use, and peer norms against drug use – have some extremely important policy implications. One 
clear implication is that these various substance-using behaviors among American young people 
are malleable – they can be changed. It has been done before. The second is that demand-side 
(rather than supply-side) factors appear to have been pivotal in bringing about most of those 
changes. The levels of marijuana availability, as reported by 12th graders, have held fairly steady 
at high levels throughout the life of the study. (Moreover, among students who abstained from 
marijuana use, as well as among those who quit, availability and price rank very low on their lists 
of reasons for not using marijuana.) And, in fact, the perceived availability of cocaine was actually 
rising during the beginning of the sharp decline in cocaine and crack use in the mid- to late-1980s, 
which occurred when the perceived risk associated with that drug rose sharply. (See Chapter 9 in 
Volume I for more examples and further discussion of this point.) However, improvements should 
not be taken for granted. Relapse is always possible; indeed, just such a relapse in the longer-term 
epidemic occurred during the early to mid-1990s, as the country let down its guard on many fronts. 
(See Chapter 8 in Volume I for a more detailed discussion.) 
 
Over the years, MTF has demonstrated that changes in perceived risk and disapproval have been 
important causes of change in the use of a number of drugs. These beliefs and attitudes are almost 
certainly influenced by the amount and nature of public attention paid to the drug issue in the 
historical period during which young people are growing up. A substantial decline in attention to 
this issue in the early 1990s very likely explains why the increases in perceived risk and 
disapproval among students ceased and began to backslide. News coverage of the drug issue 
plummeted between 1989 and 1993 (although it made a considerable comeback as surveys – 
including MTF – began to document that the nation’s drug problem was worsening again), and the 
media’s pro bono placement of ads from the Partnership for a Drug-Free America also fell 
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considerably. (During that period, MTF 12th graders showed a steady decline in their recalled 
exposure to such ads, and in the judged impact of such ads on their own drug-taking behavior.8) 
 
Also, the deterioration in the drug abuse situation first began among our youngest cohorts – 
perhaps because as they were growing up they had not had the same opportunities for vicarious 
learning from the adverse drug experiences of people around them and people portrayed in the 
media – those we have called the “unfortunate role models.” Clearly, there was a danger that, as 
the drug epidemic subsided in the 1980s and early 1990s, newer cohorts would have far less 
opportunity to learn through informal means about the dangers of drugs – that what we have called 
a generational forgetting of those risks would occur through a process of generational replacement 
of older, more drug-savvy cohorts with newer, more naive ones. This suggests that as drug use 
subsides, as it did by the early 1990s, the nation must redouble its efforts to ensure that such naive 
cohorts learn these lessons about the dangers of drugs through more formal means – from schools, 
parents, and focused messages in the media, for example – and that this more formalized 
prevention effort be institutionalized so that it will endure for the long term. 
 
Clearly, for the foreseeable future, American young people will be aware of the psychoactive 
potential of a host of drugs and will continue to have access to them – a situation quite different 
from the one that preceded the late 1960s. (Awareness and access are two necessary conditions for 
an epidemic.9) That means that each new generation of young people must learn the reasons that 
they should not use drugs. Otherwise, their natural curiosity and desire for new experiences will 
lead a great many to use. 
 
One lesson evident from the changes of the past two decades is that the types of drugs most in 
favor can change substantially over time. The illegal drugs began to decline in use in the late 1990s, 
while prescription drugs, and even over-the-counter drugs, began to gain favor. Today a good 
many of the drugs having the highest prevalence levels among teens and young adults are of this 
type, including narcotic drugs other than heroin, despite their declines in use in the past few years. 
 
Unfortunately, current conditions are well suited for a second relapse phase in drug use among 
youth and young adults in the U.S. Perceived risk for marijuana has fallen substantially in recent 
years as the recent string of states that have legalized recreational marijuana use for adults have 
led some youth to believe the drug is safe and state-sanctioned. 
 
Another lesson that derives from the MTF epidemiological data is that social influences that tend 
to reduce the initiation of substance use also have the potential to deter continuation by those who 
have already begun to use, particularly if they are not yet habitual users. Chapter 5 of Volume I 
shows how increased quitting rates have contributed importantly to downturns in the use of a 
number of drugs at different historical periods. The lesson is that primary prevention should not 
be the only goal of intervention programs; early-stage users may be persuaded to quit when their 
beliefs and attitudes regarding drugs are changed. 
 
                                                 
8 Johnston, L. D. (2002, June 19). Written and oral testimony presented at hearings on the National Youth Anti-Drug Media Campaign, held by the 
Treasury and General Government Subcommittee on Appropriations of the U.S. Senate Appropriations Committee. Published in The Congressional 
Record. 
9 Johnston, L. D. (1991). Toward a theory of drug epidemics. In L. Donohew, H. E. Sypher, and W. J. Bukoski (Eds.), Persuasive communication 
and drug abuse prevention (pp.93-131). Hillsdale, NJ, Earlbaum.  
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The following facts help to put into perspective the magnitude and variety of substance use 
problems that presently remain among young people in the U.S.: 
 
• Nearly one fourth (23%) of today’s 8th graders have tried an illicit drug (if inhalants are 
included as an illicit drug), and half (50%) of 12th graders have done so. 
 
• By their late 20s, almost two in three (64%) of today’s young adults have tried an illicit 
drug, and more than one in three (37%) have tried some illicit drug other than marijuana, 
usually in addition to marijuana. (These figures do not include inhalants.) 
 
• One in every 17 12th graders (5.9%) in 2017 smoked marijuana daily. Among young adults 
ages 19 to 28, the percentage is a little higher at one in every 13 (7.8%). Also among 12th 
graders in 2017, one in every seven (14%) has been a daily marijuana smoker at some time 
in their life for at least a month. 
 
• About one in six 12th graders (17%) had five or more drinks in a row (also called heavy 
drinking or binge drinking) on at least one occasion in just the two weeks prior to the 
survey, and we know that such behavior tends to increase among young adults one to four 
years past high school – that is, in the peak college years. Indeed, 33% of college students 
report such binge drinking. The study also has documented evidence of extreme binge 
drinking with 6.0% of 12th graders in 2017 indicating having had 10 or more drinks in a 
row, and 3.1% indicating 15 or more drinks in a row, in the prior two weeks (see Chapter 
5 in Volume I). Among college students, about one in ten report having 10 or more drinks 
in a row, and one in five report having 15 or more (further detail is provided in Chapter 9). 
 
• Even with considerable declines in smoking among U.S. adolescents since the late 1990s, 
about one in ten (10%) of 12th graders in 2017 currently smoke cigarettes, and one in 
twenty-five (4%) is already a daily smoker. In addition, we know from studying previous 
cohorts that many young adults increase their levels of smoking within a year or so after 
they leave high school. 
 
• American secondary school students and young adults show a level of involvement with 
illicit drugs that is among the highest in the world’s industrialized nations.10 Even by 
longer-term historical standards in the U.S., these levels remain extremely high, though in 
general they are not as high as in the peak years of the epidemic in the late 1970s. Heavy 
drinking also remains widespread and troublesome, though it has been declining gradually 
over a long period and now is at or near historical lows among teens and young adults. Of 
course, the continuing initiation to cigarette smoking of a fair-sized, albeit dramatically 
decreased, proportion of young people remains a matter of great public health concern. 
 
                                                 
10 A published report from a series of international collaborative studies, modeled largely after MTF, provides comparative data from national 
school surveys of 15- to 16-year-olds, conducted every four years beginning in 1995. The most recent survey was completed in 2015 in 35 European 
countries. (The report also includes 2015 MTF data from 10th graders in the United States.) See Kraus, L., Guttormsson, U., Leifman, H., Arpa, S. 
et al. (2016). The 2015 ESPAD report: Results from the European School Survey Project on Alcohol and Other Drugs. The European Monitoring 
Centre for Drugs and Drug Addiction. .See also, Johnston, L. D. (2016, September 23). National press release, "Compared with Europe, American 
teens have high rates of illicit drug use." University of Michigan News Service, Ann Arbor. University of Michigan News Service, September 23, 
2016.    
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• Vaping presents a new challenge. MTF first asked about vaping in 2015 with an expansion 
of questions in 2017. In 2017, the 30-day prevalence levels of vaping nicotine among 8th, 
10th, and 12th graders (3.5%, 8.2%, and 11.0%, respectively) are greater than those for any 
other tobacco product including cigarettes; among college students and young adults, 
cigarette smoking is still more common than vaping nicotine, with 30-day vaping 
prevalence at 6.1% and 6.5%, respectively. This increasing trend in vaping, especially for 
secondary school students, has the potential to lead to a resurgence of teen and young adult 
smoking, given that vaping among youth who have never smoked significantly predicts 
future smoking.11 
 
• Of particular note, abuse of prescription drugs by teens and young adults has declined in 
recent years, a welcome development after prevalence had stayed stubbornly high 
throughout the first decade of the 2000s. Among 12th grade students annual prevalence of 
narcotics other than heroin has declined for six years in a row and is now at the lowest 
levels since the late 1990s among college students. Annual use of sedatives among 12th 
graders, college students, and young adults declined in 2017 to the lowest levels in 20 
years, with annual prevalence now about half or less what it was in 2004-05 when it peaked 
for all three age groups. Annual use of tranquilizers is at or near the lowest levels since 
2001 (when the question was last updated) in all five age groups. The update to the question 
on amphetamines in 2013 makes long-term trends difficult to discern, although there is 
evidence of leveling and declines in all five age groups since then. Perceived risk tends to 
be relatively low for these prescription-type drugs, which we believe is a major reason why 
their use had been relatively high. 
 
• We note the seemingly unending capacity of pharmacological experts and amateurs to 
discover new substances with abuse potential that can be used to alter mood and 
consciousness (e.g., bath salts and synthetic marijuana), and of young people to discover 
the abuse potential of existing products (such as Robitussin and plants like salvia) and to 
rediscover older drugs (such as LSD and heroin). While as a society we have made 
significant progress on a number of fronts in the fight against drug abuse, we must remain 
vigilant against the opening of new fronts, as well as the reemergence of trouble on older 
ones. In particular, we must guard against generational forgetting in our newest cohorts of 
adolescents due to a lack of public attention to the issue during the time that they are 
growing up. 
 
• One of the dynamics that keeps the drug epidemic rolling is the emergence of new drugs 
whose hazards are little known. In 1999, we saw this happen with the drug ecstasy 
(MDMA). Other drugs like Rohypnol, ketamine, GHB, and OxyContin appeared in the 
1990s and were added to the list of drugs under study. Questions on use of salvia, Adderall, 
and Provigil were then added to the questionnaires. In 2011, we added synthetic 
marijuana, which turned out to be the second most used illicit drug after natural marijuana, 
and in 2012 we added bath salts. In 2014, we added questions on e-cigarettes, and in 2015 
we added questions on the more general category of “vaping,” which we discovered has 
                                                 
11 Miech, R. A., Patrick, M. E., O'Malley, P. M., & Johnston, L. D. (2017). E-cigarette use as a predictor of cigarette smoking: Results from a 1-
year follow-up of a national sample of 12th grade students. Tobacco Control, 26(e2), e106-e111.  
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made rapid inroads among today’s adolescents and young adults, leading us to ask new 
more detailed questions on vaping in 2017. The spread of such new drugs and drug devices 
(e.g. Juuls for vaping) appears to be facilitated and hastened today by young people’s 
widespread use of web-based social networks. We expect to see a continuous flow of such 
new substances onto the national scene, and believe that the task of rapidly documenting 
their emergence, establishing their adverse consequences, and quickly demystifying them 
will remain an important means by which policymakers, researchers, and educators deal 
with the continuing threats posed by such drugs. We also anticipate that there will be 
rediscoveries of older substances, as occurred in recent years with respect to the various 
psychotherapeutic prescription drugs, including tranquilizers, sedatives (barbiturates), 
and narcotic drugs. 
The drug problem is not an enemy that can be vanquished. It is more a recurring and relapsing 
public health problem that must be contained to the extent possible on an ongoing basis. Therefore, 
it is a problem that requires an ongoing, dynamic response – one that takes into account the 
continuing generational replacement of our children, the generational forgetting of the dangers of 
drugs that can occur with that replacement, and the perpetual stream of new abusable substances 
that will threaten to lure young people into involvement with drugs. 
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 18.7 20.6 22.5 25.7 28.5 31.2 29.4 29.0 28.3 26.8 26.8 24.5 22.8 21.5 21.4 20.9 19.0 19.6 19.9 21.4 20.1 18.5‡ 21.1 20.3 20.5 17.2 18.2 +1.0  
      10th Grade 30.6 29.8 32.8 37.4 40.9 45.4 47.3 44.9 46.2 45.6 45.6 44.6 41.4 39.8 38.2 36.1 35.6 34.1 36.0 37.0 37.7 36.8‡ 39.1 37.4 34.7 33.7 34.3 +0.7  
      12th Grade 44.1 40.7 42.9 45.6 48.4 50.8 54.3 54.1 54.7 54.0 53.9 53.0 51.1 51.1 50.4 48.2 46.8 47.4 46.7 48.2 49.9 49.1‡ 49.8 49.1 48.9 48.3 48.9 +0.6  
      College Students 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2 53.7 53.6 51.8 53.9 52.2 52.3 50.6 50.5 49.5 51.4 49.1 49.2 50.5‡ 53.3 52.4 53.4 54.4 55.4 +1.0
      Young Adults 62.2 60.2 59.6 57.5 57.4 56.4 56.7 57.0 57.4 58.2 58.1 59.0 60.2 60.5 60.4 59.7 59.8 59.3 59.3 58.4 59.1 58.9‡ 60.0 62.2 62.9 62.8 64.0 +1.2
      8th Grade 14.3 15.6 16.8 17.5 18.8 19.2 17.7 16.9 16.3 15.8‡ 17.0 13.7 13.6 12.2 12.1 12.2 11.1 11.2 10.4 10.6 9.8 8.7‡ 10.4 10.0 10.3 8.9 9.3 +0.4  
      10th Grade 19.1 19.2 20.9 21.7 24.3 25.5 25.0 23.6 24.0 23.1‡ 23.6 22.1 19.7 18.8 18.0 17.5 18.2 15.9 16.7 16.8 15.6 14.9‡ 16.4 15.9 14.6 14.0 13.7 -0.3  
      12th Grade 26.9 25.1 26.7 27.6 28.1 28.5 30.0 29.4 29.4 29.0‡ 30.7 29.5 27.7 28.7 27.4 26.9 25.5 24.9 24.0 24.7 24.9 24.1‡ 24.8 22.6 21.1 20.7 19.5 -1.2  
      College Students 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5 25.8‡ 26.3 26.9 27.6 28.0 26.5 26.3 25.3 22.6 25.6 24.8 24.3 23.8‡ 28.3 29.0 26.4 26.5 26.1 -0.4
      Young Adults 37.8 37.0 34.6 33.4 32.8 31.0 30.5 29.9 30.2 31.3‡ 31.6 32.8 33.9 35.2 34.0 34.8 34.2 34.7 32.8 33.3 33.2 32.8‡ 34.0 37.3 36.8 36.2 36.8 +0.6
  including 
  Inhalants a,c,d
      8th Grade 28.5 29.6 32.3 35.1 38.1 39.4 38.1 37.8 37.2 35.1 34.5 31.6 30.3 30.2 30.0 29.2 27.7 28.3 27.9 28.6 26.4 40.0‡ 25.9 25.2 24.9 20.6 23.3 +2.7 s
      10th Grade 36.1 36.2 38.7 42.7 45.9 49.8 50.9 49.3 49.9 49.3 48.8 47.7 44.9 43.1 42.1 40.1 39.8 38.7 40.0 40.6 40.8 25.1‡ 41.6 40.4 37.2 35.9 37.0 +1.1  
      12th Grade 47.6 44.4 46.6 49.1 51.5 53.5 56.3 56.1 56.3 57.0 56.0 54.6 52.8 53.0 53.5 51.2 49.1 49.3 48.4 49.9 51.8 50.3‡ 52.3 49.9 51.4 49.3 50.3 +1.1  
      College Students 52.0 50.3 49.1 47.0 47.0 49.1 50.7 55.4 54.4 54.6 53.1 52.3 54.1 52.9 53.9 53.3 52.5 51.0 51.1 50.0 49.7 52.0‡ 53.3 51.8 52.0 52.6 53.3 +0.7
      Young Adults 63.4 61.2 61.2 58.5 59.0 58.2 58.4 58.5 58.5 59.5 59.0 59.6 60.6 62.5 61.4 61.2 61.2 60.2 59.3 59.3 59.5 59.5‡ 62.2 60.6 61.0 61.4 61.7 +0.4
      8th Grade 10.2 11.2 12.6 16.7 19.9 23.1 22.6 22.2 22.0 20.3 20.4 19.2 17.5 16.3 16.5 15.7 14.2 14.6 15.7 17.3 16.4 15.2 16.5 15.6 15.5 12.8 13.5 +0.6  
      10th Grade 23.4 21.4 24.4 30.4 34.1 39.8 42.3 39.6 40.9 40.3 40.1 38.7 36.4 35.1 34.1 31.8 31.0 29.9 32.3 33.4 34.5 33.8 35.8 33.7 31.1 29.7 30.7 +1.0  
      12th Grade 36.7 32.6 35.3 38.2 41.7 44.9 49.6 49.1 49.7 48.8 49.0 47.8 46.1 45.7 44.8 42.3 41.8 42.6 42.0 43.8 45.5 45.2 45.5 44.4 44.7 44.5 45.0 +0.5  
      College Students 46.3 44.1 42.0 42.2 41.7 45.1 46.1 49.9 50.8 51.2 51.0 49.5 50.7 49.1 49.1 46.9 47.5 46.8 47.5 46.8 46.6 49.1 47.7 48.5 50.4 51.0 50.5 -0.5
      Young Adults 58.6 56.4 55.9 53.7 53.6 53.4 53.8 54.4 54.6 55.1 55.7 56.8 57.2 57.4 57.0 56.7 56.7 55.9 56.0 55.9 56.3 56.5 57.1 57.5 58.5 58.7 60.1 +1.4
      8th Grade 17.6 17.4 19.4 19.9 21.6 21.2 21.0 20.5 19.7 17.9 17.1 15.2 15.8 17.3 17.1 16.1 15.6 15.7 14.9 14.5 13.1 11.8 10.8 10.8 9.4 7.7 8.9 +1.2 s
      10th Grade 15.7 16.6 17.5 18.0 19.0 19.3 18.3 18.3 17.0 16.6 15.2 13.5 12.7 12.4 13.1 13.3 13.6 12.8 12.3 12.0 10.1 9.9 8.7 8.7 7.2 6.6 6.1 -0.5  
      12th Grade 17.6 16.6 17.4 17.7 17.4 16.6 16.1 15.2 15.4 14.2 13.0 11.7 11.2 10.9 11.4 11.1 10.5 9.9 9.5 9.0 8.1 7.9 6.9 6.5 5.7 5.0 4.9 -0.2  
      College Students 14.4 14.2 14.8 12.0 13.8 11.4 12.4 12.8 12.4 12.9 9.6 7.7 9.7 8.5 7.1 7.4 6.3 4.9 6.9 5.5 3.7 5.7 4.3 3.5 3.1 3.2 3.4 +0.2
      Young Adults 13.4 13.5 14.1 13.2 14.5 14.1 14.1 14.2 14.2 14.3 12.8 12.4 12.2 11.6 10.3 10.9 9.1 9.5 8.9 7.9 7.2 7.2 6.5 6.7 6.4 6.3 5.2 -1.1
TABLE 2-1
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28)
2016–
(Entries are percentages.)
2017
change
Any Illicit Drug a
Any Illicit Drug other
  than Marijuana a,b
Any Illicit Drug
Marijuana/Hashish
(Table continued on next page.)
Inhalants c,d
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 3.2 3.8 3.9 4.3 5.2 5.9 5.4 4.9 4.8 4.6‡ 5.2 4.1 4.0 3.5 3.8 3.4 3.1 3.3 3.0 3.4 3.3 2.8 2.5 2.0 2.0 1.9 1.9 0.0  
      10th Grade 6.1 6.4 6.8 8.1 9.3 10.5 10.5 9.8 9.7 8.9‡ 8.9 7.8 6.9 6.4 5.8 6.1 6.4 5.5 6.1 6.1 6.0 5.2 5.4 5.0 4.6 4.4 4.2 -0.2  
      12th Grade 9.6 9.2 10.9 11.4 12.7 14.0 15.1 14.1 13.7 13.0‡ 14.7 12.0 10.6 9.7 8.8 8.3 8.4 8.7 7.4 8.6 8.3 7.5 7.6 6.3 6.4 6.7 6.7 0.0  
      College Students 11.3 12.0 11.8 10.0 13.0 12.6 13.8 15.2 14.8 14.4‡ 14.8 13.6 14.5 12.0 11.0 10.6 9.1 8.5 8.0 7.8 7.4 7.6 7.8 7.6 6.5 7.7 7.2 -0.4
      Young Adults 15.7 15.7 15.4 15.4 16.1 16.4 16.8 17.4 18.0 18.4‡ 18.3 19.6 19.7 19.3 17.6 17.2 16.0 14.8 14.2 13.9 13.0 12.2 12.4 11.9 11.7 12.2 12.9 +0.7
      8th Grade 2.7 3.2 3.5 3.7 4.4 5.1 4.7 4.1 4.1 3.9 3.4 2.5 2.1 1.8 1.9 1.6 1.6 1.9 1.7 1.8 1.7 1.3 1.4 1.1 1.3 1.2 1.3 +0.1  
      10th Grade 5.6 5.8 6.2 7.2 8.4 9.4 9.5 8.5 8.5 7.6 6.3 5.0 3.5 2.8 2.5 2.7 3.0 2.6 3.0 3.0 2.8 2.6 2.7 2.6 3.0 3.2 3.0 -0.2  
      12th Grade 8.8 8.6 10.3 10.5 11.7 12.6 13.6 12.6 12.2 11.1 10.9 8.4 5.9 4.6 3.5 3.3 3.4 4.0 3.1 4.0 4.0 3.8 3.9 3.7 4.3 4.9 5.0 +0.1  
      College Students 9.6 10.6 10.6 9.2 11.5 10.8 11.7 13.1 12.7 11.8 12.2 8.6 8.7 5.6 3.7 3.5 3.3 4.3 3.3 4.0 3.7 3.1 4.4 4.5 4.8 5.1 5.3 +0.1
      Young Adults 13.5 13.8 13.6 13.8 14.5 15.0 15.0 15.7 16.2 16.4 16.0 15.1 14.6 13.4 11.2 10.1 9.6 8.1 7.3 7.2 6.1 6.2 6.3 6.6 7.0 8.0 8.8 +0.8
      8th Grade 1.4 1.7 1.7 2.2 2.5 3.0 2.6 2.5 2.4 2.3‡ 3.9 3.3 3.2 3.0 3.3 2.8 2.6 2.5 2.4 2.7 2.8 2.3 1.9 1.5 1.2 1.3 1.2 0.0  
      10th Grade 2.2 2.5 2.8 3.8 3.9 4.7 4.8 5.0 4.7 4.8‡ 6.6 6.3 5.9 5.8 5.2 5.5 5.7 4.8 5.4 5.3 5.2 4.5 4.4 4.1 3.3 3.1 2.9 -0.2  
      12th Grade 3.7 3.3 3.9 4.9 5.4 6.8 7.5 7.1 6.7 6.9‡ 10.4 9.2 9.0 8.7 8.1 7.8 7.7 7.8 6.8 7.7 7.3 6.6 6.4 5.1 4.8 4.7 4.8 +0.1  
      College Students 6.0 5.7 5.4 4.4 6.5 6.5 7.5 8.7 8.8 8.2‡ 10.7 11.0 12.8 10.1 10.6 10.1 8.5 8.2 7.8 7.1 6.9 7.2 6.8 6.8 5.1 6.6 5.0 -1.6
      Young Adults 8.4 8.0 7.6 7.4 7.8 7.9 8.5 9.4 9.3 9.9‡ 12.0 15.0 16.4 15.6 15.4 14.9 14.1 13.0 13.0 12.6 12.1 11.1 11.4 10.8 10.4 10.6 10.6 0.0
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 2.9 2.4 2.9 2.8 2.7 4.0 3.9 3.9 3.4 3.4 3.5 3.1 2.5 1.6 2.4 2.2 2.1 1.8 1.7 1.8 2.3 1.6 1.3 — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 3.1 2.0 1.9 2.0 2.2 1.9 2.4 2.7 2.3 2.3 3.1 2.5 3.0 2.7 2.0 2.4 2.1 2.2 1.6 1.6 1.7 1.1 1.4 0.6 1.2 1.9 0.3 -1.5 ss
      8th Grade, original — — — — — 3.4 3.2 2.7 2.7 4.3 5.2 4.3 3.2 2.8 2.8 2.5 2.3 2.4 2.2 3.3 2.6 2.0 1.8 1.4 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 2.4 2.3 1.7 1.5 -0.1  
      10th Grade, original — — — — — 5.6 5.7 5.1 6.0 7.3 8.0 6.6 5.4 4.3 4.0 4.5 5.2 4.3 5.5 6.4 6.6 5.0 5.7 3.7 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 5.2 3.8 2.8 2.8 0.0  
      12th Grade, original — — — — — 6.1 6.9 5.8 8.0 11.0 11.7 10.5 8.3 7.5 5.4 6.5 6.5 6.2 6.5 7.3 8.0 7.2 7.1 5.6 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 7.9 5.9 4.9 4.9
      College Students
Original 2.0 2.9 2.3 2.1 3.1 4.3 4.7 6.8 8.4 13.1 14.7 12.7 12.9 10.2 8.3 6.9 5.4 6.2 6.5 6.2 6.8 8.7 8.1 8.2 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 8.1 8.9 8.4 5.3 -3.2 s
      Young Adults
Original 3.2 3.9 3.8 3.8 4.5 5.2 5.1 7.2 7.1 11.6 13.0 14.6 15.3 16.0 14.9 14.4 13.1 13.1 11.5 12.3 11.3 11.4 11.6 11.4 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 12.5 12.9 12.5 12.6 +0.1
  Hallucinogens
    other than LSD b
  Ecstasy (MDMA) h
(Table continued on next page.)
change
  PCP g
and 12th Graders, College Students, and Young Adults (Ages 19–28)
2016–
2017
(Entries are percentages.)
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Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
Hallucinogens b,f
  LSD b
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 2.3 2.9 2.9 3.6 4.2 4.5 4.4 4.6 4.7 4.5 4.3 3.6 3.6 3.4 3.7 3.4 3.1 3.0 2.6 2.6 2.2 1.9 1.7 1.8 1.6 1.4 1.3 -0.1  
      10th Grade 4.1 3.3 3.6 4.3 5.0 6.5 7.1 7.2 7.7 6.9 5.7 6.1 5.1 5.4 5.2 4.8 5.3 4.5 4.6 3.7 3.3 3.3 3.3 2.6 2.7 2.1 2.1 0.0  
      12th Grade 7.8 6.1 6.1 5.9 6.0 7.1 8.7 9.3 9.8 8.6 8.2 7.8 7.7 8.1 8.0 8.5 7.8 7.2 6.0 5.5 5.2 4.9 4.5 4.6 4.0 3.7 4.2 +0.5  
      College Students 9.4 7.9 6.3 5.0 5.5 5.0 5.6 8.1 8.4 9.1 8.6 8.2 9.2 9.5 8.8 7.7 8.5 7.2 8.1 6.6 5.5 5.2 5.1 6.2 6.1 5.3 6.5 +1.2
      Young Adults 21.0 19.5 16.9 15.2 13.7 12.9 12.1 12.3 12.8 12.7 13.1 13.5 14.7 15.2 14.3 15.2 14.7 14.8 13.9 13.6 12.5 11.9 12.2 11.7 12.1 10.4 11.2 +0.8
      8th Grade 1.3 1.6 1.7 2.4 2.7 2.9 2.7 3.2 3.1 3.1 3.0 2.5 2.5 2.4 2.4 2.3 2.1 2.0 1.7 1.5 1.5 1.0 1.2 1.2 1.0 0.9 0.8 -0.1  
      10th Grade 1.7 1.5 1.8 2.1 2.8 3.3 3.6 3.9 4.0 3.7 3.1 3.6 2.7 2.6 2.5 2.2 2.3 2.0 2.1 1.8 1.6 1.4 1.5 1.0 1.1 0.8 0.8 0.0  
      12th Grade 3.1 2.6 2.6 3.0 3.0 3.3 3.9 4.4 4.6 3.9 3.7 3.8 3.6 3.9 3.5 3.5 3.2 2.8 2.4 2.4 1.9 2.1 1.8 1.8 1.7 1.4 1.7 +0.3  
      College Students 1.5 1.7 1.3 1.0 1.8 1.2 1.4 2.2 2.4 2.5 2.0 1.9 3.1 2.0 1.7 2.3 1.3 1.4 1.0 1.2 0.8 0.7 0.7 1.4 0.5 0.4 0.6 +0.2
      Young Adults 4.8 5.1 4.3 4.4 3.8 3.9 3.6 3.8 4.3 4.6 4.7 4.3 4.7 4.2 4.1 4.4 3.9 4.3 3.3 3.6 2.9 2.7 2.6 2.1 1.8 1.2 1.2 0.0
    than Crack j
      8th Grade 2.0 2.4 2.4 3.0 3.4 3.8 3.5 3.7 3.8 3.5 3.3 2.8 2.7 2.6 2.9 2.7 2.6 2.4 2.1 2.1 1.8 1.6 1.4 1.4 1.3 1.1 1.0 -0.1  
      10th Grade 3.8 3.0 3.3 3.8 4.4 5.5 6.1 6.4 6.8 6.0 5.0 5.2 4.5 4.8 4.6 4.3 4.8 4.0 4.1 3.4 3.0 3.0 2.9 2.2 2.3 1.9 1.9 -0.1  
      12th Grade 7.0 5.3 5.4 5.2 5.1 6.4 8.2 8.4 8.8 7.7 7.4 7.0 6.7 7.3 7.1 7.9 6.8 6.5 5.3 5.1 4.9 4.4 4.2 4.1 3.4 3.3 3.5 +0.2  
      College Students 9.0 7.6 6.3 4.6 5.2 4.6 5.0 7.4 7.8 8.1 8.3 8.6 8.5 9.3 8.1 6.2 8.0 7.1 7.9 6.7 5.4 5.1 5.2 6.2 6.4 6.5 6.1 -0.4
      Young Adults 19.8 18.4 15.1 13.9 12.4 11.9 11.3 11.5 11.8 11.7 12.1 12.8 13.5 14.4 13.3 14.4 14.0 13.9 13.5 13.1 12.2 11.8 11.8 11.6 11.8 11.9 12.6 +0.7
      8th Grade 1.2 1.4 1.4 2.0 2.3 2.4 2.1 2.3 2.3 1.9 1.7 1.6 1.6 1.6 1.5 1.4 1.3 1.4 1.3 1.3 1.2 0.8 1.0 0.9 0.5 0.5 0.7 +0.2  
      10th Grade 1.2 1.2 1.3 1.5 1.7 2.1 2.1 2.3 2.3 2.2 1.7 1.8 1.5 1.5 1.5 1.4 1.5 1.2 1.5 1.3 1.2 1.1 1.0 0.9 0.7 0.6 0.4 -0.2  
      12th Grade 0.9 1.2 1.1 1.2 1.6 1.8 2.1 2.0 2.0 2.4 1.8 1.7 1.5 1.5 1.5 1.4 1.5 1.3 1.2 1.6 1.4 1.1 1.0 1.0 0.8 0.7 0.7 0.0  
      College Students 0.5 0.5 0.6 0.1 0.6 0.7 0.9 1.7 0.9 1.7 1.2 1.0 1.0 0.9 0.5 0.7 0.5 0.7 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.5 0.1 -0.4
      Young Adults 0.9 0.9 0.9 0.8 1.1 1.3 1.3 1.6 1.7 1.8 2.0 1.8 1.9 1.9 1.7 1.9 1.6 1.9 1.6 1.8 1.7 1.6 1.6 1.4 1.6 1.6 1.4 -0.2
      8th Grade —  — — — 1.5 1.6 1.3 1.4 1.6 1.1 1.2 1.0 1.0 1.1 1.0 1.0 0.9 0.9 0.9 0.9 0.8 0.6 0.6 0.8 0.3 0.3 0.4 +0.1  
      10th Grade — — — — 1.0 1.1 1.1 1.2 1.3 1.0 0.8 1.0 0.9 0.8 0.8 0.9 0.9 0.7 0.9 0.8 0.8 0.7 0.7 0.6 0.5 0.5 0.3 -0.2  
      12th Grade — — — — 0.7 0.8 0.9 0.8 0.9 0.8 0.7 0.8 0.7 0.7 0.9 0.8 0.7 0.7 0.6 1.1 0.9 0.7 0.7 0.8 0.6 0.5 0.4 0.0  
      College Students — — — — 0.4 0.1 0.2 0.5 0.8 0.7 0.2 0.3 0.1 0.1 0.3 0.3 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.3 0.0 0.0 0.0  
      Young Adults — — — — 0.4 0.4 0.3 0.4 0.6 0.4 0.6 0.4 0.5 0.4 0.6 0.6 0.5 0.5 0.5 0.8 0.7 0.5 1.0 0.7 0.7 0.7 0.8 +0.1
      8th Grade —  — — — 1.5 1.6 1.4 1.5 1.4 1.3 1.1 1.0 1.1 1.0 0.9 0.9 0.7 0.9 0.8 0.7 0.7 0.5 0.5 0.4 0.3 0.4 0.5 +0.1  
      10th Grade — — — — 1.1 1.7 1.7 1.7 1.6 1.7 1.3 1.3 1.0 1.1 1.1 1.0 1.1 0.8 1.0 0.9 0.8 0.8 0.7 0.5 0.4 0.3 0.3 0.0  
      12th Grade — — — — 1.4 1.7 2.1 1.6 1.8 2.4 1.5 1.6 1.8 1.4 1.3 1.1 1.4 1.1 0.9 1.4 1.3 0.8 0.9 0.7 0.7 0.6 0.4 -0.2  
      College Students — — — — 0.5 1.0 1.2 2.1 1.0 2.5 1.3 1.2 1.1 1.0 0.3 0.8 0.4 0.7 0.4 0.4 0.4 0.5 0.8 0.1 0.4 0.2 0.1 0.0
      Young Adults — — — — 0.9 1.3 1.5 1.7 1.9 2.1 2.1 1.8 2.2 2.1 1.8 2.4 1.9 2.1 1.9 1.8 1.6 1.7 1.8 1.2 1.8 1.5 1.5 0.0
Heroin k,l
2017
  Cocaine other 
Cocaine
TABLE 2-1 (cont.)
2016–
(Entries are percentages.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28)
  Without a Needle l
(Table continued on next page.)
  Crack i
  With a Needle l
change
33
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
  than Heroin m,n  
      8th Grade —  — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 6.6 6.1 6.4 6.6 7.2 8.2 9.7 9.8 10.2 10.6 9.9‡ 13.5 13.2 13.5 12.8 13.4 13.1 13.2 13.2 13.0 13.0 12.2 11.1 9.5 8.4 7.8 6.8 -1.0  
      College Students 7.3 7.3 6.2 5.1 7.2 5.7 8.2 8.7 8.7 8.9 11.0‡ 12.2 14.2 13.8 14.4 14.6 14.1 12.4 14.0 12.2 12.4 10.3 10.8 9.9 6.6 7.4 6.8 -0.6
      Young Adults 9.3 8.9 8.1 8.2 9.0 8.3 9.2 9.1 9.5 10.0 11.5‡ 13.9 16.8 17.6 17.8 18.7 18.8 19.5 18.5 19.0 18.2 17.6 17.4 16.3 15.0 14.3 13.4 -0.8
      8th Grade 10.5 10.8 11.8 12.3 13.1 13.5 12.3 11.3 10.7 9.9 10.2 8.7 8.4 7.5 7.4 7.3 6.5 6.8 6.0 5.7 5.2 4.5‡ 6.9 6.7 6.8 5.7 5.7 -0.1  
      10th Grade 13.2 13.1 14.9 15.1 17.4 17.7 17.0 16.0 15.7 15.7 16.0 14.9 13.1 11.9 11.1 11.2 11.1 9.0 10.3 10.6 9.0 8.9‡ 11.2 10.6 9.7 8.8 8.2 -0.6  
      12th Grade 15.4 13.9 15.1 15.7 15.3 15.3 16.5 16.4 16.3 15.6 16.2 16.8 14.4 15.0 13.1 12.4 11.4 10.5 9.9 11.1 12.2 12.0‡ 13.8 12.1 10.8 10.0 9.2 -0.8  
      College Students 13.0 10.5 10.1 9.2 10.7 9.5 10.6 10.6 11.9 12.3 12.4 11.9 12.3 12.7 12.3 10.7 11.2 9.1 11.8 12.1 13.4 14.4‡ 16.1 15.0 13.9 13.6 12.6 -1.0
      Young Adults 22.4 20.2 18.7 17.1 16.6 15.3 14.6 14.3 14.1 15.0 15.0 14.8 15.2 15.9 14.6 15.6 15.3 14.6 14.9 16.1 16.5 17.4‡ 18.8 18.7 18.8 18.7 18.2 -0.5
  Methamphetamine p,q
      8th Grade —  — — — — — — — 4.5 4.2 4.4 3.5 3.9 2.5 3.1 2.7 1.8 2.3 1.6 1.8 1.3 1.3 1.4 1.0 0.8 0.6 0.7 0.0  
      10th Grade —  — — — — — — — 7.3 6.9 6.4 6.1 5.2 5.3 4.1 3.2 2.8 2.4 2.8 2.5 2.1 1.8 1.6 1.4 1.3 0.7 0.9 +0.2  
      12th Grade — — — — — — — — 8.2 7.9 6.9 6.7 6.2 6.2 4.5 4.4 3.0 2.8 2.4 2.3 2.1 1.7 1.5 1.9 1.0 1.2 1.1 -0.1  
      College Students —  — — — — — — — 7.1 5.1 5.3 5.0 5.8 5.2 4.1 2.9 1.9 1.9 1.0 1.1 0.6 0.3 0.9 0.7 0.8 0.6 0.6 +0.1
      Young Adults — — — — — — — — 8.8 9.3 9.0 9.1 8.9 9.0 8.3 7.3 6.7 6.3 4.7 4.3 3.2 3.5 3.1 2.3 2.4 2.2 2.6 +0.4
  Crystal Methamphetamine (Ice) q
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 3.3 2.9 3.1 3.4 3.9 4.4 4.4 5.3 4.8 4.0 4.1 4.7 3.9 4.0 4.0 3.4 3.4 2.8 2.1 1.8 2.1 1.7 2.0 1.3 1.2 1.4 1.5 +0.1  
      College Students 1.3 0.6 1.6 1.3 1.0 0.8 1.6 2.2 2.8 1.3 2.3 2.0 2.9 2.2 2.4 1.7 1.3 1.1 0.7 0.8 0.2 0.6 0.0 0.3 0.3 0.6 0.4 -0.3
      Young Adults 2.9 2.2 2.7 2.5 2.1 3.1 2.5 3.4 3.3 3.9 4.0 4.1 4.7 4.7 4.4 4.7 3.7 3.6 3.4 2.8 3.1 2.6 2.8 1.7 2.2 1.8 1.8 0.0
  (Barbiturates) m,r
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 6.2 5.5 6.3 7.0 7.4 7.6 8.1 8.7 8.9 9.2 8.7 9.5  8.8‡ 9.9 10.5 10.2 9.3 8.5 8.2 7.5 7.0 6.9 7.5 6.8 5.9 5.2 4.5 -0.7  
      College Students 3.5 3.8 3.5 3.2 4.0 4.6 5.2 5.7 6.7 6.9 6.0 5.9 5.7 7.2 8.5 6.3 5.9 6.4 6.0 5.3 3.6 3.5‡ 5.4 5.9 4.4 3.3 3.9 +0.6
      Young Adults 8.2 7.4 6.5 6.4 6.7 6.6 6.5 6.9 7.4 8.1 7.8 8.0 8.7 9.7 10.0 9.5 9.8 10.6 9.5 8.6 7.9 7.2‡ 9.5 9.0 8.3 7.4 6.4 -1.0
2016–
TABLE 2-1 (cont.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28)
(Entries are percentages.)
Sedatives 
2017
change
(Table continued on next page.)
Amphetamines m,o
Narcotics other
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 3.8 4.1 4.4 4.6 4.5 5.3 4.8 4.6 4.4 4.4‡ 5.0 4.3 4.4 4.0 4.1 4.3 3.9 3.9 3.9 4.4 3.4 3.0 2.9 2.9 3.0 3.0 3.4 +0.4  
      10th Grade 5.8 5.9 5.7 5.4 6.0 7.1 7.3 7.8 7.9 8.0‡ 9.2 8.8 7.8 7.3 7.1 7.2 7.4 6.8 7.0 7.3 6.8 6.3 5.5 5.8 5.8 6.1 6.0 0.0  
      12th Grade 7.2 6.0 6.4 6.6 7.1 7.2 7.8 8.5 9.3 8.9‡ 10.3 11.4 10.2 10.6 9.9 10.3 9.5 8.9 9.3 8.5 8.7 8.5 7.7 7.4 6.9 7.6 7.5 -0.1  
      College Students 6.8 6.9 6.3 4.4 5.4 5.3 6.9 7.7 8.2 8.8‡ 9.7 10.7 11.0 10.6 11.9 10.0 9.1 8.6 9.2 8.1 7.1 6.4 7.8 6.9 7.8 6.5 6.7 +0.2
      Young Adults 11.8 11.3 10.5 9.9 9.7 9.3 8.6 9.6 9.6 10.5‡ 11.9 13.4 13.8 14.9 14.5 15.0 14.5 15.8 13.8 14.3 13.8 13.3 13.2 12.5 12.8 12.4 12.4 -0.1
Any Prescription Drug o,t
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — 24.0 23.9 22.2 21.5 20.9 21.6 21.7 21.2‡ 22.2 19.9 18.3 18.0 16.5 -1.6  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — 1.5 1.1 1.4 1.3 1.0 1.1 0.8 1.0 1.0 1.1 1.0 1.0 0.7 0.7 0.9 2.0 1.0 0.7 0.6 0.8 0.9 0.6 -0.3  
      10th Grade — — — — — 1.5 1.7 2.0 1.8 1.3 1.5 1.3 1.0 1.2 1.0 0.8 1.3 0.9 0.7 1.4 1.2 0.8 1.1 1.0 0.5 1.0 0.7 -0.3  
      12th Grade — — — — — 1.2 1.8 3.0 2.0 1.5 1.7 — — — — — — — — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
  Any Use
      8th Grade 70.1 69.3‡ 55.7 55.8 54.5 55.3 53.8 52.5 52.1 51.7 50.5 47.0 45.6 43.9 41.0 40.5 38.9 38.9 36.6 35.8 33.1 29.5 27.8 26.8 26.1 22.8 23.1 +0.3  
      10th Grade 83.8 82.3‡ 71.6 71.1 70.5 71.8 72.0 69.8 70.6 71.4 70.1 66.9 66.0 64.2 63.2 61.5 61.7 58.3 59.1 58.2 56.0 54.0 52.1 49.3 47.1 43.4 42.2 -1.2  
      12th Grade 88.0 87.5‡ 80.0 80.4 80.7 79.2 81.7 81.4 80.0 80.3 79.7 78.4 76.6 76.8 75.1 72.7 72.2 71.9 72.3 71.0 70.0 69.4 68.2 66.0 64.0 61.2 61.5 +0.3  
      College Students 93.6 91.8 89.3 88.2 88.5 88.4 87.3 88.5 88.0 86.6 86.1 86.0 86.2 84.6 86.6 84.7 83.1 85.3 82.6 82.3 80.5 81.0 78.0 79.4 81.4 81.3 79.1 -2.2
      Young Adults 94.1 93.4 92.1 91.2 91.6 91.2 90.7 90.6 90.2 90.7 89.9 90.2 89.3 89.4 89.1 88.9 87.9 88.4 87.9 87.5 87.4 86.5 86.2 86.3 85.7 85.9 85.2 -0.7
      8th Grade 26.7 26.8 26.4 25.9 25.3 26.8 25.2 24.8 24.8 25.1 23.4 21.3 20.3 19.9 19.5 19.5 17.9 18.0 17.4 16.3 14.8 12.8 12.2 10.8 10.9 8.6 9.2 +0.6  
      10th Grade 50.0 47.7 47.9 47.2 46.9 48.5 49.4 46.7 48.9 49.3 48.2 44.0 42.4 42.3 42.1 41.4 41.2 37.2 38.6 36.9 35.9 34.6 33.5 30.2 28.6 26.0 25.1 -1.0  
      12th Grade 65.4 63.4 62.5 62.9 63.2 61.8 64.2 62.4 62.3 62.3 63.9 61.6 58.1 60.3 57.5 56.4 55.1 54.7 56.5 54.1 51.0 54.2 52.3 49.8 46.7 46.3 45.3 -0.9  
      College Students 79.6 76.8 76.4 74.4 76.6 76.2 77.0 76.8 75.1 74.7 76.1 75.1 74.9 73.4 72.9 73.1 71.6 72.5 69.1 70.5 67.9 70.0 66.5 68.8 68.6 66.7 64.8 -1.9
      Young Adults 82.9 81.1 81.4 80.7 82.1 80.7 81.4 79.8 81.6 80.4 81.1 81.2 80.9 80.1 79.9 80.9 80.1 80.1 78.2 79.0 78.9 78.9 77.4 78.3 76.4 75.2 75.4 +0.2
Tranquilizers b,m
(Entries are percentages.)
2016–
2017
change
Rohypnol u
Alcohol v
  Been Drunk w
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
  Flavored Alcoholic
    Beverages g,p
      8th Grade — — — — — — — — — — — — — 37.9 35.5 35.5 34.0 32.8 29.4 30.0 27.0 23.5 21.9 19.2 19.3 16.3 16.0 -0.3  
      10th Grade — — — — — — — — — — — — — 58.6 58.8 58.1 55.7 53.5 51.4 51.3 48.4 46.7 44.9 42.3 38.7 33.3 34.8 +1.5  
      12th Grade — — — — — — — — — — — — — 71.0 73.6 69.9 68.4 65.5 67.4 62.6 62.4 60.5 58.9 57.5 55.6 53.6 51.2 -2.4  
      College Students — — — — — — — — — — — — — 79.0 84.5 80.9 80.6 78.6 78.1 77.4 76.7 76.6 67.5 72.7 74.8 76.1 72.4 -3.7
      Young Adults — — — — — — — — — — — — — 83.2 84.6 84.4 84.0 82.6 83.5 81.4 82.2 82.4 80.9 80.6 81.0 79.9 79.2 -0.6
  Any Use
      8th Grade 44.0 45.2 45.3 46.1 46.4 49.2 47.3 45.7 44.1 40.5 36.6 31.4 28.4 27.9 25.9 24.6 22.1 20.5 20.1 20.0 18.4 15.5 14.8 13.5 13.3 9.8 9.4 -0.4  
      10th Grade 55.1 53.5 56.3 56.9 57.6 61.2 60.2 57.7 57.6 55.1 52.8 47.4 43.0 40.7 38.9 36.1 34.6 31.7 32.7 33.0 30.4 27.7 25.7 22.6 19.9 17.5 15.9 -1.6  
      12th Grade 63.1 61.8 61.9 62.0 64.2 63.5 65.4 65.3 64.6 62.5 61.0 57.2 53.7 52.8 50.0 47.1 46.2 44.7 43.6 42.2 40.0 39.5 38.1 34.4 31.1 28.3 26.6 -1.7  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade 22.2 20.7 18.7 19.9 20.0 20.4 16.8 15.0 14.4 12.8 11.7 11.2 11.3 11.0 10.1 10.2 9.1 9.8 9.6 9.9 9.7 8.1 7.9 8.0 8.6 6.9 6.2 -0.7  
      10th Grade 28.2 26.6 28.1 29.2 27.6 27.4 26.3 22.7 20.4 19.1 19.5 16.9 14.6 13.8 14.5 15.0 15.1 12.2 15.2 16.8 15.6 15.4 14.0 13.6 12.3 10.2 9.1 -1.0  
      12th Grade — 32.4 31.0 30.7 30.9 29.8 25.3 26.2 23.4 23.1 19.7 18.3 17.0 16.7 17.5 15.2 15.1 15.6 16.3 17.6 16.9 17.4 17.2 15.1 13.2 14.2 11.0 -3.2 s
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Any Vaping jj,kk
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — 21.7 17.5‡ 18.5 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — 32.8 29.0‡ 30.9 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — 35.5 33.8‡ 35.8 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — 26.0 26.8‡ 36.0 —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — 30.3 26.9‡ 34.3 —
Vaping Nicotine jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 10.6 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 21.4 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 25.0 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 22.5 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 24.8 —  
(Entries are percentages.)
Cigarettes 
Smokeless Tobacco x
(Table continued on next page.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
TABLE 2-1 (cont.)
and 12th Graders, College Students, and Young Adults (Ages 19–28)
2016–
2017
change
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Vaping Marijuana jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 4.0 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.8 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 11.9 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 14.4 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 17.2 —  
Vaping Just Flavoring  jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 17.0 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 27.5 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 30.7 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 26.7 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 21.4 —  
      8th Grade 1.9 1.7 1.6 2.0 2.0 1.8 1.8 2.3 2.7 3.0 2.8 2.5 2.5 1.9 1.7 1.6 1.5 1.4 1.3 1.1 1.2 1.2 1.1 1.0 1.0 0.9 1.1 +0.1  
      10th Grade 1.8 1.7 1.7 1.8 2.0 1.8 2.0 2.0 2.7 3.5 3.5 3.5 3.0 2.4 2.0 1.8 1.8 1.4 1.3 1.6 1.4 1.3 1.3 1.4 1.2 1.3 1.1 -0.2  
      12th Grade 2.1 2.1 2.0 2.4 2.3 1.9 2.4 2.7 2.9 2.5 3.7 4.0 3.5 3.4 2.6 2.7 2.2 2.2 2.2 2.0 1.8 1.8 2.1 1.9 2.3 1.6 1.6 0.0  
      College Students 1.4 1.7 1.9 0.5 0.8 0.6 1.6 0.9 1.3 0.6 1.5 1.2 1.2 1.6 1.0 1.9 0.6 1.6 1.3 0.7 1.1 0.4 0.8 0.9 0.6 0.8 1.2 +0.5
      Young Adults 1.7 1.9 1.5 1.3 1.5 1.5 1.4 1.4 1.9 1.4 1.4 1.6 1.8 1.9 1.8 1.8 1.7 1.8 1.8 1.7 1.3 1.7 1.2 1.7 1.6 1.4 1.4 0.0
Previously surveyed drugs that have been dropped
— — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.6 1.5 1.4 1.7 1.5 1.8 2.0 2.7 1.7 0.8 1.9 1.5 1.6 1.3 1.1 1.2 1.2 0.6 1.1 — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 1.4 1.2 1.3 1.0 — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.3 1.6 0.8 1.4 1.2 2.0 1.7 1.6 1.8 0.8 1.1 1.5 1.0 1.3 1.3 1.2 1.0 0.8 0.7 0.4 0.6 0.8 — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.  The Monitoring the Future study, the University of Michigan.  
See footnotes following Table 2-4
  Methaqualone m,s
TABLE 2-1 (cont.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28)
(Entries are percentages.)
2016–
Nitrites e
      8th Grade
2017
change
Steroids y,z
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 11.3 12.9 15.1 18.5 21.4 23.6 22.1 21.0 20.5 19.5 19.5 17.7 16.1 15.2 15.5 14.8 13.2 14.1 14.5 16.0 14.7 13.4‡ 15.2 14.6 14.8 12.0 12.9 +0.9  
      10th Grade 21.4 20.4 24.7 30.0 33.3 37.5 38.5 35.0 35.9 36.4 37.2 34.8 32.0 31.1 29.8 28.7 28.1 26.9 29.4 30.2 31.1 30.1‡ 32.1 29.9 27.9 26.8 27.8 +1.0  
      12th Grade 29.4 27.1 31.0 35.8 39.0 40.2 42.4 41.4 42.1 40.9 41.4 41.0 39.3 38.8 38.4 36.5 35.9 36.6 36.5 38.3 40.0 39.7‡ 40.1 38.7 38.6 38.3 39.9 +1.6  
      College Students 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9 36.1 37.9 37.0 36.5 36.2 36.6 33.9 35.0 35.2 36.0 35.0 36.3 37.3‡ 40.5 38.6 41.4 42.8 42.4 -0.4
      Young Adults 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 32.1 32.5 33.8 33.3 33.2 34.7 34.0‡ 36.7 37.5 39.2 39.7 41.2 +1.5
      8th Grade 8.4 9.3 10.4 11.3 12.6 13.1 11.8 11.0 10.5 10.2‡ 10.8 8.8 8.8 7.9 8.1 7.7 7.0 7.4 7.0 7.1 6.4 5.5‡ 6.3 6.4 6.3 5.4 5.8 +0.3  
      10th Grade 12.2 12.3 13.9 15.2 17.5 18.4 18.2 16.6 16.7 16.7‡ 17.9 15.7 13.8 13.5 12.9 12.7 13.1 11.3 12.2 12.1 11.2 10.8‡ 11.2 11.2 10.5 9.8 9.4 -0.4  
      12th Grade 16.2 14.9 17.1 18.0 19.4 19.8 20.7 20.2 20.7 20.4‡ 21.6 20.9 19.8 20.5 19.7 19.2 18.5 18.3 17.0 17.3 17.6 17.0‡ 17.8 15.9 15.2 14.3 13.3 -1.0  
      College Students 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4 15.6‡ 16.4 16.6 17.9 18.6 18.5 18.1 17.3 15.3 16.9 17.1 16.8 17.1‡ 19.3 20.8 18.5 19.7 18.1 -1.6
      Young Adults 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9‡ 15.4 16.3 18.1 18.8 18.5 18.4 18.1 18.9 17.4 18.5 17.6 17.2‡ 18.1 21.2 19.5 19.9 20.1 +0.2
  including
  Inhalants a,c,d
      8th Grade 16.7 18.2 21.1 24.2 27.1 28.7 27.2 26.2 25.3 24.0 23.9 21.4 20.4 20.2 20.4 19.7 18.0 19.0 18.8 20.3 18.2 17.0‡ 17.6 16.8 17.0 13.5 15.8 +2.3 ss
      10th Grade 23.9 23.5 27.4 32.5 35.6 39.6 40.3 37.1 37.7 38.0 38.7 36.1 33.5 32.9 31.7 30.7 30.2 28.8 31.2 31.8 32.5 31.5‡ 33.2 31.0 28.9 27.7 29.1 +1.4  
      12th Grade 31.2 28.8 32.5 37.6 40.2 41.9 43.3 42.4 42.8 42.5 42.6 42.1 40.5 39.1 40.3 38.0 37.0 37.3 37.6 39.2 41.5 40.2‡ 42.3 39.2 40.2 38.7 41.2 +2.5  
      College Students 29.8 31.1 31.7 31.9 33.7 35.1 35.5 39.1 37.4 37.0 38.2 37.7 36.0 35.9 37.9 35.5 36.8 35.7 35.0 34.5 36.5 36.9‡ 40.1 36.3 40.7 40.3 42.4 +2.1
      Young Adults 27.8 29.2 28.9 29.2 30.4 30.2 30.1 30.6 30.6 31.2 33.2 32.4 32.7 34.9 32.8 32.6 33.2 33.5 33.1 33.3 34.2 34.2‡ 38.3 35.3 37.3 38.2 40.7 +2.5
      8th Grade 6.2 7.2 9.2 13.0 15.8 18.3 17.7 16.9 16.5 15.6 15.4 14.6 12.8 11.8 12.2 11.7 10.3 10.9 11.8 13.7 12.5 11.4 12.7 11.7 11.8 9.4 10.1 +0.8  
      10th Grade 16.5 15.2 19.2 25.2 28.7 33.6 34.8 31.1 32.1 32.2 32.7 30.3 28.2 27.5 26.6 25.2 24.6 23.9 26.7 27.5 28.8 28.0 29.8 27.3 25.4 23.9 25.5 +1.6  
      12th Grade 23.9 21.9 26.0 30.7 34.7 35.8 38.5 37.5 37.8 36.5 37.0 36.2 34.9 34.3 33.6 31.5 31.7 32.4 32.8 34.8 36.4 36.4 36.4 35.1 34.9 35.6 37.1 +1.5  
      College Students 26.5 27.7 27.9 29.3 31.2 33.1 31.6 35.9 35.2 34.0 35.6 34.7 33.7 33.3 33.3 30.2 31.8 32.3 32.8 32.7 33.2 34.9 35.5 34.4 37.9 39.3 38.3 -1.1
      Young Adults 23.8 25.2 25.1 25.5 26.5 27.0 26.8 27.4 27.6 27.9 29.2 29.3 29.0 29.2 28.2 27.7 28.5 28.6 29.3 28.7 31.0 30.2 32.2 31.6 34.0 35.3 37.5 +2.2  
      8th Grade — — — — — — — — — — — — — — — — — — — — — 4.4 4.0 3.3 3.1 2.7 2.0 -0.7 s
      10th Grade — — — — — — — — — — — — — — — — — — — — — 8.8 7.4 5.4 4.3 3.3 2.7 -0.6  
      12th Grade — — — — — — — — — — — — — — — — — — — — 11.4 11.3 7.9 5.8 5.2 3.5 3.7 +0.2  
      College Students — — — — — — — — — — — — — — — — — — — — 8.5 5.3 2.3 0.9 1.5 1.3 0.5 -0.8
      Young Adults — — — — — — — — — — — — — — — — — — — — 7.4 5.3 3.2 1.3 1.5 1.0 0.9 -0.1
Marijuana/Hashish
2017
(Table continued on next page.)
TABLE 2-2
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
(Entries are percentages.)
change
Any Illicit Drug a
Any Illicit Drug other
  than Marijuana a,b
Any Illicit Drug
Synthetic Marijuana p,q
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 9.0 9.5 11.0 11.7 12.8 12.2 11.8 11.1 10.3 9.4 9.1 7.7 8.7 9.6 9.5 9.1 8.3 8.9 8.1 8.1 7.0 6.2 5.2 5.3 4.6 3.8 4.7 +0.9 s
      10th Grade 7.1 7.5 8.4 9.1 9.6 9.5 8.7 8.0 7.2 7.3 6.6 5.8 5.4 5.9 6.0 6.5 6.6 5.9 6.1 5.7 4.5 4.1 3.5 3.3 2.9 2.4 2.3 -0.1  
      12th Grade 6.6 6.2 7.0 7.7 8.0 7.6 6.7 6.2 5.6 5.9 4.5 4.5 3.9 4.2 5.0 4.5 3.7 3.8 3.4 3.6 3.2 2.9 2.5 1.9 1.9 1.7 1.5 -0.1  
      College Students 3.5 3.1 3.8 3.0 3.9 3.6 4.1 3.0 3.2 2.9 2.8 2.0 1.8 2.7 1.8 1.5 1.5 1.1 1.2 1.7 0.9 1.5 0.5 1.3 0.6 0.2 1.7 +1.5 s
      Young Adults 2.0 1.9 2.1 2.1 2.4 2.2 2.3 2.1 2.3 2.1 1.7 1.6 1.4 1.7 1.3 1.3 0.8 1.4 0.9 1.2 0.8 1.1 0.5 1.1 0.9 0.9 0.7 -0.1
      8th Grade 1.9 2.5 2.6 2.7 3.6 4.1 3.7 3.4 2.9 2.8‡ 3.4 2.6 2.6 2.2 2.4 2.1 1.9 2.1 1.9 2.2 2.2 1.6 1.6 1.3 1.3 1.2 1.1 -0.1  
      10th Grade 4.0 4.3 4.7 5.8 7.2 7.8 7.6 6.9 6.9 6.1‡ 6.2 4.7 4.1 4.1 4.0 4.1 4.4 3.9 4.1 4.2 4.1 3.5 3.4 3.3 3.1 2.9 2.8 -0.1  
      12th Grade 5.8 5.9 7.4 7.6 9.3 10.1 9.8 9.0 9.4 8.1‡ 9.1 6.6 5.9 6.2 5.5 4.9 5.4 5.9 4.7 5.5 5.2 4.8 4.5 4.0 4.2 4.3 4.4 +0.1  
      College Students 6.3 6.8 6.0 6.2 8.2 6.9 7.7 7.2 7.8 6.7‡ 7.5 6.3 7.4 5.9 5.0 5.6 4.9 5.1 4.7 4.9 4.1 4.5 4.5 4.0 4.3 4.5 4.1 -0.5
      Young Adults 4.5 5.0 4.5 4.8 5.6 5.6 5.9 5.2 5.4 5.4‡ 5.4 4.7 5.2 4.7 4.5 4.1 3.8 3.8 3.9 4.2 3.7 3.6 3.9 4.1 4.2 4.6 4.8 +0.1
      8th Grade 1.7 2.1 2.3 2.4 3.2 3.5 3.2 2.8 2.4 2.4 2.2 1.5 1.3 1.1 1.2 0.9 1.1 1.3 1.1 1.2 1.1 0.8 1.0 0.7 0.9 0.8 0.9 +0.1  
      10th Grade 3.7 4.0 4.2 5.2 6.5 6.9 6.7 5.9 6.0 5.1 4.1 2.6 1.7 1.6 1.5 1.7 1.9 1.8 1.9 1.9 1.8 1.7 1.7 1.9 2.0 2.1 2.1 -0.1  
      12th Grade 5.2 5.6 6.8 6.9 8.4 8.8 8.4 7.6 8.1 6.6 6.6 3.5 1.9 2.2 1.8 1.7 2.1 2.7 1.9 2.6 2.7 2.4 2.2 2.5 2.9 3.0 3.3 +0.3  
      College Students 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4 4.3 4.0 2.1 1.4 1.2 0.7 1.4 1.3 2.6 2.0 2.1 2.0 1.9 2.6 2.2 3.0 3.1 2.8 -0.2
      Young Adults 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 1.2 0.9 0.8 1.2 1.1 1.4 1.7 1.5 1.7 1.6 2.0 2.2 2.6 3.1 3.4 +0.3
      8th Grade 0.7 1.1 1.0 1.3 1.7 2.0 1.8 1.6 1.5 1.4‡ 2.4 2.1 2.1 1.9 2.0 1.8 1.6 1.6 1.5 1.8 1.8 1.3 1.2 1.0 0.8 0.8 0.7 -0.1  
      10th Grade 1.3 1.4 1.9 2.4 2.8 3.3 3.3 3.4 3.2 3.1‡ 4.3 4.0 3.6 3.7 3.5 3.7 3.8 3.3 3.5 3.5 3.5 3.0 2.7 2.6 1.9 2.0 1.8 -0.2  
      12th Grade 2.0 1.7 2.2 3.1 3.8 4.4 4.6 4.6 4.3 4.4‡ 5.9 5.4 5.4 5.6 5.0 4.6 4.8 5.0 4.2 4.8 4.3 4.0 3.7 3.0 2.9 2.7 2.9 +0.2  
      College Students 3.1 2.6 2.7 2.8 4.0 4.1 4.9 4.4 4.5 4.4‡ 5.5 5.8 7.1 5.6 5.0 5.4 4.7 4.4 4.1 4.4 3.4 3.9 3.7 3.2 3.0 3.4 2.5 -0.9
      Young Adults 1.7 1.9 1.9 2.0 2.5 2.8 3.1 3.0 3.0 3.4‡ 3.5 4.0 4.9 4.5 4.2 3.8 3.6 3.4 3.3 3.7 3.2 2.9 3.2 3.1 3.0 3.0 3.0 0.0
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.4 1.4 1.6 1.8 2.6 2.3 2.1 1.8 2.3 1.8 1.1 1.3 0.7 1.3 0.7 0.9 1.1 1.0 1.0 1.3 0.9 0.7 0.8 1.4 1.3 1.0 -0.3  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 0.3 0.3 0.2 0.3 0.3 0.2 0.5 0.6 0.6 0.3 0.6 0.3 0.3 0.1 0.6 0.2 0.3 0.4 0.1 0.2 0.3 * 0.2 0.1 0.0 0.4 0.1 -0.3
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
  PCP g
2016–
(Table continued on next page.)
Inhalants c,d
    other than LSD b
2017
change
  Hallucinogens
Hallucinogens b,f
  LSD b
39
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade, original — — — — — 2.3 2.3 1.8 1.7 3.1 3.5 2.9 2.1 1.7 1.7 1.4 1.5 1.7 1.3 2.4 1.7 1.1 1.1 0.9 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.5 1.4 1.0 0.9 -0.1  
      10th Grade, original — — — — — 4.6 3.9 3.3 4.4 5.4 6.2 4.9 3.0 2.4 2.6 2.8 3.5 2.9 3.7 4.7 4.5 3.0 3.6 2.3 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 3.8 2.4 1.8 1.7 0.0  
      12th Grade, original — — — — — 4.6 4.0 3.6 5.6 8.2 9.2 7.4 4.5 4.0 3.0 4.1 4.5 4.3 4.3 4.5 5.3 3.8 4.0 3.6 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 5.0 3.6 2.7 2.6 -0.1  
      College Students
Original 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5 9.1 9.2 6.8 4.4 2.2 2.9 2.6 2.2 3.7 3.1 4.3 4.2 5.8 5.3 5.0 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 4.9 4.2 4.7 2.5 -2.2 s
      Young Adults
Original 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 4.5 3.5 3.0 3.0 2.5 3.3 3.1 3.5 3.6 4.1 4.2 4.8 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 5.1 4.4 5.1 3.6 -1.5 ss
      8th Grade — — — — — — — — — — — — — — — — — — — 1.7 1.6 1.4 1.2 0.6 0.7 0.9 0.4 -0.6 s
      10th Grade — — — — — — — — — — — — — — — — — — — 3.7 3.9 2.5 2.3 1.8 1.2 0.9 0.9 0.0  
      12th Grade — — — — — — — — — — — — — — — — — — 5.7 5.5 5.9 4.4 3.4 1.8 1.9 1.8 1.5 -0.2  
      College Students — — — — — — — — — — — — — — — — — — 5.8 3.5 3.1 1.5 1.0 1.1 0.4 0.7 0.3 -0.4
      Young Adults — — — — — — — — — — — — — — — — — — 3.5 3.6 2.2 1.4 0.9 1.2 0.6 0.8 0.5 -0.3
      8th Grade 1.1 1.5 1.7 2.1 2.6 3.0 2.8 3.1 2.7 2.6 2.5 2.3 2.2 2.0 2.2 2.0 2.0 1.8 1.6 1.6 1.4 1.2 1.0 1.0 0.9 0.8 0.8 0.0  
      10th Grade 2.2 1.9 2.1 2.8 3.5 4.2 4.7 4.7 4.9 4.4 3.6 4.0 3.3 3.7 3.5 3.2 3.4 3.0 2.7 2.2 1.9 2.0 1.9 1.5 1.8 1.3 1.4 +0.1  
      12th Grade 3.5 3.1 3.3 3.6 4.0 4.9 5.5 5.7 6.2 5.0 4.8 5.0 4.8 5.3 5.1 5.7 5.2 4.4 3.4 2.9 2.9 2.7 2.6 2.6 2.5 2.3 2.7 +0.5  
      College Students 3.6 3.0 2.7 2.0 3.6 2.9 3.4 4.6 4.6 4.8 4.7 4.8 5.4 6.6 5.7 5.1 5.4 4.4 4.2 3.5 3.3 3.1 2.7 4.4 4.3 4.0 4.8 +0.8
      Young Adults 6.2 5.7 4.7 4.3 4.4 4.1 4.7 4.9 5.4 5.4 5.8 5.8 6.6 7.1 6.9 6.6 6.2 6.0 5.2 4.7 4.7 4.1 3.9 5.0 5.7 4.9 5.3 +0.3
      8th Grade 0.7 0.9 1.0 1.3 1.6 1.8 1.7 2.1 1.8 1.8 1.7 1.6 1.6 1.3 1.4 1.3 1.3 1.1 1.1 1.0 0.9 0.6 0.6 0.7 0.5 0.5 0.5 0.0  
      10th Grade 0.9 0.9 1.1 1.4 1.8 2.1 2.2 2.5 2.4 2.2 1.8 2.3 1.6 1.7 1.7 1.3 1.3 1.3 1.2 1.0 0.9 0.8 0.8 0.5 0.7 0.4 0.6 +0.2  
      12th Grade 1.5 1.5 1.5 1.9 2.1 2.1 2.4 2.5 2.7 2.2 2.1 2.3 2.2 2.3 1.9 2.1 1.9 1.6 1.3 1.4 1.0 1.2 1.1 1.1 1.1 0.8 1.0 +0.2  
      College Students 0.5 0.4 0.6 0.5 1.1 0.6 0.4 1.0 0.9 0.9 0.9 0.4 1.3 1.3 0.8 1.0 0.6 0.5 0.3 0.4 0.3 0.3 0.3 0.8 0.2 0.0 0.2 +0.2
      Young Adults 1.2 1.4 1.3 1.1 1.1 1.1 1.0 1.1 1.4 1.2 1.3 1.0 1.0 1.3 1.2 1.1 1.0 0.9 0.7 0.5 0.6 0.5 0.3 0.4 0.4 0.0 0.2 +0.2
  Ecstasy (MDMA ) h
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
change
Cocaine
  Crack i
Salvia p,q
(Table continued on next page.)
(Entries are percentages.)
2016–
2017
40
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
    than Crack j
      8th Grade 1.0 1.2 1.3 1.7 2.1 2.5 2.2 2.4 2.3 1.9 1.9 1.8 1.6 1.6 1.7 1.6 1.5 1.4 1.3 1.3 1.1 1.0 0.8 0.8 0.8 0.6 0.6 0.0  
      10th Grade 2.1 1.7 1.8 2.4 3.0 3.5 4.1 4.0 4.4 3.8 3.0 3.4 2.8 3.3 3.0 2.9 3.1 2.6 2.3 1.9 1.7 1.8 1.6 1.3 1.5 1.1 1.2 +0.1  
      12th Grade 3.2 2.6 2.9 3.0 3.4 4.2 5.0 4.9 5.8 4.5 4.4 4.4 4.2 4.7 4.5 5.2 4.5 4.0 3.0 2.6 2.6 2.4 2.4 2.4 2.1 2.0 2.3 +0.3  
      College Students 3.2 2.4 2.5 1.8 3.3 2.3 3.0 4.2 4.2 4.1 4.1 5.0 5.1 6.3 5.0 3.8 5.3 4.2 4.2 4.0 3.0 3.0 2.8 4.1 4.2 4.7 4.4 -0.3
      Young Adults 5.4 5.1 3.9 3.6 3.9 3.8 4.3 4.5 4.8 4.8 5.3 5.6 6.1 6.4 6.3 5.9 5.6 5.5 5.0 4.8 4.3 4.0 3.7 4.8 5.4 5.9 5.9 -0.1
      8th Grade 0.7 0.7 0.7 1.2 1.4 1.6 1.3 1.3 1.4 1.1 1.0 0.9 0.9 1.0 0.8 0.8 0.8 0.9 0.7 0.8 0.7 0.5 0.5 0.5 0.3 0.3 0.3 +0.1  
      10th Grade 0.5 0.6 0.7 0.9 1.1 1.2 1.4 1.4 1.4 1.4 0.9 1.1 0.7 0.9 0.9 0.9 0.8 0.8 0.9 0.8 0.8 0.6 0.6 0.5 0.5 0.3 0.2 -0.1  
      12th Grade 0.4 0.6 0.5 0.6 1.1 1.0 1.2 1.0 1.1 1.5 0.9 1.0 0.8 0.9 0.8 0.8 0.9 0.7 0.7 0.9 0.8 0.6 0.6 0.6 0.5 0.3 0.4 +0.1  
      College Students 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.2 0.5 0.4 0.1 0.2 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.1 0.1 0.3 0.0 0.1 0.2 0.0 -0.2
      Young Adults 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.3 0.4 0.4 0.3 0.5 0.6 0.5 0.5 0.5 0.6 0.4 0.5 0.4 0.4 0.0
      8th Grade —  — — — 0.9 1.0 0.8 0.8 0.9 0.6 0.7 0.6 0.6 0.7 0.6 0.5 0.6 0.5 0.5 0.6 0.5 0.4 0.3 0.4 0.2 0.2 0.2 0.0  
      10th Grade — — — — 0.6 0.7 0.7 0.8 0.6 0.5 0.4 0.6 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.5 0.5 0.4 0.5 0.4 0.2 0.3 0.2 -0.1  
      12th Grade — — — — 0.5 0.5 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.5 0.4 0.4 0.3 0.7 0.6 0.4 0.4 0.5 0.3 0.3 0.2 0.0  
      College Students — — — — 0.1  * 0.1 0.2 0.1 0.1 0.1  * 0.1 0.1 0.3 0.3 * 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.2 +0.2
      Young Adults — — — — 0.1 0.1 0.1 0.1 0.1  * 0.3  *  * 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.4 0.3 0.3 0.2 0.2 0.3 0.2 -0.1
      8th Grade —  — — — 0.8 1.0 0.8 0.8 0.9 0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.6 0.4 0.5 0.4 0.3 0.3 0.2 0.2 0.2 0.3 +0.1  
      10th Grade — — — — 0.8 0.9 1.1 1.0 1.1 1.1 0.7 0.8 0.5 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.5 0.4 0.4 0.3 0.3 0.2 0.1 0.0  
      12th Grade — — — — 1.0 1.0 1.2 0.8 1.0 1.6 0.8 0.8 0.8 0.7 0.8 0.6 1.0 0.5 0.6 0.8 0.7 0.4 0.4 0.5 0.4 0.3 0.2 -0.1  
      College Students — — — — 0.0 0.8 0.4 0.9 0.3 0.8 0.6 0.2 0.1 0.6 0.2 0.3 0.2 0.3 0.1 0.3 0.2 0.1 0.5 0.1 0.0 0.0 0.3 +0.3
      Young Adults — — — — 0.3 0.4 0.4 0.7 0.6 0.5 0.9 0.2 0.4 0.3 0.4 0.5 0.3 0.4 0.6 0.4 0.2 0.4 0.7 0.3 0.5 0.4 0.3 -0.1
  than Heroin m,n
      8th Grade —  — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 3.5 3.3 3.6 3.8 4.7 5.4 6.2 6.3 6.7 7.0 6.7‡ 9.4 9.3 9.5 9.0 9.0 9.2 9.1 9.2 8.7 8.7 7.9 7.1 6.1 5.4 4.8 4.2 -0.5  
      College Students 2.7 2.7 2.5 2.4 3.8 3.1 4.2 4.2 4.3 4.5 5.7‡ 7.4 8.7 8.2 8.4 8.8 7.7 6.5 7.6 7.2 6.2 5.4 5.4 4.8 3.3 3.8 3.1 -0.8
      Young Adults 2.5 2.5 2.2 2.5 3.0 2.9 3.3 3.4 3.8 4.1 5.0‡ 7.1 8.5 9.0 8.7 9.1 8.7 9.1 8.4 9.0 7.9 7.3 7.0 6.3 5.2 5.2 4.0 -1.2 s
  Cocaine other 
TABLE 2-2 (cont.)
(Table continued on next page.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2016–
2017
change
Heroin k,l
Narcotics other
  With a Needle l
  Without a Needle l
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — — — — 1.3 1.7 1.7 1.8 2.6 1.8 2.1 2.0 2.1 1.8 1.6 2.0 1.0 0.8 0.9 0.8 -0.1  
      10th Grade — — — — — — — — — — — 3.0 3.6 3.5 3.2 3.8 3.9 3.6 5.1 4.6 3.9 3.0 3.4 3.0 2.6 2.1 2.2 +0.1  
      12th Grade — — — — — — — — — — — 4.0 4.5 5.0 5.5 4.3 5.2 4.7 4.9 5.1 4.9 4.3 3.6 3.3 3.7 3.4 2.7 -0.7  
      College Students — — — — — — — — — — — 1.5 2.2 2.5 2.1 3.0 2.8 3.6 5.0 2.3 2.4 1.2 2.3 1.3 1.5 1.9 1.7 -0.2
      Young Adults — — — — — — — — — — — 1.9 2.6 3.1 3.1 3.1 2.9 3.9 5.2 3.2 2.8 2.3 2.8 2.5 2.5 2.1 1.9 -0.1
      8th Grade — — — — — — — — — — — 2.5 2.8 2.5 2.6 3.0 2.7 2.9 2.5 2.7 2.1 1.3 1.4 1.0 0.9 0.8 0.7 -0.2  
      10th Grade — — — — — — — — — — — 6.9 7.2 6.2 5.9 7.0 7.2 6.7 8.1 7.7 5.9 4.4 4.6 3.4 2.5 1.7 1.5 -0.3  
      12th Grade — — — — — — — — — — — 9.6 10.5 9.3 9.5 9.7 9.6 9.7 9.7 8.0 8.1 7.5 5.3 4.8 4.4 2.9 2.0 -1.0 ss
      College Students — — — — — — — — — — — 6.9 7.5 7.4 9.6 7.6 6.7 6.7 8.4 4.9 5.8 3.8 4.4 2.8 1.6 1.3 1.1 -0.2
      Young Adults — — — — — — — — — — — 8.2 8.6 8.9 9.3 9.1 8.9 9.1 8.9 7.8 7.1 6.3 6.2 4.8 3.8 2.7 2.7 0.0
      8th Grade 6.2 6.5 7.2 7.9 8.7 9.1 8.1 7.2 6.9 6.5 6.7 5.5 5.5 4.9 4.9 4.7 4.2 4.5 4.1 3.9 3.5 2.9‡ 4.2 4.3 4.1 3.5 3.5 0.0  
      10th Grade 8.2 8.2 9.6 10.2 11.9 12.4 12.1 10.7 10.4 11.1 11.7 10.7 9.0 8.5 7.8 7.9 8.0 6.4 7.1 7.6 6.6 6.5‡ 7.9 7.6 6.8 6.1 5.6 -0.5  
      12th Grade 8.2 7.1 8.4 9.4 9.3 9.5 10.2 10.1 10.2 10.5 10.9 11.1 9.9 10.0 8.6 8.1 7.5 6.8 6.6 7.4 8.2 7.9‡ 9.2 8.1 7.7 6.7 5.9 -0.8  
      College Students 3.9 3.6 4.2 4.2 5.4 4.2 5.7 5.1 5.8 6.6 7.2 7.0 7.1 7.0 6.7 6.0 6.9 5.7 7.5 9.0 9.3 11.1‡ 9.6 10.1 9.7 9.8 8.6 -1.2
      Young Adults 4.3 4.1 4.0 4.5 4.6 4.2 4.6 4.5 4.7 5.4 5.8 5.9 5.8 6.2 5.1 5.6 5.6 5.3 6.0 7.1 7.2 7.8‡ 7.5 8.0 7.9 7.2 7.8 +0.6
      8th Grade — — — — — — — — — — 2.9 2.8 2.6 2.5 2.4 2.6 2.1 1.6 1.8 1.5 1.3 0.7 1.1 0.9 0.6 0.8 0.4 -0.4 s
      10th Grade — — — — — — — — — — 4.8 4.8 4.1 3.4 3.4 3.6 2.8 2.9 3.6 2.7 2.6 1.9 1.8 1.8 1.6 1.2 0.8 -0.4  
      12th Grade — — — — — — — — — — 5.1 4.0 4.0 5.1 4.4 4.4 3.8 3.4 2.1 2.7 2.6 2.6 2.3 1.8 2.0 1.2 1.3 +0.1  
      College Students — — — — — — — — — — — 5.7 4.7 4.7 4.2 3.9 3.7 3.2 1.7 1.9 2.3 1.8 3.6 1.6 2.0 2.4 1.4 -0.9
      Young Adults — — — — — — — — — — — 2.9 2.9 2.7 2.5 2.6 2.4 2.4 1.7 1.7 1.5 1.6 2.0 1.6 1.8 1.2 1.2 -0.0
      8th Grade — — — — — — — — — — — — — — — — — — 2.0 2.3 1.7 1.7 1.8 1.3 1.0 1.5 1.3 -0.3  
      10th Grade — — — — — — — — — — — — — — — — — — 5.7 5.3 4.6 4.5 4.4 4.6 5.2 4.2 4.0 -0.2  
      12th Grade — — — — — — — — — — — — — — — — — — 5.4 6.5 6.5 7.6 7.4 6.8 7.5 6.2 5.5 -0.6  
      College Students — — — — — — — — — — — — — — — — — — 10.2 9.0 9.8 9.0 10.7 9.6 10.7 9.9 9.4 -0.5
      Young Adults — — — — — — — — — — — — — — — — — — 5.8 7.0 6.6 7.4 7.0 7.8 7.7 7.2 8.3 +1.1
  Vicodin m,p,aa,bb
Amphetamines m,o
Adderall m,p,q,bb
  Ritalin m,p,q,bb
  OxyContin m,p,aa,bb
(Table continued on next page.)
TABLE 2-2 (cont.)
2017
change
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2016–
42
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — 3.2 2.5 2.8 2.2 2.5 1.5 1.8 1.8 1.1 1.2 1.0 1.2 0.8 1.0 1.0 0.6 0.5 0.4 0.5 +0.1  
      10th Grade — — — — — — — — 4.6 4.0 3.7 3.9 3.3 3.0 2.9 1.8 1.6 1.5 1.6 1.6 1.4 1.0 1.0 0.8 0.8 0.4 0.4 -0.1  
      12th Grade — — — — — — — — 4.7 4.3 3.9 3.6 3.2 3.4 2.5 2.5 1.7 1.2 1.2 1.0 1.4 1.1 0.9 1.0 0.6 0.6 0.6 -0.1  
      College Students — — — — — — — — 3.3 1.6 2.4 1.2 2.6 2.9 1.7 1.2 0.4 0.5 0.3 0.4 0.2 0.0 0.4 0.1 0.5 0.0 0.4 +0.4
      Young Adults — — — — — — — — 2.8 2.5 2.8 2.5 2.7 2.8 2.4 1.9 1.5 1.0 0.9 0.7 0.5 1.0 0.6 0.5 0.7 0.4 0.6 +0.2
Crystal Methamphetamine (Ice) q
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.3 1.7 1.8 2.4 2.8 2.3 3.0 1.9 2.2 2.5 3.0 2.0 2.1 2.3 1.9 1.6 1.1 0.9 0.9 1.2 0.8 1.1 0.8 0.5 0.8 0.8 0.0  
      College Students 0.1 0.2 0.7 0.8 1.1 0.3 0.8 1.0 0.5 0.5 0.6 0.8 0.9 1.1 1.4 0.6 0.7 0.1 0.1 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.4 +0.4
      Young Adults 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 1.3 1.5 1.6 1.1 1.1 0.8 0.8 0.5 0.5 0.6 0.8 0.3 0.5 0.1 0.7 +0.6 s
      8th Grade — — — — — — — — — — — — — — — — — — — — — 0.8 1.0 0.5 0.4 0.9 0.5 -0.4  
      10th Grade — — — — — — — — — — — — — — — — — — — — — 0.6 0.9 0.9 0.7 0.8 0.4 -0.3  
      12th Grade — — — — — — — — — — — — — — — — — — — — — 1.3 0.9 0.9 1.0 0.8 0.6 -0.1  
      College Students — — — — — — — — — — — — — — — — — — — — — 0.3 0.1 0.2 0.1 0.0 0.2 +0.2
      Young Adults — — — — — — — — — — — — — — — — — — — — — 0.5 0.4 0.4 0.3 0.3 0.4 +0.1
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 3.4 2.8 3.4 4.1 4.7 4.9 5.1 5.5 5.8 6.2 5.7 6.7 6.0‡ 6.5 7.2 6.6 6.2 5.8 5.2 4.8 4.3 4.5 4.8 4.3 3.6 3.0 2.9 -0.1  
      College Students 1.2 1.4 1.5 1.2 2.0 2.3 3.0 2.5 3.2 3.7 3.8 3.7 4.1 4.2 3.9 3.4 3.6 3.7 3.1 2.5 1.7 2.2‡ 2.7 3.1 2.3 2.1 1.9 -0.1
      Young Adults 1.8 1.6 1.9 1.8 2.1 2.2 2.4 2.5 2.8 3.4 3.7 3.9 3.9 4.4 4.2 3.9 4.2 4.7 3.8 3.3 3.2 2.7‡ 3.4 3.2 2.7 2.6 2.2 -0.4
      8th Grade 1.8 2.0 2.1 2.4 2.7 3.3 2.9 2.6 2.5 2.6‡ 2.8 2.6 2.7 2.5 2.8 2.6 2.4 2.4 2.6 2.8 2.0 1.8 1.8 1.7 1.7 1.7 2.0 +0.3  
      10th Grade 3.2 3.5 3.3 3.3 4.0 4.6 4.9 5.1 5.4 5.6‡ 7.3 6.3 5.3 5.1 4.8 5.2 5.3 4.6 5.0 5.1 4.5 4.3 3.7 3.9 3.9 4.1 4.1 0.0  
      12th Grade 3.6 2.8 3.5 3.7 4.4 4.6 4.7 5.5 5.8 5.7‡ 6.9 7.7 6.7 7.3 6.8 6.6 6.2 6.2 6.3 5.6 5.6 5.3 4.6 4.7 4.7 4.9 4.7 -0.2  
      College Students 2.4 2.9 2.4 1.8 2.9 2.8 3.8 3.9 3.8 4.2‡ 5.1 6.7 6.9 6.7 6.4 5.8 5.5 5.0 5.4 4.9 4.2 3.4 4.4 3.5 4.3 4.9 3.6 -1.2
      Young Adults 3.5 3.4 3.1 2.9 3.4 3.2 3.1 3.8 3.7 4.6‡ 5.5 7.0 6.8 7.4 6.7 6.5 7.1 6.8 6.4 6.3 5.9 5.3 5.4 4.8 5.0 5.0 4.7 -0.3
Tranquilizers b,m
(Table continued on next page.)
2017
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
TABLE 2-2 (cont.)
change
(Entries are percentages.)
  Methamphetamine p,q
Sedatives
  (Barbiturates) m,r
Bath Salts (Synthetic stimulants) p,q
43
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — 17.1 16.8 15.8 15.4 14.4 15.0 15.2 14.8‡ 15.9 13.9 12.9 12.0 10.9 -1.0  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Over-the-counter Cough/Cold
      8th Grade — — — — — — — — — — — — — — — 4.2 4.0 3.6 3.8 3.2 2.7 3.0 2.9 2.0 1.6 2.6 2.1 -0.5  
      10th Grade — — — — — — — — — — — — — — — 5.3 5.4 5.3 6.0 5.1 5.5 4.7 4.3 3.7 3.3 3.0 3.6 +0.6  
      12th Grade — — — — — — — — — — — — — — — 6.9 5.8 5.5 5.9 6.6 5.3 5.6 5.0 4.1 4.6 4.0 3.2 -0.8  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — 1.0 0.8 0.8 0.5 0.5 0.7 0.3 0.5 0.6 0.7 0.5 0.7 0.5 0.4 0.5 0.8 0.4 0.4 0.3 0.3 0.5 0.4 -0.1  
      10th Grade — — — — — 1.1 1.3 1.2 1.0 0.8 1.0 0.7 0.6 0.7 0.5 0.5 0.7 0.4 0.4 0.6 0.6 0.5 0.6 0.5 0.2 0.5 0.3 -0.3  
      12th Grade — — — — — 1.1 1.2 1.4 1.0 0.8 0.9‡ 1.6 1.3 1.6 1.2 1.1 1.0 1.3 1.0 1.5 1.3 1.5 0.9 0.7 1.0 1.1 0.8 -0.4  
      College Students — — — — — — — — — — — 0.7 0.4 0.3 0.1 0.2 0.1 0.3 0.0 — — — — — — — — —
      Young Adults — — — — — — — — — — — 0.3 0.5 0.1 0.1 0.2 0.3 0.2 0.1 — — — — — — — — —
GHB p,cc
      8th Grade — — — — — — — — — 1.2 1.1 0.8 0.9 0.7 0.5 0.8 0.7 1.1 0.7 0.6 0.6 — — — — — — —
      10th Grade — — — — — — — — — 1.1 1.0 1.4 1.4 0.8 0.8 0.7 0.6 0.5 1.0 0.6 0.5 — — — — — — —
      12th Grade — — — — — — — — — 1.9 1.6 1.5 1.4 2.0 1.1 1.1 0.9 1.2 1.1 1.4 1.4 1.4 1.0 1.0 0.7 0.9 0.4 -0.5  
      College Students — — — — — — — — — — — 0.6 0.3 0.7 0.4  * 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 — — —
      Young Adults — — — — — — — — — — — 0.8 0.6 0.5 0.3 0.2 0.4 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.2 — — —
Ketamine p,dd
      8th Grade — — — — — — — — — 1.6 1.3 1.3 1.1 0.9 0.6 0.9 1.0 1.2 1.0 1.0 0.8 — — — — — — —
      10th Grade — — — — — — — — — 2.1 2.1 2.2 1.9 1.3 1.0 1.0 0.8 1.0 1.3 1.1 1.2 — — — — — — —
      12th Grade — — — — — — — — — 2.5 2.5 2.6 2.1 1.9 1.6 1.4 1.3 1.5 1.7 1.6 1.7 1.5 1.4 1.5 1.4 1.2 1.2 -0.1  
      College Students — — — — — — — — — — — 1.3 1.0 1.5 0.5 0.9 0.2 0.4 0.1 0.7 0.6 0.4 0.9 0.1 0.6 0.5 0.3 -0.1
      Young Adults — — — — — — — — — — — 1.2 0.9 0.6 0.5 0.5 0.3 0.4 0.5 0.8 0.5 0.8 0.5 0.4 0.7 0.7 0.5 -0.2
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2016–
2017
  Medicines p,q
Rohypnol u
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
change
(Table continued on next page.)
Any Prescription Drug o,t
44
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
  Any Use
      8th Grade 54.0 53.7‡ 45.4 46.8 45.3 46.5 45.5 43.7 43.5 43.1 41.9 38.7 37.2 36.7 33.9 33.6 31.8 32.1 30.3 29.3 26.9 23.6 22.1 20.8 21.0 17.6 18.2 +0.6  
      10th Grade 72.3 70.2‡ 63.4 63.9 63.5 65.0 65.2 62.7 63.7 65.3 63.5 60.0 59.3 58.2 56.7 55.8 56.3 52.5 52.8 52.1 49.8 48.5 47.1 44.0 41.9 38.3 37.7 -0.6  
      12th Grade 77.7 76.8‡ 72.7 73.0 73.7 72.5 74.8 74.3 73.8 73.2 73.3 71.5 70.1 70.6 68.6 66.5 66.4 65.5 66.2 65.2 63.5 63.5 62.0 60.2 58.2 55.6 55.7 +0.2  
      College Students 88.3 86.9 85.1 82.7 83.2 82.9 82.4 84.6 83.6 83.2 83.0 82.9 81.7 81.2 83.0 82.1 80.9 82.1 79.4 78.6 77.4 79.2 75.6 76.1 79.0 78.9 75.8 -3.2
      Young Adults 86.9 86.2 85.3 83.7 84.7 84.0 84.3 84.0 84.1 84.0 84.3 84.9 83.3 84.4 83.8 84.4 84.0 83.6 83.8 82.7 83.5 82.5 82.5 82.3 81.2 82.1 81.2 -0.8
      8th Grade 17.5 18.3 18.2 18.2 18.4 19.8 18.4 17.9 18.5 18.5 16.6 15.0 14.5 14.5 14.1 13.9 12.6 12.7 12.2 11.5 10.5 8.6 8.4 7.3 7.7 5.7 6.4 +0.7  
      10th Grade 40.1 37.0 37.8 38.0 38.5 40.1 40.7 38.3 40.9 41.6 39.9 35.4 34.7 35.1 34.2 34.5 34.4 30.0 31.2 29.9 28.8 28.2 27.1 24.6 23.4 20.5 20.4 -0.1  
      12th Grade 52.7 50.3 49.6 51.7 52.5 51.9 53.2 52.0 53.2 51.8 53.2 50.4 48.0 51.8 47.7 47.9 46.1 45.6 47.0 44.0 42.2 45.0 43.5 41.4 37.7 37.3 35.6 -1.7  
      College Students 69.1 67.3 65.6 63.1 62.1 64.2 66.8 67.0 65.4 64.7 68.8 66.0 64.7 67.1 64.2 66.2 64.8 66.8 61.5 63.8 60.1 61.5 57.9 60.5 61.6 60.7 58.0 -2.7
      Young Adults 62.0 60.9 61.1 58.8 61.6 59.9 63.2 59.6 63.2 60.6 63.1 61.8 62.9 63.8 63.5 65.7 65.8 66.0 65.5 64.8 64.0 64.6 63.1 63.5 61.2 61.0 60.9 -0.1
      8th Grade — — — — — — — — — — — — — 30.4 27.9 26.8 26.0 25.0 22.2 21.9 19.2 17.0 15.7 13.4 13.4 11.2 10.8 -0.5  
      10th Grade — — — — — — — — — — — — — 49.7 48.5 48.8 45.9 43.4 41.5 41.0 38.3 37.8 35.6 33.2 31.4 26.1 28.3 +2.3  
      12th Grade — — — — — — — — — — — — 55.2 55.8 58.4 54.7 53.6 51.8 53.4 47.9 47.0 44.4 44.2 43.6 42.8 40.0 39.6 -0.4  
      College Students — — — — — — — — — — — — — 63.2 67.0 63.5 62.6 65.0 66.1 60.3 63.0 58.1 57.6 64.2 64.5 68.5 60.3 -8.2
      Young Adults — — — — — — — — — — — — — 62.7 58.4 58.5 58.9 58.3 57.0 52.0 56.3 54.8 54.1 55.4 57.3 57.8 54.8 -3.0
    containing Caffeine p,w
      8th Grade — — — — — — — — — — — — — — — — — — — — 11.8‡ 10.9 10.2 9.5 8.4 6.5 5.6 -0.9  
      10th Grade — — — — — — — — — — — — — — — — — — — — 22.5‡ 19.7 16.9 14.3 12.8 10.6 9.9 -0.8  
      12th Grade — — — — — — — — — — — — — — — — — — — — 26.4‡ 26.4 23.5 20.0 18.3 17.0 16.9 -0.1  
      College Students — — — — — — — — — — — — — — — — — — — — 33.6‡ 33.8 39.1 32.8 34.1 29.4 31.3 +1.9
      Young Adults — — — — — — — — — — — — — — — — — — — — 28.1‡ 36.7 36.9 35.0 33.5 29.6 31.8 +2.2
  Any Use
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      College Students 35.6 37.3 38.8 37.6 39.3 41.4 43.6 44.3 44.5 41.3 39.0 38.3 35.2 36.7 36.0 30.9 30.7 30.0 29.9 28.1 25.8 23.4 23.2 22.6 20.1 18.7 16.7 -1.9
      Young Adults 37.7 37.9 37.8 38.3 38.8 40.3 41.8 41.6 41.1 40.9 41.1 39.1 38.6 39.0 39.1 36.9 36.2 35.0 33.9 33.0 31.5 29.8 29.8 27.0 26.2 23.4 23.9 +0.5
Alcohol v
change
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
2017
(Entries are percentages.)
    Beverages g,p,ee
Cigarettes
  Been Drunk w
  Flavored Alcoholic
  Alcoholic Beverages
(Table continued on next page.)
45
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — — 17.1 18.5 18.3 21.4 22.9 19.8 13.0 10.1 -2.9 s
      College Students — — — — — — — — — — — — — — — — — — — — 27.9 25.7 26.1 32.7 23.4 16.9 10.0 -6.8 ss
      Young Adults — — — — — — — — — — — — — — — — — — — — 20.1 19.1 20.4 23.3 19.2 14.8 12.2 -2.6 s
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — — 23.1 19.5 19.9 20.4 18.9 15.9 15.6 13.3 -2.4  
      College Students — — — — — — — — — — — — — — — — — — — — 23.6 20.3 19.0 24.2 19.6 17.6 14.0 -3.6
      Young Adults — — — — — — — — — — — — — — — — — — — — 19.2 18.0 18.4 18.6 17.9 15.5 16.0 +0.5
      8th Grade — — — — — — — — — — — — — — — — — — — — — 1.0 1.1 1.1 0.9 0.7 0.6 0.0  
      10th Grade — — — — — — — — — — — — — — — — — — — — — 1.6 1.2 1.3 1.1 0.9 0.6 -0.3  
      12th Grade — — — — — — — — — — — — — — — — — — — — 1.5 1.6 1.9 1.1 1.4 1.1 1.4 +0.3  
      College Students — — — — — — — — — — — — — — — — — — — — 0.0 0.3 0.2 0.5 1.1 0.3 0.7 +0.4
      Young Adults — — — — — — — — — — — — — — — — — — — — 0.3 0.6 0.3 0.5 0.4 0.5 0.8 +0.3
Snus p,s
      8th Grade — — — — — — — — — — — — — — — — — — — — — 2.4 2.0 2.2 1.9 2.2 1.1 -1.0 ss
      10th Grade — — — — — — — — — — — — — — — — — — — — — 6.9 5.2 4.5 4.0 3.0 2.6 -0.4  
      12th Grade — — — — — — — — — — — — — — — — — — — — 7.9 7.9 7.7 5.8 5.8 5.8 4.2 -1.6  
      College Students — — — — — — — — — — — — — — — — — — — — 6.5 4.7 4.8 5.0 5.8 3.3 4.3 +1.0
      Young Adults — — — — — — — — — — — — — — — — — — — — 6.1 5.7 4.8 4.8 4.8 3.6 4.6 +1.0
Any Vaping jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 13.3 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 23.9 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 27.8 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 23.5 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 23.0 —  
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
Dissolvable Tobacco p,s
TABLE 2-2 (cont.)
Small Cigars s
Tobacco using a Hookah s
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2016–
2017
change
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Vaping Nicotine jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 7.5 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 15.8 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 18.8 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 13.0 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 14.4 —  
Vaping Marijuana jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 3.0 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 8.1 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.5 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 10.7 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 12.6 —  
Vaping Just Flavoring jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 11.8 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 19.3 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 20.6 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 13.1 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 9.9 —  
      8th Grade 1.0 1.1 0.9 1.2 1.0 0.9 1.0 1.2 1.7 1.7 1.6 1.5 1.4 1.1 1.1 0.9 0.8 0.9 0.8 0.5 0.7 0.6 0.6 0.6 0.5 0.5 0.6 +0.1  
      10th Grade 1.1 1.1 1.0 1.1 1.2 1.2 1.2 1.2 1.7 2.2 2.1 2.2 1.7 1.5 1.3 1.2 1.1 0.9 0.8 1.0 0.9 0.8 0.8 0.8 0.7 0.7 0.7 0.0  
      12th Grade 1.4 1.1 1.2 1.3 1.5 1.4 1.4 1.7 1.8 1.7 2.4 2.5 2.1 2.5 1.5 1.8 1.4 1.5 1.5 1.5 1.2 1.3 1.5 1.5 1.7 1.0 1.1 0.0  
      College Students 0.6 0.2 0.9 0.2 0.4 0.2 0.7 0.2 0.9 0.1 0.6 0.5 0.3 0.6 0.5 0.8 0.6 0.1 0.7 0.3 0.2 0.3 0.8 0.5 0.3 0.0 0.6 +0.6
      Young Adults 0.5 0.4 0.3 0.4 0.5 0.3 0.5 0.4 0.6 0.4 0.4 0.4 0.5 0.5 0.5 0.3 0.7 0.4 0.7 0.8 0.2 0.4 0.5 0.7 0.5 0.4 0.3 -0.1
Previously surveyed drugs that have been dropped
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.9 0.5 0.9 1.1 1.1 1.6 1.2 1.4 0.9 0.6 0.6 1.1 0.9 0.8 0.6 0.5 0.8 0.6 0.9 — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 0.2 0.1 0.4 0.3 — — — — — — — — — — — — — — — — — — — — — — — —
(Entries are percentages.)
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2017
Nitrites e
Steroids y,z
change
2016-
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — 1.8 1.3 1.5 — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — 0.2 0.0 0.2 — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — 0.5 0.5 0.3 — — — — — — —
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.5 0.6 0.2 0.8 0.7 1.1 1.0 1.1 1.1 0.3 0.8 0.9 0.6 0.8 0.9 0.8 0.5 0.5 0.6 0.3 0.3 0.4 — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — 3.9 2.7 2.7 2.0 1.7 1.6 — — — — — — — — — — — — —
      10th Grade — — — — — — — — — 6.4 4.9 3.1 2.8 2.1 1.6 — — — — — — — — — — — — —
      12th Grade — — — — — — — — — 9.2 7.0 5.9 4.0 3.6 3.3 2.3 1.7 1.9 1.5 1.4 — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Kreteks p,ff
      8th Grade — — — — — — — — — — 2.6 2.6 2.0 1.9 1.4 — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — 6.0 4.9 3.8 3.7 2.8 — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — 10.1 8.4 6.7 6.5 7.1 6.2 6.8 6.8 5.5 4.6 2.9 3.0 1.6 1.6 — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.  The Monitoring the Future study, the University of Michigan.  
See footnotes following Table 2-4.
(Entries are percentages.)
2016-
2017
change
Methaqualone m,s
Provigil m,q
Bidis p,ff
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 5.7 6.8 8.4 10.9 12.4 14.6 12.9 12.1 12.2 11.9 11.7 10.4 9.7 8.4 8.5 8.1 7.4 7.6 8.1 9.5 8.5 7.7‡ 8.7 8.3 8.1 6.9 7.0 +0.1  
      10th Grade 11.6 11.0 14.0 18.5 20.2 23.2 23.0 21.5 22.1 22.5 22.7 20.8 19.5 18.3 17.3 16.8 16.9 15.8 17.8 18.5 19.2 18.6‡ 19.2 18.5 16.5 15.9 17.2 +1.3  
      12th Grade 16.4 14.4 18.3 21.9 23.8 24.6 26.2 25.6 25.9 24.9 25.7 25.4 24.1 23.4 23.1 21.5 21.9 22.3 23.3 23.8 25.2 25.2‡ 25.2 23.7 23.6 24.4 24.9 +0.4  
      College Students 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6 21.5 21.9 21.5 21.4 21.2 19.5 19.2 19.3 18.9 20.7 19.2 21.4 22.3‡ 22.8 22.7 23.4 24.3 23.3 -0.9
      Young Adults 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 18.5 18.9 19.3 19.8 18.9 20.6 19.9‡ 21.6 22.3 23.2 23.5 24.7 +1.2
      8th Grade 3.8 4.7 5.3 5.6 6.5 6.9 6.0 5.5 5.5 5.6‡ 5.5 4.7 4.7 4.1 4.1 3.8 3.6 3.8 3.5 3.5 3.4 2.6‡ 3.6 3.3 3.1 2.7 2.7 0.0  
      10th Grade 5.5 5.7 6.5 7.1 8.9 8.9 8.8 8.6 8.6 8.5‡ 8.7 8.1 6.9 6.9 6.4 6.3 6.9 5.3 5.7 5.8 5.4 5.0‡ 4.9 5.6 4.9 4.4 4.5 +0.1  
      12th Grade 7.1 6.3 7.9 8.8 10.0 9.5 10.7 10.7 10.4 10.4‡ 11.0 11.3 10.4 10.8 10.3 9.8 9.5 9.3 8.6 8.6 8.9 8.4‡ 8.2 7.7 7.6 6.9 6.3 -0.6  
      College Students 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4 6.9‡ 7.5 7.8 8.2 9.1 8.2 8.2 8.1 7.3 8.4 8.1 8.2 7.8‡ 8.8 10.0 9.2 8.4 7.0 -1.5
      Young Adults 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4‡ 7.0 7.7 8.3 8.5 8.2 8.1 8.6 8.9 8.5 8.6 8.4 7.8‡ 8.3 9.9 8.7 9.2 8.7 -0.5
      8th Grade 8.8 10.0 12.0 14.3 16.1 17.5 16.0 14.9 15.1 14.4 14.0 12.6 12.1 11.2 11.2 10.9 10.1 10.4 10.6 11.7 10.5 9.5‡ 10.0 9.5 9.3 7.9 8.6 +0.8  
      10th Grade 13.1 12.6 15.5 20.0 21.6 24.5 24.1 22.5 23.1 23.6 23.6 21.7 20.5 19.3 18.4 17.7 18.1 16.8 18.8 19.4 20.1 19.3‡ 20.0 19.1 17.1 16.4 18.0 +1.5  
      12th Grade 17.8 15.5 19.3 23.0 24.8 25.5 26.9 26.6 26.4 26.4 26.5 25.9 24.6 23.3 24.2 22.1 22.8 22.8 24.1 24.5 26.2 25.2‡ 26.5 24.3 24.7 24.6 25.7 +1.1  
      College Students 15.1 16.5 15.7 16.4 19.6 18.0 19.6 21.0 21.8 22.6 21.9 21.9 21.6 21.7 19.0 19.7 18.1 18.9 21.3 20.5 20.6 20.0‡ 23.5 21.1 23.3 24.1 23.4 -0.7
      Young Adults 15.4 15.3 15.1 16.1 16.1 16.4 16.9 16.7 17.4 18.8 19.2 19.5 20.1 19.6 18.0 18.4 19.1 19.3 20.3 19.6 20.3 19.1‡ 23.5 20.9 22.7 23.2 24.4 +1.2
      8th Grade 3.2 3.7 5.1 7.8 9.1 11.3 10.2 9.7 9.7 9.1 9.2 8.3 7.5 6.4 6.6 6.5 5.7 5.8 6.5 8.0 7.2 6.5 7.0 6.5 6.5 5.4 5.5 0.0  
      10th Grade 8.7 8.1 10.9 15.8 17.2 20.4 20.5 18.7 19.4 19.7 19.8 17.8 17.0 15.9 15.2 14.2 14.2 13.8 15.9 16.7 17.6 17.0 18.0 16.6 14.8 14.0 15.7 +1.7 s
      12th Grade 13.8 11.9 15.5 19.0 21.2 21.9 23.7 22.8 23.1 21.6 22.4 21.5 21.2 19.9 19.8 18.3 18.8 19.4 20.6 21.4 22.6 22.9 22.7 21.2 21.3 22.5 22.9 +0.4  
      College Students 14.1 14.6 14.2 15.1 18.6 17.5 17.7 18.6 20.7 20.0 20.2 19.7 19.3 18.9 17.1 16.7 16.8 17.0 18.5 17.5 19.4 20.5 20.6 20.8 21.1 22.2 21.2 -1.0
      Young Adults 13.5 13.3 13.4 14.1 14.0 15.1 15.0 14.9 15.6 16.1 16.7 16.9 17.3 16.5 15.8 15.7 16.0 16.0 17.0 16.1 18.3 17.7 19.0 19.2 20.1 21.6 23.0 +1.4
      8th Grade 4.4 4.7 5.4 5.6 6.1 5.8 5.6 4.8 5.0 4.5 4.0 3.8 4.1 4.5 4.2 4.1 3.9 4.1 3.8 3.6 3.2 2.7 2.3 2.2 2.0 1.8 2.1 +0.4  
      10th Grade 2.7 2.7 3.3 3.6 3.5 3.3 3.0 2.9 2.6 2.6 2.4 2.4 2.2 2.4 2.2 2.3 2.5 2.1 2.2 2.0 1.7 1.4 1.3 1.1 1.2 1.0 1.1 +0.1  
      12th Grade 2.4 2.3 2.5 2.7 3.2 2.5 2.5 2.3 2.0 2.2 1.7 1.5 1.5 1.5 2.0 1.5 1.2 1.4 1.2 1.4 1.0 0.9 1.0 0.7 0.7 0.8 0.8 0.0  
      College Students 0.9 1.1 1.3 0.6 1.6 0.8 0.8 0.6 1.5 0.9 0.4 0.7 0.4 0.4 0.3 0.4 0.1 0.4 0.1 0.5 0.3 0.2 0.1 0.3 0.2 0.0 0.9 +0.9 s
      Young Adults 0.5 0.6 0.7 0.5 0.7 0.5 0.5 0.7 0.8 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.4 0.2 0.1 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.0
2017
TABLE 2-3
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
(Entries are percentages.)
change
Any Illicit Drug a
Any Illicit Drug other
  than Marijuana a,b
Any Illicit Drug
  including
  Inhalants a,c,d
Marijuana/Hashish
Inhalants c,d
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 0.8 1.1 1.2 1.3 1.7 1.9 1.8 1.4 1.3 1.2‡ 1.6 1.2 1.2 1.0 1.1 0.9 1.0 0.9 0.9 1.0 1.0 0.6 0.8 0.5 0.6 0.6 0.5 -0.1  
      10th Grade 1.6 1.8 1.9 2.4 3.3 2.8 3.3 3.2 2.9 2.3‡ 2.1 1.6 1.5 1.6 1.5 1.5 1.7 1.3 1.4 1.6 1.4 1.2 1.1 1.2 0.9 0.9 1.1 +0.2  
      12th Grade 2.2 2.1 2.7 3.1 4.4 3.5 3.9 3.8 3.5 2.6‡ 3.3 2.3 1.8 1.9 1.9 1.5 1.7 2.2 1.6 1.9 1.6 1.6 1.4 1.5 1.6 1.4 1.6 +0.1  
      College Students 1.2 2.3 2.5 2.1 3.3 1.9 2.1 2.1 2.0 1.4‡ 1.8 1.2 1.8 1.3 1.2 0.9 1.3 1.7 1.0 1.4 1.2 1.1 1.0 1.0 1.4 0.8 1.2 +0.4
      Young Adults 1.1 1.5 1.2 1.4 1.7 1.2 1.5 1.4 1.3 1.2‡ 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 1.0 0.9 0.6 1.0 0.9 1.1 0.8 0.9 +0.1
      8th Grade 0.6 0.9 1.0 1.1 1.4 1.5 1.5 1.1 1.1 1.0 1.0 0.7 0.6 0.5 0.5 0.4 0.5 0.5 0.5 0.6 0.5 0.3 0.5 0.3 0.4 0.4 0.3 -0.1  
      10th Grade 1.5 1.6 1.6 2.0 3.0 2.4 2.8 2.7 2.3 1.6 1.5 0.7 0.6 0.6 0.6 0.7 0.7 0.7 0.5 0.7 0.7 0.5 0.6 0.6 0.6 0.7 0.8 +0.1  
      12th Grade 1.9 2.0 2.4 2.6 4.0 2.5 3.1 3.2 2.7 1.6 2.3 0.7 0.6 0.7 0.7 0.6 0.6 1.1 0.5 0.8 0.8 0.8 0.8 1.0 1.1 1.0 1.2 +0.2  
      College Students 0.8 1.8 1.6 1.8 2.5 0.9 1.1 1.5 1.2 0.9 1.0 0.2 0.2 0.2 0.1 0.3 0.3 0.8 0.3 0.7 0.5 0.4 0.4 0.5 0.7 0.4 0.8 +0.5
      Young Adults 0.8 1.1 0.8 1.1 1.3 0.7 0.9 1.0 0.8 0.8 0.7 0.3 0.2 0.1 0.1 0.2 0.2 0.4 0.2 0.4 0.3 0.3 0.4 0.4 0.7 0.6 0.6 0.0
      8th Grade 0.3 0.4 0.5 0.7 0.8 0.9 0.7 0.7 0.6 0.6‡ 1.1 1.0 1.0 0.8 0.9 0.7 0.7 0.7 0.7 0.8 0.7 0.5 0.5 0.4 0.3 0.3 0.3 0.0  
      10th Grade 0.4 0.5 0.7 1.0 1.0 1.0 1.2 1.4 1.2 1.2‡ 1.4 1.4 1.2 1.4 1.3 1.3 1.4 1.0 1.1 1.2 1.1 0.9 0.8 0.8 0.6 0.5 0.6 +0.0  
      12th Grade 0.7 0.5 0.8 1.2 1.3 1.6 1.7 1.6 1.6 1.7‡ 1.9 2.0 1.5 1.7 1.6 1.3 1.4 1.6 1.4 1.5 1.2 1.3 1.0 1.0 0.9 0.7 1.0 +0.2  
      College Students 0.6 0.7 1.1 0.8 1.6 1.2 1.2 0.7 1.2 0.8‡ 0.8 1.1 1.7 1.2 1.1 0.7 1.1 1.3 0.8 1.2 0.8 0.7 0.8 0.7 0.9 0.5 0.6 +0.1
      Young Adults 0.3 0.5 0.6 0.6 0.6 0.6 0.7 0.5 0.6 0.7‡ 0.6 0.8 1.2 0.9 0.8 0.6 0.8 0.7 0.7 0.8 0.6 0.4 0.7 0.6 0.5 0.3 0.6 +0.3
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.5 0.6 1.0 0.7 0.6 1.3 0.7 1.0 0.8 0.9 0.5 0.4 0.6 0.4 0.7 0.4 0.5 0.6 0.5 0.8 0.8 0.5 0.4 — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 0.1 0.2 0.2 0.1 * 0.1 0.1 0.2 0.2 * * 0.1 0.1 0.1 * * * 0.1 * 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0
      8th Grade, original — — — — — 1.0 1.0 0.9 0.8 1.4 1.8 1.4 0.7 0.8 0.6 0.7 0.6 0.8 0.6 1.1 0.6 0.5 0.5 0.4 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 0.7 0.5 0.3 0.4 0.0  
      10th Grade, original — — — — — 1.8 1.3 1.3 1.8 2.6 2.6 1.8 1.1 0.8 1.0 1.2 1.2 1.1 1.3 1.9 1.6 1.0 1.2 0.8 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.1 0.9 0.5 0.5 0.0  
      12th Grade, original — — — — — 2.0 1.6 1.5 2.5 3.6 2.8 2.4 1.3 1.2 1.0 1.3 1.6 1.8 1.8 1.4 2.3 0.9 1.5 1.4 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.5 1.1 0.9 0.9 0.0  
      College Students
Original 0.2 0.4 0.3 0.2 0.7 0.7 0.8 0.8 2.1 2.5 1.5 0.7 1.0 0.7 0.8 0.6 0.4 0.6 0.5 1.0 0.7 1.4 0.8 1.4 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.0 0.7 1.0 0.5 -0.5
      Young Adults
Original 0.1 0.3 0.3 0.2 0.4 0.3 0.6 0.8 1.3 1.9 1.8 1.3 0.8 0.6 0.6 0.7 0.5 0.6 0.6 0.8 0.7 1.0 1.1 1.3 — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.4 0.8 1.3 0.8 -0.5
Hallucinogens b,f
  LSD b
(Table continued on next page.)
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2016–
  Hallucinogens
2017
change
    other than LSD b
  PCP g
  Ecstasy (MDMA) h
50
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 0.5 0.7 0.7 1.0 1.2 1.3 1.1 1.4 1.3 1.2 1.2 1.1 0.9 0.9 1.0 1.0 0.9 0.8 0.8 0.6 0.8 0.5 0.5 0.5 0.5 0.3 0.4 +0.1  
      10th Grade 0.7 0.7 0.9 1.2 1.7 1.7 2.0 2.1 1.8 1.8 1.3 1.6 1.3 1.7 1.5 1.5 1.3 1.2 0.9 0.9 0.7 0.8 0.8 0.6 0.8 0.4 0.5 +0.1  
      12th Grade 1.4 1.3 1.3 1.5 1.8 2.0 2.3 2.4 2.6 2.1 2.1 2.3 2.1 2.3 2.3 2.5 2.0 1.9 1.3 1.3 1.1 1.1 1.1 1.0 1.1 0.9 1.2 +0.3  
      College Students 1.0 1.0 0.7 0.6 0.7 0.8 1.6 1.6 1.2 1.4 1.9 1.6 1.9 2.4 1.8 1.8 1.7 1.2 1.3 1.0 1.2 1.1 0.9 1.8 1.5 1.4 1.3 -0.1
      Young Adults 2.0 1.8 1.4 1.3 1.5 1.2 1.6 1.7 1.9 1.7 2.2 2.2 2.4 2.2 2.2 2.3 2.1 1.9 1.8 1.4 1.5 1.3 1.5 1.8 1.7 1.8 1.9 +0.1
      8th Grade 0.3 0.5 0.4 0.7 0.7 0.8 0.7 0.9 0.8 0.8 0.8 0.8 0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.4 0.5 0.3 0.3 0.3 0.3 0.2 0.3 +0.1  
      10th Grade 0.3 0.4 0.5 0.6 0.9 0.8 0.9 1.1 0.8 0.9 0.7 1.0 0.7 0.8 0.7 0.7 0.5 0.5 0.4 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.3 +0.1  
      12th Grade 0.7 0.6 0.7 0.8 1.0 1.0 0.9 1.0 1.1 1.0 1.1 1.2 0.9 1.0 1.0 0.9 0.9 0.8 0.6 0.7 0.5 0.6 0.6 0.7 0.6 0.5 0.6 +0.1  
      College Students 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.1 0.3 0.4 0.4 0.1 * 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0  
      Young Adults 0.4 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0
    than Crack j
      8th Grade 0.5 0.5 0.6 0.9 1.0 1.0 0.8 1.0 1.1 0.9 0.9 0.8 0.7 0.7 0.7 0.7 0.6 0.6 0.7 0.5 0.6 0.3 0.3 0.4 0.4 0.3 0.3 0.0  
      10th Grade 0.6 0.6 0.7 1.0 1.4 1.3 1.6 1.8 1.6 1.6 1.2 1.3 1.1 1.5 1.3 1.3 1.1 1.0 0.8 0.7 0.6 0.7 0.7 0.5 0.7 0.3 0.4 +0.1  
      12th Grade 1.2 1.0 1.2 1.3 1.3 1.6 2.0 2.0 2.5 1.7 1.8 1.9 1.8 2.2 2.0 2.4 1.7 1.7 1.1 1.1 1.0 1.0 0.9 0.9 1.1 0.6 1.1 +0.5 ss
      College Students 1.0 0.9 0.6 0.3 0.8 0.6 1.3 1.5 1.0 0.9 1.5 1.4 1.9 2.2 1.8 1.3 1.6 1.1 1.2 1.0 1.2 1.3 0.9 1.8 1.4 1.7 1.1 -0.6
      Young Adults 1.8 1.7 1.1 1.0 1.3 1.1 1.5 1.5 1.6 1.5 1.8 2.0 2.1 2.1 1.9 1.9 2.0 1.7 1.6 1.5 1.4 1.3 1.3 1.8 1.6 2.0 1.9 -0.2
      8th Grade 0.3 0.4 0.4 0.6 0.6 0.7 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.4 0.4 0.2 0.3 0.3 0.1 0.2 0.2 0.0  
      10th Grade 0.2 0.2 0.3 0.4 0.6 0.5 0.6 0.7 0.7 0.5 0.3 0.5 0.3 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.2 0.2 0.1 -0.1  
      12th Grade 0.2 0.3 0.2 0.3 0.6 0.5 0.5 0.5 0.5 0.7 0.4 0.5 0.4 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.2 0.3 +0.1  
      College Students 0.1 * * * 0.1 * 0.2 0.1 0.1 0.2 0.1 *  * 0.1 0.1 0.2 0.1  * 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 -0.2
      Young Adults * 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 * 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.3 0.2 -0.1
      8th Grade —  — — — 0.4 0.5 0.4 0.5 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.0  
      10th Grade — — — — 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 -0.1  
      12th Grade — — — — 0.3 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.4 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.0  
      College Students — — — — * * 0.1 * 0.1 0.1 * * 0.1 0.1 0.1 0.1 * 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 +0.1
      Young Adults — — — — * * 0.1 * 0.1 * 0.2 *  * 0.1 0.1 0.1 *  * 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.3 0.1 -0.2
change
(Table continued on next page.)
2016–
2017
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
(Entries are percentages.)
TABLE 2-3 (cont.)
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
Cocaine
  Crack i
  Cocaine other 
Heroin k,l
  With a Needle l
51
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade —  — — — 0.3 0.4 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0  
      10th Grade — — — — 0.3 0.3 0.4 0.5 0.5 0.4 0.2 0.4 0.2 0.3 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.0  
      12th Grade — — — — 0.6 0.4 0.6 0.4 0.4 0.7 0.3 0.5 0.4 0.3 0.5 0.3 0.4 0.2 0.3 0.4 0.4 0.2 0.2 0.4 0.3 0.1 0.2 0.0  
      College Students — — — — * 0.1 0.2 0.2 0.3 0.4 0.3 * * 0.3 * 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 +0.2
      Young Adults — — — — 0.1 * 0.1 0.2 0.2 0.2 0.4 * 0.1 0.1 0.1 0.3 0.2  * 0.3 0.1 0.1 0.1 0.4 0.1 0.2 0.3 0.2 -0.2
  than Heroin m,n
      8th Grade —  — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.1 1.2 1.3 1.5 1.8 2.0 2.3 2.4 2.6 2.9 3.0‡ 4.0 4.1 4.3 3.9 3.8 3.8 3.8 4.1 3.6 3.6 3.0 2.8 2.2 2.1 1.7 1.6 -0.1  
      College Students 0.6 1.0 0.7 0.4 1.2 0.7 1.3 1.1 1.0 1.7 1.7‡ 3.2 2.3 3.0 3.1 3.1 2.2 2.3 2.7 2.3 2.1 2.2 1.5 1.2 1.3 1.1 0.7 -0.5
      Young Adults 0.6 0.7 0.7 0.6 0.9 0.7 0.9 0.9 1.2 1.4 1.7‡ 2.9 2.9 3.0 3.5 3.2 3.4 3.6 3.2 3.4 2.9 2.7 2.6 2.1 1.8 1.9 1.1 -0.8 ss
      8th Grade 2.6 3.3 3.6 3.6 4.2 4.6 3.8 3.3 3.4 3.4 3.2 2.8 2.7 2.3 2.3 2.1 2.0 2.2 1.9 1.8 1.8 1.3‡ 2.3 2.1 1.9 1.7 1.7 0.0  
      10th Grade 3.3 3.6 4.3 4.5 5.3 5.5 5.1 5.1 5.0 5.4 5.6 5.2 4.3 4.0 3.7 3.5 4.0 2.8 3.3 3.3 3.1 2.8‡ 3.3 3.7 3.1 2.7 2.5 -0.2  
      12th Grade 3.2 2.8 3.7 4.0 4.0 4.1 4.8 4.6 4.5 5.0 5.6 5.5 5.0 4.6 3.9 3.7 3.7 2.9 3.0 3.3 3.7 3.3‡ 4.2 3.8 3.2 3.0 2.6 -0.4  
      College Students 1.0 1.1 1.5 1.5 2.2 0.9 2.1 1.7 2.3 2.9 3.3 3.0 3.1 3.2 2.9 2.5 3.1 2.8 3.4 4.1 4.5 4.6‡ 5.0 4.8 4.2 3.8 3.6 -0.2
      Young Adults 1.5 1.5 1.5 1.7 1.7 1.5 1.7 1.7 1.9 2.3 2.4 2.5 2.5 2.4 2.1 2.2 2.3 2.2 2.5 2.9 3.0 3.2‡ 3.0 3.5 3.1 2.9 3.1 +0.2
      8th Grade — — — — — — — — 1.1 0.8 1.3 1.1 1.2 0.6 0.7 0.6 0.6 0.7 0.5 0.7 0.4 0.5 0.4 0.2 0.3 0.3 0.2 -0.1  
      10th Grade — — — — — — — — 1.8 2.0 1.5 1.8 1.4 1.3 1.1 0.7 0.4 0.7 0.6 0.7 0.5 0.6 0.4 0.3 0.3 0.2 0.1 -0.1  
      12th Grade — — — — — — — — 1.7 1.9 1.5 1.7 1.7 1.4 0.9 0.9 0.6 0.6 0.5 0.5 0.6 0.5 0.4 0.5 0.4 0.3 0.3 +0.1  
      College Students — — — — — — — — 1.2 0.2 0.5 0.2 0.6 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0
      Young Adults — — — — — — — — 0.8 0.7 1.0 1.0 0.7 0.6 0.7 0.5 0.6 0.3 0.3 0.2 0.3 0.4 0.2 0.3 0.0 0.2 0.2 0.0
Crystal Methamphetamine (Ice) q
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.6 0.5 0.6 0.7 1.1 1.1 0.8 1.2 0.8 1.0 1.1 1.2 0.8 0.8 0.9 0.7 0.6 0.6 0.5 0.6 0.6 0.4 0.8 0.4 0.3 0.4 0.5 0.0  
      College Students * * 0.3 0.5 0.3 0.1 0.2 0.3 * * 0.1 * 0.3 0.1 0.2 * 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 +0.4
      Young Adults * 0.1 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.4 0.1 0.3 0.1 0.4 +0.3
Amphetamines m,o
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
2016–
2017
change
  Methamphetamine p,q
  Without a Needle l
Narcotics other
(Table continued on next page.)
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.1 1.3 1.7 2.2 2.1 2.1 2.6 2.6 3.0 2.8 3.2 2.9‡ 2.9 3.3 3.0 2.7 2.8 2.5 2.2 1.8 2.0 2.2 2.0 1.7 1.5 1.4 0.0  
      College Students 0.3 0.7 0.4 0.4 0.5 0.8 1.2 1.1 1.1 1.1 1.5 1.7 1.7 1.5 1.3 1.3 1.4 1.4 1.2 0.6 0.8 0.8‡ 0.9 0.7 1.0 0.9 0.5 -0.4
      Young Adults 0.5 0.5 0.6 0.6 0.8 0.8 0.9 0.9 1.1 1.3 1.7 1.5 1.5 1.8 1.7 1.5 1.6 1.9 1.2 1.1 1.1 1.1‡ 1.2 1.0 0.9 1.1 0.6 -0.5 s
      8th Grade 0.8 0.8 0.9 1.1 1.2 1.5 1.2 1.2 1.1 1.4‡ 1.2 1.2 1.4 1.2 1.3 1.3 1.1 1.2 1.2 1.2 1.0 0.8 0.9 0.8 0.8 0.8 0.7 0.0  
      10th Grade 1.2 1.5 1.1 1.5 1.7 1.7 2.2 2.2 2.2 2.5‡ 2.9 2.9 2.4 2.3 2.3 2.4 2.6 1.9 2.0 2.2 1.9 1.7 1.6 1.6 1.7 1.5 1.5 0.0  
      12th Grade 1.4 1.0 1.2 1.4 1.8 2.0 1.8 2.4 2.5 2.6‡ 2.9 3.3 2.8 3.1 2.9 2.7 2.6 2.6 2.7 2.5 2.3 2.1 2.0 2.1 2.0 1.9 2.0 +0.2  
      College Students 0.6 0.6 0.4 0.4 0.5 0.7 1.2 1.3 1.1 2.0‡ 1.5 3.0 2.8 2.7 2.2 2.1 1.8 1.6 2.2 1.3 1.6 1.1 1.2 1.7 1.6 1.8 0.9 -0.9
      Young Adults 0.9 1.0 1.0 0.8 1.1 0.7 1.1 1.2 1.3 1.8‡ 2.1 2.8 2.4 2.7 2.6 2.3 2.8 2.7 2.8 2.2 2.3 1.9 1.9 1.9 1.7 1.9 1.4 -0.5
Any Prescription Drug o,t
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — 8.6 8.1 7.8 7.2 7.3 6.9 7.2 7.0‡ 7.1 6.4 5.9 5.4 4.9 -0.5  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — 0.5 0.3 0.4 0.3 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.6 0.1 0.1 0.2 0.1 0.2 0.1 -0.1  
      10th Grade — — — — — 0.5 0.5 0.4 0.5 0.4 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.1 0.3 0.0 -0.3 s
      12th Grade — — — — — 0.5 0.3 0.3 0.3 0.4 0.3 — — — — — — — — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
  Any Use
      8th Grade 25.1 26.1‡ 24.3 25.5 24.6 26.2 24.5 23.0 24.0 22.4 21.5 19.6 19.7 18.6 17.1 17.2 15.9 15.9 14.9 13.8 12.7 11.0 10.2 9.0 9.7 7.3 8.0 +0.7  
      10th Grade 42.8 39.9‡ 38.2 39.2 38.8 40.4 40.1 38.8 40.0 41.0 39.0 35.4 35.4 35.2 33.2 33.8 33.4 28.8 30.4 28.9 27.2 27.6 25.7 23.5 21.5 19.9 19.7 -0.2  
      12th Grade 54.0 51.3‡ 48.6 50.1 51.3 50.8 52.7 52.0 51.0 50.0 49.8 48.6 47.5 48.0 47.0 45.3 44.4 43.1 43.5 41.2 40.0 41.5 39.2 37.4 35.3 33.2 33.2 -0.1  
      College Students 74.7 71.4 70.1 67.8 67.5 67.0 65.8 68.1 69.6 67.4 67.0 68.9 66.2 67.7 67.9 65.4 66.6 69.0 65.8 65.0 63.5 67.7 63.1 63.1 63.2 63.2 62.0 -1.2
      Young Adults 70.6 69.0 68.3 67.7 68.1 66.7 67.5 66.9 68.2 66.8 67.0 68.3 67.0 68.4 68.6 68.7 69.5 68.9 69.4 68.4 68.8 69.5 68.7 68.4 66.9 68.4 67.1 -1.3
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
Sedatives 
Alcohol v
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
(Entries are percentages.)
Tranquilizers b,m
  (Barbiturates) m,r
(Table continued on next page.)
Rohypnol u
2017
change
53
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade 7.6 7.5 7.8 8.7 8.3 9.6 8.2 8.4 9.4 8.3 7.7 6.7 6.7 6.2 6.0 6.2 5.5 5.4 5.4 5.0 4.4 3.6 3.5 2.7 3.1 1.8 2.2 +0.5 s
      10th Grade 20.5 18.1 19.8 20.3 20.8 21.3 22.4 21.1 22.5 23.5 21.9 18.3 18.2 18.5 17.6 18.8 18.1 14.4 15.5 14.7 13.7 14.5 12.8 11.2 10.3 9.0 8.9 -0.1  
      12th Grade 31.6 29.9 28.9 30.8 33.2 31.3 34.2 32.9 32.9 32.3 32.7 30.3 30.9 32.5 30.2 30.0 28.7 27.6 27.4 26.8 25.0 28.1 26.0 23.5 20.6 20.4 19.1 -1.3  
      College Students 45.0 45.0 43.8 42.8 37.9 40.3 46.4 44.3 44.6 43.9 44.7 44.4 40.4 47.4 43.1 47.6 46.8 45.3 42.4 43.6 39.9 40.1 40.2 42.6 38.4 40.8 34.8 -6.0
      Young Adults 35.4 35.6 34.2 34.3 33.0 33.2 35.6 34.2 37.7 35.7 36.8 37.1 37.8 39.0 39.0 42.1 41.4 40.7 40.5 39.4 39.5 39.1 37.7 39.3 34.2 36.6 36.1 -0.5
  Flavored Alcoholic
    Beverages g,p
      8th Grade — — — — — — — — — — — — — 14.6 12.9 13.1 12.2 10.2 9.5 9.4 8.6 7.6 6.3 5.7 5.5 4.0 4.4 +0.4  
      10th Grade — — — — — — — — — — — — — 25.1 23.1 24.7 21.8 20.2 19.0 19.4 15.8 16.3 15.5 14.0 12.8 11.0 12.9 +1.9  
      12th Grade — — — — — — — — — — — — — 31.1 30.5 29.3 29.1 27.4 27.4 24.1 23.1 21.8 21.0 19.9 20.8 18.3 20.2 +1.9  
      College Students — — — — — — — — — — — — — 34.1 30.9 26.2 27.5 35.8 32.3 31.5 29.5 31.3 29.1 32.9 30.5 33.5 36.7 +3.2
      Young Adults — — — — — — — — — — — — — 29.5 27.6 24.9 25.9 26.7 24.4 24.5 23.8 26.1 25.4 26.9 24.7 28.8 27.6 -1.2
  Any Use
      8th Grade 14.3 15.5 16.7 18.6 19.1 21.0 19.4 19.1 17.5 14.6 12.2 10.7 10.2 9.2 9.3 8.7 7.1 6.8 6.5 7.1 6.1 4.9 4.5 4.0 3.6 2.6 1.9 -0.7 ss
      10th Grade 20.8 21.5 24.7 25.4 27.9 30.4 29.8 27.6 25.7 23.9 21.3 17.7 16.7 16.0 14.9 14.5 14.0 12.3 13.1 13.6 11.8 10.8 9.1 7.2 6.3 4.9 5.0 +0.2  
      12th Grade 28.3 27.8 29.9 31.2 33.5 34.0 36.5 35.1 34.6 31.4 29.5 26.7 24.4 25.0 23.2 21.6 21.6 20.4 20.1 19.2 18.7 17.1 16.3 13.6 11.4 10.5 9.7 -0.8  
      College Students 23.2 23.5 24.5 23.5 26.8 27.9 28.3 30.0 30.6 28.2 25.7 26.7 22.5 24.3 23.8 19.2 19.9 17.9 17.9 16.4 15.2 12.5 14.0 12.9 11.3 8.9 8.0 -0.9
      Young Adults 28.2 28.3 28.0 28.0 29.2 30.1 29.9 30.9 30.3 30.1 30.2 29.2 28.4 29.2 28.6 27.0 26.2 24.6 23.3 22.4 21.3 19.7 20.0 17.5 16.6 14.2 15.3 +1.1
      8th Grade 6.9 7.0 6.6 7.7 7.1 7.1 5.5 4.8 4.5 4.2 4.0 3.3 4.1 4.1 3.3 3.7 3.2 3.5 3.7 4.1 3.5 2.8 2.8 3.0 3.2 2.5 1.7 -0.8 s
      10th Grade 10.0 9.6 10.4 10.5 9.7 8.6 8.9 7.5 6.5 6.1 6.9 6.1 5.3 4.9 5.6 5.7 6.1 5.0 6.5 7.5 6.6 6.4 6.4 5.3 4.9 3.5 3.8 +0.3  
      12th Grade — 11.4 10.7 11.1 12.2 9.8 9.7 8.8 8.4 7.6 7.8 6.5 6.7 6.7 7.6 6.1 6.6 6.5 8.4 8.5 8.3 7.9 8.1 8.4 6.1 6.6 4.9 -1.7 s
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Any Vaping jj,kk
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — 8.0 6.2‡ 6.6 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — 14.2 11.0‡ 13.1 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — 16.3 12.5‡ 16.6 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — 8.8 6.9‡ 11.3 —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — 9.2 6.0‡ 11.9 —
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
2017
change
(Entries are percentages.)
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Vaping Nicotine jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 3.5 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 8.2 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 11.0 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 6.1 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 6.5 —  
Vaping Marijuana jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 1.6 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 4.3 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 4.9 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 5.2 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 6.6 —  
Vaping Just Flavoring jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 5.3 —  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.2 —  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.7 —  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 4.3 —  
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 3.3 —  
Tobacco using a Hookah s,hh
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — 2.8 2.5 -0.4  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — 4.0 3.0 -0.9 s
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — 6.1 5.0 -1.1  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — 5.2 4.6 -0.7
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — 3.5 4.2 0.8
Large Cigars ii
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — 1.9 2.4 1.5 1.5 0.0  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — 3.9 3.4 2.3 2.6 +0.4  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — 6.4 7.0 6.5 5.6 -0.9  
      College Students — — — — — — — — — — — — — — — — — — — — — — — 8.4 4.9 4.4 1.7 -2.7
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — 6.6 5.9 3.9 3.5 -0.4
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — 4.1 4.1 2.8 2.6 -0.2  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — 6.9 6.1 4.9 4.0 -1.0  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — 11.9 11.4 9.5 10.1 +0.6  
      College Students — — — — — — — — — — — — — — — — — — — — — — — 9.8 5.6 5.6 4.9 -0.8
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — 6.9 6.9 4.8 5.5 0.8
Flavored Little Cigars ii
(Entries are percentages.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
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change
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — 2.5 3.3 1.9 1.6 -0.2  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — 4.4 3.8 3.0 3.0 0.0  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — 7.0 7.8 6.1 6.6 +0.4  
      College Students — — — — — — — — — — — — — — — — — — — — — — — 8.6 4.1 3.6 1.7 -2.0
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — 5.8 3.8 3.6 2.8 -0.8
      8th Grade 0.4 0.5 0.5 0.5 0.6 0.4 0.5 0.5 0.7 0.8 0.7 0.8 0.7 0.5 0.5 0.5 0.4 0.5 0.4 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 0.0  
      10th Grade 0.6 0.6 0.5 0.6 0.6 0.5 0.7 0.6 0.9 1.0 0.9 1.0 0.8 0.8 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.3 0.3 -0.1  
      12th Grade 0.8 0.6 0.7 0.9 0.7 0.7 1.0 1.1 0.9 0.8 1.3 1.4 1.3 1.6 0.9 1.1 1.0 1.0 1.0 1.1 0.7 0.9 1.0 0.9 1.0 0.7 0.8 +0.1  
      College Students 0.3 0.2 0.2 0.2 0.1 * 0.2 0.2 0.4 * 0.3 * 0.1 * * * 0.1 * 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 +0.3
      Young Adults 0.2 0.1 * 0.1 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.3 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.0
Previously surveyed drugs that have been dropped
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.4 0.3 0.6 0.4 0.4 0.7 0.7 1.0 0.4 0.3 0.5 0.6 0.7 0.7 0.5 0.3 0.5 0.3 0.6 — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults * 0.1 0.2 0.1 — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.2 0.4 0.1 0.4 0.4 0.6 0.3 0.6 0.4 0.2 0.5 0.3 0.4 0.5 0.5 0.4 0.4 0.2 0.3 0.2 0.2 0.3 — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.  The Monitoring the Future study, the University of Michigan.  
See footnotes following Table 2-4.
Regular Little Cigars ii
  Methaqualone m,s
Nitrites e
Steroids y,z
2017
change
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2016–
56
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Marijuana/Hashish
  Daily gg
      8th Grade 0.2 0.2 0.4 0.7 0.8 1.5 1.1 1.1 1.4 1.3 1.3 1.2 1.0 0.8 1.0 1.0 0.8 0.9 1.0 1.2 1.3 1.1 1.1 1.0 1.1 0.7 0.8 0.0  
      10th Grade 0.8 0.8 1.0 2.2 2.8 3.5 3.7 3.6 3.8 3.8 4.5 3.9 3.6 3.2 3.1 2.8 2.8 2.7 2.8 3.3 3.6 3.5 4.0 3.4 3.0 2.5 2.9 +0.4  
      12th Grade 2.0 1.9 2.4 3.6 4.6 4.9 5.8 5.6 6.0 6.0 5.8 6.0 6.0 5.6 5.0 5.0 5.1 5.4 5.2 6.1 6.6 6.5 6.5 5.8 6.0 6.0 5.9 -0.1  
      College Students 1.8 1.6 1.9 1.8 3.7 2.8 3.7 4.0 4.0 4.6 4.5 4.1 4.7 4.5 4.0 4.3 3.5 3.9 4.9 4.4 4.7 4.8 5.1 5.9 4.6 4.9 4.4 -0.5
      Young Adults 2.3 2.3 2.4 2.8 3.3 3.3 3.8 3.7 4.4 4.2 5.0 4.5 5.3 5.0 4.9 5.0 5.0 5.1 5.4 5.3 6.1 5.6 6.2 6.9 6.8 7.6 7.8 +0.2
  Any Daily Use
      8th Grade 0.5 0.6‡ 1.0 1.0 0.7 1.0 0.8 0.9 1.0 0.8 0.9 0.7 0.8 0.6 0.5 0.5 0.6 0.7 0.5 0.5 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0  
      10th Grade 1.3 1.2‡ 1.8 1.7 1.7 1.6 1.7 1.9 1.9 1.8 1.9 1.8 1.5 1.3 1.3 1.4 1.4 1.0 1.1 1.1 0.8 1.0 0.9 0.8 0.5 0.5 0.6 0.0  
      12th Grade 3.6 3.4‡ 3.4 2.9 3.5 3.7 3.9 3.9 3.4 2.9 3.6 3.5 3.2 2.8 3.1 3.0 3.1 2.8 2.5 2.7 2.1 2.5 2.2 1.9 1.9 1.3 1.6 +0.2  
      College Students 4.1 3.7 3.9 3.7 3.0 3.2 4.5 3.9 4.5 3.6 4.7 5.0 4.3 3.7 4.6 4.8 4.3 4.0 4.3 3.6 3.8 3.9 3.6 4.3 3.1 4.3 2.2 -2.1 s
      Young Adults 4.9 4.5 4.5 3.9 3.9 4.0 4.6 4.0 4.8 4.1 4.4 4.7 5.1 4.5 5.2 5.4 5.6 5.3 5.3 4.6 5.2 5.5 5.1 5.0 4.7 5.4 5.0 -0.4
      8th Grade 0.1 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0  
      10th Grade 0.2 0.3 0.4 0.4 0.6 0.4 0.6 0.6 0.7 0.5 0.6 0.5 0.5 0.4 0.4 0.5 0.5 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.2 +0.1  
      12th Grade 0.9 0.8 0.9 1.2 1.3 1.6 2.0 1.5 1.9 1.7 1.4 1.2 1.6 1.8 1.5 1.6 1.3 1.4 1.1 1.6 1.3 1.5 1.3 1.1 0.8 0.8 1.1 +0.3  
      College Students 0.5 0.2 0.3 0.8 0.5 0.1 1.3 0.8 1.0 0.7 0.5 0.8 1.1 0.8 0.5 0.6 0.7 0.5 0.7 0.3 1.3 0.4 0.5 0.4 0.7 0.4 0.0 -0.4
      Young Adults 0.5 0.4 0.4 0.5 0.3 0.4 0.9 0.5 0.9 0.5 0.4 0.6 0.8 0.7 0.5 0.6 0.6 0.5 1.0 0.7 0.7 0.4 0.5 0.6 0.4 0.3 0.3 0.0
  5+ Drinks in a Row
      8th Grade 10.9 11.3 11.3 12.1 12.3 13.3 12.3 11.5 13.1 11.7 11.0 10.3 9.8 9.4 8.4 8.7 8.3 8.1 7.8 7.2 6.4 5.1 5.1 4.1 4.6 3.4 3.7 +0.3  
      10th Grade 21.0 19.1 21.0 21.9 22.0 22.8 23.1 22.4 23.5 24.1 22.8 20.3 20.0 19.9 19.0 19.9 19.6 16.0 17.5 16.3 14.7 15.6 13.7 12.6 10.9 9.7 9.8 +0.1  
      12th Grade 29.8 27.9 27.5 28.2 29.8 30.2 31.3 31.5 30.8 30.0 29.7 28.6 27.9 29.2 27.1 25.4 25.9 24.6 25.2 23.2 21.6 23.7 22.1 19.4 17.2 15.5 16.6 +1.1  
      College Students 42.8 41.4 40.2 40.2 38.6 38.3 40.7 38.9 40.0 39.3 40.9 40.1 38.5 41.7 40.1 40.2 41.1 40.0 36.9 37.0 36.1 37.4 35.2 35.4 31.9 32.4 32.7 +0.3
      Young Adults 34.7 34.2 34.4 33.7 32.6 33.6 34.4 34.1 35.8 34.7 35.9 35.9 35.8 37.1 37.0 37.6 37.8 37.9 36.7 35.9 36.5 35.5 35.1 33.5 31.9 32.3 31.8 -0.5
Cigarettes
  Any Daily Use
      8th Grade 7.2 7.0 8.3 8.8 9.3 10.4 9.0 8.8 8.1 7.4 5.5 5.1 4.5 4.4 4.0 4.0 3.0 3.1 2.7 2.9 2.4 1.9 1.8 1.4 1.3 0.9 0.6 -0.3 s
      10th Grade 12.6 12.3 14.2 14.6 16.3 18.3 18.0 15.8 15.9 14.0 12.2 10.1 8.9 8.3 7.5 7.6 7.2 5.9 6.3 6.6 5.5 5.0 4.4 3.2 3.0 1.9 2.2 +0.4  
      12th Grade 18.5 17.2 19.0 19.4 21.6 22.2 24.6 22.4 23.1 20.6 19.0 16.9 15.8 15.6 13.6 12.2 12.3 11.4 11.2 10.7 10.3 9.3 8.5 6.7 5.5 4.8 4.2 -0.5  
      College Students 13.8 14.1 15.2 13.2 15.8 15.9 15.2 18.0 19.3 17.8 15.0 15.9 13.8 13.8 12.4 9.2 9.3 9.2 8.0 7.6 7.3 5.2 5.6 5.2 4.2 2.6 2.0 -0.6
      Young Adults 21.7 20.9 20.8 20.7 21.2 21.8 20.6 21.9 21.5 21.8 21.2 21.2 20.3 20.8 19.6 18.6 17.3 16.7 15.0 14.8 13.8 12.8 12.1 10.7 9.7 8.2 8.8 +0.6
TABLE 2-4
Trends in 30-Day Prevalence of Daily Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2016–
    in Last 2 Weeks
(Entries are percentages.)
2017
change
Alcohol v,gg
  Been Drunk
    Daily w,gg
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
  1/2 Pack+/Day
      8th Grade 3.1 2.9 3.5 3.6 3.4 4.3 3.5 3.6 3.3 2.8 2.3 2.1 1.8 1.7 1.7 1.5 1.1 1.2 1.0 0.9 0.7 0.6 0.7 0.5 0.4 0.3 0.2 -0.1  
      10th Grade 6.5 6.0 7.0 7.6 8.3 9.4 8.6 7.9 7.6 6.2 5.5 4.4 4.1 3.3 3.1 3.3 2.7 2.0 2.4 2.4 1.9 1.5 1.5 1.2 1.0 0.6 0.7 0.0  
      12th Grade 10.7 10.0 10.9 11.2 12.4 13.0 14.3 12.6 13.2 11.3 10.3 9.1 8.4 8.0 6.9 5.9 5.7 5.4 5.0 4.7 4.3 4.0 3.4 2.6 2.1 1.8 1.7 -0.1  
      College Students 8.0 8.9 8.9 8.0 10.2 8.4 9.1 11.3 11.0 10.1 7.8 7.9 7.6 6.8 6.7 4.9 4.3 4.3 3.8 3.9 2.5 2.4 2.4 2.4 1.4 1.7 0.2 -1.4 ss
      Young Adults 16.0 15.7 15.5 15.3 15.7 15.3 14.6 15.6 15.1 15.1 14.6 14.2 13.9 13.5 12.5 11.9 11.1 10.2 9.3 9.3 7.5 7.6 7.0 6.6 5.7 4.9 4.7 -0.2
  Daily x
      8th Grade 1.6 1.8 1.5 1.9 1.2 1.5 1.0 1.0 0.9 0.9 1.2 0.8 0.8 1.0 0.7 0.7 0.8 0.8 0.8 0.9 0.8 0.5 0.5 0.5 0.8 0.6 0.4 -0.2  
      10th Grade 3.3 3.0 3.3 3.0 2.7 2.2 2.2 2.2 1.5 1.9 2.2 1.7 1.8 1.6 1.9 1.7 1.6 1.4 1.9 2.5 1.7 2.0 1.9 1.8 1.6 1.0 0.6 -0.4  
      12th Grade — 4.3 3.3 3.9 3.6 3.3 4.4 3.2 2.9 3.2 2.8 2.0 2.2 2.8 2.5 2.2 2.8 2.7 2.9 3.1 3.1 3.2 3.0 3.4 2.9 2.7 2.0 -0.7  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.   The Monitoring the Future study, the University of Michigan.
See footnotes on the next page.
Smokeless Tobacco
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
TABLE 2-4 (cont.)
Trends in 30-Day Prevalence of Daily Use of Various Drugs for 8th, 10th,
2016–
2017
change
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Notes.  Level of significance of difference between the two most recent classes: s = .05, ss = .01, sss = .001. ' — ' indicates data not available.'' * ' indicates less 
than 0.05% but greater than  0%. ' ‡ ' indicates that the question changed the following year. See relevant footnote for that drug. See relevant figure to 
assess the impact of the wording changes. Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent
years is due to rounding.
             Approximate 
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th Graders 17,500 18,600 18,300 17,300 17,500 17,800 18,600 18,100 16,700 16,700 16,200 15,100 16,500
10th Graders 14,800 14,800 15,300 15,800 17,000 15,600 15,500 15,000 13,600 14,300 14,000 14,300 15,800
12th Graders 15,000 15,800 16,300 15,400 15,400 14,300 15,400 15,200 13,600 12,800 12,800 12,900 14,600
College Students 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440 1,350 1,340 1,260 1,270
Young Adults 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300
Approximate
Weighted  N s 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
8th Graders 17,000 16,800 16,500 16,100 15,700 15,000 15,300 16,000 14,600 14,600 14,600 14,400 16,900 15,300
10th Graders 16,400 16,200 16,200 16,100 15,100 15,900 15,200 14,900 12,900 12,900 13,000 15,600 14,700 13,500
12th Graders 14,600 14,700 14,200 14,500 14,000 13,700 14,400 14,100 12,600 12,600 12,400 12,900 11,800 12,600
College Students 1,400 1,400 1,300 1,300 1,300 1,300 1,300 1,200 1,200 1,100 1,000 1,000 900 900
Young Adults 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,700
aFor 12th graders, college students, and young adults only: Use of any illicit drug includes any use of marijuana, LSD, other hallucinogens, crack, cocaine other than crack,
or heroin; or any use of narcotics other than heroin, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders. For 8th and 10th graders only:
The use of narcotics other than heroin and sedatives (barbiturates) has been excluded because these younger respondents appear to overreport use (perhaps 
because they include the use of nonprescription drugs in their answers).  Due to changes in the amphetamines questions 2013 data for any illicit drug and any illicit 
drug other than marijuana are based on half the N  indicated.  For any illicit drug including inhalants, 8th and 10th grades, college students, and young adults are 
based on one half the N indicated for 2013; 12th graders are based on one sixth of N  indicated in 2013.
bIn 2001 the question text was changed on half of the questionnaire forms for each age group. Other psychedelics was changed to other hallucinogens and shrooms  
was added to the list of examples. For the tranquilizer list of examples, Miltown was replaced with Xanax. For 8th, 10th, and 12th graders only: The 2001 data  
presented here are based on the changed forms only;  N  is one half of N  indicated. In 2002 the remaining forms were changed to the new wording. The data are 
based on all forms beginning in 2002. Data for any illicit drug other than marijuana and data for hallucinogens are also affected by these changes and have been 
handled in a parallel manner. Beginning in 2014 LSD and hallucinogens other than LSD based on five of six forms; N  is five sixths of N  indicated. Hallucinogens 
was also effected by this change.
cFor 12th graders, college students, and young adults only: Data based on five of six forms in 1991–1998;  N  is five sixths of N  indicated. Data based on three of 
six forms beginning in 1999; N  is three sixths of N  indicated.
dInhalants are unadjusted for underreporting of amyl and butyl nitrites.
eFor 12th graders and young adults only: Data based on one of six forms;  N  is one sixth of N  indicated. Questions about nitrite use were dropped from the young 
adult questionnaires in 1995 and from the 12th-grade questionnaires in 2010.
fHallucinogens are unadjusted for underreporting of PCP.
gFor 12th graders, college students, and young adults only: Data based on one of six forms;  N  is one sixth of N  indicated. For 12th graders only: In 2011 the flavored  
alcoholic beverage question text was changed. Skyy Blue and Zima were removed from the list of examples. An examination of the data did not show any effect from 
the wording change. In 2014 the PCP triplet was dropped from one form and replaced with a single annual use question in a different form.
Footnotes for Tables 2-1 through 2-4
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hFor 8th and 10th graders only: Data based on one of two forms in 1996;  N  is one half of N  indicated. Data based on one third of N  indicated in 1997–2001 due to   
changes in the questionnaire forms. Data based on two of four forms beginning in 2002;  N  is one half of N  indicated. For 12th graders only: Data based on one of 
six forms in 1996–2001;  N  is one sixth of N  indicated. Data based on two of six forms beginning in 2002;  N  is two sixths of N  indicated. For college students and 
young adults only: Data based on two of six forms in 1991–2001;  N  is two sixths of N  indicated. Data based on three of six forms beginning in 2002; N  is three 
sixths of N  indicated. For all levels: In 2014 a revised question on use of ecstasy (MDMA) including "Molly" was added to one form at each level. The 2013 and 
2014 "Original wording" data reported here are for only the questionnaires using the original question wording. The 2014 and 2015 data reported here are for only
the questionnaires using the "Revised wording" which includes "Molly." For 8th and 10th grades the "Original wording" data are based on two of four forms in 2013 
and 2014, N  is one half of N  indicated; the "Revised wording" data are based on one of four forms in 2014, N  is one third of N  indicated and based on three of 
four forms beginning in 2015, N  is five sixths of N  indicated. For 12th grade the "Original wording" data are based on two of six forms in 2013 and 2014, N  is two 
sixths of N  indicated; the "Revised wording" data are based on one of four forms in 2014, N  is one sixth of N  indicated and based on three of six forms beginning 
in 2015, N  is three sixths of N  indicated. For college students and young adults the "Original wording" data are based on three of six forms in 2013 and 2014, N  is 
three sixths of N  indicated; the "Revised wording" data are based on one of six forms in 2014, N  is one sixth of N  indicated and based on four of six forms beginning  
in 2015, N  is four sixths of N  indicated.
iFor college students and young adults only: Data based on five of six forms beginning in 2002;  N  is five sixths of N  indicated.
jFor 12th graders only: Data based on four of six forms; N  is four sixths of N  indicated. For college students and young adults only: Data based on four of six forms; 
N  is four sixths of N  indicated.
kIn 1995, the heroin question was changed in one of two forms for 8th and 10th graders, in three of six forms for 12th graders, and in two of six forms for college  
students and young adults. Separate questions were asked for use with and without injection. In 1996, the heroin question was changed in all remaining 8th- and  
10th-grade forms. Data presented here represent the combined data from all forms. For 8th and 10th graders only: Beginning in 2015 data based on three of four 
four forms; N  is two thirds of N  indicated.
lFor 8th and 10th graders only: Data based on one of two forms in 1995;  N  is one half of N  indicated. Data based on all forms beginning in 1996. For 12th graders   
only: Data based on three of six forms; N  is three sixths of N  indicated. For college students and young adults only: Data based on two of six forms;  N  is two sixths 
of N  indicated.
mOnly drug use not under a doctor’s orders is included here.
narcotics other than heroin was updated: Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—were replaced with Vicodin, OxyContin, 
and Percocet. The 2002 data presented here are based on the changed forms only;  N  is one half of N  indicated. In 2003, the remaining forms were changed to the 
new wording. The data are based on all forms beginning in 2003. In 2013 the list of examples was changed on one form: MS Contin, Roxycodone, Hydrocodone 
(Lortab, Lorcet, Norco), Suboxone, Tylox, and Tramadol were added to the list. An examination of the data did not show any affect from the wording change.
oFor 8th, 10th, and 12th graders: In 2009, the question text was changed slightly in half of the forms. An examination of the data did not show any effect from the
wording change. In 2010 the remaining forms were changed in a like manner. In 2011 the question text was changed slightly in one form; bennies, Benzedrine and 
Methadrine were dropped from the list of examples. An examination of the data did not show any effect from the wording change. In 2013 the question wording was
changed slightly in two of the 8th and 10th grade questionnaires and in three of the 12th grade questionnaires. The new wording in 2013 asked "On how many 
occasions (if any) have taken amphetamines or other prescription stimulant drugs…" In contrast, the old wording did not include the text highlighted in red. Results 
in 2013 indicated higher prevalence in questionnaires with the new wording as compared to the old wording; it was proportionally 61% higher in 8th grade, 34%  
higher in 10th grade, and 21% higher in 12th grade.  2013 data are based on the changed forms only; for 8th, 10th, and 12th graders N  is one half of N  indicated. 
In 2014 all questionnaires included the new, updated wording.
pFor 8th and 10th graders only: Data based on one of four forms;  N  is one third of N  indicated. In 2011 the flavored alcoholic beverage question text was changed.  
Skyy Blue and Zima were removed from the list of examples. An examination of the data did not show any effect from the wording change.
qFor 12th graders only: Data based on two of six forms;  N  is two sixths of N  indicated. Provigil was dropped from the study in 2012. For college students and  
young adults only: Beginning in 2009 Salvia data based on one of six forms;  N  is one sixth of N  indicated. Data based on two of six forms in 2010, 2011, and from
2017 forward; N is two sixths of N  indicated. Data based on three of six forms from 2012-2016; N  is three sixths of N  indicated. For Synthetic Marijuana data 
based on two of six forms in 2011; N  is two sixths of N  indicated. Data based on three of six forms beginning in 2012; N  is three sixths of N  indicated. For Bath 
Salts data based on three of six forms; N  is three sixths of N  indicated. 
(Footnotes continued on next page.)
nFor 12th graders, college students, and young adults only: In 2002 the question text was changed in half of the questionnaire forms. The list of examples of 
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rFor 12th graders only: In 2004 the question text was changed in half of the questionnaire forms. Barbiturates was changed to sedatives, including barbiturates. 
Goofballs, yellows, reds, blues, and rainbows were deleted from the list of examples; Phenobarbital, Tuinal, Nembutal, and Seconal were added. An examination of 
the data did not show any effect from the wording change. In 2005 the remaining forms were changed in a like manner. In 2013 the question text was changed in 
all forms: Tuinal, Nembutal, and Seconal were replaced with Ambien, Lunesta, and Sonata. In one form the list of examples was also changed: Tuinal was dropped
from the list and Dalmane, Restoril, Halcion, Intermezzo, and Zolpimist were added. An examination of the data did not show any effect from the wording change. 
In 2013 the college student and young adult questionnaires were changed in a like manner. An examination of the data showed an affect from the wording change. 
For this reason 2012 and 2013 data are not comparable.
sFor 12th graders only: Data based on one of six forms;  N  is one sixth of N  indicated. Methaqualone was dropped from the study in 2013. For college students 
and young adults only: Data based on three of six forms from 2011-2013. N  is three sixths of N  indicated.  Beginning in 2014, data based on 2 of 6 forms. N  is two    
sixths of N  indicated.
tThe use of any prescription drug includes use of any of the following: amphetamines, sedatives (barbiturates), narcotics other than heroin, or tranquilizers…
without a doctor telling you to use them.
uFor 8th and 10th graders only: Data based on one of two forms in 1996;  N  is one half of N  indicated. Data based on three of four forms in 1997–1998; N  is two 
thirds of N  indicated. Data based on two of four forms in 1999–2001;  N  is one third of N  indicated. Data based on one of four forms beginning in 2002; N  is one
sixth of N  indicated. For 12th graders only: Data based on one of six forms in 1996–2001;  N  is one sixth of N  indicated. Data based on two of six forms in 2002–
2009; N  is two sixths of N  indicated. Data for 2001 and 2002 are not comparable due to changes in the questionnaire forms. Data based on one of six forms   
beginning in 2010; N  is one sixth of N  indicated. For college students and young adults only: Data based on two of six forms; N  is two sixths of N indicated.
vFor 8th, 10th, and 12th graders only: In 1993, the question text was changed slightly in half of the forms to indicate that a drink meant more than just a few sips.  
The 1993 data are based on the changed forms only;  N  is one half of N  indicated for these groups. In 1994 the remaining forms were changed to the new wording. 
The data are based on all forms beginning in 1994. In 2004, the question text was changed slightly in half of the forms. An examination of the data did not show any 
effect from the wording change. The remaining forms were changed in 2005. For college students and young adults: The revision of the question text resulted in
rather little change in the reported prevalence of use. The data for all forms are used to provide the most reliable estimate of change.
wFor all grades: In 2012 the alcoholic beverage containing caffeine (like Four Loko or Joose) question text was changed to alcoholic beverage mixed with an energy 
drink (like Red Bull). The data in 2011 and 2012 are not comparable due to this question change. For 12th graders only: Data based on two of six forms; N  is two
sixths of N  indicated. For college students and young adults only: been drunk data based on three of six forms; N  is three sixths of N  indicated. Alcoholic beverages 
containing caffeine data based on two of six forms;  N  is two sixths of N  indicated.
xFor 8th and 10th graders only: Data based on one of two forms for 1991–1996 and on two of four forms beginning in 1997;  N  is one half of N  indicated. For 12th 
graders only: Data based on one of six forms;  N  is one sixth of N  indicated. For 8th, 10th, and 12th graders only: Snus and dissolvable tobacco were added to the 
list of examples in 2011. An examination of the data did not show any effect from the wording change. For college students and young adults only: Questions about 
smokeless tobacco use were dropped from the analyses in 1989.
yFor 8th and 10th graders only: In 2006, the question text was changed slightly in half of the questionnaire forms. An examination of the data did not show any effect 
from the wording change. In 2007 the remaining forms were changed in a like manner. In 2008 the question text was changed slightly in half of the questionnaire forms 
An examination of the data did not show any effect from the wording change. In 2009 the remaining forms were changed in a like manner. For 12th graders only: Data
based on two of six forms in 1991–2005;  N  is two sixths of N  indicated. In 2006 a slightly altered version of the question was added to a third form. An examination  
of the data did not show any effect from the wording change. Data based on three of six forms beginning in 2006;  N  is three sixths of N  indicated. In 2007 the 
remaining forms were changed in a like manner. In 2008 the question text was changed slightly in two of the questionnaire forms. An examination of the data did not
show any effect from the wording change. In 2009 the remaining form was changed in a like manner. 
zFor college students and young adults only: Data based on two of six forms in 1990–2009;  N  is two sixths of N  indicated. In 2008, the question text was 
changed slightly. 
aaFor 12th graders only: Data based on two of six forms in 2002–2005;  N  is two sixths of N  indicated. Data based on three of six forms beginning in 2006; N  is three   
sixths of N  indicated.
bbFor college students and young adults only: Data based on two of six forms through 2009;  N  is two sixths of N  indicated. Data based on three of six forms 
beginning in 2010; N  is three sixths of N  indicated.
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ccFor 12th graders only: Data based on two of six forms in 2000;  N  is two sixths of N  indicated. Data based on three of six forms in 2001;  N  is three sixths of N   
indicated. Data based on one of six forms beginning in 2002;  N  is one sixth of N  indicated. For college students and young adults only: Data based on two of six 
forms; N  is two sixths of N  indicated. Data based on three of six forms beginning in 2010;  N  is three sixths of N  indicated. Data based on two of six forms beginning
in 2012; N  is two sixths of N  indicated.
ddFor 12th graders only: Data based on two of six forms in 2000;  N  is two sixths of N  indicated. Data based on three of six forms in 2001–2009;  N  is three sixths  
of N  indicated. Data based on two of six forms beginning in 2010;  N  is two sixths of N  indicated. For college students and young adults only: Data based on two of
six forms;  N  is two sixths of N  indicated. Data based on three of six forms beginning in 2010;  N  is three sixths of N  indicated. 
eeFor 12th graders only: The 2003 flavored alcoholic beverage data were created by adjusting the 2004 data to reflect the observed 2003 to 2004 change in a slightly 
different version of the flavored alcoholic beverage question. In 2004 the original question was revised to include wine coolers among the examples―a change that had 
very little effect on the observed prevalence-of-use rate.
ffFor 12th graders only: Data based on two of six forms in 2000–2008;  N  is two sixths of N  indicated. Beginning in 2009 data based on one of six forms; N  is one 
sixth of N  indicated.
ggDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes and smokeless tobacco, for which actual daily use is measured, and
for 5+ drinks, for which the prevalence of having five or more drinks in a row in the last two weeks is measured.
hhFor 8th and 10th graders only: Data based on two of four forms.  N  is one third of N  indicated.  For 12th graders only: Data based on four of six forms; N  is four
sixths of N  indicated.  For college students and young adults only: Data based on one of six forms; N  is one sixth of N  indicated.
iiFor 8th and 10th graders only: Data based on two of four forms; N  is one third of N  indicated.  For 12th graders only: Data based on two of six forms; N  is two 
sixths of N  indicated.  For college students and young adults only: Data based on one of six forms; N  is one sixth of N  indicated.
jjFor 8th and 10th graders only: Data based on one of four forms; N  is one third of N  indicated.  For 12th graders only: Data based on two of six forms.  N  is two
sixths of N  indicated.  For college students and young adults only: Data based on one of six forms;N  is one sixth of N  indicated.
kkIn 2017, the surveys switched from asking about vaping in general to asking separately about vaping nicotine, marijuana, and just flavoring. 
Beginning in 2017, data presented for any vaping are based on these new questions
Footnotes for Tables 2-1 through 2-4 (cont.)
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Illicit drug use index includes any use of marijuana, LSD, other hallucinogens, crack, cocaine other than crack, or heroin; 
or any use of narcotics other than heroin which is not under a doctor’s orders, stimulants, sedatives 
(barbiturates), methaqualone (excluded since 1990), or tranquilizers. Beginning in 1982, the question 
about stimulant use (i.e., amphetamines) was revised to get respondents to exclude the inappropriate 
reporting of nonprescription stimulants. The prevalence rate dropped slightly as a result of this 
methodological change.  In 2013, the question on use of amphetamines was changed such that  "Amphetamines" was replaced
with "Amphetamines and other stimulant drugs."  Data for any illicit drug were affected by this change.
            FIGURE 2-1
            Trends in Annual Prevalence of an Illicit Drug Use Index
            across 5 Populations
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Chapter 3 
 
STUDY DESIGN AND PROCEDURES 
 
Monitoring the Future (MTF) incorporates several survey designs into one study, yielding analytic 
power beyond the sum of those component parts. The components include cross-sectional studies, 
repeated cross-sectional studies, and panel studies of individual cohorts and sets of cohorts. The 
annual cross-sectional surveys provide point estimates of various behaviors and conditions in any 
given year for a number of subpopulations (e.g., 8th graders, 10th graders, 12th graders, college 
students, all young adult high school graduates ages 19–30, 35-year-olds, 40-year-olds, etc.), as 
well as point estimates for various subgroups within these different populations. Repeating these 
annual cross-sectional surveys over time allows an assessment of change across history in 
consistent age segments of the population, as well as among subgroups. The panel study feature 
permits the examination of developmental change in the same individuals as they assume adult 
responsibilities, enter and leave various adult roles and environments, and continue further into 
adulthood. It also permits an assessment of a number of outcomes later in life that MTF has shown 
to be linked to substance use in adolescence and beyond.1 
 
Finally, with a series of panel studies of sequential graduating class cohorts we are able to offer 
distinctions among, and explanations for, three fundamentally different types of change: period, 
age, and cohort. It is this feature that creates a synergistic effect in terms of analytic and 
explanatory power.2,3 
 
RESEARCH DESIGN AND PROCEDURES FOR THE 12th GRADE SURVEYS 
Twelfth graders have been surveyed in the spring of each year since 1975. Each year’s data 
collection has taken place in about 140 public and private high schools selected to provide an 
accurate representative cross-section of 12th graders throughout the coterminous United States (see 
Figure 3-1). 
 
The Population under Study 
Senior year of high school is a strategic point at which to monitor drug use and related attitudes of 
youth. First, completion of high school represents the end of an important developmental period 
in this society, demarcating both the end of universal education and, for many, the end of living 
full-time in the parental home. Therefore, it is a logical point at which to take stock of cumulated 
influences. Further, completion of high school represents a jumping-off point—a point from which 
                                                 
1 Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008) The Education–Drug Use 
Connection: How Successes and Failures in School Relate to Adolescent Smoking, Drinking, Drug Use, and Delinquency. New York: Lawrence 
Erlbaum Associates/Taylor & Francis; Bachman, J. G., O'Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002) 
The Decline of Substance Use in Young Adulthood: Changes in Social Activities, Roles, and Beliefs. Mahwah, New Jersey: Lawrence Erlbaum; 
Bachman, J. G., Wadsworth, K. N., O'Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, Drinking, and Drug Use in Young 
Adulthood: The Impacts of New Freedoms and New Responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
2 Bachman, J. G., Johnston, L. D., O'Malley, P. M., Schulenberg, J. E., & Miech, R. A. (2015). The Monitoring the Future project after four 
decades: Design and procedures (Monitoring the Future Occasional Paper No. 82). Ann Arbor, MI: Institute for Social Research, University of 
Michigan.  
3 For a more detailed description of the full range of research objectives of Monitoring the Future, see Johnston, L. D., O’Malley, P. M., Schulenberg, 
J. E., Bachman, J. G., Miech, R. A., & Patrick, M. E. (2016). The objectives and theoretical foundation of the Monitoring the Future study 
(Monitoring the Future Occasional Paper No. 84). Ann Arbor, MI: Institute for Social Research.  
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young people diverge into widely differing social environments and experiences. Thus senior year 
is a good time to take a “before” measure, allowing for the subsequent calculation of changes that 
may be attributable to the environmental transitions occurring in young adulthood, including 
college attendance, civilian employment, military service, and role transitions such as marriage, 
parenthood, divorce, etc. Finally, there are some important practical advantages built into the 
original system of data collections with samples of 12th graders. The need for systematically 
repeated, large-scale samples from which to make reliable estimates of change requires that 
considerable emphasis be put on cost efficiency as well as feasibility. The last year of high school 
constitutes the final point at which a reasonably good national sample of an age-specific cohort 
can be drawn and studied economically. 
 
The Omission of Dropouts 
One limitation in the MTF study design is the exclusion of individuals who drop out of high school 
before graduation—approximately 6–15% of each age cohort nationally, according to U.S. Census 
statistics. (The dropout rate has been declining in recent years; 6% is the most recent estimate.4) 
Clearly, the omission of high school dropouts introduces biases in the estimation of certain 
characteristics of the entire age group; however, for most purposes, the small proportion of 
students who drop out sets outer limits on the bias. Further, since the bias from missing dropouts 
should remain relatively constant from year to year, their omission should introduce little or no 
bias in year-to-year change estimates. Indeed, we believe the changes observed over time for those 
who are surveyed in the 12th grade are likely to parallel the changes for dropouts in most instances. 
Appendix A in this volume addresses in detail the likely effects of the exclusion of dropouts (as 
well as absentees from school) on estimates of drug use prevalence and trends among the entire 
age cohort. 
 
Sampling Procedures and Sample Weights 
A multistage random sampling procedure is used to secure the nationwide sample of 12th graders 
each year. Stage 1 is the selection of particular geographic areas, Stage 2 is the selection of one or 
more high schools in each area (with probability proportionate to the student enrollment size for 
the grade in question), and Stage 3 is the selection of 12th graders within each high school. Up to 
350 twelfth graders in each school may be included. In schools with fewer 12th graders, the usual 
procedure is to include all of them in the data collection, though a smaller sample is sometimes 
taken (either by randomly sampling entire classrooms or by some other unbiased, random method) 
to accommodate the needs of the school. Weights are assigned to compensate for differential 
probabilities of selection at each stage of sampling. Final weights are normalized to average 1.0 
(so that the weighted number of cases equals the unweighted number of cases overall). In order to 
be able to check observed trends in any given one-year interval, schools participate in the study 
for two consecutive years on a staggered schedule, with one half of them being replaced with a 
new random half-sample of schools each year. Therefore in any given year about half of the 
schools in the sample are participating for the first time and the other half are participating for their 
second and final year. This three-stage sampling procedure, with annual replacement of half of the 
sample of schools each year, has yielded the numbers of participating schools and students shown 
in Table 3-1. 
                                                 
4 National Center for Education Statistics. (2016). Table 103.10, Percentage of the population 3 to 34 years old enrolled in school, by sex, 
race/ethnicity, and age group: Selected years, 1980 through 2015. Digest of Education Statistics. Washington, DC: NCES. 
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Questionnaire Administration 
About three weeks prior to the questionnaire administration date, parents of the target respondents 
are sent a letter by first-class mail, usually from the principal, announcing and describing the MTF 
study and providing parents with an opportunity to decline participation of their son or daughter if 
they wish. A flyer outlining the study in more detail is enclosed with the letter. Copies of the flyers 
are also given to the students by teachers in the target classrooms in advance of the date of 
administration. The flyers make clear that participation is entirely voluntary. Local Institute for 
Social Research representatives and their assistants conduct the actual questionnaire 
administrations following standardized procedures detailed in an instruction manual. The 
questionnaires are administered in classrooms during a normal class period whenever possible; 
however, circumstances in some schools require the use of larger group administrations. Teachers 
are asked to remain present in the classroom to help maintain order, but to remain at their desks so 
that they cannot see students’ answers. 
 
Questionnaire Format 
Because many questions are needed to cover all of the many topic areas in the MTF study, much 
of the questionnaire content for 12th graders is divided into six different questionnaire forms 
distributed to participants in an ordered sequence that ensures six virtually identical random 
subsamples. (Five questionnaire forms were used between 1975 and 1988.) About one third of 
each form consists of key, or “core,” variables common to all forms. All demographic variables 
are contained in this core set of measures. Key drug use variables are also in the core, while many 
of the specific drugs that have been added over time are not in the core set, but are in one or more 
forms. Many questions on attitudes, beliefs, and perceptions of relevant features of the social 
environment are in fewer forms, and data are thus based on fewer cases—a single form would have 
one fifth of the total number of cases in 1975–1988 (approximately 3,300 per year) and one sixth 
of the total beginning in 1989 (approximately 2,500 per year). All tables in this report list the 
sample sizes upon which the statistics are based, stated in terms of the weighted number of cases 
(which, as explained above, is roughly equivalent to the actual number of cases). 
 
RESEARCH DESIGN AND PROCEDURES FOR THE 8th AND 10th GRADE SURVEYS 
In 1991, MTF was expanded to include nationally representative samples of 8th and 10th grade 
students surveyed on an annual basis. Separate samples of schools and students are drawn at each 
grade level. In general, the procedures used for the annual in-school surveys of 8th and 10th grade 
students closely parallel those used for 12th graders, including the selection of schools and students, 
questionnaire administration, and questionnaire format. A major exception is that only two 
different questionnaire forms were used in 8th and 10th grade from 1991 to 1996, expanding to four 
forms beginning in 1997. The same four questionnaire forms are used for both 8th and 10th graders; 
most of the content is drawn from the 12th grade surveys, including the core section. Thus, key 
demographic variables and measures of drug use and related attitudes and beliefs are generally 
identical for all three grades. Many fewer questions about other values and attitudes are included 
in the 8th and 10th grade forms, in part because we think that many of them are likely to be more 
fully formed by 12th grade and, therefore, are best monitored there. 
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About 15,000 8th grade students in approximately 150 schools (mostly middle schools) and about 
15,000 10th grade students in approximately 125 schools are surveyed each year (see Table 3-1). 
 
Mode of Administration 
Since 1999, all surveys for 8th and 10th graders have been fully anonymous. In previous years, 
MTF collected confidential, personal identification information from these respondents, and from 
1991 to 1993 this information was used to follow up with 8th and 10th graders in a manner similar 
to follow-ups of 12th graders.5 Follow-up of 8th and 10th graders was discontinued after 1993, 
precluding the need for further collection of confidential, personal identification information. 
Considerations supporting a switch to fully anonymous surveys in 8th and 10th grade included the 
following: (a) school cooperation might be easier to obtain; and (b) to the extent that collecting 
contact information had any effect on survey responses such an effect would be removed from the 
national data, which are widely compared with results of state and local surveys (nearly all of 
which use anonymous questionnaires), thus making those comparisons more valid.  
 
MTF considered in detail the effects of an anonymous survey as compared to a confidential survey 
that collected personal identification information. In 1998 the half-sample of 8th and 10th grade 
schools beginning their two-year participation in MTF received fully anonymous questionnaires, 
while the half-sample participating for their second and final year continued to get the confidential 
questionnaires that had been previously in use by MTF since 1991.  
 
Examination of the 1998 results, based on the two equivalent half-samples at grades 8 and 10, 
revealed that there was no effect of anonymous as compared to confidential surveys among 10th 
graders and only a very modest effect, if any, in self-reported substance use rates among 8th graders 
(with prevalence levels slightly higher in the anonymous condition).6 All tables and figures in this 
volume combine data from both half-samples of 8th graders surveyed in a given year. This is also 
true for 10th graders, for whom we found no methodological effect, and 12th graders, for whom we 
assumed no such effect since none was found for 10th graders. (See this chapter’s later section 
entitled “Representativeness and Sample Accuracy” for a further discussion of half-samples 
among all three grades.) 
 
Questionnaire Forms and Sample Proportions 
Beginning in 1997, in order to increase the measurement content in the study of 8th and 10th graders, 
the number of forms was expanded from two to four, although they are not distributed in equal 
numbers. Forms 1, 2, 3, and 4 are assigned to one third, one third, one sixth, and one sixth of the 
students, respectively. Thus, if a question appears on only one form, it is administered to either 
one third or one sixth of the sample. A question in two forms may be assigned to one third of the 
sample (one sixth plus one sixth), one half of the sample (one third plus one sixth), or two thirds 
of the sample (one third plus one third). A question in three forms may be assigned to two thirds 
(one third plus one sixth plus one sixth), or five sixths of the sample (one third plus one third plus 
                                                 
5 A book reporting results from analyses of these younger panels was published in 2008. See Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., 
Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use connection: How successes and failures in school relate 
to adolescent smoking, drinking, drug use, and delinquency. New York: Lawrence Erlbaum Associates/Taylor & Francis. 
6 We have examined in detail the effects of administration mode using multivariable controls to assess the effects of the change on 8th-grade self-
report data. Our findings generally show even less effect than is to be found without such controls. See O’Malley, P. M., Johnston, L. D., Bachman, 
J. G., & Schulenberg, J. E. (2000). A comparison of confidential versus anonymous survey procedures: Effects on reporting of drug use and related 
attitudes and beliefs in a national study of students. Journal of Drug Issues, 30, 35–54.  
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one sixth). Footnotes to the tables indicate what proportion of all respondents in each grade was 
asked the question, if that proportion is other than the entire sample. All of the samples, whether 
based on one or more forms, are random samples. 
 
RESEARCH DESIGN AND PROCEDURES FOR THE 12th GRADE FOLLOW UP 
SURVEYS 
Beginning with the graduating class of 1976, some members of each 12th grade class have been 
selected to be surveyed by mail after high school. From the 12,000–19,000 twelfth graders 
originally surveyed in a given senior class, a representative sample of 2,450 is randomly chosen 
for follow-up. In order to ensure that drug-using populations are adequately represented in the 
follow-up surveys, 12th graders reporting 20 or more occasions of marijuana use in the previous 
30 days (i.e., daily users), or any use of the other illicit drugs in the previous 30 days are selected 
with higher probability (by a factor of 3.0) than the remaining 12th graders. Differential weighting 
is then used in all follow-up analyses to compensate for these differential sampling probabilities. 
Because those in the drug-using stratum receive a weight of only 0.33 in the calculation of all 
statistics to correct for their overrepresentation at the selection stage, there are actually more 
follow-up respondents than are reported in the weighted numbers given in the tables; and in recent 
years actual numbers average about 22% higher than the weighted numbers. The 2,450 participants 
selected from each 12th grade class are randomly split into two groups of 1,225 each—one group 
to be surveyed on even-numbered calendar years in a series of biannual follow-up surveys, and the 
other group to be surveyed on odd-numbered years also in a series of biannual follow-up surveys. 
This two-year cycle is intended to reduce respondent burden and to thereby potentially yield better 
retention rates. By alternating the two half-samples, MTF collects data from every graduating class 
each year (through age 30), even though any given respondent participates only every other year. 
 
Until 2002, each respondent was surveyed biennially up to seven times; at the seventh follow-up, 
which would occur either 13 or 14 years after graduation, the respondents had reached modal age 
31 or 32. In 2002, as a cost-saving measure, the seventh biennial follow-up was discontinued, and 
since then each respondent is surveyed every other year until modal age 29 or 30. Additional 
follow-ups then occur at modal ages 35, 40, 45, 50, 55, and beginning in 2018, age 60. These data, 
gathered on representative national samples over such a large portion of the life span, are extremely 
rare and can provide needed insight into the etiology and life-course history of substance use and 
relevant behaviors. 
 
Follow-Up Procedures 
Using information provided by 12th grade respondents on a tear-off card (requesting the 
respondent’s name, address, phone numbers, and more recently, email address), contact is 
maintained with the subset of people selected for inclusion in the follow up panels. Newsletters 
are sent to them each year, providing a short summary of results on a variety of survey topics. 
Name and address corrections are requested from both the U.S. Postal Service and the individual. 
Questionnaires are sent in the spring to each individual biennially through age 30, then at 5-year 
intervals. A check (for $25 in recent years), made payable to the respondent, is attached to the 
front of each questionnaire.7 Reminder letters and postcards are sent at fixed intervals thereafter; 
                                                 
7 Until 1991, the follow-up checks were for $5. After an experiment indicated that an increase was warranted, the check amount was raised to $10 
beginning with the class of 1992. The check amount was raised to $20 in 2006, and to $25 beginning in 2008. 
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telephone callers attempt to gather up-to-date location information for those respondents with 
whom we are trying to make contact; and, finally, those whom we can contact but who have not 
responded receive a prompting phone call from the Survey Research Center’s phone interviewing 
facility in Ann Arbor, Michigan. If requested, a second copy of the questionnaire is sent. No 
questionnaire content is administered by phone. If a respondent asks not to be contacted further, 
that wish is honored. 
 
Follow-Up Questionnaire Format 
The questionnaires used in the follow-up surveys of 19- to 30-year-olds parallel those used in 12th 
grade. Many of the questions are the same, including the core section dealing with drug use. 
Respondents are consistently mailed the same form of the questionnaire that they first received in 
12th grade so that changes over time in their behaviors, attitudes, experiences, and so forth can be 
measured directly. Questions specific to high school status and experiences are dropped in the 
follow-ups, and questions relevant to post–high school status and experiences are added (mostly 
in the core section). The post-high school questions deal with issues such as college attendance, 
military service, civilian employment, marriage, and parenthood. In the study’s early follow-ups 
(through 1988), the sample size for a question appearing on a single form was one fifth of the total 
sample. A sixth form was introduced in 12th grade beginning with the class of 1989 and extended 
a year later to the follow-up surveys. Therefore, since 1990, a question appearing on a single form 
has been administered to one sixth of the total sample in the 19-30 young adult age band. Single-
form data from a single cohort are typically too small to make reliable estimates; therefore, in most 
cases where they are reported, single-form data from several adjacent cohorts are combined. 
 
For the five-year interval surveys beginning at age 35, both half-samples from a class cohort are 
surveyed simultaneously and only one questionnaire form is used. Much of the questionnaire 
content is maintained but streamlined with a focus on the major family and work issues relevant 
to respondents ages 35 to 60; we have also added measures of substance use disorders and health 
outcomes. 
 
REPRESENTATIVENESS AND SAMPLE ACCURACY 
School Participation 
Schools are invited to participate in the MTF study for a two-year period. For each school that 
declines to participate, a similar school (in terms of size, geographic area, urbanicity, etc.) is 
recruited as a replacement. In 2017, either an original school or a replacement school was obtained 
in 90% of the sample units. With very few exceptions, each school participating in the first year 
has agreed to participate in the second year as well. Figure 3-2 provides the year-specific school 
participation rates and the percentage of units filled since 1977. As shown in the figure, 
replacements for schools that decline participation are obtained in the vast majority of cases. 
 
Two questions are sometimes raised with respect to school participation rates: (a) Are participation 
rates sufficient to ensure the representativeness of the sample? (b) Does variation in participation 
rates over time contribute to changes in estimates of drug use?  
 
With respect to participation rates ensuring that the sample is representative, the selection of a 
comparable replacement school that is demographically close to the original school occurs in 
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practically all instances in which an original school does not participate. This should almost 
entirely remove problems of bias in region, urbanicity, and the like that might result from certain 
schools declining to participate.  
 
Among participating schools, there is very little difference in substance use levels between the 
sample of participating schools that were original selections, taken as a set, and the schools that 
were replacements. Averaged over the years 2003 through 2015 for grades 8, 10, and 12 combined, 
the difference between original schools and replacement schools averaged 0.26 percentage points 
in the observed prevalence averaged across a number of drug use measures: two indexes of annual 
illicit drug use, the annual prevalence of each of the major illicit drug classes, and several measures 
of alcohol and cigarette use. For half of the measures prevalence was higher in the replacement 
selections and in the other half it was higher in the original selections; specifically, out of 39 
comparisons (13 drugs and drug indexes for each grade), prevalence was higher in 20 of the 
original selections and in 19 of the replacement selections.  
 
Potential biases could be subtle, however. If, for example, it turned out that most schools with 
“drug problems” refused to participate, the sample would be seriously biased. And if any other 
single factor were dominant in most refusals, that reason for refusal might also suggest a source of 
serious bias. However, the reasons schools fail to participate tend to be varied and are often a 
function of happenstance events specific to that particular year, such as a weather-related event 
that reduced the number of school days or the fact that the school already committed to participate 
in a number of other surveys that year; only very few schools, if any, object specifically to the 
drug-related survey content. 
 
If it were the case that schools differed substantially in drug use, then which particular schools 
participated could have a greater effect on estimates of drug use. However, the great majority of 
variance in drug use lies within schools, not between schools.8 For example, from 2003 to 2015 
for schools with 8th, 10th, or 12th grade students, about 2% to 8% of the variance in smoking 
cigarettes or drinking alcohol in the past 30 days was between schools. Among the illicit drugs, 
marijuana showed the largest amount of between-school variation, averaging between slightly less 
than 4% up to 5% for annual use, and 3% to 4% for 30-day use. Annual prevalence of cocaine use 
averaged between less than 1% and 1.5%, while prevalence of annual heroin use averaged less 
than 0.5%. Further, some, if not most, of the between-schools variance is due to differences related 
to factors such as region and urbanicity, which remain well controlled in the present sampling 
design. 
 
With respect to participation rates and changes in estimates of drug use, it is extremely unlikely 
that results have been significantly affected by changes in school participation rates. If changes in 
participation rates seriously affected prevalence estimates, there would be noticeable bumps up or 
down in concert with the changing rates. But this series of surveys produces results that are very 
smooth and generally change in an orderly fashion from one year to the next. Moreover, different 
substances trend in distinctly different ways. We have observed, for example, marijuana use 
decreasing while cocaine use was stable (in the early 1980s), alcohol use declining while cigarette 
use held steady (in the mid- to late 1980s), ecstasy use rising sharply while cocaine use showed 
                                                 
8 O’Malley, P. M., Johnston, L. D., Bachman, J. G., Schulenberg, J. E., & Kumar, R. (2006). How substance use differs among American secondary 
schools. Prevention Science, 7, 409–420.  
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some decline (late 1990s, early 2000s); and marijuana use continuing to rise while alcohol use hit 
historic lows (since 2011). Moreover, attitudes and perceptions about drugs have changed 
variously, but generally in ways quite consistent with the changes in actual use. All of these 
patterns are explainable in terms of psychological, social, and cultural factors; they cannot be 
explained by the common factor of changes in school participation rates.  
 
Of course, there could be some sort of constant bias across the years, but even in the unlikely event 
that there is, it seems highly improbable that it would be of much consequence for policy purposes, 
given that it would not affect trends and likely would have a very modest effect on levels of 
prevalence. Thus, we have a high degree of confidence that school refusal rates have not seriously 
biased the survey results. 
 
Nevertheless, securing the cooperation of schools has become increasingly difficult. This is a 
problem common to the field, not specific to MTF. Therefore, beginning with the 2003 survey, we 
have provided payment to schools as a means of increasing their incentive to participate. (By that 
time, several other ongoing school-based survey studies already were using payments to schools.) 
 
At each grade level, half of each year’s sample comprises schools that started their participation 
the previous year, and half comprises schools that began participating in the current year. (Both 
samples are national replicates, meaning that each is drawn to be nationally representative by 
itself.) This staggered half sample design is used to check on possible fluctuations in the year-to-
year trend estimates due to school turnover. For example, separate sets of one-year trend estimates 
are computed based on students in the half-sample of schools that participated in both 2016 and 
2017, then based on the students in the half-sample that participated in both 2015 and 2016, and 
so on. Thus, each one-year matched half-sample trend estimate derived in this way is based on a 
constant set of schools (about 65 in 12th grade, for example, over a given one-year interval). When 
the trend data derived from the matched half-sample (examined separately for each class of drugs) 
are compared with trends based on the total sample of schools, the results are usually highly 
similar, indicating that the trend estimates are affected little by school turnover or shifting 
participation rates. As would be expected, levels of absolute prevalence for a given year are not as 
precisely estimated using just the half sample because the sample size is only half as large. 
 
Student Participation 
In 2017, completed questionnaires were obtained from 87% of all sampled students in 8th grade, 
85% in 10th grade, and 79% in 12th grade (see Table 3-1 for response rates in all years). In the large 
majority of cases, students are missed due to absence from school and/or class at the time of data 
collection; for reasons of cost efficiency, we typically do not schedule special follow up data 
collections for absent students. Because students with fairly high rates of absenteeism also report 
above-average rates of drug use, some degree of bias is introduced into the prevalence estimates 
by missing the absentees. Much of that bias could be corrected through the use of special weighting 
based on the self-reported absentee rates of the students who did respond; however, we decided 
not to use such a weighting procedure because the bias in overall drug use estimates was 
determined to be quite small and the necessary weighting procedures would have introduced 
greater sampling variance in the estimates. Appendix A in this report illustrates the changes in 
trend and prevalence estimates that would result if corrections for absentees had been included. Of 
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course, some students simply refuse, when asked, to complete a questionnaire. However, the 
proportion of explicit refusals amounts to less than 1.8% of the target sample for each grade. 
 
Sampling Accuracy of the Estimates 
Confidence intervals (95%) are provided in Tables 4-1a through 4-1d for lifetime, annual, 30-day, 
and daily prevalence of use for 8th, 10th, and 12th grade students. As can be seen in Table 4-1a, 
confidence intervals for lifetime prevalence for 12th graders average less than ±1.9% across a 
variety of drug classes. That is, if we took a large number of samples of this size from the universe 
of all schools containing 12th graders in the coterminous United States, 95 times out of 100 the 
sample would yield a result that would be less than 1.9 percentage points divergent from the result 
we would get from a comparable massive survey of all 12th graders in all schools. This is a high 
level of sampling accuracy, permitting detection of fairly small changes from one year to the next. 
Confidence intervals for the other prevalence periods (last 12 months, last 30 days, and current 
daily use) are generally smaller than those for lifetime use. In general, confidence intervals for 8th 
and 10th graders are very similar to those observed for 12th graders. Some drugs (smokeless 
tobacco, PCP, and others, as indicated in the footnotes for Tables 2-1 to 2-4) are measured on only 
one or two questionnaire forms; these drugs will have somewhat larger confidence intervals 
because they are based on smaller sample sizes. 
 
The Appendix C of Volume 1 published in years 2017 and earlier reported information on how to 
calculate confidence intervals for point estimates and how to calculate statistics that test the 
significance of changes over time or of differences between subgroups. This appendix is no longer 
necessary with the opening of MTF’s remote portal at the National Addiction and HIV Data 
Archive Program, which now allows researchers to compute such statistics directly using MTF 
weights and clustering variables. Interested readers may refer to Appendix C of earlier volumes 
for the information it provides about design effects and how their computational influence varies 
by substance. 
 
PANEL SURVEYS  
Results from the panel studies that follow respondents in each graduating class of 12th graders into 
adulthood are reported in Volume II9 of this series, which also provides detailed information on 
the panel research design and retention rates in its own chapter on study design and procedures 
(Volume II, Chapter 3). 
 
VALIDITY OF MEASURES OF SELF-REPORTED DRUG USE 
Are sensitive behaviors such as drug use honestly reported? Like most studies dealing with 
sensitive behaviors, we have no direct, totally objective validation of the present measures; 
however, the considerable amount of existing inferential evidence strongly suggests that the MTF 
self-report questions produce largely valid data. Here we briefly summarize this evidence.10  
                                                 
9 Schulenberg, J. E., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Miech, R. A., & Patrick, M. E. (2017). Monitoring the Future national 
survey results on drug use, 1975-2016: Volume II, college students and adults ages 19-55. Ann Arbor: Institute for Social Research, The University 
of Michigan.  
10 A more complete discussion may be found in: Johnston, L. D. & O’Malley, P. M. (1985). Issues of validity and population coverage in student 
surveys of drug use. In B. A. Rouse, N. J. Kozel, & L. G. Richards (Eds.), Self-report methods of estimating drug use: Meeting current challenges 
to validity (NIDA Research Monograph No. 57 (ADM) 85 1402). Washington, DC: U.S. Government Printing Office; Johnston, L. D., O’Malley, 
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First, using a three-wave panel design, we established that the various measures of self-reported 
drug use have a high degree of reliability—a necessary condition for validity.11 In essence, 
respondents were highly consistent in their self-reported behaviors over a three- to four-year time 
interval. Second, we found a high degree of consistency among logically related measures of use 
within the same questionnaire administration. Third, the proportion of 12th graders reporting some 
illicit drug use has reached two thirds of all respondents in peak years and over 80% in some follow 
up years, constituting prima facie evidence that the degree of underreporting must be very limited. 
Fourth, 12th graders’ reports of use by their unnamed friends—about whom they would presumably 
have considerably less reason to conceal information about use—have been highly consistent with 
self-reported use in the aggregate, both in terms of prevalence and trends in prevalence, as 
discussed in Chapter 9. Fifth, we have found self-reported drug use to relate in consistent and 
expected ways based on theory to a number of other attitudes, behaviors, beliefs, and social 
situations—strong evidence of “construct validity.” Sixth, the missing data levels for the self-
reported use questions are only very slightly higher than for the preceding nonsensitive questions, 
in spite of explicit instructions to respondents immediately preceding the drug section to leave 
blank those questions they feel they cannot answer honestly. Seventh, an examination of 
consistency in reporting of lifetime use conducted on the long-term panels of graduating seniors 
found quite low levels of recanting of earlier reported use of the illegal drugs.12 There was a higher 
level of recanting for the psychotherapeutic drugs, suggesting that adolescents may actually 
overestimate their use of some drugs because of misinformation about definitions, and this 
knowledge improves as they get older. Finally, the great majority of respondents, when asked, say 
they would answer such questions honestly if they were users.13  
 
As an additional step to assure the validity of the data, we check for logical inconsistencies in the 
answers to the triplet of questions about use of each drug (i.e., lifetime, annual, and 30-day use), 
and if a respondent exceeds a maximum number of inconsistencies across the set of drug use 
questions, his or her record is deleted from the data set. Similarly, we check for improbably high 
rates of use of multiple drugs and delete such cases, assuming that the respondents are not taking 
the task seriously. Fortunately, very few cases (<3%) have to be eliminated for these reasons. 
 
This is not to argue that self-reported measures of drug use are necessarily valid in all studies. In 
MTF we have gone to great lengths to create a situation and set of procedures in which respondents 
recognize that their confidentiality will be protected. We have also tried to present a convincing 
case as to why such research is needed. The evidence suggests that a high level of validity has been 
obtained. Nevertheless, insofar as any remaining reporting bias exists, we believe it to be in the 
direction of underreporting. Thus, with the possible exception of the psychotherapeutic drugs, we 
                                                 
P. M., & Bachman, J. G. (1984). Drugs and American high school students: 1975–1983 (DHHS (ADM) 85 1374). Washington, DC: U.S. 
Government Printing Office; Wallace, J. M., Jr., & Bachman, J. G. (1993). Validity of self-reports in student-based studies on minority populations: 
Issues and concerns. In M. de LaRosa (Ed.), Drug abuse among minority youth: Advances in research and methodology (NIDA Research 
Monograph No. 130). Rockville, MD: National Institute on Drug Abuse. 
11 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. International Journal of the 
Addictions, 18, 805–824. 
12 Johnston, L. D. & O’Malley, P. M. (1997). The recanting of earlier reported drug use by young adults. In L. Harrison (Ed.), The validity of self-
reported drug use: Improving the accuracy of survey estimates (NIDA Research Monograph No. 167, pp. 59–80). Rockville, MD: National Institute 
on Drug Abuse. 
13 For a discussion of reliability and validity of student self-report measures of drug use like those used in MTF across varied cultural settings, see 
Johnston, L. D., Driessen, F. M. H. M., & Kokkevi, A. (1994). Surveying student drug misuse: A six-country pilot study. Strasbourg, France: 
Council of Europe.  
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believe our estimates to be lower than their true values, even for the obtained samples, but not 
substantially so. 
 
Consistency and Measurement of Trends 
MTF is designed to be sensitive to changes from one time period to another. A great strength of 
this study is that the measures and procedures have been standardized and applied consistently 
across many years. To the extent that any biases remain because of limits in school and/or student 
participation, and to the extent that there are distortions (lack of validity) in the responses of some 
students, it seems very likely that such problems will exist in much the same proportions from one 
year to the next. In other words, biases in the survey estimates will tend to be consistent from one 
year to another, meaning that our measurement of trends should be affected very little. The smooth 
and consistent nature of most trend curves reported for the various drugs provides rather 
compelling empirical support for this assertion. 
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Grade: 8th 10th 12th 8th 10th 12th 8th 10th 12th Total 8th 10th 12th Total 8th 10th 12th
1975 — — 111 — — 14 — — 125 — — — 15,791 — — — 78
1976 — — 108 — — 15 — — 123 — — — 16,678 — — — 77
1977 — — 108 — — 16 — — 124 — — — 18,436 — — — 79
1978 — — 111 — — 20 — — 131 — — — 18,924 — — — 83
1979 — — 111 — — 20 — — 131 — — — 16,662 — — — 82
1980 — — 107 — — 20 — — 127 — — — 16,524 — — — 82
1981 — — 109 — — 19 — — 128 — — — 18,267 — — — 81
1982 — — 116 — — 21 — — 137 — — — 18,348 — — — 83
1983 — — 112 — — 22 — — 134 — — — 16,947 — — — 84
1984 — — 117 — — 17 — — 134 — — — 16,499 — — — 83
1985 — — 115 — — 17 — — 132 — — — 16,502 — — — 84
1986 — — 113 — — 16 — — 129 — — — 15,713 — — — 83
1987 — — 117 — — 18 — — 135 — — — 16,843 — — — 84
1988 — — 113 — — 19 — — 132 — — — 16,795 — — — 83
1989 — — 111 — — 22 — — 133 — — — 17,142 — — — 86
1990 — — 114 — — 23 — — 137 — — — 15,676 — — — 86
1991 131 107 117 31 14 19 162 121 136 419 17,844 14,996 15,483 48,323 90 87 83
1992 133 106 120 26 19 18 159 125 138 422 19,015 14,997 16,251 50,263 90 88 84
1993 126 111 121 30 17 18 156 128 139 423 18,820 15,516 16,763 51,099 90 86 84
1994 116 116 119 34 14 20 150 130 139 419 17,708 16,080 15,929 49,717 89 88 84
1995 118 117 120 34 22 24 152 139 144 435 17,929 17,285 15,876 51,090 89 87 84
1996 122 113 118 30 20 21 152 133 139 424 18,368 15,873 14,824 49,065 91 87 83
1997 125 113 125 27 18 21 152 131 146 429 19,066 15,778 15,963 50,807 89 86 83
1998 122 110 124 27 19 20 149 129 144 422 18,667 15,419 15,780 49,866 88 87 82
1999 120 117 124 30 23 19 150 140 143 433 17,287 13,885 14,056 45,228 87 85 83
2000 125 121 116 31 24 18 156 145 134 435 17,311 14,576 13,286 45,173 89 86 83
2001 125 117 117 28 20 17 153 137 134 424 16,756 14,286 13,304 44,346 90 88 82
2002 115 113 102 26 20 18 141 133 120 394 15,489 14,683 13,544 43,716 91 85 83
2003 117 109 103 24 20 19 141 129 122 392 17,023 16,244 15,200 48,467 89 88 83
2004 120 111 109 27 20 19 147 131 128 406 17,413 16,839 15,222 49,474 89 88 82
2005 119 107 108 27 20 21 146 127 129 402 17,258 16,711 15,378 49,347 90 88 82
2006 122 105 116 29 18 20 151 123 136 410 17,026 16,620 14,814 48,460 91 88 83
2007 119 103 111 32 17 21 151 120 132 403 16,495 16,398 15,132 48,025 91 88 81
2008 116 103 103 28 19 17 144 122 120 386 16,253 15,518 14,577 46,348 90 88 79
2009 119 102 106 26 17 19 145 119 125 389 15,509 16,320 14,268 46,097 88 89 82
2010 120 105 104 27 18 22 147 123 126 396 15,769 15,586 15,127 46,482 88 87 85
2011 117 105 110 28 21 19 145 126 129 400 16,496 15,382 14,855 46,733 91 86 83
2012 115 107 107 27 19 20 142 126 127 395 15,678 15,428 14,343 45,449 91 87 83
2013 116 103 106 27 17 20 143 120 126 389 15,233 13,262 13,180 41,675 90 88 82
2014 111 98 105 30 16 17 141 114 122 377 15,195 13,341 13,015 41,551 90 88 82
2015 111 102 101 30 18 20 141 120 121 382 15,015 16,147 13,730 44,892 89 87 83
2016 117 92 100 25 18 20 142 110 120 372 17,643 15,230 12,600 45,473 90 88 80
2017 109 89 105 22 17 18 131 106 123 360 16,010 14,171 13,522 43,703 87 85 79
Source.   The Monitoring the Future study, the University of Michigan.  
TABLE 3-1
Sample Sizes and Response Rates
Number of Number of Total Total Student Response
Public Schools Private Schools Number of Schools Number of Students Rate (%)
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Schools Included in One Year's Data Collection
Eighth, Tenth, and Twelfth Grades
FIGURE 3-1
One dot equals one school.
Source: The Monitoring the Future Study, the University of Michigan.
Note:
FIGURE 3-1
 Schools included in 1 Year’s Data Collection
8th, 10th, and 12th Grades
Source. The Monitoring the Future study, the University of Michigan.
Note. One dot equals one school.
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Percent of slots 
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Total 96 98 97 96 96 95 92 93 91 90
Source:  The Monitoring the Future study, the University of Michigan.
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Chapter 4 
PREVALENCE OF DRUG USE  
IN EARLY, MIDDLE, AND LATER ADULTHOOD 
Longitudinal panel studies that track the same individuals across several years are typically used 
to examine developmental changes with age, as is evident in many of our publications. At the same 
time, the multiple cohort feature of the MTF design provides a useful snapshot of each age group 
in a given year, showing the prevalence of use of various substances for each age group in that 
year, thus enabling us to compare these prevalence rates with those of the same age in earlier years. 
This chapter highlights such prevalence data for the adult age groups covered by MTF, starting 
right after high school and moving through middle and into older adulthood. Each age group is 
defined by the modal age for its graduating high school class cohort.1 We will see that recent use 
tends to be higher in the early post-high school age groups, corresponding to the new freedoms 
associated with leaving high school and often moving away from the parental home.2,3 But 
sometimes there are also strong cohort effects that underlie differences among age groups at a 
given point in time; in this chapter we will see evidence of both age-related differences and cohort 
effects. 
Estimates of drug use in the adult population are most often generated through household survey 
interviews of cross-sections of the general population. In the present study, our estimates come 
from self-reported mail questionnaires from respondents in the follow-up surveys. These are 
representative samples of previous classes of high school students who started their participation 
in MTF in their senior year. As described in more detail in Chapter 3, MTF has conducted ongoing 
panel studies on representative samples from each graduating high school senior class beginning 
with the class of 1976. From each class, two matched nationally representative subpanels of 
roughly 1,200 students each are randomly selected to comprise the long-term follow-up panels; 
one of these two subpanels is surveyed every even-numbered year after graduation, and the other 
is surveyed every odd-numbered year, up through age 29/30. Beginning at modal age 35, data 
collection occurs at the same time for both subpanels at five-year intervals. So, while each cohort 
participates every year up through age 30, each individual respondent participates only every other 
year until age 29/30. This alternating panel design was chosen to reduce the burden and 
repetitiveness of participating in the panel study every year while still allowing for full age 
coverage between 19 and 30. Thus, in a given year, the study includes respondents ages 19–30 
from one of the two subpanels from each of the last 12 senior classes previously participating in 
MTF.4  
1 High school seniors have a modal age (the most common age) of 18; therefore, in a follow-up conducted 12 years later they would have a modal 
age of 30. 
2 Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
3 Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use 
connection: How successes and failures in school relate to adolescent smoking, drug use, and delinquency. New York: Lawrence Erlbaum 
Associates/Taylor & Francis. 
4 Through 2001, the follow-ups also included modal ages 31 and 32. This seventh follow-up was dropped in 2002 because we believed that the 
costs were no longer justified by the marginal benefits of having these follow-up data, given that an age-35 survey was being conducted. Throughout 
the time between surveys, we send annual newsletters to respondents in order to help maintain contact. 
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In 2017, representative samples of the classes of 2005 through 2016—modal ages 19 to 30—were 
surveyed using the same set of standard young adult survey instruments at each age. (There are six 
different questionnaire forms and each individual receives the form corresponding to the form he 
or she completed in 12th grade.) For brevity, we refer to this 19- through 30-year-old age range as 
“young adults” in this chapter. 
To build on these important national panels of young adults, we extend the surveys into and beyond 
middle adulthood. The middle adulthood surveys are conducted beginning at modal age 35 (that 
is, 17 years after high school graduation) and at five-year intervals thereafter. In each of these later 
follow-ups, the two sub-panels from the relevant graduating class are both surveyed in the same 
year, using a single questionnaire form instead of the six forms that were used from age 19 to 30. 
The content of the questionnaires is revised to some degree across age to be more relevant to the 
different developmental periods, although key substance use and other measures remain the same. 
The results of the 2017 follow-up surveys characterize the population of high school graduates of 
modal ages 19–30, 35, 40, 45, 50, and 55. As discussed in Chapter 1, the high school dropout 
segment, which represents the 7%–15% missing from the senior year surveys, is missing from all 
of the follow-up surveys as well. Thus, the results presented here are not necessarily generalizable 
to the entire population of each age, but are generalizable to the great majority of young and 
middle-aged adults—those who completed high school. 
Figures 4-1 through 4-21 contain 2017 prevalence data by age, corresponding to respondents ages 
19–30, as well as 35-, 40-, 45-, 50-, and 55-year-olds. For comparison purposes, data are also 
included for the 2017 high school senior class, listed as 18-year-olds. Figures provided in Chapter 
5 contain the trend data for each of these age groups derived from the repeated cross-sectional 
surveys, including 12th graders and high school graduates through age 55. In the figures in Chapters 
4 and 5, age groups spanning the young adult years have been paired into two-year intervals in 
order to increase the number of cases, and thus the precision, for each point estimate. The data for 
ages 35, 40, 45, 50, and 55 are, of necessity, based on a single age in each case. As indicated above, 
both half-samples from a given class cohort are included in each year’s samples of 35-, 40-, 45-, 
50-, and 55-year-olds. In 2017 the paired half-samples came from the high school graduating 
classes of 2000, 1995, 1990, 1985, and 1980, respectively. The respective weighted numbers of 
cases were 739, 818, 760, 780, and 919. (Actual unweighted numbers are somewhat higher, 
because those from the oversampled drug-using stratum in high school—which was drawn at three 
times the rate of the others to assure a sufficient sample of drug users—are counted as only one 
third of a case in the weighted follow-up data. This is discussed more in Chapter 3.) 
The reweighting procedures used to adjust the panel data for the effects of panel attrition are 
described in Chapter 3. 
REPLICABILITY OF FINDINGS 
It is worth noting that any pattern of age-related differences found in one year can be checked in 
an adjacent year (i.e., the previous or succeeding year’s volume) for replicability, because two 
non-overlapping half-samples of follow-up respondents in the 19-to-30 age band are surveyed on 
alternating years. In the case of the 35-, 40-, 45-, 50-, and 55-year-olds, two entirely different 
graduating classes make up the samples for any two adjacent, chronological years of the survey 
results. 
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THE IMPORTANCE OF ADJUSTED LIFETIME PREVALENCE ESTIMATES 
In Figures 4-1 through 4-21, two different estimates of lifetime prevalence are provided. One 
estimate is based on the respondents’ most recent (i.e., 2017) responses about ever having used the 
drug in question (the blue bar). The other estimate takes into account each respondent’s answers 
regarding lifetime use gathered from all of the previous data collections in which he or she 
participated (the white bar). To be categorized as one who has used the drug based on all past 
answers regarding that drug, a respondent must have reported either lifetime use in the most 
recent data collection and/or reported some use in his or her lifetime on at least two earlier data 
collections. (Because respondents of ages 18 through 20 cannot have their responses adjusted on 
the basis of two earlier data collections, adjusted prevalence rates are reported only for ages 21 
and up.) Most other epidemiological studies can present only an unadjusted estimate because they 
have data from a single cross-sectional survey. An adjusted estimate of the type used here is 
possible only when panel data have been gathered so that a respondent can be classified as having 
used a drug at some time in his or her life, based on earlier answers, even though he or she no 
longer indicates lifetime use in the most recent survey. 
The divergence of these two estimates increases as time passes; consistent divergences within age 
across history suggest this is largely an age effect (rather than a period or cohort effect). Obviously, 
there is more opportunity for inconsistency within individuals as the number of data collections 
increases. Our judgment is that the truth lies somewhere between the two estimates: the lower 
estimate may be depressed by tendencies to forget, forgive, or conceal earlier use, whereas the 
upper estimate may include earlier response errors or incorrect definitions of drugs that 
respondents appropriately corrected in later surveys as they became more knowledgeable. It should 
be noted that a fair proportion of those giving inconsistent answers across time had earlier reported 
having used the given drug only once or twice in their lifetime. 
As we have reported in depth elsewhere, the cross-time stability of self-reported usage measures, 
taking into account both prevalence and frequency of self-reported use, is still very high.5 Note 
that the divergence between the two lifetime prevalence estimates is greatest for the 
psychotherapeutic drugs (including amphetamines, sedatives, narcotics other than heroin, and 
tranquilizers) and for the derivative index of use of an illicit drug other than marijuana (Figure 
4-2), which is heavily affected by the estimates of use of these psychotherapeutic drugs (without 
a doctor’s orders). We believe this is due to respondents having greater difficulty accurately 
categorizing psychotherapeutic drugs (usually taken in pill form) with a high degree of certainty—
especially if such a drug was used (without a doctor’s orders) only once or twice. We expect higher 
inconsistency across time when the event—and in many of these cases, a single event—is reported 
with a relatively low degree of certainty at quite different points in time. Those who have gone 
beyond simple experimentation with one of these drugs would likely be able to categorize them 
with a higher degree of certainty. Also, those who have experimented more recently (i.e., in the 
past month or year) should have a higher probability of recall as well as fresher information for 
accurately categorizing the drug. 
5 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. International Journal of the 
Addictions, 18, 805–824. 
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We provide both estimates of lifetime use across the list of drugs to make clear that a full use of 
respondent information provides a possible range for lifetime prevalence estimates, not a single 
point. However, by far the most important use of the prevalence data is to track trends in current 
(as opposed to lifetime) use. Thus, we are much less concerned about the nature of the variability 
in the lifetime estimates than we might otherwise be. The lifetime prevalence estimates are of 
importance primarily in showing the degree to which a drug class has penetrated the general 
population overall as well as particular cohorts; we believe that the evidence from the lifetime 
estimates suggests that other cross-sectional surveys of adults are subject to underreporting and 
that to some degree such underreporting increases with age, because adolescence and early 
adulthood are the periods in the life course during which most drug use occurs.6 
PREVALENCE OF DRUG USE ACROSS AGE GROUPS7 
Figures 4-1 through 4-21 provide 2017 prevalence rates for each class of drugs, covering 
respondents ages 18 to 55.  
To begin this summary, we note three general age-related trends in prevalence; these trends were 
evident in 2017 as they have been in our previous annual findings. First, for nearly all illicit drugs 
considered across ages 18 to 55, lifetime prevalence was higher for the older age groups, as would 
be expected (because of both age effects and cohort effects, with the current older cohorts being 
from the highest drug using cohorts in the life of the study). The high levels of lifetime use among 
adults at ages 50 and 55 in 2017 are especially noteworthy, with adjusted lifetime prevalence of 
ever using any illicit drug being over eight out of ten for 2017 55-year-olds and similarly high for 
50-year-olds. Second, annual and current illicit drug use in 2017 are highest among those in their 
early 20s for nearly all drugs, and then lower in subsequent age groups through age 55. In 
particular, regarding marijuana, annual use (39-41%) and 30-day use (25-26%) were highest for 
21-24 year-olds, with both declining mostly linearly with age to 15% and 10%, respectively, at 
age 55. Third, these age trends of annual and current use did not generally apply for alcohol and 
tobacco in 2017, with most age patterns being either rather flat across age or showing increases 
with age. An important exception is binge drinking (5+ drinks in a row in last two weeks), which 
was highest at age 21/22 in 2017 at 40% and then progressively lower across age groups to 17% 
among 55-year-olds. Details of and exceptions to these general age-related trends are provided 
below. As we note, age-related trends likely reflect, to some extent, cohort effects and secular 
trends. 
• The adjusted lifetime prevalence figures are most striking for today’s 55-year-olds (the
high school class of 1980), who were passing through adolescence near the peak of the
1970s drug epidemic. Some 86% reported trying an illicit drug (lifetime prevalence,
adjusted), leaving only 14% who reported never having done so (Figure 4-1). Staying with
6 For a more detailed analysis and discussion, see Johnston, L. D., & O’Malley, P. M. (1997). The recanting of earlier-reported drug use by young 
adults. In L. Harrison & A. Hughes (Eds.), The validity of self-reported drug use: Improving the accuracy of survey estimates (NIDA Research 
Monograph No. 97-4147). Washington, DC: National Institute on Drug Abuse. 
7 This section discusses differences in the current year as a function of age, but it should be noted that these age differences are confounded with 
cohort differences. Thus, although the discussion is accurate with respect to age differences, it is not necessarily the case that the age differences 
would be similar in other time periods. In fact, our recent evidence, including many findings provided in Chapter 5, suggests both similarities and 
differences by age across cohorts. See also Jager, J., Schulenberg, J. E., O'Malley, P. M., & Bachman, J. G. (2013). Historical variation in drug use 
trajectories across the transition to adulthood: The trend toward lower intercepts and steeper, ascending slopes. Development and Psychopathology, 
25(2), 527-543. 
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the adjusted lifetime figures, four out of five 55-year-olds (79%) said they had tried 
marijuana (Figure 4-3), and about three quarters (74%) said they had tried some other 
illicit drug (Figure 4-2), including almost half (47%) who had tried cocaine specifically 
(Figure 4-7). The adjusted lifetime prevalence of any illicit drug for 2017 50-year-olds 
(high school class of 1985) was somewhat lower than for the 55 year olds, but still notably 
high at 81%; moving down the age spectrum, prevalence for 35-45 year-olds was 75-78% 
in 2017. It is clear from Figure 4-1 (and many of the other figures in this chapter) that the 
parents and grandparents of today’s teenagers and young adults represent very drug-
experienced generations; this may help to explain the acceptance of medical marijuana in 
a large number of states and legalization of recreational marijuana use for adults in a 
growing number of states. 
• In 2017, almost half (49%) of the high school seniors reported trying at least one illicit
drug in their lifetime, typically marijuana (45%). Lifetime prevalence figures tend to be
higher for those in their 20s, suggesting that initiation of some drugs continues for many
youth through their 20s. Among 29- to 30-year-olds adjusted lifetime prevalence reached
77% for any illicit drug, 69% for marijuana, 55% for any illicit drug other than
marijuana, and 21% for cocaine. The 29- to 30-year-olds graduated from high school in
2005 and 2006—long after the peak of the 1970s drug epidemic and after the peak of the
relapse phase in the epidemic during the late 1990s; even in these relatively low drug-using
cohorts, only about one fourth (23%) report never having tried an illegal drug.
• Despite the higher lifetime prevalence rates of illicit drugs among older age groups, these
older groups generally showed annual or 30-day prevalence rates that are typically
considerably lower than those of today’s 12th graders and young adults, suggesting that
desistence more than offsets the incidence of initiating use of most illicit drugs during the
years after high school.
In analyses published elsewhere, we looked closely at patterns of change in drug use with 
age and identified post-high school experiences that contribute to declining levels of annual 
or current use of drugs as respondents grow older. For example, the likelihood of marriage 
increases with age, and we have found that marriage is consistently associated with 
declines in alcohol use, heavy (binge) drinking, marijuana use, and cocaine use, and most 
likely just about all of the other illicit drugs as well.8 
8 For example: a) Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug 
use in young adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates; and Bachman, J. G., 
O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in young adulthood: 
Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates; b) O’Malley, P. M., Bachman, J. G., Johnston, L. D., 
& Schulenberg, J. E. (2004). Studying the transition from youth to adulthood: Impacts on substance use and abuse. In J. S. House, F. T. Juster, R. 
L. Kahn, H. Schuman, & E. Singer (Eds.), A telescope on society: Survey research and social science at the University of Michigan and beyond 
(pp. 305–329). Ann Arbor, MI: The University of Michigan Press; c) Staff, J., Schulenberg, J. E., Maslowsky, J., Bachman, J. G., O’Malley, P. M., 
Maggs, J. L., & Johnston, L. D. (2010). Substance use changes and social role transitions: Proximal developmental effects on ongoing trajectories 
from late adolescence through early adulthood. Development and Psychopathology, 22 (Special issue: Developmental cascades: Part 2), 917-932; 
d) Maggs, J. L., Jager, J., Patrick, M. E., & Schulenberg, J. E. (2012). Social patterning in early adulthood in the USA: Adolescent predictors and
concurrent wellbeing across four distinct configurations. Longitudinal and Life Course Studies (Special Section: Transition to Adulthood in the 
UK, the US and Finland; Guest Editors: J. E. Schulenberg and I. Schoon), 3(2), 190-210; e) McCabe, S. E., Kloska, D. D., Veliz, P., Jager, J., & 
Schulenberg, J. E. (2016). Developmental course of nonmedical use of prescription drugs from adolescence to adulthood in the United States: 
National longitudinal data. Addiction, 111(12), 2166-2176. 
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• For use of any illicit drug (Figure 4-1), annual prevalence was highest among 21- to 22-
year-olds in 2017 (44%) and lowest among the older age groups, ranging between 30% and 
19% among 35- to 55-year-olds. Thirty-day prevalence was 25% among 12th graders and 
26% among 21-22 year-olds, while it was lower among 29-30 year-olds (20%) and lowest 
among 55-year-olds (13%).  
 
• Lifetime prevalence rates for marijuana (Figure 4-3) in 2017 generally increased with age 
through the 20s, with adjusted lifetime prevalence reaching 69% among those aged 29-30. 
But, against the general pattern of increasing lifetime prevalence with age, rates were level 
or even slightly lower among 35-, 40-, and 45-year-olds at 71%, 68%, and 65%, 
respectively. This pattern of lifetime use leveling or even being lower, especially among 
40- and 45-year-olds, was also true for some other illicit drugs (e.g., amphetamines, 
cocaine, narcotics other than heroin), highlighting cohort effects. The 40- and 45-year-olds 
graduated from high school in 1995 and 1990, respectively, when prevalence of marijuana 
and other drugs were at or near historic lows across the past four decades.   
 
• Annual and 30-day prevalence rates for marijuana in 2017 were highest at ages 21-22 at 
41% and 26% respectively, and then generally declined through age 45, reaching 15% and 
8% respectively, and then remained fairly level through age 55. Thus, as is evident in 
Figure 4-3 comparing annual and 30-day prevalence with lifetime prevalence, it is clear 
that greater proportions of the older cohorts have discontinued use. 
 
• Current daily marijuana use (defined as using on 20 or more occasions in the past 30 days) 
in 2017 showed some age differences (as shown in Figure 4-3 in this chapter as well as in 
Figure 5-3c in Chapter 5), standing at 6% at age 18, 9% at ages 21-24, and then dropping 
with age to 3% at ages 45 to 55. This suggests that most respondents who were daily users 
at some point in their teenage and young adult years are no longer daily users in later 
adulthood. 
 
• New questions about vaping marijuana were added to the young adult surveys in 2017. 
Lifetime prevalence was relatively flat from age 19 to 28, at 15% to 20%, and was lowest 
at age 29-30, at 9% (Table 4-2). Annual prevalence ranged from 11% to 17% among 19- 
to 28-year olds, and was lowest among 29-30 year olds at 5.8% (Table 4-3). Thirty-day 
prevalence ranged from 4.1% to 8.4% among 19-30 year olds (Table 4-4). 
 
• Synthetic marijuana refers to a set of substances that contain synthetic cannabinoids that 
are meant to mimic the effects of cannabinoids found in natural marijuana; synthetic 
cannabinoids are created artificially and typically sprayed on herbal and plant material, 
which is then smoked. These substances have been sold over-the counter in head shops, 
gas stations, on the Internet, and in other venues under various brand names like “spice” 
and “K-2.” Only 0.9% of young adults ages 19 to 30 years reported using synthetic 
marijuana in the last 12 months in 2017 (Table 4-3). Use rates were higher among the 19- 
to 22-year-olds (over 1%) than the older groups (less than 1%). Clearly, synthetic 
marijuana is not a commonly used drug, especially beyond the early 20s. 
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• Another important class of synthetic drugs called bath salts was added to the MTF
questionnaires in 2012. Fortunately, the rates of use of these dangerous over-the-counter
stimulants containing cathinones, which are intended to mimic the effects of
amphetamines, are quite low at this point. In 2017, the high school seniors had an annual
prevalence rate of 0.6%; among young adults 19-30, prevalence in 2017 was 0.3%, with
some minor variation by age (Table 4-3).
• Adjusted rates for lifetime use of any illicit drug other than marijuana (Figure 4-2)
showed an appreciable rise with age in 2017, reaching 55% for the 29- to 30-year-old age
group and 74% among 55-year-olds. In other words, about three quarters of all 55-year-
olds have tried some illicit drug other than marijuana, and about half of today’s 30-year-
olds have done so.
In 2017, both annual and past 30-day use were highest in the early- to mid-20s. Both rose 
with age from 13% and 6%, respectively, at age 18 to 23% and 10% at age 23-24; they 
then declined somewhat unevenly by age stratum through the 20s, reaching 17% and 8%, 
respectively, at age 29-30. Among those age 35 and older, annual prevalence declined from 
15% at age 35 to 9% at age 55; 30-day prevalence declined from 6% at age 35 to 5% at age 
55. A number of the individual drugs that comprise this general category show lower rates
of use at higher ages for annual prevalence, usually with the highest rate observed at ages 
18–24. This is particularly true for amphetamines, hallucinogens, LSD specifically, 
hallucinogens other than LSD, inhalants, and MDMA (ecstasy, Molly). The falloff across 
age-strata is not as great nor as consistent for cocaine, crack, other cocaine, crystal 
methamphetamine (ice), heroin, narcotics other than heroin, sedatives (barbiturates), 
and tranquilizers, though in general, usage rates are somewhat lower among those in their 
30s and older than among those in their early- to mid-20s. Several of these classes of drugs 
are discussed individually next.  
• Hallucinogens (Figure 4-10) have been used by a fair proportion of adults. Adjusted
lifetime rates in 2017 were between 25% and 29% for the 35- to 50-year-olds.
(Hallucinogens are not included in the age 55 survey.) Lifetime prevalence was lower at
younger ages, and was at 11%, adjusted, at age 21-22. Annual prevalence peaked at 6% at
age 23-24, was 2% at age 29-30, and 2% or less at the older ages.
• LSD (Figure 4-11) had been the most prevalent hallucinogen for some time. It had a fairly
limited adjusted lifetime prevalence among young adults in 2017, reaching a high of 13%
by age 25-26. Annual prevalence was highest among 21-24 year-olds at 4%, falling
thereafter to 1% by ages 29-30. LSD use was not asked of those over age 30.
• Hallucinogens other than LSD (Figure 4-12), which means psilocybin (“magic
mushrooms”) for the most part, had a higher adjusted lifetime prevalence among young
adults in 2017 than LSD, reaching 20% by age 29-30. Among young adults aged 19-30,
annual prevalence was similar for hallucinogens other than LSD (2.8%) and for LSD
(2.9%) (Table 4-3). Use was not asked of those over age 30.
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• Inhalants is not a commonly used category of drugs among adults. In 2017, adjusted
lifetime prevalence increased across age strata, peaking at 12% among 29-30 year-olds.
Annual prevalence was highest at ages 18-20 (2%) and declined with age, while 30-day
rates were already quite low by age 18 and did not have much more room to decline.
Clearly, current use of inhalants is almost absent beyond about age 18, and we know from
data presented in Volume I that much of the decline in use with age has already occurred
by 10th grade. Use is not asked of those over age 30.
• For amphetamines used without a doctor’s orders, lifetime prevalence was much higher
among the older age groups, with adjusted lifetime prevalence increasing from 17% at age
21-22 to 30% at age 29-30 and to 50% at age 55 in 2017 (Figure 4-4). This increase with
age reflects in part the addition of new users who initiate use in adulthood, but also
reflecting some cohort differences carried over from high school. As is true for most
psychotherapeutic drugs, corrected lifetime prevalence and contemporaneously reported
lifetime prevalence diverge considerably especially among those age 35 and older.
However, more recent use, as reflected in annual prevalence (Table 4-3 and Figure 4-4),
was considerably lower among the older age groups, peaking at 9% at age 21-22 and
declining to 6% at age 29-30 and to 1% by age 55. These age differences have not always
been true; the present pattern reflects a sharper historic decline in use among older
respondents than has occurred among 12th graders, as well as cohort differences in having
ever used these drugs. These trends are discussed in the next chapter.
• Ritalin, a stimulant widely prescribed for the treatment of attention deficit hyperactivity
disorder or ADHD, shows a relatively low annual prevalence of nonmedical use, between
0.2% and 2.0% between ages 19 and 30 in 2017 (Table 4-3).
• Adderall, an amphetamine stimulant also used in the treatment of ADHD, showed a
substantially higher annual prevalence of nonmedical use in 2017 compared to Ritalin, and
it also dropped off in use with age, from 11% among those aged 21-22 to 6.0% among
those age 29-30. The higher rates of use among those in their early 20s are consistent with
the interpretation that initially Ritalin and perhaps now Adderall are sometimes used by
college students in an effort to enhance their academic performance (Table 4-3).
Respondents over age 30 are not asked about Ritalin or Adderall use.
• Questions on the use of methamphetamine are contained in only two of the six
questionnaire forms for young adults, so estimates are less reliable than those based on all
six forms. In 2017 adjusted lifetime use increased across age strata, from 3% for 21- to 22-
year-olds to 6% for 29- to 30-year-olds. This suggests that much initiation of
methamphetamine use occurs after high school, though more recent cohorts of high school
graduates have been reporting considerably lower levels of use post high school. Annual
prevalence did not vary much with age, however, remaining at 0.2–1.6% for ages 18–30 in
this population of high school graduates (Table 4-3 and Figure 4-5.) Respondents over age
30 are not asked about methamphetamine use.
• Crystal methamphetamine (ice) is also included on only two questionnaire forms through
age 30 and is not asked of older respondents. In 2017, adjusted lifetime prevalence was
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highest at 4% among those age 27-30. Among the 19- to 30-year-old respondents 
combined, only 0.7% now reported any use in the prior year—similar to the 0.8% reported 
by 12th graders (Table 4-3 and Figure 4-6). 
• Nonmedical use of Sedatives (barbiturates) showed adjusted lifetime prevalence rates in
2017 that rose fairly linearly from age 21-22 (5%) through age 55 (29%) (Figure 4-14).
Annual use was more similar across ages 19 to 55 at about 1–3%. In summary, because of
the substantial long-term decline in sedative (barbiturate) use over the life of MTF, the 55-
year-olds had by far the highest adjusted lifetime prevalence (29%); but they were not any
more likely to be currently using than the younger age groups.9
• Nonmedical use of tranquilizers (Figure 4-16) shows a similar picture to that for sedatives,
with a general increase across age-bands in adjusted lifetime prevalence through age 40
(28%), with a slight dip among those age 45 (26%), reflecting a likely cohort effect in terms
of the lower use among adolescents in the late 1980s. Those aged 50 and 55 again showed
higher, indeed the highest, levels of adjusted lifetime prevalence (33% and 39%,
respectively). Annual prevalence of tranquilizer use was similar across the age groups,
ranging between 4% and 5% across all groups except those aged 45 (2%) and 55 (3%).
Thirty-day prevalence was 1–2% across all age groups.
• Adjusted lifetime prevalence of nonmedical use of narcotics other than heroin (Figure 4-
15) varied considerably across the age groups in 2017 from 10% for those age 21-22 to
29% for those age 29-30; it was 35% at age 35, 33% at age 40, 28% at age 45, 33% at age 
50, and 36% at age 55. These age differences in adjusted lifetime prevalence reflect cohort 
effects, with the oldest and more recent cohorts through age 35 showing higher prevalence 
than those aged 40 and 45 who were adolescents during the late 1980s when use of these 
and other substances tended to be lower compared to younger and older cohorts (consistent 
with findings regarding tranquilizers summarized above and cocaine summarized below). 
Annual prevalence of narcotics other than heroin ranged from 3% to 5% across all age 
groups. Thirty-day prevalence showed little difference across the age bands, with rates at 
1–2% up through age 55.  
• Adjusted lifetime prevalence of cocaine in 2017 was lowest among 21-24 year olds (11%)
and generally increased through age 35 (23%); it then leveled through ages 40 and 45
(23%), continued to increase at age 50 (35%), and peaked at age 55 (47%) (Figure 4-7).
This uneven age progression is indicative of a cohort effect, with the 40-45 year olds being
from lower drug using 12th grade cohorts (as discussed in Chapter 5, there have been clear
cohort effects in cocaine use over the years). Annual prevalence peaked at 6-7% at ages
21-26, and was otherwise at 3% to 5% among those between ages 18 and 35 in 2017; annual
use was only 1-2% in the age groups beyond 35. Thirty-day (current) use peaked at 3%
among 23-26 year olds, and was otherwise 1-2% across ages 18 to 55.Very few (0-1%) of
the 35- to 55-year-olds today are current users of cocaine, despite the fact that so many of
9 Barbiturates were the dominant form of sedatives in use when these questions were first introduced. In the intervening years, a number of non-
barbiturate sedatives have entered the market and largely displaced barbiturates. We believe that a number of users of non-barbiturate sedatives are 
reporting them in answer to this question, which also defines them in terms of the conditions for which they are prescribed. In recognition of this 
fact, we now label them as “sedatives (barbiturates).” The rewording of the question was made in half of the questionnaire forms in 2004 and in 
the other half in 2005. 
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them used it at least once in their lifetime. Among 55-year olds, 47% used cocaine at some 
time in their life, but only 0.4% reported using it in the past month. In other words, 
noncontinuation rates for cocaine are now extremely high among adults—particularly older 
adults. 
• In 2017, adjusted lifetime prevalence of crack use (Figure 4-8) was much lower than
general cocaine use. It ranged between 1% for those age 21-22 and 8% for those age 29-
30 through age 45; it was highest at 14% for those age 50, and slightly lower at 13% for
those age 55, reflecting something of a cohort effect due to the rather transient popularity
of crack in the early to mid-1980s and a brief resurgence in the mid-1990s. Thirty-day
prevalence was less than 0.5% in all of these age groups. Annual prevalence also was
highest among 18-year-olds at 0.8%, and was between 0% and 0.5% for all other age
groups. We believe that the prevalence estimates for crack are especially likely to be
impacted by the omission of high school dropouts. It seems likely that panel respondents
who become dependent on crack (or other illicit drugs like heroin) would be less likely
than average to respond to the questionnaires; therefore, such extreme users are no doubt
underrepresented among the panel respondents.
• MDMA (ecstasy, and, more recently, Molly) is asked about in four of the six follow-up
questionnaire forms up through age 30. Molly was added as an example in half of the
questionnaire forms in 2014 and in all forms in 2015. As Table 5-2 in the next chapter
shows, the inclusion of Molly appears to have only raised the annual prevalence estimate
in 2014 (when the two versions could be compared) by a little—from 4.8% to 5.1%. In
2017, among all 19- to 30-year-olds combined, 13.1% said they have tried MDMA,
compared to 4.9% of 12th graders. Lifetime MDMA prevalence increased to 15% among
those ages 23-24 and then peaked at 17% among those ages 25-28 (Figure 4-17). Annual
prevalence was at a peak at 6% at age 23-24 and was otherwise at 5% or below at ages 18–
30 in 2017. Thirty-day MDMA use was at 1% or lower for all age strata between 18 and
30 years in 2017. There clearly has been a high degree of noncontinuation of the use of this
drug in 18-30 year olds, and the large differences across age groups likely reflect cohort
effects. (Note in Figure 4-17 that there is practically no difference between the current
reporting of lifetime prevalence and the adjusted figures.)
• A question about the use of salvia was introduced into one questionnaire form in 2009 as
a single tripwire question asking only the frequency of use in the past twelve months (Table
4-3). Salvia has some mild hallucinogenic properties. It is not currently regulated by the
federal government, but a number of states have restrictions on it, and other states are
considering restrictions; previously, there had been considerable attention in the media paid
to its potential for harm. Annual prevalence for ages 19 through 30 combined is very low;
it stood at 0.5% in 2017, but prevalence dropped for ascending age strata from 1.1% among
21- to 22-year-olds down to 0.4 % among 29- to 30-year-olds. Older respondents are not
asked the question.
• In 2017, all alcohol prevalence estimates were higher among young adults than among 12th
graders, and they generally increased after high school, through at least the mid-20s
(Figures 4-20a and 4-20b). Prevalence rates varied only modestly among the older age
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groups. Lifetime prevalence changed very little after age 30, due in large part to a “ceiling 
effect.” Thirty-day use rose sharply from 33% among 18-year-olds to a peak of 74% among 
23-24 year-olds, then declined slightly through age 55, to 66%. Current daily drinking 
(Figure 4-20b) increased gradually and steadily across age strata, peaking at 11% at age 
55. Among the various measures of alcohol consumption, occasions of heavy drinking
(i.e., having five or more drinks in a row on at least one occasion in the two weeks prior to 
the survey, also called “binge drinking”) showed considerable differences by age (Figure 
4-20b). Prevalence was 17% at age 18 and 22% among those ages 19-20. It was highest at 
40% at age 21-22; it then ranged from 29% to 34% through age 29-30 and declined across 
age strata to 17% among 55-year-olds. We have interpreted this increasing-then-decreasing 
relationship with age as reflecting an age effect—not a cohort effect—because it seems to 
replicate across different graduating class cohorts and also because it has been linked 
directly to age-related events such as leaving the parental home (which increases heavy 
drinking) and marriage (which decreases it).10 Clearly, binge drinking is most popular 
among people in their twenties and falls off after that. Still, between ages 35 and 55, one-
fourth to one-sixth of the respondents report current binge drinking.  
Extreme binge drinking (also referred to as high-intensity drinking)11,12,13,14 is a concept 
that was introduced into MTF surveys in 2005. Two measures are used; drinking 10 or 
more drinks on one or more occasions in the prior two weeks and drinking 15 or more 
drinks on one or more occasions in the prior two weeks.15 Among all young adults 19-30, 
prevalence of having 10 or more drinks on at least one occasion in the two weeks prior to 
the survey was 10.9% in 2017 or roughly one in every nine respondents (Table 4-5); in 
considering separate ages, it was 7.7% at ages 19-20, ranged between 11.0% and 12.9% at 
ages 21-28, and was 9.6% at age 29-30. The combined age 19-30 prevalence for having 15 
or more drinks on at least one occasion in the prior two weeks was 3.3% or about one in 
30 respondents; in considering separate age groups, it was highest among 23-24 year olds 
(4.9%). These questions are not asked of respondents over age 30.  
• Cigarette smoking showed an unusual pattern of age-related differences, influenced to
some extent by cohort differences (Figure 4-21). Current (30-day) smoking prevalence
was lowest among 18-20 year olds (10%), highest among the 21-26 year olds (17%-18%),
and declined to 12% at ages 29-30; it was then between 13% and 15% among the older
10 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade 
of change, 1976–1986. American Journal of Public Health, 78(10), 1315–1321. See also a) Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., 
Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young adulthood: The impacts of new freedoms and new 
responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates; b) Schulenberg, J. E., & Maggs, J. L. (2002). A developmental perspective on alcohol 
use and heavy drinking during adolescence and the transition to young adulthood. Journal of Studies on Alcohol, Supplement, (14), 54-70. 
 11 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O’Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence of 
binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41(7), 
1319-1328. 
12 Patrick, M. E. & Terry-McElrath, Y. M. (2017). High-intensity drinking by underage young adults in the United States. Addiction, 112, 82-93. 
13 Patrick, M. E., Terry-McElrath, Y. M., Kloska, D. D., & Schulenberg, J. E. (2016). High-intensity drinking among young adults in the United 
States: Prevalence, frequency, and developmental change. Alcoholism: Clinical and Experimental Research, 40, 1905-1912. 
14 Terry-McElrath, Y. M. & Patrick, M. E. (2016). Intoxication and binge and high-intensity drinking among US young adults in their mid-20s. 
Substance Abuse, 37, 597-605.  
15 Because these two measures have been included in only one of the six questionnaire forms used with young adults, the numbers of cases are very 
limited, less than 200 weighted cases per year for each two-year age band from 19 to 30. Therefore, the estimates may be less reliable than those 
based on more cases.  
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adults, with the exception of 10% among 45-year-olds. (In the past as discussed in Chapter 
5, rates used to be about the same for 12th graders and those in their early 20s, partly because 
most initiation of cigarette use happens in high school, suggesting that noncontinuation 
rates have become higher among those who tried cigarettes in high school). Among 18-30 
year olds, the prevalence of daily smoking generally was higher among the older age strata, 
peaking at age 27-28 (11%); among those aged 35-55, it was 10-11%. At older ages, a 
rising proportion of current smokers—that is, those reporting any smoking in the past 30 
days—also reported daily smoking. Through age 30 a majority of those indicating any 
smoking in the prior year were not daily smokers; the proportion then declined with age so 
that among those age 55 only about a quarter of those who smoked in the prior year were 
not daily smokers.  
The prevalence of smoking half a pack or more of cigarettes per day was 2% among 18-
year-olds and ranged between 4% and 6% among 21- to 35-year-olds; it was higher at 8% 
among 40-year-olds, 6% among 45-year-olds, and 9% among 50-55 year olds. The 
proportions of current smokers who smoked a half-pack or more per day also were higher 
among older respondents in 2017: about one fifth among 18-year-olds (2% smoking a half-
pack or more divided by 10% who are 30-day smokers), about one third among 29- to 30-
year olds (4% smoking a half-pack or more divided by 12% who are 30-day smokers), and 
nearly three fourths among 55-year-olds (9% smoking a half-pack or more divided by 13% 
who are 30-day smokers).  
In essence, lighter smoking (in the past 12 months, but not in the past 30-days) falls off as 
one moves up the age bands beyond age 30, after which regular/heavy smoking accounts 
for increasing proportions of all current smoking, as may be seen in Figure 4-21. 
• Past 30-day prevalence of smokeless tobacco use (asked in one of the six questionnaire
forms) stood at 9% among all young adults in 2017 (most of it by males, as will be
discussed below) in 2017. Daily prevalence was 1.9% among all young adults, with the
highest rate observed among 21- to 22-year-olds (4.7%) (Tables 4-4 and 4-5).
• In 2017, we expanded the vaping questions to get at specific substances being vaped,
including nicotine, marijuana, and just flavoring. With regard to vaping nicotine, lifetime
use was at 23% in 2017 among young adults aged 19-30. It was highest at 29% at age 19-
20, and then showed some uneven decline across ascending age strata through age 29-30
(15%) (Table 4-2). It may well be that those in adolescence or early young adulthood are
most susceptible to starting to use vaporizers. Among young adults, 30-day prevalence of
vaping nicotine in 2017 was 6.2% for those aged 19-30; it was highest among those ages
23-24 (8.3%) and lowest among those aged 25-26 (3.6%) (Table 4-4).
• Questions have been added recently on the consumption by young adults of tobacco in
various specific forms other than cigarettes. Tripwire questions were added for these forms
of tobacco use in 2011, providing only annual prevalence and frequency data (Table 4-3).
Past-year prevalence of use in 2017 among 19- to 30-year-olds was 11% for using a hookah
to smoke tobacco, 15% for smoking small cigars, 4% for using snus, and only 0.7% for
using dissolvable tobacco. Among young adults, hookah smoking was highest among 23-
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to 24-year-olds at 15% and declined steadily to 8% at ages 29 to 30. (Rather than being an 
age effect, this could represent more of a cohort effect corresponding to the increased and 
then decreased popularity of this practice.) Annual prevalence of smoking small cigars was 
highest among 23- to 26-year-olds at 17% and lower at increasing ages, dropping to 11-
15% at age 27-30. Annual prevalence of use of snus was highest among the 23- to 24-year-
olds at 6.5% vs. 3-4% among the older age groups of young adults. Annual prevalence of 
dissolvable tobacco use was 1.4% or less among all young adult age groups. 
• Questions on anabolic steroid use (Figure 4-18) were added to one questionnaire form in
1989 and to an additional form in 1990, making it difficult to determine age-related
differences with much accuracy due to limited sample sizes. Overall, 1.3% of all 19- to 30-
year-olds in 2017 reported having used steroids in their lifetime and 0.3% in the prior 12
months. Use did not vary greatly or systematically by age. Questions about steroid use are
not asked of respondents over age 30.
In sum, lifetime prevalence in some of the older age groups, who passed through adolescence in 
the heyday of the drug epidemic, showed remarkably high lifetime rates of illicit drug use—
particularly when lifetime prevalence was corrected for the recanting of previously reported use. 
This highlights the importance of cohort effects when considering age-related changes (for 
example, for some drugs, tranquilizers and narcotics other than heroin, there was a lower lifetime 
prevalence in 2017 at age 45 compared to those younger and older, consistent with their lower 
prevalence as teens in the late 1980s). However, current use of most illicit drugs was substantially 
lower among those over age 30 than among those in their late teens to early 20s. For the two licit 
drugs, alcohol and cigarettes, the picture is different; there is less falloff in active use with age, 
and there are higher levels of daily alcohol use and regular cigarette smoking in the older ages. 
When considering these various prevalence estimates, it is important to recall that our samples are 
based on high school graduates and thus exclude those who drop out of high school, a group that 
tends to show higher prevalence of most substances; in addition, we are less likely to maintain 
persistent heavy drug users in our sample. 
PREVALENCE COMPARISONS FOR SUBGROUPS OF YOUNG ADULTS 
Subgroup differences for 19- to 30-year-olds are presented in Tables 4-1 through 4-5. While Table 
4-1 provides only gender differences, the remaining tables have prevalence rates by gender, age, 
region of the country, and population density. Each of these subgroup dimensions is discussed 
separately below. 
Gender Differences 
In general, most of the gender differences in drug use that are observed among young adults (19-
30) were observed in high school students as well. See Tables 4-1 and 4-5 for the full set of gender
comparisons. 
• Among the full young adult sample ages 19 to 30 in 2017, more males than females
reported past-year use of any illicit drug (43% vs. 38%), marijuana (40% vs. 34%), and
any illicit drug other than marijuana (23% vs. 18%). Similarly, more males than females
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reported 30-day use of any illicit drug (28% vs. 21%), marijuana (26% vs. 20%), and any 
illicit drug other than marijuana (10.4% vs. 7.5%). 
 
• With regard to vaping marijuana, based on new questions added to the young adult surveys 
in 2017, annual prevalence was 15.6% for males and 8.7% for females. For 30-day 
marijuana vaping, prevalence was 8.8% and 4.4%, respectively. Thus, as of 2017, it 
appears that the gender gap for marijuana use is larger regarding vaping marijuana than 
overall marijuana use, with males about twice as likely as females to vape marijuana in 
past year and past 30 days. 
 
• Males had higher annual prevalence rates for nearly all illicit drugs in 2017, sometimes 
with ratios of two times greater or more among infrequently used drugs (salvia, heroin, 
OxyContin, Ritalin, and methamphetamine) (Table 4-3).  
 
• With one minor exception, all measures of cocaine use showed higher 2017 rates of use by 
male than female 19- to 30-year-olds. Annual cocaine use was reported by 6.9% of males 
and 3.9% of females, powder cocaine use by 7.3% of males and 4.8% of females, and 
crack use by 0.2% of males and 0.1% of females. 
 
• Other large gender differences among 19- to 30-year-olds in 2017 were found in daily 
marijuana use (10.0% for males vs. 6.2% for females), daily alcohol use (8.5% vs. 3.1%), 
and occasions of heavy (binge) drinking—having five or more drinks in a row in the prior 
two weeks (39% vs. 27%). 
 
• There is a particularly large gender difference in the measures of extreme binge drinking 
in 2017: the rate for having 10 or more drinks on at least one occasion in the prior two 
weeks across ages 19-30 was 17.9 % for males vs. 6.3% for females. The rate for having 
15 or more drinks was 6.8% for males and 0.9% for females.  
 
• Annual prevalence of synthetic marijuana use in 2017 was low among young adult males 
and females (1.5% vs. 0.5%), as was use of bath salts (0.5% vs. 0.2%) (Table 4-1). 
 
• MDMA use (street names “ecstasy” and “Molly”) was slightly higher among males than 
among females with annual prevalence rates in 2017 of 4.4% and 2.9%, respectively. 
 
• Annual prevalence of use of narcotics other than heroin outside of medical supervision 
was also slightly higher in 2017 among males than females (5.1% versus 3.7%) (Table 4-
1). The use of Vicodin, one of the most widely used drugs in the class, was very slightly 
higher for males (3.2%) than females (2.5%); similarly, OxyContin use was slightly higher 
for males (3.1%) than males (1.3%) (Table 4-3). 
 
• The use of amphetamines was higher among males than among females with 2017 annual 
prevalence of 9.1% and 6.4%, respectively. 
 
• In 2017, 19- to 30-year-old males were more likely than females to smoke cigarettes in the 
past year (28% vs. 20%) and past month (19% vs. 12%); males were also more likely to 
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have smoked daily in the past month (10.4% vs. 7.3%), and to have smoked half a pack or 
more per day in the past month (5.6% vs. 3.8%) (Table 4-1). This current (and recent) 
gender gap is in contrast to earlier years of MTF; in the 1980s, there were few male-female 
differences, and it was not until the early 1980s when males started having higher cigarette 
use than females.  
• Based on new vaping questions added in 2017, annual prevalence of vaping nicotine was
higher at ages 19-30 for males than females (18% vs. 10%), and the same was true
regarding 30-day prevalence (8.8% vs. 4.4%). Again, as was true regarding gender
differences for vaping marijuana, the gender gap for vaping nicotine is greater than that for
smoking cigarettes (with males being almost twice as likely as females to vape nicotine).
• Among young adults there was a very large gender difference in 2017 in the use of
smokeless tobacco, with males much more likely than females to have used in their lifetime
(43% vs. 12%) and in the past month (19.2% vs. 2.0%) (Table 4-1). Almost all past-year
use of snus occurred among males (9.0% vs. 0.9% among females) as was true for
dissolvable tobacco (1.3% vs. 0.3%, respectively) (Table 4-3).
• In 2017, males were three times as likely to have smoked small cigars in the past year as
females (26.2% vs. 7.9%). The same was true for past 30-day use of regular little cigars
(5.8% vs. 1.2%) and for flavored little cigars (6.6% vs 3.7%).
• There was less gender difference in the annual use of hookah pipes (12.4% vs. 10.8%,
respectively).
• Steroid use among young adults is relatively rare, with adjusted lifetime prevalence being
2.9% for males and 0.3% for females in 2017 among 19-30 year-olds. Annual and 30-day
prevalence estimates were 0.4% or below for males and females.
Regional Differences 
Follow-up respondents are asked in what state they resided as of March of current year. States are 
then grouped into the same regions used in the analysis of high school data.16 Tables 4-2 through 
4-5 present regional differences in lifetime, annual, 30-day, and current daily prevalence for 19- 
to 30-year-olds combined. 
• There exist some regional differences in the annual prevalence of marijuana use, with
2017 rates being higher in the Northeast (40%) and West (40%) than the Midwest (34%)
and the South (33%). Likewise, regarding annual prevalence of any illicit drug use, rates
were somewhat higher in the Northeast (44%) and West (44%) than in the Midwest (39%)
and South (37%).
16 States are grouped into regions as follows: Northeast—Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, 
New Jersey, and Pennsylvania; Midwest—Ohio, Indiana, Illinois, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, 
Nebraska, and Kansas; South—Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, 
Florida, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and Texas; West—Montana, Idaho, Wyoming, Colorado, 
New Mexico, Arizona, Utah, Nevada, Washington, Oregon, and California. 
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• In 2017, the annual prevalence of any illicit drug other than marijuana (Table 4-3) was
highest in the West (23%), similar in the Northeast (20%) and Midwest (20%), and lowest
in the South (17%).
• The annual prevalence for synthetic marijuana in 2017 was quite low and did not differ
significantly by region (ranging from 0.5% to 1.2%) (Table 4-3).
• The annual prevalence for vaping marijuana, based on new questions added in 2017, was
higher in the Northeast (14.4%) and West (14.9%) than in the Midwest (10.6%) and South
(8.4%); thus, regional ranking of vaping marijuana is similar to overall marijuana use.
• In 2017, the use of hallucinogens tended to be highest in the West and lowest in the South.
Annual prevalence of hallucinogen use was 7.0% and 3.3% in the West and South,
respectively; for LSD, it was 4.1% and 2.4%, respectively; and for hallucinogens other
than LSD, it was 5.2% and 1.9%, respectively.
• For MDMA (ecstasy and more recently “Molly”), annual 2017 prevalence was
considerably higher in the West (6.3%) than in the other regions of the country, with annual
prevalence in the Northeast (3.0%), the South (2.5%) and the Midwest (2.7%).
• In 2017, annual prevalence of cocaine was higher in the West (7.7%) and Northeast (5.5%)
than in the South (4.0%) and Midwest (3.8%).
• The annual prevalence of Adderall in 2017 was similar across regions with it being slightly
higher in the Northeast (8.5%) and Midwest (8.3%) than the South (7.8%) and West
(7.1%).
• For the remaining illicit drugs, it is noteworthy that the use of LSD, hallucinogens other
than LSD, MDMA (ecstasy and Molly), and cocaine tended to be higher in 2017 among
young adults in the West than the other regions. Across other illicit drugs, regional
differences in 2017 were not substantial (Tables 4-2 through 4-5).
• Prevalence rates for alcohol use are typically somewhat higher in the Northeast and
Midwest regions than in the South and West; this pattern still pertained in 2017 and was
generally true among 12th graders as well (as reported in Volume I). For binge drinking
among 19- to 30-year-olds, the Northeast and Midwest were at 36% and 35% respectively,
with the South at 28% and the West at 27% (Table 4-5). Regarding extreme binge drinking
among 19- to 30-year-olds, having 10 or more drinks in a row was more common in the
Midwest (17.5%) and Northeast (13.5%) than in the South and West (6.9% for both). Self-
reported drunkenness showed a similar pattern (Table 4-4), as would be expected.
• Cigarette smoking among young adults tended to be somewhat higher in the Midwest and
South and lowest in the West in 2017. Thirty-day prevalence was 16% in both the Midwest
and South, 14% in the Northeast and 13% in the South (Table 4-4); similarly, for smoking
a half pack or more per day, prevalence was 5.5% for the Midwest, 5.3% for the South,
4.4% for the Northeast, and 2.3% for the West (Table 4-5).
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• Regional differences for vaping nicotine in 2017 were slight, with 30-day prevalence of
vaping nicotine being higher for the Northeast (7.7%) than for the South (6.4%), West
(6.1%), and Midwest (5.1%) (Table 4-4). Thus, regional differences for vaping nicotine do
not follow those for smoking cigarettes, although the Ns by region for vaping nicotine are
relatively small.
• Use of flavored little cigars (Table 4-4) did not show much regional difference in 2017,
with the 30-day prevalence ranging from 5.5% in the Northeast to 4.0% in the West.
Similarly, the 30-day prevalence of regular little cigars (i.e., non-flavored) varied rather
little across region, ranging from 4.0% in the Northeast to 2.1% in the West.
• Thirty-day prevalence for the use of large cigars in 2017 ranged from 6.3% in the Midwest
to 1.7% in the Northeast (Table 4-4).
• The 30-day prevalence of smokeless tobacco use in 2017 was highest in the West (13.3%)
than the other regions (ranging from 7.5% to 8.7%) (Table 4-4).
• The annual use of snus in 2017 was higher in the Midwest (6.2%) and West (4.9%)
compared to the Northeast (3.1%) and South (3.0%).
• Annual use of a hookah to smoke tobacco was highest in West (13.5%), compared to the
Northeast (11.7%), South (11.3%), and Midwest (9.6%) (Table 4-3).
Population Density Differences 
Population density is measured by asking respondents to select the response category that best 
describes the size and nature of the community where they lived during March of the year in which 
they completed the follow-up questionnaire. The various categories are listed in Tables 4-2 through 
4-5; the population sizes given to the respondent to help define each level are provided in a footnote 
to each table.17 See Tables 4-2 through 4-5 for the tabular results on 19- to 30-year-olds combined. 
• Differences in illicit drug use by population density tend to be modest, perhaps more
modest than is commonly supposed. Among the general population, use of most illicit
drugs is broadly distributed among all areas from rural to urban. To the extent that there
are variations, almost all of the associations are positive with regard to density, with
rural/country areas having the lowest levels of use, and small towns having the next lowest.
Medium-sized cities, large cities, and very large cities tend to be higher. In 2017, positive
associations with population density existed for annual prevalence of any illicit drug
(ranging from 30.6% for farm/country to 48.5% for very large city), any illicit drug other
than marijuana (ranging from 14.5% to 27.6%, respectively), and marijuana (27.8% to
45.6%, respectively); annual prevalence of vaping marijuana showed the same pattern
17 An examination of the 1987 and 1988 drug use data for the two most urban strata revealed that the modest differences in prevalence rates between 
the suburbs and their corresponding cities were not worth the complexity of reporting them separately; accordingly, since then these categories 
have been merged to increase sample sizes. 
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(7.0% to 18.6%, respectively). Most of the drugs that comprise the measure of any illicit 
drug other than marijuana showed a similar pattern, with exceptions noted below. 
• Annual prevalence of cocaine, ecstasy, and hallucinogens other than LSD tended to be
twice as high in 2017 in very large cities (10.4%, 7.0%, and 5.4%, respectively) than the
other density strata, with little difference among them (Table 4-3).
• Annual prevalence was distinctly higher in the farm/country stratum compare to the other
four strata for some uncommonly used drugs including methamphetamine (1.7% vs. 0.2-
0.8%), crystal methamphetamine (1.6% vs. 0.3-0.9%), and bath salts (1.6% vs. 0-0.4%).
• Differences among density strata were quite small in 2017 for annual prevalence of
narcotics other than heroin, ranging from 3.7% to 4.4% (and the same was true for
OxyContin and Vicodin specifically) (Table 4-3). Similarly, many of the illicit drugs with
relatively low annual prevalence did not show substantial variation by population density,
including use of synthetic marijuana, PCP, salvia, crack, heroin, sedatives, Ketamine,
and steroids (Table 4-3).
• Among young adults age 19-30, the lifetime and annual alcohol use measures all showed
a slight positive association with population density, while 30-day use had a somewhat
stronger positive association, with 63% of the farm/country stratum reporting alcohol use
in the prior 30 days versus 77% of those in very large cities.
Prevalence of binge drinking among young adults was positively associated with
population density as well (Table 4-5), with 26% of those in the farm/country stratum
indicating having had five or more drinks in a row at least once in the prior two weeks
compared to 40% of those in the very large cities. Daily alcohol use in the prior month was
also slightly positively associated with population density in 2017 with 3.5% of young
adults in the farm/country stratum indicating daily use versus 8.4% in the very large cities.
For 10 or more drinks in a row in the past two weeks (extreme binge drinking), prevalence
was highest in large cities (13.5%), next highest in small towns (11.2%) and farm/country
(10.9%), and lowest in very large cities (9.8%) and medium cities (8.8%) (Table 4-5).
• Contrary to what we find for almost all other substances, there exists a negative association
between population density and daily cigarette smoking, which was highest in the
farm/country stratum (daily prevalence of 15%) and lowest in the large and very large cities
(daily prevalence rate of 8% and 7%, respectively). Smoking at the half-pack-a-day level
in the prior 30 days was about five times as high in the farm/country stratum as in very
large cities (11% vs. 2%, respectively; Table 4-5).
• Annual prevalence of small cigars was highest in the very large cities (20%) and ranged
from 12% to 16% in the other population density strata. (As noted in Table 4-3, Ns are
relatively small for these and other forms of tobacco use summarized below.)
• Thirty-day prevalence of flavored little cigars was highest in the farm/country stratum
(10.0%) and lower in all other strata (2.2% to 5.0%). Similarly, 30-day prevalence of
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regular little cigars was highest in the farm/country stratum (6.9%) and lower in the other 
strata (1.5% to 3.3%) (Table 4-4). 
• The annual prevalence of hookah smoking (Table 4-3) was highest in very large cities
(17.0%) and declined with population density, being smallest in the farm/country stratum
(6.6%).
• On the other hand, 30-day prevalence of smokeless tobacco use was very high in the
farm/country stratum (19.4%) and mixed among the other strata (lowest in large cities at
4.4%) (Table 4-4).
• The annual prevalence of snus by young adults varied rather little by population density
but tended to be higher in the farm/country and small town strata (6.0% and 5.3%,
respectively) versus 3.1-4.3% in the other strata (Table 4-3).
• Finally, vaping nicotine varied little by population density. Annual prevalence in 2017 was
15.0% in the farm/country stratum, 12.4%-13.8% in the city strata, and 11.8% in the small
town stratum (Table 4-3) Thirty-day prevalence was very similar across the strata, ranging
from 5.8% to 6.4% (Table 4-4).
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Males Females Total
Approximate Weighted N = 1,800 2,600 4,400
Annual 43.1 38.2 40.1
30-Day 27.7 21.4 23.9
 Annual 22.8 17.5 19.6
30-Day 10.4 7.5 8.6
Annual 39.7 34.0 36.3
30-Day 26.2 19.5 22.2
Daily b 10.0 6.2 7.7
Annual c  1.5  0.5  0.9
Annual 1.2 0.4 0.7
30-Day 0.4 0.3 0.4
Annual 6.5 2.8 4.3
30-Day 1.2 0.6 0.8
Annual 4.6 1.8 2.9
30-Day 0.8 0.4 0.5
Annual 4.5 1.7 2.8
30-Day 0.8 0.3 0.5
Annual * 1.0 *
30-Day * 0.9 *
Annual 4.4 2.9 3.5
30-Day 0.9 0.7 0.8
Annual 6.9 3.9 5.1
30-Day 3.0 1.3 1.9
Annual 0.2 0.1 0.2
30-Day * 0.1 0.0
Annual 7.3 4.8 5.8
30-Day 3.1 1.3 2.0
Annual 0.6 0.3 0.4
30-Day 0.3 0.2 0.2
Annual 0.4 0.1 0.2
30-Day 0.1 0.1 0.1
Annual 0.4 0.3 0.3
30-Day 0.1 0.2 0.2
Synthetic Marijuana 
Prevalence of Use of Various Types of Drugs by Gender
TABLE 4-1
Heroin
     Hallucinogens other than LSD e
(Entries are percentages.)
among Respondents of Modal Ages 19–30, 2017
Hallucinogens e
Inhalants c
Marijuana
Any Illicit Drug a
Any Illicit Drug other than Marijuana a 
     LSD e
     Other Cocaine f
     Crack e
     PCP d
Cocaine
     MDMA (Ecstasy, Molly) f
     With a Needle g
     Without a Needle g
(Table continued on next page.)
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Males Females Total
Approximate Weighted N = 1,800 2,600 4,400
Annual 5.1 3.7 4.2
30-Day 1.3 1.2 1.2
Annual 9.1 6.4 7.5
30-Day 3.2 2.7 2.9
Annual 0.8 0.4 0.6
30-Day 0.2 0.2 0.2
Annual 0.9 0.5 0.7
30-Day 0.3 0.3 0.3
Annual 0.5 0.2 0.3
Annual 2.6 1.9 2.2
30-Day 0.6 0.6 0.6
Annual 4.9 4.5 4.7
30-Day 1.5 1.5 1.5
Annual 82.0 82.1 82.0
30-Day 71.6 65.5 68.0
Daily b 8.5 3.1 5.2
5+ Drinks in a Row in Last 2 Weeks 38.5 26.6 31.4
10+ Drinks in a Row in Last 2 Weeks d 17.9 6.3 10.9
15+ Drinks in a Row in Last 2 Weeks d 6.8 0.9 3.3
Annual 65.6 57.1 60.5
30-Day 41.0 31.6 35.4
Daily b 0.5 0.2 0.3
Annual 47.4 54.1 51.5
30-Day 20.9 27.6 25.0
Annual 28.0 19.8 23.0
30-Day 18.5 12.3 14.8
Daily 10.4 7.3 8.6
1/2 Pack+/Day 5.6 3.8 4.5
Lifetime 36.1 24.3 28.9
Annual 26.1 15.6 19.7
30-Day 18.7 7.4 11.9
Lifetime 21.2 10.9 15.0
Annual 16.3 7.8 11.1
30-Day 9.4 4.3 6.3
Lifetime 27.7 18.2 21.9
Annual 17.9 9.6 12.9
30-Day 11.0 4.2 6.9
Bath Salts (Synthetic Stimulants) c
Any Vaping g
     Vaping Marijuana g
Cigarettes
Alcohol
Tranquilizers h
Sedatives (Barbiturates) h
     Flavored Alcoholic Beverages d
     Been Drunk c
TABLE 4-1 (cont.)
Prevalence of Use of Various Types of Drugs by Gender
among Respondents of Modal Ages 19–30, 2017
(Entries are percentages.)
Amphetamines, Adjusted h,i
Crystal Methamphetamine (Ice) g
Methamphetamine g
Narcotics other than Heroin h
     Vaping Nicotine g
(Table  continued on next page.)
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Lifetime 20.0 16.0 17.6
Annual 9.7 7.0 8.1
30-Day 6.2 1.7 3.4
Smokeless Tobacco d
Lifetime 42.9 12.0 24.8
30-Day 19.2 2.0 9.1
Daily 4.6 0.0 1.9
Steroids g
Annual 0.4 0.1 0.3
30-Day 0.2 0.1 0.2
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, 
sedatives (barbiturates), or tranquilizers  not under a doctor’s orders.
bDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, and 5+ drinks, 
measured as having five or more drinks in a row in the last two weeks.
cThis drug was asked about in three of the six questionnaire forms. Total  N  is approximately 2,200.
dThis drug was asked about in one of the six questionnaire forms. Total  N  is approximately 700. 
eThis drug was asked about in five of the six questionnaire forms. Total  N  is approximately 3,600. 
fThis drug was asked about in four of the six questionnaire forms. Total  N  is approximately 2,900. 
gThis drug was asked about in two of the six questionnaire forms. Total  N  is approximately 1,500. 
hOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
     Vaping Just Flavoring g
among Respondents of Modal Ages 19–30, 2017
TABLE 4-1 (cont.)
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Any Illicit Drug
Any Illicit other than Hallucinogens MDMA
Drug a Marijuana a Marijuana Inhalants b Hallucinogens d LSD d other than LSD d   PCP c (Ecstasy,Molly) f Cocaine Crack d
Total 4,400 65.3 38.6 61.0 5.6 13.6 8.6 11.6 1.0 13.1 12.3 1.6
Gender
    Male 1,800 67.1 42.6 63.4 6.9 19.3 12.7 17.2 1.6 15.0 15.7 2.0
    Female 2,600 64.1 35.8 59.4 4.8 9.8 6.0 7.9 0.6 11.8 10.0 1.4
Modal Age
     19–20 700 55.7 25.7 50.0 3.8 7.4 5.1 4.9 * 4.4 5.0 0.6
     21–22 700 60.9 30.4 57.6 3.2 10.7 7.9 7.4 0.4 10.5 10.3 1.1
     23–24 700 65.3 39.1 63.7 6.0 14.2 10.0 11.9 * 14.7 10.7 0.9
     25–26 700 67.0 43.3 62.7 6.0 16.5 11.7 14.5 0.4 16.6 14.8 0.9
     27–28 800 69.4 43.7 65.1 6.8 15.0 9.0 13.7 0.6 15.8 14.5 2.3
     29–30 700 71.3 46.4 65.0 7.7 17.0 7.8 16.2 3.9 15.4 17.3 3.7
Region
    Northeast 800 69.1 36.8 65.0 5.8 13.0 8.5 11.0 0.4 13.7 12.4 1.5
    Midwest 1,100 64.7 38.9 59.9 4.2 13.8 9.5 11.5 0.6 11.8 10.9 1.2
    South 1,400 62.8 36.4 57.7 5.8 11.4 7.0 9.4 2.1 10.6 11.1 2.1
    West 1,000 66.0 41.7 63.4 6.9 16.6 10.1 14.8 0.2 17.8 15.3 1.5
Population Density e
    Farm/Country 400 63.2 37.0 56.6 6.0 12.9 7.6 11.9 2.1 8.9 10.8 3.5
    Small Town 1,100 61.8 35.6 56.5 5.0 12.3 7.6 10.0 0.6 9.5 10.5 1.6
    Medium City 1,100 63.2 35.1 59.2 5.7 12.2 8.2 9.7 1.3 13.1 9.9 1.2
    Large City 1,000 66.7 40.2 62.8 6.4 14.2 10.1 12.1 0.3 14.3 13.0 1.5
    Very Large City 700 72.8 46.3 71.0 5.2 17.6 9.5 16.4 0.4 19.8 19.1 1.5
Weighted N 
TABLE 4-2
Lifetime Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2017
(Entries are percentages.)
Approximate
(Table continued on next page.)
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Crystal
Other Heroin with Heroin without Narcotics other Methamphetamine
Cocaine f Heroin a Needle g a Needle g than Heroin h Amphetamines h,i Methamphetamine g  (Ice) g
Total 4,400 13.9 1.6 0.8 1.6 14.9 19.3 3.1 2.2
Gender
    Male 1,800 17.3 2.1 1.3 2.6 18.1 22.1 3.6 2.6
    Female 2,600 11.6 1.2 0.4 1.0 12.8 17.5 2.7 1.9
Modal Age
     19–20 700 4.9 0.2 * 0.4 7.4 10.3 1.2 0.7
     21–22 700 10.0 0.6 0.4 0.6 8.8 15.8 2.9 1.3
     23–24 700 13.4 1.0 0.4 1.4 13.9 20.2 2.1 1.4
     25–26 700 15.9 2.1 1.4 2.6 17.8 21.8 2.5 1.3
     27–28 800 17.5 2.7 1.5 2.3 18.5 21.7 4.0 3.9
     29–30 700 19.9 2.6 1.0 2.3 21.7 24.4 5.3 4.0
Region
    Northeast 800 15.0 2.4 1.3 2.8 13.5 18.1 1.8 0.2
    Midwest 1,100 11.4 1.2 0.7 1.2 15.6 21.6 2.8 2.5
    South 1,400 12.2 1.1 0.5 1.1 13.6 18.4 2.9 2.1
    West 1,000 18.3 2.2 1.1 1.7 17.3 18.3 4.7 3.6
Population Density e
    Farm/Country 400 13.3 2.3 2.4 2.0 17.8 16.9 7.1 3.8
    Small Town 1,100 11.3 1.2 0.7 1.9 13.9 16.3 2.3 1.8
    Medium City 1,100 10.5 1.6 0.4 1.5 13.6 18.2 3.3 2.5
    Large City 1,000 15.5 1.4 1.0 1.3 15.4 19.8 2.7 1.2
    Very Large City 700 22.4 2.0 0.2 1.7 16.7 25.7 2.3 2.9
Weighted N 
TABLE 4-2 (cont.)
Lifetime Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2017
(Entries are percentages.)
(Table continued on next page.)
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Flavored 
Sedatives Been Alcoholic Vaping Vaping
(Barbiturates) h Tranquilizers h Alcohol Drunk b Beverages c Cigarettes Any Vaping g Marijuana g Nicotine g
Total 4,400 7.3 13.4 86.3 76.4 80.4 — 31.7 15.8 23.1
Gender
    Male 1,800 8.9 14.7 85.7 77.7 78.9 — 38.0 20.2 28.7
    Female 2,600 6.2 12.5 86.7 75.5 81.4 — 27.6 13.0 19.4
Modal Age
     19–20 700 3.8 7.6 69.9 54.5 61.4 — 35.8 15.0 20.4
     21–22 700 4.5 9.1 85.9 74.1 83.7 — 36.4 16.5 28.5
     23–24 700 5.6 12.0 90.2 81.1 79.6 — 36.3 20.2 24.8
     25–26 700 8.6 15.2 88.5 81.9 82.5 — 30.8 15.9 26.1
     27–28 800 9.3 17.1 89.7 82.3 87.1 — 32.4 18.0 24.1
     29–30 700 11.3 18.3 91.5 80.6 86.2 — 19.3 9.3 14.8
Region
    Northeast 800 6.5 12.6 89.6 81.7 85.9 — 35.4 21.2 24.7
    Midwest 1,100 7.8 13.6 88.4 80.7 83.1 — 29.0 13.7 21.9
    South 1,400 6.8 13.2 85.3 72.9 74.7 — 30.5 12.5 22.9
    West 1,000 7.7 14.0 82.5 71.7 80.7 — 34.4 19.0 23.6
Population Density e
    Farm/Country 400 7.5 12.6 82.4 74.5 81.2 — 30.3 11.1 24.1
    Small Town 1,100 7.5 11.9 84.0 73.7 76.4 — 28.8 12.1 20.5
    Medium City 1,100 6.2 12.7 84.5 74.7 83.2 — 31.3 14.6 22.2
    Large City 1,000 7.5 15.1 89.2 77.3 80.9 — 32.1 16.9 23.4
    Very Large City 700 8.2 15.1 90.9 84.3 81.1 — 37.5 24.9 26.9
TABLE 4-2 (cont.)
Lifetime Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2017
(Entries are percentages.)
Approximate
(Table continued on next page.)
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Vaping Smokeless
Just Flavoring g Tobacco c Steroids g
Total 4,400 19.1 24.8 1.3
Gender
    Male 1,800 20.7 42.9 2.9
    Female 2,600 18.2 12.0 0.3
Modal Age
     19–20 700 27.5 21.8 1.4
     21–22 700 29.3 23.5 1.2
     23–24 700 20.8 34.6 1.8
     25–26 700 16.8 2.1 0.9
     27–28 800 14.0 32.2 1.9
     29–30 700 8.4 28.2 0.7
Region
    Northeast 800 22.6 23.3 1.6
    Midwest 1,100 16.5 22.8 0.9
    South 1,400 19.4 25.3 1.9
    West 1,000 19.4 28.2 1.0
Population Density e
    Farm/Country 400 18.5 38.3 *
    Small Town 1,100 18.7 25.1 1.6
    Medium City 1,100 22.2 24.7 1.4
    Large City 1,000 17.0 15.3 0.8
    Very Large City 700 18.0 32.5 2.5
Source. The Monitoring the Future study, the University of Michigan.
Notes.  ' — ' indicates data not available.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders.
bThis drug was asked about in three of the six questionnaire forms. Total N is approximately 2,200.
cThis drug was asked about in one of the six questionnaire forms. Total N is approximately 700.
dThis drug was asked about in five of the six questionnaire forms. Total N  is approximately 3,600.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; and a very large city as having over 500,000. 
Within each level of population density, suburban and urban respondents are combined.
fThis drug was asked about in four of the six questionnaire forms. Total N is approximately 2,900.
gThis drug was asked about in two of the six questionnaire forms. Total N  is approximately 1,500.
hOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
Weighted N 
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Any Any Illicit Drug
Illicit other than Synthetic Hallucinogens MDMA
Drug a Marijuana a Marijuana Marijuana c Inhalants c Hallucinogens e      LSD e other than LSD e   PCP d (Ecstasy,Molly) f Salvia c Cocaine Crack e
Total 4,400 40.1 19.6 36.3 0.9 0.7 4.3 2.9 2.8 0.4 3.5 0.5 5.1 0.2
Gender
     Male 1,800 43.1 22.8 39.7 1.5 1.2 6.5 4.6 4.5 1.0 4.4 0.8 6.9 0.2
     Female 2,600 38.2 17.5 34.0 0.5 0.4 2.8 1.8 1.7 * 2.9 0.4 3.9 0.1
Modal Age
     19–20 700 41.8 17.1 38.3 1.6 1.7 4.6 3.0 3.2 * 1.8 1.0 3.0 0.3
     21–22 700 43.7 19.1 41.1 1.1 1.0 4.9 3.8 2.5 * 4.8 1.1 6.6 0.4
     23–24 700 42.4 22.9 38.7 0.9 0.4 5.8 4.2 3.7 * 5.7 * 5.6 0.1
     25–26 700 40.0 22.3 34.7 0.3 * 5.0 3.4 3.5 * 3.3 * 7.2 *
     27–28 800 38.4 19.0 34.9 0.8 0.6 3.6 2.5 2.2 0.3 2.3 0.6 4.0 0.1
     29–30 700 34.9 17.3 30.4 0.8 0.8 2.2 0.8 1.9 1.9 2.9 0.4 4.0 0.1
Region
     Northeast 800 43.7 20.1 40.4 0.5 0.8 3.2 2.4 2.2 0.4 3.0 1.0 5.5 0.2
     Midwest 1,100 39.0 19.6 33.9 0.7 0.6 4.2 3.1 2.4 0.6 2.7 0.4 3.8 0.1
     South 1,400 36.9 17.2 33.2 1.2 0.4 3.3 2.4 1.9 0.6 2.5 0.4 4.0 0.3
     West 1,000 43.7 22.7 40.4 1.1 1.4 7.0 4.1 5.2 * 6.3 0.5 7.7 0.1
Population Density j
     Farm/Country 400 30.6 14.5 27.8 1.3 0.5 3.1 2.2 2.5 0.7 2.4 0.8 3.2 0.6
     Small Town 1,100 35.6 16.2 31.0 1.0 0.6 3.3 2.2 2.0 * 2.4 0.6 3.3 0.1
     Medium City 1,100 40.4 18.7 35.6 0.9 1.1 3.8 2.7 2.2 0.5 3.1 0.4 4.1 0.1
     Large City 1,000 42.8 20.5 40.1 0.7 0.4 4.6 3.6 2.7 0.2 3.1 0.8 5.3 0.3
     Very Large City 700 48.5 27.6 45.6 1.0 1.1 7.1 3.8 5.4 * 7.0 * 10.4 0.2
(Table continued on next page.)
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Heroin Narcotics Crystal
Other Heroin with without a other than Methamphetamine
Cocaine f Heroin a Needle b Needle b Heroin g OxyContin c,g Vicodin c,g Amphetamines g,i Ritalin c,g Adderall c,g Methamphetamine b (Ice) b
Total 4,400 5.8 0.4 0.2 0.3 4.2 2.0 2.8 7.5 1.0 7.9 0.6 0.7
Gender
     Male 1,800 7.3 0.6 0.4 0.4 5.1 3.1 3.2 9.1 1.5 9.7 0.8 0.9
     Female 2,600 4.8 0.3 0.1 0.3 3.7 1.3 2.5 6.4 0.7 6.7 0.4 0.5
Modal Age
     19–20 700 2.8 * * * 3.6 1.7 1.2 6.7 1.1 5.6 0.2 0.5
     21–22 700 6.1 0.2 * * 3.3 2.3 1.5 9.5 1.7 10.9 1.6 0.8
     23–24 700 6.9 0.5 0.4 0.6 4.1 1.6 3.5 8.4 2.0 10.0 0.3 0.2
     25–26 700 8.2 0.4 0.5 0.5 4.7 2.0 3.7 7.3 0.7 7.0 0.8 0.8
     27–28 800 5.1 0.7 0.2 0.4 4.6 1.9 3.4 7.2 0.5 7.9 0.4 1.1
     29–30 700 5.4 0.5 * 0.4 5.0 2.5 3.3 5.7 0.2 5.9 0.2 0.7
Region
     Northeast 800 7.5 0.7 0.6 0.7 4.5 2.3 2.3 8.0 2.0 8.5 0.3 *
     Midwest 1,100 4.6 0.3 * 0.1 4.3 1.7 4.0 8.4 1.2 8.3 0.8 1.0
     South 1,400 3.7 0.2 0.1 0.2 3.9 1.8 1.2 7.2 0.6 7.8 0.6 0.6
     West 1,000 8.8 0.7 0.2 0.4 4.6 2.6 4.0 6.6 0.7 7.1 0.6 1.0
Population Density j
     Farm/Country 400 3.0 0.7 0.4 0.4 4.4 2.2 2.3 5.3 0.5 6.7 1.7 1.6
     Small Town 1,100 3.3 0.2 0.3 0.6 3.7 1.0 2.0 6.2 1.2 7.0 0.4 0.5
     Medium City 1,100 4.1 0.5 * 0.3 4.5 2.5 2.8 7.3 0.5 6.9 0.4 0.9
     Large City 1,000 6.6 0.2 0.2 0.2 4.4 2.0 3.4 8.3 1.0 8.1 0.8 0.3
     Very Large City 700 13.6 0.6 * 0.2 4.1 2.8 3.4 9.9 2.0 11.5 0.2 0.7
(Table continued on next page.)
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Alcoholic  
Bath Salts Flavored Beverages Tobacco
(synthetic Sedatives Been Alcoholic containing  using a Small Vaping
stimulants) c (Barbiturates) g Tranquilizers g GHB b Ketamine b Alcohol Drunk c Beverages d Caffeine b Cigarettes Hookah c Cigars b Any Vaping b Marijuana b
Total 4,400 0.3 2.2 4.7 - 0.4 82.0 60.5 51.5 30.6 23.0 11.4 15.3 21.1 11.4
Gender
     Male 1,800 0.5 2.6 4.9 - 0.6 82.0 65.6 47.4 37.7 28.0 12.4 26.2 27.4 15.6
     Female 2,600 0.2 1.9 4.5 - 0.3 82.1 57.1 54.1 25.8 19.8 10.8 7.9 17.0 8.7
Modal Age
     19–20 700 0.5 2.0 3.8 - 0.8 63.9 46.8 49.1 23.0 17.6 11.6 16.1 25.4 12.3
     21–22 700 0.8 2.1 4.2 - 0.5 83.8 64.7 70.1 37.1 26.5 14.1 16.7 22.2 11.1
     23–24 700 * 2.2 4.9 - 0.5 87.6 65.0 61.9 34.9 25.4 14.9 17.4 25.2 16.5
     25–26 700 0.2 2.5 5.4 - 0.6 84.3 65.9 54.1 34.0 26.8 12.0 17.2 21.7 11.2
     27–28 800 0.4 2.3 5.0 - 0.2 84.4 60.7 36.9 29.4 22.7 8.3 11.0 20.9 11.6
     29–30 700 * 2.1 4.6 - * 85.7 57.7 35.8 24.8 19.0 7.9 14.6 12.0 5.8
Region
     Northeast 800 0.4 1.8 4.8 - 0.5 86.3 66.2 56.5 28.1 23.9 11.7 17.0 24.0 14.4
     Midwest 1,100 0.2 2.5 4.8 - 0.3 85.7 64.5 47.1 34.3 25.1 9.6 18.6 19.8 10.6
     South 1,400 0.5 2.2 4.3 - 0.5 79.9 57.7 52.1 29.0 22.7 11.3 13.8 19.7 8.4
     West 1,000 0.2 2.0 4.9 - 0.5 76.9 54.6 51.6 30.4 20.8 13.5 12.7 23.4 14.9
Population Density j
     Farm/Country 400 1.6 2.4 3.6 - 0.3 77.9 53.6 57.4 21.1 31.2 6.6 15.3 20.2 7.0
     Small Town 1,100 * 2.1 3.7 - 0.2 79.9 59.4 53.8 31.4 24.7 9.0 15.3 17.3 6.7
     Medium City 1,100 0.3 1.7 5.4 - 0.6 79.9 58.0 52.1 26.4 20.2 11.2 11.9 20.1 10.9
     Large City 1,000 0.4 2.2 4.8 - 0.5 84.9 61.4 54.1 33.4 21.7 12.4 16.3 23.1 13.6
     Very Large City 700 0.2 2.8 5.6 - 0.4 87.2 69.0 42.9 37.6 22.9 17.0 19.9 25.4 18.6
(Table continued on next page.)
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Vaping Vaping Dissolvable
Nicotine b Just Flavoring b Tobacco b Snus b Steroids g
Total 4,400 13.3 8.8 0.7 4.3 0.3
Gender
     Male 1,800 18.3 10.5 1.3 9.0 0.4
     Female 2,600 10.0 7.7 0.3 0.9 0.1
Modal Age
     19–20 700 14.3 16.1 1.2 4.6 1.0
     21–22 700 16.7 11.4 0.7 4.3 0.2
     23–24 700 15.3 10.2 1.4 6.5 0.4
     25–26 700 12.0 7.4 0.4 3.2 *
     27–28 800 13.8 5.5 0.3 4.2 *
     29–30 700 7.7 3.6 0.4 2.6 *
Region
     Northeast 800 13.1 11.0 0.5 3.1 0.4
     Midwest 1,100 15.4 8.1 1.2 6.2 0.3
     South 1,400 12.0 8.4 0.4 3.0 0.4
     West 1,000 13.3 9.5 0.9 4.9 *
Population Density j
     Farm/Country 400 15.0 6.7 0.9 6.0 *
     Small Town 1,100 11.8 8.2 0.5 5.3 0.6
     Medium City 1,100 12.4 10.4 0.9 3.1 0.3
     Large City 1,000 13.8 8.8 0.8 3.3 0.1
     Very Large City 700 13.7 7.8 0.0 4.3 *
Source. The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives  (barbiturates), or tranquilizers not under a doctor’s orders.
bThis drug was asked about in two of the six questionnaire forms. Total N  is approximately 1,500.
cThis drug was asked about in three of the six questionnaire forms. Total  N  is approximately 2,200.
dThis drug was asked about in one of the six questionnaire forms. Total  N  is approximately 700.
eThis drug was asked about in five of the six questionnaire forms. Total  N  is approximately 3,600.
fThis drug was asked about in four of the six questionnaire forms. Total N  is approximately 2,900.
gOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
jA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; and a very large city as having over 500,000. 
Within each level of population density, suburban and urban respondents are combined.
Weighted N
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Any Illicit Drug a Hallucinogens 
Any Illicit other than other than MDMA
Drug a Marijuana Marijuana Inhalants b Hallucinogens d      LSD d LSD d   PCP c (Ecstasy,Molly) f Cocaine Crack d
Total 4,400 23.9 8.6 22.2 0.4 0.8 0.5 0.5 0.4 0.8 1.9 0.0
Gender
     Male 1,800 27.7 10.4 26.2 0.4 1.2 0.8 0.8 0.9 0.9 3.0 *
     Female 2,600 21.4 7.5 19.5 0.3 0.6 0.4 0.3 * 0.7 1.3 0.1
Modal Age
     19–20 700 23.3 5.7 22.0 0.1 0.7 0.5 0.3 * 0.5 1.1 0.1
     21–22 700 26.3 9.2 25.7 0.9 1.8 1.2 0.8 * 1.0 1.5 0.2
     23–24 700 25.7 10.0 24.6 0.4 0.7 0.3 0.7 * 1.0 2.9 *
     25–26 700 24.8 9.5 21.8 * 0.5 0.4 0.3 * 0.5 2.9 *
     27–28 800 23.4 8.6 21.1 0.4 0.9 0.5 0.6 0.3 1.0 1.3 *
     29–30 700 19.6 8.5 17.8 0.3 0.3 0.2 0.2 1.6 0.5 2.0 *
Region
     Northeast 800 26.9 8.7 25.0 0.6 0.3 0.3 0.3 * 0.5 1.9 *
     Midwest 1,100 21.4 9.0 18.8 0.2 1.0 0.6 0.5 0.6 0.4 1.3 *
     South 1,400 21.7 7.6 20.2 0.2 0.5 0.4 0.2 0.6 0.5 1.6 0.1
     West 1,000 28.3 10.0 26.9 0.6 1.5 0.8 1.1 * 1.8 3.4 0.1
Population Density e
     Farm/Country 400 18.0 6.2 17.3 0.5 0.5 0.5 * * * 1.1 0.4
     Small Town 1,100 22.2 7.3 19.7 0.2 0.7 0.4 0.4 * 0.9 1.4 *
     Medium City 1,100 22.3 7.8 20.8 0.6 1.0 0.6 0.3 0.5 0.8 1.2 *
     Large City 1,000 24.6 8.4 24.4 0.2 0.7 0.5 0.6 0.3 0.7 1.7 0.1
     Very Large City 700 32.0 13.9 27.9 0.4 1.2 0.6 0.9 * 1.1 5.1 *
(Entries are percentages.)
Approximate
Weighted N
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Narcotics Crystal
Other Heroin Heroin other than Methamphetamine 
Cocaine f Heroin With Needle g Without Needle g Heroin h Amphetamines h,i Methamphetamine g (Ice) g
Total 4,400 2.0 0.2 0.1 0.2 1.2 2.9 0.2 0.3
Gender
     Male 1,800 3.1 0.3 0.1 0.1 1.3 3.2 0.2 0.3
     Female 2,600 1.3 0.2 0.1 0.2 1.2 2.7 0.2 0.3
Modal Age
     19–20 700 0.6 * * * 0.7 2.5 0.2 0.5
     21–22 700 1.3 0.2 * * 1.1 4.4 0.4 0.7
     23–24 700 3.2 0.2 * 0.4 0.7 3.0 0.1 *
     25–26 700 2.9 0.2 0.2 0.2 0.9 3.1 0.2 0.4
     27–28 800 1.4 0.4 0.2 0.2 2.1 2.2 0.2 0.4
     29–30 700 2.7 0.2 * 0.2 1.8 2.2 * *
Region
     Northeast 800 3.1 0.4 0.2 0.4 1.3 3.1 * *
     Midwest 1,100 1.3 0.1 * 0.1 1.3 3.1 0.1 0.5
     South 1,400 1.3 0.2 0.1 0.1 1.2 3.0 0.5 0.4
     West 1,000 3.2 0.3 * 0.2 1.2 2.6 * 0.2
Population Density e
     Farm/Country 400 1.9 0.5 0.4 0.4 2.0 1.2 0.8 1.2
     Small Town 1,100 1.3 0.1 0.1 0.1 0.8 2.6 0.2 0.1
     Medium City 1,100 1.0 0.3 * 0.3 1.2 2.8 * 0.4
     Large City 1,000 1.5 0.1 * * 0.8 3.3 0.2 0.2
     Very Large City 700 6.2 0.3 * 0.2 2.2 3.9 0.2 0.2
Approximate
Weighted N
(Table continued on next page.)
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Flavored
Sedatives Been  Alcoholic Large Flavored Little Regular Little
(Barbiturates) h Tranquilizers h Alcohol Drunk b Beverages c Cigarettes Cigars c Cigars c Cigars c
Total 4,400 0.6 1.5 68.0 35.4 25.0 14.8 4.4 4.9 2.9
Gender
     Male 1,800 0.6 1.5 71.6 41.0 20.9 18.5 8.2 6.6 5.8
     Female 2,600 0.6 1.5 65.5 31.6 27.6 12.3 2.2 3.7 1.2
Modal Age
     19–20 700 1.0 1.1 46.0 25.1 22.4 9.6 3.5 4.9 4.8
     21–22 700 0.4 1.2 72.7 40.7 42.3 17.3 2.6 10.0 1.1
     23–24 700 0.5 1.3 74.1 39.3 33.5 16.9 2.7 4.1 3.4
     25–26 700 0.4 1.1 71.7 37.8 24.4 17.6 3.0 2.9 2.0
     27–28 800 0.8 2.2 68.9 36.4 13.6 14.8 5.3 4.9 2.5
     29–30 700 0.5 1.8 71.5 31.5 12.9 12.0 9.4 1.5 3.5
Region
     Northeast 800 0.5 1.5 73.9 39.8 31.1 13.7 1.7 5.5 4.0
     Midwest 1,100 1.0 1.6 73.4 39.0 20.6 16.4 6.3 5.0 2.8
     South 1,400 0.6 1.4 64.0 34.0 26.0 15.7 4.5 4.7 3.1
     West 1,000 0.1 1.4 62.3 28.2 26.1 12.5 4.3 4.0 2.1
Population Density e
     Farm/Country 400 0.5 1.7 63.3 30.3 28.4 21.5 4.9 10.0 6.9
     Small Town 1,100 0.7 1.5 63.9 32.6 30.4 15.8 4.0 4.8 2.6
     Medium City 1,100 0.4 1.5 65.0 34.3 28.6 11.8 6.2 4.5 1.5
     Large City 1,000 0.6 1.7 71.1 34.8 26.0 14.5 3.8 5.0 3.3
     Very Large City 700 0.8 1.2 77.4 45.3 12.6 14.5 3.5 2.2 2.9
(Entries are percentages.)
Approximate
Weighted N
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Vaping Vaping Vaping Smokeless
Any Vaping g Marijuana g Nicotine g Just Flavoring g Tobaccoc Steroids g
Total 4,400 11.3 6.1 6.2 2.9 9.1 0.2
Gender
     Male 1,800 16.4 8.8 8.9 4.8 19.2 0.2
     Female 2,600 8.0 4.4 4.4 1.7 2.0 0.1
Modal Age
     19–20 700 13.0 6.0 7.4 4.9 8.4 0.6
     21–22 700 11.1 6.1 6.0 3.9 5.9 *
     23–24 700 13.5 8.4 8.3 2.8 18.0 0.4
     25–26 700 8.5 4.6 3.6 3.1 2.1 *
     27–28 800 13.2 7.4 7.2 2.0 9.3 *
     29–30 700 8.7 4.1 4.8 1.2 7.8 *
Region
     Northeast 800 13.0 6.8 7.7 4.5 8.7 0.4
     Midwest 1,100 9.9 5.5 5.1 2.9 7.5 0.3
     South 1,400 10.5 4.3 6.4 2.6 7.9 0.1
     West 1,000 14.1 10.4 6.1 2.3 13.3 *
Population Density e
     Farm/Country 400 10.3 2.7 6.0 2.3 19.4 *
     Small Town 1,100 9.9 4.2 5.8 3.5 7.3 0.4
     Medium City 1,100 10.6 5.4 6.4 3.4 11.9 0.3
     Large City 1,000 12.5 7.9 6.1 2.9 4.4 *
     Very Large City 700 13.1 9.7 6.3 1.7 9.2 *
Source. The Monitoring the Future study, the University of Michigan.
Notes.    ' * ' indicates a prevalence rate of less than 0.05%.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders.
bThis drug was asked about in three of the six questionnaire forms. Total N  is approximately 2,200.
cThis drug was asked about in one of the six questionnaire forms. Total N  is approximately 700.
dThis drug was asked about in five of the six questionnaire forms. Total N  is approximately 3,600.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; and a very large city as having over 500,000.   
Within each level of population density, suburban and urban respondents are combined.
fThis drug was asked about in four of the six questionnaire forms. Total N is approximately 2,900.
gThis drug was asked about in two of the six questionnaire forms. Total N  is approximately 1,500.
hOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
(Entries are percentages.)
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Alcohol: Alcohol: Alcohol:
5+ Drinks 10+ Drinks 15+ Drinks Cigarettes:
in a Row in in a Row in in a Row in 1/2 Pack+ Smokeless
Marijuana Daily Alcohol Daily Last 2 Weeks Last 2 Weeks c Last 2 Weeks c Cigarettes Daily per Day Tobaccoc
Total 4,400 7.7 5.2 31.4 10.9 3.3 8.6 4.5 1.9
Gender
     Male 1,800 10.0 8.5 38.5 17.9 6.8 10.4 5.6 4.6
     Female 2,600 6.2 3.1 26.6 6.3 0.9 7.3 3.8 0.0
Modal Age:
     19–20 700 6.2 1.1 22.1 7.7 1.9 4.8 2.7 0.0
     21–22 700 9.0 4.4 39.8 12.9 4.0 8.7 3.8 4.7
     23–24 700 9.2 6.4 31.2 11.8 4.9 9.6 5.9 1.4
     25–26 700 8.0 5.5 33.8 11.0 1.9 9.4 4.8 0.9
     27–28 800 6.6 6.9 31.4 12.6 4.5 10.9 5.8 2.6
     29–30 700 6.9 6.4 28.7 9.6 2.0 7.4 4.1 1.6
Region
     Northeast 800 7.8 4.9 35.7 13.5 3.2 8.3 4.4 0.5
     Midwest 1,100 6.7 5.7 34.9 17.5 4.0 9.4 5.5 1.5
     South 1,400 7.3 5.0 28.4 6.9 3.3 9.7 5.3 1.2
     West 1,000 10.0 5.2 27.1 6.9 2.1 6.1 2.3 4.3
Population Density b
     Farm/Country 400 7.2 3.5 25.7 10.9 3.5 15.1 10.8 1.5
     Small Town 1,100 7.2 4.7 28.7 11.2 3.0 10.2 5.7 1.9
     Medium City 1,100 6.5 4.6 28.8 8.8 1.8 7.1 4.0 2.3
     Large City 1,000 8.7 5.2 32.7 13.5 3.3 7.6 3.3 1.9
     Very Large City 700 9.3 8.4 40.4 9.8 4.9 6.5 2.2 1.4
Source. The Monitoring the Future study, the University of Michigan.
aDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, 
and 5+ drinks, measured as having five or more drinks in a row in the last two weeks.
bA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; 
and a very large city as having over 500,000. Within each level of population density, suburban and urban respondents are combined.
cThis drug was asked about in one of the six questionnaire forms. Total N  is approximately 700.
Approximate
Weighted N
TABLE 4-5
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.  
aThe questions on hallucinogen use are not included in the age 55 questionnaire.  Therefore, the data presented here include hallucinogens
for ages 18 to 50, but not for age 55.
FIGURE 4-1
ANY ILLICIT DRUGa
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aThe questions on hallucinogen use are not included in the age 55 questionnaire.  Therefore, the data presented here include hallucinogens
for ages 18 to 50, but not for age 55.
FIGURE 4-2
ANY ILLICIT DRUG OTHER THAN MARIJUANAa
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding some bars with the same number may have uneven height.
FIGURE 4-3
MARIJUANA
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, 30-Day, and Daily Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-4
AMPHETAMINES
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of methamphetamines were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-5
METHAMPHETAMINE
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of crystal methamphetamine were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-6
CRYSTAL METHAMPHETAMINE (ICE)
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding some bars with the same number may have uneven height.
FIGURE 4-7
COCAINE
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-8
CRACK COCAINE
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-9
OTHER COCAINE
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens were not included in the questionnaires for 55-year-olds.
FIGURE 4-10
HALLUCINOGENS a 
among Respondents of Modal Ages 18 through 50b
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of LSD were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-11
LSD
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens other than LSD were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-12
HALLUCINOGENS OTHER THAN LSD a 
among Respondents of Modal Ages 18 through 30 b
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding some, bars with the same number may have uneven height.
aUnadjusted for the possible underreporting of amyl and butyl nitrites. 
bQuestions about the use of inhalants were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-13
INHALANTS a 
among Respondents of Modal Ages 18 through 30 b
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-14
SEDATIVES (BARBITURATES)
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-15
NARCOTICS OTHER THAN HEROIN
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-16
TRANQUILIZERS
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of ecstasy were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-17
ECSTASY (MDMA, Molly)
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of steroids were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
FIGURE 4-18
STEROIDS
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-19
HEROIN
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-20a
ALCOHOL
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes. Due to rounding some bars with the same number may have uneven height.
FIGURE 4-20b
ALCOHOL
by Age Group, 2017
2-Week Prevalence of 5 or More Drinks in a Row and
30-Day Prevalence of Daily Use 
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Source. The Monitoring the Future study, the University of Michigan.
Notes. Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-21
CIGARETTES
among Respondents of Modal Ages 18 through 55
by Age Group, 2017
Annual, 30-Day, Daily, and Half-Pack-a-Day Prevalence
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Chapter 5 
 
TRENDS IN DRUG USE 
IN EARLY AND MIDDLE ADULTHOOD 
 
In this chapter, we examine historical trends through 2017 in substance use for various age bands 
covering early and middle adulthood, ages 19 through 55. We use MTF panel data from graduating 
high school seniors spanning more than four decades. Although such panel data are typically used 
to study stability and change in the same individuals over time, we use the data here cross-
sectionally to consider how substance use has varied across the years by each age group, much as 
we use the repeated cross-sectional surveys of secondary school students to track changes in 
behaviors over time for particular grade levels (8, 10, and 12) in Volume I. In the early 1990s, we 
began to document large and important increases among secondary school students in the use of 
several substances, particularly marijuana and cigarettes. The increases continued among 12th 
graders through 1997, as discussed in Volume I. One of the important issues addressed in this 
chapter is whether such increases occurred only among adolescents or whether those higher-using 
graduating classes have carried their higher levels of drug use with them as they moved into young 
adulthood. In other words, are they exhibiting lasting differences across class cohorts, known as 
cohort effects? These would be indicated by the inflection points in the cross-time trends (turning 
either up or down) coming sequentially across the age strata as cohorts age with a time lag between 
adjacent strata. 
 
Figures 5-1 through 5-19c present separate trend lines for two-year age strata through age 30,1 that 
is, respondents who are one to two years beyond high school, three to four years beyond high 
school, and so on. These two-year age strata are used to reduce the random fluctuations that would 
be seen with one-year strata due to smaller sample size.2 Each data point through age 30 in these 
figures is based on approximately 740 to 900 weighted cases drawn from two adjacent high school 
classes; actual (unweighted) numbers of cases are somewhat higher than those shown in the 
tables.3 Figures 5-1 through 5-19c also present trend data from respondents at modal ages 35, 40, 
45, 50, and 55 based on follow-up data collected at those ages. Beginning at age 35, the age strata 
are constituted in a slightly different way, in that the two half-samples from a single graduating 
class (which up through age 30 had been surveyed in alternating years) are now both surveyed in 
the same year.4 Modal age 55 was first added to the survey in 2013, so no trend results were 
reported until 2014. The figures also include trend data for 18-year-olds for comparison purposes. 
                                                 
1 MTF collected age 31 and 32 data from 1990 through 2001, then stopped collecting data from this age group to put resources instead into longer 
term data collections at 5 year intervals after age 30. Thus, starting in 2002, we collected data from young adults biennially through age 30, and 
from middle adults every five years starting at age 35. Beginning with this current Volume, we no longer present trends on the age 31-32 year band; 
for such trends, please see the previous edition of this Volume. Schulenberg, J. E., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Miech, R. A., 
& Patrick, M. E. (2017). Monitoring the Future national survey results on drug use, 1975-2016: Volume II, college students and adults ages 19-
55. Ann Arbor: Institute for Social Research, The University of Michigan.  
2 Strictly speaking, these two-year strata are not age strata, because they are based on all respondents in the given year from two adjacent high 
school classes, and they do not take into account the minor differences in individual respondents’ ages within each graduating class; however, they 
are close approximations to age strata, and we characterize them by the modal age of the respondents as ages 19 to 20, 21 to 22, and so on.  
3 For example, in the 2016 data, the 19- to 20-year-old stratum is composed of participating respondents from the high school graduating classes of 
2015 and 2014, respectively; the 21- to 22-year-old stratum contains data from the classes of 2013 and 2012, respectively; and so on. 
4 In 2017, the 35-year-olds are graduates from the high school class of 2000 (weighted N = 739), the 40-year-olds from the high school class of 
1995 (weighted N = 818), the 45-year-olds from the high school class of 1990 (weighted N = 760), the 50-year-olds are graduates from the high 
school class of 1985 (weighted N = 781), and the 55-year-olds are graduates from the high school class of 1980 (weighted N=919). The unweighted 
actual Ns are somewhat higher. 
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The page following the figure for each drug contains a table of values for each point in the trend 
lines separately for the various age strata. 
 
Tables 5-1 through 5-5 are derived from the same data but presented in tabular form for 19- to 28-
year-olds combined. Data are given for each year in which they are available for that full age band 
(i.e., from 1986 onward). The percentage point changes between 2016 and 2017 are listed in the 
second to last column, along with an indication about the statistical significance of this one-year 
change. Beginning with this edition of Volume II, we include percentage point changes over the 
past five years (2012-2017) in the last column, indicating whether the five-year change is 
significant. Respondents ages 29 and over are omitted from the tables. However, the full data for 
those respondents are contained in Figures 5-1 through 5-19c.  
 
RECENT TRENDS IN DRUG USE AMONG YOUNG ADULTS AGES 19-28 
In this section, we focus on recent trends over the past year and past five years in substance use 
among young adults ages 19 to 28 combined (shown in Tables 5-1 through 5-4). Longer term 
trends are summarized in the next section. 
  
• The percent of young adults ages 19 to 28 indicating use of any illicit drug in the prior 12 
months continued to increase—up by a nonsignificant 1.5 percentage points over 2016 
prevalence to reach 41.2%. This is up from a recent low of 32.1% in 2006 (Table 5-2). As 
shown in the last column in Table 5-2, this prevalence increased a significant 7.2 
percentage points over the past five years, that is, since 2012. Correspondingly, 30-day use 
of any illicit drug increased a significant 4.8 percentage points over the past five years, 
rising to 24.7% in 2017 (Table 5-3). These increases primarily have been due to the 
increases in marijuana use.  
 
• Marijuana use showed a one-year nonsignificant 2.2 percentage point rise in annual 
prevalence to 37.5% in 2017. This was up from 27.7 % in 2006—the most recent low point. 
Levels today for this age group are at the highest they have been in over three decades, 
just over the 36.5% prevalence in 1986 when we began tracking this age span (Table 5-2). 
The five-year change in annual marijuana use was a significant increase of 7.3 percentage 
points. Likewise, 30-day use of marijuana has increased significantly by 5.3 percentage 
points across the past five years, rising to 23.0% in 2017, an all-time high (Table 5-3). 
Thus, as of 2017 annual and 30-day marijuana use among young adults aged 19-28 are at 
the highest levels in the 32 years that MTF has been monitoring their use. As shown in 
Figure 5-3a, the percentage point increases over the past five years have been greater for 
those in their mid- to late-20s than for those in their early 20s (e.g., annual use increased 
across the five years by 4.3, 8.4, and 8.4 percentage points for the 19-20, 23-24, and 27-28 
age bands, respectively). Although the trends for the 35-55 year olds are considered in the 
next section, it is worth noting here that their annual and 30-day marijuana use also 
increased in recent years through 2017 (e.g., between 2013 and 2017, annual use rose 6.5, 
3.5, 3.3, 2.1, and 2.9 percentage points, respectively, for 35-, 40-, 45-, 50-, and 55-year-
olds; 2017 prevalence was 24%, 18%, 15%, 14%, and 15%, respectively). Thus, it is likely 
that the recent increases in marijuana across all age bands of adults 19-55 reflect both 
secular trends as well as cohort effects. 
 
136
Monitoring the Future
• Daily or near daily marijuana use (defined as use of marijuana on 20 or more occasions 
in the past 30 days) among young adults increased nonsignificantly between 2016 and 2017 
to 7.8% , the highest level ever observed in this young adult population since tracking their 
use began over 30 years ago. It is over three times the level in 1992 (2.3%), the low point 
since 1986 (Table 5-4). Daily marijuana increased a significant 2.2 percentage points over 
the past five years. Thus, as of 2017, one-in-thirteen young adults aged 19-28 is a daily 
marijuana user.  
 
• Annual use of synthetic marijuana remained essentially unchanged in 2017 at 0.9% (Table 
5-2). This is down appreciably from the 7.4% annual prevalence observed in 2011, when 
use of this drug was first measured; the five-year decrease was significant. This decline 
parallels a sharp decline in synthetic marijuana use among secondary school students. 
 
• Annual use of any illicit drug other than marijuana showed a one-year nonsignificant 
increase of 0.2 percentage points to 20.1% in 2017, following a significant increase in 2014 
when it rose from 18.1% to 21.2%. This annual prevalence had been relatively stable from 
2003 to 2013, at between 17% and 19%. The five-year increase between 2012 and 2017 
was a significant 2.9 percentage points. As summarized below, the significant increase over 
the past five years in this index of any illicit drug other than marijuana appears largely to 
be due to five-year significant increases in annual use of hallucinogens, specifically LSD, 
and cocaine, specifically cocaine other than crack. If the use of narcotics other than heroin 
had not declined appreciably in that period (as we summarize below), the increase would 
have been greater. 
 
• Hallucinogens and LSD specifically showed slight one-year increases in 2017, and 
significant five-year increases. Between 2012 and 2017, annual use of hallucinogens rose 
significantly from 3.6% to 4.8%, and LSD rose significantly from 1.6% to 3.4% (Table 5-
2).  
 
• The annual prevalence of cocaine (any type including crack and cocaine powder) among 
young adults showed a one-year nonsignificant increase in 2017 to 5.3%, up from an all-
time low of 3.9% in 2013. The increase of 1.2 percentage points over the past five years is 
significant (Table 5-2). Annual use of cocaine other than crack (typically in powdered 
form) showed a one-year leveling of 5.9%, as well as a five-year significant increase of 1.9 
percentage points. Annual use of crack, however, declined unevenly and nonsignificantly 
over the past five years from 0.5% to 0.2%, indicating that this drug is now all but forgotten 
among young adult high school graduates, at least.  
 
• A few specific illicit drugs showed recent declines. Most notably, annual use of narcotics 
other than heroin by young adults showed a significant one-year decline in 2017 to 4.0%, 
as well as a significant five-year decline of 3.3 percentage points. Its peak was 9.1% in 
2006 and 2008 (Table 5-2). Correspondingly, annual use of Vicodin showed a significant 
five-year decline of 3.6 percentage points to 2.7% in 2017; its peak was 9.3% in 2005. 
OxyContin appears to have leveled at very low prevalence, decreasing nonsignificantly to 
1.9% in 2017. This is an important class of substances, accounting for many overdose 
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deaths, so the fact that use is now in decline among young adults is a very favorable 
development for the nation's health.5  
 
• Annual use of MDMA (ecstasy, and more recently Molly) has also declined, showing a 
significant one-year decrease of 1.5 percentage points 2017. In 2014, we added Molly as 
an example, and since then, annual use has declined from 5.1% to 3.6% (Table 5-2).   
 
• Annual prevalence for salvia has declined as well, showing a significant five-year decline 
from 1.4% in 2012 to 0.5% in 2017. Salvia use is now at its lowest point since it was first 
measured in 2009, when it was 3.5%. Clearly, this drug has not made a large or lasting 
impression on young adults. 
 
• The annual use of several other illicit drugs have shown some leveling in recent years as 
summarized in Table 5-2. In particular, the annual use of amphetamines showed some 
uneven change in the past few years among young adults, including a nonsignificant one-
year increase in 2017 to 7.8%, the same level as it was five years ago in 2012 (Table 5-2). 
Annual use of Adderall showed a similar pattern of recent uneven change, increasing 
nonsignificantly in 2017 to 8.3%, showing a net five-year nonsignificant increase of 1 
percentage point. 
 
• Annual prevalence of both sedatives (barbiturates) and tranquilizers has also been fairly 
level in recent years among young adults, both at or near all-time lows in 2017; for 
sedatives (barbiturates), it was 2.2%, showing a nonsignificant five-year decline of 0.5 
percentage points; for tranquilizers, it was 4.7%, showing a nonsignificant five-year 
decline of 0.6 percentage points (Table 5-2). 
 
• There have been some recent declines in alcohol use among young adults. Whereas annual 
use has leveled in recent years, with a five-year nonsignificant decline to 81.2% in 2017, 
annual prevalence of been drunk declined a significant 4.9 percentage points in the past 
five years to 60.9% in 2017 (Table 5-2). The 30-day prevalence of alcohol use declined 
significantly over the past five years from 69.5% in 2012 to 67.1% in 2017; the 30-day 
prevalence of been drunk declined nonsignificantly from 39.1% in 2012 to 36.1% in 2017 
(Table 5-3). The annual use of alcoholic beverages containing caffeine showed some 
uneven declines in recent years, showing a net significant five-year decline of 4.9 
percentage points in 2017 to 31.8% (Table 5-2). The annual use of flavored alcoholic 
beverages has also shown uneven change in recent years; in 2017 it was 54.8%, the same 
level as in 2012.   
 
Binge drinking—having five or more drinks on one or more occasions in the prior two 
weeks (also known as occasions of heavy drinking) —declined gradually from 2008 (when 
37.9% of young adults indicated such use) through 2015 (31.9%), about where it remained 
in 2017 (31.8%); the five-year decline of 3.6 percentage points was significant (Table 5-
4). This decline among young adults follows a similar decline among high school seniors. 
Extreme binge drinking (also known as high intensity drinking) has shown some uneven 
                                                 
5 National Institute on Drug Abuse, (2017). Overdose death rates. Accessed July 2, 2017, at https://www.drugabuse.gov/related-topics/trends-
statistics/overdose-death-rates  
138
Monitoring the Future
change in recent years among young adults (due to some extent to the relatively small Ns 
that are asked these questions, only one-sixth of the sample). For having 10 or more drinks 
on one or more occasions in the past two weeks, prevalence increased significantly from 
2016 to 2017 to 11.2% (with a net nonsignificant five-year increase of 0.5 percentage 
points); prevalence of having 15 or more drinks increased nonsignificantly to 3.5% in 2017 
(with a net nonsignificant five-year decline of 1.0 percentage points) (Table 5-4).  
 
• Cigarette smoking among young adults showed significant declines over the past five 
years, a continuation of longer-term declines; nonetheless, there is evidence that some 
declines stalled in 2017. Annual prevalence increased nonsignificantly in 2017 (23.4% in 
2016 and 23.9% in 2017, but was still lower than 26.2% in 2015); the five-year decline of 
5.9 percentage points was significant (Table 5-2). Thirty-day prevalence increased 
nonsignificantly from 14.2% in 2016 to 15.3% in 2017 (but was still lower than 16.6% in 
2015); the five-year decline of 4.4 percentage points was significant. (Table 5-3). Daily 
smoking increased nonsignificantly from 8.2% in 2016 to 8.6% in 2017 (but was still lower 
than 9.7% in 2015); the five-year decline of 4.0 percentage points was significant (Table 
5-4). Half-pack-a-day smoking by young adults declined by a nonsignificant 0.2 
percentage points to 4.7% in 2017; the five-year decline of 2.9 percentage points was 
significant (Table 5-4). On all of these measures of smoking, the 2016 levels were at 
historic lows, and 2017 was the first year we did not see continued declines, though levels 
were still lower than they were in 2015, suggesting a possible leveling of cigarette use 
among young adults. In any event, the more general pattern of decline, including the 
significant five-year declines, follow appreciable declines to historic lows among high 
school seniors (Figures 5-19a, b, and c). 
 
In summary of the recent trends among young adults age 19-28, marijuana use has increased to 
all-time highs, which is true for annual use, 30-day use, and daily use; the five-year increases from 
2012 to 2017 for all three levels of marijuana use were significant. As of 2017, nearly four-in-ten 
young adults (38%) used marijuana at least once in the past year, nearly one-in-four (23%) used it 
at least once in the past month, and one-in-thirteen (7.8%) was a daily or near-daily marijuana 
user. Concerning illicit drugs other than marijuana, annual use has been steady the last few years, 
with the five-year trend showing a significant increase of 2.9 percentage points to 20% in 2017. 
This increase corresponds with recent increases in annual use of certain illicit drugs including 
hallucinogens, specifically LSD, and cocaine other than crack, all three showing significant five-
year increases in 2017 to 4.6%, 3.4%, and 5.9%, respectively. In contrast, annual nonmedical use 
of narcotics other than heroin showed a significant one-year decline in 2017 to 4.0%, with the 
five-year decline also being significant; Vicodin specifically showed a significant five-year decline 
in annual use to 2.7% in 2017. MDMA (ecstasy, and more recently Molly) has also been declining, 
with a significant one-year decrease in annual use to 3.6% in 2017; it has declined from 5.1% since 
2014 (when we first included Molly as an example). Nonmedical use of amphetamines, sedatives 
(barbiturates), and tranquilizers all have been fairly steady in recent years, showing no significant 
change across the past five years; 2017 annual prevalence was 7.8%, 2.2%, and 4.7%, respectively. 
There have been continued recent declines in alcohol use among young adults, with annual 
prevalence of been drunk decreasing significantly by 4.9 percentage points across the past five 
years to 61% in 2017; binge drinking declined a significant 3.6 percentage points across the past 
five years to 31.8% in 2017. Finally, cigarette use continued to decline at least through 2016, with 
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annual, 30-day, daily, and half-pack a day prevalence declining significantly over the past five 
years; however, in 2017, the levels for the first three increased nonsignificantly, suggesting that 
the continued decreases may have stalled.  
 
LONGER-TERM TRENDS IN EARLY AND MIDDLE ADULTHOOD 
In this section we consider longer-term trends among 19-28 year-olds as well as all age groups, 
giving attention to how trends have varied by age and specifically cohort.  
 
• Longer-term declines among young adults in the annual prevalence of several drugs 
appeared to end in 1992 or 1993 (Table 5-2, Figure 5-1). Among the 19- to 28-year-old 
young adult sample, this was true for the use of any illicit drug, marijuana, any illicit drug 
other than marijuana, hallucinogens, narcotics other than heroin, crack, amphetamines, 
sedatives (barbiturates), and tranquilizers. In 1994, annual prevalence for most drugs 
remained steady. Cocaine other than crack reached its low point in 1994 after a period of 
substantial decline that began in the late 1980s. In 1995 there again were modest increases 
(a percentage point or less) in the annual prevalence of almost all of the drug classes in 
Table 5-2, some of which were statistically significant. 
 
Thus, it was clear that by 1992 or 1993 the downward secular trend (i.e., period effect) 
running back to the 1980s and observable in all of these age strata (as well as among 
adolescents) had ended. What has happened since then, however, is more of a cohort effect, 
reflecting an interaction between age and period such that only adolescents showed an 
increase in illicit drug use initially, and they then carried those new (higher) levels of drug 
use with them as they entered older age bands. Figure 5-1 shows the effects of generational 
replacement on the use of any illicit drug, as the teens of the early 1990s reached their 20s. 
While all age groups generally moved in parallel through about 1992, the youngest age 
bands first showed signs of increase in their overall level of illicit drug use. The 18-year-
olds shifted up first, followed by the 19- to 20-year-olds in 1994, the 21- to 22-year-olds 
in 1996, the 23- to 26-year-olds in 1999, the 29- to 30-year-olds in 2004, and the 35-year-
olds in 2008. So far, the 40-, 45-, 50- and 55-year-olds have not shown much systematic 
increase in any illicit drug use through 2014. (It is noteworthy that 8th graders, who are not 
included in these graphs but are described in Volume I, actually began an increase in use a 
year earlier than the 12th graders, suggesting a cohort effect was already underway before 
use turned upward among 12th graders.) 
 
Then, from 2007 to 2013, use among 12th graders and several of the youngest young adult 
age bands increased, and a number of the older age bands followed suit in subsequent years 
including increases among 35-year-olds starting in 2013, among 40-year-olds starting in 
2015, and among 45-year-olds in 2017, once again suggesting a cohort effect (see Figure 
5-1). 
 
To summarize, in the earlier decline phase of the drug epidemic, annual prevalence of use 
of any illicit drug moved in parallel for all age strata, as illustrated in Figure 5-1; this 
pattern reflects a secular trend, because a similar change is observed simultaneously across 
different age levels. After 1992—in what we have called the “relapse phase” of the popular 
drug epidemic that began in the 1960s—a quite different pattern emerged: 8th graders 
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increased their drug use first, followed by 10th and 12th graders; then the next-oldest age 
group increased use, but with a little delay; the next-oldest then increased use, but with a 
longer delay; and so on. This pattern reflects a classic cohort effect, in which different age 
groups are not all moving in parallel; rather, different age groups show increases when the 
cohorts (i.e., high school classes) having heavier use at an earlier stage in development 
reach the relevant age level. In addition, note that the slopes of the age bands are 
successively less steep in the older age groups, suggesting that some of the cohort effect 
may be dissipating with maturation, quite likely indicating an age effect. But we think it 
unlikely that only cohort effects are occurring (in addition to the long-established age 
effects); period effects also likely play a role.  
 
• Use of marijuana shows an almost identical pattern to the illicit drug use index—not 
surprising given the fact that marijuana, by far the most prevalent of the illicit drugs, tends 
to drive the index (Figure 5-3a). After a long and steady decline from the late 1970s to the 
early 1990s, annual marijuana use leveled for a while among young adults before beginning 
a gradual increase. Virtually all of this increase was attributable to the two youngest age 
bands (18 and 19 to 20) until 1996, when the 21- to 22-year-olds began to show a rise. The 
older age bands then tended to show increases fairly sequentially, with 29- to 30- and 35-
year-olds showing significant increases in 2008. The 18-year-olds’ use of marijuana in the 
prior 12 months declined after 1997 and, later, several of the succeeding age bands through 
age 26 began to show declines in a pattern that again suggests lasting cohort differences. 
Since about 2006, however, use has been rising not only among the 18-year-olds but also 
among all age bands through 2017, including uneven increases for 35- to 45-year-olds (and 
for 50- and 55-year-olds since 2008 and 2013, respectively), thus indicating a secular trend. 
This strongly suggests an impact on use by culture-wide events to which all of the age 
bands are exposed and by which they all were affected during this historical period. 
Changing attitudes toward marijuana use, perhaps driven in part by the legalization of 
medical use in many states and more recently by legalization of recreational use for adults 
in some states, likely have played an important role in this secular trend.  
 
• A similar pattern emerged for current daily marijuana use (Figure 5-3c). In the mid- to 
late 1990s, daily marijuana use among 35- and 40-year-olds was as high as or higher than 
use among some younger age groups, suggesting a lasting cohort effect on this behavior, 
because the cohorts comprising those older age strata grew up in a period of particularly 
high adolescent marijuana use. However, in more recent years through the mid-2000s, the 
35-, 40-, and 45-year-olds were similar to respondents ages 27 to 30, who had among the 
lowest levels of daily use in adolescence. An important finding shown in Figure 5-3c is 
that, although the various age groups had been moving in parallel for many years at fairly 
similar levels of prevalence, the trends diverged considerably in the 1990s in a staggered 
fashion, such that the 18- to 30-year-olds came to have distinctly higher levels of daily 
marijuana use than the older age groups, again reflecting stable cohort differences and 
perhaps age effects in the middle-to-late adult ages (this is discussed further below when 
considering the strong cohort effects in cigarette use). In 2010 the upturn in daily marijuana 
use that had been occurring at younger ages (best seen in the table accompanying Figure 
5-3c) reached the age-35 stratum, with a significant increase from their 2009 prevalence 
rate putting the age 35 group back in company with the younger adults. Since about 2010, 
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the increase has been greater for those in the mid- to late-20s through age 40, and these age 
groups had higher levels of daily use in 2017 than they did in 2010, reaching levels well 
above those observed in the early to mid-1990s (Figure 5-3c and associated table).  
 
• The index of using any illicit drug other than marijuana has shown a similar transition in 
the pattern of change. Period effects seemed to predominate in the 1980s until about 1992, 
but a cohort-related pattern of change emerged thereafter (Figure 5-2). And, while the rise 
in annual use leveled by 1997 among 18-year-olds, it began rising in 1999 among 19- to 
20-year-olds, in 2000 among 21- to 22-year-olds, in 2002 among 23- to 24-year-olds, in 
2005 among 29- to 30-year-olds, and so on. The primary difference from the picture for 
marijuana is that the increases were not as sharp in the 1990s for most of the age groups. 
(Compare Figure 5-2 with Figure 5-1 to see the difference.) Between about 2000 and 2008, 
annual use remained fairly steady or dropped some for 12th graders and 19-22 year olds, 
and increased for the other age groups, particularly the 23-30 year olds. Since about 2008 
the levels of use of any illicit drug other than marijuana in nearly all age groups have 
remained fairly steady, except for 12th graders who have shown a decline.   
 
• With regard to inhalants, the large separation of trend lines for the younger age groups in 
Figure 5-4 shows that, across many cohorts, annual use has dropped consistently and 
sharply with age, particularly in the first few years after high school. In fact, of all the 
populations covered by MTF, the 8th graders (not shown in Figure 5-4) have had the highest 
rate of use, indicating that the decline in use with age starts at least as early as 8th or 9th 
grade. Like cocaine, inhalants have shown a strong age effect, but unlike cocaine, use of 
inhalants declines rather than increases with age and the age effect has sustained throughout 
the life of the study. 
 
Figure 5-4 also shows that, until the mid-1990s, there was a long-term gradual increase in 
annual inhalant use (unadjusted for underreporting of nitrite inhalants), one which was 
greatest among 12th graders, next greatest among 19- to 20-year-olds, and next greatest 
among 21- to 22-year-olds. Respondents more than six years past high school, who 
historically have had a negligible rate of use, did not exhibit the increases in use seen 
among the younger respondents, which began at least as early as 1977 among 12th graders 
and in 1983 among 19- to 20-year-olds. There was some subsequent increase among 21- 
to 22-year-olds and, later still, an increase among 23- to 24-year-olds. After 1995, this long-
term trend, reflecting a cohort effect, began to reverse in the two youngest age strata 
(coincident with an anti-inhalant media campaign by the Partnership for a Drug-Free 
America) as well as among several other age strata, suggesting a period effect due to some 
culture-wide influence, such as a media campaign. Subsequently, further declines among 
several age strata are suggestive of a cohort effect. Those in their mid- to late-20s have 
generally shown very low rates of inhalant use throughout the course of the study (this 
question is not asked of the age 35 and above groups). 
 
• In the late 1980s and first half of the 1990s, LSD use also increased among those in their 
teens and early 20s much more than among the older strata, as Figure 5-6 illustrates. Over 
the interval 1985 to 1996, there was a gradual but considerable increase in annual LSD use 
among respondents ages 18 to 24, which was sharpest among 12th graders and 19- to 20-
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year-olds. The increase did not seem to radiate up the age spectrum beyond age 26. A 
turnaround began among 12th graders after 1995 and then among the older age groups in a 
somewhat staggered fashion, again indicative of a cohort effect. Declines through 2003 
were greatest among 18- to 24-year-olds, who had attained the highest rates of LSD use. 
Use declined considerably from 2001 to 2003 in all age bands (including 8th and 10th 
graders), and then leveled through 2007 at historically low rates, suggesting that an 
important secular trend may have set in, which was quite possibly related to decreased 
availability of the drug. Since 2007 there has been evidence of a very gradual increase in 
use in all age groups 18-30, particularly among those ages 18 to 26; in the past few years, 
use also has increased somewhat among the 27-30 year-olds (this question is not asked for 
those age 40 and older). It thus appears that LSD may be making a gradual comeback 
among young adults since about 2007. 
 
• The use of hallucinogens other than LSD showed a similar and fairly parallel decline in 
use among all age bands through the 1980s, indicating a secular trend (Figure 5-7). During 
the relapse phase for many drugs during the 1990s, there was a substantial increase in use 
among the younger age bands, but not among those ages 27 or older. The increases in the 
older age bands did not appear for some time, indicating a cohort effect at work. Since 
about 2003 through 2017, the prevalence of use of hallucinogens other than LSD has 
continued to decline gradually among 18-20 year-olds, declined gradually and leveled 
among 21-24 year olds, was fairly level among 25-28 year-olds, and showed some minor 
increase among 29-30 year-olds. The different age groups have thus converged in their 
usage levels. 
 
• The annual prevalence for MDMA use (ecstasy and more recently Molly) among those 
aged 19 to 28 was at about 1.5% in 1989 and 1990 (Table 5-2 and Figure 5-8). After 1991 
it dropped to around 0.8% for several years before rising significantly in 1995. Ecstasy use 
then rose sharply in all of the young adult age strata, most notably in the younger age bands 
(19 through 26) through 2001. Use among 12th graders, which was not measured until 1996, 
was by then the highest of any of the age groups at 4.6% annual prevalence. Twelfth 
graders’ use declined by a full percentage point through 1998 before jumping 
significantly—by two full percentage points—in 1999. (Use by 10th graders also jumped 
significantly in 1999.) Thus it appears that young people from their mid-teens to mid-20s 
“discovered” ecstasy after some years of low and relatively level use. In 2000 the sharp 
increase in use continued among ages 15 to 16 (10th graders) through age 26—with highs 
of over 10% among 19- to 22-year-olds—and also showed up among 8th graders for the 
first time. By 2001 the increase had slowed and even begun to reverse among those aged 
18 to 26. We attributed the deceleration in 2001 to a fairly sharp increase in perceived risk 
of ecstasy use in that year, and based on that, we predicted a turnaround in use in 2002. In 
2002, and again in 2003, perceived risk increased sharply and, as Figure 5-8 illustrates, all 
age bands showed a reversal with a sharp decrease in use. Clearly, the decrease has been 
sharpest in the younger age bands, perhaps because a cohort effect is at work in the upper 
ages, helping to offset a downward secular trend. From about 2005 through 2014 there was 
some rebound in ecstasy use in all age bands through age 30 (older respondents are not 
asked about this drug), and the increase was staggered, suggesting that another cohort effect 
was underway. Between 2014 and 2017, there has been some decrease or leveling for many 
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of the age groups in annual MDMA use; however, there was a continued increase for a few 
age groups, most notably those aged 23-24, who had the highest prevalence among young 
adults in 2017 at 5.7%.  
 
• Several drug classes exhibited a faster decline in use among the older age groups than 
among 12th graders during the earlier period of decline in the 1980s (see Figures 5-1 
through 5-19c). These included any illicit drug, any illicit drug other than marijuana, 
amphetamines, hallucinogens (until 1987), LSD (through 1989), and methaqualone, but 
not marijuana. 
 
• In fact, a crossover was evident for some drugs when 12th graders were compared to young 
adults. In earlier years 12th graders had lower usage levels, but for some years after 1993 
they tended to have higher levels than post-high school respondents for use of any illicit 
drug, marijuana, hallucinogens, LSD specifically, crack cocaine, tranquilizers, and 
crystal methamphetamine (ice). However, they have approached the levels of adults in 
recent years in most cases. 
 
• Cocaine (Figure 5-9) gives quite a dramatic picture of change. Unlike most other drugs, 
annual use of cocaine has generally tended to rise with age after high school, usually 
peaking three to four years past graduation from the mid-1970s through the mid-1990s. 
This was a classic example of an age effect. Despite the large age differences in absolute 
prevalence during that period, all age strata moved in a fairly parallel way through 1991, 
indicating that a secular trend was taking place in addition to the age effect. All age strata 
began a sharp and sustained decline in use after 1986—again reflecting a period effect. The 
two youngest strata (12th graders and 19- to 20-year-olds) leveled by 1992, whereas use 
continued a decelerating decline for a few years beyond that in the older age groups, 
signaling the continuation of a cohort effect that began earlier. From 1994 to 1999, annual 
prevalence of cocaine use rose some in the five youngest strata (i.e., those younger than 
27) on a somewhat staggered basis, with the three older groups still decreasing a bit more 
over that same period. This, to some degree, reversed the age differences that were so 
prominent in the 1970s and 1980s.  
 
Cohort-related change appears to have predominated in the 1990s, quite possibly as the 
result of “generational forgetting” of the cocaine-related casualties so evident in the early 
to mid-1980s. In other words, those in the older cohorts retained that learning experience, 
but those in the newer cohorts never had it. The fact that from 1994 to 1996 the 35-year-
olds had higher lifetime prevalence levels of cocaine use than some of the younger age 
groups also suggests some lasting cohort-related differences established during the peak 
years of the cocaine epidemic. From about 2005 or 2006 through 2013 there was a gradual 
decline in cocaine use in all age bands, but particularly among the younger ages who had 
earlier attained higher prevalence levels. In 2014, however, there was a significant increase 
in cocaine use among young adults ages 19 to 28 combined, but not among 18-year-olds 
nor among those older than 30. Between 2014 and 2017, use either leveled or declined for 
most age groups; however, for those aged 21-26, there was some continued increase, 
reaching 5.6% to 7.2% annual use (Figure 5-9). This recent continued increase, at least for 
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those in their early- to mid-20s, suggests a possible resurgence in cocaine use since the 
relapse that started in the early 1990s.  
 
Crack use was added to the 12th graders’ questionnaires in 1986 and to the follow-up 
questionnaires in 1987. The decline in annual crack use, which began right after the 
introduction of these questions, ended in 1991 among 12th graders, and by 1994 it had 
ended among young adults (Figure 5-10 and Table 5-2). Among 19- to 28-year-olds, the 
annual prevalence rate held at about 1%, which was down from the peak levels of just over 
3% in 1986 through 1988. As was true for a number of other drugs, crack use began to rise 
after 1993 among 12th graders, at the beginning of the relapse phase in the epidemic, but 
not in the older age strata until years later, when increases were observed in a somewhat 
staggered pattern going up the age scale. Again, a cohort effect due to generational 
replacement seems to have been occurring. Since 1994, 18-year-olds have had the highest-
reported rates of use, though they have shown considerable decline since 1999. Among all 
young adults ages 19-28, crack use had its lowest prevalence in 2016 and 2017 (0.2% or 
lower, compared with 3.2% in 1986).    
 
• Use of heroin increased appreciably in 1995 among 12th graders and young adults ages 19 
to 24, but not among the older age bands (Figure 5-11). It remained at this higher plateau 
in these younger age bands through 2000 or 2001, before falling off some, particularly 
among 12th graders. Among young adults aged 19-28, annual use had previously been quite 
stable from at least as far back as 1986 through 1994 at 0.2% (Table 5-2), and it stabilized 
again at a higher level of 0.4% from 1995 through 2017. Use among 12th graders has 
declined since 2000, among 19- to 20-year-olds since 2001, and among the 21 to 22-year-
olds since 2006, but it remains fairly stable (at a very low rate of use) among the older age 
groups.  
 
• Among 19- to 28-year-olds, use of narcotics other than heroin leveled after 1991, 
following a long period of slow, fairly steady decline (Figure 5-12 and Table 5-2). After 
1992 twelfth graders showed an appreciable increase in use, which continued for more than 
a decade into 2004, while 19- to 20-year-olds showed some increase after 1994, 21- to 22-
year-olds after 1996, 23- to 24-year-olds after 1997, and the older age groups after 2000. 
Thus, cohort-related change appears to have been occurring during the 1990s and beyond 
for this class of drugs as well, following a long period of secular trends. In 2002, the 
question text was changed on three of the six questionnaire forms to update the list of 
examples of narcotic drugs other than heroin. Talwin, laudanum, and paregoric, each of 
which had negligible rates of use by 2001, were replaced by Vicodin, OxyContin, and 
Percocet. As a consequence of this revision, reported use rates increased in 2002 as may 
be seen in Figure 5-12. Data presented for 2002 are from three of the six questionnaire 
forms with the new wording (which showed higher prevalence rates than the older question 
did). All six questionnaire forms contained the new wording beginning in 2003, so the data 
presented for 2003 onward are based on all forms. Although the older version of the 
question showed no significant changes occurring in 2002, there was a significant increase 
in narcotics use observed in 2003 (based on the new question in both 2002 and 2003). 
Among 19- to 28-year-olds, annual prevalence reached a peak level of 9.1% in 2006; it has 
since fallen by more than half to 4.0% by 2017. Some turnaround was observed among 19- 
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to 22-year-olds after 2004 in the use of this important class of drugs, but use continued to 
rise in some of the older age bands through 2007 to 2009, likely reflecting a cohort effect. 
Use of these drugs outside of medical supervision remains relatively high in all age groups 
studied here, with 2017 rates of around 4–5% among those ages 18 to 30, at 5.2% among 
those age 35, and at a somewhat lower annual prevalence of 3.5% to 4.8% among those 
ages 40 to 55. Overall, in the past few years, use of this important class of drugs has either 
leveled or decreased in younger age groups and leveled or increased slightly for those age 
35 and older. 
 
• The annual prevalence rates for Vicodin and OxyContin, first measured in 2002 (separately 
from the general question about narcotics other than heroin), were appreciable (8.2% and 
1.9%, respectively) for 19- to 28-year-olds. Increases were observed for these two drugs in 
subsequent years. Among 19- to 28-year-olds (Table 5-2), the annual prevalence of 
OxyContin use rose from 1.9% in 2002 to 3.1% in 2004 through 2006—changes that were 
fairly parallel to those observed among 12th graders over the same interval (when their 
slightly higher annual prevalence rose from 4.0% in 2002 to 5.5% in 2005). The increases 
in OxyContin use between 2002 and 2005 were significant for both 12th graders and 19- to 
28-year-olds. Annual prevalence was stable from 2004 to 2007 at about 3% for young 
adults, increased to 5.2% in 2009, but was down to 1.9% by 2017. Vicodin use (Table 5-
2) rose by less, but started from a higher base, with annual prevalence increasing slightly 
among 19- to 28-year-olds, from 8.2% in 2002 to 8.9% in 2004; it remained at about 9% 
through 2009, followed by a decline to 2.7% by 2017. Thus, since 2009 the annual 
prevalence of both OxyContin and Vicodin among young adults has declined by over half. 
Given the widespread concern about these narcotic drugs, which are among those most 
cited in overdose deaths, this downturn is very good news.  
 
• In the late 1970s, amphetamine use rose some with age beyond high school, but after a 
long period of secular decline in use from 1981 to the early 1990s, this relationship had 
reversed (see Figure 5-13). The declines were greatest in the older strata and least among 
12th graders, even though use decreased substantially in all groups. As was true for many 
illicit drugs, amphetamine use began to rise among 12th graders after 1992, and eventually 
among the 19- to 24-year-olds; but there was only a small increase among 25- to 30-year-
old respondents. In other words, another cohort-related pattern of change was beginning to 
emerge in the 1990s for amphetamines, and the increase in use has really only developed 
since 2006 among the 25- to 30-year-olds as can be seen in Figure 5-13. While 
amphetamine use declined a fair amount among 12th graders between 2002 and 2009 (from 
11.1% to 6.6%), there was less proportional decline among 18- to 20-year-olds and really 
no decline among the 21- to 55-year-old age strata. After 2009 there was some resurgence 
in use, particularly among the younger age groups in 12th grade and college age. It may 
well be that the use of amphetamines for studying was what caused this resurgence. In 
recent years, use has leveled or begun to decline at most younger ages and increased 
somewhat among the 25- to 40-year-olds, quite possibly as a result of a continuing cohort 
effect. Among those strata ages 45 and older, use has been very low, and there has been 
little change for more than a decade. For several years, the age differences in amphetamine 
use through age 55 have been of considerable magnitude and mostly ordinal; however, 
146
Monitoring the Future
since about 2009, it has been curvilinear, with use being highest for 21-22 year olds. (See 
the table accompanying Figure 5-13.)  
 
• Since 1990, when it was first measured, use of crystal methamphetamine (ice) has 
remained at low rates in the young adult population (Figure 5-14). However, among 19- to 
28-year-olds combined, annual prevalence rose from 0.4% in 1992 to 1.6% by 2005 (Table 
5-2). (Use had been rising among 12th graders and 19- to 20-year-olds specifically between 
2000 and 2002, reaching peak levels, but since then their use has declined to low levels.) 
For 19-28 year olds, use declined from 2005 through 2016, reaching 0.1%; in 2017, there 
was a significant increase to 0.7%, but still among the lowest levels for the past decade. 
General methamphetamine use was first measured in 1999; its use was stable until 2005 
among 19- to 28-year-olds, with annual prevalence fluctuating between 2.4% and 2.8%. 
Use has declined since to 0.6% by 2017 (Table 5-2). (Use of these drugs is not asked of 
those over age 30.) 
 
• Sedative (barbiturate) use (Figure 5-15) outside of medical supervision showed a long-
term parallel decline in all age groups covered through the late 1970s and 1980s, leveling 
by about 1988. While use then remained low and quite level for most of the age bands for 
about five years, it began to rise by 1993 among 18-year-olds, by 1995 among 19- to 20-
year-olds, by 1997 among 21- to 22-year-olds, by 1998 among 23- to 24-year-olds, by 2001 
among 25- to 28-year-olds, and by 2005 among 29- to 30-year-olds. The same cohort-
related pattern of change seen during the 1990s for many other drugs also exists for 
sedatives (barbiturates); like most other drugs, this pattern was preceded by a long period 
of secular change during which all age groups moved in parallel. While use leveled off 
among most age groups by 2005, the 35-, 40-, and 45-year-olds all showed increases in 
sedative (barbiturate) use between 2006 and 2008. However, their usage rates leveled after 
2008. In 2017 the annual usage rates for the 35- to 55-year-olds were about 2-3%. Sedative 
use among 18-year-olds declined steadily after 2005, among 19- to 20-year-olds after 2008, 
and among 21- to 22-year-olds after 2009, suggesting another cohort effect. From 2011 
through 2017 the usage rates in most age strata leveled off or declined slightly. The 12th 
graders have consistently had the highest annual prevalence for sedative use without 
medical supervision, though their continued decline has resulted in relatively little 
differences among the age groups in 2016 and 2017. 
 
• Tranquilizers (Figure 5-16) follow a similar pattern to that just described for sedatives 
(barbiturates). One difference is that the 12th graders’ annual prevalence rate has not always 
been the highest among the various age groups, as was the case for sedatives (barbiturates), 
although it was highest between 1994 and 2000 as a result of a greater increase in 
tranquilizer use among the 12th graders than in the young adult strata. Since about 2004, 
however, as use rose and then leveled among those in their early 20s, the 12th graders no 
longer stood out as having the highest rate of tranquilizer use. In fact, the 21- to 22-year-
olds or 23- to 24-year-olds had the highest rate in 2005 through 2009; in 2011, the 25- to 
26-year-olds had the highest rate; and in 2012 the 27- to 28-year-olds had the highest rate 
of use. Use then increased among the 29- to 30-year-olds, who had the highest rate in 2015. 
This was another clear example of a cohort-related pattern of change. In the past five or six 
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years, use has leveled or declined for almost all age groups, though the 21-24 year-olds 
have shown some uneven increases and decreases. 
 
• Use of anabolic steroids has been substantially lower after high school than during 12th 
grade (Figure 5-17), ever since measures were first introduced in 1991 (in two follow-up 
questionnaire forms). The age-related differences are not consistent; prevalence rates 
among the young adult strata are all quite low and do not appear to trend in any systematic 
way. (In general, as covered in Volume I, it seems that the rise in steroid use from 1999 to 
2003 among 8th and 10th graders and from 2001 to 2004 among 12th graders was largely 
specific to those age groups.) Annual prevalence rates are now very low for respondents in 
all young adult strata of ages 19-30 (ranging from less than 0.1% to 1.0%). 
 
• Alcohol trends for the older age groups (Figures 5-18a–d) have been somewhat different 
than for the younger age groups in some interesting ways. For annual and 30-day 
prevalence, the declines for the two youngest age strata (12th graders and those one to two 
years past high school) during the 1980s were greater than for the older age groups. These 
differential trends were due in part to the effects of changes in minimum drinking age laws 
in many states—changes that would be expected to affect primarily the age groups under 
age 21. However, because similar (though weaker) trends were evident among 12th graders 
in states that maintained a constant minimum drinking age of 21, the changed laws cannot 
account for all the downward trends, suggesting that there was also a more general 
downward trend in alcohol consumption during the 1980s.6 By 1994, the declines in 30-
day prevalence had slowed or discontinued for virtually all age groups until 1997, when 
they began to turn downward again for 12th graders, and 1999, when they began to decline 
among 19- to 20-year-olds. The long term declines in the 30-day prevalence of alcohol use 
have been substantial—from 72% in 1980 to 33% in 2017 among 18-year-olds, and from 
77% in 1981 to 46% in 2017 among 19- to 20-year-olds. Since about 1997, as the declines 
continued in the under-21 groups (that is, those under the minimum legal drinking age), no 
such declines occurred among the 21 and older groups; in fact, there have been some 
modest increases in all these groups. These trends have resulted in substantial differences 
in 30-day drinking rates between those 18 to 20 years of age (33% to 46%) versus those 21 
and over (66% to 74%)—much larger differences than when we first looked at them in the 
1980s. 
 
• Occasions of heavy drinking or binge drinking has continued an uneven but substantial 
decline for 18 and 19-20 year-olds since the early 2000s through 2017, reaching levels at 
or near the lowest ever in 2017 at 17% and 22%, respectively, down from the all-time highs 
in 1981 of 41% and 43%, respectively (Figure 5-18d). Respondents three to four years past 
high school show the smallest downward trend since the early 1980s, but even this age 
group has shown declines in the past decade from 46% in 2007 to 40% in 2017. One 
important segment of that age stratum is composed of college students who have shown 
less decline in alcohol use over the past quarter century (see Chapter 9, which also shows 
prevalence of extreme binge drinking/high-intensity drinking).  
 
                                                 
6 O’Malley, P. M., & Wagenaar, A. C. (1991). Effects of minimum drinking age laws on alcohol use, related behaviors, and traffic crash involvement 
among American youth: 1976–1987. Journal of Studies on Alcohol, 52, 478–491. 
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Across the life of the study, declines in binge drinking have been modest among those aged 
23-30. Note that the binge drinking trend lines for different age groups (Figure 5-18d) are 
spread out on the vertical dimension, reflecting large and persisting age differentials (age 
effects) in this behavior. The relationship with age is curvilinear, however. In the past 
decade, the 21- to 26-year-olds have consistently shown the highest rates of binge drinking. 
Binge drinking had been gradually increasing since the early 2000s through about 2008 
among 25- to 30-year-olds, perhaps reflecting a cohort effect that emerged during the 
period of increasing adolescent binge drinking in the early 1990s, but this has turned around 
in recent years, with binge drinking among 25-30 year-olds now being the lowest it has 
been for several years. Among those aged 35 to 55, binge drinking has shown some uneven 
increases over the years, with recent leveling for most age groups.  
 
From the early 1980s through the mid-1990s, rates of daily drinking (Figure 5-18c) fell by 
considerable proportions in all age strata for which we have data, reflecting a secular trend 
and an important change in drinking patterns in the culture. Among 19- to 28-year-olds 
combined, daily drinking declined from 1987 (6.6%) to 2000 (4.1%), but has since 
increased unsteadily to 5.0% by 2017 (Table 5-4). Daily drinking rates now show a fairly 
linear age trend, and have generally been highest for the age 55 group in recent years, 
whereas daily drinking has declined substantially among 18-year-olds and 19- to 20-year-
olds over the life of the study. In 2017 there was a considerable difference among the age 
strata in rates of daily drinking, ranging from 1% among 19-20-year-olds to 10% to 11% 
among 50- and 55-year-olds. 
 
It is worth noting that the 35-, 40-, 45-, 50-, and 55-year-olds have had among the lowest 
rates of binge drinking but among the highest rates of daily drinking in recent years. These 
patterns—particularly the high rate of daily drinking—likely reflect age effects as well as 
perhaps some enduring cohort differences (because these cohorts had considerably higher 
rates of daily drinking when they were in high school). They may also have been influenced 
by the widely disseminated medical findings that suggest that one or two drinks per day 
for males and one per day for females have some benefits for heart health.7,8 That may be 
a more salient message for those who are in their forties or above than for younger people. 
Whether there really are such health effects has been questioned since.9,10  
 
• The prevalence rates for cigarette smoking show more complex trends than most other 
substances, due to the long-term presence of both cohort and age effects, plus slightly 
different patterns of such effects on the several different measures of smoking during the 
past 30 days (one or more cigarettes per month, one or more cigarettes per day, and a half 
pack or more of cigarettes per day). 
 
                                                 
7 Manttari, M., Tenkanen, L., Alikoski, T., & Manninen, V. (1997). Alcohol and coronary heart disease: The roles of HDL-cholesterol and smoking. 
Journal of Internal Medicine, 241, 157–63. 
8 Savolainen, M. J., & Kesaniemi, Y. A. (1995). Effects of alcohol on lipoproteins in relation to coronary heart disease. Current Opinions in 
Lipidology, 6, 243–50. 
9 Keyes, K., & Miech, R. A. (2013). Commentary on Dawson et al. (2013): Drink to Your Health? Maybe Not. Addiction, 108(4), 723-724. 
10 Goulden, R. (2016). Moderate alcohol consumption is not associated with reduced all-cause mortality. The American Journal of Medicine 129, 
180-186. 
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In the earlier years of MTF, the curves across time were of the same general shape for each 
age band (Figures 5-19a–c), but each of those curves tended to be displaced to the right of 
the immediately preceding age group, which was two years younger. The pattern is clearest 
in Figure 5-19c (half pack plus per day) during the late 1970s and 1980s. This pattern is 
very similar to the one described in Volume I for lifetime smoking rates for various grade 
levels below senior year; it is the classic pattern exhibited by a cohort effect,11 and we 
believe that the persisting cohort differences are due to the dependence-producing 
characteristics of cigarette smoking. 
 
The declining levels of cigarette smoking observed in the 12th grade classes of 1978 
through 1981 were later observable in the early-30s age band, as those same high school 
graduating classes grew older (Figures 5-19b and c). This was true at least through about 
1991. By then there had been a considerable convergence of rates across age groups, largely 
because there were few cohort differences among the senior classes who graduated from 
the early to mid-1980s through the early 1990s—a period of fairly level cigarette use in 
high school. 
 
In addition to these cohort differences, there are somewhat different age trends in which, 
as respondents grow older, the proportion smoking at all in the past 30 days declines some, 
while the proportion smoking a half pack per day actually increases. Put another way, many 
of the light smokers in high school either transition to heavier smoking or quit smoking.12-
14 
 
The picture was further complicated in the 1990s when it appears that a new cohort effect 
emerged, with smoking among adolescents rising sharply (beginning after 1991 for 8th and 
10th graders and after 1992 for 12th graders). The 19- to 20-year-olds soon showed a rise at 
the beginning of the 1990s—perhaps responding to some of the same social forces as the 
adolescents (including the Joe Camel advertising campaign); but 21- to 24-year-olds did 
not show an increase until about 1995, and 25- to 26-year-olds until about 1996. Young 
adults over age 26 showed a modest increase from 1997 through 2004, but a decline in use 
since then; it is quite possible that an upward cohort effect was at least partially offset by a 
downward secular trend during this period. 
 
After about 1999, smoking rates among nearly all age groups leveled or declined, 
suggesting that societal forces may be affecting all age groups in a similar way, giving rise 
to a secular trend. Large increases in the price of cigarettes (due at least in part to sales tax 
increases15 and later federal excise taxes) and a great deal of adverse publicity for the 
                                                 
11 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade 
of change, 1976–1986. American Journal of Public Health, 78, 1315–1321. 
12 To illustrate, in the graduating class cohort of 1976, 39% were 30-day smokers in senior year, 39% by ages 19 to 20, but only 29% by ages 29-
30—a net drop of 11 percentage points over the entire interval. By way of contrast, 19% of that class was half-pack-a-day smokers in senior year, 
24% by ages 19 to 20, and 22% at ages 29-30—a net gain of five percentage points and three percentage points over the respective intervals.  
13 Bachman, J. G., Wadsworth, K. N., O'Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
14 Bachman, J. G., O'Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in 
young adulthood: Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates 
15 Huang, J., & Chaloupka, F. J. (2012). The impact of the 2009 federal tobacco excise tax increase on youth tobacco use. NBER Working Paper 
18026. National Bureau of Economic Research, Cambridge, MA. 
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tobacco industry are highly plausible candidates, as are the introduction of the national 
anti-smoking campaign of the American Legacy Foundation, an increase in state and 
national anti-smoking advertising, the demise of the Joe Camel campaign and all billboard 
advertising, and the imposition of no-smoking regulations in many public and workplace 
settings by states and municipalities. From 2003 through 2016, thirty-day, daily, and half-
pack smoking have all declined among 35-, 40-, and 45-year-olds; recent trends among 50- 
and 55-year-olds have shown some modest declines (Figures 5-19a through 5-19c). 
 
As mentioned above, there was a nonsignificant increase in 2017 among 19-28 year olds 
in annual, 30-day, and daily smoking (though 2017 levels were still lower than 2015 
levels), suggesting that continued decreases in cigarette smoking may have stalled. As 
shown in Figure 19a, this pattern of possible leveling for 30-day smoking in 2017 is 
especially evident among 21-26 year olds (with 2017 levels higher than 2016 levels and 
similar to 2015 levels); however, this pattern was not evident among younger and older 
age groups including 35-55 year olds, who generally showed continued decline. This 
stalling pattern was also evident for daily smoking (Figure 5-19b), but in this case, it held 
for 19-28 year olds and 35-55 year olds; nonetheless the 2017 levels are still lower than the 
2015 levels for most age groups, suggesting that the stalling may be temporary. 
 
• Apart from cigarettes, none of the other drugs included in the study showed a clear long-
term pattern of enduring cohort differences in the earlier years of MTF (the 1970s and 
1980s), despite wide variations in their use by different cohorts at a given age. There was 
one exception for daily marijuana use (long-term trends are summarized above, but we 
give them more detail here by way of contrast with cigarette smoking trends). A modest 
cohort effect was observable for daily marijuana use (Figure 5-3c) during the late 1970s 
and early 1980s.16 But as subsequent classes leveled at lower rates of use, evidence for the 
cohort effect faded. The emergence in the 1990s of a new epidemic of marijuana use among 
teens once again yielded a strong pattern of cohort effects. As can be seen in Figure 5-3c, 
daily use rose sharply among 12th graders and 19- to 20-year-olds after 1992, among 21- 
to 22-year-olds after 1993 with a sharp rise occurring in 1997, among 23- to 24-year-olds 
after 1998, among 25- to 26-year-olds after 2000, among 27- to 28-year-olds in 2003, 
among 29- to 30-year-olds in 2005, among 35- and 40-year-olds in 2006, and among 45-
year-olds in 2007. This is not unlike the pattern of change for cigarette smoking that 
occurred in the 1990s (Figure 5-19a). The cohort effect for daily marijuana use may be 
attributable, in part, to the very strong association between that behavior and regular 
cigarette smoking. The net effect of all of this is that a considerable age difference has 
emerged in current daily marijuana use since the early 1990s, when there was practically 
no difference. The cohort effect resulting from the rise in use among 18-year-olds in the 
latter half of the 1990s has been working its way up the age spectrum, and in 2010 was 
observable in the form of a significant increase among 35-year-olds (more recent trends in 
daily marijuana use are discussed above).  
 
• In sum of longer-term trends, up until 1992, trends in illicit drug use were highly parallel 
across 12th graders and young adult age groups, indicating a secular trend. (Cigarettes and 
                                                 
16 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade 
of change, 1976–1986. American Journal of Public Health, 78, 1315–1321. 
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alcohol showed a different pattern.) Since 1992, however, there has been considerable 
divergence in the trends for different age bands on a number of drugs as use among 
adolescents rose sharply, followed by subsequent rises among 19- to 20-year-olds, 21- to 
22-year-olds, and so on. This divergence indicated a new cohort effect, quite possibly 
reflecting a generational forgetting of the dangers of drugs by the cohorts who reached 
senior year in the early to mid-1990s. Data discussed in Chapter 6, “Attitudes and Beliefs 
about Drugs among Young Adults,” provide additional evidence for this interpretation.  
TRENDS FOR IMPORTANT SUBGROUPS OF YOUNG ADULTS 
Four-year age bands are used here to examine subgroup trends in order to yield sufficiently large 
numbers of cases to permit reliable estimates for the various subgroups being examined. Subgroup 
data for young adult respondents of each gender and for respondents from communities of different 
sizes are available for 19- to 22-year-olds since 1980, 23- to 26-year-olds since 1984, and 27- to 
30-year-olds since 1988. (Subgroup data are not presented for the ages above 30.) A question about 
state of residence was added in 1987 to all follow-up questionnaires, permitting trend data to be 
calculated for the four regions of the country since then (MTF samples within these four regions, 
so each is represented by these data). These various subgroup data are not presented in tables or 
figures here because of the substantial amount of space they would require. However, for the reader 
interested in more detail, these are available in a separate MTF Occasional paper. Subgroup data 
on young adults through 2017 are available in MTF Occasional Paper 91 at 
http://www.monitoringthefuture.org/pubs/occpapers/mtf-occ91.pdf. That document contains both 
tabular and graphic presentations of the data, with the graphs, which are by far the easier to read, 
showing each subgroup in a different color. A synopsis of trends through 2017 for young adults is 
presented below. 
Gender Differences in Trends 
• Over the long term, gender differences narrowed for some drugs among young adults in
each of these three age bands (19-22, 23-26, 27-30), primarily when a steeper decline in
use among males (who generally had higher rates of use) occurred in the 1980s. The
overall picture, though, is one of parallel trends, with use among males remaining
consistently and modestly higher for most drugs, including the indexes of annual use of
any illicit drug and of any illicit drug other than marijuana (see Table 5-5, which lists
prevalence for 19-28 year-olds separately by gender, for example, and Figures 1 and 4 in
Occasional Paper 91). In general, the gender gap for 19-22 year olds annual prevalence
of any illicit drug has been somewhat narrower than in the other age bands across the years
through 2017 (but note that the trends for the three age bands are not on the same scale in
the figures).
• The downward trend in marijuana use among 19- to 22-year-olds between 1980 and 1989
was also a bit sharper among males than females, narrowing the gap between the two
groups. Annual prevalence fell by 22 percentage points (to 34%) among males, compared
to a drop of 14 percentage points (to 31%) among females, leaving a difference of three
percentage points (Figure 7 in Occasional Paper 91). From 1995 through 2017, the gender
gap has averaged about 5 to 9 percentage points in all three age groups—that is, for 19-
to 22-year-olds, 23- to 26-year-olds, and 27- to 30-year-olds. In the past three years, the
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gender gap for 19-22 year-olds has diminished to 2 percentage points for annual marijuana 
use. 
Similarly, between 1980 and 1993, daily marijuana use for the 19–22 age group fell from 
12.9% to 2.9% among males, and 6.1% to 1.7% among females, narrowing the rather 
large gap that existed in the early 1980s (Figure 9 in Occasional Paper 91). As overall 
use rose after 1993, the gap widened again. Among 23- to 26-year-olds, as daily use first 
began to increase in 1998 and 1999, the gap between the genders began to widen. In the 
oldest age group (ages 27–30), the difference had been fairly constant, with daily 
marijuana use among males generally being about two percentage points higher than 
among females; however, from 2005 through 2015, the gender gap widened somewhat 
before narrowing in the last two years.. Consistent with what is true for overall trends, 
daily marijuana use in 2017 was at or near historic highs for both males and females 
across the three age groups, at 10.0% and 6.3% respectively for 19-22 year-olds, 11.8% 
and 6.3% respectively for 23-26 year-olds, and 8.0% and 6.0% respectively for 27-30 
year-olds. 
• In all three age bands, use of synthetic marijuana by males tended to be higher than use 
by females. In 2011, when use was first measured, it was highest among the 19- to 22-
year-olds with males higher than females; it has fallen sharply over the past six years for 
both genders and the gap between them has closed considerably (Figure 14 in Occasional 
Paper 91). Annual prevalence in 2017 for the 19-22 age group was 1.9% for males and 
1.0% for females. The two older age bands started out with considerably lower rates in 
2011, but also have shown some decline since then, narrowing the gender difference in 
both groups; the exception is that among 27- to 30-year-olds in 2017, males increased 
significantly to 1.9% and females stayed low at 0.1%.
• Inhalant use, while always quite low in these young adult age groups, was fairly 
consistently higher among males than females; however, this difference has disappeared 
in the past few years after a long period of decline in which prevalence declined to 2% or 
lower for all groups since 2011 (Figure 17 in Occasional Paper 91).
• For LSD, males have consistently had higher rates of use than females (Figure 22 in 
Occasional Paper 91). Among 19- to 22-year-olds, the male–female differences tended 
to diminish as use declined (from 1980 to 1985 and again from 1999 to 2004) and expand 
as use increased (1986–1995). Since 2011, the gender gap has widened again as use has 
increased somewhat, with males having about twice the level of females; annual 
prevalence for males and females were at highest levels since 2001, at 5.1% and 2.7%, 
respectively. In the two older age bands there was less change in use, and differences had 
been relatively consistent (with males higher) since data have been available, beginning 
in 1984 for 23- to 26-year-olds and in 1988 for 27- to 30-year-olds. After 1999 and 2001 
for the two older groups, respectively, overall LSD use dropped, substantially narrowing 
the gender differences. Males began to show these declines first, and both genders moved 
to almost no use of LSD between 2003 and 2009. Beginning in 2009 among the 23- to 26-
year-olds, use increased for males especially in 2016 and 2017, widening the gender gap, 
with females showing some increase through 2016; in 2017, males increased to 6.4% (an 
all-time high) and females decreased to 1.9%. Similarly, the gender gap among 27-30
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year-olds in annual use of LSD began to widen again as use increased somewhat for males 
in 2011 and especially 2016 and 2017, with females showing some slight increase in the 
past few years; in 2017, levels were 2.5% and 1.1% respectively. Overall, it appears that 
there has been some return of LSD use in the last few years among young adults, 
especially among males. 
• Use of hallucinogens other than LSD taken as a group has consistently been higher 
among males in all three age strata with the difference growing larger when use increased 
some in the late 1990s and early 2000s (Figure 25, Occasional Paper 91). The differences 
have been greatest in the youngest of the three age strata and least in the oldest one. Use 
and gender differences have been relatively level for several years through 2016, showing 
no increase in recent years, in contrast to the recent increases in LSD; the exception is that 
use increased to 6.2% among 23-26 year old males in 2017, an all-time high (consistent 
with the 2017 increase in LSD for this age group of males).
• MDMA (ecstasy and more recently Molly) exhibited little or no gender difference in any
of the three age bands before use began to grow in the late 1990s (Figure 28 in Occasional 
Paper 91). Between then and 2009, there was little gender difference in ecstasy use among 
19- to 22-year-olds. From 2009 through 2016, use rose some for males, slightly widening 
the gender differences; but in 2017, used declined among males such that there was no 
longer a gender difference. In the older age groups, a gender difference opened up after 
1997, with males fairly consistently having higher rates of use among both 23- to 26-year-
olds and 27- to 30-year-olds. From about 2009 to 2016, use among 23- to 26-year-olds 
rose unevenly for both genders with little consistent difference between males and 
females. In 2017, use rose significantly for males 23 to 26 years old to 7.1% and declined 
nonsignificantly to 2.7% for females. Among 27- to 30-year-olds between 2010 and 2016, 
use increased more for males, widening the gender difference (even though females have 
increased some in the past few years); in 2017, however, use declined significantly for 
males to 2.3% and declined nonsignificantly for females to 2.8% such that there is no 
longer a gender difference. 
• The annual prevalence of salvia use (Figure 31 in Occasional Paper 91) was much higher 
among males in the 19- to 22-year-olds when first measured in 2009, and somewhat higher 
in the two older age groups. However, use by males has dropped dramatically in the years 
since then; an exception is that use rose nonsignificantly in 2017 for 27- to 30-year-old 
males to 1.2%. Use by females has also dropped, and in 2017 use was negligible except 
among 19- to 22-year-old females (at 1.1%).
• Males have had higher rates of cocaine use than females since MTF began. During the 
period of sharp decline from the peak levels in annual cocaine prevalence (1986–1993), 
use dropped more among males than females, narrowing the gender differences that 
existed (Figure 34 in Occasional Paper 91). In the 19- to 22-year-old age band, by 1993 
annual prevalence for males had declined by 16 percentage points (to 4.5%) versus 13 
percentage points among females (to 2.8%). In the 23- to 26-year-old age band, there was 
also a narrowing of the gender difference between 1986 and 1993, with annual prevalence 
down 19 percentage points among males (to 6.9%) and 13 percentage points among
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females (to 4.2%). Use in the 27- to 30-year-old group also dropped faster among males 
between 1988 (when data were first available) and 1997—down 13 percentage points 
versus 7 among females. In sum, during the period of sharp decline in overall cocaine use, 
the gender differences—which had been fairly large—narrowed considerably in all three 
of these age bands. During the resurgence in cocaine use of the 1990s and into the early 
2000s, which occurred on a somewhat staggered basis over the years, the gap between 
genders expanded only slightly. In the past decade, overall use and gender differences 
have remained fairly level in all age groups, with the gender difference generally being 
less among the 19-22 age group than the two older age groups, though it narrowed in 2017. 
Among 23- to 26-year-old males, use rose significantly in 2017 to 9.9% (this is the same 
group for which LSD and hallucinogens other than LSD rose significantly in 2017).   
• Crack followed a similar pattern during the earlier period of decline, though the 
proportional difference between the two genders had been consistently higher than for 
cocaine overall in the first decade of measurement (Figure 37 in Occasional Paper 91). 
With crack, though, there was some gender convergence (between 1992 and 1998) among 
19- to 22-year-olds, as use among males declined slightly and use among females rose 
gradually; the genders converged somewhat for the two older groups in the late 1990s. 
After 1999, there was no consistent change for some years in differences between males 
and females. In all three age bands, males consistently had slightly higher crack usage 
rates, at least until a greater decline among males in recent years has nearly eliminated the 
differences and brought all of the annual prevalence rates below 1%.
• There have been modest gender differences in heroin use for any of the three age 
groupings of young adults in recent years, with males generally having higher rates of use 
than females. There were no gender differences when the project first reported results for 
young adults in the 1980s, and differences emerged only when heroin prevalence rose in 
the last half of the 1990s during the relapse phase of the drug epidemic (Figure 40 in 
Occasional Paper 91). As of 2017, prevalence ranged between 0% and 0.9% across both 
genders in the three age groups.
• Among 19- to 22-year-olds, both genders showed some decline in their nonmedical use 
of narcotics other than heroin between 1980 and 1991, with a near elimination of 
previous gender differences (males had been higher). (Figure 43 in Occasional Paper 91.) 
Beginning in 1994, use by males began to rise in this age group, while use by females 
began to rise a year later. Some gender differences developed as use increased, with use 
by males being higher; after 2006, as use declined, there was a smaller difference, with 
annual prevalence in 2017 at 3.8% for males and 3.3% for females. The picture for 23- to 
26-year-olds is very similar except that the increase in use occurred a few years later (in 
1997 and 1998). The gender difference (males higher) had been eliminated by 1988, but 
re-emerged after 1995 as use increased more among males. Since 2010, use has declined 
for both genders, with a consistent gender difference of about 2 percentage points. Among 
27- to 30-year-olds, there has been a smaller gender difference and the least increase in 
use in the 2000s. Still, use increased for both genders after 1999 and leveled in the mid- 
2000s, with males emerging with modestly higher rates of use most years thereafter.
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• Since 2002, the first year in which the survey gathered data on nonmedical use of 
OxyContin, its use has generally been higher among males than females for all three age 
bands (Figure 46 in Occasional Paper 91). Both genders showed some increase in use 
between 2002 and 2009 or 2010, followed by some falloff since then in the two younger 
age bands. In the past few years, there have not been consistent gender differences in any 
of the age groups. Among the 27- to 30-year-olds in 2017, use increased nonsignificantly 
for males and decreased significantly for females, widening the gender gap (consistent 
with what was reported above for narcotics other than heroin).
• Nonmedical use of Vicodin, first measured in 2002, also has been higher among males in 
most years. There was a somewhat larger increase in use among males in all age bands 
initially, but the males began to trend down earlier than the females, reducing the 
disparities in use such that in 2015-2017 the gender difference was nearly eliminated in 
all three age bands (Figure 49 in Occasional Paper 91).
• In general, there have been no appreciable gender differences in amphetamine use for 
some years in any of these three young adult age bands. Between 1981 and 1991, rates of 
amphetamine use were similar for males and females and showed substantial and parallel 
downward trends for both genders (Figure 52 in Occasional Paper 91). Among 19- to 22-
year-olds, annual prevalence of use dropped 22 percentage points for males (to 5.2% in 
1991) and 21 percentage points for females (to 4.7% in 1991). There were small increases 
in annual prevalence for both genders in the 19- to 22-year-old age group after 1991, in 
the 23- to 26-year-old age group after 1995, and in the 27- to 30-year-old age band after 
2000, but the genders diverged only slightly (with males higher). At about 2008, annual 
amphetamine use began drifting up slowly in all three age bands, with males consistently 
a bit higher than females. Among the 23- to 26-year-olds and the 27- to 30-year olds, 
while use has been fairly level for females in recent years, it has increased some for males. 
In 2017, the increase was significant for males in both age of these older age groups, rising 
to 10.4% and 9.3%, respectively. These two age groups of males who showed significant 
increases in amphetamine use are the same ones who showed increases in annual use of 
some other illicit drugs in 2017: the age 23-26 males showed significant increases in LSD, 
hallucinogens other than LSD, and cocaine; and the 27-30 year old males showed 
nonsignificant increases in narcotics other than heroin, and OxyContin.
• Nonmedical use of Ritalin, a prescription stimulant used in the treatment of ADHD, was 
added to MTF questionnaires in 2002 (Figure 55 in Occasional Paper 91). Findings for 
the first decade show prevalence being somewhat higher for males than females, after 
which gender differences have tended to be small and inconsistent.
• Like Ritalin, nonmedical use of Adderall (another prescription stimulant) has generally 
been slightly higher among males than females since 2009, when the question was added 
(Figure 58 in Occasional Paper 91). The largest gender difference in annual use was 
initially among 19- to 22-year-olds, the age band that includes most of those in college, 
and this difference diminished in 2016 as use dropped for males. Since 2011 a fair-sized 
gender difference emerged among the 23- to 26-year-olds that closed in 2016 as use 
dropped among males; however, use rose significantly for males in 2017 and remained
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unchanged for females. The gender differences generally have been small among those 
over age 26, although use rose nonsignificantly for males in 2017. These increases in use 
for the latter two age groups of males are consistent with their significant increases in 
amphetamine use in 2017 noted above.  
• A question on methamphetamine use was introduced in 1999 (Figure 59 in Occasional 
Paper 91); by 2011, after many years of decline, annual prevalence was at or below 1%
for both genders in all age groups, and has been 1.8% or less since then. Throughout, 
males showed slightly higher prevalence than females; however, in recent years, gender 
differences have been small or nonexistent.
• Crystal methamphetamine (“ice”) was added to the study’s coverage in 1990 (Figure 62 
in Occasional Paper 91). In the early 1990s, use was low and very similar for both genders 
in all three young adult age bands. In the mid-1990s the younger two age bands showed a 
greater increase in annual use among males, opening a gender gap. The gap then narrowed, 
though males on average were slightly more likely to report use of crystal 
methamphetamine until 2005. From 2009 through 2017 the gender differences have been 
small and inconsistent. In 2017, annual prevalence was between 0.0% and 0.9% for 
females in the three age groups and between 0.6% and 1.2% for males. It should be noted 
that the estimates are a bit unstable for this drug due to limited sample sizes.
• Questions about the use of “bath salts”—stimulant designer drugs (synthetic cathinones) 
meant to mimic the effects of amphetamines—were first introduced in 2012, so there are 
as yet only limited data on trends in their use (Figure 65 in Occasional Paper 91). Among 
19- to 22-year-olds in 2012 there was a large gender difference in use (annual prevalence 
of 3.0% among males vs. 0.5% among females); however, there was virtually no gender 
difference in the two older age bands (0.7% vs. 0.6%, respectively, among 23- to 26-year-
olds and less than 0.5% for both genders among 27- to 30-year-olds). In 2013 the large 
gap between the genders among the 19- to 22-year-olds disappeared as males that age 
showed a significant 2.8 percentage point decline in use. This decline coincided with a 
dramatic 18 percentage point increase in the perceived risk of trying bath salts (for males 
and females combined). A similar change in perceived risk occurred among both older 
groups, as well, no doubt serving to hold their usage rates very low. As of 2017, annual 
use was below 1.3% among both males and females in all three age bands.
• As sedative (barbiturate) use declined through the 1980s, the modest gender differences 
(males were higher) were virtually eliminated in all three age bands (Figure 68 in 
Occasional Paper 91). Beginning in the early 1990s, a staggered increase in use by both 
genders emerged across all three age groups, with males increasing more than females, 
thereby again opening a small difference in the late 1990s and into the 2000s. From about 
2008 through 2017, use declined and generally leveled for males and females in the three 
age groups, essentially eliminating gender differences.
• For tranquilizers, both genders showed a long, gradual decline and very similar rates of 
use from 1980 through about 1993 in all three age bands (Figure 71 in Occasional Paper 
91). Beginning in 1995, use increased for both genders in the 19- to 22-year-old group,
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followed by an increase beginning after 1997 among 23- to 26-year-olds and after 1999 
among 27- to 30-year-olds, again reflecting cohort effects driven by generational 
replacement. Some gender differences emerged during these periods of increase and 
remained during part of the subsequent decrease after 2002 and 2003 for the two younger 
age bands. Males generally reported somewhat higher usage rates, though the gender 
differences have narrowed in recent years as use has generally declined or leveled for all 
three age groups.  
• Inhalant use has generally been quite a bit higher among males than females, particularly 
in the younger age groups (Figure 17 in Occasional Paper 91). The 19- to 22-year-old 
group showed a gradual upward shift from 1980 to 1988, followed by a leveling for some 
years for both genders. In 1997, annual inhalant use began to decline among 19- to 22-
year-old females, followed by males in 2001; however, the gender gap did not diminish 
much with this decline until 2005, when there was a convergence that continued through 
2016. Among 23- to 26-year-olds the gender gap widened as use by males increased 
between 1992 and 1999, though a subsequent decline in use among males narrowed the 
gap, almost eliminating it by 2005. It then re-emerged between 2008 and 2012 and 
diminished since then. In the oldest age stratum, use among males has generally been 
slightly higher, though the prevalence of inhalant use has been very low in this age group 
(under 1.3% in 2017).
• Use of three “club drugs”— Rohypnol, GHB, and ketamine—has tended to be a bit more 
concentrated among males in all three age strata (Figures 74, 76, and 79 in Occasional 
Paper 91), but the estimates are not very stable because of the limited numbers of cases 
upon which they are based. By 2009, annual prevalence rates were very low for all three 
drugs, and gender differences were small; this has continued to be the case in the years 
since then. Rohypnol was dropped from the study in 2010 because of the low numbers of 
users, at which point no gender difference remained in any of the three age groups. (In 
earlier years use by males had tended to exceed use by females.)
• For alcohol, 30-day prevalence rates (Figure 82 in Occasional Paper 91) exhibited a 
gradual, parallel decline from 1981 through 1992 for both genders in the 19- to 22-year-
old age group. Thirty-day prevalence fell from 83% to 72% among males and from 75%
to 62% among females by 1992. There has been a convergence since then, beginning in 
the late 1990s, because use by males has declined slightly while use by females increased 
slightly through 2008. The increasing proportion of women attending college may help to 
explain this convergence, at least in part. The gender difference was virtually eliminated 
in this age group by 2004 and use has remained quite level since then for both genders 
through 2017 (61% for males and 60% for females). In the two older age bands, there was 
a more modest, parallel decline for both genders, from 1985 through 1992 in the case of 
23- to 26-year-olds, and at least from 1988 (when data were first available) to 1991 or 
1992 in the case of 27- to 30-year-olds. From 1992 through 2017, use among males in the 
older two age bands showed fairly level rates of use; but use among females rose 
gradually, narrowing the difference among 23- to 26-year-olds (76% vs. 71% in 2017); 
among the 27- to 30-year-olds, although use by females had been trending upward, it 
declined significantly in 2017, widening the gender gap (77% vs. 66% in 2017).
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Gender differences in daily drinking (Figure 83 in Occasional Paper 91) have been 
somewhat consistent over the years in each of the three age groups, with males always 
higher than females but gender differences decreasing in the two younger age groups. 
Among 19- to 22-year-olds daily drinking showed a general long-term decline from about 
1981 or 1982 through about 1992, with daily use falling more among males, considerably 
reducing but far from eliminating what had been a large gender difference. To illustrate, 
in 1981, 11.8% of males reported daily use versus 4.0% of females; the comparable 1992 
statistics were 5.3% and 2.7%. After 1995, daily drinking began to increase among 19- to 
22-year-olds for both genders, but leveled a few years later. From 2002 to 2005 their daily 
use was rising among males and falling among females, increasing their differences, but 
since 2005 there has been a considerable convergence with daily use among males falling 
and use among females increasing modestly through 2014. In 2017 a gender difference 
remained for daily drinking in the 19- to 22-year-old age group—5.5% for males versus 
1.2% for females—but not nearly as large as it was in 1981 (11.8% vs. 4.0%, respectively). 
The gender differences have been larger and longer lasting for the two older age groups. 
Although the gap diminished in 2014 for the 23- to 26-year-olds, it has widened since then 
through 2017 (9.1% for males vs. 3.8% for females). Among the 27- to 30-year-olds the 
gender difference has increased since 2000, with use rising for both genders, but to a 
greater extent among males; in 2017 their daily drinking rates were 10.7% for males vs. 
4.1% for females.  
There are also long-established and large gender differences in all three age groups in the 
prevalence of binge drinking or occasions of heavy drinking (Figure 84 in Occasional 
Paper 91). Males in the 19- to 22-year-old band have shown some longer-term decline in 
this statistic, from 54% in 1986 to 45% in 1995 to 37% in 2017. Use by females declined 
less, from 33% in 1981 to 28% in 1995 before rising some to 34% in 2006, and then back 
to 28% in 2017. Thus, the gender gap has narrowed considerably (from 24 percentage 
points in 1986 to 17 percentage points in 1995 to just 9 percentage points by 2017). In the 
two older age bands (23- to 26-year-olds and 27- to 30-year-olds), the sizable gender 
differences remained mostly stable as the binge drinking rates drifted steadily upward in 
both genders since the early 1990s, at least until 2009 or 2010. These rates have leveled 
or even declined a bit in both genders among 19- to 22-year-olds for about the past eight 
years (to 37% vs. 28% in 2017), among 23- to 26-year-olds over the past six years (to 
38% vs. 28% in 2017), and among the 27- to 30-year-olds in the past five years (to 
40% vs. 24% in 2017), suggesting a cohort effect. (Figure 85 in Occasional Paper 91 
shows gender differences by college student status for those aged 19-22; substance use by 
college student status is covered in this Volume in Chapters 8 and 9.)
• Most striking for cigarette smoking by young adults are the similarities between the 
genders in both absolute levels and trends. All three age groups showed a long-term 
decline in 30-day smoking rates for both males and females (Figure 91 in Occasional 
Paper 91). For 19- to 22-year-olds, declines occurred from 1980 through 1991 and again 
since 1999; for 23- to 26-year-olds, declines occurred from 1984 to 1995 and again since 
2001; for the 27- to 30-year-olds, declines occurred from 1988 through 2001 and again 
since about 2006. These staggered patterns again reflect a cohort effect moving up the age
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scale. Among those aged 19–22 years, females had slightly higher rates of 30-day smoking 
until 1992; but there was a crossover and since 1994 males have had a higher 30-day 
prevalence of smoking. Since 1998, males 23–26 years old have had a higher 30-day 
prevalence of smoking than females. Among those 27–30 years old, males have generally 
had a higher 30-day prevalence, with the gender gap increasing some in recent years. 
Overall, from about 2007 through 2017, gender differences have widened a bit in all three 
age groups because females showed a more consistent decline than males over the years. 
As discussed earlier in this chapter, there is some evidence of a leveling in 2017 of the 
continued decline in 30-day smoking among young adults, especially 21- to 26-year-olds; 
as shown in Figure 91 in Occasional Paper 91, this pattern of leveling is evident for both 
males and females in the 19-22 age group (use increased nonsignificantly 1.8 percentage 
points to 17.2% for males, and 0.9 percentage points to 11.3% for females) and in the 23- 
26 age group (use increased nonsignificantly 3.7 percentage points for males to 22.2%, 
and 0.7 percentage points to 13.6% for females); use continued its gradual decline to 
historical lows in 2017 for 27-30 year olds (15.9% vs. 12.0%). 
Male and female trends in daily smoking (Figure 92 in Occasional Paper 91) rates have 
also been quite parallel over most of the time for which data are available, particularly in 
the two younger age groups. Among 19- to 22-year-olds there was a crossover after 
1993—before that point, females had slightly higher daily smoking rates, whereas males 
generally did from 1994 onward, primarily because use was rising faster among males 
through 1999. Both genders in this age group have shown considerable, parallel declines 
since 1999; however, after reaching all-time lows in 2016, use rose nonsignificantly for 
both males and females (1.1 percentage points to 8.0% vs 0.7 percentage points to 6.1%). 
Among 23- to 26-year-olds, the genders had very similar smoking rates until males started 
reporting higher daily smoking rates from 1996 on. Males declined less after 1998, 
opening up a modest gap; however, this gap has narrowed some in recent years as smoking 
has declined a bit more among males. However, in 2017, use increased nonsignificantly 
2.8 percentage points to 12.9% for males, and continued to decline for females to 7.1% 
(all-time low). In the oldest age band, the two genders were quite close until males opened 
a gap in 2002, and their rate has generally remained somewhat higher since then, though 
diminishing in 2017 as the males showed recent declines. In 2017 the prevalence rates for 
daily smoking in the oldest age band were 10.0% among males and 8.7% among females, 
both at all-time lows.  
Smoking half-pack-a-day shows similar trends to daily smoking, though the gender 
differences are a little larger, with males showing higher rates than females since 1993 in 
the youngest age band, since 1989 in the middle age band, and since 1988 in the 
oldest age band, when use data for this group were first available (Figure 93 in Occasional 
Paper 91). However, all three age groups have shown a convergence by 2017, with most 
groups reaching all-time lows. The exception was that smoking half-pack-a-day 
increased nonsignificantly 1.5 percentage points to 7.8% in 2017 among 23- to 26-year 
old males, consistent with increases in 30-day and daily smoking in this age group of 
males. 
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• Hookah smoking generally has been slightly higher among males than females in all three 
age bands, but use has been declining and with that a convergence has taken place (Figure 
98 in Occasional Paper 91).
• There has been a large and fairly consistent gender difference in the use of small cigars, 
dissolvable tobacco, and snus, specifically, with males having higher prevalence rates in 
all three age groups (Figures 101, 104, and 107 in Occasional Paper 91). It is notable that 
dissolvable tobacco and snus use rose nonsignificantly for the 23-26 year-old males in the 
past two years.
Regional Differences in Trends 
The respondent’s current state of residence was first asked in the 1987 follow-up surveys; thus 
trend data by region exist only for the interval since then. In this case, changes have been examined 
for all 19- to 28-year-olds combined to increase estimate reliability. Because gender, for example, 
crosscuts all regions, it has less sampling error than when the sample is divided into four separate 
regions. (Each region is represented by between 800 and 2,200 weighted cases in all years. Actual 
case counts are somewhat higher.) By combining across all ages, we lose the ability to see the 
cohort effects that have occurred with many drugs, but we are able to see whether overall 
trends are similar across regions. Note that the charts showing regional differences in 
Occasional Paper 91 differ from those just discussed for gender differences. There are no 
longer three age bands depicted: the freed space on each page is used to add additional 
prevalence periods (i.e., lifetime, annual, and 30-day). But for the most part we continue to 
concentrate on annual prevalence.  
In general, the changes that have occurred since 1987 have been fairly consistent across regions, 
particularly in terms of the direction of change. The four regions of the country—Northeast, 
Midwest, South, and West—have generally moved in parallel. Rather than include the large 
number of tables or figures necessary to show regional trends, we provide a verbal synopsis 
instead. The detailed information on subgroup trends through 2017 are available in graphic and 
tabular forms in MTF Occasional Paper 91. 
• There were substantial drops among young adults in all four regions between 1987 (the
initial measurement point) and 1991 for any illicit drug, marijuana, any illicit drug other
than marijuana, cocaine, crack, and amphetamines. After 1991, most or all regions
showed some increase and then a leveling in the use of these drugs (except cocaine, which
continued to decline through the mid-1990s, inched up thereafter, remained fairly level
through 2006, and has declined since).
The proportions of 19- to 28-year-olds using any illicit drug have been consistently lowest 
in the South and highest in the West and Northeast; but the regional differences have been 
fairly modest (Figure 2 in Occasional Paper 91). For example, in 2017 the Northeast and 
West had the highest annual prevalence at 45% while the South was lowest at 38%. In 
general, for use of illicit drugs in 2017, the West showed greater relative increases.
• For marijuana use (Figure 10 in Occasional Paper 91), the South has consistently been 
lowest, and the Midwest consistently has been second lowest. Generally, the other two 
regions have been fairly close to one another. However, the differences have generally not
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been great. The 2017 annual prevalence rates ranged from 34% (South) to 42% (West). 
Regional differences in daily marijuana use have been relatively low over the years. The 
South has generally had the lowest levels of daily use. In 2017, daily use ranged from 
7.0% (Midwest) to 10.7% (West), with the West showing the largest increase in 2017. 
• For the use of any illicit drug other than marijuana (Figure 5 in Occasional Paper 91), 
the regional differences are not large and the regions have moved in parallel. The West 
stood out as consistently highest in annual use until 2000, with the other three regions 
being very similar; since 2001, use in the Northeast generally has been about as high as in 
the West, though in 2017, use declined nonsignificantly for the Northeast (to 20%) and 
increased nonsignificantly for the West (to 24%). In 2017, the South had the lowest annual 
prevalence at 17%.
• Data on use of synthetic marijuana have been gathered since 2011 (Figure 15 in 
Occasional Paper 91). These data show a considerable decline between 2011 (when 
annual prevalence ranged from 5.5% in the Northeast to 9.7% in the Midwest) and 2017 
in all four regions. There remains little difference among the regions in annual prevalence, 
which ranges from 0.1% to 1.5% in 2017.
• From 1987 (when data were first available) through 1994, rates of inhalant use remained 
relatively stable, quite low, and about equal in all four regions among 19- to 28-year-olds. 
Annual use then rose in the Northeast in 1995 and 1996 and remained higher than in the 
other regions through 2000, before dropping back to rates comparable to the other three 
regions (Figure 18 in Occasional Paper 91). Except for that divergence, the regions have 
moved very much in parallel for this class of drugs. Annual prevalence in 2017 is at low 
levels in this age group, ranging between 0.4% in the Midwest and 1.6% in the West.
• From 1987 (when data were first available) through 2001, the West had the highest level 
of lifetime prevalence for LSD (Figure 23 in Occasional Paper 91). From 1991 through 
1995, the West had slightly higher annual prevalence rates of LSD than the other three 
regions among young adults. Otherwise the lifetime and annual prevalence has been quite 
similar in all four regions; all showed sharp declines in LSD use after 2001, though use 
had been declining some in all regions for several years prior to that. From about 2009 
through 2017, all four regions have shown some modest increase in annual prevalence of 
LSD, with the Northeast typically having slightly higher annual prevalence through 2014, 
and the West having the highest levels in 2015 and 2017. In 2017, prevalence of annual 
use was 4.7% and 3.6% in the West and Midwest, respectively, and 3.0% and 2.6%, 
respectively, in the Northeast and South.
• Salvia, which was first measured with a tripwire question in 2009, showed a continuous 
decline from 2009 through 2013 in the West (which started out highest) and the South 
(Figure 32 in Occasional Paper 91). Use began to decline in the Midwest after 2010 and 
in the Northeast after 2011. Use was very low in all regions by 2017 at 0.8% or less annual 
prevalence, compared to 2.5% to 5.4% in the four regions in 2009.
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• Questions about MDMA (ecstasy and more recently Molly) were added to the follow-up 
surveys of young adults in 1989 (Figure 29 in Occasional Paper 91). Through 1993, rates 
were highest in the West and South and a little lower in the Northeast and Midwest 
regions. Subsequently, use in the Northeast began to increase (as was true among 12th 
graders), exceeding levels of use found in the South and West from 1999 to 2001. The 
Midwest has quite consistently had a much lower level of ecstasy use than the other three 
regions, although it was joined by the South in recent years. In 2000 all four regions 
showed a sharp and fairly parallel increase in ecstasy use; the rise decelerated in 2001 and 
use began to decline thereafter in all regions. As discussed elsewhere, we believe that this 
decrease may have been caused by growing concern about the hazards of ecstasy use. By 
2003, little regional difference remained in annual prevalence, largely because the 
declines in use were most pronounced in the Northeast and West. By 2007, use was down 
a little more in all regions; but after 2007 ecstasy use generally was increasing in the West 
until it leveled after 2012, before increasing again in 2016, thereby reopening regional 
differences that remained in 2017. In 2017 annual prevalence rates among young adults 
were 6.8% in the West, 2.7% in the Northeast, 2.9% in the South, and 2.5% in the 
Midwest.
• The considerable declines in cocaine use, observed in all regions between 1987 and 1991, 
were greatest in the two regions that had attained the highest levels of use by the mid- 
1980s—the West and Northeast (Figure 35 in Occasional Paper 91). These regional 
differences had diminished considerably by 1992 after a large overall decline in use had 
taken place. Similar to the finding for 12th graders, in 1992 the decline in annual 
prevalence stalled in all regions except the Northeast. A gradual further decline then 
occurred in all regions through 1996 (1997 for the West) before a slight rise began to 
occur, likely reflecting the effects of young adults forgetting of the hazards of cocaine use 
as a result of generational replacement. Regional variability in annual cocaine prevalence 
was minimal for some years after the mid-1990s, but since 2005, use in the Midwest and 
South has declined more than in the West and Northeast, creating some regional 
difference; for the past few years, use has been increasing unevenly for the West and has 
been fairly level for the other three regions. Annual prevalence for the young adult age 
band in 2017 was 8.1% in the West, 5.5% in the Northeast, 4.1% in the South, and 4.0%
in the Midwest.
• Through about 2011, lifetime prevalence of crack use generally has been highest in the 
West since crack use was first measured in 1987, as has been true for cocaine in general 
(Figure 38 in Occasional Paper 91). All four regions exhibited an appreciable drop in 
crack use between 1987 and 1991, again with the greatest declines in the West and 
Northeast, where prevalence had been the highest. Use then generally leveled in all 
regions except the South, where it continued a gradual decline through 1997. As was true 
for cocaine generally, annual prevalence for crack use among the regions have converged 
and are at very low levels, ranging from 0.1% to 0.3% in 2017.
• The regions have trended fairly similarly in their prevalence of amphetamine use by 
young adults (Figure 53 in Occasional Paper 91). The only modest exception was that 
use declined more in the Northeast (which started out lowest) in the period 1987 to 1992,
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giving it a substantially lower rate than the other three regions; it remained lowest until 
1998. The West fairly consistently had the highest rate through about 2000, although not 
by much. By the late 1990s, the Northeast had caught up to the Midwest and South, 
making the regional differences very small; there have been no consistent regional 
differences since 2000 (annual prevalence ranged from 5.0% to 5.9%), with all regions 
showing uneven increases. In 2017 the annual prevalence rates ranged between 7.2% in 
the South and West and 8.9% in the Midwest. 
• Methamphetamine use (Figure 60 in Occasional Paper 91) has been measured only since 
1999 (though crystal methamphetamine, discussed next, has been in the study for a longer 
interval). It shows some differences in rates among the regions and some differential 
trending, with a gradual decline for some years in annual prevalence in the Northeast 
(where use has generally been lowest) and a gradual increase in the West (where use has 
usually been highest) from 2000–2004, after which use declined in the West. Use in the 
other two regions remained fairly flat until 2006, when both showed some decline. Use in 
the West fell after 2006, leaving very little variability among regions by 2012. (Lifetime 
prevalence reached particularly high levels in the West, starting at 16% in 1999, and 
declining fairly steadily to 5% in 2017.) Annual prevalence in 2017 ranged from 0.4% in 
the Northeast to 0.8% in the Midwest.
• The West consistently has had the highest rates for crystal methamphetamine (ice) use, 
and until recently the regional differences were very substantial, particularly in terms of 
lifetime use (Figure 63 in Occasional Paper 91). The Northeast has generally had the 
lowest prevalence. When data were first available on crystal methamphetamine in 1990, 
the West had a lifetime prevalence of 5.1% versus a range of 1.7% to 2.3% in the other 
three regions. By 2006, the lifetime prevalence rate in the West had increased to 8.8%, 
and lifetime prevalence in the Midwest and South grew quite steadily over that interval. 
This strongly suggests that crystal methamphetamine use among young adults diffused 
from the West primarily to the South and Midwest regions, but diffused much less to the 
Northeast, which has had the lowest prevalence since 1998. The annual prevalence figures 
tell a similar story, but also show that there was a spike in past-year use in the West from 
1991 to 1995 before use there declined and then stabilized at around 2% from 1997 
through 2001. Rates then rose again in the West between 2001 and 2003 and stabilized at 
a slightly higher level around 2.7%. Since 2006, use in the West declined, narrowing the 
differences among regions. In 2017, annual use of crystal methamphetamine stood 
between 0.0% and 1.0% across all regions.
• Bath salts (synthetic stimulants sold over the counter) were first included in the study in 
2012 and showed some regional variation, though all regions had an annual prevalence of 
use below 1.7% (Figure 66 in Occasional Paper 91). Use by young adults was highest in 
the Northeast at 1.6% in 2012, but use in all regions has fallen from the 2012 levels, and 
the differences among regions are now minor, ranging from 0.2% in the Midwest to 0.6%
in the South in 2017.
• The annual prevalence for sedatives (barbiturates) remained flat, and at about equivalent
levels, in all four regions of the country from 1987, when first measured, through 1994
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(Figure 69 in Occasional Paper 91). Rates then rose gradually and in parallel in all regions 
for a number of years until about 2003, followed by some leveling and then some decline 
after 2008, followed by a leveling since 2011; regional differences have been consistently 
small. In 2017 annual prevalence ranged from 1.5% in the Northeast to 2.7% in the 
Midwest. 
• The picture for tranquilizers (Figure 72 in Occasional Paper 91) is similar to that for 
sedatives (barbiturates). Annual prevalence generally held fairly steady in all regions from 
1987 through 1993, even though lifetime use was declining steadily in all regions through 
1997. After 1993 there was some increase in all regions in lifetime and annual use, with 
the South experiencing the most increase through 2004, after which all regions showed a 
leveling in use, followed by gradual uneven declines in use for the four regions since about 
2007 through 2017. The regional differences have been small, though they grew a bit 
larger during the period of increasing use in the late 1990s, primarily because the South 
showed a greater increases in lifetime and annual use than the other regions and had the 
highest prevalence through about 2008; since then, there have been few consistent 
regional differences. Annual prevalence in 2017 ranged from 4.1% in the South to 5.2%
in the West.
• Levels and trends in heroin use were quite comparable across the four regions from 1987 
through 2006 (Figure 41 in Occasional Paper 91). All regions had low and stable rates 
through the early 1990s. A gradual increase was observed from about 1993 through 2000, 
during the relapse phase in the overall drug epidemic, and annual prevalence was fairly 
stable in all regions through roughly 2004. After that, there was a steady increase in heroin 
use in the Northeast from 0.4% in 2004 to 1.1% in 2009, and also an increase in the West, 
from 0.3% in 2004 to 0.8% in 2009. After 2009 young adults in these two regions 
continued to have the highest prevalence of heroin use through 2012. In 2013, use 
continued to rise in the Northeast bringing its annual prevalence up to 1.8%, compared to 
0.2% to 0.5% in the other three regions. This rise in the Northeast is consistent with 
statements by governors in the Northeast that they were facing a rising level of heroin use. 
The rate in the West fell back to 0.5% in 2013. In 2014 there was a significant decline in 
annual prevalence in the Northeast, leaving it only slightly higher than the other regions 
(at 0.6% vs. 0.3%–0.4%). In 2015 the Northeast showed a small and nonsignificant rise 
back to 1.1% while the other regions remained level at 0.3% to 0.4%. In 2017, annual use 
dropped back to 0.8% in the Northeast and to 0.1% in the South while rising slightly in 
the Northeast and West, opening some difference among the regions (ranging from 0.1%
to 0.8% in 2017).
• Trends in annual prevalence of the use of narcotics other than heroin have been quite 
parallel for the four regions (Figure 44 in Occasional Paper 91). After a period of slight 
decline between 1987 and 1993 in all regions, a gradual, long-term, and substantial 
increase occurred from the mid-1990s through 2003 or 2004, depending on the region, 
with little systematic change through 2010, at which point use began to decline gradually 
in all regions—a decline that for the most part continued up through 2017. The South 
tended to have the lowest prevalence of use from 2003 through 2013, with the other three 
regions being tightly grouped; however, all regions were about the same in 2017, with
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annual prevalence ranging from 3.4% to 5.0%. It is noteworthy that trends in lifetime 
prevalence have been consistent with annual trends noted above, including the recent 
declines and lack of regional differences (13.0% to 14.9% in 2016); however, in 2017, 
regional differences opened up some with lifetime use significantly lower in the Northeast 
(down 4.1 percentage points to 10.8%) and nonsignificantly higher in the West (up 2.2 
percentage points to 16.7%). 
• The annual prevalence of OxyContin use without medical supervision was highest in the 
Northeast and lowest in the West in 2002, when it was first measured (Figure 47 in 
Occasional Paper 91). Use rose some in all regions through about 2009, and it has shown 
a substantial decline in all regions since then. The Midwest had the lowest prevalence rate 
from 2010 through 2017 (except for 2013). The four regions were fairly tightly grouped 
in 2017, with annual prevalence ranging from 1.4% to 2.8%. In general, regional 
differences have not appeared very consistent due to the limited sample sizes.
• Annual prevalence of use for Vicodin without medical supervision showed considerable 
variation among the regions between 2002, when it was first measured, and 2010 (Figure 
50 in Occasional Paper 91). The West and Midwest generally had the highest rates, with 
the South the lowest and the Northeast in between. However, the West and Midwest have 
shown declines in use since 2005 and 2006, respectively, narrowing the differences; use 
has since declined for all regions since 2010 with the South generally continuing to have 
the lowest prevalence. Annual prevalence rates in 2017 were 1.1% in the South, 2.6% in 
the Northeast, 3.5% in the Midwest, and 4.2% in the West. (It should be noted that the 
sample sizes are more limited than usual for Vicodin and OxyContin, because questions 
about their use are contained on only two of the six questionnaire forms. Consequently, 
the trends are less smooth.)
• When two club drugs, GHB and ketamine, were first measured in 2002, the Northeast 
stood out as having a higher rate of annual use (especially so for ketamine); but use in the 
Northeast dropped over the next two years, bringing that region’s usage rates down to the 
same very low levels as the other three regions (Figures 77 and 80 in Occasional Paper 
91). There appears to have been a little resurgence of ketamine use between 2008 and 
2010 in all regions except the Midwest, followed by a decline in all regions in 2011. In 
2012 through 2017 ketamine use stood higher in the Northeast than in the other regions. 
In 2017, annual use ranged from 0.3% in the South to 0.7% in the Northeast. GHB use 
also appeared to rise in the Northeast in 2012, but use then fell back in 2013. Because of 
consistent very low levels of GHB (annual use ranging from 0.0% to 0.3% in 2015), it 
was dropped from the surveys to make room for items on other drugs).
• Note: Questions about the use of Rohypnol were discontinued in 2010. Rohypnol use 
(Figure 75 in Occasional Paper 91) remained very low in all four regions from 2002, 
when it was first measured, through 2009, not reaching 1% in any region. For this reason, 
questions about its use were dropped from the surveys in 2010 to make room for other 
drugs.
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• With respect to alcohol use (Figure 86 in Occasional Paper 91), there were modest 
declines in 30-day prevalence in all four regions between 1987 (when the first 
measurement was available for 19- to 28-year-olds) and 1992. The rates for 30-day 
prevalence among young adults then leveled in all regions. The West and South have 
consistently had lower rates of 30-day use than the Northeast and Midwest (as has 
generally been true among 12th graders). In 2017, 30-day use ranged from 61.7% in the 
West to 72.3% in the Northeast.
Current daily use of alcohol also showed a decline from the first (1987) data collection 
through about 1994 or 1995 in all regions. The proportional declines were substantial—
on the order of 40–50%. (This decline corresponds to a period of appreciable decline in 
daily drinking among 12th graders, though we can tell from their longer-term data that 
their decline started in 1980; thus the decline may well have begun earlier among 19- to 
28-year-olds as well.) After the mid-1990s there was some upward trending in daily 
prevalence in all regions through about 2007 or 2008, followed by a leveling. Across the 
years, there have not been consistent regional differences. In 2017 the four regions had 
rates of daily alcohol use between 4.5% (Northeast) and 5.4% (West). 
Binge drinking (or occasions of heavy drinking) was fairly level in all regions between 
1987 and the late 1990s or early 2000s. There were then some modest increases through 
about 2006, followed by a leveling and even a slight decline, particularly in the West. 
Throughout the years, prevalence has been consistently higher in the Midwest and 
Northeast. Declines since 2011 have been greater for the Midwest and Northeast, with 
smaller declines in the West and South, narrowing the regional differences somewhat. In 
2017, prevalence of binge drinking was 28% in the West, 29% in the South, and 36% in 
both the Midwest and Northeast. 
• There have been highly consistent regional differences among young adults in cigarette 
smoking since data were first available in 1987—they exist for monthly, daily, and half-
pack-daily prevalence rates. The West has consistently had the lowest rates all three 
measures of cigarette use across the years. The other three regions have tended to cluster 
fairly closely, but usually with the Midwest highest and the Northeast a little lower (Figure 
94 in Occasional Paper 91). However, as prevalence levels have fallen in recent years, 
the rates have converged, with rather little regional difference remaining in 2017. In 
general, all of the smoking measures have shown parallel movements across regions, 
suggesting that the forces accounting for changes have been nationwide in scope. (It 
should be remembered that, as illustrated earlier in this chapter, there are strong cohort 
effects in smoking that are obscured to a considerable degree when we combine age 
groups across a 10-year age span, as we have done in the present analyses.)
As noted above, 2017 was the first year in many that did not show continued declines in 
30-day and daily cigarette smoking, with some nonsignificant increases suggesting a 
leveling in cigarette smoking among young adults. Thirty-day and daily smoking 
continued to decline (nonsignificantly) in 2017 for the Northeast (to 13.7% and 8.1%, 
respectively), but nonsignificant increases and leveling were evident for the other three 
regions. For the Midwest, 30-day use increased 2.0 percentage points to 17.6%, and daily 
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use increased 0.8 percentage points to 10.0%; for the South, 30-day use increased 2.5 
percentage points to 15.9%, and daily use increased 1.6 percentage points to 9.9%. For 
the West, the increases were smaller but began in 2016: 30-day use increased from 12.4% 
in 2015 to 12.7% in 2016 to 13.3% in 2017; daily use increased from 5.5% in 2015 to 
6.6% in 2016, and leveled to 6.5% in 2017. These increases, while not statistically 
significant, suggest that the consistent annual declines in cigarette use that have been 
evident for years may be coming to an end, at least for young adults in the Midwest, South, 
and West. 
• Smoking using a hookah (Figure 99 in Occasional Paper 91) has not shown important
regional differences, with annual prevalence generally declining for all regions from 2014
through 2017. Annual use of small cigars and snus have shown some modest decreases
or leveling in all regions from 2011 (when first asked) to 2017, with use in both generally
highest in the Midwest (Figures 102 and 108 in Occasional Paper 91, respectively).
Annual use of dissolvable tobacco (Figure 105 in Occasional Paper 91) has been below
1% in all regions since 2011 (when first asked) through 2017, with the exception of the
Midwest showing a nonsignificant increase of 1.2 percentage points in 2017 to 1.5% (and
the Northeast showed a one-year spike to 1.5% in 2014).
Population Density Differences in Trends  
The analyses presented here for population density return to the use of three four-year age groups 
of young adults (19-22, 23-26, and 27-30); these age groupings allow a longer time interval to be 
examined for the younger strata and for cross-age comparisons of the trends. Among young adults, 
five levels of population density are distinguished based on the respondent’s answer to the 
question, “During March of this year did you live mostly . . .”; answer alternatives were “in a very 
large city (over 500,000 people), in a large city (100,000 to 500,000), in a medium-sized city 
(50,000 to 100,000), in a small city or town (under 50,000), or on a farm/in the country.” Data on 
the suburbs of cities of each size were combined with the corresponding city. These various 
subgroup data are not presented in tables or figures here because of the substantial amount of space 
they would require. Rather, a verbal synopsis of what they contain is presented. More detailed 
information on subgroup trends will soon be available in both graphic and tabular form in MTF 
Occasional Paper 91. 
• Annual use of any illicit drug among young adults generally has moved in parallel among
the various community-size strata. The farm/country stratum has tended to have the lowest
use. The other four community-size strata have differed little from one another, though
the very large cities have generally ranked at the top in all three age bands and have shown
more of a recent increase in annual prevalence than the other strata (Figure 3 in Occasional
Paper 91). Across the years among the 19- to 22-year-olds, annual prevalence has been
similarly high among the cities of all sizes and lowest among the farm/country stratum; in
2017, annual prevalence was: 32% for the farm/country stratum, 40% for small towns,
46% for medium-sized cities, 44% for large-sized cities, and 45% for very large cities.
Among 23- to 26-year-olds and 27- to 30-year-olds, population density differences in
annual use have expanded in recent years, though still generally maintaining the positive
relation with community size; in 2017, annual prevalence for the two age groups was 30%
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and 29% for farm/country, 33% and 32% for small towns, 39% and 35% for medium 
cities, 48% and 38% for large cities, and 54% and 48% for very large cities.  
• Trends in the use of any illicit drug other than marijuana tell a similar story, with annual 
use generally highest in very large cities and lowest in farm/country communities across 
the age groups (Figure 5 in Occasional Paper 91). There was a long period of fairly 
parallel declines along with some convergence of usage rates among the community-size 
strata at all three age levels (among 19- to 22-year-olds it was between 1981 and 1992), 
followed by an increase in use and more recently a leveling. In general, medium, large, 
and very large city strata have all tended to share about the same rates, while the 
farm/country stratum has tended to have the lowest rates, particularly prior to 1990; the 
differences by population density have been quite small since about 2000 through about 
2012 across the three age groups. After 2012 or 2013 the most noteworthy change has 
been increased prevalence in the very large cities among the two older age groups, 
particularly in 2017, which appears to be primarily the result of increases in marijuana 
use, discussed next.
• Marijuana use (Figure 11 in Occasional Paper 91) has moved pretty much in parallel 
among the various community-size strata over the time intervals for which data exist. 
Among all three age strata annual prevalence of marijuana use tends to be ordinally related 
to population density, with the farm/country stratum having the lowest annual prevalence 
of marijuana use and the very large cities having the highest. Among 19- to 22-year-olds, 
the annual prevalence rates have been quite close among communities of all sizes, except 
for the farm/country stratum. Use in the farm/country stratum fell less in the decline period 
during the ‘80s and rose more slowly in the subsequent increase than in the other 
community-size strata in the 90s, first narrowing and then increasing the gap; in 2017, 
annual prevalence was 29% for farm/country, 37% for small towns, and 40%-45% among 
cities. In the past few years among 23- to 26-year-olds and 27-30 year olds, the differences 
among the communities have widened some as use among the large and very large cities 
increased faster than among the other strata. In 2017, annual prevalence was 28% and 
27% for farm country, 28% and 26% for small towns, 35% and 31% for medium cities, 
42% and 35% for large cities, and 52% and 42% for very large cities.
• Daily marijuana use (Figure 13 in Occasional Paper 91) has also moved largely in 
parallel among the five population-density strata within each age band, with few 
consistent differences among the strata over the years. The population-density strata all 
showed some decline in daily use from 1980 through about 1992, suggesting a period 
effect influencing all ages, and then more of a staggered increase from 1992 through 2000 
among the 19-22 year-olds, from roughly 1998 to 2003 among the 23- to 26-year-olds, 
and from roughly 2004 to 2008 among the 27- to 30-year-olds, indicative of a cohort 
effect. Over the past decade, there have been few systematic differences between the strata 
in the three age groups, with all showing uneven increases. In 2017, daily use for 19- to 
22-year-olds ranged from 5.7% for farm/country to 9.6% for very large cities; for 23- to 
26-year-olds, it ranged from 6.3% among small towns to 11.7% among very large cities; 
and for 27- to 30-year-olds, it ranged from 6.2% in medium cities to 7.5% in very large 
cities.
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• Synthetic marijuana, such as “K-2” and “Spice,” was added to the study in 2011; data 
covering only a six-year interval exist so far (Figure 16 in Occasional Paper 91). The 
farm-country stratum had the highest annual prevalence initially in the two youngest age 
bands, but their use fell sharply and significantly in the years since then. In 2017 the annual 
prevalence among 19- to 22-year-olds was 3.7% and ranged from 0.8% to 1.5% among 
the other four strata. In the older age groups, use started from a lower level and generally 
has fallen in all community size strata as well, such that in 2017 annual prevalence ranged 
from 0.0% to 1.4% among 23- to 26-year-olds and 27- to 30-year-olds.
• In general, there have not been large differences in LSD use among young adults as a 
function of community size since 1983 (Figure 24 in Occasional Paper 91). Among 19-
to 22-year-olds (the young adult age group with by far the highest rates of LSD use prior 
to 2003), use in communities of all sizes declined appreciably in the early to mid-1980s, 
particularly in the urban strata, eliminating modest prior differences by 1984. From around 
1989 through 1996, there was some increase in LSD use in all population-density strata 
among 19- to 22-year-olds, with the most rural areas generally continuing to have the 
lowest prevalence of use. After 1997, there was some decline in LSD use in all 
community-size strata among 19- to 22-year-olds, followed by a sharp decline occurring 
from 2001 to 2003, with all strata moving in concert. Since 2011, there have been uneven 
increases in annual use among all strata. In 2017, prevalence ranged from 0.8% in 
farm/country to 4.4% in large cities. The 23- to 26-year-old respondents had some modest 
increases after 1989 in all community-size strata, though the increases had virtually ended 
by 1995. From about 1999 through about 2011, there were declines in all strata, with the 
largest decline occurring from 2001–2003 in most strata. (In Volume I in this series, we 
discussed how a sharp decline in supply may be responsible for the sizable decline in use 
among all ages after 2001.) Since about 2011, however, annual use has shown some 
unsteady increase through 2017, with annual prevalence in 2017 ranging from 1.9% in 
farm/country communities to 6.6% in very large cities. In the oldest age group, LSD use 
has remained very low and for the most part quite stable, but also with some decline after 
2001; until recently, there has been very little difference among the community size strata. 
Since about 2010 through 2017, annual use increased unevenly for all strata; in 2017 it 
ranged from 0.8% in small towns to 3.6% in the farm/country stratum.
• The use of hallucinogens other than LSD (Figure 27 in Occasional Paper 91), taken as 
a class, has also shown considerably higher rates in the youngest age band compared to 
the two older ones, suggesting a consistent sharp falloff in use with age—an age effect.
(The drug most often reported in this general class has been psilocybin or shrooms, as is 
true among 12th graders as well.) Use of this general class of drugs has tended to be highest 
in very large cities and lowest in farm/country communities across the years in the three 
age groups. Use fell in communities of all sizes among young adults between 1980 and 
about 1988. Among 19- to 22-year-olds, there was then a leveling of use for a few years, 
followed by an extended increase in use among all community-size strata. By 2003 the 
rates attained by each stratum exceeded those originally observed in 1980; there have been 
some declines and leveling since then in most strata. However, in the past few years, 
annual use has increased unevenly for those in very large cities, reaching 7.1% in 2017
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(and ranging between 1.2% and 3.5% for the other four strata). The 23- to 26-year-old 
group showed slightly rising rates of use between 1998 and 2004, followed by some 
uneven leveling through 2017. Sharp increases occurred in the very large cities in 1999 
and 2000, in 2010, and 2017; in 2017, annual use was 5.8% in very large cities and 3.0% 
to 3.1% in the other four strata. The 27- to 30-year-olds have generally had low rates of 
use, and the trend lines were very flat with only minor community-size stratum differences 
until 2001, when all strata, especially the very large cities, began to increase before 
showing some uneven leveling after 2005 through 2017. However, since 2012 and through 
2017, there has been an uneven increase in annual use in the very large city stratum, 
reaching 4.3% in 2017 (and ranging between 0.8% and 2.7% in the other four strata). 
Thus, both LSD and hallucinogens other than LSD have been showing a particular 
increase in use in the very large cities among young adults generally. 
• Salvia (or salvia divinorum) use was first measured in 2009 and has shown somewhat 
irregular trend lines since then (Figure 33 in Occasional Paper 91). The overall picture is 
clearly one of decreasing use since 2009 in the youngest age-group and since 2010 in the 
middle age-group. Annual prevalence rates started out highest in the farm/country stratum 
among the two younger age groups; but use fell sharply in all strata and in all age groups 
by about 2012 and is now very low for this drug across all population density strata and 
age groups; in 2017, it ranged from 0.0% to 2.7% among 19- to 22-year-olds, it was less 
than 0.5% across all strata among the 23- to 26-year-olds, and it ranged from 0.0% to 1.0%
among the 27- to 30-year-olds.
• MDMA (Ecstasy and more recently Molly) use was first measured in 1989, and since then 
has shown some of the largest short-term changes of any drug among young adults (Figure 
30 in Occasional Paper 91). Among 19- to 22-year-olds annual use in 1989 was highest 
in the very large cities (5% annual prevalence), but declined in all population-density 
strata between 1989 and 1994 (to 1.6% or less). By 1998, use had begun to increase in all 
community-size strata within this age band, except in the farm/country stratum. The 
farm/country stratum moved up sharply in 1999, but then the three most urban strata 
jumped sharply in 2000, opening a fair gap in use with large and very large cities having 
rates nearly twice as high as any of the other strata in 2002. All community-size strata 
showed large declines in ecstasy use after 2000 or 2001, which lasted through 2004, 
narrowing the differences among them. In 2011, ecstasy use in the very large cities rose 
sharply and has stayed highest there in the years since, with the other strata showing some 
leveling or uneven decline; in 2017, annual use was lowest in the farm/country stratum at 
1.3% and highest in very large cities at 5.7%. Among the 23- to 26-year-olds, all 
population-density strata increased from about 1994 through 2000 (with a large increase 
among very large cities to 15%), then declined, or at least remained level, through 2003, 
and then stayed level through 2008 when differences by community size were negligible 
(ranging between 2.2% and 3.5%). After 2008 through 2017, annual use began to diverge 
among the communities, with use rising for very large cities and leveling or declining 
unevenly for the other strata; in 2017, annual prevalence among 23-26 year-olds was 8.9%
for very large cities and 3.1% to 4.8% for the other four strata. Considerably less increase 
in ecstasy use occurred among 27- to 30-year-olds, though there was some increase in the 
largest cities starting after 1996 and in the large and medium-sized cities after 1999. From
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1997 through 2005 the very large cities stood out as having the highest rates of ecstasy 
use, but the differences were modest through 2012. Between 2012 and 2017, annual 
prevalence again started to rise among very large cities but tended to level or decline for 
the other four strata; in 2017, use was 6.3% in very large cities and 1.3% to 2.0% in the 
other four strata. It thus appears that over the past several years ecstasy use has made a 
comeback among young adults in the country’s very large cities. 
Ecstasy use trends tell an interesting story. In very large cities use peaked in all three age 
bands in 2000 and then began to decline. The medium-sized cities were beginning to level 
or decline by 2001 in the two younger age bands. The small town and farm/country strata 
peaked in 2001 in all age groups. These data support our belief, based on school-level 
analyses of secondary schools, that the presence of this drug was still diffusing 
geographically—in this case, from more urban to more rural areas—and, were it not for 
this continued diffusion, ecstasy use would actually have begun to decline nationally a 
year earlier. The data from 12th graders on perceived risk provide the clue as to the most 
likely cause of this turnaround; they showed a large jump in the level of perceived risk 
associated with ecstasy use from 2000 through 2003. Unlike most other drugs discussed 
here, the pattern of change since the mid-1990s appears to reflect secular trends rather 
than cohort effects, with all age groups moving largely in parallel—that is, until the recent 
resurgence of use in the very large cities which has been staggered across the age bands 
largely consistent with a cohort effect.   
• In the early 1980s, cocaine use was positively correlated with population density, with the 
highest use in the very large cities (Figure 36 in Occasional Paper 91). The important 
drop in cocaine use that began after 1986 slowed considerably after 1992 or 1993 in all 
three age strata and in communities of all sizes, by which time the positive association 
with population density had been virtually eliminated. Among 19- to 22-year-olds there 
was a slow sustained increase in cocaine use among all community-size strata after about 
1993 or 1994, and among 23- to 26-year-olds after about 1998. There was some decline 
in the mid-2000s in all strata except large cities, which showed a decline in subsequent 
years. As just stated, usage rates among the population-density strata tended to converge 
considerably during the period of decline; this convergence remains, except for the very 
large cities, which since 2007 have shown rates of cocaine use somewhat higher than the 
less densely populated areas in all three age bands. In the 27- to 30-year-old age group, a 
gradual increase in use emerged in nearly all population-density strata after 2000, no doubt 
reflecting a cohort effect working its way up the age spectrum. By 2004, all of the strata 
in the oldest age band leveled or declined from their peak rates; the single exception was 
very large cities, where use remained relatively high and even increased through 2015. In 
2016 and 2017, the very large cities showed some leveling or modest increases for the 
youngest and oldest age bands (to 7.8% and 8.5%, respectively in 2017); among the 23-
to 26-year-olds, it declined significantly in 2016 and increased significantly in 2017 to 
15.3%. The farm/country stratum has tended to have the lowest rates of cocaine use 
throughout and in all three age groups.
• Crack use among all age groups peaked in 1987 or 1988 (strongly suggesting a secular
trend at work at that time) and then, after declining appreciably, bottomed out in most all
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population-density strata for several years through 2017 (Figure 39 in Occasional Paper 
91). Use reported in these young adult samples at all three age levels has borne practically 
no systematic association with community size, and for the most part the strata have all 
tended to move in parallel, with the youngest age band tending to be highest in the 
farm/country stratum in many of the years. In 2017, annual prevalence was at or below 
0.3% across all strata in the older two age bands, and among 19- to 22-year-olds use was 
at or below 2.2% in all strata. Clearly, as we have indicated in other chapters in this 
volume, crack cocaine may have become all but forgotten among young adults who are 
high school graduates. 
• Amphetamine use showed virtually no differences associated with urbanicity in any of 
the three age groups through about 2008, with some differences occurring since through 
2017, with annual use generally lowest in the farm/country stratum and highest in very 
large cities (Figure 54 in Occasional Paper 91). The trend curves were highly similar for 
all levels of population density within each young adult age group, with the single 
exception that among the 23- to 26-year-olds of the five strata the three urban strata 
exhibited the greatest increase in amphetamine use after 2008; they were joined by the 
small town stratum in 2012, leaving the farm/country stratum with the lowest rate of use 
through 2017. Also, the 19- to 22-year-olds in the very large cities showed a sharp increase 
in use in 2013 and 2014, with annual prevalence reaching 14.6% in 2014, compared to 8.0 
to 10.1% in the other age strata; use in very large cities in this age group declined in 2015 
and 2016, leveling in 2017 (in 2017, use ranged from 5.7% in small towns to 10.4% in 
large cities). A similar pattern occurred for the 23- to 26-year-olds, with use tending to 
increase among very large cities and large cities and declining or leveling for the other 
three strata; in 2017 use ranged from 3.1% in the farm/country stratum to 13.8% in very 
large cities. For 27- to 30-year-olds, use has generally leveled for farm/country and small 
town strata and increased unevenly for the city strata; in 2017, use ranged from 5.0% for 
small towns to 8.4% for very large cities.
• Due to limited sample sizes, estimates of the use of crystal methamphetamine (ice) as a 
function of population density have been quite erratic across time in all three age groups, 
particularly in the earlier years of collecting such data (Figure 64 in Occasional Paper 
91). Since 2007, annual use has been relatively low in all strata and age bands and in 2017, 
very low use was found across all strata in the three age groups (between 0.0% and 2.0%); 
the exception is the increase to 5.1% in 2017 among 19- to 22-year-olds in the 
farm/country stratum. Since the late 1990s, through about 2013 to 2015, the farm/country 
and small town segments have tended to show the highest rates of crystal 
methamphetamine use in the two older age bands.
• The use of methamphetamine in any form has been measured only since 1999 (Figure 61 
in Occasional Paper 91). In general, the farm/country stratum has shown higher than 
average rates of use in the two youngest age groups, with higher rates in particular from 
2001 to 2005 among 19- to 22-year-olds and from 2004 to 2007 among the 23- to 26-year-
olds. Among the 27- to 30-year-olds the farm/country stratum was highest from 2009 to 
2013, suggesting a cohort effect at work in that rural stratum. Otherwise there has been 
little systematic difference. Among 19- to 22-year-olds, all community-size strata have
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shown substantial declines in annual use since 2003 or 2004, reaching very low levels by 
2007 through 2017 at 2% or lower; the exception is that use increased to 4.4% in the 
farm/country stratum in 2017 (versus 0.0% to 1.7% in the other four strata). Annual use 
has declined some over the same interval among 23- to 26-year-olds (2017 prevalence 
ranged from 0.0% to 1.1%). Among 27- to 30-year-olds annual use generally declined 
from 2002 to 2006 in all population-density strata; after 2009, this group showed a slight 
rebound in use, particularly in the farm-country stratum already mentioned; 2017 
prevalence ranged from 0.0% to 1.2%.  
• Bath salts were added to the study in 2012, so trends are available only since then (Figure 
67 in Occasional Paper 91). They showed a high prevalence of annual use (6.5% annual 
prevalence) in 2012 in the farm/country stratum among 19- to 22-year-olds, but a 
significant decline in 2013 such that there have been practically no differences among the 
different levels of population density in the years since; the exception is that use increased 
to 4.5% in the farm/country stratum in 2017 (versus 0.0% to 0.8% in the other four strata). 
Among 23- to 26-year-olds, annual use started highest in 2012 in small towns and 
farm/country areas, but dropped there the next year; in 2017, annual prevalence ranged 
from 0.0% to 0.5%. Use among 27- to 30-year olds has been negligible all along, with 
annual prevalence ranging between 0.0% and 0.9% across all strata since 2012. These 
findings suggest that this type of drug use tended to be concentrated among younger 
people and in more rural areas; otherwise the use of bath salts is almost nonexistent.
• Note: Methaqualone was dropped from the study in 1990. Methaqualone use, which in
1981 was strongly positively associated with population density, dropped to annual
prevalence rates of 0.8% or below in all community-size strata for all three age bands by
1989. For that reason, its use is no longer measured in MTF.
• Unlike methaqualone, sedatives (barbiturates) have never shown much variation by 
population density, at least as far back as 1980, with trends showing gradual declines 
(through about 1992, 1995, and 2000 for the three age groups, respectively), then increases 
(through about 2002, 2004, and 2007 for the three age groups, respectively), and more 
recently gradual declines or leveling. (Figure 70 in Occasional Paper 91). This remained 
true in all three age bands through 2017, with the single exception that among 19- to 22-
year-olds use in the farm country areas emerged as highest between 2011 and 2014. 
Otherwise the trends have been similar within each age band. In 2017, annual use across 
all strata in the three age groups was below 4%. The sequences of change among the age 
bands are consistent with cohort effects.
• Tranquilizer use among young adults has also had little or no association with population 
density over the time interval under study (Figure 73 in Occasional Paper 91). Like 
sedatives (barbiturates), there was an earlier period of decline, staggered inflection points, 
a long period of gradual increase, and then a leveling staggered up the age band from 
about 2003–2005 through 2017. In recent years, tranquilizer use has tended to be 
somewhat lower in the farm/country stratum in the three age groups, but otherwise, there 
have been few consistent differences among the strata. In 2017, annual use across all strata 
in the three age groups ranged between 3% and 7%.
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• From 1980 to 1995, annual heroin prevalence was less than 1.0%—usually much less—
in all population-density strata for all three age bands (Figure 42 in Occasional Paper 91). 
After 1994, use among 19- to 22-year-olds in all community-size strata rose and reached 
1.0% in the three most urban strata by 1998. In fact, in the very large cities, it reached 
2.1% in 2000 (vs. 0.3–0.6% in the other strata). Use levels have been lower among 23- to 
26-year-olds and lower still among 27- to 30-year-olds, making it difficult to discern 
systematic differences among the population-density strata in those age bands. In 2017 
the annual prevalence of heroin was 0.9% or lower in all community-size strata for all 
three young adult age bands, and it was much lower in most.
• The annual use of narcotics other than heroin (Figure 45 in Occasional Paper 91) had 
some positive association with population density among 19- to 22-year-olds through the 
early 1990s; however, it has shown rather little systematic association since then. Use of 
narcotics other than heroin increased substantially in all community-size strata after 1993 
in the case of 19- to 22-year-olds, after about 1996 in the case of 23- to 26-year-olds, and 
after about 1998 in the case of 27- to 30-year-olds; however, no systematic differentiation 
by community size was evident during those periods of increasing use. Clearly a cohort 
effect was at work, and the increasing use of these drugs was quite widespread. Use 
leveled off since about 2004 in the youngest age band, 2006 in the middle age band, and 
2007 in the oldest age band. In the past few years, annual use continued to level or decline 
for most strata across the age groups, with the exception of some nonsignificant increase 
among the two older age bands in very large cities to 8.1% and 6.9%, respectively, in 2016 
(levels for others ranged from 4% to 6%). In 2017, use continued to decline or level in all 
age groups in all population density strata, with annual prevalence ranging between 1.7%
and 5.5%. Still, use remains at considerably higher levels, particularly in the two older 
age bands, than was true back in the 1980s and early 1990s.
• Sample sizes for two of the narcotic drugs of particular interest, OxyContin and Vicodin, 
are not sufficient to estimate population-density differences or trends with a reasonable 
degree of accuracy (Figures 48 and 51 in Occasional Paper 91).
• The absolute levels of inhalant use have remained low in these age groups, particularly 
above age 22 (Figure 19 in Occasional Paper 91). However, during the mid- to late 1980s, 
there was a gradual increase in use among 19- to 22-year-olds in all community-size strata. 
No strong or consistent association with population density has appeared, though the very 
large cities have not infrequently had higher rates than the other areas among 19- to 22-
year-olds, particularly in the period 1998 through 2000. Among both the 19- to 22-year-
olds and the 23- to 26-year-olds, there has been some falloff in inhalant use since the late 
1990s through 2017 in all population-density levels. In 2017, annual use was between 
0.0% and 2.6% in all strata across the age groups.
• Limitations in sample sizes make estimation of differences and trends as a function of 
population density difficult for the club drugs GHB (Figure 78 in Occasional Paper 91) 
and Ketamine (Figure 81 in Occasional Paper 91).
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• There have been few differences as a function of population density in the annual and 30-
day prevalence of drinking alcohol among 19- to 22-year-olds since data were first 
available in 1980, except that the farm/country stratum has tended to have lower-than-
average use across the years; in 2017, 30-day use was 53% for the farm/country stratum 
and 59% to 64% in the other strata (Figures 87 and 88 in Occasional Paper 91). In the 
two older age bands, however, there has been a fairly consistent positive correlation 
between population density and use of alcohol in the past 30 days—though not a very 
strong one. In 2017, 30-day use ranged from 67% in the farm/country stratum to 83% in 
very large cities among 23- to 26-year olds; and among 27- to 30-year-olds, it ranged from 
64% in medium cities to 80% in very large cities. Trends have been fairly parallel for all 
strata in all age bands. There have also been no consistent trend differences in current 
daily drinking associated with population density in any of the three age bands, though 
since the early 2000s the very large cities have tended to have the highest rates among the 
two older age groups (Figure 89 in Occasional Paper 91).
• For binge drinking or occasions of heavy drinking (Figure 90 in Occasional Paper 91), 
all community-size strata have been fairly close across time, with few consistent 
population density differences at all three age levels (exceptions noted below). Among 
19- to 22-year-olds, the farm/country stratum has fairly consistently shown a lower 
prevalence of binge drinking across the years. Binge drinking has declined for all groups 
since about 2007, with prevalence in 2017 ranging from 26% in the farm/country stratum 
to 34% in large cities. Among 23- to 26-year olds, the farm/country stratum has also 
tended to have the lowest binge drinking across the years, and very large cities having the 
highest, particularly since about 2002. Differences among the strata started to expand in 
2007 and converged again in 2014, with the differences in binge drinking ordinal across 
the five strata. Between 2014 and 2017, binge drinking increased for very large cities, and 
leveled or declined for the other strata; prevalence in 2017 ranged from 19% for the 
farm/country stratum and 47% for very large cities, with the other strata ranging from 28%
to 34%. Among the 27- to 30-year olds, binge drinking has tended to be highest in very 
large cities across the years, particularly since about 2002. Differences among the strata 
began to emerge in 2006, with binge drinking rising in very large and large cities through 
2013/2014, and leveling or declining for the other strata. Prevalence in 2017 ranged from 
25% in small towns to 40% in very large cities. To summarize, binge drinking has tended 
to be lowest in the farm/country stratum in all three age bands, and has risen among very 
large cities in the two older age bands since the early 2000s, with greater differences 
emerging as a function of population density.
• Cigarette smoking has generally been negatively associated with population density in all 
three age strata, without much evidence of differential trends related to population density 
(Figures 95, 96, and 97 in Occasional Paper 91). There is one exception: Among 19- to 
22-year-olds, all smoking prevalence measures rose from 1997 through 1999 in the 
farm/country and small town strata, while in most other strata they remained level. The 
differences in 1999 were most striking for half-pack-a-day smoking among the 19- to 22-
year-olds—24% for farm/country, 19% for small town, 15% for both medium-sized and 
large cities, and 10% for very large cities. Compare this with 1985, when there was 
virtually no difference in half-pack-a-day smoking rates among these strata (all were at
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18% or 19%). Thus, smoking among those in their early 20s became more concentrated 
in the nonurban populations. In fact, among 19- to 22-year-olds, the farm/country stratum 
has usually had the highest rate of daily smoking since 1986, and the small town stratum 
has generally ranked second since then. As smoking has declined in all strata in the 
youngest group, this difference has diminished, though not so much in the older two age 
bands. Among the two older age groups, the farm/country stratum has been highest more 
often than not. Among 19- to 22-year-olds, there has been a decline in 30-day prevalence 
in most population density strata since about 2000 or 2001, down in 2016 to 10% in very 
large cities and 18% in farm/country communities, and among 23- to 26-year-olds since 
2005, down in 2016 to 10% in large cities and 19% in farm/country communities; 
prevalence has been declining among 27- to 30-year-olds since about 2009, down in 2016 
to 12% in very large cities and 17% in farm/country communities. These staggered recent 
declines across communities are consistent with cohort effects. Note also that 
differentiation among the different population density strata is greatest for half-pack-a-
day smoking, particularly among the oldest age stratum. 
As noted above, the 2017 evidence suggests that cigarette smoking may be leveling for 
young adults. With regard to population density, there is some evidence to support this 
among some of the strata among the two younger age bands. Among 19- to 22-year-olds, 
30-day use increased nonsignificantly for four of the five strata: for farm/country, it 
increased 1.7 percentage points to 19.6%; for small towns, it increased 2.8 percentage 
points to 15.4%; for large cities, it increased 3.5 percentage points to 13.6%; and for very 
large cities, it increased 6.8 percentage points to 16.7%. In medium size cities, it 
significantly decreased 4.7 percentage points to 8.8%. Similarly, daily smoking for this 
age group increased for the same four strata in 2017, significantly so for very large cities. 
Among the 23- to 26-year-olds, 30-day use increased for three of the strata: for 
farm/country, it increased nonsignificantly 7.6 percentage points to 27.0%; for large cities, 
it increased significantly 5.5 percentage points to 15.8%; and for very large cities, it 
increased nonsignificantly 3.2 percentage points to 19.3%. In small towns and medium 
cities, 30-day cigarette use decreased nonsignificantly to 16.7% and 14.4%, respectively. 
Similarly, daily smoking for this age group increased nonsignificantly for the 
farm/country stratum and large cities, and decreased nonsignificantly for the other three 
strata. However, among the 27- to 30-year-olds, both 30-day and daily smoking continued 
to decline in all strata (though 30-day use did increase nonsignificantly 0.6 percentage 
points in the farm/country stratum).  
• Smoking using a hookah has been measured since 2011 (Figure 100 in Occasional Paper 
91), and its use has tended to be positively correlated with population density for all age 
groups. Annual use has been declining among 19- to 22-year olds, and this decline 
continued in 2017 for the middle three strata with significant declines in each. For the two 
older age groups, use either leveled or declined nonsignificantly in 2017, consistent with 
recent trends in these two age groups.
• Use of small cigars has not differed much as a function of population density, and use has 
been fairly flat in all strata since first measured in 2011 (Figure 103 in Occasional Paper
91). 
177
Chapter 5: Trends in Drug Use
• Use of dissolvable tobacco (Figure 106 in Occasional Paper 91) has tended to be very 
low in all strata.
• Use of snus, specifically, has also tended to be quite low, but again with the farm/country 
stratum tending to be highest, particularly in the youngest age group, though their usage 
level has been falling fast (Figure 109 in Occasional Paper 91).
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Any Illicit Drug a 70.5 69.9 67.9 66.4 64.5 62.2 60.2 59.6 57.5 57.4 56.4 56.7 57.0 57.4 58.2 58.1 59.0 60.2 60.5 60.4 59.7 59.8 59.3 59.3 58.4 59.1 58.9 60.0 62.2 62.9 62.8 64.0 +1.2 +5.1 sss
Any Illicit Drug
  other than Marijuana a 48.4 47.0 44.6 42.7 40.8 37.8 37.0 34.6 33.4 32.8 31.0 30.5 29.9 30.2 31.3 31.6 32.8 33.9 35.2 34.0 34.8 34.2 34.7 32.8 33.3 33.2 32.8 34.0 37.3 36.8 36.2 36.8 +0.6 +4.0 sss
Marijuana 66.5 66.0 63.8 62.8 60.2 58.6 56.4 55.9 53.7 53.6 53.5 53.8 54.4 54.6 55.1 55.7 56.8 57.2 57.4 57.0 56.7 56.7 55.9 56.0 55.9 56.3 56.5 57.1 57.5 58.5 58.7 60.1 +1.4 +3.6 ss
Inhalants b 12.3 12.7 12.6 13.2 12.5 13.4 13.5 14.1 13.2 14.5 14.1 14.1 14.2 14.2 14.3 12.8 12.4 12.2 11.6 10.3 10.9 9.1 9.5 8.9 7.9 7.2 7.2 6.5 6.7 6.4 6.3 5.2 -1.1 -2.0 ss
  Nitrites c 2.6 6.9 6.2   — 1.9 1.4 1.2 1.3 1.0   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — — —
Hallucinogens d,y 18.5 17.1 17.0 15.9 16.1 15.7 15.7 15.4 15.4 16.1 16.4 16.7 17.4 18.0 18.4 18.3 19.6 19.7 19.3 17.6 17.2 16.0 14.8 14.2 13.9 13.0 12.2 12.4 11.9 11.7 12.2 12.9 +0.7 +0.7
  LSD y 14.6 13.7 13.8 12.7 13.5 13.5 13.8 13.6 13.8 14.5 15.0 15.0 15.7 16.2 16.4 16.0 15.1 14.6 13.4 11.2 10.1 9.6 8.1 7.3 7.2 6.1 6.2 6.3 6.6 7.0 8.0 8.8 +0.8 +2.6 sss
  Hallucinogens
    other than LSD d,y 12.6 11.4 10.6 9.4 9.1 8.4 8.0 7.6 7.4 7.8 7.9 8.4 9.4 9.3 9.9 12.0 15.0 16.4 15.6 15.4 14.9 14.1 13.0 13.0 12.6 12.1 11.1 11.4 10.8 10.4 10.6 10.6 0.0 -0.5
  PCP e 8.4 4.8 5.0   — 2.5 3.1 2.0 1.9 2.0 2.2 1.9 2.4 2.7 2.3 2.3 3.1 2.5 3.0 2.7 2.0 2.4 2.1 2.2 1.6 1.6 1.7 1.1 1.4 0.6 1.2 1.9 0.3 -1.5 ss -0.8
  MDMA (Ecstasy, Molly) z, original   —   —   — 3.3 3.7 3.2 3.9 3.8 3.8 4.5 5.2 5.1 7.2 7.1 11.6 13.0 14.6 15.3 16.0 14.9 14.4 13.1 13.1 11.5 12.3 11.3 11.4 11.6 11.4   —   —   —   —   —
Revised   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 12.5 12.9 12.5 12.6 +0.1 —
Cocaine 32.0 29.3 28.2 25.8 23.7 21.0 19.5 16.9 15.2 13.7 12.9 12.0 12.3 12.8 12.7 13.1 13.5 14.7 15.2 14.3 15.2 14.7 14.8 13.9 13.6 12.5 11.9 12.2 11.7 12.1 10.4 11.2 +0.8 -0.7
  Crack g   — 6.3 6.9 6.1 5.1 4.8 5.1 4.3 4.4 3.8 3.9 3.6 3.8 4.3 4.6 4.7 4.3 4.7 4.2 4.1 4.4 3.9 4.3 3.3 3.6 2.9 2.7 2.6 2.1 1.8 1.2 1.2 0.0 -1.5 sss
  Other Cocaine h   — 28.2 25.2 25.4 22.1 19.8 18.4 15.1 13.9 12.4 11.9 11.3 11.5 11.8 11.7 12.1 12.8 13.5 14.4 13.3 14.4 14.0 13.9 13.5 13.1 12.2 11.8 11.8 11.6 11.8 11.9 12.6 +0.7 +0.8
Heroin 1.3 1.3 1.1 1.0 0.9 0.9 0.9 0.9 0.8 1.1 1.3 1.3 1.6 1.7 1.8 2.0 1.8 1.9 1.9 1.7 1.9 1.6 1.9 1.6 1.8 1.7 1.6 1.6 1.4 1.6 1.6 1.4 -0.2 -0.2
  With a Needle i   —   —   —   —   —   —   —   —   — 0.4 0.4 0.3 0.4 0.6 0.4 0.6 0.4 0.5 0.4 0.6 0.6 0.5 0.5 0.5 0.8 0.7 0.5 1.0 0.7 0.7 0.7 0.8 +0.1 +0.2
  Without a Needle i   —   —   —   —   —   —   —   —   — 1.0 1.4 1.5 1.7 1.9 2.1 2.1 1.8 2.2 2.1 1.8 2.4 1.9 2.1 1.9 1.8 1.6 1.7 1.8 1.2 1.8 1.5 1.5 0.0 -0.2
  Narcotics other than Heroin j,k 10.7 10.6 9.8 9.6 9.4 9.3 8.9 8.1 8.2 9.0 8.3 9.2 9.1 9.5 10.0 11.5 13.9 16.8 17.6 17.8 18.7 18.8 19.5 18.5 19.0 18.2 17.6 17.4 16.3 15.0 14.3 13.4 -0.8 -4.2 sss
Amphetamines, Adjusted j,l 32.3 30.8 28.8 25.3 24.4 22.4 20.2 18.7 17.1 16.6 15.3 14.6 14.3 14.1 15.0 15.0 14.8 15.2 15.9 14.6 15.6 15.3 14.6 14.9 16.1 16.5 17.4 18.8 18.7 18.8 18.7 18.2 -0.5 +0.7
  Methamphetamine i   —   —   —   —   —   —   —   —   —   —   —   —   — 8.8 9.3 9.0 9.1 8.9 9.0 8.3 7.3 6.7 6.3 4.7 4.3 3.2 3.5 3.1 2.3 2.4 2.2 2.6 +0.4 -0.9
  Crystal Methamphetamine (Ice) i   —   —   —   — 2.5 2.9 2.2 2.7 2.5 2.1 3.1 2.5 3.4 3.3 3.9 4.0 4.1 4.7 4.7 4.4 4.7 3.7 3.6 3.4 2.8 3.1 2.6 2.8 1.7 2.2 1.8 1.8 0.0 -0.8
↓
TABLE 5-1
Trends in Lifetime Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
(Table continued on next page.)
2016– 
2017 
change
2012– 
2017 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Sedatives (Barbiturates) j,u 11.1 9.7 8.9 7.9 8.7 8.2 7.4 6.5 6.4 6.7 6.6 6.5 6.9 7.4 8.1 7.8 8.0 8.7 9.7 10.0 9.5 9.8 10.6 9.5 8.6 7.9 7.2 9.5 9.0 8.3 7.4 6.4 -1.0 -0.8
  Sedatives, Adjusted j,m 16.7 15.0 13.2 12.1   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
  Methaqualone j 13.1 11.6 9.7 8.7   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Tranquilizers d,j 17.6 16.5 15.1 13.5 12.9 11.8 11.3 10.5 9.9 9.7 9.3 8.6 9.6 9.6 10.5 11.9 13.4 13.8 14.9 14.5 15.0 14.5 15.8 13.8 14.3 13.8 13.3 13.2 12.5 12.8 12.4 12.4 -0.1 -0.9
Alcohol n 94.8 94.9 94.8 94.5 94.3 94.1 93.4 92.1 91.2 91.6 91.2 90.7 90.6 90.2 90.7 89.9 90.2 89.3 89.4 89.1 88.9 87.9 88.4 87.9 87.5 87.4 86.5 86.2 86.3 85.7 85.9 85.2 -0.7 -1.2
  Been Drunk o   —   —   —   —   — 82.9 81.1 81.4 80.7 82.1 80.7 81.4 79.8 81.6 80.4 81.1 81.2 80.9 80.1 79.9 80.9 80.1 80.1 78.2 79.0 78.9 78.9 77.4 78.3 76.4 75.2 75.4 +0.2 -3.5 ss
  Flavored Alcoholic Beverages p   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 83.2 84.6 84.4 84.0 82.6 83.5 81.4 82.2 82.4 80.9 80.6 81.0 79.9 79.2 -0.6 -3.2
Cigarettes   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Any Vaping i,aa   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 30.3 26.9 34.3   —   —
  Vaping Marijuana i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 17.2   —   —
  Vaping Nicotine i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 24.8   —   —
  Vaping Just Flavoring i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 21.4   —   —
Steroids q   —   —   — 1.1 1.2 1.7 1.9 1.5 1.3 1.5 1.5 1.4 1.4 1.9 1.4 1.4 1.6 1.8 1.9 1.8 1.8 1.7 1.8 1.8 1.7 1.3 1.7 1.2 1.7 1.6 1.4 1.4 0.0 -0.3
Source. The Monitoring the Future study, the University of Michigan.
See footnotes following Table 5-4.
TABLE 5-1 (cont.)
2016– 
2017 
change
2012– 
2017 
change
Trends in Lifetime Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
  Crystal Methamphetamine (Ice) i
180
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Any Illicit Drug a 41.9 39.3 36.3 32.8 30.7 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 32.1 32.5 33.8 33.3 33.2 34.7 34.0 36.7 37.5 39.2 39.7 41.2 +1.5 +7.2 sss
Any Illicit Drug
  other than Marijuana a 27.0 23.9 21.3 18.3 16.7 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 18.4 18.1 18.9 17.4 18.5 17.6 17.2 18.1 21.2 19.5 19.9 20.1 +0.2 +2.9 ss
Marijuana 36.5 34.8 31.8 29.0 26.1 23.8 25.2 25.1 25.5 26.5 27.0 26.8 27.4 27.6 27.9 29.2 29.3 29.0 29.2 28.2 27.7 28.5 28.6 29.3 28.7 31.0 30.2 32.2 31.6 34.0 35.3 37.5 +2.2 +7.3 sss
Synthetic Marijuana v   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 7.4 5.3 3.2 1.3 1.5 1.0 0.9 -0.1 -4.3 sss
Inhalants b 1.9 2.1 1.8 1.9 1.9 2.0 1.9 2.1 2.1 2.4 2.2 2.3 2.1 2.3 2.1 1.7 1.6 1.4 1.7 1.3 1.3 0.8 1.4 0.9 1.2 0.8 1.1 0.5 1.1 0.9 0.9 0.7 -0.1 -0.4
  Nitrites c 2.0 1.3 1.0   — 0.4 0.2 0.1 0.4 0.3   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Hallucinogens d,y 4.5 4.0 3.9 3.6 4.1 4.5 5.0 4.5 4.8 5.6 5.6 5.8 5.2 5.4 5.4 5.4 4.7 5.2 4.7 4.5 4.1 3.8 3.8 3.9 4.2 3.7 3.6 3.9 4.1 4.2 4.6 4.8 +0.1 +1.2 ss
  LSD y 3.0 2.9 2.9 2.7 3.3 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 1.2 0.9 0.8 1.2 1.1 1.4 1.7 1.5 1.7 1.6 2.0 2.2 2.6 3.1 3.4 +0.3 +1.8 sss
  Hallucinogens
    other than LSD d,y 2.5 2.1 1.9 1.8 1.7 1.7 1.9 1.9 2.0 2.5 2.8 3.1 3.0 3.0 3.4 3.5 4.0 4.9 4.5 4.2 3.8 3.6 3.4 3.3 3.7 3.2 2.9 3.2 3.1 3.0 3.0 3.0 0.0 0.0
  PCP e 0.8 0.4 0.4   — 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.5 0.6 0.6 0.3 0.6 0.3 0.3 0.1 0.6 0.2 0.3 0.4 0.1 0.2 0.3 0.0 0.2 0.1 0.0 0.4 0.1 -0.3 0.0
  MDMA (Ecstasy, Molly) z, original   —   —   — 1.4 1.5 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 4.5 3.5 3.0 3.0 2.5 3.3 3.1 3.5 3.6 4.1 4.2 4.8   —   —   —   —   —
Revised   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 5.1 4.4 5.1 3.6 -1.5 ss   —
  Salvia w   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 3.5 3.6 2.2 1.4 0.9 1.2 0.6 0.8 0.5 -0.3 -0.9 s
Cocaine 19.7 15.7 13.8 10.8 8.6 6.2 5.7 4.7 4.3 4.4 4.1 4.6 4.9 5.4 5.4 5.8 5.8 6.6 7.1 6.9 6.6 6.2 6.0 5.2 4.7 4.7 4.1 3.9 5.0 5.7 4.9 5.3 +0.3 +1.2 ss
  Crack g 3.2 3.1 3.1 2.5 1.6 1.2 1.4 1.3 1.1 1.1 1.1 1.0 1.1 1.4 1.2 1.3 1.0 1.0 1.3 1.2 1.1 1.0 0.9 0.7 0.5 0.6 0.5 0.3 0.4 0.4 0.0 0.2 +0.2 -0.3
  Other Cocaine h   — 13.6 11.9 10.3 8.1 5.4 5.1 3.9 3.6 3.9 3.8 4.3 4.5 4.8 4.8 5.3 5.6 6.1 6.4 6.3 5.9 5.6 5.5 5.0 4.8 4.3 4.0 1.0 4.8 5.4 5.9 5.9 -0.1 +1.9 sss
Heroin 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.3 0.4 0.4 0.3 0.5 0.6 0.5 0.5 0.5 0.6 0.4 0.5 0.4 0.4 0.0 -0.1
  With a Needle i   —   —   —   —   —   —   —   —   — 0.1 0.1 0.1 0.1 0.1 * 0.3 * * 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.4 0.3 0.3 0.2 0.2 0.3 0.2 -0.1 -0.1
  Without a Needle i   —   —   —   —   —   —   —   —   — 0.3 0.4 0.4 0.6 0.6 0.5 0.9 0.2 0.4 0.3 0.4 0.5 0.3 0.4 0.6 0.4 0.2 0.4 0.7 0.3 0.5 0.4 0.3 -0.1 -0.1
Narcotics other than Heroin j,k 3.1 3.1 2.7 2.8 2.7 2.5 2.5 2.2 2.5 3.0 2.9 3.3 3.4 3.8 4.1 5.0 7.1 8.5 9.0 8.7 9.1 8.7 9.1 8.4 9.0 7.9 7.3 7.0 6.3 5.2 5.2 4.0 -1.2 s -3.3 sss
  OxyContin j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 1.9 2.6 3.1 3.1 3.1 2.9 3.9 5.2 3.2 2.8 2.3 2.8 2.5 2.5 2.1 1.9 -0.1 -0.4
  Vicodin j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 8.2 8.6 8.9 9.3 9.1 8.9 9.1 8.9 7.8 7.1 6.3 6.2 4.8 3.8 2.7 2.7 0.0 -3.6 sss
Amphetamines, Adjusted j,l 10.6 8.7 7.3 5.8 5.2 4.3 4.1 4.0 4.5 4.6 4.2 4.6 4.5 4.7 5.4 5.8 5.9 5.8 6.2 5.1 5.6 5.6 5.3 6.0 7.1 7.2 7.8 7.5 8.0 7.9 7.2 7.8 +0.6 +0.1
  Ritalin j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 2.9 2.9 2.7 2.5 2.6 2.4 2.4 1.7 1.7 1.5 1.6 2.0 1.6 1.8 1.2 1.2 -0.0 -0.4
  Adderall j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 5.8 7.0 6.6 7.4 7.0 7.8 7.7 7.2 8.3 +1.1 +1.0
  Provigil j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.5 0.5 0.3   —   —   —   —   —   —   —   —
  Methamphetamine i   —   —   —   —   —   —   —   —   —   —   —   —   — 2.8 2.5 2.8 2.5 2.7 2.8 2.4 1.9 1.5 1.0 0.9 0.7 0.5 1.0 0.6 0.5 0.7 0.4 0.6 +0.2 -0.3
  Crystal Methamphetamine (Ice) i   —   —   —   — 0.4 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 1.3 1.5 1.6 1.1 1.1 0.8 0.8 0.5 0.5 0.6 0.8 0.3 0.5 0.1 0.7 +0.6 s +0.1
↓
(List of drugs continued.)
2012– 
2017 
change
TABLE 5-2
Trends in Annual Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
(Table continued on next page.)
2016– 
2017 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Bath Salts (synthetic stimulants) o   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.5 0.4 0.4 0.3 0.3 0.4 +0.1 -0.1
Sedatives (Barbiturates) j,u 2.3 2.1 1.8 1.7 1.9 1.8 1.6 1.9 1.8 2.1 2.2 2.4 2.5 2.8 3.4 3.7 3.9 3.9 4.4 4.2 3.9 4.2 4.7 3.8 3.3 3.2 2.7 3.4 3.2 2.7 2.6 2.2 -0.4 -0.5
  Sedatives, Adjusted j,m 3.0 2.5 2.1 1.8   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
  Methaqualone j 1.3 0.9 0.5 0.3   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Tranquilizers d,j 5.4 5.1 4.2 3.7 3.7 3.5 3.4 3.1 2.9 3.4 3.2 3.1 3.8 3.7 4.6 5.5 7.0 6.8 7.4 6.7 6.5 7.1 6.8 6.4 6.3 5.9 5.3 5.4 4.8 5.0 5.0 4.7 -0.3 -0.6
Rohypnol i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.3 0.5 0.1 0.1 0.2 0.3 0.2 0.1   —   —   —   —   —   —   —   —   —   —
GHB x   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.8 0.6 0.5 0.3 0.2 0.4 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.2   —   —   —   —
Ketamine x   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 1.2 0.9 0.6 0.5 0.5 0.3 0.4 0.5 0.8 0.5 0.8 0.5 0.4 0.7 0.7 0.5 -0.2 -0.3
Alcohol n 88.6 89.4 88.6 88.1 87.4 86.9 86.2 85.3 83.7 84.7 84.0 84.3 84.0 84.1 84.0 84.3 84.9 83.3 84.4 83.8 84.4 84.0 83.6 83.8 82.7 83.5 82.5 82.5 82.3 81.2 82.1 81.2 -0.8 -1.2
  Been Drunk o   —   —   —   —   — 62.0 60.9 61.1 58.8 61.6 59.9 63.2 59.6 63.2 60.6 63.1 61.8 62.9 63.8 63.5 65.7 65.8 66.0 65.5 64.8 64.0 64.6 63.1 63.5 61.2 61.0 60.9 -0.1 -3.7 s
   Flavored Alcoholic Beverages p   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 62.7 58.4 58.5 58.9 58.3 57.0 52.0 56.3 54.8 54.1 55.4 57.3 57.8 54.8 -3.0 0.0
   Alcoholic Beverages 
      containing Caffeine I,t   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 28.1 36.7 36.9 35.0 33.5 29.6 31.8 +2.2 -4.9 ss
Cigarettes 40.1 40.3 37.7 38.0 37.1 37.7 37.9 37.8 38.3 38.8 40.3 41.8 41.6 41.1 40.9 41.1 39.1 38.6 39.0 39.1 36.9 36.2 35.0 33.9 33.0 31.5 29.8 29.8 27.0 26.2 23.4 23.9 +0.5 -5.9 sss
   Small Cigars o   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 19.2 18.0 18.4 18.6 17.9 15.5 16.0 +0.5 -1.9
   Tobacco using a Hookah o   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 20.1 19.1 20.4 23.3 19.2 14.8 12.2 -2.6 s -6.9 sss
Any Vaping i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 23.0   —   —
  Vaping Marijuana i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 12.6   —   —
  Vaping Nicotine i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 14.4   —   —
  Vaping Just Flavoring i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 9.9   —   —
Dissolvable Tobacco i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.3 0.6 0.3 0.5 0.4 0.5 0.8 +0.3 +0.2
Snus i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 6.1 5.7 4.8 4.8 4.8 3.6 4.6 +1.0 -1.1
Steroids q   —   —   — 0.5 0.3 0.5 0.4 0.3 0.4 0.5 0.3 0.5 0.4 0.6 0.4 0.4 0.4 0.5 0.5 0.5 0.3 0.7 0.4 0.7 0.8 0.2 0.4 0.5 0.7 0.5 0.4 0.3 -0.1 -0.1
Source. The Monitoring the Future study, the University of Michigan.
See footnotes following Table 5-4.
2012– 
2017 
change
TABLE 5-2 (cont.)
Trends in Annual Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
2016– 
2017 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Any Illicit Drug a 25.8 23.4 20.5 17.7 15.9 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 18.5 18.9 19.3 19.8 18.9 20.6 19.9 21.6 22.3 23.2 23.5 24.7 +1.2 +4.8 sss
Any Illicit Drug
  other than Marijuana a 13.0 10.7 9.5 7.5 6.0 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8.3 8.5 8.2 8.1 8.6 8.9 8.5 8.6 8.4 7.8 8.3 9.9 8.7 9.2 8.7 -0.5 +0.9
Marijuana 22.0 20.7 17.9 15.5 13.9 13.5 13.3 13.4 14.1 14.0 15.1 15.0 14.9 15.6 16.1 16.7 16.9 17.3 16.5 15.8 15.7 16.0 16.0 17.0 16.1 18.3 17.7 19.0 19.2 20.1 21.6 23.0 +1.4 +5.3 sss
Inhalants b 0.4 0.6 0.6 0.5 0.6 0.5 0.6 0.7 0.5 0.7 0.5 0.5 0.7 0.8 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.4 0.2 0.1 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.0 +0.1
  Nitrites c 0.5 0.5 0.4   — 0.1   * 0.1 0.2 0.1   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Hallucinogens d,y 1.3 1.2 1.1 1.1 0.9 1.1 1.5 1.2 1.4 1.7 1.2 1.5 1.4 1.3 1.2 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 1.0 0.9 0.6 1.0 0.9 1.1 0.8 0.9 +0.1 +0.3
  LSD y 0.9 0.8 0.8 0.8 0.6 0.8 1.1 0.8 1.1 1.3 0.7 0.9 1.0 0.8 0.8 0.7 0.3 0.2 0.1 0.1 0.2 0.2 0.4 0.2 0.4 0.3 0.3 0.4 0.4 0.7 0.6 0.6 0.0 +0.3 s
  Hallucinogens
    other than LSD d,y 0.6 0.6 0.4 0.5 0.4 0.3 0.5 0.6 0.6 0.6 0.6 0.7 0.5 0.6 0.7 0.6 0.8 1.2 0.9 0.8 0.6 0.8 0.7 0.7 0.8 0.6 0.4 0.7 0.6 0.5 0.3 0.6 +0.3 +0.1
  PCP e 0.2 0.1 0.3   — 0.2 0.1 0.2 0.2 0.1 * 0.1 0.1 0.2 0.2 * * 0.1 0.1 0.1 * * * 0.1 * * 0.1 * 0.2 0.1 * 0.1 0.1 0.0 +0.1
  MDMA (Ecstasy, Molly) z, origina   —   —   — 0.4 0.2 0.1 0.3 0.3 0.2 0.4 0.3 0.6 0.8 1.3 1.9 1.8 1.3 0.8 0.6 0.6 0.7 0.5 0.6 0.6 0.8 0.7 1.0 1.1 1.3   —   —   —   —   —
Revised   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 1.4 0.8 1.3 0.8 -0.5   —
Cocaine 8.2 6.0 5.7 3.8 2.4 2.0 1.8 1.4 1.3 1.5 1.2 1.5 1.7 1.9 1.7 2.2 2.2 2.4 2.2 2.2 2.3 2.1 1.9 1.8 1.4 1.5 1.3 1.5 1.8 1.7 1.8 1.9 +0.1 +0.6 s
  Crack g   — 1.0 1.2 0.7 0.4 0.4 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.1 * 0.1 0.0 0.0
  Other Cocaine h   — 4.8 4.8 3.4 2.1 1.8 1.7 1.1 1.0 1.3 1.1 1.5 1.5 1.6 1.5 1.8 2.0 2.1 2.1 1.9 1.9 2.0 1.7 1.6 1.5 1.4 1.3 1.3 1.8 1.6 2.0 1.9 -0.2 +0.6
Heroin 0.1 0.1 0.1 0.1 0.1   * 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 * 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.3 0.2 -0.1 0.0
Narcotics other than Heroin j,k 0.9 0.9 0.7 0.7 0.7 0.6 0.7 0.7 0.6 0.9 0.7 0.9 0.9 1.2 1.4 1.7 2.9 2.9 3.0 3.5 3.2 3.4 3.6 3.2 3.4 2.9 2.7 1.0 2.1 1.8 1.9 1.1 -0.8 ss -1.6 sss
Amphetamines, Adjusted j,l 4.0 3.2 2.7 2.1 1.9 1.5 1.5 1.5 1.7 1.7 1.5 1.7 1.7 1.9 2.3 2.4 2.5 2.5 2.4 2.1 2.2 2.3 2.2 2.5 2.9 3.0 3.2 3.0 3.5 3.1 2.9 3.1 +0.2 -0.2
  Methamphetamine i   —   —   —   —   —   —   —   —   —   —   —   —   — 0.8 0.7 1.0 1.0 0.7 0.6 0.7 0.5 0.6 0.3 0.3 0.2 0.3 0.4 0.2 0.3 0.3 0.2 0.2 0.0 -0.2
  Crystal Methamphetamine (Ice) i   —   —   —   —   —   * 0.1 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.4 0.1 0.3 0.1 0.4 +0.3 +0.1
↓
2016– 
2017 
change
2012– 
2017 
change
TABLE 5-3
Trends in 30-Day Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
(Table continued on next page.)
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Sedatives (Barbiturates) j,u 0.7 0.7 0.7 0.5 0.6 0.5 0.5 0.6 0.6 0.8 0.8 0.9 0.9 1.1 1.3 1.7 1.5 1.5 1.8 1.7 1.5 1.6 1.9 1.2 1.1 1.1 1.1 1.2 1.0 0.9 1.1 0.6 -0.5 s -0.5 ss
  Sedatives, Adjusted j,m 0.9 0.8 0.7 0.5   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
  Methaqualone j 0.3 0.2 0.1 *   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Tranquilizers d,j 1.8 1.6 1.4 1.2 1.1 0.9 1.0 1.0 0.8 1.1 0.7 1.1 1.2 1.3 1.8 2.1 2.8 2.4 2.7 2.6 2.3 2.8 2.7 2.8 2.2 2.3 1.9 1.9 1.9 1.7 1.9 1.4 -0.5 -0.4
Alcohol n 75.1 75.4 74.0 72.4 71.2 70.6 69.0 68.3 67.7 68.1 66.7 67.5 66.9 68.2 66.8 67.2 68.3 67.0 68.4 68.6 68.7 69.5 68.9 69.4 68.4 68.8 69.5 68.7 68.4 66.9 68.4 67.1 -1.3 -2.3 s
  Been Drunk o   —   —   —   —   — 35.4 35.6 34.2 34.3 33.0 33.2 35.6 34.2 37.7 35.7 36.8 37.1 37.8 39.0 39.0 42.1 41.4 40.7 40.5 39.4 39.5 39.1 37.7 39.3 34.2 36.6 36.1 -0.5 -3.0
  Flavored Alcoholic Beverage p   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 29.5 27.6 24.9 25.9 26.7 24.4 24.5 23.8 26.1 25.4 26.9 24.7 28.8 27.6 -1.2 +1.5
Cigarettes 31.1 30.9 28.9 28.6 27.7 28.2 28.3 28.0 28.0 29.2 30.1 29.9 30.9 30.3 30.1 30.2 29.2 28.4 29.2 28.6 27.0 26.2 24.6 23.3 22.4 21.3 19.7 20.0 17.5 16.6 14.2 15.3 +1.1 -4.4 sss
Any Vaping i,aa   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 9.2 6.0 11.9   —   —
  Vaping Marijuana i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 6.6   —   —
  Vaping Nicotine i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 6.5   —   —
  Vaping Just Flavoring i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 3.3   —   —
Steroids q   —   —   — 0.2 0.1 0.2 0.1 * 0.1 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.3 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.0 +0.1
Source. The Monitoring the Future study, the University of Michigan.
See footnotes following Table 5-4.
2012– 
2017 
change
TABLE 5-3 (cont.)
Trends in 30-Day Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
2016– 
2017 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
Marijuana s 4.1 4.2 3.3 3.2 2.5 2.3 2.3 2.4 2.8 3.3 3.3 3.8 3.7 4.4 4.2 5.0 4.5 5.3 5.0 4.9 5.0 5.0 5.1 5.4 5.3 6.1 5.6 6.2 6.9 6.8 7.6 7.8 +0.2 +2.2 sss
Cocaine 0.2 0.1 0.2 0.1   * 0.1   * 0.1   * 0.1   *   *   * 0.1 * 0.1 * * 0.1 0.1 0.1 * * 0.1 * * * * 0.1 * 0.1 * -0.1 0.0
Amphetamines 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.0 +0.1
Alcohol
  Daily n,s 6.1 6.6 6.1 5.5 4.7 4.9 4.5 4.5 3.9 3.9 4.0 4.6 4.0 4.8 4.1 4.4 4.7 5.1 4.5 5.2 5.4 5.6 5.3 5.3 4.6 5.2 5.5 5.1 5.0 4.7 5.4 5.0 -0.4 -0.5
  Been Drunk o,s   —   —   —   —   — 0.5 0.4 0.4 0.5 0.3 0.4 0.9 0.5 0.9 0.5 0.4 0.6 0.8 0.7 0.5 0.6 0.6 0.5 1.0 0.7 0.7 0.4 0.5 0.6 0.4 0.3 0.3 0.0 -0.1
  5+ Drinks in a Row in
     Last 2 Weeks 36.1 36.2 35.2 34.8 34.3 34.7 34.2 34.4 33.7 32.6 33.6 34.4 34.1 35.8 34.7 35.9 35.9 35.8 37.1 37.0 37.6 37.8 37.9 36.7 35.9 36.5 35.5 35.1 33.5 31.9 32.3 31.8 -0.5 -3.6 sss
  10+ Drinks in a Row in
     Last 2 Weeks e   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 11.7 11.9 12.3 12.7 12.8 12.1 11.9 10.8 9.8 10.5 9.6 7.3 11.2 +4.0 s +0.5
  15+ Drinks in a Row in
     Last 2 Weeks e   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 5.3 4.8 5.3 4.8 4.7 4.5 4.2 4.5 3.7 3.7 2.8 2.4 3.5 +1.2 -1.0
Cigarettes
  Daily 25.2 24.8 22.7 22.4 21.3 21.7 20.9 20.8 20.7 21.2 21.8 20.6 21.9 21.5 21.8 21.2 21.2 20.3 20.8 19.6 18.6 17.3 16.7 15.0 14.8 13.8 12.8 12.1 10.7 9.7 8.2 8.8 +0.6 -4.0 sss
  1/2 Pack+/Day 20.2 19.8 17.7 17.3 16.7 16.0 15.7 15.5 15.3 15.7 15.3 14.6 15.6 15.1 15.1 14.6 14.2 13.9 13.5 12.5 11.9 11.1 10.2 9.3 9.3 7.5 7.6 7.0 6.6 5.7 4.9 4.7 -0.2 -2.9 sss
Source. The Monitoring the Future study, the University of Michigan.
See footnotes on the following page.
2016– 
2017 
change
2012– 
2017 
change
TABLE 5-4
Trends in 30-Day Prevalence of Daily Use of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Any Illicit Drug
   Total 41.9 39.3 36.3 32.8 30.7 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 32.1 32.5 33.8 33.3 33.2 34.7 34.0 36.7 37.5 39.2 39.7 41.2 +1.6 +7.2 sss
   Males 45.3 42.6 39.5 35.7 33.6 30.0 31.4 31.1 32.3 32.1 31.6 31.9 33.6 33.9 34.4 34.9 35.6 36.0 37.0 35.3 35.9 35.4 37.4 35.3 38.1 38.3 37.7 38.4 40.6 42.9 43.0 43.8 +0.8 +6.1 sss
   Females 39.0 36.5 33.6 30.5 28.3 24.5 25.8 26.1 25.3 28.1 27.3 27.1 27.1 27.6 28.2 30.1 30.2 31.0 31.4 31.1 29.5 30.7 31.4 32.0 29.9 32.4 31.5 35.4 35.3 36.7 37.5 39.5 +2.0 +8.0 sss
Any Illicit Drug
 other than Marijuana
   Total 27.0 23.9 21.3 18.3 16.7 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 18.4 18.1 18.9 17.4 18.5 17.6 17.2 18.1 21.2 19.5 19.9 20.1 +0.2 +2.9 ss
   Males 30.4 26.5 23.8 21.0 19.1 16.4 16.3 14.7 16.2 16.2 15.4 15.6 16.2 16.7 17.8 17.2 18.9 19.8 21.3 20.4 21.8 20.3 21.1 18.7 21.5 19.9 19.5 19.7 23.7 22.9 23.1 23.0 -0.1 +3.5 s
   Females 24.0 21.6 19.4 16.2 14.7 12.5 12.2 11.6 10.5 12.0 11.4 12.0 11.0 11.5 12.9 14.1 14.6 17.0 17.1 17.3 16.0 16.7 17.5 16.6 16.5 16.2 15.7 17.1 19.4 17.2 17.7 18.2 +0.4 +2.5 s
 
Any Illicit Drug
   Total 25.8 23.4 20.5 17.7 15.9 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 18.5 18.9 19.3 19.8 18.9 20.6 19.9 21.6 22.3 23.2 23.5 24.8 +1.3 +4.9 sss
   Males 29.9 27.1 23.7 21.1 18.8 18.3 17.9 17.4 19.5 18.6 19.0 19.8 20.1 20.0 21.5 21.9 22.8 22.4 23.1 22.0 22.5 22.7 22.8 22.4 23.9 24.5 23.8 25.4 24.7 26.9 26.6 28.9 +2.3 +5.1 ss
   Females 22.2 20.2 17.8 15.0 13.5 12.5 12.4 12.9 12.1 13.5 13.3 13.8 13.2 15.0 15.6 16.6 16.3 18.3 16.3 16.4 15.7 16.4 16.9 18.0 15.5 18.2 17.3 18.9 20.6 20.8 21.5 22.0 +0.6 +4.8 sss
Any Illicit Drug 1.0
 other than Marijuana
   Total 13.0 10.7 9.5 7.5 6.0 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8.3 8.5 8.2 8.1 8.6 8.9 8.5 8.6 8.4 7.8 8.3 9.9 8.7 9.2 8.7 -0.5 +0.9
   Males 15.2 12.3 10.6 9.1 6.8 6.6 6.5 5.9 7.1 6.8 5.7 6.8 7.1 7.3 7.8 8.1 8.5 9.2 10.6 9.2 10.2 10.0 10.0 8.5 10.0 10.0 9.0 9.4 11.4 10.7 10.8 10.2 -0.6 +1.2
   Females 11.0 9.4 8.7 6.2 5.3 4.4 4.7 4.0 3.9 4.8 4.0 4.5 4.4 5.1 5.4 6.3 7.1 7.7 7.1 7.6 6.8 7.7 8.1 8.5 7.6 7.5 7.0 7.5 9.0 7.3 8.1 7.7 -0.5 +0.7
 
All Respondents
   Total 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600
   Males 3,200 3,100 3,000 2,900 3,000 3,000 3,000 3,000 2,900 2,800 2,700 2,800 2,700 2,600 2,400 2,400 2,200 2,200 2,300 2,200 2,100 1,900 2,000 2,000 2,000 1,800 1,900 900 1,700 1,600 1,500 1,500
   Females 3,700 3,700 3,700 3,700 3,700 3,600 3,700 3,700 3,600 3,600 3,600 3,600 3,500 3,400 3,300 3,400 3,100 3,100 3,400 3,200 3,000 2,900 2,900 2,900 2,900 2,800 2,700 1,300 2,500 2,400 2,200 2,100
Source. The Monitoring the Future study, the University of Michigan.
Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone (until 1990), or tranquilizers not under a doctor’s orders.
2012– 
2017 
change
TABLE 5-5
Trends in Annual and 30-Day Prevalence of an Illicit Drug Use Index a
among Respondents of Modal Ages 19–28
Total and by Gender
Approximate Weighted N
2016– 
2017 
change
Percentage who used in last 12 months
Percentage who used in past 30 days
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Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
The illicit drugs not listed here show a daily prevalence of 0.2% or less in all years.
' * ' indicates a prevalence rate of less than 0.05%.
' — ' indicates data not available.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone 
(until 1990), or tranquilizers not under a doctor’s orders.  
bThis drug was asked about in four of the five questionnaire forms in 1986–1989;  N  is four fifths of N  indicated. Data were based on five of the six questionnaire 
forms in 1990–1998;   N  is five sixths of N  indicated. Data were based on three of six questionnaire forms in 1999–2017;  N  is three sixths of N  indicated. 
cThis drug was asked about in one questionnaire form.  N  is one fifth of N  indicated in 1986–1988 and one sixth of  N  indicated in 1990–1994. 
dIn 2001 the question text was changed on three of the six questionnaire forms. Other psychedelics was changed to other hallucinogens, and shrooms was added 
to the list of examples. For tranquilizers, Miltown was replaced with Xanax. Beginning in 2002 the remaining forms were changed to the new wording. 
eThis drug was asked about in one of the five questionnaire forms in 1986–1988;  N  is one fifth of N  indicated. Data were based on one of six questionnaire 
forms in 1990–2017;   N  is one sixth of N  indicated. 
fThis drug was asked about in two of the five questionnnaire forms in 1989;  N  is two fifths of N  indicated. Data were based on two of the six questionnaire forms 
in 1990–2001;  N  is two sixths of N  indicated. Data were based on three of the six questionnaire forms in 2002–2017;  N  is three sixths of N  indicated. 
gThis drug was asked about in two of the five questionnaire forms in 1987–1989;  N  is two fifths of N  indicated. Data were based on all six questionnaire forms 
in 1990–2001. Data were based on five of six questionnaire forms in 2002–2017;  N  is five sixths of N  indicated. 
hThis drug was asked about in one of the five questionnaire forms in 1987–1989;  N  is one fifth of N  indicated. Data were based on four of the six questionnaire 
forms in 1990–2017;   N  is four sixths of N  indicated.
iThis drug was asked about in two of the six questionnaire forms;  N  is two sixths of N  indicated. 
jOnly drug use that was not under a doctor’s orders is included here. 
kIn 2002 the question text was changed in three of the six questionnaire forms. The list of examples of narcotics other than heroin was updated: Talwin, laudanum, 
and paregoric—all of which had negligible rates of use by 2001—were replaced by Vicodin, OxyContin, and Percocet. The 2002 data presented here are based 
on the changed forms only;  N  is three sixths of N  indicated. In 2003 the remaining forms were changed to the new wording. The data are based on all forms 
in 2003 and beyond. 
lBased on the data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.  
mSedatives, adjusted” data are a combination of barbiturate and methaqualone data. 
nIn 1993 and 1994, the question text was changed slightly in three of the six questionnaire forms to indicate that a drink meant more than just a few sips. Because 
this revision resulted in rather little change in reported prevalence in the surveys of high school graduates, the data for all forms combined are used in order to 
provide the most reliable estimate of change. After 1994 the new question text was used in all six of the questionnaire forms. 
oThis drug was asked about in three of the six questionnaire forms; N  is three sixths of N  indicated.  For small cigars only, beginning in 2014 question asked on 
two of the six questionnaire forms; N is two sixths of N indicated.
pThis drug was asked about in one of the six questionnaire forms; N  is one sixth of N  indicated. 
qThis drug was asked about in one of the five questionnaire forms in 1989; N  is one fifth of N  indicated. Data were based on two of the six questionnaire forms 
in 1990–2017; N is two sixths of N  indicated.
rThis drug was asked about in two of the six questionnaire forms in 2002 –2009; N  is two sixths of N indicated.  Data were based on three of the six 
questionnaire forms in 2010-2017.  N is three sixths of N indicated.
sDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, and 5+ drinks, measured as having 
five or more drinks in a row in the last two weeks.
tIn 2012 the alcoholic beverage containing caffeine question text was changed to alcoholic beverage mixed with an energy drink. The data in 2011 and 2012
are not comparable due to this question change.
uIn 2013 the question text was changed on all forms: Tuinal, Nembutal, and Seconal were replaced with Ambien, Lunesta, and Sonata.  The data in 2012 and
2013 are not comparable due to this question change.
vThis drug was asked about in two of the six questionnaire forms in 2011-2012; N is two sixths of N indicated.  Data were based on three of the six 
questionaire forms in 2013-2017; N is three sixths of N indicated.
wThis drug was asked about in one of the six questionnaire forms in 2009; N is one sixth of N indicated; Data were based on two of the six questionnaire
forms in 2010-2011; N is two sixths of N indicated.  Data were based on three of the six questionnaire forms in 2012-2017; N is three sixths of N indicated.
xThis drug was asked about in two of the six questionnaire forms in 2002-2009; N is two sixths of N indicated; Data were based on three of the six questionnaire
forms in 2010-2011; N is three sixths of N indicated.  Data were based on two of the six questionnaire forms in 2012-2017; N is two sixths of N indicated.
yThis drug was asked about in all available questionnaire forms until 2014.  Beginning in 2014, data are based on five of the six questionnaire forms; N is 
five sixths of N indicated.
Footnotes for Tables 5-1 through 5-4
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zThis drug was asked about in two of the five questionnnaire forms in 1989;  N  is two fifths of N  indicated. Data were based on two of the six questionnaire forms 
in 1990–2001;  N  is two sixths of N  indicated. Data were based on three of the six questionnaire forms in 2002–2013;  N  is three sixths of N  indicated.  In 2014,
a version of the question was added to an additional form that included "molly" in the description.  In 2015 the remaining forms were changed to this updated
wording.  Data for both versions of the question are included here.  Beginning in 2015, data based on four of th six questionnaire forms.  N  is four sixths of
N  indicated.
aaIn 2017, the surveys switched from asking about vaping in general to asking separately about vaping nicotine, marijuana, and just flavoring.  
Beginning in 2017, data presented for any vaping are based on these new questions.
Footnotes for Tables 5-1 through 5-4 (cont.)
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FIGURE 5-1
ANY ILLICIT DRUG
Trends in Annual Prevalence
 among Respondents of Modal Ages 18 through 55, by Age Group
(Figure continued on next page.)
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 48.1
1977 51.1
1978 53.8 55.8
1979 54.2 54.5
1980 53.1 54.5 55.3
1981 52.1 53.4 55.4
1982 49.4 50.2 51.2 51.7
1983 47.4 47.4 49.9 48.9
1984 45.8 45.9 47.3 44.0 44.0
1985 46.3 45.7 46.3 47.8 45.2
1986 44.3 42.6 45.8 42.8 39.3 38.4
1987 41.7 39.5 42.3 37.9 40.1 36.2
1988 38.5 39.4 38.2 36.6 34.4 32.5 30.5
1989 35.4 35.7 35.0 31.4 30.5 30.9 28.9
1990 32.5 32.3 32.7 30.7 29.6 27.4 23.0
1991 29.4 28.1 29.9 27.0 25.2 23.9 24.5
1992 27.1 29.7 30.0 29.2 26.4 25.3 23.1                                                         
1993 31.0 30.5 30.2 29.8 25.6 24.6 21.7
1994 35.8 32.2 31.6 27.3 25.5 23.6 22.4 19.5
1995 39.0 35.6 31.9 28.5 27.3 23.9 21.3 21.6
1996 40.2 36.1 33.0 27.6 23.4 23.7 22.7 21.2
1997 42.4 36.7 33.5 27.3 25.4 20.7 22.2 20.3
1998 41.4 40.6 34.1 27.4 23.9 22.0 19.6 18.1 20.3
1999 42.1 40.4 33.3 31.1 24.5 20.8 19.0 17.7 16.7
2000 40.9 39.3 36.9 29.6 25.5 21.4 20.3 19.1 17.2
2001 41.4 38.4 40.2 31.1 27.4 22.9 21.1 17.8 15.8
2002 41.0 39.4 36.7 35.2 27.6 22.9 20.9 18.1 18.2
2003 39.3 38.1 38.3 34.6 27.5 26.3 20.6 17.9 15.8 17.8
2004 38.8 38.0 36.5 34.5 31.6 26.8 22.0 18.5 17.5 15.8
2005 38.4 38.9 36.4 31.9 32.0 24.3 25.2 18.2 19.1 15.3
2006 36.5 36.3 36.0 32.7 28.6 25.7 25.9 17.5 16.2 17.2
2007 35.9 35.2 35.0 34.1 29.3 28.5 22.7 17.5 17.4 18.3
2008 36.6 35.5 36.7 34.4 31.8 30.1 28.2 22.1 17.5 17.3 17.9
2009 36.5 35.5 38.8 34.1 29.6 27.4 27.9 20.0 19.1 17.0 16.0
2010 38.3 32.5 38.1 36.3 31.6 27.1 26.2 20.2 16.7 19.1 18.3
2011 40.0 37.9 37.5 35.4 32.1 29.9 26.2 24.2 16.9 17.8 16.8
2012 39.7 36.2 36.8 35.3 29.7 31.6 25.1 21.1 17.6 18.6 18.6
2013 40.1 37.5 42.4 35.9 32.0 34.9 25.6 23.3 18.7 17.7 17.0 16.6
2014 38.7 40.8 40.6 37.2 36.3 32.5 31.7 26.6 17.5 17.1 17.1 15.8
2015 38.6 40.6 42.0 41.2 38.1 33.9 27.5 28.0 19.6 18.4 19.2 18.3
2016 38.3 43.9 44.4 40.0 34.0 36.6 30.6 27.3 23.1 17.6 17.8 19.0
2017 39.9 41.8 43.7 42.4 40.0 38.4 34.9 30.1 22.1 20.3 19.3 19.7
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
FIGURE 5-1 (cont.)
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Trends in Annual Prevalence
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(Figure continued on next page.)
FIGURE 5-2
ANY ILLICIT DRUG OTHER THAN MARIJUANA
Trends in Annual Prevalence
 among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 25.4
1977 26.0
1978 27.1 28.6
1979 28.2 30.2
1980 30.4 33.3 35.5
1981 34.0 34.2 37.0
1982 30.1 32.4 34.2 35.4
1983 28.4 29.8 33.7 33.2
1984 28.0 27.5 31.6 29.4 30.2
1985 27.4 26.9 29.5 33.4 30.3
1986 25.9 24.7 29.1 29.3 25.5 26.5
1987 24.1 22.2 25.6 22.6 25.7 23.3
1988 21.1 21.3 22.8 21.1 21.0 20.4 20.0
1989 20.0 17.6 19.4 18.8 17.6 18.2 17.4
1990 17.9 16.5 17.4 17.5 16.6 15.2 12.4
1991 16.2 13.8 14.9 14.6 14.4 13.6 13.2
1992 14.9 13.4 15.4 14.8 13.4 13.2 11.6                                                          
1993 17.1 13.5 13.5 12.9 13.0 11.5 9.9
1994 18.0 14.6 14.1 12.9 12.0 11.1 10.8 11.2
1995 19.4 18.6 15.2 11.5 11.6 10.9 11.0 10.4
1996 19.8 17.4 13.7 13.1 10.0 10.7 10.3 11.4
1997 20.7 17.6 17.7 12.1 10.7 8.4 11.0 10.0
1998 20.2 17.3 15.3 12.9 10.8 8.9 7.8 8.2 9.3
1999 20.7 18.7 14.1 14.8 11.6 8.6 8.1 9.3 7.9
2000 20.4 19.6 17.0 15.0 12.5 9.9 7.4 9.3 7.7
2001 21.6 18.0 20.0 14.1 13.3 11.4 9.9 8.8 7.3
2002 20.9 19.6 18.9 17.2 14.6 11.4 10.9 9.6 9.7
2003 19.8 19.9 20.7 20.1 14.5 15.1 11.6 9.5 6.7 8.9
2004 20.5 20.2 21.2 21.2 16.3 14.6 11.8 11.0 8.3 9.3
2005 19.7 20.2 20.5 18.0 19.7 14.2 15.8 10.5 9.4 8.4
2006 19.2 18.1 22.0 19.4 16.9 15.1 15.3 10.8 9.8 10.3
2007 18.5 17.8 19.7 19.1 17.0 16.9 13.0 11.0 11.3 10.7
2008 18.3 16.8 19.5 21.3 19.1 18.0 16.5 13.7 11.3 10.7 10.0
2009 17.0 14.6 22.9 17.6 17.8 14.1 17.2 13.3 10.4 9.6 10.3
2010 17.3 17.2 20.0 20.1 19.5 15.8 14.5 12.5 9.3 11.5 10.8
2011 17.6 17.4 18.2 19.3 17.3 15.8 13.7 13.6 9.6 9.8 9.4
2012 17.0 17.0 17.9 18.8 15.0 17.2 13.7 12.5 10.8 11.3 10.2
2013 17.8 16.7 23.4 18.3 15.1 16.8 14.4 13.0 9.6 9.5 8.6 7.0
2014 15.9 21.1 23.4 20.8 21.7 18.7 20.3 15.0 8.9 9.1 8.7 7.9
2015 15.2 15.6 21.6 22.5 19.7 18.2 15.5 16.3 10.6 9.9 10.5 9.0
2016 14.3 18.9 23.6 18.8 18.2 19.8 16.7 14.5 12.2 9.0 9.2 9.1
2017 13.3 17.1 19.1 22.9 22.3 19.0 17.3 15.0 11.2 9.5 9.3 8.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-3a
MARIJUANA
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 44.5
1977 47.6
1978 50.2 52.8
1979 50.8 51.0
1980 48.8 49.7 50.1
1981 46.1 49.0 51.1
1982 44.3 44.9 45.8 46.0
1983 42.3 43.0 45.4 43.8
1984 40.0 41.4 42.1 38.6 38.3
1985 40.6 40.3 40.9 42.0 39.2
1986 38.8 39.1 39.6 36.6 34.1 32.5
1987 36.3 35.8 37.4 33.7 35.4 31.4
1988 33.1 36.2 33.7 32.0 29.7 26.7 25.4
1989 29.6 32.2 31.6 27.3 26.2 26.8 24.7
1990 27.0 28.4 28.2 26.6 24.1 22.6 20.0
1991 23.9 25.4 26.8 23.2 21.8 20.9 21.0
1992 21.9 26.9 26.9 26.6 23.5 21.2 20.1                                                          
1993 26.0 27.9 26.1 26.5 22.2 21.3 18.8
1994 30.7 29.3 29.2 24.6 22.6 20.1 19.0 14.5
1995 34.7 31.8 28.1 25.8 24.4 20.4 18.2 17.2
1996 35.8 34.2 30.6 25.8 21.7 20.6 19.5 16.3
1997 38.5 34.8 30.6 25.1 23.3 18.0 18.0 17.5
1998 37.5 37.2 31.9 25.5 21.2 19.9 16.9 14.9 17.1
1999 37.8 37.9 31.5 27.4 21.8 18.2 16.0 14.7 13.8
2000 36.5 37.0 33.2 26.9 22.7 18.8 18.4 13.8 13.7
2001 37.0 35.4 37.5 28.3 25.0 19.4 17.1 14.8 12.5
2002 36.2 36.4 34.3 31.8 24.5 19.4 17.5 13.7 14.6
2003 34.9 35.9 33.1 30.0 24.3 21.2 17.0 13.0 13.4 14.0
2004 34.3 34.5 32.5 27.7 27.6 22.4 16.4 13.0 13.9 11.9
2005 33.6 34.9 32.6 26.8 26.4 19.7 18.9 12.9 14.3 11.7
2006 31.5 33.2 31.1 28.5 24.0 20.9 19.9 11.4 11.0 11.6
2007 31.7 33.1 30.5 29.3 24.7 24.4 18.3 10.8 11.6 12.6
2008 32.4 32.1 33.3 27.4 25.9 23.6 22.3 14.2 10.7 11.1 11.7
2009 32.8 33.2 33.7 29.5 25.2 23.3 22.5 12.6 12.2 11.6 10.1
2010 34.8 30.6 34.0 30.5 25.5 22.3 21.5 14.6 12.0 12.7 11.4
2011 36.4 34.4 34.8 31.8 27.0 25.8 20.9 17.7 10.6 11.6 10.8
2012 36.4 34.0 34.0 30.3 25.6 26.5 19.8 14.4 12.5 12.3 12.2
2013 36.4 35.5 36.7 34.3 28.4 25.2 22.4 17.1 14.3 11.9 11.9 12.1
2014 35.1 38.0 34.7 30.5 28.8 25.6 24.1 20.0 12.6 11.7 12.6 11.5
2015 34.9 38.6 37.8 32.7 33.5 26.9 22.2 21.1 14.7 13.3 12.8 12.8
2016 35.6 41.4 40.7 36.4 29.0 30.1 26.0 19.7 16.7 11.8 11.7 12.8
2017 37.1 38.3 41.1 38.7 34.7 34.9 30.4 23.8 17.8 15.2 14.3 15.0
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-3b
MARIJUANA
Trends in 30-Day Prevalence  
among Respondents of Modal Ages 18 through 55, by Age Group 
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 32.2
1977 35.4
1978 37.1 38.0
1979 36.5 37.5
1980 33.7 33.9 35.9
1981 31.6 34.2 35.3
1982 28.5 28.6 29.1 30.3
1983 27.0 25.7 29.3 29.7
1984 25.2 24.6 26.4 25.4 24.9
1985 25.7 22.8 25.2 26.8 24.8
1986 23.4 22.9 23.3 23.0 19.9 20.7
1987 21.0 20.4 21.8 19.6 21.5 20.3
1988 18.0 20.1 18.5 17.4 17.2 16.1 15.4
1989 16.7 16.3 15.9 15.6 14.7 14.7 15.0
1990 14.0 15.2 14.3 13.4 13.4 12.9 11.5
1991 13.8 13.2 14.7 13.0 13.0 13.5 12.7
1992 11.9 14.1 14.7 12.5 12.6 12.0 12.2                                                          
1993 15.5 14.6 13.8 13.6 12.4 12.3 11.2
1994 19.0 15.3 16.5 13.3 12.9 11.6 11.4 8.7
1995 21.2 18.7 15.4 12.2 11.7 10.4 10.8 11.1
1996 21.9 19.9 16.4 14.2 12.6 11.0 10.5 8.8
1997 23.7 19.9 18.9 14.0 10.5 10.1 9.4 10.7
1998 22.8 20.1 17.5 13.8 11.8 10.5 9.0 9.1 10.5
1999 23.1 23.1 17.8 15.3 12.0 8.9 9.3 8.8 8.3
2000 21.6 22.3 19.8 14.7 12.5 10.7 9.8 8.3 8.5
2001 22.4 21.0 22.9 14.9 14.5 10.3 8.3 8.8 8.3
2002 21.5 22.2 20.1 17.2 14.8 9.9 9.0 8.9 8.1
2003 21.2 22.5 18.2 18.9 14.5 12.2 8.9 7.1 8.2 8.4
2004 19.9 20.7 18.3 15.6 15.1 12.0 8.5 7.8 8.3 6.5
2005 19.8 18.9 17.9 14.1 15.9 11.9 11.9 7.0 8.1 7.2
2006 18.3 17.5 17.4 16.2 14.0 13.1 10.1 6.2 6.7 6.3
2007 18.8 18.4 18.0 16.2 13.6 13.5 10.4 5.8 6.7 6.9
2008 19.4 17.9 17.8 16.2 13.3 14.2 12.9 7.8 6.6 6.4 7.2
2009 20.6 19.5 20.0 16.0 15.3 13.3 12.1 5.9 6.8 7.3 5.9
2010 21.4 18.0 18.0 17.3 13.6 13.5 11.0 8.9 7.1 7.3 6.8
2011 22.6 20.4 21.9 18.1 15.5 15.0 10.9 10.1 6.5 7.3 5.9
2012 22.9 21.6 19.8 18.0 14.0 14.6 11.5 9.1 6.5 6.6 7.3
2013 22.7 21.8 23.0 20.0 15.8 13.9 13.7 10.4 8.2 5.7 7.5 7.6
2014 21.2 24.3 21.2 17.8 17.4 15.1 13.2 11.1 6.8 7.1 8.1 8.1
2015 21.3 22.6 22.5 19.0 20.7 15.4 12.8 13.2 8.8 7.8 8.0 8.6
2016 22.5 24.9 25.1 22.3 18.0 18.2 15.3 10.8 10.5 7.2 7.4 6.4
2017 22.9 22.0 25.7 24.6 21.8 21.1 17.8 13.9 10.8 8.2 9.4 9.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-3c
MARIJUANA
Trends in 30-Day Prevalence of Daily Use
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 8.2
1977 9.1
1978 10.7 10.5
1979 10.3 10.9
1980 9.1 8.1 10.9
1981 7.0 7.9 9.4
1982 6.3 6.6 6.4 8.1
1983 5.5 5.2 6.2 6.7
1984 5.0 4.7 5.3 5.5 6.0
1985 4.9 4.6 4.5 5.8 6.1
1986 4.0 3.5 4.1 4.9 3.6 4.8
1987 3.3 3.4 3.9 4.3 5.0 4.6
1988 2.7 3.5 3.5 3.1 3.4 3.0 3.2
1989 2.9 2.8 3.1 3.0 3.3 4.1 3.2
1990 2.2 2.3 2.5 2.7 2.7 2.4 2.2
1991 2.0 2.1 2.4 2.1 2.5 2.6 2.6
1992 1.9 1.4 2.6 2.3 2.6 2.5 2.9                                                           
1993 2.4 2.3 2.3 2.7 2.5 2.3 2.7
1994 3.5 3.1 2.9 3.1 2.7 2.2 2.4 2.3
1995 4.6 4.7 3.4 3.3 2.3 2.5 2.5 2.6
1996 4.9 4.9 3.2 2.3 3.1 2.5 2.2 2.3
1997 5.8 5.4 5.3 2.6 2.5 2.7 2.3 3.5
1998 5.6 5.2 5.2 3.1 2.4 2.3 2.4 2.7 3.2
1999 6.0 6.2 4.6 5.1 3.1 2.8 2.5 1.9 2.1
2000 6.0 6.0 5.5 3.8 3.4 2.0 2.2 2.7 2.6
2001 5.8 6.1 7.0 4.7 4.6 2.3 2.6 2.3 1.8
2002 6.0 6.0 6.0 5.5 2.7 2.5 2.3 3.0 3.0
2003 6.0 6.5 6.0 6.6 3.5 4.0 1.9 2.1 2.4 2.6
2004 5.6 6.0 5.1 5.3 5.5 2.9 2.0 2.5 1.8 2.0
2005 5.0 6.4 4.6 4.5 5.9 3.0 3.9 2.1 1.9 2.1
2006 5.0 5.2 5.3 5.3 5.0 4.3 2.5 2.8 2.3 1.4
2007 5.1 5.1 4.9 5.2 4.1 5.7 3.2 1.9 2.3 2.7
2008 5.4 4.1 6.1 5.4 5.5 4.3 4.8 2.2 2.2 2.7 2.0
2009 5.2 5.8 6.3 5.8 5.1 3.7 5.4 1.7 2.1 2.2 2.0
2010 6.1 6.0 5.1 5.8 4.0 5.3 4.0 3.8 2.3 2.2 2.2
2011 6.6 6.6 6.3 6.9 5.8 4.6 3.7 2.7 2.7 2.7 2.3
2012 6.5 6.2 6.1 5.7 5.1 5.1 4.5 3.6 2.6 2.2 2.7
2013 6.5 6.2 7.8 6.2 5.8 5.1 2.9 3.3 2.3 2.4 2.1 2.7
2014 5.8 7.9 7.7 6.8 6.1 6.1 5.7 5.1 1.4 2.6 2.5 2.4
2015 6.0 7.9 6.3 7.0 7.0 5.5 4.7 5.3 4.1 2.5 2.9 2.8
2016 6.0 7.0 8.8 9.6 6.6 6.2 6.7 3.7 3.4 2.8 2.2 2.7
2017 5.9 6.2 9.0 9.2 8.0 6.6 6.9 5.1 4.5 2.7 2.6 3.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
aBeginning in 2002, respondents were followed through age 30 instead of age 32 as in past years.
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FIGURE 5-4
INHALANTS a  
Trends in Annual Prevalence 
among Respondents of Modal Ages 18 through 32, b by Age Group
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Age 18  Ages 
19–20 
Ages    
21–22
Ages    
23–24
Ages    
25–26
Ages    
27–28
Ages    
29–30
Year
1976 3.0
1977 3.7
1978 4.1 2.6
1979 5.4 2.4
1980 4.6 2.5 1.8
1981 4.1 2.2 2.0
1982 4.5 2.7 1.9 1.9
1983 4.3 3.0 2.0 1.4
1984 5.1 2.9 1.7 1.5 0.6
1985 5.7 3.4 1.8 2.1 0.8
1986 6.1 3.5 2.6 1.2 1.2 0.8
1987 6.9 4.2 3.0 1.4 0.9 0.7
1988 6.5 4.4 2.7 1.0 0.5 0.1 0.5
1989 5.9 3.7 2.1 1.9 0.5 0.8 0.4
1990 6.9 4.0 2.3 1.4 0.5 0.7 0.3
1991 6.6 4.0 2.3 1.0 1.2 0.6 0.6
1992 6.2 3.5 3.0 1.3 0.6 0.4 0.6
1993 7.0 3.6 2.8 1.9 0.7 0.8 0.4
1994 7.7 3.1 3.3 1.9 0.7 0.6 0.6
1995 8.0 5.0 2.1 2.1 1.7 0.7 0.8
1996 7.6 4.2 2.7 1.8 0.9 0.7 *
1997 6.7 4.7 2.8 1.6 1.0 0.5 1.0
1998 6.2 4.1 2.4 1.1 1.7 0.9 0.1
1999 5.6 3.1 3.3 3.0 0.4 1.2 0.5
2000 5.9 3.2 3.0 2.4 1.0 0.9 0.1
2001 4.5 3.4 2.4 0.9 0.8 1.0 0.7
2002 4.5 2.8 1.9 1.9 0.8 0.6 0.5
2003 3.9 2.2 1.4 0.9 1.3 1.0 0.5
2004 4.2 3.1 2.1 1.6 1.2 0.3 0.6
2005 5.0 1.5 2.2 1.0 0.4 1.2 1.4
2006 4.5 2.4 2.1 0.9 0.5 0.4 0.5
2007 3.7 1.8 1.0 0.4 0.4 0.5 0.5
2008 3.8 1.8 1.5 1.7 1.1 0.9 0.7
2009 3.4 1.5 1.2 0.8 0.5 0.3 0.3
2010 3.6 1.9 2.1 1.1 0.6 0.5 0.7
2011 3.2 1.1 1.2 0.5 0.7 0.6 0.7
2012 2.9 2.1 0.9 1.5 0.7 0.2 0.6
2013 2.5 0.4 0.9 0.8 0.2 0.2 0.3
2014 1.9 1.7 0.8 1.5 0.2 1.1 0.7
2015 1.9 1.7 0.8 1.5 0.2 1.1 0.7
2016 1.7 0.6 0.6 0.7 0.7 1.6 0.2
2017 1.5 1.7 1.0 0.4 * 0.6 0.8
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.
aUnadjusted for the possible underreporting of amyl and butyl nitrites. Chapter 5, Volume I , shows that 
such an adjustment would flatten the trend for seniors considerably because the line was adjusted up more
in the earlier years, when nitrite use was more prevalent. Questions about nitrite use were dropped from the 
follow-up questionnaires beginning in 1995. 
bQuestions about the use of inhalants were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
by Age Group
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FIGURE 5-5
HALLUCINOGENS a   
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 50, c by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50
Year
1976 9.4
1977 8.8
1978 9.6 9.5
1979 9.9 10.9
1980 9.3 9.7 10.1
1981 9.0 8.6 10.9
1982 8.1 9.9 9.3 8.1
1983 7.3 7.2 7.4 7.4
1984 6.5 6.0 7.5 5.4 4.7
1985 6.3 5.1 5.7 4.9 4.7
1986 6.0 6.3 5.7 4.6 3.0 2.4
1987 6.4 5.9 5.2 3.7 2.4 2.7
1988 5.5 5.8 5.8 3.8 2.5 1.3 2.1
1989 5.6 5.8 4.3 3.8 2.0 1.7 1.4
1990 5.9 6.3 5.0 4.4 2.3 1.8 1.2
1991 5.8 6.2 5.7 4.4 3.2 2.4 1.5
1992 5.9 6.7 7.2 4.2 3.7 2.2 1.9                                                         
1993 7.4 6.9 5.0 4.7 3.0 2.1 1.3
1994 7.6 6.7 6.8 4.3 3.0 2.4 1.5 0.8
1995 9.3 9.6 6.6 4.9 3.7 2.3 1.9 0.7
1996 10.1 10.1 6.2 5.4 3.2 2.2 1.4 0.5
1997 9.8 9.6 8.0 5.0 3.7 1.8 1.6 1.0
1998 9.0 8.1 6.7 5.2 3.2 2.0 1.4 0.6 0.8
1999 9.4 9.4 6.8 5.9 2.7 1.7 1.4 0.8 0.5
2000 8.1 8.0 7.4 4.9 3.9 2.6 1.7 0.5 0.9
2001 9.1 9.0 8.1 4.6 3.1 1.8 1.7 0.8 0.2
2002 6.6 7.3 5.8 5.2 2.8 2.2 2.0 0.3 0.7
2003 5.9 7.7 7.1 5.8 2.8 2.5 1.5 0.6 0.5 0.6
2004 6.2 6.3 6.7 4.4 3.2 2.6 1.4 1.0 0.5 0.3
2005 5.5 6.4 5.3 4.0 4.3 2.1 2.1 0.3 0.4 0.1
2006 4.9 5.8 5.3 4.6 2.1 2.4 1.5 0.4 0.1 0.1
2007 5.4 5.4 4.8 3.5 2.7 2.6 1.3 0.4 0.4 0.2
2008 5.9 5.2 5.5 3.3 3.2 1.7 2.9 1.1 0.2 0.1 0.2
2009 4.7 4.7 5.8 3.7 2.8 2.4 2.2 0.8 0.5 0.3 0.3
2010 5.5 5.3 5.1 4.7 3.5 2.3 2.1 1.8 0.6 0.3 0.2
2011 5.2 4.6 5.3 3.2 3.0 2.4 1.7 1.4 0.8 0.7 0.1
2012 4.8 5.3 3.9 3.7 2.6 2.1 2.3 1.1 0.2 0.6 0.1
2013 4.5 5.0 4.7 4.1 2.7 2.7 2.6 1.2 0.5 0.3 0.1
2014 4.0 5.6 4.7 4.3 3.2 2.8 2.4 1.4 0.2 0.7 0.4
2015 4.2 4.6 5.6 3.4 4.6 2.9 2.7 2.8 0.8 0.1 0.4
2016 4.3 4.6 5.7 4.8 5.4 2.9 4.2 1.5 1.0 0.2 0.5
2017 4.4 4.6 4.9 5.8 5.0 3.6 2.2 1.7 1.4 0.9 0.5
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens were not included in the questionnaires for 55-year-olds.
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FIGURE 5-6
LSD
Trends in Annual Prevalence  
among Respondents of Modal Ages 18 through 35,b by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 
b
Year
1976 6.4
1977 5.5
1978 6.3 6.2
1979 6.6 8.1
1980 6.5 7.2 7.9
1981 6.5 6.4 8.0
1982 6.1 7.7 6.9 6.0
1983 5.4 5.4 4.9 4.6
1984 4.7 4.3 5.1 3.1 2.7
1985 4.4 3.3 3.3 2.9 2.9
1986 4.5 4.5 4.4 2.7 1.5 1.6
1987 5.2 4.7 3.7 2.2 1.6 1.8
1988 4.8 4.9 4.2 2.9 1.6 0.8 1.5
1989 4.9 4.5 3.2 2.7 1.4 1.1 0.8
1990 5.4 5.3 4.0 3.5 1.8 1.5 0.8
1991 5.2 5.4 5.0 3.8 2.5 1.9 1.0
1992 5.6 6.3 6.0 3.5 3.2 1.6 1.4
1993 6.8 6.2 4.3 3.5 2.4 1.8 1.0
1994 6.9 6.2 5.7 3.2 2.4 1.6 1.0 0.6
1995 8.4 8.2 5.5 4.1 2.6 1.7 1.4 0.4
1996 8.8 8.7 4.9 4.6 2.0 1.6 1.0 0.5
1997 8.4 7.8 5.5 4.0 2.6 1.3 0.8 0.5
1998 7.6 5.9 4.4 3.5 2.1 1.0 1.0 0.3
1999 8.1 7.7 4.5 4.3 1.9 1.2 0.8 0.6
2000 6.6 6.3 4.9 2.6 2.5 1.6 1.0 0.3
2001 6.6 6.4 4.7 2.5 1.7 1.3 1.1 0.5
2002 3.5 3.3 1.8 2.2 1.0 0.7 0.9 *
2003 1.9 1.9 1.2 1.4 0.6 0.6 0.4 *
2004 2.2 1.5 1.4 0.7 0.5 0.3 0.2 0.4
2005 1.8 1.5 1.0 0.7 0.7 0.1 0.4 0.1
2006 1.7 2.1 1.4 1.1 0.6 0.7 0.2 0.1
2007 2.1 1.5 1.3 1.4 0.9 0.6 0.3   —
2008 2.7 2.0 2.7 0.9 0.8 0.4 0.5   —
2009 1.9 2.2 2.7 1.4 1.0 0.6 0.2   —
2010 2.6 2.4 1.5 1.7 1.1 0.6 0.2   —
2011 2.7 2.6 2.7 1.5 1.1 0.4 0.9   —
2012 2.4 2.5 1.6 1.6 1.3 0.7 0.3   —
2013 2.2 2.9 2.9 2.0 1.5 0.7 0.7   —
2014 2.5 3.5 2.7 2.2 1.5 1.1 0.7   —
2015 2.9 3.1 4.1 2.1 2.9 0.9 1.1   —
2016 3.0 3.9 3.5 3.3 3.5 1.6 2.2   —
2017 3.3 3.0 3.8 4.2 3.4 2.5 0.8   —
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.  
aBeginning in 2002, respondents were followed through age 30 instead of age 32 as in past years.  
bQuestions about LSD use were not included in the questionnaires administered to the 40-, 45-, and 50-year-olds, or the 
35-year-olds after 2006.
among Respondents of Modal Ages 18 through 35, by Age Group
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FIGURE 5-7
HALLUCINOGENS OTHER THAN LSD a 
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 35, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 
b
Year
1976 7.0
1977 6.9
1978 7.3 7.1
1979 6.8 7.3
1980 6.2 5.4 5.8
1981 5.6 4.6 6.5
1982 4.7 6.1 5.2 4.0
1983 4.1 3.9 4.3 4.2
1984 3.8 3.2 4.1 3.5 3.0
1985 3.6 3.2 3.7 2.8 2.7
1986 3.0 3.6 2.6 2.7 2.0 1.4
1987 3.2 2.5 2.7 2.4 1.3 1.5
1988 2.1 2.4 3.2 1.8 1.2 0.7 0.9
1989 2.2 3.0 2.0 1.9 1.2 0.8 0.9
1990 2.1 2.6 2.4 1.6 1.0 0.7 0.6
1991 2.0 2.6 2.2 1.4 1.3 1.0 0.6
1992 1.7 1.9 3.1 1.9 1.5 0.8 0.8
1993 2.2 2.8 1.9 2.2 1.4 0.9 0.8
1994 3.1 2.2 3.1 2.0 1.3 1.2 0.9 0.5
1995 3.8 3.9 3.2 1.9 1.8 1.1 0.7 0.3
1996 4.4 4.4 3.5 2.8 1.6 0.9 0.7 0.1
1997 4.6 5.1 5.2 2.3 1.6 1.0 1.1 0.6
1998 4.6 4.8 3.7 3.1 1.8 1.4 0.7 0.5
1999 4.3 4.2 4.2 3.6 1.5 0.9 0.8 0.4
2000 4.4 4.6 4.7 3.7 2.1 1.6 1.1 0.3
2001 5.9 5.5 5.9 3.0 1.9 0.9 1.0 0.4
2002 5.4 6.5 5.2 4.1 2.5 1.7 1.6 0.3
2003 5.4 7.3 6.9 5.5 2.5 2.2 1.3 0.6
2004 5.6 6.0 6.3 4.0 3.1 2.4 1.4 0.8
2005 5.0 6.2 5.0 3.7 4.0 2.1 1.9 0.2
2006 4.6 5.3 4.9 4.2 2.0 2.1 1.4 0.4
2007 4.8 5.2 4.7 3.0 2.4 2.5 1.2   —
2008 5.0 4.7 4.5 3.0 2.8 1.6 2.6   —
2009 4.2 4.1 4.5 3.1 2.4 2.2 2.2   —
2010 4.8 4.9 4.6 3.9 3.0 2.1 2.0   —
2011 4.3 3.9 4.3 2.6 2.8 2.3 1.3   —
2012 4.0 4.4 3.3 3.0 1.9 1.9 2.1   —
2013 3.7 4.1 3.7 3.4 2.2 2.4 2.3   —
2014 3.0 4.2 3.5 3.0 2.5 2.3 2.0   —
2015 2.9 3.5 3.4 2.4 3.2 2.5 2.3   —
2016 2.7 2.9 4.2 3.4 2.8 1.8 3.5   —
2017 2.9 3.2 2.5 3.7 3.5 2.2 1.9   —
Source. The Monitoring the Future study, the University of Michigan.
Notes.  '— ' indicates data not available.  
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens other than LSD were not included in the questionnaires administered to the 40-, 45-, 
and 50-year-olds, or the 35-year-olds after 2006.
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FIGURE 5-8
ECSTASY (MDMA, Molly)
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 32, a by Age Group
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Year Original Revised Original Revised Original Revised Original Revised Original Revised Original Revised Original Revised
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989 1.9 2.1 1.3 0.3 1.0 0.1
1990 2.2 2.0 1.5 1.0 0.7 0.3
1991 0.6 1.1 1.0 0.6 0.6 0.7
1992 1.8 1.7 0.4 0.8 0.4 *
1993 1.1 0.5 1.2 0.5 0.7 *
1994 0.6 1.4 0.9 0.2 0.4 0.3
1995 2.2 2.1 1.3 1.2 1.4 0.3
1996 4.6 3.7 1.9 1.1 1.1 0.7 0.5
1997 4.0 3.1 3.9 1.3 1.6 0.5 1.4
1998 3.6 4.0 3.7 2.3 1.8 2.3 *
1999 5.6 4.9 4.6 3.3 3.4 1.8 0.7
2000 8.2 9.1 9.8 7.0 6.9 2.6 2.4
2001 9.2 11.0 10.8 6.8 4.3 4.1 2.6
2002 7.4 6.3 9.3 8.3 4.4 2.6 2.4
2003 4.5 5.3 5.3 5.2 3.4 3.1 1.2
2004 4.0 4.2 2.4 3.2 4.0 3.7 0.9
2005 3.0 4.1 3.3 2.8 2.3 2.5 2.0
2006 4.1 3.8 3.4 3.6 2.0 2.1 2.2
2007 4.5 3.1 2.7 2.6 1.9 1.9 1.4
2008 4.3 4.7 4.7 2.0 2.7 2.1 2.0
2009 4.3 3.4 3.9 3.4 2.7 1.8 1.9
2010 4.5 5.0 4.8 4.4 1.6 1.8 1.0
2011 5.3 4.8 4.7 3.7 2.5 2.3 2.0
2012 3.8 5.8 5.5 4.2 2.6 2.1 2.2
2013 4.0 5.0 5.9 4.9 3.3 2.0 1.6
2014 3.6 5.0 5.2 5.4 5.9 5.4 4.8 2.2 4.4 7.9 3.3 3.8 1.8 4.9
2015   — 3.6   — 5.2   — 4.2   — 4.8   — 4.5   — 3.5   — 2.6
2016   — 2.7   — 5.1   — 6.9   — 4.2   — 4.3   — 4.8   — 3.3
2017   — 2.6   — 1.8   — 4.8   — 5.7   — 3.3   — 2.3   — 2.9
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.
aQuestions about use of ecstasy (MDMA, Molly) were not included in the questionnaires administered to the 35-, 
40-, 45-, and 50-year-olds.
bIn 2014, a version of the question was added to an additional form that included "molly" in the description.  In 2015 the remaining forms 
changed to this updated wording.  Data for both versions of the question are included here.  
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FIGURE 5-9
COCAINE
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 6.0
1977 7.2
1978 9.0 11.8
1979 12.0 15.0
1980 12.3 16.3 19.8
1981 12.4 15.9 20.5
1982 11.5 16.9 21.6 22.9
1983 11.4 13.8 21.2 20.8
1984 11.6 14.6 20.6 20.2 21.1
1985 13.1 15.4 19.2 23.5 21.6
1986 12.7 15.9 20.4 22.8 19.7 19.9
1987 10.3 13.4 16.0 16.2 17.4 15.6
1988 7.9 10.6 14.1 15.1 15.2 14.2 14.0
1989 6.5 7.6 11.8 12.0 10.7 12.2 11.6
1990 5.3 5.6 8.7 9.5 9.9 9.9 8.1
1991 3.5 3.8 6.1 7.2 7.4 6.9 6.7
1992 3.1 3.7 5.1 6.5 6.6 7.2 6.7                                                          
1993 3.3 3.2 4.1 4.6 6.3 5.8 4.7
1994 3.6 3.2 3.9 4.8 4.2 5.4 6.0 4.7
1995 4.0 3.9 4.3 4.5 4.6 4.6 4.5 4.3
1996 4.9 3.7 4.2 4.8 3.8 4.3 4.3 5.1
1997 5.5 4.5 5.8 4.9 4.3 3.7 4.3 4.1
1998 5.7 5.3 6.0 5.2 3.7 3.9 3.7 4.4 4.5
1999 6.2 5.7 5.6 6.8 5.0 3.9 3.6 4.6 4.1
2000 5.0 5.8 6.3 6.3 4.8 3.6 2.7 3.9 3.5
2001 4.8 6.0 7.5 5.4 5.4 4.8 2.8 3.5 3.0
2002 5.0 6.5 7.0 6.0 5.6 4.0 4.4 3.6 3.7
2003 4.8 6.3 7.4 8.3 5.4 5.5 4.9 2.7 3.1 3.4
2004 5.3 6.3 8.6 8.4 6.7 5.2 3.6 3.3 3.3 3.9
2005 5.1 6.4 7.5 6.7 8.2 5.7 4.5 2.8 2.8 2.9
2006 5.7 5.7 8.4 6.9 6.6 5.2 4.7 2.5 3.0 3.4
2007 5.2 5.8 7.2 5.8 6.4 5.9 4.1 2.0 2.7 3.6
2008 4.4 5.0 7.3 5.8 6.5 5.3 5.2 3.3 2.0 2.7 2.0
2009 3.4 3.2 6.9 6.9 4.5 4.7 5.6 2.5 2.2 3.4 2.6
2010 2.9 3.4 4.9 5.9 4.8 4.7 4.0 2.6 2.0 2.4 1.8
2011 2.9 3.9 4.3 6.1 6.0 3.4 3.3 2.9 1.3 2.1 1.6
2012 2.7 3.4 3.5 5.4 3.8 4.2 3.3 2.3 1.5 1.5 1.8
2013 2.6 2.6 4.8 4.2 4.4 3.5 3.4 3.3 2.2 2.0 1.7 1.0
2014 2.6 4.6 4.7 4.7 5.9 5.2 4.6 3.1 1.8 1.5 1.7 1.3
2015 2.5 4.5 4.7 7.0 6.9 5.2 3.7 4.6 1.6 1.7 1.9 0.9
2016 2.3 3.0 6.6 6.0 4.2 4.7 4.2 3.0 2.3 1.4 2.1 1.4
2017 2.7 3.0 6.6 5.6 7.2 4.0 4.0 4.9 2.1 1.5 1.5 1.5
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-10
CRACK COCAINE
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 55, by Age Group
0
10
20
30
’76 ’77 ’78 ’79 ’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
18 Years
19–20 Years
21–22 Years
23–24 Years
25–26 Years 
27–28 Years 
29–30 Years 
35 Years
40 Years
45 Years
50 Years
55 Years
211
Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986 4.1
1987 3.9 2.7 4.1 3.4 2.4 3.0
1988 3.1 2.7 2.9 4.0 2.7 3.0 3.2
1989 3.1 1.8 3.6 3.1 1.9 2.0 2.8
1990 1.9 1.0 1.6 2.1 2.3 1.3 1.7
1991 1.5 0.6 1.3 1.4 1.5 1.6 1.1
1992 1.5 1.3 1.3 1.3 1.3 1.6 0.9                                                          
1993 1.5 1.2 1.1 1.2 1.3 1.7 1.0
1994 1.9 1.2 1.1 0.8 1.0 1.5 1.5 1.0
1995 2.1 1.0 1.3 1.0 1.1 0.9 1.5 1.0
1996 2.1 1.3 1.4 1.2 0.7 0.8 1.0 1.5
1997 2.4 1.3 1.2 1.0 0.7 0.6 1.5 0.8
1998 2.5 1.3 1.4 1.2 0.4 0.8 0.7 1.2 1.5
1999 2.7 2.4 1.2 1.5 0.9 0.8 1.3 1.1 1.0
2000 2.2 1.6 1.6 1.2 1.1 0.6 0.5 0.8 0.5
2001 2.1 1.7 1.4 1.1 1.0 1.3 0.7 0.7 0.6
2002 2.3 1.7 1.0 1.1 0.7 0.6 0.9 1.3 1.0
2003 2.2 1.8 1.2 1.1 0.5 0.6 0.8 0.7 0.8 1.1
2004 2.3 1.6 1.8 1.2 1.1 0.8 0.6 0.5 0.8 1.2
2005 1.9 1.3 1.8 1.1 0.8 1.0 1.2 0.7 0.8 0.6
2006 2.1 1.4 1.5 0.9 1.2 0.5 0.3 0.8 0.5 1.1
2007 1.9 0.8 0.8 1.0 1.5 1.0 0.3 0.5 0.3 0.7
2008 1.6 1.2 0.9 0.9 0.9 0.7 0.5 0.5 0.4 0.7 0.4
2009 1.3 0.8 0.7 0.9 0.6 0.6 0.7 0.8 0.4 1.0 0.7
2010 1.4 0.8 0.3 0.6 0.5 0.4 0.6 0.6 0.2 0.4 0.7
2011 1.0 0.6 0.5 0.6 0.5 0.7 0.6 0.1 0.2 0.6 0.5
2012 1.2 0.6 0.3 0.6 0.4 0.4 0.3 0.2 0.3 0.6 0.5
2013 1.1 0.3 0.7 0.2 0.5 * 0.3 0.2 0.1 0.5 0.4 0.3
2014 1.1 0.8 0.3 0.1 0.4 0.6 0.5 0.9 0.2 0.2 0.5 0.3
2015 1.1 0.4 0.4 0.5 0.6 0.3 0.5 0.5 0.5 0.3 0.3 0.2
2016 0.8 * * * * 0.1 0.2 0.1 0.3 0.2 0.5 0.3
2017 1.0 0.3 0.4 0.1 * 0.1 0.1 0.4 * 0.1 0.2 0.3
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-11
HEROIN
Trends in Annual Prevalence  
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 0.8
1977 0.8
1978 0.8 0.4
1979 0.5 0.3
1980 0.5 0.2 0.6
1981 0.5 0.5 0.4
1982 0.6 0.2 0.4 0.2
1983 0.6 0.2 0.3 0.6
1984 0.5 0.2 0.3 0.2 0.2
1985 0.6 0.1 0.3 0.2 0.3
1986 0.5 0.1 0.2 0.1 0.2 0.3
1987 0.5 0.2 0.3 0.1 0.3 0.3
1988 0.5 0.1 0.2 0.1 0.1 0.3 0.2
1989 0.6 0.2 0.2 0.1 0.1 0.2 0.3
1990 0.5 * 0.1 0.1 0.1 * *
1991 0.4 0.1 0.2 0.2 0.1 0.1 0.2
1992 0.6 0.1 0.3 0.2 0.1 0.2 0.1                                                          
1993 0.5 0.1 0.2 0.2 0.1 0.2 *
1994 0.6 0.1 0.1 0.1 0.2 0.2 0.3 0.3
1995 1.1 0.5 0.4 0.6 0.1 0.1 0.4 0.2
1996 1.0 0.7 0.5 0.3 0.3 0.1 0.2 0.2
1997 1.2 0.4 0.7 0.1 0.3 0.2 0.3 0.1
1998 1.0 1.1 0.4 0.2 0.3 0.1 0.1 0.1 0.4
1999 1.1 0.6 0.4 0.5 0.2 0.3 0.1 0.4 *
2000 1.5 0.7 0.5 0.4 0.3 0.1 0.1 0.1 0.1
2001 0.9 1.0 0.5 0.5 0.3 0.3 0.2 0.1 0.1
2002 1.0 0.4 0.1 0.3 0.3 0.1 0.2 0.2 0.3
2003 0.8 0.4 0.4 0.5 0.1 0.6 0.2 0.3 0.2 0.2
2004 0.9 0.4 0.5 0.3 0.2 0.1 0.3 0.1 * 0.2
2005 0.8 0.6 0.7 0.3 0.2 0.4 0.5 * * *
2006 0.8 0.5 0.6 0.3 0.4 * 0.1 0.3 0.2 0.1
2007 0.9 0.3 0.5 0.3 0.2 0.2 0.2 0.1 0.1 0.1
2008 0.7 0.6 0.9 0.6 0.3 0.2 0.3 0.1 * * 0.2
2009 0.7 0.8 0.7 0.7 0.5 0.3 0.3 0.4 * 0.1 0.3
2010 0.9 0.4 0.3 0.8 0.6 0.3 0.2 0.3 0.1 * 0.2
2011 0.8 0.4 0.4 0.6 0.5 0.4 0.3 0.0 0.1 0.1 *
2012 0.6 0.4 0.6 0.3 0.7 0.3 0.4 0.1 0.1 0.1 0.1
2013 0.6 0.5 0.8 0.6 0.8 0.6 0.4 0.6 0.2 0.2 0.1 *
2014 0.6 0.2 0.3 0.4 0.7 0.4 0.2 0.6 * 0.1 0.3 0.2
2015 0.5 0.2 0.3 0.8 0.7 0.5 0.6 0.1 * * 0.3 *
2016 0.3 0.1 0.4 0.5 0.6 0.5 0.5 0.6 * 0.1 0.2 0.1
2017 0.4 * 0.2 0.5 0.4 0.7 0.5 0.1 0.1 0.3 * 0.1
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not availa  
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 5.7
1977 6.4
1978 6.0 4.7
1979 6.2 4.7
1980 6.3 5.6 4.9
1981 5.9 4.9 5.0
1982 5.3 4.4 3.5 4.4
1983 5.1 4.2 4.0 3.3
1984 5.2 3.9 3.3 3.5 2.7
1985 5.9 3.4 3.8 3.8 3.4
1986 5.2 4.2 3.8 2.7 2.0 2.7
1987 5.3 3.7 3.6 2.4 2.5 3.0
1988 4.6 3.1 3.6 2.3 2.5 1.6 2.2
1989 4.4 3.0 3.4 2.4 2.4 2.9 2.1
1990 4.5 3.9 2.7 2.7 2.3 1.5 1.5
1991 3.5 3.2 2.4 2.4 2.4 1.8 1.8
1992 3.3 2.2 3.4 2.2 2.6 1.7 1.9                                                          
1993 3.6 2.5 2.9 2.0 2.0 1.4 1.3
1994 3.8 2.7 2.9 2.6 1.8 2.1 1.7 1.7
1995 4.7 4.7 3.1 2.5 1.8 2.4 1.9 1.6
1996 5.4 4.7 2.6 2.9 2.1 2.0 2.1 1.8
1997 6.2 4.3 5.0 2.7 2.2 2.0 2.6 2.0
1998 6.3 4.3 4.3 3.5 3.0 1.9 1.5 1.2 1.7
1999 6.7 5.5 4.2 4.1 3.0 1.8 1.8 2.1 1.4
2000 7.0 6.2 5.0 4.2 2.9 2.1 2.5 2.1 1.7
2001 6.7 7.0 6.8 4.3 3.7 3.1 2.9 2.4 1.6
2002 9.4 8.3 8.9 8.2 6.0 4.3 4.2 4.4 3.4
2003 9.3 9.9 9.6 9.7 6.4 6.7 5.1 3.4 2.3 2.8
2004 9.5 10.4 9.2 9.5 7.9 7.5 5.4 4.8 2.9 3.4
2005 9.0 9.9 10.2 7.6 8.8 6.9 7.8 4.3 3.4 3.1
2006 9.0 8.6 11.5 9.5 8.5 7.0 7.7 5.6 4.5 3.5
2007 9.2 8.2 9.4 9.4 8.5 8.1 6.1 3.8 5.8 4.4
2008 9.1 8.6 8.4 10.5 9.4 8.6 7.1 7.4 4.7 3.2 3.3
2009 9.2 6.4 11.0 8.0 9.8 6.7 8.9 6.0 4.7 4.1 4.0
2010 8.7 8.1 9.2 10.0 10.1 7.8 6.9 6.7 4.0 5.0 4.7
2011 8.7 7.7 7.7 7.8 9.0 7.6 6.7 5.8 4.9 4.0 4.2
2012 7.9 6.5 7.0 7.9 7.1 8.2 6.0 6.3 4.7 4.6 4.4
2013 7.1 7.1 6.9 7.2 6.9 6.8 6.5 6.6 4.1 3.0 3.1 2.5
2014 6.1 5.3 6.5 5.9 7.6 6.2 6.1 6.2 3.6 4.2 3.5 3.0
2015 5.4 3.6 4.7 6.4 5.9 5.4 6.0 5.6 4.5 3.6 4.6 3.4
2016 4.8 3.7 5.8 4.7 5.9 5.9 4.9 7.0 5.6 4.5 3.6 3.9
2017 4.2 3.6 3.3 4.1 4.7 4.6 5.0 5.2 4.8 3.9 3.5 3.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
aIn 2002 the question text was changed on half of the questionnaire forms for 18- to 30-year-olds. The list of examples of 
narcotics other than heroin was updated. Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—
were replaced by Vicodin, OxyContin, and Percocet. The 2001 data presented here are based on all forms. The 2002 data are 
based on the changed forms only. In 2003 the remaining forms were changed to the new wording. The data are 
based on all forms in 2003. Beginning in 2002 data were based on the changed question text for 35- and 40-year-olds. 
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FIGURE 5-13
AMPHETAMINES
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 15.8
1977 16.3
1978 17.1 18.2
1979 18.3 21.5
1980 20.8 23.8 25.5
1981 26.0 25.5 26.7
1982 20.3 23.9 22.4 21.8
1983 17.9 19.7 19.9 18.3
1984 17.7 15.8 17.4 14.0 14.9
1985 15.8 14.5 13.0 14.1 12.5
1986 13.4 11.0 13.0 11.4 8.6 9.1
1987 12.2 9.1 9.9 7.9 8.3 7.9
1988 10.9 9.2 8.1 7.6 6.4 5.0 5.5
1989 10.8 6.9 6.8 5.1 5.5 4.3 5.0
1990 9.1 6.6 5.5 5.3 4.0 4.3 2.7
1991 8.2 4.9 4.9 3.8 3.4 4.0 2.9
1992 7.1 5.6 4.3 4.0 2.7 3.5 3.3                                                          
1993 8.4 5.4 4.8 3.8 2.9 2.6 2.4
1994 9.4 5.4 5.3 4.5 3.9 2.9 2.6 2.4
1995 9.3 7.2 5.7 3.0 3.5 2.7 2.5 1.9
1996 9.5 6.5 4.9 4.1 2.5 2.5 2.6 1.9
1997 10.2 5.9 7.3 3.8 3.2 2.0 2.7 1.7
1998 10.1 7.5 5.0 4.3 2.9 2.3 1.8 1.7 1.7
1999 10.2 7.9 5.0 4.5 3.4 2.6 2.4 1.9 1.2
2000 10.5 9.3 6.0 4.8 3.6 2.7 1.4 1.8 1.4
2001 10.9 8.7 7.9 5.2 3.6 3.2 1.9 1.9 1.0
2002 11.1 9.1 7.1 5.8 3.9 3.3 2.1 1.2 1.4
2003 9.9 8.6 7.5 5.8 3.1 3.6 2.6 2.2 1.0 1.4
2004 10.0 8.5 6.7 7.1 4.6 3.9 2.2 1.5 1.1 0.9
2005 8.6 7.0 6.8 5.0 3.8 2.6 3.0 1.2 0.8 0.5
2006 8.1 6.5 7.6 6.1 4.4 3.3 2.9 1.4 1.6 1.4
2007 7.5 6.7 7.5 5.9 4.2 3.3 2.1 1.5 0.8 1.1
2008 6.8 5.9 6.7 5.7 4.0 4.1 2.6 0.7 1.1 0.9 0.6
2009 6.6 6.2 9.0 5.4 5.3 3.5 2.9 1.9 0.9 0.7 1.0
2010 7.4 8.3 9.0 7.7 5.9 4.3 3.2 1.3 0.7 0.8 0.8
2011 8.2 8.7 8.8 8.8 5.3 3.8 3.2 1.4 0.6 1.3 1.0
2012 7.9 9.3 9.4 8.4 5.8 5.5 4.3 1.4 1.0 1.0 0.4
2013 9.2 8.6 9.5 7.5 5.6 5.7 2.9 2.2 1.5 1.2 1.0 0.7
2014 8.1 9.9 9.6 6.9 7.7 5.9 5.3 2.5 1.5 0.9 0.9 0.2
2015 7.7 7.6 10.6 8.4 7.4 5.4 5.0 3.5 1.9 1.0 1.0 0.4
2016 6.7 9.1 9.4 6.3 5.8 5.7 5.1 3.3 2.9 0.9 1.1 0.7
2017 5.9 6.7 9.5 8.4 7.3 7.2 5.7 4.1 2.2 2.1 0.7 0.9
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-14
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Age 18  Ages 
19–20 
Ages    
21–22
Ages    
23–24
Ages    
25–26
Ages    
27–28
Ages    
29–30
Year
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990 1.3 0.3 0.7 0.4 0.3 0.5 0.3
1991 1.4 0.4 0.5 0.4 0.2 * 0.1
1992 1.3 0.3 0.1 0.7 0.8 0.3 0.4
1993 1.7 1.4 1.0 0.9 0.1 0.6 0.3
1994 1.8 1.3 0.4 1.7 0.6 0.3 0.7
1995 2.4 1.1 2.2 0.8 0.2 0.8 0.6
1996 2.8 1.5 0.7 1.4 0.1 0.5 0.2
1997 2.3 0.7 1.5 1.3 0.4 0.3 0.7
1998 3.0 2.0 1.1 1.4 0.6 * *
1999 1.9 1.4 0.6 1.5 0.8 0.4 *
2000 2.2 1.3 1.2 2.3 0.7 0.7 *
2001 2.5 1.9 0.9 0.6 1.1 0.8 0.3
2002 3.0 2.6 1.2 1.6 0.9 0.8 0.7
2003 3.0 2.6 1.2 1.6 0.9 0.8 0.7
2004 2.0 1.7 1.2 1.1 0.9 1.3 0.1
2005 2.3 2.4 1.7 1.0 1.7 1.3 1.7
2006 1.9 1.6 1.7 0.5 0.6 1.0 0.9
2007 1.6 0.9 0.9 1.8 1.2 0.6 0.7
2008 1.1 0.7 0.2 1.4 0.8 0.7 0.3
2009 0.9 0.5 0.5 1.3 0.8 0.7 0.3
2010 0.9 0.7 0.5 0.3 0.7 * 0.1
2011 1.2 0.4 0.5 0.3 0.3 0.9 0.1
2012 0.8 0.7 0.5 0.1 0.6 1.0 0.5
2013 1.1 0.3 0.2 1.2 1.2 1.0 1.2
2014 0.8 0.3 0.3 0.3 0.3 0.2 0.7
2015 0.5 * 0.4 0.4 1.2 0.3 0.6
2016 0.8 * 0.4 * 0.2 * *
2017 0.8 0.5 0.8 0.2 0.8 1.1 0.7
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.
aQuestions about use of crystal methamphetamine were not included in the questionnaires administered 
to the 35-, 40-, 45-, and 50-year-olds.
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FIGURE 5-15
SEDATIVES (BARBITURATES)
Trends in Annual Prevalence  
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 9.6
1977 9.3
1978 8.1 6.4
1979 7.5 6.9
1980 6.8 4.5 5.7
1981 6.6 4.7 5.8
1982 5.5 4.4 4.1 4.1
1983 5.2 3.5 3.1 3.7
1984 4.9 3.5 2.5 2.6 3.3
1985 4.6 2.0 2.3 3.0 3.4
1986 4.2 2.2 2.9 2.3 1.8 2.4
1987 3.6 1.9 2.7 1.5 2.1 2.3
1988 3.2 2.2 1.9 2.1 1.7 1.2 2.1
1989 3.3 1.6 1.8 1.8 1.3 1.7 1.4
1990 3.4 1.7 1.7 2.3 2.2 1.8 1.6
1991 3.4 1.8 1.4 2.0 2.5 1.4 1.6
1992 2.8 1.7 1.8 1.7 1.5 1.4 2.0                                                          
1993 3.4 1.9 1.6 1.7 1.8 2.3 1.1
1994 4.1 2.3 2.2 1.7 1.1 1.6 1.4 1.9
1995 4.7 3.4 2.6 1.4 1.2 1.4 1.7 1.7
1996 4.9 3.3 2.4 2.2 1.0 1.7 1.6 1.6
1997 5.1 4.0 3.5 1.5 1.5 1.0 1.8 1.3
1998 5.5 3.8 3.1 2.4 1.7 1.5 1.0 1.1 0.9
1999 5.8 5.0 2.5 3.2 1.8 1.1 1.2 1.6 1.5
2000 6.2 4.9 3.9 4.3 2.2 1.4 0.9 0.9 1.6
2001 5.7 5.2 4.8 3.4 2.7 2.1 1.3 1.8 1.4
2002 6.7 5.8 3.8 4.4 2.9 2.3 1.7 1.4 1.0
2003 6.0 5.2 4.8 3.9 2.5 3.1 1.5 1.3 0.7 1.0
2004 6.5 6.0 4.4 5.0 3.3 2.8 1.9 1.2 1.0 1.0
2005 7.2 5.1 5.0 3.8 4.0 2.8 4.4 1.4 1.3 1.4
2006 6.6 4.3 4.8 4.7 3.3 2.3 3.7 1.0 1.2 1.5
2007 6.2 4.4 4.1 4.6 3.8 4.0 3.2 3.8 2.4 2.5
2008 5.8 5.4 4.9 5.0 4.0 4.1 2.9 3.5 3.7 3.5 3.2
2009 5.2 3.5 5.6 2.9 4.1 2.6 2.9 3.1 2.9 2.7 3.0
2010 4.8 3.0 3.8 3.5 2.6 3.5 2.5 3.0 1.9 3.2 3.0
2011 4.3 2.9 2.8 3.5 4.1 2.7 2.2 4.1 2.2 2.0 2.5
2012 4.5 2.6 2.8 3.1 1.9 2.9 2.2 3.1 2.8 2.3 2.3
2013 4.8 3.1 3.6 3.6 4.2 2.7 2.6 2.6 2.7 2.7 1.8 2.2
2014 4.3 3.4 3.9 3.1 2.8 2.6 3.5 3.7 2.6 2.3 2.1 1.6
2015 3.6 2.1 3.5 3.1 2.5 2.3 2.2 2.3 2.2 2.7 3.3 2.7
2016 3.0 2.5 3.1 2.8 2.0 2.9 2.4 2.2 1.9 2.1 1.6 2.5
2017 2.9 2.0 2.1 2.2 2.5 2.3 2.1 3.1 2.1 2.2 2.2 1.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-16
TRANQUILIZERS
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 10.3
1977 10.8
1978 9.9 9.4
1979 9.6 9.8
1980 8.7 8.8 9.0
1981 8.0 7.4 7.3
1982 7.0 5.6 7.2 8.6
1983 6.9 5.1 5.8 6.6
1984 6.1 5.4 5.4 5.6 6.7
1985 6.1 4.4 4.5 6.2 7.1
1986 5.8 4.2 5.4 5.2 5.4 6.8
1987 5.5 4.0 5.5 4.1 5.8 6.2
1988 4.8 3.5 4.5 4.2 4.3 4.8 4.6
1989 3.8 3.4 3.5 3.8 2.9 4.6 4.1
1990 3.5 3.0 3.6 3.8 5.0 3.3 3.9
1991 3.6 2.7 3.2 4.0 3.9 3.8 4.2
1992 2.8 2.2 3.8 3.4 4.5 3.4 3.7                                                          
1993 3.5 2.1 3.1 3.2 3.7 3.8 2.7
1994 3.7 1.9 2.9 3.1 3.3 3.6 3.2 3.1
1995 4.4 3.7 3.5 3.0 3.1 3.4 3.5 3.6
1996 4.6 3.5 3.7 3.0 2.4 2.9 3.1 3.6
1997 4.7 4.7 3.6 2.9 1.9 2.0 4.1 3.0
1998 5.5 4.2 4.5 3.7 3.6 2.9 2.4 2.2 3.0
1999 5.8 4.1 4.2 4.2 3.5 2.6 2.1 3.4 2.0
2000 5.7 5.5 5.3 5.3 3.7 3.0 2.7 3.2 3.0
2001 6.9 6.1 7.1 5.4 5.3 3.9 4.2 4.3 3.7
2002 7.7 8.8 7.8 6.4 7.0 4.9 5.0 4.0 4.2
2003 6.7 8.0 7.0 7.2 6.3 5.2 4.3 3.8 2.2 2.9
2004 7.3 8.0 8.1 8.3 6.8 5.6 4.8 3.6 3.5 3.1
2005 6.8 6.5 8.5 6.3 7.7 4.3 7.4 4.4 3.8 2.9
2006 6.6 6.1 7.6 6.8 5.6 6.2 6.6 4.0 3.5 4.0
2007 6.2 5.7 7.6 7.5 7.4 7.6 5.0 3.5 4.5 3.9
2008 6.2 7.1 6.3 8.1 6.7 5.7 6.5 5.6 3.1 3.8 4.2
2009 6.3 4.3 7.7 7.1 7.4 5.7 7.2 5.0 4.1 2.5 2.9
2010 5.6 5.2 6.6 7.2 7.2 5.2 6.4 4.4 3.7 4.3 3.8
2011 5.6 5.3 5.2 6.6 7.2 5.2 5.1 6.2 3.0 3.8 2.7
2012 5.3 4.8 4.3 5.9 5.1 6.6 4.1 3.1 3.3 4.6 4.3
2013 4.6 4.8 4.8 6.8 4.6 6.1 5.5 4.7 3.8 3.3 4.1 2.6
2014 4.7 5.0 3.8 3.8 6.0 5.1 5.7 6.4 3.9 2.9 3.5 2.7
2015 4.7 4.7 4.9 5.6 5.2 4.8 6.1 5.6 4.0 3.8 3.1 3.9
2016 4.9 4.2 7.0 4.9 3.6 5.1 5.0 3.9 3.6 3.9 3.7 2.9
2017 4.7 3.8 4.2 4.9 5.4 5.0 4.6 4.5 4.0 1.9 3.9 3.3
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-17
STEROIDS
Trends in Annual Prevalence  
among Respondents of Modal Ages 18 through 32, a by Age Group
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Age 18  Ages 
19–20 
Ages    
21–22
Ages    
23–24
Ages    
25–26
Ages    
27–28
Ages    
29–30
Year
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989 1.9
1990 1.7
1991 1.4 0.4 0.3 0.4 0.5 0.8 0.4
1992 1.1 0.5 0.1 0.7 0.4 * 0.2
1993 1.2 * 0.9 0.4 * 0.2 *
1994 1.3 0.5 0.6 * 0.2 0.5 *
1995 1.5 0.4 0.6 0.8 0.2 * *
1996 1.4 0.3 0.1 0.3 1.0 * *
1997 1.4 0.6 0.2 0.9 0.5 0.2 *
1998 1.7 0.8 0.2 0.2 0.3 0.4 *
1999 1.8 0.5 1.1 0.1 1.0 0.1 *
2000 1.7 0.1 0.4 0.3 0.2 0.9 *
2001 2.4 0.4 0.9 * * 0.6 0.3
2002 2.5 1.0 0.3 0.4 0.3 * 1.1
2003 2.1 0.5 0.8 0.2 0.5 0.3 1.1
2004 2.5 0.8 0.2 0.5 0.5 0.3 *
2005 1.5 0.6 0.4 0.6 0.6 0.3 *
2006 1.8 0.4 1.0 * * 0.1 *
2007 1.4 0.6 1.0 0.3 0.5 1.0 *
2008 1.5 0.9 0.1 0.3 0.3 0.3 0.3
2009 1.5 1.0 0.4 1.3 * 0.6 0.3
2010 1.5 0.4 1.9 0.3 0.6 0.7 *
2011 1.2 * 0.3 * 0.2 0.3 0.1
2012 1.3 0.3 0.5 0.9 0.1 0.1 0.8
2013 1.5 0.7 0.3 0.6 0.4 0.5 *
2014 1.5 0.9 0.5 0.3 1.2 0.5 0.3
2015 1.7 0.3 0.4 0.5 1.1 * *
2016 1.0 0.5 0.4 0.8 0.2 0.1 *
2017 1.1 1.0 0.2 0.4 * * *
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not availa  
aQuestions about the use of steroids were not included in the questionnaires administered to the 35-, 
40-, 45-, and 50-year-olds.
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FIGURE 5-18a
ALCOHOL
Trends in Annual Prevalence   
among Respondents of Modal Ages 18 through 55, by Age Group
0
10
20
30
40
50
60
70
80
90
100
’76 ’77 ’78 ’79 ’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
18 Years
19–20 Years
21–22 Years
23–24 Years
25–26 Years 
27–28 Years 
29–30 Years 
35 Years
40 Years
45 Years
50 Years
55 Years
227
Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 85.7
1977 87.0
1978 87.7 89.8
1979 88.1 90.6
1980 87.9 89.0 90.2
1981 87.0 90.6 91.6
1982 86.8 88.6 91.8 90.0
1983 87.3 88.5 91.8 91.7
1984 86.0 88.7 89.1 90.4 88.2
1985 85.6 88.5 89.8 91.6 89.9
1986 84.5 88.2 90.1 88.1 88.8 87.8
1987 85.7 88.2 90.8 89.7 90.5 87.8
1988 85.3 86.6 89.5 89.7 89.4 87.7 87.2
1989 82.7 87.5 89.1 88.7 87.5 88.0 86.0
1990 80.6 85.6 89.6 88.2 87.5 86.4 86.9
1991 77.7 84.6 89.0 88.1 87.7 85.3 85.0
1992 76.8 81.9 87.9 89.1 86.7 85.6 84.5                                                          
1993 76.0 80.6 85.9 87.8 87.8 85.7 83.2
1994 73.0 78.2 84.4 86.6 86.0 84.5 82.6 82.5
1995 73.7 78.3 85.7 87.8 86.7 85.7 83.3 82.1
1996 72.5 79.6 84.4 85.7 85.9 85.3 84.7 83.5
1997 74.8 79.2 85.1 85.4 86.4 85.9 83.7 82.3
1998 74.3 79.7 86.3 84.9 83.8 85.3 84.2 82.3 77.3
1999 73.8 79.6 85.5 85.2 85.0 85.4 85.4 81.0 80.0
2000 73.2 79.7 86.2 87.2 84.2 82.9 83.7 81.0 80.3
2001 73.3 77.6 87.0 86.7 86.3 84.2 84.3 82.7 81.5
2002 71.5 78.0 85.8 88.0 88.3 84.7 83.6 85.1 80.0
2003 70.1 75.0 84.3 87.6 86.4 83.6 83.9 82.6 81.6 78.9
2004 70.6 75.2 86.8 87.2 87.9 86.1 83.5 86.7 79.8 79.2
2005 68.6 77.3 84.4 86.6 85.6 85.3 84.8 85.8 81.6 80.3
2006 66.5 77.9 83.6 88.2 86.4 86.9 84.0 83.7 80.5 82.8
2007 66.4 72.9 87.8 87.8 86.1 85.8 85.9 84.0 85.2 80.7
2008 65.5 72.3 88.6 86.6 86.4 84.7 87.8 84.3 82.0 80.3 79.0
2009 66.2 71.4 85.2 89.3 88.2 87.2 84.8 83.5 86.6 81.3 79.7
2010 65.2 68.8 83.4 89.2 86.7 86.6 86.7 85.0 86.1 81.1 80.3
2011 63.5 71.5 82.1 88.3 90.6 86.4 85.1 89.0 84.4 80.6 82.1
2012 63.5 70.3 81.8 85.0 89.4 86.7 84.2 87.2 83.0 84.4 80.2
2013 62.0 68.4 82.8 84.7 87.9 89.6 86.6 86.7 83.5 81.5 79.7 76.9
2014 60.2 67.3 84.0 85.3 85.5 90.2 86.4 89.2 84.1 84.8 83.3 77.9
2015 58.2 67.9 84.3 85.0 83.7 85.8 88.4 85.9 81.9 85.3 80.6 78.4
2016 55.6 67.6 86.5 85.0 84.4 85.2 90.8 87.3 85.7 83.0 81.5 80.5
2017 55.7 63.9 83.8 87.6 84.3 84.4 85.7 87.9 83.5 84.6 83.2 81.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-18b
ALCOHOL
Trends in 30-Day Prevalence
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 68.3
1977 71.2
1978 72.1 75.8
1979 71.8 76.5
1980 72.0 76.6 78.3
1981 70.7 77.0 80.5
1982 69.7 75.7 79.9 77.9
1983 69.4 73.9 79.3 78.9
1984 67.2 73.6 78.1 77.6 75.2
1985 65.9 73.3 75.9 79.7 76.8
1986 65.3 72.9 77.2 75.7 76.3 73.6
1987 66.4 72.5 77.2 74.9 77.7 75.0
1988 63.9 69.6 76.2 75.9 74.1 74.6 72.1
1989 60.0 69.8 73.8 72.2 72.5 73.9 72.3
1990 57.1 66.6 74.1 73.6 71.4 70.9 70.2
1991 54.0 64.5 75.3 72.4 71.6 69.8 69.6
1992 51.3 61.0 72.7 73.0 69.8 69.1 69.2                                                          
1993 51.0 60.5 71.6 73.1 69.9 68.3 66.2
1994 50.1 59.9 70.4 70.1 70.4 69.9 67.0 65.1
1995 51.3 59.2 70.4 72.3 71.8 68.0 67.0 66.8
1996 50.8 58.1 69.5 69.2 68.5 69.3 68.0 64.7
1997 52.7 59.0 69.1 69.3 70.9 70.4 65.8 65.3
1998 52.0 59.7 69.4 70.3 66.3 68.7 66.1 62.9 59.8
1999 51.0 62.0 69.2 70.2 70.0 70.2 67.4 64.2 64.2
2000 50.0 59.1 70.5 71.5 68.7 64.6 65.2 64.0 63.1
2001 49.8 59.0 71.8 70.6 68.7 66.5 66.2 63.7 65.6
2002 48.6 59.2 71.9 71.9 71.2 67.9 65.4 67.3 65.4
2003 47.5 56.7 69.5 72.7 69.1 67.2 66.5 63.7 66.2 62.2
2004 48.0 56.7 72.4 72.8 72.4 68.8 64.5 70.3 63.7 65.7
2005 47.0 59.0 70.1 71.2 73.0 70.3 65.7 68.5 65.1 65.4
2006 45.3 57.6 69.7 73.8 70.4 72.8 68.7 63.3 62.3 66.7
2007 44.4 54.7 74.5 73.1 73.8 71.9 69.8 67.5 66.9 64.1
2008 43.1 53.8 74.4 74.0 73.9 69.8 73.4 65.0 66.3 67.9 63.7
2009 43.5 52.9 72.9 78.4 75.1 70.7 71.5 65.6 71.0 66.5 64.5
2010 41.2 51.2 71.6 74.6 73.6 72.2 69.1 67.7 72.7 67.0 67.1
2011 40.0 52.3 69.3 75.7 76.4 71.8 69.6 71.1 68.6 65.2 68.3
2012 41.5 54.1 70.5 73.5 76.7 73.4 70.8 69.5 68.0 72.0 65.7
2013 39.2 51.5 70.5 72.7 75.9 73.9 71.1 70.0 69.0 67.2 66.7 61.9
2014 37.4 50.1 71.1 71.0 73.2 77.3 73.2 73.1 67.8 71.6 66.5 64.4
2015 35.3 47.9 70.1 73.1 70.0 74.2 74.7 72.5 68.1 69.7 67.8 65.9
2016 33.2 49.2 73.0 73.9 71.6 72.3 76.1 72.2 69.4 69.1 67.6 68.7
2017 33.2 46.0 72.7 74.1 71.7 68.9 71.5 72.5 71.5 69.7 70.8 66.3
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-18c
ALCOHOL
Trends in 30-Day Prevalence of Daily Use
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 5.6
1977 6.1
1978 5.7 7.6
1979 6.9 7.7
1980 6.0 7.0 8.4
1981 6.0 7.2 7.7
1982 5.7 7.5 7.8 8.2
1983 5.5 5.3 8.0 8.5
1984 4.8 5.8 7.7 6.8 7.5
1985 5.0 5.6 6.4 7.3 7.5
1986 4.8 5.3 6.3 6.2 5.3 7.3
1987 4.8 5.7 7.0 6.1 6.9 7.2
1988 4.2 4.8 7.2 6.2 6.3 5.7 7.6
1989 4.2 4.7 5.0 5.1 6.0 6.9 5.6
1990 3.7 4.0 4.9 5.3 4.8 4.9 5.6
1991 3.6 3.7 4.9 5.4 4.9 6.2 5.9
1992 3.4 3.3 4.4 4.2 6.1 4.4 5.8                                                          
1993 2.5 3.2 5.1 4.9 5.1 4.7 4.6
1994 2.9 3.3 3.9 3.7 3.3 5.4 5.0 7.2
1995 3.5 3.1 3.5 4.1 4.4 4.7 4.1 5.5
1996 3.7 2.7 5.1 4.8 3.7 3.6 5.1 7.5
1997 3.9 4.8 4.6 4.5 5.1 4.2 5.9 4.8
1998 3.9 3.6 5.7 3.9 3.4 3.1 3.4 6.0 6.9
1999 3.4 4.1 5.9 4.7 5.1 4.3 5.2 5.2 7.5
2000 2.9 3.9 5.3 4.2 3.8 3.5 3.9 5.2 6.5
2001 3.6 3.6 6.2 4.6 5.0 2.7 4.3 5.8 7.5
2002 3.5 3.9 5.6 5.0 5.4 3.7 3.8 4.8 6.6
2003 3.2 3.6 5.7 6.5 4.6 5.1 3.5 3.9 7.8 7.8
2004 2.8 3.7 5.7 5.5 4.3 3.5 3.8 6.3 6.6 9.0
2005 3.1 3.6 6.0 5.8 6.0 4.6 5.8 6.1 7.2 8.5
2006 3.0 4.3 5.9 5.7 5.2 5.8 4.5 5.3 7.0 9.5
2007 3.1 3.4 6.1 6.0 6.5 6.2 5.1 8.1 6.1 8.8
2008 2.8 2.3 5.5 6.3 6.4 6.3 4.8 5.4 7.2 9.9 11.0
2009 2.5 2.5 5.7 6.5 5.9 6.5 7.1 6.9 8.5 9.3 9.2
2010 2.7 1.8 5.4 4.9 5.6 5.7 6.1 6.0 7.8 7.2 10.5
2011 2.1 2.4 6.1 5.2 5.7 7.0 5.3 7.6 7.4 7.7 11.3
2012 2.5 3.0 4.9 6.4 5.9 7.5 7.2 6.3 8.3 9.5 10.6
2013 2.2 2.7 4.9 4.9 6.9 6.5 5.8 6.7 8.7 8.4 10.8 10.5
2014 1.9 2.9 5.6 5.2 5.7 5.8 7.6 8.0 7.3 8.8 9.8 10.0
2015 1.9 1.6 3.9 5.2 5.6 7.5 7.8 9.8 8.6 10.0 9.6 11.2
2016 1.3 2.0 6.0 4.5 6.4 7.5 6.8 7.9 8.5 8.7 9.7 14.5
2017 1.6 1.1 4.4 6.4 5.5 6.9 6.4 8.7 8.0 10.0 10.0 11.1
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-18d
ALCOHOL
Trends in 2-Week Prevalence of Having 5 or More Drinks in a Row
among Respondents of Modal Ages 18 through 55, by Age Group
0
10
20
30
40
50
60
70
’76 ’77 ’78 ’79 ’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
18 Years
19–20 Years
21–22 Years
23–24 Years
25–26 Years 
27–28 Years 
29–30 Years 
35 Years
40 Years
45 Years
50 Years
55 Years
233
Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 37.1
1977 39.4
1978 40.3 41.1
1979 41.2 42.1
1980 41.2 42.7 40.7
1981 41.4 43.1 43.6
1982 40.5 41.7 41.6 37.1
1983 40.8 40.9 42.3 39.3
1984 38.7 41.0 40.4 35.1 33.7
1985 36.7 41.2 40.4 37.3 33.3
1986 36.8 41.2 40.8 35.8 31.5 30.1   
1987 37.5 37.2 41.0 36.6 33.3 32.2
1988 34.7 37.3 42.0 37.0 30.7 28.0 26.7
1989 33.0 36.9 39.3 35.4 31.7 29.8 26.3
1990 32.2 36.0 38.1 35.5 32.0 28.9 25.2
1991 29.8 37.0 40.3 34.4 31.5 28.8 24.3
1992 27.9 34.0 39.9 34.9 31.8 29.2 25.7                           
1993 27.5 34.6 40.3 35.0 32.1 29.0 25.1
1994 28.2 34.5 40.5 32.9 30.9 28.5 27.5 21.1
1995 29.8 31.7 38.5 35.6 28.7 26.9 26.3 20.0
1996 30.2 32.7 38.2 36.3 30.0 29.7 24.9 21.9
1997 31.3 36.5 40.2 33.4 31.5 29.3 26.5 22.3
1998 31.5 34.5 39.7 35.3 31.3 28.9 26.6 20.4 19.7
1999 30.8 35.3 40.2 38.1 33.0 32.0 26.9 21.4 20.5
2000 30.0 35.3 40.6 37.0 31.5 29.1 24.0 22.2 18.3
2001 29.7 36.3 42.4 38.2 33.7 29.2 27.3 20.6 21.3
2002 28.6 36.0 40.7 39.4 34.9 28.9 25.8 22.9 20.8
2003 27.9 33.6 39.9 39.3 35.1 31.1 26.4 22.4 20.7 20.1
2004 29.2 35.5 41.7 40.4 36.4 31.3 26.9 21.6 20.2 19.2
2005 27.1 36.3 40.4 39.2 37.7 31.5 29.1 23.0 22.2 19.6
2006 25.4 33.9 42.2 43.2 36.0 32.5 29.1 22.5 20.0 19.8
2007 25.9 31.4 45.8 39.8 38.3 33.4 28.4 23.6 20.4 19.4
2008 24.6 30.7 42.1 42.2 40.0 35.0 31.9 24.4 21.9 20.9 20.0
2009 25.2 28.1 41.2 41.7 39.5 34.2 32.1 21.8 25.1 21.8 17.9
2010 23.2 28.2 39.3 40.1 36.6 35.6 32.6 23.0 21.6 22.1 17.8
2011 21.6 29.8 39.2 39.9 38.7 35.0 30.4 25.7 22.2 20.0 19.1
2012 23.7 29.5 39.1 37.5 36.3 35.1 32.8 24.3 22.2 21.0 19.0
2013 22.1 27.2 40.2 37.7 37.0 33.6 30.9 24.4 24.3 20.1 20.3 17.0
2014 19.4 28.2 38.4 33.6 32.2 35.5 31.0 24.0 22.3 23.4 21.9 17.7
2015 17.2 23.7 34.8 35.0 34.8 31.6 27.7 29.2 20.3 20.5 22.0 18.9
2016 15.5 23.1 38.2 34.7 34.7 30.3 29.8 25.3 22.6 24.2 21.7 19.1
2017 16.6 22.1 39.8 31.2 33.8 31.4 28.7 27.5 24.5 23.2 19.8 16.9
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-19a
CIGARETTES
Trends in 30-Day Prevalence  
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 38.8
1977 38.4
1978 36.7 39.3
1979 34.4 39.3
1980 30.5 36.0 37.9
1981 29.4 34.9 37.5
1982 30.0 32.1 36.2 36.7
1983 30.3 32.5 33.5 36.5
1984 29.3 31.5 32.2 33.6 33.7
1985 30.1 30.9 32.4 31.9 35.3
1986 29.6 30.0 32.0 29.9 31.3 32.5
1987 29.4 30.1 32.4 31.7 28.2 32.3
1988 28.7 28.4 29.8 29.9 27.3 29.1 28.9
1989 28.6 27.7 29.4 29.4 29.5 27.2 30.2
1990 29.4 27.2 28.6 27.8 28.4 26.5 27.8
1991 28.3 27.6 28.3 28.5 28.3 28.2 24.4
1992 27.8 29.5 29.0 28.4 26.3 27.8 23.8                                                          
1993 29.9 29.0 29.2 28.1 27.7 25.4 25.8
1994 31.2 31.3 28.8 27.0 26.4 25.0 25.5 24.8
1995 33.5 33.4 31.8 28.0 25.7 26.8 25.2 26.1
1996 34.0 34.0 32.3 30.1 26.8 26.0 23.4 25.4
1997 36.5 34.0 32.3 29.1 27.6 24.9 24.6 22.3
1998 35.1 33.9 33.7 30.9 29.9 25.6 23.1 23.6 24.3
1999 34.6 36.1 33.4 32.4 25.6 22.9 22.7 22.6 23.5
2000 31.4 32.2 33.6 29.5 28.2 26.5 21.2 24.0 23.5
2001 29.5 32.8 34.0 31.1 28.6 24.2 20.4 20.4 22.9
2002 26.7 29.8 32.6 31.9 27.3 24.7 24.4 21.9 18.9
2003 24.4 27.0 30.5 31.0 27.0 26.3 22.0 20.1 21.9 20.7
2004 25.0 27.9 31.3 31.5 29.6 25.9 21.9 20.0 20.0 20.2
2005 23.2 27.5 29.2 29.3 30.7 26.3 23.5 19.1 21.4 22.1
2006 21.6 24.6 27.3 28.1 29.1 26.3 24.4 17.7 17.3 18.9
2007 21.6 22.6 27.8 26.7 27.5 26.6 22.9 17.8 18.3 17.6
2008 20.4 21.8 24.5 26.5 24.5 25.7 24.0 20.4 17.8 17.3 18.8
2009 20.1 21.2 25.2 24.1 22.6 23.9 24.0 17.3 16.2 17.8 17.0
2010 19.2 19.6 22.8 23.0 24.3 22.5 23.9 18.3 15.2 18.3 19.9
2011 18.7 18.5 23.3 22.0 23.4 19.6 20.5 19.7 15.1 15.3 16.0
2012 17.1 16.8 18.9 20.4 20.7 22.0 18.6 18.0 12.8 15.9 15.4
2013 16.3 18.4 20.8 21.4 19.5 20.0 16.5 17.8 16.6 13.4 15.3 14.0
2014 13.6 15.8 18.9 18.3 16.3 18.1 19.0 18.0 13.5 15.4 14.5 14.6
2015 11.4 14.8 17.0 18.1 18.0 15.2 15.5 18.4 13.8 10.3 16.7 15.3
2016 10.5 9.2 15.5 14.9 15.4 15.6 14.8 16.1 13.5 12.1 13.7 13.2
2017 9.7 9.6 17.3 16.9 17.6 14.8 12.0 15.1 14.3 10.3 12.9 12.9
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-19b
CIGARETTES
Trends in 30-Day Prevalence of Daily Use 
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 28.8
1977 28.8
1978 27.5 31.0
1979 25.4 31.2
1980 21.3 29.3 31.1
1981 20.3 26.0 31.4
1982 21.1 23.9 28.6 30.1
1983 21.2 24.4 26.0 30.6
1984 18.7 24.1 25.3 27.8 28.7
1985 19.5 23.2 25.3 25.1 30.4
1986 18.7 21.9 24.4 25.2 27.3 27.6
1987 18.7 22.5 24.2 26.0 23.7 27.9
1988 18.1 19.5 22.3 24.0 22.9 25.0 25.4
1989 18.9 18.9 22.5 23.3 25.0 22.9 26.4
1990 19.1 19.2 20.2 22.2 23.3 22.2 24.2
1991 18.5 19.4 20.6 22.5 22.8 23.9 21.0
1992 17.2 20.5 21.2 20.9 20.3 21.8 20.3                                                          
1993 19.0 21.1 20.5 20.1 21.9 20.1 21.7
1994 19.4 21.9 21.1 19.9 19.8 20.5 20.9 22.5
1995 21.6 22.2 24.0 20.0 19.2 20.9 20.1 23.0
1996 22.2 22.5 22.8 22.8 21.1 19.4 18.6 22.1
1997 24.6 22.7 21.4 21.5 19.2 17.6 19.7 18.3
1998 22.4 23.8 22.8 21.2 21.9 19.5 17.2 20.4 21.7
1999 23.1 25.6 24.2 21.4 19.6 16.0 17.2 19.7 20.9
2000 20.6 22.7 25.1 21.2 20.1 19.7 15.8 20.1 20.8
2001 19.0 21.9 23.6 22.4 20.9 17.2 14.4 16.4 20.1
2002 16.9 20.6 23.9 23.5 19.8 18.1 17.4 18.2 16.7
2003 15.8 18.8 20.8 21.5 20.4 19.8 16.4 16.3 19.0 19.0
2004 15.6 18.2 21.5 23.3 22.7 18.2 16.7 14.8 16.6 17.8
2005 13.6 17.6 19.2 20.4 22.5 18.6 18.9 14.5 18.5 20.1
2006 12.2 14.4 17.7 19.5 22.0 20.2 18.3 13.5 14.6 16.7
2007 12.3 12.9 18.3 17.5 19.2 19.3 16.8 13.9 15.8 15.4
2008 11.4 14.3 16.1 17.9 17.4 18.3 17.4 16.5 14.7 14.6 16.8
2009 11.2 12.8 14.9 16.2 15.3 16.5 16.7 13.7 12.7 15.6 15.4
2010 10.7 11.1 15.5 15.3 16.2 16.2 17.3 14.3 12.3 16.4 18.0
2011 10.3 10.2 15.0 13.7 17.0 13.4 14.8 15.7 11.8 13.6 14.2
2012 9.3 9.5 11.5 13.1 14.1 16.0 14.3 13.4 10.5 13.8 13.5
2013 8.5 10.8 12.0 13.1 10.9 13.8 11.3 12.4 13.5 11.0 13.2 13.2
2014 6.7 8.1 10.8 11.1 11.6 12.1 13.5 13.4 9.7 12.0 13.0 12.9
2015 5.5 6.8 10.0 11.0 11.4 9.1 11.3 13.5 11.6 8.5 14.2 13.4
2016 4.8 3.5 8.3 8.6 9.7 10.4 10.9 11.3 9.9 9.9 11.3 11.6
2017 4.2 4.8 8.7 9.6 9.4 10.9 7.4 11.4 11.4 8.3 11.4 11.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
FIGURE 5-19b (cont.)
CIGARETTES
Trends in 30-Day Prevalence of Daily Use 
 among Respondents of Modal Ages 18 through 55, by Age Group
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(Figure continued on next page.)
FIGURE 5-19c
CIGARETTES
Trends in 30-Day Prevalence of Smoking a Half Pack or More per Day
among Respondents of Modal Ages 18 through 55, by Age Group
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Age 18  Ages 19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 Age 40 Age 45 Age 50 Age 55
Year
1976 19.2
1977 19.4
1978 18.8 23.8
1979 16.5 24.6
1980 14.3 21.9 25.2
1981 13.5 19.3 25.3
1982 14.2 18.0 23.0 24.6
1983 13.8 17.2 19.7 25.1
1984 12.3 17.2 21.2 22.8 24.1
1985 12.5 16.6 20.4 20.8 24.8
1986 11.4 16.2 19.3 21.1 22.0 23.2
1987 11.4 15.6 19.3 21.6 19.9 23.3
1988 10.6 13.8 17.3 18.4 18.6 20.6 22.3
1989 11.2 13.0 16.4 18.6 20.6 19.0 22.0
1990 11.3 14.3 15.0 17.4 19.6 18.2 20.5
1991 10.7 12.7 14.1 17.4 18.2 19.0 16.7
1992 10.0 14.5 15.1 15.5 15.8 17.9 17.0                                                          
1993 10.9 14.5 14.5 15.2 17.4 16.3 17.9
1994 11.2 15.0 15.6 15.0 15.0 15.9 16.8 19.1
1995 12.4 15.2 18.1 15.3 14.2 16.3 16.5 19.1
1996 13.0 14.7 15.7 16.1 15.0 14.8 15.2 18.5
1997 14.3 15.4 14.7 16.4 13.2 12.8 15.9 15.4
1998 12.6 16.9 16.2 14.5 15.5 14.8 12.2 16.3 18.7
1999 13.2 16.3 16.4 14.8 15.0 12.4 13.2 17.3 17.2
2000 11.3 14.6 17.2 14.1 14.8 14.7 12.5 15.7 17.2
2001 10.3 13.9 15.9 15.8 15.1 12.6 11.4 13.4 15.9
2002 9.1 12.8 14.4 15.9 14.1 13.9 14.0 13.0 13.6
2003 8.4 11.7 13.8 15.4 14.0 14.8 12.7 12.4 14.9 16.8
2004 8.0 11.6 12.7 15.2 15.6 12.8 12.5 10.9 14.2 15.4
2005 6.9 10.1 12.1 13.9 13.6 13.1 14.1 11.3 16.0 16.4
2006 5.9 8.8 10.9 12.8 14.0 13.6 13.5 10.7 12.2 14.2
2007 5.7 7.5 10.7 10.6 14.3 13.0 12.6 10.5 12.1 12.3
2008 5.4 7.3 9.8 11.5 10.9 12.0 12.3 12.4 11.6 12.2 13.9
2009 5.0 7.4 9.1 8.6 10.3 11.8 10.5 11.1 8.5 13.0 12.2
2010 4.7 6.7 9.3 9.6 11.3 10.1 10.7 10.8 9.1 13.3 14.4
2011 4.3 4.5 7.9 8.2 9.7 7.6 9.2 10.8 8.7 11.0 11.1
2012 4.0 4.6 7.3 8.2 7.7 10.4 7.8 10.8 7.7 10.6 11.2
2013 3.4 5.4 6.5 8.1 6.4 8.5 7.1 8.9 10.2 8.7 10.3 11.1
2014 2.6 4.3 6.4 7.1 7.5 7.5 8.0 8.7 7.0 9.1 10.5 10.8
2015 2.1 3.6 5.1 7.0 6.6 6.2 7.7 9.1 9.2 6.4 11.4 11.2
2016 1.8 1.8 4.4 5.4 5.7 6.8 6.9 8.3 7.4 7.7 8.9 9.0
2017 1.7 2.7 3.8 5.9 4.8 5.8 4.1 6.2 7.8 5.8 8.9 8.9
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
FIGURE 5-19c (cont.)
CIGARETTES
Trends in 30-Day Prevalence of Smoking a Half Pack or More per Day
 among Respondents of Modal Ages 18 through 55, by Age Group
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Chapter 6 
ATTITUDES AND BELIEFS ABOUT DRUGS 
AMONG YOUNG ADULTS 
One of the most important theoretical contributions of MTF has been to demonstrate the extent to 
which attitudes and beliefs about drugs can help explain the use of drugs. Earlier volumes in this 
monograph series, as well as other publications from the study, have demonstrated that shifts in 
certain attitudes and beliefs—in particular the degree of risk of harm perceived to be associated 
with use of a particular drug—are important in explaining changes in actual drug-using behavior. 
Indeed, on a number of occasions we have accurately predicted such changes in use by using 
perceived risk as a leading indicator of use.1 In this chapter, we review trends in these attitudes 
and beliefs held by young adults since 1980. 
PERCEIVED HARMFULNESS OF DRUGS 
Figures 6-1 through 6-32 present three separate trend lines for four-year age strata (that is, 
respondents who are one to four years beyond high school [modal ages 19–22], five to eight years 
beyond high school [modal ages 23–26], and nine to twelve years beyond high school [modal ages 
27–30]). For comparison purposes, data are also included for the high school senior classes, listed 
as modal age 18-year-olds. Figures 6-1 to 6-3 present trends in the percentages of young adults 
aged 18 to 30 who perceive a “great risk” of harm (physically or in other ways) associated with 
three different levels of marijuana use—trying it once or twice (experimental), smoking it 
occasionally, and smoking it regularly. Subsequent figures do the same for selected levels of use 
of various other licit and illicit drugs. Table 6-1 provides the tabular information underlying the 
figures.  
For most of the life of the study, these questions were contained in one questionnaire form only, 
limiting the numbers of follow-up cases. Accordingly, we have used the four-year age bands to 
increase the available sample sizes to about 250–600 weighted cases per year for each age band, 
thereby improving the reliability of the estimates. (The numbers of weighted cases are given at the 
end of Table 6-1. The actual numbers of respondents are somewhat larger.) Still, these are 
relatively small sample sizes for young adults compared to those available regarding attitudes for 
8th, 10th, and 12th graders, and thus the change estimates are relatively less stable.  
Beginning with 2012 we expanded the numbers of forms from which these data are drawn; this 
increased the sample sizes from that point forward, thus improving the reliability of both the point 
1 See also: Bachman, J. G., Johnston, L. D., O’Malley, P. M., & Humphrey, R. H. (1988). Explaining the recent decline in marijuana use: 
Differentiating the effects of perceived risks, disapproval, and general lifestyle factors. Journal of Health and Social Behavior, 29, 92–112; 
Bachman, J. G., Johnston, L. D., & O’Malley, P. M. (1990). Explaining the recent decline in cocaine use among young adults: Further evidence 
that perceived risks and disapproval lead to reduced drug use. Journal of Health and Social Behavior, 31, 173–184; Bachman, J. G., Johnston, L. 
D., & O’Malley, P. M. (1998). Explaining recent increases in students’ marijuana use: Impacts of perceived risks and disapproval, 1976 through 
1996. American Journal of Public Health, 88, 887–892; Johnston, L. D. (1981). Characteristics of the daily marijuana user. In R. de Silva, R. L. 
DuPont, & G. K. Russell (Eds.), Treating the marijuana-dependent person (pp. 12–15). New York: The American Council on Marijuana; Johnston, 
L. D. (1985). The etiology and prevention of substance use: What can we learn from recent historical changes? In C. L. Jones & R. J. Battjes (Eds.), 
Etiology of drug abuse: Implications for prevention (NIDA Research Monograph No. 56, DHHS Publication No. ADM 85 1335, pp. 155–177). 
Rockville, MD: National Institute on Drug Abuse; Keyes, K. M., Schulenberg, J. E., O’Malley, P. M., Johnston, L. D., Bachman, J. G., Li, G., & 
Hasin, D. (2011). The social norms of birth cohorts and adolescent marijuana use in the United States, 1976-2007. Addiction, 106(10), 1790-1800. 
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estimates and the trend estimates. Because the questions are contained in different numbers of 
forms for the different drugs, the sample sizes vary between drugs, as is noted in the tables. For 
each question, we include data from all available forms.  
 
Because of the nature of the MTF design, trend data are available for a longer period for 19- to 22-
year-olds (since 1980) than for 23- to 26-year-olds (since 1984) or 27- to 30-year-olds (since 1988). 
Also displayed in Table 6-1 are comparison data for 12th graders, shown here as 18-year-olds, from 
1980 onward. (See also Table 8-3 in Volume I for the longer-term trends in 12th graders’ levels of 
perceived risk.) Questions about these attitudes and beliefs are not included in the questionnaires 
for respondents over age 30 due to the length limitations imposed by using a single questionnaire 
form for respondents ages 35 and older.  
 
• Table 6-1 and Figures 6-1 to 6-32 illustrate considerable differences in the degree of risk 
of harm young adults have associated with various drugs. In general, the results closely 
have paralleled the distinctions in degree of risk across various drugs made by 12th graders.  
 
• Marijuana was seen as the least risky of the illicit drugs, although sharp distinctions were 
made between different levels of marijuana use (Table 6-1, Figures 6-1 through 6-3). In 
2017, experimental use of marijuana (i.e., try it once or twice) was perceived as being of 
great risk by only 7% to 10% of all high school graduates ages 19–30, whereas regular use 
was perceived to carry great risk by a considerably higher percentage (23–27%). Since 
2006 there have been very substantial declines in perceived risk of regular marijuana use; 
in 2006, 55-58% of all four age groups saw great risk, and by 2017, 23-27% did so. These 
substantial declines suggest a possible period effect, that may well have been due to the 
increasing discussion about liberalizing marijuana laws, including for medical use and 
more recently for recreational use by adults. While actual law changes were specific to 
individual states, the discussions were very prominent nationwide, and we believe had a 
direct effect on perceived risk across the nation. Levels of perceived risk of regular 
marijuana use in 2017 were the lowest observed since each of the young adult age groups 
was included in the study – going back to 1980 in the case of 19-22 year olds; each age 
group declined in 2017 including significant declines for 23-26 and 29-30 year olds, 
dropping 6.9 and 4.7 percentage points, respectively. And likely not coincidentally, 
prevalence of daily marijuana use in 2017 was at a new high among young adults at 7.8% 
(as discussed in Chapter 5). 
 
• In the mid-1980s and early 1990s, fewer of the older age groups attached great risk to 
regular use of marijuana than did the younger respondents (Figure 6-3). Indeed, there was 
a regular negative ordinal relationship between age and perceived risk for some years after 
1980, when the first such comparisons were available. Although at first this looked like an 
age effect, the MTF design allowed us to recognize it as a cohort effect; the younger cohorts 
initially perceived marijuana as more dangerous than the older cohorts did and persisted in 
such beliefs as they grew older. Newer cohorts, however, showed lower levels of perceived 
risk that they then carried up the age spectrum. In the past few years, age differences have 
been slight. 
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The decline in perceived risk in regular use that began in the 1990s was greater in the 
younger age bands, including grades 8 and 10, and least among the 27- to 30-year-olds. 
We believe that much of the eventual decline in perceived risk in the older age bands 
resulted directly from replacement of earlier cohorts by later, less concerned ones. The 
credibility of this view is strengthened by the 1993–1995 reversal of the relationship 
between age and perceived risk of regular use. This reversal is consistent with an 
underlying cohort effect and could not simply reflect an association between age and a 
regular change in these attitudes. The decline in perceived risk of regular marijuana use 
ended in a somewhat staggered fashion—among 12th graders in 1999, among 19- to 22-
year-olds in 2001, among 23- to 26-year-olds in 2002, and among 27- to 30-year-olds in 
2004. This was also indicative of a cohort effect playing out in these attitudes. In 2007 all 
four age strata showed declines of three to four percentage points in perceived risk of 
regular marijuana use; although no one of these declines was statistically significant taken 
alone, the consistency across all four groups suggests that the shift was real. Since then the 
declines have continued, though somewhat erratically; but all four age groups showed 
substantial declines between 2006 and 2017 in perceived risk of regular marijuana use, 
suggesting a possible period effect. Indeed, the age bands 18, 23-26, and 27-30 all showed 
significant one-year declines in perceived risk of regular marijuana use from 2014 to 2015, 
with continuing (but nonsignificant) declines for all age groups in 2016, and continuing 
significant declines in the older two age groups and nonsignificant declines in the two 
younger age groups in 2017. The 2017 levels are at all-time lows for all age groups. 
• Young adults (ages 19–30) viewed experimental use of any of the other illicit drugs as
distinctly riskier than the experimental use of marijuana (which was at 7% to 10% in 2017).
About 30–37% of young adults thought trying sedatives (barbiturates) involved great risk;
the corresponding figures were 26–37% for amphetamines, 32–41% for LSD, 44–48% for
narcotics other than heroin, 43–51% for ecstasy (MDMA), 46–50% for cocaine powder,
and 71–74% for heroin. Note that two classes of prescription drugs – sedatives and
amphetamines – have among the lowest levels of perceived risk among this set. (Perceived
risk of tranquilizers is not asked, but likely would rank low as well.)
• Items about perceived risk of synthetic marijuana use were added to the questionnaires in
2012 (Figures 6-4 and 6-5). These drugs are sold over the counter in small packets
containing plant material that has been sprayed with any number of chemicals with
chemical structures similar to cannabinoids. The percent seeing great risk in trying
synthetic marijuana in the three young adult age bands were 29–31% in 2012 and 41-43%
in 2017, reflecting a clear increase in perceived risk in all four age groups over that interval.
Following increases of 3 to 8 percentage points in perceived risk for all three young adult
age groups between 2015 and 2016, it leveled or declined nonsignificantly for each of these
age groups between 2016 and 2017; nonetheless 2017 levels of perceived risk are at lowest
or second lowest for all three since 2012. Correspondingly, as discussed in Chapter 5, use
of synthetic marijuana has fallen precipitously since 2012 as perceived risk has risen.
• Perceived risk of experimental use of LSD continued to decline in 2017 for all four age
groups (significantly so for the 23-26 age group); proportions seeing great risk of harm in
experimental use were 30%, 35%, 32%, and 41%, respectively. The older age groups have
243
Chapter 6: Attitudes and Beliefs
been more likely to see LSD as dangerous (Figures 6-6 and 6-7). These age distinctions 
became sharper through about 2001 for experimental use, as perceived risk declined more 
in the younger age groups—again indicating some important cohort changes in these 
attitudes, quite likely as a result of generational forgetting of the dangers of LSD. 
Generational forgetting is a phenomenon wherein younger replacement cohorts no longer 
carried the beliefs—nor had the direct or vicarious experience upon which those beliefs 
were based—that the older cohorts had at that age. (The implications of generational 
forgetting for prevention are discussed in the last section of this chapter.) The distinctions 
continued to grow for regular use of LSD through 2015 as perceived risk among the 18-
year-olds continued a long-term decline. In 2016 and 2017, it declined for the older age 
groups too (with the decline in 2017 being significant for the 19-22 year olds) reducing the 
age gap in perceived risk. Correspondingly, as discussed in Chapter 5, LSD has shown 
some recent resurgence among young adults, though annual use declined nonsignificantly 
in 2017. 
• Perceived risk of experimenting with MDMA (ecstasy and, more recently, Molly) declined
nonsignificantly for the three young adult age groups in 2017 (to 44%, 43%, and 51%,
respectively). These questions were introduced in the follow-up surveys in 1989, but were
not asked of 12th graders until 1997 (due to concerns about introducing the secondary
school students to a drug with such an alluring name). (See Figures 6-18 and 6-19.) At the
beginning of the 1990s, all young adult age groups viewed ecstasy as a fairly dangerous
drug, even for experimentation. But, again, the different age bands showed diverging trends
during the 1990s, with the oldest two age bands continuing to see ecstasy as quite
dangerous, but the 19- to 22-year-olds (and very likely the 12th graders, for whom we did
not have data until 1997) coming to see it as less so. In 2000, 38% of 12th graders saw great
risk in trying ecstasy versus 49% of 27- to 30-year-olds; in 2001, the corresponding figures
were 46% and 54%. In fact, three of the four age groups showed appreciable increases in
perceived risk of ecstasy use in 2001, which led us to predict a decline in use. The increase
in perceived risk continued in 2002 in the two youngest age strata, and their use of ecstasy
did, indeed, begin to decline—and decline sharply (see chapter 5). Perceived risk of using
once or twice continued to rise among 18-year-olds, whose levels exceeded the levels seen
in the other age bands from 2004 through 2009. Since about 2010, perceived risk of trying
ecstasy has generally converged among the age groups, showing some uneven change for
young adults including a recent decline for all three age groups, and a leveling for 12th
graders. In 2017, perceived risk ranged from 43% to 51% for all four age groups (Figure
6-18).
• Perceived risk of salvia use (Table 6-1) was included for the first time in 2012 in the young
adult questionnaires; the percent seeing great risk in trying salvia ranged from 19% to 23%
among the young adults in 2012 and from 21% to 24% in 2017.
• Recent years showed little systematic change in perceived risk of cocaine use among young
adults and not a great deal of difference in this belief among the different age groups
(Figures 6-9 through 6-11). In 2017, perceived risk of experimental use declined
nonsignificantly for all four age groups to between 48% and 51%, with negligible age
differences. Regarding previous trends, a decline in perceived risk of trying cocaine and
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occasional use began among 19- to 22-year-olds after 1994, among 23- to 26-year-olds 
after 1999, and among 27- to 30-year-olds after 2001, suggesting a cohort effect in this 
belief (Figures 6-9 and 6-10). Young adults generally reported somewhat higher perceived 
risk with respect to regular cocaine use than did 12th graders (Figure 6-11). The age 
differences were smaller for occasional and experimental use. Since the early 1990s, 
perceived risk of regular use of cocaine gradually declined among 12th graders, likely due 
to generational forgetting of the dangers of this drug, and resulted in an increasing gap 
between them and the older age groups (Figure 9-10). 
To illustrate cohort effects in the trends, we note that between 1980 and 1986, among 12th 
graders and the young adult age groups, the danger associated with using cocaine on a 
regular basis grew considerably -- by 13 and 17 percentage points, respectively. 
Interestingly, these changed beliefs did not translate into changed behavior until the 
perceived risk associated with experimental and occasional use began to rise sharply after 
1986. When these two measures rose, a sharp decline in actual use occurred. We 
hypothesized that respondents saw only these lower levels of use as relevant to them and, 
therefore, saw themselves as vulnerable only to the dangers of such use. (No one starts out 
planning to be a heavy user; further, in the early 1980s, cocaine was not believed to be 
addictive.) Based on this hypothesis, we included the additional question about occasional 
use in 1986, just in time to capture a sharp increase in perceived risk later that year. This 
increase occurred largely in response to the growing media frenzy about cocaine—and 
crack cocaine, in particular—and to the widely publicized, cocaine-related deaths of 
several public figures (most notably Len Bias, a collegiate basketball star and a top 
National Basketball Association draft pick). After stabilizing for a few years, perceived 
risk began to fall off around 1992 among 12th graders, but not among the older age 
groups—again suggesting that lasting cohort differences were emerging. Now, about 30 
years later, none of the young adult age groups has had much exposure to the cocaine 
epidemic of the mid-1980s, which likely explains why there no longer is much age-related 
difference in the level of perceived risk, except with regards to regular use, for which 12th 
graders have been showing a declining level of perceived risk, unlike any of the young 
adult strata (Figure 6-11). This likely reflects a generational forgetting of the dangers of 
cocaine by cohorts that are further and further from the peak of the cocaine epidemic in the 
mid-1980s. 
• Perceived harmfulness of crack use had been lowest among 12th graders for many years
through 2012 (Figures 6-12 through 6-14); we no longer ask these questions of young
adults. High school seniors have been considerably less likely than any of the older age
groups to view occasional and regular use of crack cocaine as dangerous. Trend data
(available since 1987) on the risks perceived to be associated with crack use showed
increases in 1987–1990 for all age groups, followed by relatively little change in the older
age strata. During the 1990s, twelfth graders showed decreases in the perceived risk of
experimental use of crack—perhaps reflecting the onset of generational forgetting of its
dangers—leaving them as perceiving considerably less risk than the older groups. The
young adult age groups showed a staggered decline in this measure, with 19- to 22-year-
olds showing a decline after 1994, 23- to 26-year-olds since 1996, and 27- to 30-year-olds
after 2001. As a result, the several ages differed more in their levels of perceived risk of
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crack use, until declines in the older age groups after about 2002. Given this lack of 
historical or age variation, questions about perceived risk of crack use were dropped from 
the young adult questionnaires in 2012 to make room for such questions about other drugs. 
• Perceived risk of trying amphetamines continued to show uneven change across the four
age groups in 2017, increasing nonsignificantly for all but the 23-26 year olds (which
showed a significant decrease) to 32%, 37%, 26%, and 32%, respectively (Figure 6-23).
Regarding earlier trends, perceived risk increased in all four age strata very gradually from
1980, when first measured, through 2010, with little difference among them. In 2011 it
dropped in all strata and then held level thereafter through 2016 when it ranged from 31%
to 34% across the four age groups. (Note that in 2011, we changed examples of
amphetamines from “uppers, pep pills, bennies, speed” to “uppers, speed, Adderall, Ritalin,
etc.”, which appears to account for the change in 2011.) Across the years, there was more
difference among the age groups with regard to the risk attached to regular amphetamine
use (Figure 6-24), with the older two strata generally seeing greater risk than the younger
two strata, and especially the 12th graders. The younger two strata showed an increase in
perceived risk during the 1980s and then some fallback in the early 1990s, before
stabilizing. The sharp decline observed for experimental use after 2010 was also seen for
regular use from 2009 to 2011 among 12th graders and from 2011 through 2012 among all
of the young adult strata; since then, change has been uneven for the four age groups. With
few exceptions, the risk of regular use continued to decline each year for all age groups
through 2017.
• Perceived risk questions for Adderall were added to the young adult questionnaires for the
first time in 2012. They showed that perceived risk of using once or twice ranged from
29% to 30% in the three young adult age bands in 2012. Perceived risk decreased
nonsignificantly in 2017 for the two older age groups to a range of 28% to 33% (Table 6-
1).  
• Measures of perceived risk of crystal methamphetamine (ice) use are no longer included
for young adults (Table 6-1). These measures were introduced in 1990, and the results
showed what might be an important reason for its lack of rapid spread. More than half of
all 12th graders and young adults perceived it as quite dangerous even to try, perhaps
because it was likened to crack in many media accounts. (Both drugs come in crystal form,
both are burned and the fumes inhaled, both are stimulants, and both can produce a strong
dependence.) There was rather little age-related difference in perceived risk associated with
use of crystal methamphetamine in 1990 and 1991, although the two youngest age groups
were somewhat higher. But as perceived risk fell considerably among 12th graders (and
eventually among 19- to 22-year-olds) and held steady or rose in the oldest two age groups,
an age-related difference emerged. Twelfth graders have fairly consistently had the lowest
level of perceived risk since 2002. Since about 2003 or 2004, perceived risk has risen some
among all of the age strata, narrowing the age-related differences that had emerged for a
few years. In 2011 perceived risk of trying this drug stood at 67% among 12th graders and
at 73–75% in all of the older strata. Given this lack of variation in recent years and low
levels of actual use, these questions were discontinued in the young adult (but not in the
secondary school) surveys in 2012 to make room for such questions about other drugs.
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• In 2012 perceived risk questions about the use of bath salts—over-the-counter synthetic
stimulants—were added to the questionnaires (Table 6-1). That year fairly high proportions
of the young adults saw great risk of harm in even trying bath salts (45-49%), but
considerably fewer of the 18-year-olds did (33%). Perceived risk has increased
dramatically for bath salts in all four age strata, with increases ranging from 18 percentage
points among 12th graders to 22 to 24 percentage points in the three young adult age strata.
In 2017 even trying bath salts once or twice was seen as dangerous by between 68% and
72% in the young adult age strata—very high levels. (Some of this shift occurred because
fewer respondents chose the “Can’t say, drug unfamiliar” option, suggesting that more of
them were familiar with the drug and the risks associated with it.)
• Perceived risk of experimental use of heroin has shown long-term gradual increases for all
age groups, though it appears to have leveled in the past few years, with 2017 percentages
being 63%, 71%, 74%, and 74%, respectively. Across the years, young adults have been
more cautious than 12th graders about heroin use, suggesting some age effect. (See Figures
6-20 through 6-22.) In general, there has been relatively little change over the years in the
proportions of all age groups seeing regular heroin use as dangerous, with the great
majority of each group (over 85%) consistently holding this viewpoint (Figure 6-22).
However, with regard to perceived risk of experimental use of heroin, there was a long-
term gradual rise in all age strata from the mid-1980s through 2015, with it showing some
leveling since (Figure 6-20). From 1980 to 1986 there was a downward shift among 12th
graders in the proportion seeing great risk associated with trying heroin (a trend that began
in 1975 noted in Volume I) and some decline among 19- to 22-year-olds. Following this
decline, young adults showed a gradually increasing caution about heroin use in the latter
half of the 1980s—possibly due to heroin injection being associated with the spread of
HIV—followed by a leveling through most of the 1990s (note that young adult data does
not extend back equally far for all young adult age groups). In 2017, as in all previous
years, more young adults than 12th graders saw experimental and occasional heroin use as
risky (Figures 6-20 and 6-21); and this difference has grown some since the early 1990s
with regard to regular use, suggesting some generational forgetting of the dangers seen by
older age groups (Figure 6-22).
It is noteworthy for public health purposes that in 1996 and 1997, young adults’ perceived 
risk of experimental use of heroin increased some, as happened among 12th graders (as well 
as among 8th and 10th graders). These various trends could reflect, in chronological order, 
(a) the lesser attention paid to heroin by the media during the late 1970s and early 1980s 
as cocaine took center stage; (b) the subsequent great increase in attention paid to 
intravenous heroin use in the latter half of the 1980s due to the recognition of its importance 
in the spread of HIV/AIDS; (c) the emergence in the 1990s of heroin so pure that people 
no longer needed to use a needle to administer it; and (d) the subsequent increased attention 
given to heroin by the media (partly as a result of some overdose deaths by public figures 
and partly prompted by the emergence of “heroin chic” in the design industry), as well as 
through an anti-heroin media campaign launched by the Partnership for a Drug-Free 
America in June 1996.  
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• Perceived risk questions about narcotics other than heroin (without medical supervision)
were first asked of the young adults in 2012; between 43% and 47% of the three age groups
saw great risk of harm in experimenting with such drugs. Little has changed since them,
with rates ranging between 44% and 48% in 2017. None of the one-year changes have been
significant over the years (Table 6-1). Many more see regular use as having great risk of
harm (between 73% and 78% in 2017) with rather little systematic change since 2012. As
with heroin use discussed above, young adults have tended to see use of narcotics other
than heroin as more risky than have 12th graders. It may seem surprising, given the heavy
public attention paid to narcotic drugs in recent years that perceived risk has not risen. On
the other hand, it is quite high relative to many of the controlled substances and perhaps
there was a rise prior to 2012.
• In 2017, a minority of young adults saw binge drinking or occasions of heavy drinking
(having 5 or more drinks in a row) on weekends as dangerous (38–42%), as did a slightly
larger proportion of 12th graders (46%; Figure 6-30). The belief that heavy drinking carries
great risk increased over the 1980s in these age groups, rising among 12th graders from
36% in 1980 to 49% in 1992. Among 19- to 22-year-olds, it rose from a low of 30% in
1981 to 42% in 1992; the increases among the older groups were smaller. The increase in
this belief could well help to explain the important decline in actual heavy drinking, and
could in turn be explained by the media campaigns against drunk driving and the increase
in the drinking age in a number of states.2 Following a staggered pattern, perceived risk of
harmfulness reached a peak among 18-year-olds in 1992, among 19- to 22-year-olds in
1993, among 23- to 26-year-olds in 1994, and among 27- to 30-year-olds in 1995,
suggesting some cohort effect in this important belief. This staggered pattern of additional
peaks occurred again in 1996 for 18-year-olds, in 1998 for 19- to 22-year olds, and in 1999
for the two older groups. It also appears that this cohort effect followed a period effect of
increased perceived risk that took place for all age groups earlier in the 1980s. Since 1998
through 2017, perceived risk of heavy drinking has not changed much among the 19–30
age groups but has risen slightly among the 18-year-olds.
• The perception that having one or two drinks per day is dangerous continues to be low for
all four age groups, with 2017 percentages of 9.3%, 6.5%, 4.1%, and 3.3%, respectively
(Figure 6-28). Between 1980 and 1991, a very gradually increasing proportion of all four
age groups viewed this as being risky, but then they all showed a parallel decrease in
perceived risk of this behavior through at least 2000. It seems likely that the earlier increase
was due to the general rising concern about the consequences of alcohol use, particularly
drunk driving, and that the subsequent decline in perceived risk was due to increasing
reports of cardiovascular health benefits of light-to-moderate daily alcohol consumption.
From about 2001 through 2017, there has been little systematic change in this belief in any
of the age strata, and there has been little difference by age across the entire 35-plus-year
interval. However, since 2006, 18-year-olds have generally seen the most risk from daily
drinking.
2 See O’Malley, P. M., & Johnston, L. D. (1999). Drinking and driving among U.S. high school seniors: 1984–1997. American Journal of Public 
Health, 89, 678–684; O’Malley, P. M., & Johnston, L. D. (2003). Unsafe driving by high school seniors: National trends from 1976 to 2001 in 
tickets and accidents after use of alcohol, marijuana and other illegal drugs. Journal of Studies on Alcohol, 64, 305–312; and O’Malley, P. M., & 
Johnston, L. D. (2013). Driving after drug use or alcohol use by American high school seniors, 2001-2011. American Journal of Public Health, 
103(11), 2027-2034.  
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• In 2017, more than four fifths (84–86%) of young adults perceived regular pack-a-day
cigarette smoking as entailing high risk (Figure 6-31). In recent years, 18-year-olds
consistently showed lower perceived risk than young adults did (and as reported in Volume
I, 10th graders were still lower and 8th graders lowest). Clearly, there is an age effect in
young people coming to understand the dangers of smoking. Unfortunately, it appears that
much of the learning about the risks of smoking happens after a great deal of smoking
initiation has occurred and many young people have already become addicted. These
beliefs about smoking risks have strengthened very gradually in all age groups from senior
year forward during the years we have monitored them (see Table 6-1 and Figure 6-31).
The parallel changes in these beliefs across the different age groups indicate a period effect,
suggesting that all of the age groups responded to common influences in the larger culture.
These influences are discussed at length in Volume I in chapter 8 on attitudes and beliefs.
The rise in perceived risk slowed between 2002 and 2011, with only slight increases,
mainly in the two youngest age strata. Changes since 2011 have been minimal.
• In 2014 items concerning perceived risk of using e-cigarettes regularly were added to the
12th grade and young adult surveys. In 2014, regular e-cigarette use was seen as dangerous
by 14% of the 12th graders and 17% to 22% of the young adults (Table 6-1). Perceived risk
increased for all age groups in 2015 and again in 2016, with 18% of the 12th graders and
28% to 31% of the young adults reporting regular use as dangerous (2015 to 2016 increases
were significant for 19-22 and 23-26 year-olds); however, these increases appear to have
stalled for all age groups in 2017, with percentages being 16% for 12th graders and 27% to
32% for three young adult strata.
• The regular use of smokeless tobacco was seen as dangerous by 51–56% of young adults
and 38% of 12th graders in 2017, revealing a strong ordinal association with age—the older
the age, the higher the perceived risk. These beliefs gradually strengthened from 1986
through about 2001 in all age groups covered (Figure 6-32 and Table 6-1), particularly
among the two older age groups. As with cigarettes, the change appears to reflect a secular
trend (period effect) because of its parallel occurrence in all age groups. Perceived risk has
not changed among the young adults in any systematic fashion since 2001; these data are
based on only one form, so year-to-year fluctuations can appear relatively large.
PERSONAL DISAPPROVAL OF DRUG USE 
For most of the life of the study, follow-up respondents were asked the same questions asked of 
12th graders in one of the six questionnaire forms concerning the extent to which they personally 
disapprove of various drug-using behaviors among “people (who are 18 or older).” Trends in the 
answers of young adults in the three age bands of 19 to 22, 23 to 26, and 27 to 30 are contained in 
Table 6-2. Comparison data for 12th graders are also provided for 1980 onward. (See Table 8-6 in 
Volume I for the longer-term trends in 12th graders’ levels of disapproval associated with using the 
various drugs.) As with the perceived risk questions, starting in 2012 the estimates were based on 
all questionnaire forms on which each disapproval question was located in order to increase sample 
size and, therefore, reduce sampling error. Each question is footnoted in Table 6-2 to indicate on 
how many forms it was contained in 2012 and thereafter. All summaries below pertain to Table 6-
2. 
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• In general, disapproval levels of adult use of the various drugs ranked similarly across
substances for both 12th graders and young adults. The great majority of young adults
disapproved of using, or even experimenting with, all of the illicit drugs other than
marijuana. For example, 94% or more of young adults in 2017 disapproved of regular use
of each of the following drugs: LSD, cocaine, heroin, and sedatives (barbiturates). Fully
72% to 97% of young adults disapproved of even experimenting with each of these same
drugs. Many of these attitudes differed rather little as a function of age in 2017.
• Even for marijuana, about a third of young adults (28–34%) disapproved of
experimentation, about four-tenths (40–43%) disapproved of occasional use, and about
two-thirds (64–67%) still disapproved of regular use in 2017; corresponding percentages
for 12th graders in 2017 were 39%, 47%, and 65%. These 2017 percentages in disapproval
of marijuana represent declines for all four age groups regarding all three intensities of
marijuana use (with half of these declines being significant – see Table 6-2); they are all
at all-time lows since 1980.
Among drugs measured, marijuana use has shown the widest fluctuations in disapproval 
over time—generally, fluctuations that parallel the changes in perceived risk (though 
sometimes with a one-year lag, with the change in perceived risk coming first). The most 
fluctuation has occurred among the younger age groups (Table 6-2). Among 12th graders, 
disapproval of regular marijuana use increased substantially in the 1980s, peaked in the 
early 1990s, declined some in the 1990s, and then leveled around 1998 with little change 
for some years thereafter. Since 2009, however, 12th graders have shown a fair decline in 
disapproval, falling from 80% in 2009 to 65% in 2017. The 19- to 22-year-olds had a quite 
similar pattern, with a recent decline from 81% in 2009 to 67% in 2017. Among 23- to 26-
year-olds, some declines started later in the 1990s but were modest until about 2007, when 
disapproval of regular marijuana use fell from 85% to 65% in 2017. Thus since 2007 there 
has been a considerable decline in disapproval of regular (and occasional) marijuana use 
in all four age groups; the pattern is consistent with a secular trend, which would alert us 
to a possible increase in marijuana use. Indeed, such an increase in use has been occurring 
among 19- to 28-year-olds since 2010 through 2017(see Table 5-2). 
• As is true for perceived risk of experimental use of LSD (summarized above), disapproval
of experimental use continued its recent decline in 2017 for all four age groups
(significantly so for 12th graders and 27-30 year olds), with the percent disapproving of
experimental use being 78%, 73%, 74%, and 72%, respectively. All-time lows in
disapproval occurred in 2016 and 2017 for the four groups. Still, the majority disapprove
of such experimental use, which has been true since 1980, when these data were first
available. Beginning around 1990, all age groups decreased some in their disapproval of
trying LSD (starting from very high levels of disapproval at 90–91%). The decline was
steepest among 12th graders, but there was a reversal in this group’s disapproval in 1997,
and then an increase through 2006. Disapproval in the older age groups declined less and
in staggered fashion; this trend showed some evidence of a reversal among 19- to 22-year-
olds and 23- to 26-year-olds since 2001 and 2002, respectively. The pattern again suggested
lasting cohort differences in these attitudes. Since about 2010, disapproval levels generally
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showed consistent declines, reaching the all-time lows in 2016 and 2017 (ranging from 
72% to 78%). Disapproval of regular LSD use has been near the top of the scale for more 
than three decades, ranging from 92% to 99%.  
• In 2017, experimenting with MDMA (ecstasy, and, more recently, Molly) was disapproved
of by 85% of 12th graders and by 78% to 80% of the young adults. First measured among
young adults in 2001, disapproval of MDMA use was positively associated with age in the
early 2000s. In 2001 disapproval of trying ecstasy was quite high, and from 2001 to 2010,
disapproval rose to even higher levels in all age groups, with little systematic change since
then. Due to the advent of Molly—reputedly a stronger form of MDMA than ecstasy—the
question for young adults was changed to MDMA in 2015 with both ecstasy and Molly
given as examples (there was no evidence that the addition of Molly as an example had the
effect of raising the disapproval level, as might have been expected; indeed, there was a
nonsignificant decline in disapproval of occasional use in 2015).
• Disapproval of all three levels of heroin use (experimental, occasional, and regular use)
has remained very high and fairly stable since MTF began, though there was a very gradual
increase in disapproval in all age strata from the mid-1980s through around 2005, followed
by a leveling. In 2017, disapproval of occasional and regular use was 96% to 98% in all
age groups; disapproval of trying heroin was 94% to 97% across the age groups. For public
health purposes, a noteworthy minor exception to the general pattern of trends for
disapproval of heroin use was a little slippage in disapproval of experimental use that
occurred among 12th graders (but not young adults) from 1991 through 1996 (from 96% to
92%)—a period during which heroin usage rates were rising.
• Disapproval of regular cocaine use rose gradually among 19- to 22-year-olds, from 89%
in 1981 to 99% in 1990, with little change thereafter (97% in 2017), and the older young
adult age groups had similar trends (Table 6-2). In fact, all three young adult age bands
were 96% or above in disapproving of regular use in 2017. Disapproval of experimental
cocaine use increased during the 1980s, peaking first among 12th graders at 94% in 1991.
It then peaked in 1995 among 19- to 22-year-olds (at 94%) and 23- to 26-year-olds (at
92%). Finally, it peaked in 1999 at 90% among 27- to 30-year-olds, suggesting both a
period and a cohort effect at work. All age groups had some modest falloff in disapproval
since those peak levels were attained. The last five years, in particular, have shown
consistent declines for all four age groups, with 2017 disapproval of experimental cocaine
use ranging from 76% to 88%. This recent decline in disapproval could signal some future
resurgence in cocaine use.
• Disapproval of experimenting with amphetamines was at or near all-time lows in 2016;
however, in 2017, it increased significantly for 19-22 year olds (80%), increased
nonsignificantly for 23-26 year olds (76%), and continued to decline for 27-30 year olds
(74%). Disapproval of experimental use rose gradually in the 1980s as use was falling;
thereafter, disapproval leveled in the mid-80% range through 2010, with almost no
difference among the age strata. For example, trying amphetamines once or twice was
disapproved of by 73–74% of 19- to 26-year-olds in 1984, compared to 84% by 1990. After
a long period of level disapproval, all strata showed a slight drop in disapproval in 2011,
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followed by another leveling for most age groups, followed by another sharp drop of 10 
percentage points in 2014 among 19- to 22-year-old age group (which contains most of the 
college students). In the past few years, there has been some further decline, with each 
young adult age group reaching lowest levels since the early 1980s in 2016 or 2017.  
Disapproval of regular use started out very high among all age strata in the early 1980s and 
rose even higher by the early 1990s, where it remained for all age strata until 2011; after 
that there was a slight decline, but a leveling by 2012 that has largely continued into 2017 
with disapproval above 90% for all age groups.  
Some of the decline and age-group differences in disapproval of amphetamine use in all 
four age groups since 2010 is likely explained by a change in the question wording. 
Adderall and Ritalin were included in the question for the first time in 2011 as examples 
of amphetamines. There had been very little difference among the various age strata in 
either their levels or trends in disapproval until the significant decline in 2014, which 
brought the college-age group (19- to 22-year-olds) considerably below the other age 
groups in their disapproval of experimenting with amphetamines. In 2017, with the 
increase in disapproval among 19-22 year olds and the decrease among 27-30 year olds, 
the age differences were reversed (80%, 76%, and 74%, respectively); the 12th graders 
showed the highest level of disapproval at 82%. 
• Disapproval of experimental use of sedatives (barbiturates) was at 86%, 88%, 81%, and
76% across the four age groups, respectively, in 2017, continuing its modest decline over
the past five years for all age groups, with the exception of a significant increase in
disapproval among 19-22 year olds. Over the years, disapproval of sedatives has moved
very much in parallel with that for amphetamines. Disapproval increased significantly
during the 1980s, accompanied by declining use. Disapproval of trying sedatives was at
84–85% in 1984 compared to 89–91% by 1990. Disapproval of sedative use slipped some
among 12th graders after 1992 and among 19- to 22-year-olds after 1994, with the 23- to
26-year-olds following suit after 1996, and the 27- to 30-year-old stratum in 2004. This
pattern of staggered change again suggests cohort effects, reflecting lasting cohort
differences in these attitudes. In 2017, disapproval of experimental use stood between 76%
and 88%, while disapproval of regular use was close to 100%.
• The story for alcohol is quite an interesting one, in that changes in the minimum drinking
age seem to have led to modest changes in norms for the affected cohorts. Between 1980
and 1992, an increasing proportion of 12th graders favored total abstention; the percent
who disapproved of drinking even just one or two drinks rose from 16% in 1980 to 33% in
1992. This figure fell back slightly and stood at 27% in 2017. Among 19- to 22-year-olds
there was a modest increase in disapproving of any use between 1985 and 1989 (from 15%
to 22%), where it held for some years; it remained at 18% in 2017. For the two oldest age
groups, there has been rather little change in these attitudes so far, ranging from 12% to
15% in 2017. These differing trends may reflect the fact that during the 1980s, the drinking
age was raised in a number of states so that by 1987 it was 21 in all states; this change
would have had the greatest effect on 12th graders, who may have incorporated the legal
restrictions into their normative structure and, as they entered young adulthood, brought
252
Monitoring the Future
these new norms with them. But the changes may be exhibited only among respondents in 
the cohorts that were underage after the time that the new law raising the minimum drinking 
age went into effect.  
Disapproval of having one or two drinks nearly every day has not shown any such cohort 
effects, because all age groups have generally moved in parallel, at similar levels of 
disapproval through 2004. The three youngest age bands (which include 12th graders 
through 26-year-olds) showed an increase in disapproval of having one to two drinks daily 
up until about 1990 suggesting some secular trending (little data were yet available on the 
oldest age group), but disapproval has declined a fair amount in all of the age groups since 
then. Starting in 2004, a bit of a gap opened up between 12th graders and young adults that 
has remained through 2017, as 12th graders showed some increase and then leveling in 
disapproval of having one to two drinks daily and young adults, especially the oldest group, 
continued to show declines. In 2017, disapproval was 71% for 12th graders and 62%, 54%, 
and 50% for the three older age groups, respectively.  
The pattern of cross-time changes in disapproval of heavy daily drinking (having four or 
five drinks nearly every day) for young adults closely parallels what was observed for the 
perceived risk associated with light daily drinking. This holds especially in terms of overall 
declines among the older group, though the level of disapproval was much higher for heavy 
than for light daily use, as would be expected (above 90% in 2017 for all age groups). 
Declines in both variables among the young adults may well be due to widely publicized 
reports that some cardiovascular benefits may result from having one or two drinks per 
day. 
• Disapproval of binge drinking (also called occasions of heavy drinking) on weekends has
shown quite a bit of variation over the years as well as age differences. In 2017, disapproval
was 73% for 12th graders and 64% to 66% for the young adults. Trends have been uneven
over the years, but in general, disapproval has slowly increased for 12th graders from the
most recent low of 63% in 1999 to 73% in 2017, has slowly increased for 19- to 22-year
olds from the most recent low of 58% in 2002 to 65% in 2017, has shown little systematic
change for 23- to 26-year olds since 1984 (ranging between 56% and 71%), and has slowly
decreased for 27- to 30-year olds from the most recent high of 74% in 2004 to 66% in 2017.
It is important to note that the age-based trends in disapproval often mirrored the 
corresponding trends in prevalence of heavy drinking. In particular, from the early 1980s 
for the two youngest age groups there was a considerable increase in disapproval that 
continued through 1992 for 12th graders (who then showed some drop-off) and through 
1996 among 19- to 22-year-olds (who then also showed some drop-off). As Figure 5-18d 
illustrates, the prevalence of occasions of heavy drinking declined substantially among 12th 
graders and 19- to 22-year-olds between 1981 and the early 1990s, as norms became more 
restrictive. There was little or no change in disapproval among the 27- to 30-year-olds, 
either in their levels of disapproval or in their rates of occasions of heavy drinking, until 
the early 2000s, when disapproval began to drop and occasions of heavy drinking began to 
increase.  
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• Some fluctuations in the disapproval of cigarette smoking occurred over the decades 
covered by MTF. Twelfth graders showed some increase in disapproval of pack-or-more-
a-day smoking between 1982 (69%) and 1992 (74%). Their disapproval then fell through 
1997 (to 67%) as their smoking increased; disapproval then increased for several years (to 
82% in 2006) before leveling, as smoking declined. In 2017, 87% disapproved of pack-or-
more-a-day smoking. The 19- to 22-year-olds showed a similar increase in disapproval 
from 66% in 1982 to 85% in 2017. All four age strata showed some upward drift in their 
level of disapproval of smoking since about 1999 (reaching 81–85% in 2017), suggesting 
a secular change in attitudes during this period.  
 
COHORT DIFFERENCES AND THEIR IMPLICATIONS FOR PREVENTION AND 
THEORY 
An important theoretical point to be made—based on the strong evidence reported here for cohort 
effects in perceived risk and disapproval of many of the drugs under study—is that among the 
causes of cohort differences in actual use are lasting cohort differences in these critical attitudes 
and beliefs. In other words, the attitudes and beliefs brought into adulthood from adolescence tend 
to persevere and continue to shape individual and population drug use over the life course. 
 
A second point has to do with the causes of these attitudinal cohort effects. We noted earlier that 
the older respondents are more likely than the younger ones to see as dangerous the use of 
marijuana, LSD, heroin, narcotics other than heroin, amphetamines, ecstasy, crystal 
methamphetamine, cocaine, crack, and sedatives (barbiturates). Some years ago, Lloyd Johnston 
proposed a framework for a theory of drug epidemics in which direct learning (from personal use) 
and vicarious learning (from observing use by others in both the immediate and mass media 
environments) play important roles in changing these key attitudes.3 To the extent that the data on 
perceived risk represent cohort effects (enduring differences between class cohorts), these findings 
would be consistent with this theoretical perspective. Clearly, use of these particular drugs was 
greater when the older cohorts were growing up, and public attention and concern regarding the 
consequences of these drugs were greatest in the 1970s and early to mid-1980s. In the early 1970s, 
LSD was alleged to cause brain and chromosomal damage, as well as bad trips, flashbacks, and 
behavior that could prove dangerous. Methamphetamine use was discouraged with the slogan 
“speed kills.” In the early 1980s there was an epidemic of cocaine use, and it reached a pinnacle 
in 1986 with the widely reported deaths of sports stars and others from cocaine. In addition, there 
was an epidemic of heroin use in the early 1970s. Later cohorts (through the mid-1990s, at least) 
were not exposed to those experiences while growing up. While there may have been a secular 
trend toward greater perceived risk for drugs in general, in the case of LSD there may have also 
been an operating cohort effect (with younger cohorts seeing less danger) offsetting the secular 
trend among 12th graders; the net effect was a decrease in 12th graders’ perceived risk of LSD use 
after 1980. 
 
This vicarious learning explanation has a very practical implication for national strategy for 
preventing future epidemics. Because fewer in their immediate social circles and fewer public role 
models may be using these drugs and exhibiting the adverse consequences of use during certain 
                                                 
3 Johnston, L. D. (1991). Toward a theory of drug epidemics. In L. Donohew, H. E. Sypher, & W. J. Bukoski (Eds.), Persuasive communication 
and drug abuse prevention (pp. 93–131). Hillsdale, NJ: Lawrence Erlbaum. 
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historical periods, future cohorts of youth may have less opportunity to learn about the adverse 
consequences of these drugs in the normal course of growing up. Unless those hazards are 
convincingly communicated to them in other ways—for example, through school prevention 
programs, by their parents, and through the mass media, including public service advertising—
they will become more susceptible to a new epidemic of use of the same or similar drugs. 
In Volume I, we reported an increase in use of several drugs in 8th, 10th, and 12th grades in 1994 
through 1997. This increase suggests that this form of generational forgetting may well have 
occurred during those years. For the cohorts that follow such a rise in use, there is once again an 
increased opportunity for vicarious learning from the adverse experiences of those around them, 
but by that time, members of affected cohorts have had to learn the hard way what consequences 
await those who become involved with the various drugs. In the 2000s we have seen drug use 
subside to some degree, which once again has created the conditions for generational forgetting of 
the dangers of many of these drugs. We are now seeing some softening of attitudes among teens 
and young adults regarding marijuana, and occasional use of ecstasy and cocaine, which suggests 
a real possibility of future increases in use among young adults of the future. 
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Try marijuana 18 10.0 13.0 11.5 12.7 14.7 14.8 15.1 18.4 19.0 23.6 23.1 27.1 24.5 21.9 19.5 16.3 15.6 14.9 16.7
  once or twice f 19–22 8.3 7.8 9.7 9.7 12.8 11.2 13.0 12.9 16.8 16.9 17.8 19.1 19.7 19.4 18.8 13.3 16.9 14.8 13.4
23–26 — — — — 9.6 10.0 12.4 14.5 16.0 14.0 17.7 14.0 15.0 13.0 15.0 15.8 18.5 15.1 16.7
27–30 — — — — — — — — 14.6 16.0 17.0 15.7 15.1 14.0 14.8 16.1 16.2 16.1 16.4
Smoke marijuana  18 14.7 19.1 18.3 20.6 22.6 24.5 25.0 30.4 31.7 36.5 36.9 40.6 39.6 35.6 30.1 25.6 25.9 24.7 24.4
  occasionally f  19–22 13.9 14.2 16.9 16.7 21.7 20.6 22.4 23.0 28.7 29.1 30.1 30.2 29.5 30.3 31.3 25.5 25.6 22.0 22.0
23–26 — — — — 15.8 16.3 20.9 20.8 26.8 25.3 30.4 26.2 27.4 24.0 25.5 27.7 27.3 26.4 26.8
27–30 — — — — — — — — 24.2 25.7 28.7 27.4 27.5 26.8 28.1 28.3 28.1 26.0 25.8
Smoke marijuana  18 50.4 57.6 60.4 62.8 66.9 70.4 71.3 73.5 77.0 77.5 77.8 78.6 76.5 72.5 65.0 60.8 59.9 58.1 58.5
  regularly f 19–22 43.9 47.8 52.4 58.4 62.2 66.8 67.6 69.4 72.4 74.9 73.0 75.0 69.3 69.2 65.0 62.1 61.3 60.7 53.4
23–26 — — — — 52.9 57.5 59.4 65.3 68.3 72.1 71.0 70.9 67.3 64.1 63.2 64.2 62.7 64.1 62.7
27–30 — — — — — — — — 67.5 69.1 69.2 67.5 68.8 69.4 65.6 69.2 67.3 65.0 63.6
Try synthetic marijuana 18 — — — — — — — — — — — — — — — — — — —
  once or twice g 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take synthetic marijuana 18 — — — — — — — — — — — — — — — — — — —
  occasionally g  19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try LSD once or 18 43.9 45.5 44.9 44.7 45.4 43.5 42.0 44.9 45.7 46.0 44.7 46.6 42.3 39.5 38.8 36.4 36.2 34.7 37.4
  twice h  19–22 44.8 44.4 45.0 44.7 46.0 44.3 47.6 49.4 49.2 49.5 49.3 48.0 45.6 42.4 42.3 40.3 44.4 40.1 38.7
23–26 — — — — 48.3 46.9 47.9 51.5 53.7 50.7 52.0 50.1 49.7 49.0 46.8 45.8 46.1 46.6 45.7
27–30 — — — — — — — — 53.3 55.6 54.6 52.5 53.0 51.5 53.5 52.5 50.1 52.0 52.0
Take LSD 18 83.0 83.5 83.5 83.2 83.8 82.9 82.6 83.8 84.2 84.3 84.5 84.3 81.8 79.4 79.1 78.1 77.8 76.6 76.5
  regularly h 19–22 83.4 85.3 86.2 86.0 84.5 86.4 87.1 85.6 85.4 85.5 85.8 86.6 87.0 81.3 81.0 80.5 82.4 83.6 78.6
23–26 — — — — 89.0 86.6 88.7 90.0 89.2 89.0 88.2 89.1 87.3 85.3 87.5 86.3 84.7 85.6 82.1
27–30 — — — — — — — — 89.1 91.2 92.0 87.1 88.5 89.0 89.2 88.4 87.0 87.2 90.5
Try PCP once or 18 — — — — — — — 55.6 58.8 56.6 55.2 51.7 54.8 50.8 51.5 49.1 51.0 48.8 46.8
  twice h 19–22 — — — — — — — 63.6 63.8 — — — — — — — — — —
23–26 — — — — — — — 64.8 63.2 — — — — — — — — — —
27–30 — — — — — — — — 65.9 — — — — — — — — — —
Try ecstasy 18 — — — — — — — — — — — — — — — — — 33.8 34.5
  (MDMA, Molly) once 19–22 — — — — — — — — — 45.2 47.1 48.8 46.4 45.0 51.1 48.3 46.7 45.5 42.7
  or twice h 23–26 — — — — — — — — — 49.5 47.2 47.4 45.5 41.9 50.6 49.3 50.4 50.5 47.7
27–30 — — — — — — — — — 44.9 48.7 47.7 44.2 51.7 47.3 50.0 50.6 48.8 50.4
Take ecstasy 18 — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — — — — — — — — — — — — — — — — — —
  occasionally h  23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try salvia 18 — — — — — — — — — — — — — — — — — — —
  once or twice d,k 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take salvia 18 — — — — — — — — — — — — — — — — — — —
  occasionally k 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try cocaine 18 31.3 32.1 32.8 33.0 35.7 34.0 33.5 47.9 51.2 54.9 59.4 59.4 56.8 57.6 57.2 53.7 54.2 53.6 54.6
  once or twice h 19–22 31.4 30.4 33.3 28.7 33.1 33.2 35.5 45.9 51.9 51.5 58.1 58.7 56.1 60.5 63.8 57.7 61.9 55.5 55.4
23–26 — — — — 31.3 31.1 35.9 48.0 47.1 51.3 51.5 50.5 53.5 54.1 56.0 58.7 57.2 63.1 60.2
27–30 — — — — — — — — 45.3 53.0 51.6 52.6 51.8 54.7 53.5 56.4 53.6 54.6 60.5
Take cocaine 18 — — — — — — 54.2 66.8 69.2 71.8 73.9 75.5 75.1 73.3 73.7 70.8 72.1 72.4 70.1
  occasionally h 19–22 — — — — — — 53.8 61.3 67.1 72.6 74.6 72.6 74.9 75.4 78.0 73.4 76.6 76.1 71.2
23–26 — — — — — — 50.9 62.6 63.2 69.9 69.9 70.3 69.9 72.8 70.3 76.0 71.3 76.5 74.2
27–30 — — — — — — — — 62.6 66.6 66.6 69.1 69.9 69.1 69.9 70.0 67.8 73.8 73.2
Take cocaine 18 69.2 71.2 73.0 74.3 78.8 79.0 82.2 88.5 89.2 90.2 91.1 90.4 90.2 90.1 89.3 87.9 88.3 87.1 86.3
  regularly h  19–22 65.2 69.3 71.5 75.2 75.1 82.9 82.0 88.0 90.3 89.1 93.9 93.5 92.9 91.7 92.2 91.5 92.2 91.6 88.7
23–26 — — — — 75.6 76.9 83.0 88.9 90.9 91.2 91.2 92.7 89.9 91.9 92.6 93.3 90.6 93.2 92.9
27–30 — — — — — — — — 88.9 92.0 91.4 90.9 92.0 91.6 92.1 91.3 91.6 92.7 93.0
(Years 
Cont.)
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Age Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Try marijuana 18 15.7 13.7 15.3 16.1 16.1 15.9 16.1 17.8 18.6 17.4 18.5 17.1 15.6 14.8 14.5 12.5 12.3 12.9 11.9 -1.1  
  once or twice f 19–22 12.5 14.3 11.9 13.3 17.1 15.3 15.6 14.4 10.8 17.4 13.2 16.8 13.4 12.9 11.8 9.3 10.6 9.4 9.8 +0.4
23–26 16.4 13.1 13.0 15.1 15.3 13.6 13.0 13.9 13.0 12.5 10.6 12.7 10.5 10.1 9.7 9.6 9.5 9.0 6.9 -2.2 s
27–30 16.1 14.4 17.3 16.2 18.0 13.8 14.5 14.5 16.6 11.4 12.3 11.5 12.4 12.5 10.2 8.8 7.9 7.3 6.9 -0.4
Smoke marijuana  18 23.9 23.4 23.5 23.2 26.6 25.4 25.8 25.9 27.1 25.8 27.4 24.5 22.7 20.6 19.5 16.4 15.8 17.1 14.1 -3.0 s
  occasionally f 19–22 19.8 25.8 18.0 21.0 24.1 23.2 24.3 22.1 22.3 23.6 23.1 19.9 19.6 20.6 19.1 15.4 15.6 13.0 13.3 +0.3
23–26 26.4 24.9 20.5 24.5 22.2 22.7 21.6 22.3 20.2 18.5 18.1 19.3 15.5 17.1 14.4 14.8 13.7 14.1 9.7 -4.4 sss
27–30 25.3 25.8 25.0 30.2 27.9 25.1 24.8 21.8 25.6 21.6 21.7 18.6 19.3 19.7 16.0 14.8 12.1 11.1 9.9 -1.3
Smoke marijuana  18 57.4 58.3 57.4 53.0 54.9 54.6 58.0 57.9 54.8 51.7 52.4 46.8 45.7 44.1 39.5 36.1 31.9 31.1 29.0 -2.1  
  regularly f 19–22 55.2 58.0 49.6 56.7 57.8 57.2 55.3 54.5 50.4 51.6 46.4 49.8 43.0 43.5 39.4 35.1 33.3 30.0 27.3 -2.7
23–26 60.1 60.3 55.1 53.7 56.7 54.2 53.6 55.9 52.5 52.4 43.0 47.1 39.3 40.1 35.9 34.5 30.6 30.2 23.3 -6.9 sss
27–30 66.1 64.0 61.7 63.5 64.7 59.3 57.0 54.9 51.5 51.2 47.4 48.5 42.2 43.5 40.3 35.3 30.6 29.4 24.7 -4.7 ss
Try synthetic marijuana 18 — — — — — — — — — — — — — 23.5 25.9 32.5 33.0 35.6 33.0 -2.6  
  once or twice g  19–22 — — — — — — — — — — — — — 30.6 33.1 36.1 39.3 42.6 42.7 +0.1
23–26 — — — — — — — — — — — — — 29.1 29.4 38.5 40.4 45.1 40.8 -4.2
27–30 — — — — — — — — — — — — — 28.9 32.7 35.1 37.3 45.4 41.7 -3.7
Take synthetic marijuana 18 — — — — — — — — — — — — — 32.7 36.2 39.4 40.9 43.9 40.0 -3.9  
  occasionally g 19–22 — — — — — — — — — — — — — 38.5 40.1 44.5 47.6 53.9 52.6 -1.2
23–26 — — — — — — — — — — — — — 37.3 38.6 47.2 49.5 53.0 50.8 -2.2
27–30 — — — — — — — — — — — — — 36.3 41.0 43.1 46.6 53.2 52.2 -1.0
Try LSD once or 18 34.9 34.3 33.2 36.7 36.2 36.2 36.5 36.1 37.0 33.9 37.1 35.6 34.7 33.1 34.9 35.5 33.2 31.7 30.0 -1.7  
  twice h  19–22 38.1 37.9 37.5 35.3 39.7 39.2 38.7 43.5 40.9 46.5 38.5 40.9 43.5 43.5 40.3 40.1 39.4 36.5 34.5 -2.0
23–26 49.3 44.9 48.5 45.7 43.8 40.7 39.9 38.1 42.8 43.8 43.0 48.7 44.1 47.2 43.0 42.4 38.0 42.5 32.1 -10.4 s
27–30 49.9 46.4 46.7 44.9 47.5 47.2 47.9 44.9 44.6 42.4 41.7 41.5 45.2 45.8 45.2 45.6 47.6 43.7 41.3 -2.4
Take LSD 18 76.1 75.9 74.1 73.9 72.3 70.2 69.9 69.3 67.3 63.6 67.8 65.3 65.5 66.8 66.8 62.7 60.7 58.2 56.1 -2.1  
  regularly h 19–22 82.2 81.6 79.2 81.1 78.6 78.4 77.8 78.9 77.5 73.9 74.8 72.8 74.4 78.0 76.6 74.7 72.7 75.7 65.1 -10.6 ss
23–26 85.4 84.1 86.0 85.3 84.3 83.5 80.8 82.0 80.3 80.2 82.0 83.1 81.4 78.9 79.0 76.0 71.7 73.9 68.7 -5.2
27–30 87.8 85.3 86.9 85.3 87.5 83.9 87.9 82.2 85.7 82.9 80.2 87.0 83.0 83.2 83.8 80.3 79.9 73.2 71.7 -1.5
Try PCP once or 18 44.8 45.0 46.2 48.3 45.2 47.1 46.6 47.0 48.0 47.4 49.7 52.4 53.9 51.6 53.9 53.8 54.4 55.1 53.6 -1.5  
  twice h 19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
Try ecstasy 18 35.0 37.9 45.7 52.2 56.3 57.7 60.1 59.3 58.1 57.0 53.3 50.6 49.0 49.4 47.5 47.8 49.5 48.8 49.1 +0.3  
  (MDMA, Molly) once 19–22 37.6 37.9 40.5 46.8 50.1 52.3 53.8 51.0 50.3 51.4 51.4 50.7 49.9 45.9 52.4 50.7 47.7 51.2 43.9 -7.3
  or twice h,m 23–26 50.0 46.7 45.7 45.6 45.9 44.9 51.2 46.4 51.4 46.3 46.4 47.5 54.2 43.7 49.1 56.5 48.8 50.5 43.2 -7.3
27–30 50.9 48.9 53.6 52.0 58.8 49.1 50.2 46.5 51.9 43.5 43.5 52.0 51.3 44.3 51.4 52.0 54.5 52.1 51.3 -0.8
Take ecstasy 18 — — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — 72.5 77.8 81.7 78.3 80.0 82.5 79.3 81.9 79.2 76.2 71.6 76.7 75.3 72.9 66.9 72.1 64.2 -7.8
  occasionally h,m 23–26 — — 72.5 71.9 73.6 77.4 77.2 77.0 78.7 78.6 76.2 79.1 76.9 76.6 69.8 77.6 69.1 69.1 69.8 +0.7
27–30 — — 75.2 76.5 79.9 76.9 74.7 70.4 72.0 71.3 71.4 69.7 77.8 75.0 76.8 71.6 73.1 69.0 71.0 +2.0
Try salvia 18 — — — — — — — — — — — 39.8 38.7 13.8 12.9 14.1 13.1 13.0 10.2 -2.8  
  once or twice d,k 19–22 — — — — — — — — — — — — — 22.5 21.4 25.9 23.7 23.8 23.6 -0.2
23–26 — — — — — — — — — — — — — 18.6 19.6 24.5 23.5 30.9 21.0 -9.9 s
27–30 — — — — — — — — — — — — — 18.8 20.6 18.4 21.7 25.2 21.3 -3.8
Take salvia 18 — — — — — — — — — — — — — 23.1 21.3 20.0 17.6 16.3 13.8 -2.5  
  occasionally k 19–22 — — — — — — — — — — — — — 29.2 30.6 32.6 32.6 28.3 29.8 +1.5
23–26 — — — — — — — — — — — — — 26.6 25.5 31.1 31.2 38.6 33.6 -5.0
27–30 — — — — — — — — — — — — — 24.7 25.7 25.4 28.8 32.3 29.2 -3.2
Try cocaine 18 52.1 51.1 50.7 51.2 51.0 50.7 50.5 52.5 51.3 50.3 53.1 52.8 54.0 51.6 54.4 53.7 51.1 52.7 49.5 -3.2  
  once or twice h 19–22 52.8 56.7 48.9 55.5 55.0 55.5 55.6 54.0 55.8 56.7 54.9 56.8 56.2 57.0 56.3 56.3 57.4 55.8 51.2 -4.6
23–26 62.6 63.1 62.4 61.0 55.4 52.1 53.0 52.5 56.9 55.0 56.6 56.7 54.9 60.3 50.9 57.3 49.1 55.2 48.1 -7.1
27–30 61.7 59.9 60.9 58.8 56.4 61.4 56.5 58.1 54.8 56.1 52.0 51.6 54.7 51.8 53.8 50.1 53.1 53.2 50.1 -3.1
Take cocaine 18 70.1 69.5 69.9 68.3 69.1 67.2 66.7 69.8 68.8 67.1 71.4 67.8 69.7 69.0 70.2 68.1 66.3 68.6 64.6 -4.0 s
  occasionally h 19–22 68.0 72.4 70.0 69.9 70.3 70.2 72.1 71.0 71.5 72.4 67.2 72.9 70.3 78.0 76.5 74.9 76.4 71.5 73.3 +1.8
23–26 77.8 76.2 74.2 75.4 68.3 74.1 70.4 68.5 70.9 67.2 74.9 71.6 71.6 76.9 75.8 75.8 69.5 70.7 67.3 -3.4
27–30 75.4 76.5 78.1 74.3 72.6 75.3 76.2 74.6 72.1 73.9 65.4 71.5 71.0 73.2 77.9 70.7 71.5 69.6 71.9 +2.3
Take cocaine 18 85.8 86.2 84.1 84.5 83.0 82.2 82.8 84.6 83.3 80.7 84.4 81.7 83.8 82.6 83.3 80.6 79.1 78.3 74.9 -3.5  
  regularly h 19–22 88.5 90.7 85.1 88.3 87.4 87.1 89.2 86.2 86.7 87.0 88.6 87.9 86.3 92.3 91.4 89.7 90.4 89.6 92.2 +2.5
23–26 92.7 92.9 91.1 91.5 88.5 91.5 88.0 90.9 88.0 86.5 89.2 90.9 88.0 91.2 91.2 92.4 86.4 92.0 85.5 -6.6 s
27–30 92.4 92.3 94.5 91.2 92.9 91.3 94.0 90.0 89.9 91.1 88.8 92.7 87.2 91.2 91.7 88.7 90.0 91.6 89.5 -2.1
↓
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Try crack once 18 — — — — — — — 57.0 62.1 62.9 64.3 60.6 62.4 57.6 58.4 54.6 56.0 54.0 52.2
  or twice h 19–22 — — — — — — — 59.4 67.3 68.5 69.4 66.9 65.4 63.5 70.1 61.9 65.2 62.0 59.3
23–26 — — — — — — — 59.1 63.5 69.8 67.3 66.9 67.1 64.2 69.3 64.8 68.6 64.7 67.3
27–30 — — — — — — — — 66.5 64.9 68.7 66.8 64.3 68.8 65.6 66.4 66.7 68.5 66.5
Take crack 18 — — — — — — — 70.4 73.2 75.3 80.4 76.5 76.3 73.9 73.8 72.8 71.4 70.3 68.7
  occasionally h 19–22 — — — — — — — 75.0 77.3 81.8 82.3 82.7 81.9 83.6 84.3 78.8 83.5 79.1 79.1
23–26 — — — — — — — 70.3 74.0 79.9 81.1 83.9 84.4 81.6 83.2 81.4 85.9 80.8 84.2
27–30 — — — — — — — — 76.4 76.7 82.6 81.8 79.1 83.6 78.6 81.1 81.3 85.3 81.7
Take crack 18 — — — — — — — 84.6 84.8 85.6 91.6 90.1 89.3 87.5 89.6 88.6 88.0 86.2 85.3
  regularly h  19–22 — — — — — — — 89.6 91.1 94.1 94.9 95.6 93.4 96.2 96.0 94.2 94.7 93.3 92.8
23–26 — — — — — — — 88.0 89.2 91.5 94.2 95.4 94.1 93.4 94.9 95.5 96.1 91.4 95.6
27–30 — — — — — — — — 89.6 89.5 95.3 94.4 93.3 93.5 93.0 94.0 94.3 96.0 94.3
Try cocaine 18 — — — — — — — 45.3 51.7 53.8 53.9 53.6 57.1 53.2 55.4 52.0 53.2 51.4 48.5  
   powder once 19–22 — — — — — — — 44.0 48.6 51.1 54.5 52.7 56.2 49.7 62.0 55.8 57.1 53.8 53.0
   or twice i 23–26 — — — — — — — 41.0 43.6 48.4 48.9 47.4 45.9 45.6 52.5 48.9 57.2 53.6 54.1
27–30 — — — — — — — — 42.0 45.1 46.2 43.3 42.3 49.9 47.1 48.2 48.9 49.1 49.8
Take cocaine 18 — — — — — — — 56.8 61.9 65.8 71.1 69.8 70.8 68.6 70.6 69.1 68.8 67.7 65.4
  powder 19–22 — — — — — — — 58.0 59.0 63.2 70.0 69.9 72.6 70.6 75.4 73.0 77.4 70.7 73.0
  occasionally i 23–26 — — — — — — — 50.0 53.2 62.2 63.3 67.0 65.8 64.0 68.8 68.8 76.1 72.8 77.0
27–30 — — — — — — — — 53.6 52.7 60.9 59.2 61.2 64.3 61.0 65.9 68.2 69.7 68.5
Take cocaine 18 — — — — — — — 81.4 82.9 83.9 90.2 88.9 88.4 87.0 88.6 87.8 86.8 86.0 84.1
  powder 19–22 — — — — — — — 86.6 87.6 91.3 92.5 93.8 92.1 94.0 94.9 93.5 93.8 92.8 91.5
  regularly i 23–26 — — — — — — — 82.9 84.1 88.5 92.4 93.8 91.3 92.4 92.8 92.1 94.8 90.8 93.7
27–30 — — — — — — — — 85.1 86.7 92.7 91.1 91.5 92.5 90.7 92.7 91.7 93.0 92.3
Try heroin once 18 52.1 52.9 51.1 50.8 49.8 47.3 45.8 53.6 54.0 53.8 55.4 55.2 50.9 50.7 52.8 50.9 52.5 56.7 57.8
  or twice g  19–22 57.8 56.8 54.4 52.5 58.7 51.0 55.5 57.9 58.9 59.6 58.3 59.9 59.8 58.9 60.8 58.9 61.0 63.9 60.7
23–26 — — — — 58.2 59.2 60.8 66.6 65.4 62.3 64.1 62.4 63.7 65.0 63.3 64.1 63.5 67.3 67.3
27–30 — — — — — — — — 66.0 69.7 67.5 66.1 66.5 69.3 69.6 66.4 66.4 67.9 69.7
Take heroin 18 70.9 72.2 69.8 71.8 70.7 69.8 68.2 74.6 73.8 75.5 76.6 74.9 74.2 72.0 72.1 71.0 74.8 76.3 76.9
  occasionally g 19–22 77.5 77.8 73.6 74.5 74.9 73.6 77.2 77.6 77.5 79.8 80.8 80.2 81.6 78.8 79.0 77.9 82.1 84.7 80.4
23–26 — — — — 81.2 80.7 78.9 84.5 82.4 80.8 83.4 84.4 81.5 82.1 80.8 85.3 82.4 86.5 83.9
27–30 — — — — — — — — 86.0 86.8 85.3 84.3 84.9 86.2 86.8 83.1 83.8 85.8 86.6
Take heroin 18 86.2 87.5 86.0 86.1 87.2 86.0 87.1 88.7 88.8 89.5 90.2 89.6 89.2 88.3 88.0 87.2 89.5 88.9 89.1
  regularly g  19–22 87.2 89.9 87.5 88.6 86.8 90.2 90.7 90.2 89.6 90.8 91.2 91.5 92.2 89.2 91.2 89.9 94.0 93.7 92.4
23–26 — — — — 92.0 90.1 90.6 92.8 91.5 91.3 91.0 92.6 91.3 91.6 93.0 93.5 92.7 94.4 93.4
27–30 — — — — — — — — 92.7 93.5 93.0 90.7 91.3 92.6 93.8 92.4 92.1 93.8 95.0
Try narcotics other than 18 — — — — — — — — — — — — — — — — — — —
  heroin once 19–22 — — — — — — — — — — — — — — — — — — —
  or twice h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try narcotics other than 18 — — — — — — — — — — — — — — — — — — —
  heroin regularly h 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try 18 29.7 26.4 25.3 24.7 25.4 25.2 25.1 29.1 29.6 32.8 32.2 36.3 32.6 31.3 31.4 28.8 30.8 31.0 35.3
  amphetamines  19–22 24.6 24.6 27.8 24.8 26.9 23.9 27.1 27.4 31.7 28.9 35.6 32.8 34.5 33.3 36.3 32.9 36.8 30.1 31.7
  once or twice b,h 23–26 — — — — 29.6 29.4 29.4 34.1 33.2 32.5 35.3 31.0 32.7 32.6 32.9 34.3 34.9 37.8 40.9
27–30 — — — — — — — — 35.2 37.5 36.9 36.5 36.2 34.0 37.5 36.0 36.2 34.5 37.6
Take 18 69.1 66.1 64.7 64.8 67.1 67.2 67.3 69.4 69.8 71.2 71.2 74.1 72.4 69.9 67.0 65.9 66.8 66.0 67.7
  amphetamines 19–22 71.9 69.9 68.3 69.9 68.4 68.5 72.3 72.0 73.9 71.3 74.0 77.1 73.5 73.5 71.6 72.2 75.8 72.3 71.9
  regularly b,h 23–26 — — — — 75.8 77.2 75.6 78.2 77.4 76.7 77.8 79.4 76.4 76.2 73.6 80.5 78.5 79.1 77.5
27–30 — — — — — — — — 80.6 82.9 83.3 79.4 80.3 79.8 78.4 77.7 75.6 77.4 81.1
Try crystal 18 — — — — — — — — — — — 61.6 61.9 57.5 58.3 54.4 55.3 54.4 52.7
  methamphetamine (ice) h 19-22 — — — — — — — — — — 57.8 58.6 57.7 57.5 61.4 58.9 61.1 56.4 55.8
23–26 — — — — — — — — — — 56.5 56.0 55.6 52.0 61.0 57.8 64.1 60.7 58.2
27–30 — — — — — — — — — — 59.6 57.2 52.7 60.3 57.9 58.5 59.1 59.8 59.9
(Years 
Cont.)
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Age Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Try crack once 18 48.2 48.4 49.4 50.8 47.3 47.8 48.4 47.8 47.3 47.5 48.4 50.2 51.7 52.0 55.6 54.5 53.6 53.9 51.6 -2.3  
  or twice h 19–22 56.1 52.9 54.1 54.1 55.1 56.8 56.6 55.3 51.9 54.9 54.9 53.7 56.6 — — — — — — —
23–26 64.6 63.2 59.8 60.9 58.5 56.4 60.6 54.7 58.4 50.5 50.6 58.4 61.6 — — — — — — —
27–30 65.0 62.9 69.3 67.4 66.0 62.6 61.9 56.8 64.1 56.2 56.2 62.2 60.4 — — — — — — —
Take crack 18 67.3 65.8 65.4 65.6 64.0 64.5 63.8 64.8 63.6 65.2 64.7 64.3 66.2 66.5 69.5 68.5 67.8 66.2 65.3 -0.9  
  occasionally h  19–22 75.5 74.9 72.3 75.3 75.3 76.0 75.0 72.8 77.7 75.7 75.7 73.6 74.8 — — — — — — —
23–26 81.6 84.0 80.1 82.2 77.1 76.4 78.6 76.8 79.8 75.2 75.2 77.7 82.8 — — — — — — —
27–30 79.8 81.6 84.4 81.5 81.9 82.1 79.5 82.8 79.1 77.3 77.3 80.1 79.6 — — — — — — —
Take crack 18 85.4 85.3 85.8 84.1 83.2 83.5 83.3 82.8 82.6 83.4 84.0 83.8 83.9 84.0 85.4 82.0 81.2 81.9 79.8 -2.2  
  regularly h  19–22 92.3 91.1 89.6 91.1 93.8 93.3 92.5 90.3 90.3 93.6 93.6 93.1 90.8 — — — — — — —
23–26 94.4 95.6 93.4 94.7 92.2 92.5 93.1 93.3 93.1 91.8 91.8 93.7 94.1 — — — — — — —
27–30 95.2 93.5 96.8 94.2 94.4 94.0 95.2 94.1 93.6 93.1 93.1 93.9 92.6 — — — — — — —
Try cocaine 18 46.1 47.0 49.0 49.5 46.2 45.4 46.2 45.8 45.1 45.1 46.5 48.2 48.0 48.1 49.9 49.9 49.0 49.3 45.1 -4.1 s
   powder once 19–22 47.9 48.0 47.1 47.9 49.4 48.7 50.2 48.7 46.8 48.3 48.3 44.4 51.3 52.2 51.3 52.8 52.9 52.6 50.4 -2.1
   or twice i 23–26 53.8 53.2 53.9 52.5 50.8 46.0 53.3 45.8 48.1 44.1 44.2 43.9 47.4 52.5 47.4 48.9 49.2 48.4 47.0 -1.4
27–30 49.7 52.2 53.3 54.4 56.6 52.5 52.9 49.0 53.6 47.2 47.2 52.1 48.3 53.5 48.3 51.2 49.8 48.5 45.5 -3.0
Take cocaine 18 64.2 64.7 63.2 64.4 61.4 61.6 60.8 61.9 59.9 61.6 62.6 62.6 64.2 62.6 65.4 64.8 62.8 62.9 60.1 -2.8  
  powder 19–22 69.3 69.3 64.4 68.9 69.3 68.6 68.1 66.4 67.1 68.5 68.5 63.7 64.5 69.4 64.5 69.7 70.3 68.2 67.8 -0.4
  occasionally i 23–26 70.8 76.0 70.5 73.7 67.9 64.6 69.9 66.7 69.9 64.5 64.5 65.5 68.2 73.0 68.2 65.9 66.6 64.1 63.9 -0.2
27–30 70.1 71.3 73.5 71.9 71.7 71.5 71.7 73.1 69.3 64.9 65.0 68.9 68.8 71.0 68.8 67.3 64.8 64.2 62.7 -1.5
Take cocaine 18 84.6 85.5 84.4 84.2 82.3 81.7 82.7 82.1 81.5 82.5 83.4 81.8 83.3 83.3 83.9 81.5 80.1 80.7 78.8 -1.9  
  powder 19–22 92.4 90.7 89.8 91.0 92.0 91.6 90.7 89.1 89.5 92.3 92.3 90.7 91.0 88.3 90.2 88.6 89.6 89.8 87.3 -2.5
  regularly i 23–26 93.6 94.2 92.2 93.4 89.1 89.4 91.2 92.9 92.3 90.5 90.5 91.0 93.8 90.6 88.7 86.1 88.1 87.3 88.4 +1.1
27–30 93.1 91.5 94.0 93.3 94.1 93.1 93.9 92.4 92.5 90.1 90.2 92.1 91.5 92.2 90.9 89.2 91.4 89.2 85.3 -4.0 s
Try heroin once 18 56.0 54.2 55.6 56.0 58.0 56.6 55.2 59.1 58.4 55.5 59.3 58.3 59.1 59.4 61.7 62.8 64.0 64.5 63.0 -1.5  
  or twice g  19–22 63.5 63.2 64.0 63.1 64.6 67.3 66.5 65.0 69.6 67.7 67.3 64.2 66.5 66.8 68.9 66.1 70.4 70.5 70.9 +0.4
23–26 68.0 70.7 71.9 69.8 70.6 67.5 69.2 67.0 68.3 70.1 69.2 75.6 71.3 74.8 69.2 70.8 72.0 74.2 73.7 -0.5
27–30 70.1 67.4 68.2 70.9 72.3 68.4 74.4 70.8 70.2 70.2 67.6 69.6 69.1 70.4 72.7 71.7 74.5 72.6 74.3 +1.7
Take heroin 18 77.3 74.6 75.9 76.6 78.5 75.7 76.0 79.1 76.2 75.3 79.7 74.8 77.2 78.0 78.2 77.9 78.0 78.7 74.6 -4.1 s
  occasionally g  19–22 82.5 82.0 83.6 82.2 84.9 85.1 83.8 84.3 85.4 84.5 83.3 81.3 82.9 82.1 85.0 83.3 85.8 85.9 86.3 +0.4
23–26 88.5 86.6 88.4 90.0 88.3 86.7 87.5 85.2 86.5 88.0 87.8 90.0 88.6 84.2 85.1 85.9 86.0 87.4 87.1 -0.3
27–30 87.1 86.5 86.4 87.9 87.4 88.6 91.2 88.3 88.5 87.7 87.7 90.1 85.8 86.2 88.6 83.7 88.2 85.0 89.4 +4.5 s
Take heroin 18 89.9 89.2 88.3 88.5 89.3 86.8 87.5 89.7 87.8 86.4 89.9 85.5 87.9 88.6 87.6 85.7 84.8 85.4 83.3 -2.2  
  regularly g  19–22 92.8 94.0 91.3 92.6 93.9 94.3 94.9 94.2 93.6 92.3 92.6 90.8 91.8 93.8 93.5 94.0 93.3 93.2 94.9 +1.7
23–26 93.7 94.8 95.9 96.3 96.5 96.0 94.8 95.8 93.1 95.7 94.5 97.1 94.2 92.5 95.0 96.2 92.5 95.3 94.8 -0.6
27–30 93.7 94.2 94.5 95.9 94.9 95.0 97.3 95.3 94.8 95.4 93.9 97.2 94.7 93.6 96.2 96.1 95.6 94.5 95.9 +1.4
Try narcotics other than 18 — — — — — — — — — — — 40.4 39.9 38.4 43.1 42.7 44.1 43.6 42.0 -1.6  
  heroin once 19–22 — — — — — — — — — — — — — 47.3 46.1 49.8 50.6 49.9 47.8 -2.1
  or twice h 23–26 — — — — — — — — — — — — — 45.3 44.1 45.2 46.4 45.8 45.7 -0.1
27–30 — — — — — — — — — — — — — 43.0 47.3 48.5 45.6 45.8 43.7 -2.1
Try narcotics other than 18 — — — — — — — — — — — 74.9 75.5 73.9 75.8 72.7 73.9 72.4 70.8 -1.6  
  heroin regularly h 19–22 — — — — — — — — — — — — — 70.3 74.9 76.0 76.2 76.2 73.2 -3.0
23–26 — — — — — — — — — — — — — 78.2 75.6 75.8 75.6 76.3 77.8 +1.6
27–30 — — — — — — — — — — — — — 76.2 75.7 76.0 74.9 76.7 78.1 +1.4
Try 18 32.2 32.6 34.7 34.4 36.8 35.7 37.7 39.5 41.3 39.2 41.9 40.6 34.8 34.3 36.3 34.1 34.0 31.1 31.9 +0.8  
  amphetamines 19–22 33.7 35.0 34.2 38.1 40.2 36.8 38.3 40.0 38.4 42.1 39.3 40.8 34.7 31.9 33.8 32.8 34.5 32.2 36.8 +4.6
  once or twice b,h 23–26 41.8 39.9 41.6 38.0 38.3 33.2 39.1 37.0 38.0 40.8 40.7 42.2 31.4 37.8 31.4 37.4 33.5 34.0 26.1 -7.8 s
27–30 36.3 39.4 38.5 39.0 40.5 39.2 38.2 39.7 37.4 36.5 36.2 38.5 36.9 35.3 34.0 30.4 32.1 30.5 31.6 +1.1
Take 18 66.4 66.3 67.1 64.8 65.6 63.9 67.1 68.1 68.1 65.4 69.0 63.6 58.7 60.0 59.5 55.1 54.3 51.3 50.0 -1.3  
  amphetamines 19–22 72.4 73.4 71.1 72.7 75.0 72.4 74.1 72.1 73.8 74.2 74.7 76.9 66.1 69.8 63.9 65.3 63.8 61.5 60.4 -1.0
  regularly b,h 23–26 78.7 79.0 77.7 77.9 80.1 75.1 80.1 78.3 77.0 76.5 73.9 80.8 69.7 68.3 64.9 68.5 59.0 65.8 57.8 -8.0
27–30 82.6 80.8 79.9 79.8 81.5 77.6 78.9 78.9 77.6 78.9 80.1 81.3 75.1 73.5 67.8 65.6 65.1 62.6 64.9 +2.4
Try crystal 18 51.2 51.3 52.7 53.8 51.2 52.4 54.6 59.1 60.2 62.2 63.4 64.9 66.5 67.8 72.2 70.2 70.0 70.0 69.3 -0.6  
  methamphetamine (ice) h 19-22 50.6 49.2 52.5 56.5 60.0 60.3 63.1 63.5 65.0 70.0 70.0 70.7 74.2 — — — — — — —
23–26 61.3 60.1 59.2 57.7 58.6 55.9 63.9 63.9 66.6 65.6 65.6 70.1 74.6 — — — — — — —
27–30 61.0 59.7 66.4 62.5 66.6 62.8 62.6 64.9 67.9 62.0 62.0 70.2 72.9 — — — — — — —
↓
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Try bath salts (synthetic 18 — — — — — — — — — — — — — — — — — — —
  stimulants) once   19–22 — — — — — — — — — — — — — — — — — — —
  or twice h  23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try bath salts (synthetic 18 — — — — — — — — — — — — — — — — — — —
  stimulants) 19–22 — — — — — — — — — — — — — — — — — — —
  occasionally h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try Adderall 18 — — — — — — — — — — — — — — — — — — —
  once or twice h   19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take Adderall 18 — — — — — — — — — — — — — — — — — — —
  occasionally h 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try sedatives/ 18 30.9 28.4 27.5 27.0 27.4 26.1 25.4 30.9 29.7 32.2 32.4 35.1 32.2 29.2 29.9 26.3 29.1 26.9 29.0
  barbiturates 19–22 27.6 26.4 30.5 25.4 29.9 25.0 30.7 29.6 32.7 30.5 36.4 33.5 33.5 33.4 35.0 30.5 34.1 31.4 27.7
  once or twice c,h 23–26 — — — — 32.2 29.9 30.2 35.5 35.8 32.9 37.9 31.8 33.5 32.8 34.0 34.8 35.8 37.3 40.3
27–30 — — — — — — — — 37.2 38.7 39.0 37.0 38.2 36.5 40.5 36.6 37.2 35.7 36.7
Take sedatives/ 18 72.2 69.9 67.6 67.7 68.5 68.3 67.2 69.4 69.6 70.5 70.2 70.5 70.2 66.1 63.3 61.6 60.4 56.8 56.3
  barbiturates 19–22 74.0 73.3 72.7 71.3 71.6 71.7 74.5 73.0 74.0 71.7 75.5 75.5 73.6 71.1 69.4 66.4 70.7 69.5 65.1
  regularly c,h 23–26 — — — — 77.4 77.0 74.9 79.9 79.8 76.6 80.5 77.7 76.3 75.0 74.3 77.6 77.1 75.2 73.9
27–30 — — — — — — — — 81.5 83.7 84.0 79.6 78.6 80.2 78.3 77.7 74.1 77.1 79.9
Try one or two drinks 18 3.8 4.6 3.5 4.2 4.6 5.0 4.6 6.2 6.0 6.0 8.3 9.1 8.6 8.2 7.6 5.9 7.3 6.7 8.0
  of an alcoholic 19–22 3.0 3.4 3.1 2.3 4.7 3.1 5.4 3.5 3.9 5.9 6.1 5.4 5.8 6.6 6.5 4.5 3.3 3.2 4.2
  beverage (beer, 23–26 — — — — 5.5 3.0 6.5 6.6 4.2 5.1 5.7 4.4 5.6 3.2 4.5 4.3 4.8 4.4 4.4
  wine, liquor) i 27–30 — — — — — — — — 5.0 6.3 4.4 6.6 5.6 4.7 4.1 6.7 4.7 4.0 6.2
Take one or two 18 20.3 21.6 21.6 21.6 23.0 24.4 25.1 26.2 27.3 28.5 31.3 32.7 30.6 28.2 27.0 24.8 25.1 24.8 24.3
  drinks nearly 19–22 22.7 22.9 23.2 23.2 25.0 26.3 27.3 26.1 26.5 28.1 30.1 29.1 30.2 28.0 27.5 24.0 23.0 24.2 22.1
  every day i 23–26 — — — — 27.8 27.4 26.9 30.2 29.1 27.8 31.1 30.4 31.6 25.9 26.2 26.1 22.0 20.2 21.0
27–30 — — — — — — — — 27.4 31.7 32.2 31.7 30.9 28.0 27.4 27.2 24.0 24.8 20.8
Take four or five 18 65.7 64.5 65.5 66.8 68.4 69.8 66.5 69.7 68.5 69.8 70.9 69.5 70.5 67.8 66.2 62.8 65.6 63.0 62.1
  drinks nearly 19–22 71.2 72.7 73.3 72.7 76.2 74.1 74.0 76.4 72.8 75.7 76.1 75.5 71.8 72.1 70.3 72.5 68.5 71.4 70.4
  every day i 23–26 — — — — 76.7 77.9 80.1 77.2 81.8 76.9 79.7 80.2 78.0 76.7 77.5 75.2 72.0 75.1 69.3
27–30 — — — — — — — — 79.3 81.7 84.7 79.1 79.9 79.1 76.6 82.2 76.1 79.3 75.7
Have five or more 18 35.9 36.3 36.0 38.6 41.7 43.0 39.1 41.9 42.6 44.0 47.1 48.6 49.0 48.3 46.5 45.2 49.5 43.0 42.8
  drinks once 19–22 34.2 30.1 33.5 36.6 37.9 40.2 34.6 36.7 36.9 42.4 40.6 40.8 41.8 42.4 41.9 39.9 40.7 36.6 42.0
  or twice each 23–26 — — — — 38.4 39.7 39.1 39.8 35.8 37.7 40.2 39.3 37.6 36.2 40.2 37.9 39.1 37.4 41.1
  weekend i 27–30 — — — — — — — — 41.0 42.3 44.1 42.2 45.1 42.9 43.2 44.6 41.5 40.0 40.2
Smoke one or 18 63.7 63.3 60.5 61.2 63.8 66.5 66.0 68.6 68.0 67.2 68.2 69.4 69.2 69.5 67.6 65.6 68.2 68.7 70.8
  more packs of 19–22 66.5 61.7 64.0 62.1 69.1 71.4 70.4 70.6 71.0 73.4 72.5 77.9 72.6 76.0 71.2 71.6 73.8 76.3 77.2
  cigarettes 23–26 — — — — 71.1 70.1 75.7 73.6 75.5 71.4 78.5 75.3 76.3 78.4 76.4 76.0 76.0 77.6 76.5
  per day f 27–30 — — — — — — — — 72.8 75.2 77.8 75.4 77.6 75.0 75.3 75.6 73.0 80.3 80.9
Use electronic cigarettes 18 — — — — — — — — — — — — — — — — — — —
  (e-cigarettes) regularly 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Use smokeless 18 — — — — — — 25.8 30.0 33.2 32.9 34.2 37.4 35.5 38.9 36.6 33.2 37.4 38.6 40.9
  tobacco 19–22 — — — — — — 29.7 34.1 31.1 37.1 33.5 38.9 40.1 43.3 37.6 42.3 40.9 46.5 47.4
  regularly h 23–26 — — — — — — 37.0 38.5 35.8 37.9 40.1 38.9 41.6 44.6 42.9 46.6 47.2 46.2 48.4
27–30 — — — — — — — — 42.8 42.8 43.8 44.3 44.1 47.3 46.3 44.2 43.6 50.2 52.6
Approximate Weighted N 18 3,234 3,604 3,557 3,305 3,262 3,250 3,020 3,315 3,276 2,796 2,553 2,549 2,684 2,759 2,591 2,603 2,449 2,579 2,564
Per Form = 19–22 590 585 583 585 579 547 581 570 551 565 552 533 527 480 490 500 469 464 431
23–26 540 512 545 531 527 498 511 505 518 503 465 446 438 420 413
27–30 513 587 490 486 482 473 443 450 422 434 416
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Age Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Try bath salts (synthetic 18 — — — — — — — — — — — — — 33.2 59.5 59.2 57.5 54.9 51.3 -3.6  
  stimulants) once   19–22 — — — — — — — — — — — — — 44.5 62.7 68.8 65.2 69.6 68.4 -1.2
  or twice h 23–26 — — — — — — — — — — — — — 46.7 66.3 67.3 69.4 70.9 68.6 -2.3
27–30 — — — — — — — — — — — — — 48.7 64.5 73.7 72.4 73.3 72.1 -1.2
Take bath salts (synthetic 18 — — — — — — — — — — — — — 45.0 69.9 68.8 67.4 64.2 61.5 -2.7  
  stimulants) 19–22 — — — — — — — — — — — — — 52.6 70.1 76.1 75.3 78.8 78.6 -0.2
  occasionally h 23–26 — — — — — — — — — — — — — 54.0 75.3 76.7 77.7 78.7 78.8 +0.1
27–30 — — — — — — — — — — — — — 55.9 71.5 78.4 77.4 80.7 81.4 +0.7
Try Adderall 18 — — — — — — — — — — — 33.3 31.2 27.2 31.8 33.6 34.3 32.5 32.0 -0.5  
  once or twice h   19–22 — — — — — — — — — — — — — 30.0 27.7 31.5 27.5 30.6 32.9 +2.3
23–26 — — — — — — — — — — — — — 28.9 32.9 32.2 29.8 32.9 27.5 -5.4
27–30 — — — — — — — — — — — — — 29.4 32.7 35.9 33.2 37.0 32.4 -4.6
Take Adderall 18 — — — — — — — — — — — 41.6 40.8 35.3 38.8 41.5 41.6 40.9 40.6 -0.3  
  occasionally h 19–22 — — — — — — — — — — — — — 38.8 39.8 41.8 40.2 43.0 45.4 +2.5
23–26 — — — — — — — — — — — — — 39.7 44.8 44.9 41.3 42.5 37.1 -5.4
27–30 — — — — — — — — — — — — — 44.1 45.0 45.3 44.2 47.7 46.5 -1.2
Try sedatives/ 18 26.1 25.0 25.7 26.2 27.9 24.9 24.7 28.0 27.9 25.9 29.6 28.0 27.8 27.8 29.4 29.6 28.9 27.4 26.9 -0.5  
  barbiturates 19–22 28.5 30.3 30.0 30.7 32.7 26.7 26.9 28.9 28.1 31.9 26.2 28.7 30.1 32.8 30.5 32.7 32.1 33.5 37.1 +3.6
  once or twice c,h 23–26 39.4 37.0 38.5 34.7 36.5 22.2 29.8 26.3 25.9 28.4 31.1 36.2 28.8 35.9 31.8 34.8 33.9 31.3 30.6 -0.7
27–30 35.2 36.3 40.9 37.3 38.6 31.4 31.7 28.8 28.0 27.8 27.5 27.4 34.4 28.7 31.9 25.0 34.2 34.8 30.4 -4.4
Take sedatives/ 18 54.1 52.3 50.3 49.3 49.6 54.0 54.1 56.8 55.1 50.2 54.7 52.1 52.4 53.9 53.3 50.5 50.6 47.0 44.0 -3.0  
  barbiturates 19–22 64.7 64.6 61.8 64.5 63.8 60.2 64.4 61.3 63.2 64.0 59.4 64.6 63.6 68.2 64.7 66.9 63.0 63.8 64.6 +0.8
  regularly c,h 23–26 75.1 73.8 73.1 73.1 72.8 63.9 67.0 67.6 64.8 66.8 64.4 69.6 64.9 71.4 67.6 72.3 64.5 65.2 62.9 -2.3
27–30 80.7 75.5 78.2 75.4 79.0 70.1 75.2 68.0 70.0 70.4 69.0 71.1 71.4 70.7 72.6 64.2 67.0 66.6 64.4 -2.1
Try one or two drinks 18 8.3 6.4 8.7 7.6 8.4 8.6 8.5 9.3 10.5 10.0 9.4 10.8 9.4 8.7 9.9 8.6 10.3 9.5 9.3 -0.2  
  of an alcoholic 19–22 5.7 5.4 4.8 6.6 7.5 5.1 3.8 7.7 5.1 7.9 4.1 6.8 7.2 6.4 5.8 5.7 4.9 4.9 6.5 +1.7
  beverage (beer, 23–26 6.6 3.5 5.5 5.1 5.7 4.7 5.3 5.1 4.8 6.5 5.7 5.5 4.0 3.5 4.3 5.4 5.1 3.9 4.1 +0.2
  wine, liquor) i 27–30 5.9 4.7 5.5 3.1 6.9 4.6 7.3 4.2 6.2 3.4 4.1 4.7 6.6 4.8 4.0 3.8 3.5 3.4 3.3 -0.1
Take one or two 18 21.8 21.7 23.4 21.0 20.1 23.0 23.7 25.3 25.1 24.2 23.7 25.4 24.6 23.7 23.1 21.1 21.5 21.6 21.6 +0.1  
  drinks nearly 19–22 23.9 22.1 19.6 22.7 19.8 21.3 22.1 22.0 19.0 24.4 20.6 20.8 20.1 23.1 20.0 22.4 19.9 18.6 17.8 -0.7
  every day i 23–26 26.0 21.7 23.5 23.4 19.1 22.9 19.9 22.5 21.2 21.0 21.1 20.8 14.4 18.4 18.8 17.5 17.2 17.4 15.4 -2.1
27–30 25.3 22.0 22.7 21.7 21.4 21.8 23.7 20.2 21.5 21.5 20.6 18.2 16.9 19.8 17.4 16.5 15.9 15.9 15.4 -0.5
Take four or five 18 61.1 59.9 60.7 58.8 57.8 59.2 61.8 63.4 61.8 60.8 62.4 61.1 62.3 63.6 62.4 61.2 59.1 59.1 58.7 -0.4  
  drinks nearly 19–22 69.9 69.9 64.5 71.1 66.4 65.3 63.0 66.6 68.8 68.5 67.1 65.6 67.4 69.6 68.7 67.9 70.2 70.4 65.1 -5.4 s
  every day i 23–26 72.8 71.7 75.8 74.9 71.1 74.2 71.2 72.4 70.2 70.0 67.8 68.3 69.9 73.1 69.7 69.2 71.2 70.7 70.1 -0.6
27–30 75.1 77.4 72.8 76.2 70.6 72.1 77.5 73.0 76.5 77.1 71.6 71.6 73.8 71.2 68.3 72.6 69.4 71.1 70.0 -1.1
Have five or more 18 43.1 42.7 43.6 42.2 43.5 43.6 45.0 47.6 45.8 46.3 48.0 46.3 47.6 48.8 45.8 45.4 46.9 48.4 45.7 -2.7  
  drinks once 19–22 37.2 38.9 37.2 37.8 40.4 38.1 37.5 37.2 43.4 41.7 35.2 40.7 40.1 41.6 40.6 43.8 41.8 43.6 39.6 -4.0
  or twice each 23–26 40.2 34.9 39.0 36.8 36.3 37.9 36.8 38.4 39.7 37.0 36.2 35.8 33.6 39.5 40.2 38.7 40.8 39.7 37.8 -1.9
  weekend i 27–30 41.9 37.9 41.6 40.6 42.5 40.5 44.0 39.1 40.4 40.4 40.1 38.6 42.0 41.6 37.2 41.2 40.6 39.6 42.0 +2.4
Smoke one or 18 70.8 73.1 73.3 74.2 72.1 74.0 76.5 77.6 77.3 74.0 74.9 75.0 77.7 78.2 78.2 78.0 75.9 76.5 74.9 -1.6  
  more packs of 19–22 75.7 77.1 76.6 80.6 77.8 81.1 80.5 80.8 79.3 79.5 80.3 79.7 81.5 82.3 82.8 82.8 83.5 84.8 83.8 -1.0
  cigarettes 23–26 80.9 79.7 83.9 85.1 83.6 84.1 81.6 86.4 80.7 83.6 82.0 83.2 84.8 83.1 82.9 82.8 85.1 84.2 84.3 +0.1
  per day f 27–30 80.7 78.4 82.7 80.6 82.0 81.7 84.1 83.8 84.3 86.6 83.6 89.3 86.6 84.6 84.1 83.9 85.9 85.4 86.3 +0.8
Use electronic cigarettes 18 — — — — — — — — — — — — — — — 14.2 16.2 18.2 16.1 -2.1  
  (e-cigarettes) regularly l 19–22 — — — — — — — — — — — — — — — 16.8 21.6 27.7 26.6 -1.1
23–26 — — — — — — — — — — — — — — — 21.7 23.0 28.6 28.2 -0.4
27–30 — — — — — — — — — — — — — — — 19.0 27.6 30.8 32.3 +1.5
Use smokeless 18 41.1 42.2 45.4 42.6 43.3 45.0 43.6 45.9 44.0 42.9 40.8 41.2 42.6 44.3 41.6 40.7 38.5 38.1 38.4 +0.2  
  tobacco 19–22 47.0 52.0 48.4 53.6 50.8 49.9 47.6 46.4 48.9 48.7 44.6 45.8 46.0 56.7 52.8 47.8 47.8 48.7 51.4 +2.7
  regularly h 23–26 53.1 49.8 59.8 61.4 58.9 57.8 55.8 59.1 55.3 51.0 52.2 54.2 53.7 59.4 53.5 53.4 47.3 52.5 54.6 +2.1
27–30 53.6 49.9 53.2 56.7 58.2 55.7 58.9 57.5 61.4 61.7 53.6 59.2 62.5 59.6 58.5 51.6 57.1 59.8 55.8 -4.0
Approximate Weighted N  18 2,306 2,130 2,173 2,198 2,466 2,491 2,512 2,407 2,450 2,389 2,290 2,440 2,408 2,331 2,098 2,067 2,174 1,992 2,175
Per Form = 19–22 447 424 430 395 402 447 412 411 375 377 393 363 374 345 337 314 315 270 281
23–26 418 400 392 382 401 426 408 361 351 375 345 363 366 323 337 319 296 284 264
27–30 400 377 384 369 380 388 374 358 344 350 337 343 319 335 320 282 312 259 284
Source. The Monitoring the Future study, the University of Michigan.
Q. How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they . . .
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
2016– 2017 
change
Percentage saying “great risk” a
TABLE 6-1 (cont.)
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Trying marijuana 18 39.0 40.0 45.5 46.3 49.3 51.4 54.6 56.6 60.8 64.6 67.8 68.7 69.9 63.3 57.6 56.7 52.5 51.0 51.6
  once or twice j 19–22 38.2 36.1 37.0 42.0 44.1 46.6 51.6 52.8 55.8 62.4 59.6 60.4 57.8 60.6 63.5 57.1 55.4 56.2 55.9
23–26 — — — — 41.2 38.6 42.6 49.1 48.7 52.5 57.5 58.8 55.0 54.6 52.3 51.9 56.3 54.5 55.3
27–30 — — — — — — — — 49.0 50.9 53.8 54.6 51.9 56.8 55.7 57.5 54.1 59.0 55.7
Smoking 18 49.7 52.6 59.1 60.7 63.5 65.8 69.0 71.6 74.0 77.2 80.5 79.4 79.7 75.5 68.9 66.7 62.9 63.2 64.4
  marijuana  19–22 49.6 49.1 51.3 56.0 60.4 62.6 66.7 67.2 69.5 77.3 76.3 77.0 74.8 75.8 76.9 70.4 68.9 70.2 67.8
  occasionally j 23–26 — — — — 54.8 52.8 57.0 64.9 63.4 69.4 73.7 73.3 74.0 71.9 70.9 68.1 72.5 69.2 70.4
27–30 — — — — — — — — 65.3 67.1 68.9 73.0 67.2 72.2 69.4 72.5 70.5 74.5 72.4
Smoking 18 74.6 77.4 80.6 82.5 84.7 85.5 86.6 89.2 89.3 89.8 91.0 89.3 90.1 87.6 82.3 81.9 80.0 78.8 81.2
  marijuana  19–22 74.3 77.2 80.0 81.8 84.9 86.7 89.2 88.7 89.1 91.2 93.1 91.3 89.5 90.2 90.1 86.8 87.7 88.1 85.3
  regularly j 23–26 — — — — 80.6 81.3 83.3 87.4 86.9 90.4 91.0 89.6 90.2 92.1 90.3 90.1 88.9 88.1 87.5
27–30 — — — — — — — — 87.6 87.5 89.7 89.6 87.2 89.4 88.7 91.9 89.9 92.1 89.2
Trying LSD 18 87.3 86.4 88.8 89.1 88.9 89.5 89.2 91.6 89.8 89.7 89.8 90.1 88.1 85.9 82.5 81.1 79.6 80.5 82.1
  once or twice h 19–22 87.4 84.8 85.9 88.4 88.1 89.1 90.4 90.0 90.9 89.3 90.5 88.4 84.6 88.5 86.8 84.2 83.0 83.1 80.8
23–26 — — — — 87.3 87.1 88.0 89.9 91.4 91.0 90.7 89.1 88.8 86.9 87.3 87.1 86.7 87.9 84.1
27–30 — — — — — — — — 91.0 87.2 89.7 87.9 85.6 88.8 88.2 87.4 88.7 88.7 87.3
Taking LSD 18 96.7 96.8 96.7 97.0 96.8 97.0 96.6 97.8 96.4 96.4 96.3 96.4 95.5 95.8 94.3 92.5 93.2 92.9 93.5
  regularly h 19–22 98.2 97.4 97.7 97.6 97.6 98.8 98.5 98.0 98.1 97.5 99.1 97.5 97.0 97.8 97.7 96.8 97.0 97.4 96.3
23–26 — — — — 99.2 98.0 98.5 99.0 98.0 98.4 98.3 98.4 98.3 98.1 97.7 96.7 97.7 96.1 97.6
27–30 — — — — — — — — 98.8 97.1 98.9 98.9 97.5 98.5 98.7 98.6 98.1 97.5 97.4
Trying ecstasy 18 — — — — — — — — — — — — — — — — — 82.2 82.5
  (MDMA, Molly) 19–22 — — — — — — — — — — — — — — — — — — —
  once or twice h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Taking ecstasy 18 — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — — — — — — — — — — — — — — — — — —
  occasionally h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Trying cocaine 18 76.3 74.6 76.6 77.0 79.7 79.3 80.2 87.3 89.1 90.5 91.5 93.6 93.0 92.7 91.6 90.3 90.0 88.0 89.5
  once or twice h 19–22 73.0 69.3 69.9 74.1 72.5 77.6 78.9 82.3 85.3 88.8 90.1 91.2 90.6 92.7 93.9 94.2 92.0 91.7 89.9
23–26 — — — — 70.2 70.5 72.1 80.0 82.9 85.5 88.3 88.0 87.3 89.2 89.2 91.8 90.7 91.5 89.0
27–30 — — — — — — — — 82.1 81.0 85.5 86.9 83.9 85.7 86.6 86.6 88.3 89.2 90.3
Taking cocaine 18 91.1 90.7 91.5 93.2 94.5 93.8 94.3 96.7 96.2 96.4 96.7 97.3 96.9 97.5 96.6 96.1 95.6 96.0 95.6
  regularly h 19–22 91.6 89.3 91.9 94.6 95.0 96.3 97.0 97.2 97.9 97.4 98.9 97.9 98.4 97.8 98.8 98.2 97.9 98.0 97.8
23–26 — — — — 95.7 95.3 97.3 98.1 97.6 98.3 98.4 98.5 98.7 98.4 98.8 97.7 97.8 96.9 98.5
27–30 — — — — — — — — 98.1 97.0 99.3 99.0 97.2 98.7 99.0 98.9 98.5 97.9 97.8
Trying heroin 18 93.5 93.5 94.6 94.3 94.0 94.0 93.3 96.2 95.0 95.4 95.1 96.0 94.9 94.4 93.2 92.8 92.1 92.3 93.7
  once or twice h 19–22 96.3 95.4 95.6 95.2 95.1 96.2 96.8 96.3 97.1 96.4 98.3 95.9 95.9 96.3 96.6 95.6 95.2 95.6 95.1
23–26 — — — — 96.7 94.9 96.4 97.1 97.4 96.7 96.8 96.9 96.3 95.4 96.5 95.9 96.1 95.2 94.6
27–30 — — — — — — — — 97.9 95.8 97.5 96.6 94.8 97.3 94.7 96.3 96.0 96.9 95.9
Taking heroin 18 96.7 97.2 96.9 96.9 97.1 96.8 96.6 97.9 96.9 97.2 96.7 97.3 96.8 97.0 96.2 95.7 95.0 95.4 96.1
  occasionally h 19–22 98.6 97.8 98.3 98.3 98.6 98.7 98.3 98.3 98.3 97.9 99.2 98.2 98.1 98.1 98.3 97.7 97.9 97.8 98.2
23–26 — — — — 99.2 98.2 98.8 99.1 98.4 98.3 98.1 99.0 98.7 98.4 98.6 97.7 98.7 97.4 97.5
27–30 — — — — — — — — 99.2 97.3 99.0 98.9 97.0 98.9 98.7 98.9 98.0 98.7 97.6
Taking heroin 18 97.6 97.8 97.5 97.7 98.0 97.6 97.6 98.1 97.2 97.4 97.5 97.8 97.2 97.5 97.1 96.4 96.3 96.4 96.6
  regularly h 19–22 99.2 98.5 98.6 98.7 98.7 99.1 98.9 98.6 98.4 98.3 99.5 98.5 98.3 98.4 98.8 98.4 98.3 98.1 98.3
23–26 — — — — 99.4 98.8 99.1 99.4 98.7 98.7 98.5 99.3 99.2 98.9 98.8 98.7 98.9 97.6 98.5
27–30 — — — — — — — — 99.4 97.6 99.4 99.0 97.8 99.0 99.4 99.1 98.6 98.4 98.1
TABLE 6-2
Trends in Proportions Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Q.  Do you disapprove of 
people (who are 18 or 
older) doing each of the 
following?
Percentage disapproving e
(Years 
Cont.)
(Table continued on next page.)
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Age 
Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Trying marijuana 18 48.8 52.5 49.1 51.6 53.4 52.7 55.0 55.6 58.6 55.5 54.8 51.6 51.3 48.8 49.1 48.0 45.5 43.1 39.0 -4.1 s
  once or twice j 19–22 54.0 55.2 49.3 48.7 54.2 48.3 50.3 51.2 47.6 52.7 46.7 50.5 49.0 46.0 44.2 39.7 37.4 36.7 33.6 -3.1
23–26 55.7 54.8 51.2 52.4 47.8 53.4 47.7 47.5 54.6 46.2 44.9 42.5 38.8 40.9 38.1 37.8 34.6 36.3 29.2 -7.1 sss
27–30 52.6 58.0 54.4 56.9 54.9 55.4 52.1 52.0 50.9 49.3 49.3 48.5 46.5 42.7 38.7 35.1 33.0 31.5 27.8 -3.6
Smoking 18 62.5 65.8 63.2 63.4 64.2 65.4 67.8 69.3 70.2 67.3 65.6 62.0 60.9 59.1 58.9 56.7 52.9 50.5 46.7 -3.8  
  marijuana  19–22 66.4 70.7 64.6 62.3 68.0 64.3 67.9 62.6 64.1 63.3 59.8 61.3 61.7 58.2 54.9 50.7 50.0 45.9 42.7 -3.2
  occasionally j 23–26 71.1 68.6 67.4 64.0 63.8 69.3 65.6 62.2 68.0 64.5 62.4 59.1 53.1 55.8 51.3 51.3 49.1 46.8 41.5 -5.2 s
27–30 71.5 72.2 70.9 69.1 71.2 69.1 68.2 68.7 67.5 63.7 63.7 62.7 63.7 58.3 55.0 50.0 47.3 44.0 39.8 -4.2 s
Smoking 18 78.6 79.7 79.3 78.3 78.7 80.7 82.0 82.2 83.3 79.6 80.3 77.7 77.5 77.8 74.5 73.4 70.7 68.5 64.7 -3.9 s
  marijuana  19–22 84.5 86.6 84.5 82.8 84.8 82.7 84.4 82.5 83.7 83.6 80.8 80.7 78.1 77.0 75.7 71.3 71.0 70.6 67.3 -3.4
  regularly j 23–26 86.1 83.9 86.4 81.7 82.3 87.4 84.3 81.9 85.3 84.3 80.2 78.3 76.4 76.7 73.6 71.4 70.4 68.8 65.0 -3.8
27–30 90.0 89.5 89.3 88.8 87.7 88.6 86.3 86.4 86.8 86.0 84.4 81.7 83.2 77.8 75.9 75.0 71.8 69.0 63.5 -5.5 ss
Trying LSD 18 83.0 82.4 81.8 84.6 85.5 87.9 87.9 88.0 87.8 85.5 88.2 86.5 86.3 87.2 86.6 85.0 81.7 82.4 78.0 -4.4 s
  once or twice h 19–22 83.2 82.3 81.4 83.7 86.2 85.0 87.6 85.4 88.5 86.5 83.0 86.7 83.3 84.0 83.5 77.8 75.5 70.3 72.5 +2.2
23–26 84.8 80.3 83.0 79.2 80.1 84.0 84.0 84.5 87.6 81.8 85.0 82.6 80.1 83.3 79.7 79.8 76.8 73.9 73.9 +0.1
27–30 86.6 87.2 85.7 82.7 85.6 82.5 82.2 82.0 84.1 82.7 84.5 85.1 85.1 82.4 81.4 82.2 77.9 80.0 71.8 -8.2 s
Taking LSD 18 94.3 94.2 94.0 94.0 94.4 94.6 95.6 95.9 94.9 93.5 95.3 94.3 94.9 95.2 95.3 94.7 92.5 92.4 92.7 +0.3  
  regularly h 19–22 97.0 96.8 96.5 96.9 98.4 97.3 98.9 97.8 97.7 96.8 96.8 96.6 96.5 96.0 96.7 97.0 95.2 95.4 93.9 -1.5
23–26 98.0 97.0 97.1 97.9 96.9 97.1 98.7 97.0 98.4 97.4 98.2 96.5 95.9 97.4 96.1 95.8 96.6 93.1 95.9 +2.8
27–30 97.9 98.6 98.2 98.0 98.2 98.2 97.2 96.7 97.2 97.1 98.6 98.6 97.1 97.3 97.2 97.3 96.0 96.4 94.0 -2.4
Trying ecstasy 18 82.1 81.0 79.5 83.6 84.7 87.7 88.4 89.0 87.8 88.2 88.2 86.3 83.9 87.1 84.9 83.1 84.5 84.0 85.1 +1.2  
  (MDMA, Molly) 19–22 — — 81.5 80.3 87.2 83.5 90.3 87.5 88.5 89.5 89.1 91.4 85.9 87.9 83.9 83.7 79.7 83.2 78.2 -5.0
  once or twice h,m 23–26 — — 80.6 80.6 80.2 83.1 83.9 83.9 87.4 83.9 85.0 86.9 85.1 85.2 79.9 83.6 79.1 82.8 79.9 -2.9
27–30 — — 84.2 84.0 86.3 83.2 82.4 82.2 81.8 82.7 83.0 81.9 86.6 83.7 84.5 81.9 84.6 81.5 78.6 -3.0
Taking ecstasy 18 — — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — 92.8 91.8 95.6 93.8 96.7 94.0 95.3 94.8 95.2 95.3 91.8 94.4 92.3 94.6 90.7 90.2 93.1 +2.9
  occasionally h,m 23–26 — — 90.5 91.8 92.1 93.3 94.4 93.7 94.3 94.0 95.4 94.3 92.5 93.3 92.1 93.5 90.7 91.6 91.7 +0.1
27–30 — — 91.7 93.0 94.3 91.0 92.1 93.4 92.8 94.1 93.6 92.6 94.5 93.5 93.0 93.9 93.2 92.0 88.1 -3.9
Trying cocaine 18 89.1 88.2 88.1 89.0 89.3 88.6 88.9 89.1 89.6 89.2 90.8 90.5 91.1 91.0 92.3 90.0 89.0 88.4 88.0 -0.4  
  once or twice h 19–22 90.9 89.9 87.7 87.9 89.3 87.7 92.3 88.2 89.2 85.8 87.8 87.1 90.1 89.7 90.5 86.7 86.0 84.3 85.6 +1.3
23–26 91.3 87.1 90.1 85.8 86.4 87.4 88.3 84.4 87.6 84.5 86.2 86.0 82.7 86.0 85.7 84.8 82.9 77.5 80.8 +3.2
27–30 90.4 89.4 90.3 88.5 91.5 88.0 87.0 85.8 87.7 87.4 88.3 87.3 87.0 85.6 82.5 85.0 79.1 83.7 75.8 -7.9 s
Taking cocaine 18 94.9 95.5 94.9 95.0 95.8 95.4 96.0 96.1 96.2 94.8 96.5 96.0 96.0 96.8 96.7 96.3 95.2 94.8 94.8 -0.1  
  regularly h 19–22 97.6 98.0 97.2 97.0 98.2 98.5 98.7 98.9 99.0 97.6 97.6 97.6 97.2 97.6 97.4 97.8 97.8 97.2 97.0 -0.2
23–26 98.3 97.8 97.5 97.5 97.6 98.1 98.9 97.3 98.1 98.0 98.7 97.6 97.3 98.8 97.8 97.7 97.5 94.5 97.0 +2.5
27–30 98.8 98.7 98.4 97.8 98.8 98.8 97.8 97.2 97.9 97.3 99.0 99.0 98.4 98.5 98.0 97.6 98.0 96.9 96.1 -0.8
Trying heroin 18 93.5 93.0 93.1 94.1 94.1 94.2 94.3 93.8 94.8 93.3 94.7 93.9 94.3 95.8 95.6 94.7 94.2 94.1 93.7 -0.4  
  once or twice h 19–22 95.5 94.1 94.2 95.0 96.4 95.9 98.8 95.6 97.6 95.7 95.5 95.8 96.7 95.9 96.3 96.5 96.1 94.9 96.8 +1.8
23–26 96.3 93.1 95.0 94.8 95.0 95.0 96.1 93.7 97.2 95.6 94.9 94.5 95.5 95.7 94.7 97.2 96.5 93.4 96.6 +3.2
27–30 96.7 95.9 96.4 94.4 97.6 94.9 95.6 93.9 96.4 96.2 95.4 96.3 95.7 95.9 94.8 95.3 95.2 95.9 95.5 -0.4
Taking heroin 18 95.7 96.0 95.4 95.6 95.9 96.4 96.3 96.2 96.8 95.3 96.9 96.2 96.3 97.0 96.9 96.6 95.3 95.5 95.5 0.0  
  occasionally h 19–22 97.2 98.0 97.9 97.9 98.3 98.9 99.4 98.2 98.8 97.3 97.9 97.5 97.7 97.4 98.0 97.8 97.5 97.4 97.7 +0.3
23–26 98.5 98.2 97.8 97.5 97.2 98.5 98.3 97.7 98.8 98.3 98.5 97.1 99.0 99.0 98.1 98.1 98.1 96.6 97.7 +1.0
27–30 98.8 98.6 98.4 98.6 98.7 98.1 97.7 97.1 98.1 98.2 98.6 99.3 98.1 97.9 97.7 97.3 98.0 98.3 97.4 -0.9
Taking heroin 18 96.4 96.6 96.2 96.2 97.1 97.1 96.7 96.9 97.1 95.9 97.4 96.4 96.7 97.4 97.4 97.1 96.4 95.7 95.9 +0.2  
  regularly h 19–22 98.2 98.5 98.2 98.3 98.8 99.0 99.2 98.9 99.1 98.3 98.1 97.6 97.9 98.3 98.4 97.9 98.1 97.6 97.7 +0.1
23–26 98.7 98.8 98.4 98.3 98.6 98.9 98.9 98.0 99.0 99.1 99.2 97.6 99.3 99.1 98.3 98.9 98.1 97.0 98.4 +1.4
27–30 98.8 98.7 98.7 98.4 99.3 98.8 99.1 97.5 98.2 98.4 99.0 99.3 98.6 98.3 97.9 97.6 98.5 98.9 98.0 -1.0
↓
(List of drugs continued.)  
Percentage disapproving e
Q.  Do you disapprove of 
people (who are 18 or 
older) doing each of the 
following?
TABLE 6-2 (cont.)
Trends in Proportions Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
2016–   
2017 
change
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Trying 18 75.4 71.1 72.6 72.3 72.8 74.9 76.5 80.7 82.5 83.3 85.3 86.5 86.9 84.2 81.3 82.2 79.9 81.3 82.5
  amphetamines  19–22 74.5 70.5 68.9 74.0 73.0 75.6 78.9 79.9 81.8 85.3 84.4 83.9 83.8 87.2 88.3 85.0 84.4 83.3 84.6
  once or twice b,h 23–26 — — — — 74.2 74.2 74.6 80.3 83.5 83.3 84.1 84.8 83.4 84.8 82.7 86.0 86.4 85.7 83.5
27–30 — — — — — — — — 83.5 81.0 84.3 83.7 80.9 83.5 82.0 83.1 85.8 86.3 85.9
Taking 18 93.0 91.7 92.0 92.6 93.6 93.3 93.5 95.4 94.2 94.2 95.5 96.0 95.6 96.0 94.1 94.3 93.5 94.3 94.0
  amphetamines 19–22 94.8 93.3 94.3 93.4 94.9 96.6 96.9 95.1 97.5 96.8 97.5 97.7 96.7 97.3 97.9 96.8 97.2 97.8 96.7
  regularly b,h 23–26 — — — — 96.6 95.9 96.6 97.0 97.2 98.1 97.9 97.9 97.7 98.4 97.7 97.0 97.9 97.0 98.0
27–30 — — — — — — — — 98.1 96.5 98.6 97.8 96.8 97.7 99.0 98.9 98.2 98.1 97.7
Trying sedatives/ 18 83.9 82.4 84.4 83.1 84.1 84.9 86.8 89.6 89.4 89.3 90.5 90.6 90.3 89.7 87.5 87.3 84.9 86.4 86.0
   barbiturates 19–22 83.5 82.3 83.8 85.1 85.2 86.1 88.3 87.5 90.1 92.0 91.1 90.4 88.8 90.7 91.1 90.5 89.1 86.6 85.8
   once or twice c,h 23–26 — — — — 84.0 84.5 84.4 89.8 90.7 89.4 88.8 87.9 88.8 88.5 88.0 89.3 88.3 88.3 87.4
27–30 — — — — — — — — 90.5 88.3 88.4 88.8 86.6 88.9 87.6 88.0 89.4 88.8 88.4
18 95.4 94.2 94.4 95.1 95.1 95.5 94.9 96.4 95.3 95.3 96.4 97.1 96.5 97.0 96.1 95.2 94.8 95.3 94.6
   barbiturates 19–22 96.6 95.6 97.3 96.5 96.6 98.1 98.0 97.0 97.9 97.7 98.7 98.0 97.9 98.2 98.7 97.7 97.9 97.7 97.7
   regularly c,h 23–26 — — — — 98.4 98.5 97.7 98.6 98.3 98.3 98.5 98.5 98.6 98.5 98.5 97.4 98.4 97.4 98.5
27–30 — — — — — — — — 98.4 97.1 99.1 98.5 97.7 98.4 99.1 99.0 98.5 97.9 97.7
Trying one or two 18 16.0 17.2 18.2 18.4 17.4 20.3 20.9 21.4 22.6 27.3 29.4 29.8 33.0 30.1 28.4 27.3 26.5 26.1 24.5
  drinks of an alcoholic 19–22 14.8 14.5 13.9 15.5 15.3 15.4 16.9 16.0 18.4 22.4 17.6 22.2 16.9 20.8 22.2 22.0 22.0 18.3 21.5
  beverage (beer, 23–26 — — — — 17.4 16.1 13.2 17.7 13.7 17.5 18.6 19.5 17.4 18.1 17.6 16.5 18.0 15.8 18.6
  wine, liquor) j 27–30 — — — — — — — — 19.5 19.1 18.7 18.8 17.9 19.5 18.6 18.2 16.1 17.4 15.2
Taking one or two 18 69.0 69.1 69.9 68.9 72.9 70.9 72.8 74.2 75.0 76.5 77.9 76.5 75.9 77.8 73.1 73.3 70.8 70.0 69.4
  drinks nearly 19–22 67.8 69.7 71.3 73.3 74.3 71.3 77.4 75.3 76.5 80.0 79.7 77.1 76.0 75.0 78.0 74.7 73.5 73.2 70.3
  every day j 23–26 — — — — 71.4 73.7 71.6 72.7 74.6 74.4 77.6 76.9 75.5 74.2 73.3 69.7 70.6 68.4 70.2
27–30 — — — — — — — — 76.0 73.9 73.3 76.1 69.5 73.5 72.4 71.8 71.4 71.8 69.8
Taking four or five 18 90.8 91.8 90.9 90.0 91.0 92.0 91.4 92.2 92.8 91.6 91.9 90.6 90.8 90.6 89.8 88.8 89.4 88.6 86.7
  drinks nearly 19–22 95.2 93.4 94.6 94.6 94.6 94.8 94.9 95.7 94.8 96.1 95.8 96.4 95.5 95.1 96.2 95.5 94.2 93.9 92.4
  every day j 23–26 — — — — 96.2 95.0 95.5 96.9 94.3 95.9 96.9 96.1 95.7 95.7 95.7 95.2 96.5 93.8 96.1
27–30 — — — — — — — — 97.4 94.6 96.1 95.3 94.8 94.8 96.4 96.7 96.4 96.2 95.0
Having five or 18 55.6 55.5 58.8 56.6 59.6 60.4 62.4 62.0 65.3 66.5 68.9 67.4 70.7 70.1 65.1 66.7 64.7 65.0 63.8
  more drinks 19–22 57.1 56.1 58.2 61.0 59.7 59.4 60.3 61.6 64.1 66.3 67.1 62.4 65.6 63.5 68.1 66.0 69.2 66.5 63.2
  once or twice 23–26 — — — — 66.2 68.3 66.5 67.5 65.2 63.2 66.9 64.6 69.6 66.8 66.9 65.3 70.9 66.6 69.5
  each weekend j 27–30 — — — — — — — — 73.9 71.4 73.1 72.1 68.4 73.4 73.5 73.7 72.4 73.0 71.1
Smoking one or 18 70.8 69.9 69.4 70.8 73.0 72.3 75.4 74.3 73.1 72.4 72.8 71.4 73.5 70.6 69.8 68.2 67.2 67.1 68.8
  more packs of 19–22 68.7 68.1 66.3 71.6 69.0 70.5 71.4 72.7 73.8 75.6 73.7 73.2 72.6 72.8 75.3 69.8 72.2 74.3 72.3
  cigarettes 23–26 — — — — 69.9 68.7 67.5 69.7 66.4 71.1 71.5 77.2 73.6 72.9 70.3 72.2 73.0 71.7 73.9
  per day j 27–30 — — — — — — — — 72.8 69.4 73.5 71.2 70.7 73.8 72.3 73.9 72.7 74.3 71.7
Approximate Weighted N 18 3,261 3,610 3,651 3,341 3,254 3,265 3,113 3,302 3,311 2,799 2,566 2,547 2,645 2,723 2,588 2,603 2,399 2,601 2,545
Per Form = 19–22 588 573 605 579 586 551 605 587 560 567 569 533 530 489 474 465 480 470 446
23–26 542 535 560 532 538 516 524 495 538 514 475 466 449 423 401
27–30 526 509 513 485 512 462 442 450 430 453 449
(Table continued on next page.)
Q.  Do you disapprove of 
people (who are 18 or 
older) doing each of the 
following?
Taking sedatives/
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Age 
Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Trying 18 81.9 82.1 82.3 83.8 85.8 84.1 86.1 86.3 87.3 87.2 88.2 88.1 84.1 83.9 84.9 83.1 81.4 82.1 81.9 -0.2  
  amphetamines 19–22 84.9 83.8 82.1 81.4 86.3 82.1 88.2 84.9 84.8 86.7 85.4 86.9 80.5 81.3 83.7 73.6 76.4 70.9 80.0 +9.0 s
  once or twice b,h 23–26 84.5 82.4 83.9 83.5 79.9 81.6 81.3 79.0 85.8 79.7 84.4 84.1 76.5 80.7 77.3 81.4 76.9 72.9 75.5 +2.6
27–30 86.4 84.5 86.0 86.4 84.9 82.4 81.3 81.1 84.5 83.7 82.9 84.3 81.1 81.9 81.5 80.8 74.6 78.6 73.8 -4.8
Taking 18 93.7 94.1 93.4 93.5 94.0 93.9 94.8 95.3 95.4 94.2 95.6 94.9 92.9 93.9 93.2 93.0 92.2 92.2 92.0 -0.2  
  amphetamines 19–22 97.5 96.1 97.3 96.4 97.1 97.1 98.4 97.5 98.6 96.2 96.8 96.2 92.1 94.1 94.4 92.8 94.0 93.3 93.6 +0.3
  regularly b,h 23–26 97.0 97.6 96.8 96.3 97.2 95.9 98.3 96.2 97.6 97.3 98.1 96.8 94.8 95.9 94.6 92.4 93.7 90.4 94.4 +3.9
27–30 98.2 98.5 97.6 97.4 98.1 98.0 97.6 96.4 98.4 97.2 98.1 98.0 97.5 95.8 96.8 96.3 94.8 94.6 94.6 0.0
Trying sedatives/ 18 86.6 85.9 85.9 86.6 87.8 83.7 85.4 85.3 86.5 86.1 87.7 87.6 87.3 88.2 88.9 88.5 87.4 86.5 85.9 -0.5  
   barbiturates 19–22 86.6 84.2 85.2 84.2 87.7 81.8 86.6 83.4 82.7 82.1 84.7 85.2 85.4 88.0 88.6 86.3 87.1 80.3 87.6 +7.2 s
   once or twice c,h 23–26 87.3 85.2 86.9 86.8 81.8 80.3 81.6 80.5 84.3 77.7 83.3 80.9 80.6 83.8 84.4 84.4 84.5 82.1 80.9 -1.2
27–30 87.6 87.3 88.5 86.9 89.2 81.8 78.7 80.1 83.5 80.5 82.5 80.3 83.3 83.1 82.6 82.5 81.2 79.2 75.9 -3.3
Taking sedatives/ 18 94.7 95.2 94.5 94.7 94.4 94.2 95.2 95.1 94.6 94.3 95.8 94.7 95.1 96.1 95.8 95.0 94.7 94.8 94.4 -0.4  
   barbiturates 19–22 97.3 97.4 96.9 97.8 98.5 96.6 98.3 98.1 98.3 96.7 96.7 96.3 96.7 96.4 96.5 97.8 96.7 95.4 96.6 +1.2
   regularly c,h 23–26 97.6 97.4 97.0 97.1 97.1 96.1 98.0 96.3 97.8 96.7 98.4 95.7 98.1 97.3 97.2 96.6 95.7 94.9 95.5 +0.6
27–30 98.5 98.1 98.4 97.2 98.4 98.1 96.5 95.6 97.4 97.4 98.4 98.6 97.0 97.7 97.1 97.4 97.7 98.0 95.9 -2.1
Trying one or two 18 24.6 25.2 26.6 26.3 27.2 26.0 26.4 29.0 31.0 29.8 30.6 30.7 28.7 25.4 27.3 29.2 28.9 28.8 27.2 -1.6  
  drinks of an alcoholic 19–22 18.3 18.4 16.3 18.3 20.1 20.7 22.3 17.8 17.3 20.5 19.1 23.7 21.6 21.4 19.6 17.9 17.5 18.3 17.7 -0.5
  beverage (beer, 23–26 19.1 19.9 15.9 18.1 13.0 16.3 13.5 14.7 14.9 12.5 16.0 15.4 10.9 14.1 13.5 14.2 12.8 15.5 14.7 -0.8
  wine, liquor) j 27–30 15.9 14.8 15.9 18.4 15.4 18.8 16.1 15.0 14.2 11.9 11.5 13.3 11.8 14.7 13.2 11.7 12.1 11.4 11.5 +0.2
Taking one or two 18 67.2 70.0 69.2 69.1 68.9 69.5 70.8 72.8 73.3 74.5 70.5 71.5 72.8 70.8 71.9 71.7 71.1 71.8 70.8 -1.1  
  drinks nearly 19–22 67.3 66.7 68.3 63.9 66.9 68.1 64.6 68.2 65.1 65.2 67.4 68.4 71.0 65.7 64.0 61.6 63.3 64.2 62.1 -2.1
  every day j 23–26 73.4 66.3 66.5 62.7 65.0 61.7 64.4 62.0 62.4 66.4 62.0 62.5 55.7 53.9 54.4 53.3 53.4 58.6 53.9 -4.7
27–30 67.9 65.9 68.9 70.9 63.1 66.7 60.5 62.0 65.8 59.5 63.7 61.4 61.7 55.6 51.3 52.0 54.8 50.0 50.0 0.0
Taking four or five 18 86.9 88.4 86.4 87.5 86.3 87.8 89.4 90.6 90.5 89.8 89.7 88.8 90.8 90.1 90.6 91.9 89.7 91.1 90.7 -0.3  
  drinks nearly 19–22 92.4 92.8 94.2 92.6 92.5 92.2 93.2 92.9 92.9 94.0 93.6 92.2 93.9 91.9 92.1 91.1 92.1 92.0 92.6 +0.6
  every day j 23–26 95.1 94.3 93.5 93.7 92.6 93.1 94.8 92.9 95.6 94.9 94.6 93.9 94.7 92.8 91.8 91.4 92.4 93.6 91.4 -2.2
27–30 97.2 95.3 96.1 95.4 95.6 96.0 92.8 92.7 95.0 93.9 96.0 94.3 95.8 92.1 92.1 93.4 91.8 91.2 90.5 -0.8
Having five or 18 62.7 65.2 62.9 64.7 64.2 65.7 66.5 68.5 68.8 68.9 67.6 68.8 70.0 70.1 71.6 72.6 71.9 74.2 72.5 -1.7  
  more drinks 19–22 63.5 65.1 58.3 57.5 61.9 59.4 60.1 59.3 59.1 63.4 62.3 62.7 65.4 64.7 66.3 64.7 66.6 68.6 65.4 -3.2
  once or twice 23–26 68.1 66.2 66.0 61.2 65.5 60.9 64.5 59.7 62.4 63.0 59.5 61.7 55.9 63.0 63.3 62.0 62.6 69.4 64.4 -5.0 s
  each weekend j 27–30 73.1 73.1 73.0 70.9 71.5 73.8 67.5 67.3 71.5 66.4 65.8 67.5 64.9 63.3 65.0 64.1 66.1 64.0 65.8 +1.8
Smoking one or 18 69.5 70.1 71.6 73.6 74.8 76.2 79.8 81.5 80.7 80.5 81.8 81.0 83.0 83.7 82.6 85.0 84.1 85.3 86.6 +1.3  
  more packs of 19–22 70.1 73.1 73.2 73.4 73.4 74.8 81.5 77.2 81.0 80.4 81.8 82.9 83.8 79.5 81.0 80.6 82.7 85.7 85.4 -0.3
  cigarettes 23–26 73.8 72.7 77.3 74.8 75.7 76.2 74.8 74.1 76.2 77.9 77.3 77.9 80.3 78.2 77.8 80.0 80.3 83.5 85.0 +1.5
  per day j 27–30 71.0 78.6 75.2 78.8 76.2 77.6 77.3 73.9 81.1 74.5 80.9 79.6 79.5 79.1 79.9 79.9 82.2 82.2 81.1 -1.1
Approximate Weighted N 18 2,310 2,150 2,144 2,160 2,442 2,455 2,460 2,377 2,450 2,314 2,233 2,449 2,384 2,301 2,147 2,078 2,193 2,000 2,129
Per Form = 19–22 449 416 413 402 396 431 378 378 333 365 368 364 340 356 280 316 264 252 225
23–26 397 389 404 346 385 403 374 364 325 335 328 347 309 334 312 308 284 271 234
27–30 429 395 368 359 346 370 367 330 355 339 325 334 306 312 301 304 262 258 276
Source. The Monitoring the Future study, the University of Michigan.
Q.  Do you disapprove of 
people (who are 18 or 
older) doing each of the 
following?
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
2016– 
2017 
change
Percentage disapproving e
TABLE 6-2 (cont.)
Trends in Proportions Disapproving of Drug Use
265
Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
The illicit drugs not listed here show a daily prevalence of 0.2% or less in all years.
' * ' indicates a prevalence rate of less than 0.05%.
' — ' indicates data not available.
aAnswer alternatives were: (1) No risk, (2) Slight risk, (3) Moderate risk, (4) Great risk, and (5) Can’t say, drug unfamiliar.
bIn 2011 the list of examples was changed from upper, pep pills, bennies, and speed to uppers, speed, Adderall, Ritalin, etc.  These changes likely explain the 
discontinuity in the 2011 results.
cIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, 
yellows, etc. to just downers. 
These changes likely explain the discontinuity in the 2003 and 2004 results. 
dFor 12th graders only: In 2011 the question on perceived risk of using salvia once or twice appeared at the end of a questionnaire form.  In 2012 the question was
moved to an earlier section of the same form.  A question on perceived risk of using salvia occasionally was also added following the question on perceived risk of 
trying salvia once or twice.  These changes likely explain the discontinuity in the 2012 result.
eAnswer alternatives were: (1) Don’t disapprove, (2) Disapprove, and (3) Strongly disapprove. Percentages are shown for categories (2) and (3) combined.
fAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.   In 2012 and following
data based on five questionnaire forms.
gAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.  In 2012 and following
data based on two questionnaire forms.
hData based on one questionnaire form.
iAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.   In 2012 and following
data based on three questionnaire forms.
jAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.  In 2012 and following
data based on four questionnaire forms.
kAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.  In 2012 and 2013
two questionnaire forms.  Data based on one questionnaire form in 2014 and following.
lData based on two questionnaire forms for all years reported.
mBeginning in 2014 for Age 18 and 2015 for the other age groups, "molly" was added to the questions on perceived risk of using MDMA.  The same change was 
made to the questions on disapproval of MDMA use for all age groups in 2015.   Data for the two versions of the questions are not comparable due to this
change in the question text.  
Footnotes for Tables 6-1 through 6-2
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-1
Trends in Harmfulness of MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-2
Trends in Harmfulness of MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-3
Trends in Harmfulness of MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-4
Trends in Harmfulness of SYNTHETIC MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
Trends in Harmfulness of SYNTHETIC MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 19–22, 23–26, and 27–30
Occasional Use
FIGURE 6-5
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-6
Trends in Harmfulness of LSD Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-7
Trends in Harmfulness of LSD Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
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Source. The Monitoring the Future study, the University of Michigan.
Trying Once or Twice
FIGURE 6-8
Trends in Harmfulness of PCP Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
0
20
40
60
80
100
’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17
PE
R
C
EN
T 
SA
YI
N
G
 G
R
EA
T 
R
IS
K
YEAR OF ADMINISTRATION
18 23-26
19-22 27-30
274
 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-9
Trends in Harmfulness of COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-10
Trends in Harmfulness of COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-11
Trends in Harmfulness of COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-12
Trends in Harmfulness of CRACK COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-13
Trends in Harmfulness of CRACK COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
Regular Use
FIGURE 6-14
Trends in Harmfulness of CRACK COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-15
Trends in Harmfulness of COCAINE POWDER Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-16
Trends in Harmfulness of COCAINE POWDER Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-17
Trends in Harmfulness of COCAINE POWDER Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
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Source. The Monitoring the Future study, the University of Michigan.
a In 2014 in the Age 18 questionnaire, "molly" was added to the question text.  In 2015, the same change was made to the questionnaires for the other age groups.  This likely explains the discontinuity in results for the affected years.
FIGURE 6-18
Trends in Harmfulness of ECSTASY (MDMA, Molly)a Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
a In 2015, "molly" was added to the question text. This likely explains the discontinuity in results for the affected years.
FIGURE 6-19
Trends in Harmfulness of ECSTASY (MDMA, Molly)a Use as Perceived by
Respondents in Modal Age Groups of 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-20
Trends in Harmfulness of HEROIN Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-21
Trends in Harmfulness of HEROIN Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-22
Trends in Harmfulness of HEROIN Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2011 the list of examples was changed from upper, pep pills, bennies, and speed to uppers, speed, Adderall, Ritalin, etc.  These changes likely explain the discontinuity in the 2011 results.   
FIGURE 6-23
Trends in Harmfulness of AMPHETAMINEa Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2011 the list of examples was changed from upper, pep pills, bennies, and speed to uppers, speed, Adderall, Ritalin, etc.  These changes likely explain the discontinuity in the 2011 results.   
Regular Use
FIGURE 6-24
Trends in Harmfulness of AMPHETAMINEa Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. 
These changes likely explain the discontinuity in the 2003 and 2004 results. 
FIGURE 6-25
Trends in Harmfulness of SEDATIVE (BARBITURATE)a Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. 
These changes likely explain the discontinuity in the 2003 and 2004 results. 
Regular Use
FIGURE 6-26
Trends in Harmfulness of SEDATIVE (BARBITURATE)a Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-27
Trends in Harmfulness of ALCOHOL Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-28
Trends in Harmfulness of ALCOHOL Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Having One or Two Drinks per Day
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Source. The Monitoring the Future study, the University of Michigan.
Having Four or Five Drinks per Day
FIGURE 6-29
Trends in Harmfulness of ALCOHOL Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
Having Five or More Drinks Once or Twice Each Weekend
FIGURE 6-30
Trends in Harmfulness of BINGE DRINKING as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-31
Trends in Harmfulness of TOBACCO Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Smoking One or More Packs of Cigarettes per Day
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Source. The Monitoring the Future study, the University of Michigan.
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
FIGURE 6-32
Trends in Harmfulness of SMOKELESS TOBACCO Use as Perceived by
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Chapter 7 
THE SOCIAL CONTEXT 
The social contexts in which individuals place and otherwise find themselves can influence the 
likelihood of using drugs in a number of ways. The context can provide social modeling and social 
norms for either use or abstention from use. Through friends and friends’ contacts it can also 
influence the availability of drugs and bring about an awareness of new drugs, including 
knowledge of their existence and their potential for altering mood and consciousness. Since its 
inception, MTF has measured three important features of the social context: (1) peer groups’ norms 
about drug use, (2) amount of direct exposure to drug use by friends and others, and (3) perceived 
availability of drugs. All three factors are measured by self-reports and are therefore measures of 
the perceived context, though evidence suggests that they bear a strong correlation with the actual 
context (e.g., consistency between one’s own reported attitudes and behaviors regarding substance 
use and perceived peer attitudes and behaviors). We believe that these three factors exert important 
influences on substance use at both the individual (micro) and the aggregate (macro) level. 
In Volume I, we examined these factors among secondary school students. In this chapter, we do 
the same for the young adult population ages 19 to 30, whose social contexts typically differ 
considerably from what they were in high school. Most high school graduates today enter college, 
many get civilian jobs, and some enter military service. These transitions almost always change 
the institutional contexts experienced by young adults (e.g., colleges, work organizations, military 
services) and therefore the circles of people to whom they are exposed and with whom they 
develop friendships. Such transitions also alter the potential consequences of drug use if it is 
discovered by authorities in the relevant institution; for example, consequences today can be quite 
severe for those in military service, and we have shown that illicit drug use drops when young 
people enter the military.1  
Each of the question sets discussed here is contained in only one of the six questionnaire forms, so 
the case counts are lower than those presented in most chapters in this volume. Therefore, these 
prevalence and trend estimates are more subject to random fluctuation or “noise” compared to 
those based on more questionnaire forms in this volume as well as those covered in Volume I 
(MTF’s cross-sectional secondary school samples are much larger than its young adult samples). 
As we did in Chapter 6, when examining age variation within those aged 19-30, we use four-year 
age bands (19-22, 23-26, 27-30) to increase the available sample sizes to about 250–600 weighted 
cases per year for each age band, thereby improving the reliability of the estimates. (The numbers 
of weighted cases are given at the end of Table 7-1. The actual numbers of respondents are 
somewhat larger.) 
In addition, we include consideration of norms, exposure, and availability where relevant among 
those age 35 and older. In such cases, the data are based on larger numbers because just one form 
is used for all respondents at each particular age.  
1 Bachman, J. G., Freedman-Doan, P., O’Malley, P. M., Johnston, L. D., & Segal, D. R. (1999). Changing patterns of drug use among U.S. military 
recruits before and after enlistment. American Journal of Public Health, 89, 672-677. 
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PEER NORMS AMONG YOUNG ADULTS (AGES 18–30) 
Table 7-1 provides current levels and trends in perceived friends’ disapproval of experimental, 
occasional and regular use of marijuana, alcohol, and cigarettes as reported by 12th graders, 19- to 
22-year-olds, 23- to 26-year-olds, and 27- to 30-year-olds. Trend data are available since 1980, 
1984, and 1988, respectively, for these three 4-year age groupings of young adults. The survey 
question reads, “How do you think your close friends feel (or would feel) about you… [smoking 
marijuana once or twice]?” The answer categories are “don’t disapprove,” “disapprove,” and 
“strongly disapprove.” Percentages discussed below are for the last two categories combined. 
 
The results for perceived peer norms are generally quite consistent with those for personal 
disapproval in the aggregate. Exceptions are trying marijuana once or twice and smoking one or 
more packs of cigarettes per day, for which friends’ attitudes are consistently reported as more 
disapproving than respondents' own attitudes (especially in the oldest age band), and heavy 
weekend drinking, for which friends’ attitudes are seen as less disapproving than their own. The 
question set regarding friends’ disapproval employs a shorter list of drug-using behaviors but 
includes the same answer scale, stated in terms of strength of disapproval associated with different 
use levels of the various drugs, as do the questions on the respondent’s own attitudes about those 
behaviors (discussed in Chapter 6). While peer disapproval and personal disapproval questions 
appear on different questionnaire forms and therefore have different sets of respondents, the forms 
are distributed randomly in respondents’ senior year of high school and should leave no systematic 
sample differences.  
 
Perceptions of Close Friends’ Attitudes (Ages 18 to 30) 
Table 7-1 provides trends for each age band in the proportions of respondents indicating how their 
close friends would feel about the respondent engaging in various drug-using behaviors. For 
purposes of simplification, we begin by addressing results across the entire 19- to 30-year age band 
(tabular data for the entire age band are not presented). Then we distinguish among the three young 
adult age bands: 19–22, 23–26, and 27–30, along with 18-year-olds. In 2010 questions about 
friends’ disapproval were dropped from the young adult follow-up questionnaires for all drugs 
except marijuana, occasions of heavy drinking, and cigarettes. The dropped questions had shown 
a high degree of redundancy with respondents’ reports of their own attitudes in the aggregate, and 
thus were deleted to make room for other items. 
 
• Generally, the peer norms reported by young adults one to 12 years past high school have 
been quite similar to those reported by 12th graders.  
 
• In 2017, with regard to marijuana, about 4-in-10 young adults (41%) thought their close 
friends would disapprove of their trying it, about half (49%) thought their close friends 
would disapprove of occasional use, and about 7 in 10 (69%) thought close friends would 
disapprove of regular use. Clearly the norms differ as a function of level of marijuana use, 
but for all levels of use they tend to be fairly restrictive for a good portion of young adults. 
In comparison, in 2017, corresponding rates for 12th graders were 44%, 51%, and 65%, 
showing somewhat less differentiation as a function of level of marijuana use than young 
adults show. 
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• For each of the illicit drugs other than marijuana, 2009 was the last year in which results 
on peer norms were available. At that time, the great majority of young adults, nearly 9-in-
10, said that their close friends would disapprove of their even trying such drugs once or 
twice; 89% indicated this for cocaine, 87% for LSD, and 87% for amphetamines. (We 
stopped asking these questions beginning in 2010 to make space for new items on the 
survey and because the data that they provided on peer norms so closely tracked what their 
own attitudes were in the aggregate; below we provide a quick summary of trends for these 
three measures up through 2009.)  
 
• In 2017, with regard to friends’ disapproval of heavy drinking on weekends, about half 
(52% to 56%) of any of the young adult age groups thought that their close friends would 
disapprove of their having five or more drinks once or twice each weekend. These levels 
of disapproval are considerably lower than among 18-year-olds (69%). These levels are 
also lower than perceived disapproval of daily drinking. In 2009 (when we last asked these 
questions), nearly two thirds (63%) of young adults said their close friends would 
disapprove if they were daily drinkers, and 9 out of 10 (91%) thought friends would 
disapprove if they had four or five drinks nearly every day.  
 
• Peer disapproval of cigarette smoking is very high in all four age bands: In 2017, 85% of 
12th graders said their friends would disapprove of pack-a-day smoking, as did 90% to 91% 
of 19- to 30-year-olds. 
 
Trends in Peer Norms (Ages 18 to 30) 
Important changes in the social acceptability of drug-using behaviors among both 12th graders’ 
and young adults’ peers have occurred since MTF began (see Table 7-1). We present summaries 
of trends, summarizing previous years to set the stage for recent trends. 
 
• In 2017, perceived peer disapproval of experimental, occasional, and regular use of 
marijuana among young adults were at or near historic lows since the early 1980s. This 
follows a period of declines in perceived peer disapproval for nearly a decade, as 
summarized below. 
 
Among 12th graders, the proportion saying their close friends would disapprove of their 
trying marijuana rose from 41% in 1979 to 73% in 1992—a period of substantial decline 
in use. Friends’ disapproval also grew substantially stronger in all of the young adult age 
bands in the years for which data are available. For example, among 19- to 22-year-olds, 
the proportion thinking their close friends would disapprove if they even tried marijuana 
rose from 41% in 1981 to 65% in 1992 (Table 7-1). A similar peak in disapproval occurred 
for 23- to 26-year-olds in 1992 and 1993, and among 27- to 30-year-olds in 1994 and 
1995—66% for both age bands; these trends suggest some cohort effects as classes of 
higher disapproving 12th graders grew older. In all age groups, peer disapproval 
subsequently declined, though the declines were earliest and greatest among 12th graders, 
again consistent with cohort effects. The decline ended in 1997 for 12th graders and began 
to reverse, but continued through 2002 among 19- to 26-year-olds. There was little 
systematic change for several years among 19- to 26-year-olds, but more recently—since 
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about 2008—their friends’ disapproval declined appreciably for all three levels of 
marijuana use. In 2013 all young adult age groups showed a further decline in disapproval 
of experimental marijuana use; indeed, the declines for the older two age bands were large 
and statistically significant. For example, the percent of 23- to 26-year-olds and 27- to 30-
year-olds saying that their close friends would disapprove of their trying marijuana fell by 
about 9 percentage points in that one year, possibly reflecting both cohort effects and a 
secular trend. In 2013, about half of each age group (48% to 52%) said that their close 
friends would disapprove of their trying marijuana, down from between 57–62% as 
recently as 2008. Since 2013, perceived peer disapproval has continued to decline, reaching 
41% to 42% in 2017, which is at or near new historic lows since the early 1980s.    
 
Close friends’ disapproval of occasional and regular marijuana use also rose until the early 
1990s among 18-year-olds, and then declined between 1992 and 1997. It declined through 
1999 among 19- to 22-year-olds and continued to decline among 23- to 30-year-olds 
through 2003. Recent peak years of friends’ disapproval of trying marijuana were 2006 for 
12th graders, 2008 for 19- to 26-year-olds, and 2010 for 27- to 30-year-olds. In essence, 
peer norms have moved in a way consistent with the existence of some lasting cohort 
differences in these norms, as well as in use. A more formal analysis of age, period, and 
cohort effects in disapproval came to the same conclusion.2 In the past decade or so, there 
have been continuing declines in friends’ disapproval of occasional and regular use among 
all age groups, suggesting more of a secular trend effect. In 2017 about half of young adults 
(48% to 49%) said that their close friends would disapprove of their smoking marijuana 
occasionally, and a large majority still said they would disapprove regular use (68% to 
71%). 2017 levels of close friends’ disapproval of occasional and regular marijuana use 
are at or near historic lows since the early 1980s. Clearly peer norms among young adults, 
as well as teens, have become more accepting of marijuana use in recent years, 
corresponding to their increased use. 
 
• There was a gradual increase in peer disapproval of trying an amphetamine for all age 
groups (18–30) through 1991, followed by a small decline evident among 12th graders 
through 1997. Between 1997 and 2009—the last year we asked this question of young 
adults and for which data are available—levels of disapproval among 18- to 30-year-olds 
increased to some extent, though not dramatically. In 2009, disapproval levels for trying 
an amphetamine were at 87% for all four age groups. Based on the data available on trends 
in respondents’ own disapproval (see Chapter 6), it seems likely that peer disapproval 
among young adults has weakened in recent years, as it has for 12th graders. 
 
• Perceived peer norms for LSD were measured from 1980 through 2009 among the follow-
up respondents. Through 1991, peer disapproval of trying LSD showed very little change 
in any of the age bands, but it fell some in the 1990s, especially among 18-year-olds and 
subsequently among 19- to 22-year-olds. These declines bottomed out in a staggered 
fashion, beginning with the 12th graders in 1997, which thereafter showed a seven-
percentage-point increase in peer disapproval. There was a five-percentage-point increase 
among 19- to 22-year-olds (after 2000), and a three-percentage-point increase among 23- 
                                                 
2 Keyes, K. M., Schulenberg, J. E., O’Malley, P. M., Johnston, L. D., Bachman, J. G., Li, G., & Hasin, D. (2011). The social norms of birth cohorts 
and adolescent marijuana use in the United States, 1976-2007. Addiction, 106(10), 1790-1800. 
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to 26-year-olds (after 2001)—again suggestive of a cohort effect in these norms. In 2009, 
the last year we asked, there was almost no difference among the age groups, with 85% to 
87% of respondents in each age group saying their friends would disapprove of their trying 
LSD. 
 
• Perceived peer norms regarding cocaine use were measured from 1986 through 2009, after 
which such questions were dropped. In the eight-year interval from 1986 to 1994, self-
reported cocaine use declined substantially as peer norms in all age bands shifted toward 
disapproval. For example, by 1994, 95% of the 19- to 22-year-olds thought their close 
friends would disapprove of their trying cocaine once or twice. After 1994, peer norms 
against use continued to strengthen a bit in the upper age bands, perhaps through 
generational replacement, but weakened slightly in the younger age bands, likely reflecting 
a new cohort effect. By 2009 (the last year we asked) there was little difference by age in 
peer norms against cocaine use, with 85% to 91% saying their friends would disapprove of 
their even trying it. By way of contrast, in 1986 that statistic ranged between 71% and 80% 
among 18- to 26-year-olds. 
 
• Peer norms against occasions of heavy drinking on weekends (five or more drinks once or 
twice each weekend) among the three young adult age groups have tended to be weakest 
for the 19- to 22-year-old age group, in which such behavior is most common, and strongest 
for the 27- to 30-year-old group. Since 2002, disapproval of such drinking has also been 
low for the 23- to 26-year-old group relative to the other two age bands. Among 12th 
graders, friends’ attitudes had become somewhat more restrictive between 1981 and 1992 
(and respondents’ own occasions of heavy drinking declined during that interval), but 
attitudes were fairly level for some years and then rose from 56% in 2002 to 69% by 2017). 
There was a similar upward trend in peer disapproval among the various young adult age 
bands that followed a staggered pattern, again likely reflecting a cohort effect in these 
norms. However, between 1997 and 2000 the 19- to 22-year-old age group became 
somewhat less disapproving of occasions of heavy drinking on weekends; this was 
followed by a decline in perceived peer disapproval between 2001 and 2004 among 23- to 
26-year-olds, and a decline from 2004 to 2009 among 27- to 30-year-olds. Despite some 
increases in peer disapproval over the years, this potentially health-compromising form of 
drinking has the least restrictive perceived peer norms of all of the substance-using 
behaviors measured in MTF, yet about half still report peer disapproval. The recent 
increase in peer disapproval among 12th graders was not mirrored among the older age 
strata; thus peer disapproval of binge drinking became highest among the 12th graders, 
contrary to the situation in the late 1990s when 12th graders were the lowest. In 2017 the 
proportions saying that their friends would disapprove of such heavy weekend drinking 
was between 52% and 56% for the three young adult age bands compared to 69% among 
the 12th graders. 
 
• Peer norms against cigarette smoking one or more packs per day have strengthened in 
staggered fashion among 18-year-olds and the young adult age groups. Between 1998 and 
2008, the proportion saying that their close friends would disapprove of their smoking a 
pack or more of cigarettes per day rose from 69% to 83% among 18-year-olds and from 
69% to 86% among 19- to 22-year-olds. The two older strata did not see a comparable 
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change until peer disapproval among 23- to 26-year-olds rose from 77% in 2005 to 88% in 
2009, at which time their disapproval leveled. The change did not manifest itself among 
the 27- to 30-year-olds until 2010; their rates of peer disapproval of smoking, which for 
some years had the highest rates of disapproval for smoking among the four age groups, 
stayed fairly level after 2000, until there was a 4.4-percentage-point jump in 2010, followed 
by a leveling. This pattern again suggests some cohort effects in peer norms working their 
way up the age spectrum. In 2017, very large proportions across the age bands reported 
that their friends would disapprove of pack-a-day smoking, ranging from 85% among 18-
year-olds to 90–91% among the young adult age groups. 
 
In the early years of MTF, peer disapproval of smoking a pack or more of cigarettes per 
day rose among 12th graders from 64% (1975) to 73% (1979). There was little further net 
change for 13 years through 1992, when friends’ disapproval stood at 76%. During the 
relapse in the drug epidemic between 1992/1993 and 1997/1998, all age groups showed a 
decrease in perceived peer disapproval of smoking—consistent with a secular trend.  
 
• It is noteworthy that peer norms for so many drugs have shown cohort effects in their 
patterns of change across age bands. In addition to cohort effects, secular trend effects are 
evident, with the recent declines in peer disapproval of marijuana use, similar for all four 
age groups, suggesting a secular trend. 
 
ADULTS’ EXPOSURE TO DRUG USE THROUGH FRIENDS AND OTHERS  
(AGES 18–55) 
Exposure to drug use is important because it provides both the modeling of the behavior by peers 
(possibly including direct encouragement to use) and immediate access. Exposure is measured by 
two sets of questions, each appearing on a (different) single questionnaire form. The first set asks 
the respondent to estimate what proportion of his or her friends use each drug, while the second 
set asks, “During the LAST TWELVE MONTHS how often were you around people who were 
using each of the following to get high?” The same questions are asked of 12th graders, and their 
results are included here for comparison purposes in Tables 7-2 and 7-3 and Figures 7-1 through 
7-24. (Questions about direct exposure to drug use were not included in the questionnaires for 35- 
to 55-year-olds due to the space limitations imposed by the use of a single questionnaire form at 
each of these ages.) We continue to present four-year age bands for the friends’ use measures in 
order to increase the reliability of the estimates. Ages 35, 40, 45, 50, and 55 are shown as one-year 
age bands, with both half-samples from each of those cohorts being surveyed at those modal ages. 
Starting with age 35, each year has a larger number of cases than single years at the earlier ages 
because all respondents in a cohort at later ages complete the relevant questionnaire items, 
compared with only one sixth of those at younger ages. At the end of each table in this chapter is 
a summary of the weighted number of cases upon which each annual estimate is based. (The actual 
numbers of cases are somewhat higher.)  
 
Exposure to Drug Use (Ages 18 to 55) 
• Relatively high proportions of young adults in all of these age bands have had at least some 
friends who use some illicit drug (including marijuana); that proportion varies considerably 
with age, with older respondents reporting that fewer of their friends use (Table 7-2). In 
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2017, illicit drug use by at least some friends was reported by 80% of 12th graders, 84% of 
19- to 20-year-olds, 79% of 23- to-26-year-olds, 78% of 27- to 30-year-olds, 63% of 35-
year-olds, 49% of 40-year-olds, 44% of 45-year-olds, 44% of 50-year-olds, and 42% of 
55-year-olds; for the 27-30, 35, 40, 45, 50, and 55 year old groups, the 2017 levels 
constitute all-time highs (largely due to continued increase in friends’ use of marijuana as 
discussed below).3  
 
Clearly, among adults, the older the respondent, the less likely he or she is to report having 
friends who use any illicit drugs. In 2017, the proportions who said that most or all of their 
friends use one or more of the illicit drugs were much lower: 26% for 12th graders, between 
10% and 26% for the 19- to 30-year-olds, and between 1% and 7% for the 35-, 40-, 45-, 
50-, and 55-year-olds—quite a dramatic difference across ages and one that is consistent 
with the large differences in their own self-reported current use. 
 
• With regard to illicit drugs other than marijuana, taken as a whole, considerably fewer 
respondents reported that any of their friends use compared to what is true for marijuana 
use (see below): 40% for 12th graders, 50–51% for 19- to 30-year-olds, and 19-29% for 35- 
to 55-year-olds in 2017.3 The proportions who said that most or all of their friends use 
illicit drugs other than marijuana in 2017 were 5%, 3-6%, and less than 1%, respectively. 
Thus, very low proportions of the older age groups appear to be deeply immersed in a drug 
culture involving illicit drugs beyond marijuana. 
 
• With respect to individual illicit drugs, exposure among all of the age groups was greatest 
for marijuana, with the percentages in 2017 saying they have any friends who use ranging 
from 78% for 18-year-olds to 37% for 55-year-olds; for the age groups 27-30 through 55, 
the 2017 levels constitute new historic highs as discussed further below. 
 
• The next-highest exposures were for amphetamines (21% among 12th graders, 35% among 
19- to 22-year-olds, 32% among 23- to 26-year-olds, and 30% among 27- to 30-year-olds) 
and narcotics other than heroin (18% among 12th graders, 19% among19- to 22-year-olds, 
19% among 23- to 26-year-olds, and 27% among 27- to 30-year-olds) followed by cocaine, 
hallucinogens other than LSD, and MDMA (ecstasy and, more recently, Molly). (Use of 
several illicit drugs was not asked of the age groups above 30 due to space limitations in 
the single questionnaire form used at each of those ages. See Table 7-2.) 
 
• For the remaining illicit drugs, the proportion of young adults reporting that some friends 
use a given drug was 10% or higher in at least one of the four young age strata for the 
following drugs: sedatives (barbiturates) (12–15%), LSD (14–23%), steroids (9–14%), 
and tranquilizers (8–11%). See Table 7-2 for specifics. 
 
• For most illicit drugs, the proportion of young adults having any friends who use them 
decreases with each higher age band, consistent with the age differentials in self-reported 
                                                 
3 Due to a printing error in the young adult questionnaire in 2015, data cannot be reported for friends’ use in the young adult age bands in that one 
year for this index as well as for some individual drugs that were directly affected. We believe that the 2014 data present a reasonable approximation 
of what the values likely would be in 2015. This applies to some but not all of the measures of the individual drugs. This situation was remedied in 
the 2016 surveys. 
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use. The steepest declines occur with inhalants—in 2017, 7% of 18-year-olds reported that 
some friends use versus only 4% of 27- to 30-year-olds. (Inhalant use is not asked of the 
age groups above 30, precisely because of this sharp decline in use with age.) As reported 
in Volume I, the decline with age in inhalant use is actually well under way by 10th grade. 
 
• In the past few years, reported friends’ use of cocaine has been highest among young 
adults, and this continued in 2017 with 17% for 12th graders, and 23% to 29% for 19-30 
year olds. Those 35, 40, 45, 50, and 55 years old are asked separately about cocaine powder 
and crack use; in 2017 far fewer reported having friends who use cocaine powder—13% 
for age 35 and 4% to 7% for the four older groups.  
 
• For crack, however, the story is different, with reported friends’ use of crack declining 
with age. In 2017, 8% of 12th graders reported having any friends using crack, versus 5% 
to 8% of 19- to 30-year-olds, and 1% to 2% of 35- to 55-year-olds.  
 
• The proportions who report having any friends who take heroin are now showing uneven 
age differences. In 2017, these percentages were 5.3%, 3.6%, 7.0%, and 3.7% for the age 
groups of 18, 19-22, 23-26, and 27-30, respectively. These age differences are much 
smaller than in earlier years, due to greater declines with time among the younger age 
groups. (This question is not asked of those age 35 and over.) 
 
• At present, the percentages reporting any friends who use narcotics other than heroin are 
higher among older respondents: in 2017, 18% of 18-year-olds, 19% of the 19- to 22-year-
olds, 19% of the 23- to 26-year-olds, and 27% of 27- to 30-year-olds. This was not always 
the case. In the late 1990s and early 2000s perceptions of friends’ use were lower among 
older respondents (Table 7-2). 
 
• In general, it appears that some respondents who report that their friends use illicit drugs 
are themselves not directly exposed to that use by their friends, judging by the differences 
in proportions saying they have some friends who use (Table 7-2) and the proportions who 
say they have been around people who were using during the prior year (Table 7-3 and 
Figure 7-1). That is, as has been true all along, more respondents report use by friends than 
report being around others who were using. When considering trends in the next section, 
we give more attention to findings from the exposure measure concerning being around 
others who use. 
 
• With respect to alcohol use, the great majority of young adults have at least some friends 
who get drunk at least once a week, although this peaks in their early to mid-20s and then 
drops off gradually with age: in 2017, 58% of 12th graders, 77% of 19- to 22-year-olds, 
76% of 23- to 26-year-olds, 79% of 27- to 30-year-olds, 68% of 35-year-olds, 59% of 40-
year-olds, 54% of 45-year-olds, 47% of 50-year-olds, and 39% of 55-year-olds.4 Given the 
potential serious consequences of this behavior, these rates are troublingly high across a 
wide age range. The proportions who say most or all of their friends get drunk once a week 
differ more substantially by age, with a peak in the respondents’ early 20s. In 2017, 12% 
                                                 
4 Due to the previously mentioned printing error, data are not available for the three young adult age bands in 2015, though they are included for 
the other age bands in Table 7-2. This situation was remedied for 2016 data. 
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of 12th graders, 26% of 19- to 22-year-olds, 20% of 23- to 26-year-olds, 17% of 27- to 30-
year-olds, and 10% for 35-year-olds to 3% of 55-year-olds responded that most or all of 
their friends get drunk once a week. Note in particular how high these rates are among the 
high school and college-age populations, most of whom are underage. In terms of having 
any direct exposure during the prior year to people who were drinking alcohol “to get high 
or for ‘kicks’,” having some such exposure was almost universal in the three age groups of 
young adults: 82%, 90%, and 84%, respectively, as well as among 18-year-olds (79%) 
(Table 7-3 and Figure 7-23). 
 
• From ages 19 through 30, 76% to 79% reported in 2017 having at least a few friends who 
smoke cigarettes, compared to 54% of the 12th graders; there is a falloff through middle 
adulthood, reaching 49% at age 55. Similarly, 5% to 8% of the 18- to 30-year-olds state 
that most or all of their friends smoke. Above those ages, the proportions decline to 5% for 
35-year-olds and 2–4% for those 40 years of age and older.  
 
Trends in Exposure to Drug Use (Ages 18 to 55)  
Tables 7-2 and 7-3 also provide trend data on the proportions of respondents’ friends using drugs 
and the proportion of respondents who say they have been exposed to drug use by others. Both of 
these measures of exposure to use will be discussed in this section. As noted previously, trends are 
available for 19- to 22-year-olds since 1980, for 23- to 26-year-olds since 1984, and for 27- to 30-
year-olds since 1988. Data for 35-, 40-, 45-, 50-, and 55-year-olds are available on friends’ use 
since 1994, 1998, 2003, 2008, and 2013, respectively. (Questions about being around drug users 
were not included in the questionnaires administered to respondents age 35 and older, so those age 
bands are not included in Table 7-3 or Figures 7-1 through 7-24. However, they were asked about 
the proportions of their friends using.) Twelfth-grade data have also been included in these tables 
for comparison purposes. 
 
Figures 7-1 through 7-24 provide graphic presentation of trends in exposure to use. 
 
• An examination of Table 7-3 and Figures 7-1 through 7-6 shows that exposure to illicit 
drug use (in the 12 months preceding the survey) generally declines across the age bands 
for any illicit drug, marijuana, and any illicit drug other than marijuana, as well as many 
of the specific other illicit drugs (Figures 7-7 through 7-24). Up until the past few years, 
this age-band ordering was consistent across different historical periods; however, as 
summarized below, the past few years have shown some re-ordering of age groups, with, 
for example, 19- to 22-year-olds having higher exposure than 12th graders for any illicit 
drug other than marijuana and for amphetamines. An important exception to the long-
standing age group ordering of exposure is cocaine, which did not show a decline in 
exposure with increasing age until after 1996. (Prior to that it showed an increase with 
increasing age.) Thus, up until the past few years, with the exception of cocaine, the 
consistent ordering of declining exposure across the age groups reflect age effects (changes 
with age observed across multiple cohorts) in both exposure to use and in personal use of 
most drugs.   
 
• Until 1992, young adults’ trends in exposure to use tended to parallel those observed for 
12th graders. From 1980 to 1992, that meant a decreasing number of respondents were 
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exposed to any illicit drug use (Table 7-3 and Figure 7-1) or reported any such use in their 
own friendship circle (Table 7-2). After 1992, however, an important divergence in trends 
emerged: 12th graders showed a substantial increase in both friends’ use and exposure to 
use (as well as self-reported use); 19- to 22-year-olds showed a similar rise, but lagged by 
a few years; 23- to 26-year-olds subsequently showed some rise; while the 27- to 30-year-
old age band did not show a rise until 2002. As discussed in earlier chapters, this pattern 
no doubt reflects the emergence of lasting cohort differences that emerged in secondary 
school and, driven by generational replacement, continued up the age spectrum as the 
secondary school students grew older. The age differentials expanded in the 1990s during 
the relapse phase in the drug epidemic; first observed among the 12th graders, the increases 
in use then occurred on a staggered basis. The age differentials have diminished 
considerably during the 2000s, and especially since 2009, as exposure generally leveled 
among the younger age groups but rose among the older ones as the cohort effect worked 
its way up the age spectrum (see Figure 7-1). Trends were mostly level between 2012 and 
2016, with some modest increase among those aged 19-22 and 23-26. In 2017, exposure 
increased five percentage points for 23-26 year olds (nonsignificant) and ten percentage 
points for 27-30 year olds (significant), bringing them to all-time highs and further 
reducing the age gap (largely due to exposure to marijuana use as discussed next). 
 
• Marijuana showed a very similar pattern of change compared to any illicit drug. It is 
particularly noteworthy that, while 34% of 19- to 22-year-olds in 1980 said most or all of 
their friends used marijuana, only 8% said the same in 1991 (Table 7-2). Clearly, the 
number of friendship groupings in which marijuana use was widespread dropped 
dramatically in the 1980s. This measure of friends’ use more than doubled to 19% by 1999 
during the relapse phase in the larger epidemic, where it remained for a couple of years 
before falling to 12% by 2008, then increasing to 24% by 2017. Self-reported use (Figure 
5-3a) and friends’ use both increased significantly among 18-year-olds in 2008, which we 
interpreted as a turnaround in the marijuana situation.  
 
Since 2006, the other young adult age strata have shown a considerable increase in the 
proportion reporting some friends using marijuana, ranging from 78% for 23-26 year-olds 
to 37% for 55-year-olds in 2017 (showing a significant increase from 2016). Similar trends 
occurred for being around those using in the past year, as shown in Figure 7-5. In the past 
few years, reporting any exposure increased for the 23-26 and 27-30 age groups, while it 
remained level for the 12th graders and 19-22 year olds. In 2017, the two older groups 
increased four and nine percentage points, respectively (significantly so for the 27-30 year 
olds), thus reaching all-time highs for any exposure to marijuana use. 
 
• The proportion of respondents reporting having any friends who use any illicit drugs other 
than marijuana began to decline after 1982 in the two younger age groups spanning 18–
22 (for whom we had data at that time; see Table 7-2 regarding use by friends, and also 
Figure 7-3 regarding exposure to use). By 1991/1992 there had been a considerable drop 
in all four age groups (spanning 18–30). This drop appears to be due particularly to 
decreases in friends’ use of cocaine and amphetamines, although there were decreases for 
sedatives (barbiturates) and tranquilizers as well. The levels then began to rise among the 
18- to 22-year-olds in the early 1990s, while at the same time declining further for the 23- 
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to 30-year-olds, reflecting lasting cohort effects, opening up a large age-related difference 
in friends’ use in the 1990s and into the early 2000s. The 23- to 26-year-olds showed a 
later increase in friends’ use and the 27- to 30-year-olds showed a still later increase. After 
2001 there was some decline in reported friends’ use in the two youngest age strata while 
friends’ use continued to climb in the older two strata. The net effect was to narrow the age 
differences among the young adult strata considerably.   
 
More recently, the gap among the four age bands covering ages 18-30 has narrowed for the 
proportions saying that they have any friends who use some illicit drug other than 
marijuana. Between 2003 and 2012, there was little change among 18-year-olds, followed 
by a consistent decrease through 2017. For 19-22 year-olds, the trend has remained fairly 
level from 2003 through 2017. For 23-30 year-olds, there was an unsteady increase for the 
past decade through 2017. Among those aged 35 and older, considerably fewer report 
having any friends who use, but the past few years have shown increasing trends for 35- 
year-olds, with fairly level trends for those 40 and older (see Table 7-2 for the specifics). 
The similar trends in exposure to use are shown in Figure 7-3, though it is noteworthy that 
exposure has been increasing unevenly for the young adults. Also, the proportions 
indicating “often” being exposed to the use of any illicit drugs other than marijuana (Figure 
7-4) has not changed a great deal in recent years except for a gradual increase continuing 
in the older three age groups, also reflecting a lasting cohort effect. 
 
• Between 1986 and about 1992, all four age groups showed a considerable drop in the 
proportion of respondents with friends who used cocaine (Table 7-2) and in exposure to 
cocaine use (Figure 7-11). (Self-reported use declined sharply in the same period.) After 
that decline, the rates of friends’ use peaked in 1998 among 18- and 19-22 year-olds, 
remained fairly steady through 2007, and declined since through 2017, with the 19-22 year 
olds showing a nonsignificant increase in 2017. For 23-26 year-olds, friends’ use increased 
through 2004 and then declined unsteadily through 2016, showing a nonsignificant 
increase in 2017. For 27-30 year-olds, friends’ use peaked in 2009 and has remained fairly 
steady since then. These changes, staggered somewhat by age since the mid-1990s, reflect 
cohort effects. For 35-55 year olds (who are asked about cocaine powder specifically), 
there have been some recent modest increases for the 35- and 40-year-olds, with the recent 
trends remaining fairly steady for the 45-55 year olds. Regarding recent trends in being 
around those who use cocaine (Figure 7-11 and Table 7-3), any exposure has remained 
fairly steady for 18-year-olds across the last five years (2013-2017) and showed some 
uneven increase among the young adult age groups such that age differences were slight in 
2017. The story for crack has been fairly similar to that for cocaine regarding friends’ use 
(Table 7-2).  
 
• There were substantial increases between the early 1990s and about 2000 in the proportion 
of 18-year-olds and 19- to 22-year-olds reporting that they have friends using narcotics 
other than heroin without medical supervision, and there were smaller increases among 
23- to 30-year-olds, resulting in some considerable age-related differences. After 2002, the 
proportions of 18-year-olds and 19- to 22-year-olds declined some, while the 23- to 30-
year-olds continued to increase in a classic cohort-effect pattern of change, thus narrowing 
the age differences by 2009. There was a wording change in 2010 that served to increase 
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the rates considerably for all age groups. After 2010, all four of these age bands have shown 
a decline through 2017 in exposure to use and in having any friends who use these narcotic 
drugs (Tables 7-2 and 7-3, Figure 7-15); the exception is that for the 27-30 year olds, any 
exposure increased significantly in 2017. The proportional declines have been largest in 
the younger age bands. 
 
• The proportions saying that any of their friends use MDMA (ecstasy, and more recently, 
Molly) increased sharply in all age groups between 1992 and 2001 or 2002, though in a 
staggered fashion (Table 7-2). Twelfth graders showed the first sharp increase beginning 
after 1992, 19- to 22-year-olds after 1994, 23- to 26-year-olds after 1996 and 27- to 30-
year-olds after 1997. These sharp increases ended among 12th graders in 2001 and among 
19- to 30-year-olds a year later. Since those peak levels, the proportions saying that they 
had any friends using ecstasy have generally declined through about 2012 and 2013 for all 
age groups. Friends’ use continued to decline modestly for 12th graders through 2017, 
whereas it has shown some uneven increases for the young adults. The staggered nature of 
past increases suggests a cohort effect at work, but the nearly simultaneous decline in the 
early 2000s strongly suggests a secular trend, likely due to the heavy media coverage 
during that period of adverse consequences associated with ecstasy use. 
 
• For all four of the youngest age groups (spanning ages 18–30), the proportions saying that 
they were often exposed to others drinking alcohol declined modestly between 1987 and 
1992 (Figure 7-24, Table 7-3). The next decade saw rather little change in the four youngest 
age bands. Since 2002, however, exposure among the 18-year-olds declined considerably 
through 2017. The recent trend for 19-22 year-olds peaked in 2007, declined through 2013, 
and then increased modestly through 2016 and then decreased nonsignificantly in 2017; it 
peaked in 2012 for 23-26 year-olds, declined through 2014 and then increased modestly 
again through 2017; and it peaked in 2012 for 27-30 year-olds and showed some modest 
decline through 2017. This is again indicative of a cohort effect with staggered decreases 
radiating up the age spectrum as the cohorts age. The continuing decline among the 18-
year-olds, along with the recent increases among young adults, has served to widen the age 
gap in the past few years.  
 
• The age groups above age 30 have consistently been much less likely to report that any of 
their friends get drunk at least once a week, compared with those ages 18 to 30 (Table 7-
2). These proportions increased starting at different times: after 1998 among 35-year-olds, 
after 2004 among 40-year-olds, and after 2005 among 45-year-olds, suggesting somewhat 
enduring cohort differences. The net effect has been to reduce the differences separating 
those in their 20s from those older in terms of the proportion having any friends who get 
drunk at least once a week. In the past decade, this trend toward smaller age differences 
among adults continued, with 18-year-olds showing consistent declines, 19-26 year olds 
showing modest declines, and those 27 and above showing modest increases. In 2017, it 
remained the case that the majority of those aged 18 through 45 have friends who get drunk 
at least once a week, with those aged 50 and 55 at 47% and 39%, respectively. On the other 
hand, the proportions saying that most or all of their friends get drunk often are 
considerably smaller and decline sharply with age.  
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• Among 12th graders, the proportion who said most or all of their friends smoked cigarettes 
declined appreciably between 1975 and 1981, the same period in which self-reported use 
declined (Table 7-2). After that, neither measure showed much change until about 1992. 
Thereafter, substantial increases in both measures occurred. By 1997, one-third (34%) of 
12th graders reported that most or all of their friends smoked cigarettes (up from 21% in 
1992); since then, that statistic declined (along with self-reported use) to 14% in 2008, 
where it leveled for a few years, and then declined again reaching 7% in 2017. Among 19- 
to 22-year-olds, a decline in friends’ use occurred between 1980 (or possibly earlier) and 
1985, followed by a leveling through 1994. The percentage saying most or all of their 
friends smoke increased from 22% in 1994 to 29% in 2000, before declining steadily and 
considerably to a new low of 5% in 2017. Among 23- to 26-year-olds, a downturn was 
evident between 1984 (the first year for which data are available) and 1988, after which 
reported friends’ use leveled (8% in 2017). After 2002, some slight increases occurred 
through 2005 among the 27-30 year olds, followed by an unsteady decline through 2016, 
reaching a new low of 6% in 2016 and 2017. These staggered changes, until about 1998, 
illustrate that cohort effects were moving up the age spectrum. Among those aged 35-55, 
the proportion of those responding that most or all of their friends smoked cigarettes have 
consistently declined over the years since they entered the study (except 35-year-olds who 
showed some increase in the middle 1990s). Since 1998 (or the earliest year available for 
the age bands above age 30), the proportion saying that any of their friends smoked 
cigarettes showed consistent decline for all age groups through 2017.  
 
Implications for Validity  
Nearly all of these changes in exposure to drug use parallel changes in self-reported use by these 
age groups. This pattern reinforces the validity of self-report data, because there would presumably 
be less motivation to distort answers about the proportion of an unnamed set of friends who use a 
drug than about one’s own use. The systematic nature of the patterns of change across age strata 
(whether in terms of parallel changes consistent with a secular trend, or systematically staggered 
ones consistent with a cohort-related trend) is also supportive of the data validity. 
 
PERCEIVED AVAILABILITY OF DRUGS AMONG ADULTS (AGES 18–55) 
Adults participating in the follow-up surveys receive questions identical to those asked of 12th 
graders regarding how difficult they think it would be to get each of the various drugs if they 
wanted them. The questions are contained in only one of the six questionnaire forms used through 
modal age 30. Data for the young adult follow-up samples, which are grouped into the same four-
year age bands used above (19–22, 23–26, 27–30), are presented in Table 7-4, along with data for 
12th graders and 35-, 40-, 45-, 50-, and 55-year-olds. Sample sizes are presented at the bottom of 
the table. The availability question is not asked for all drugs in the adult samples, as may be seen 
in Table 7-4. 
 
Perceived Availability 
Much like 12th graders, substantial proportions of the American adult population have access to 
various illicit drugs. (We do not ask about access to alcohol and cigarettes because we assume 
these are readily available to all adults.) Table 7-4 presents trends in perceived availability for the 
various substances. 
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• Marijuana was by far the most readily available of the illicit drugs in 2017 (and in all 
previous years) with 87–90% of the young adult age groups (19–30) saying it would be 
“fairly easy” or “very easy” to get if they wanted some. Perceived access decreased 
somewhat with age after age 30, but even at age 55, over three quarters of respondents 
(77%) say they could get marijuana fairly or very easily (Table 7-4). That is, as of 2017, 
well over 80% of adults aged 19-45, and 77% of those aged 50 and 55, report marijuana 
being readily available if they wanted it.  
 
• Though less available than marijuana, amphetamines were still fairly available, with 53-
58% of young adults and 33–36% of those 35, 40, 45, 50, and 55 years old reporting that 
amphetamines would be fairly or very easy to get (Table 7-4). 
 
• Cocaine was reported as readily available in 2017 by a significant proportion of young 
adults, with 37–40% saying it would be easy to get—higher than the 27% observed among 
the18-year-olds (Table 7-4). Powdered cocaine availability was highest among those ages 
23 to 35 at 34–36% in 2017. Crack was seen as available to smaller proportions than 
powdered cocaine and was most available to those ages 23 and above (23–29%) in 2017. 
Interestingly, perceived availability for both forms of cocaine tended to rise as age 
increased from 19-22 to 27-30. 
 
• In 2017 about one fifth (19%) of 12th graders, and about one fifth (20–22%) of 19-26 year-
olds said that they could get heroin fairly or very easily, though far fewer report having 
used heroin (Table 7-4). Reported availability was higher for the 27- to 30-year-olds (29%), 
again showing that availability tended to rise with age. (The question is not asked of 
respondents above age 30.) 
 
• Perceived availability of narcotics other than heroin also rose with age. In 2017, the 
percentage of those who said that such drugs would be fairly or very easy to get was 36%, 
40%, 48%, and 58%, respectively across the four age groups (Table 7-4). (The question is 
not asked of respondents above age 30.) 
 
• Perceived availability of sedatives (barbiturates) showed some increase with age in 2017: 
23%, 30%, 28%, and 37% across the four age groups, respectively (Table 7-4). (The 
question is not asked of respondents above age 30.) 
 
• Tranquilizers were reported as available in 2017 by considerably fewer respondents (15–
18%), which historically was not always the case (Table 7-4). (The question is not asked 
of respondents above age 30.) 
 
• Ecstasy (MDMA) was seen as readily available to 29–35% of young adults and 12th graders 
in 2017 (Table 7-4). (The question is not asked of respondents above age 30.) 
 
• Hallucinogens other than LSD (such as psilocybin) were reported as fairly or very easy 
to get in 2017 by 28% of 12th graders, and 32%, 30%, and 27% for the three young adult 
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age groups, respectively, showing a peak of availability among 19-22 year olds (Table 7-
4). (The question is not asked of respondents above age 30.) 
 
• Perceived availability of LSD was also highest for the 19-22 year olds at 33% (a significant 
increase over 2016 level of 25%); it was 26% for 12th graders, 23% for 23-26 year olds, 
and 18–22% among those 27 to 50 years old (Table 7-4). 
 
• Crystal methamphetamine (ice) was perceived to be fairly or very easy to get by 14% of 
12th graders, and by 11%, 16%, and 18% of the young adult age groups, respectively (Table 
7-4). (The question is not asked of respondents above age 30.) 
 
• Anabolic steroids were perceived to be fairly or very easy to get by between 19% and 24% 
of all four age strata (Table 7-4). (The question is not asked of respondents above age 30.) 
 
Trends in Perceived Availability  
• Marijuana has been almost universally perceived to be available by older adolescents and 
young and middle adults throughout the historical periods covered by the data. Overall, 
perceived availability has risen in the six older age groups on whom trend data are available 
during the 2000s—that is, from 27- through 55-year-olds—but has simultaneously 
declined among 12th graders and held relatively steady among 19- to 23-year-olds. As a 
result, there is now less variability by age in the reported availability of marijuana (Table 
7-4). From the peak year in 1979, perceived availability decreased slightly through 1991 
among 12th graders and decreased slightly more from 1980 through 1991 among 19- to 22-
year-olds. After the late 1990s, the trends in availability across the 18 through 30 age bands 
had generally been quite parallel, suggesting secular trends in prevailing conditions that 
affected availability. Perceived availability has increased in the past several years through 
2017 for those aged 35 to 55, resulting in it being only somewhat higher for those aged 18-
30 (80-90%) than for those aged 35 to 55 (77–85%), and with it now being at all-time highs 
for the latter group.  
 
• Historic highs in perceived availability of cocaine occurred in the 1980s among all three 
young adult age strata (ages 19–30), reaching highest proportions in 1988 and 1989, at 
which time the older young adult age strata had higher availability than the younger ages. 
(From a policy perspective, it is worth noting that in 1987 the perceived availability of 
cocaine increased while use actually dropped sharply.) In the early 1990s, all four groups 
reported decreased availability by 4–7 percentage points—quite parallel to the drop in 
numbers of those who had friends who were users and to the decline in personal use. Until 
about 2000, there was some falloff in perceived cocaine availability in all age strata through 
age 30—particularly among those ages 23 through 30—and an increasing convergence. 
From about 2007 through 2012 and 2013, all four age strata showed considerable declines 
in reported cocaine availability, followed by a leveling for all age groups except the 19-22 
year-olds who have shown a modest increase through 2017. (The question is not asked of 
respondents above age 30.) 
 
• Crack availability peaked in 1988–1989 for all age groups (it was first assessed in 1987) 
and declined through 1992, with little further change until 1995. Since 1995 through 2017, 
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crack availability has declined substantially in all of the lower four age strata (ages 18–30). 
Data on 35-, 40-, 45-, and 50-year-olds are available for shorter intervals, but also show 
appreciable declines from initial measurements. 
 
• In 2017, between 17% and 33% of each age group said they could get LSD fairly easily, 
which contrasts quite dramatically with the mid-1990s, when over 50% of those in the 
younger age strata said they could get it. Across the decades measured, the trends in LSD 
availability among young adults have had some parallels to those among 12th graders. For 
12th graders, there was a drop of about 10 percentage points in the mid-1970s, and a later 
drop from 1980 to 1986. The latter drop, at least, was paralleled in the data from 19- to 22-
year-olds. After 1986, LSD availability increased considerably in all age bands, reaching 
its peak levels by 1995 during the relapse phase of the illicit drug epidemic. At that time a 
considerable age-related difference developed, with availability lower in the older age 
groups. Since 1995, availability has fallen substantially in all age bands but particularly in 
the youngest two age bands, narrowing the differences among the age groups. Indeed, the 
drop-off in availability of LSD to 12th graders and 19- to 22-year-olds was quite sharp in 
2002, probably contributing to the steep decline in use that year because changes in 
attitudes and beliefs about LSD cannot explain it. Over the past decade through 2017, 
availability has either remained largely steady (among 18-year-olds and those 40 and older) 
or declined somewhat (among 23-35 year olds); in contrast, it rose significantly for those 
aged 19-22. Across all age bands in 2017, availability was the highest among 19-22 year 
olds (33%) and considerably lower among those ages 27 and above (18–22%). Fifty-five-
year-olds are not asked the question. 
 
• Since 2001 through 2017, the general pattern among young adults regarding the availability 
of hallucinogens other than LSD has been one of decline. Levels of availability are more 
differentiated by age than in prior decades, with it being higher for younger respondents, 
though these differences have diminished in recent years. (This question is not asked of 
respondents over age 30.) In the early 1980s, there was a fair decline among all age groups 
in the availability of hallucinogens other than LSD. There was little additional change 
through 1992. From 1992 to 1995, the three youngest age groups all showed an increase in 
availability, with 12th graders showing the largest increase. From 1996 to 2000, availability 
was fairly steady. All age groups showed substantial increases in 2001, undoubtedly due 
to the changed question wording which added shrooms, among other substances, to the 
examples of hallucinogens. (Shrooms refer primarily to psilocybin mushrooms.) It appears 
that the inclusion of shrooms as an example introduced a greater variability with age in 
reported availability of hallucinogens other than LSD taken as a class.  
 
• MDMA (ecstasy and, more recently including Molly) questions were first introduced in 
MTF surveys in 1989 and 1990 (and are not asked of those over age 30). Availability rose 
very substantially in all of these age groups during the 1990s and early 2000s. Among 12th 
graders, reported availability nearly tripled from 22% in 1989 to 62% in 2001—the peak 
year of use for 12th graders. All four age groupings showed sharp increases in 2000 and 
2001, with the older age groups continuing to increase through 2002—their peak year for 
use. The availability of ecstasy showed considerable declines through 2017 among the two 
youngest strata after 2002 and among the 23- to 30-year-olds since about 2004. Reported 
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availability of ecstasy varied little by age in 2017, ranging between 29% and 35% among 
18-year-olds and the three young adult strata covered. 
 
• All four age groups have shown some gradual, modest decline in heroin availability since 
about 1997 or 1998, during which interval there has been rather little variability in heroin 
availability across the 18-to-30 age range. (The question is not asked of respondents over 
age 30.) Heroin availability varied within a fairly narrow range from 1980 to 1985, then 
increased in all age groups through 1990. For the younger ages (18–22) heroin availability 
rose further through 1995 while in the older two age groups it increased some later in the 
1990s. It is clear that heroin was much more available to all of these age groups in the 
1990s than it was in the 1980s. This increase in the availability—and purity—of heroin 
most likely led to the emergence of non-injection forms of heroin use observed during this 
period. In the past decade, heroin availability declined for 12th graders through 2017; it 
declined somewhat for young adults through 2012, and then increased modestly or leveled 
for all young adult age groups.  
 
• The availability of narcotics other than heroin rose slowly among all four age groups from 
1980 until recent years, with the exception of a period of considerable stability from 1989 
through 1994. (Respondents over age 30 are not asked this question.) After 1994, the 
modest increase in availability was accompanied by steadily rising use. Recent years 
showed a very slight falloff in availability among all age strata except the 27- to 30-year-
olds, who continued to show an increase through 2013, followed by a sharp and significant 
8.2 percentage point drop in 2014. Indeed, all four age strata showed substantial drops in 
the availability of narcotics in 2014, three of which were statistically significant. Across 
2015 through 2017, the two younger age strata showed further (nonsignificant) declines, 
whereas the 23-30 year-olds showed some leveling or uneven declines. It seems clear that 
availability of these drugs has been going down since 2011, especially in the younger age 
strata, likely in response to state and federal efforts to reduce their abuse by reducing 
availability with state registries, etc. (Note that reported availability jumped in 2010, when 
new drugs, including Vicodin and OxyContin, were added to the list of examples in the 
question.) For the most part, there has not been a consistent difference by age in the 
availability of narcotics other than heroin among those ages 18 to 30; prior to 2011 the 
predominant trend was one of increasing availability over a long period of time in the 23- 
to 30-year-old segment. The addition of newer drugs, like OxyContin and Vicodin, to the 
list of examples resulted in some further increase, which suggests that availability climbed 
considerably more over the previous decade or so than the data based on the original 
question had suggested.  
 
• In general, the age groups above age 30 have reported somewhat lower availability of 
amphetamines than the younger strata, but not dramatically lower. Furthermore, the ages 
19 to 30 have had the highest levels of availability in recent years, partly because 
availability among 12th graders declined appreciably since 1998, when they had the highest 
level of availability. These differential rates of reported availability across the age groups 
emerged after 1992, when prevalence of use began to rise among 12th graders. In 1982, 
availability peaked for both 12th graders and 19- to 22-year-olds, after which it fell through 
1991 by 14–15 percentage points. Among 23- to 26-year-olds, there was a decline of 14 
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percentage points between 1984 (when data were first available) and 2005. For 27- to 30-
year-olds, reported availability decreased by nine percentage points between 1988 (the first 
measurement point) and 2005. Decreases also occurred among 35-year-olds in the 2000s 
but some reversal has been evident in recent years. In 2011 all age strata from age 18 
through age 35 showed an increase in perceived availability for amphetamines, statistically 
significant for those 19-22 and 23-26 years old, followed by an uneven decrease for 18-
year-olds and most other age groups through 2017, the exceptions being uneven increases 
for the 19-22 and 27-30 year olds (with the 2017 increase for the latter group being 
significant). It should be noted that the examples of amphetamines used in the question text 
were updated in 2011 to include Adderall and Ritalin, while “pep pills” and “bennies” were 
eliminated as outdated examples. Therefore, the sharp rise in reported availability of 
amphetamines in 2011 among young adults may be due to the revision of the examples 
provided. 
 
• By way of contrast to amphetamines, crystal methamphetamine or “ice” exhibited an 
increase in availability in the 1990s, rising for all four age strata from 1991 to 1998/1999 
before stabilizing with similar rates of availability from ages 18 to 30. (This question was 
not asked of those over 30.) All four strata have shown some decline in recent years through 
2017, starting with the youngest three age strata after 2006 and the 27- to 30-year-olds after 
2008. In recent years through 2017, availability has been lowest for the youngest three age 
bands—a reversal of the situation in the early 1990s (Table 7-4). 
 
• Sedatives (barbiturates) exhibited a long-term decline in availability over more than two 
decades from about 1981 or 1982 through 2003 in the two younger groups—a 20-
percentage-point drop among 12th graders and a 23-percentage-point drop among 19- to 
22-year-olds. All groups showed increased perceived availability in 2004—no doubt due 
primarily to an updating of the examples given in the question—followed by an overall 
decline. As of 2017, there was a decline of 23 percentage points among 12th graders since 
2004, of 17 percentage points among the 19- to 22-year-olds since 2007, of 23 percentage 
points among 23- to 26-year-olds since 2006, and of 11 percentage points among 27- to 
30-year-olds since 2007. In 2017, perceived availability was higher in the 27- to 30-year-
old group (37%) than in the 18-year-old group (23%).  
 
• Tranquilizer availability has declined long-term by about four fifths among 12th graders, 
from 72% in 1975 to 15% in 2017. Since 1980, when data were first collected for 19- to 
22-year-olds, tranquilizer availability has declined by over three fourths (from 67% in 1980 
to 15% in 2017), such that previous differences in availability between these two groups 
were eliminated by 1992. The older young adult age groups have also shown a considerable 
decline in the availability of tranquilizers through 2017, thus narrowing the differences 
among them. For the most part, trend lines for the different age groups have been quite 
parallel, as has been true for sedatives (barbiturates). Indeed, tranquilizers have shown the 
most consistent pattern of change in perceived availability since MTF began. By 2017 only 
15% of the 18-year-olds said that tranquilizers were fairly or very easy to get, and only 
15% to 18% of the three young adult age bands said the same. 
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• Data on steroid availability were first gathered in 1990 (Table 7-4). There has been some 
decline in availability in all age groups since about 2000, including a sharper rate of decline 
in the youngest three age strata after 2007. (This question was not asked of those over 30.) 
While younger respondents used to report higher levels of availability than those in the 
older strata, by 2017 there was not much difference among them (from 19% to 24%). 
Eighteen-year-olds reported the lowest level of perceived availability in 2014 due to a 
significant decrease of 6.6 percentage points that year, bringing 18-year-olds to 22% (20% 
in 2017)—a decline of more than half since 1991. In fact, all of the age groups were at or 
near their lowest point in 2017. 
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Q. How do you think your 
close friends feel (or would 
feel) about you. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Trying marijuana once  18 42.6 46.4 50.3 52.0 54.1 54.7 56.7 58.0 62.9 63.7 70.3 69.7 73.1 66.6 62.7 58.1 55.8 53.0 53.8
  or twice 19–22 41.0 40.6 46.9 47.1 51.6 54.5 55.2 54.7 58.7 63.0 63.6 64.7 64.7 63.4 63.7 58.5 64.3 58.4 57.0
23–26 — — — — 47.7 47.0 49.1 53.9 58.2 62.6 61.3 64.5 65.6 65.5 63.2 63.8 61.2 59.3 66.5
27–30 — — — — — — — — 58.6 58.7 61.4 64.6 63.5 64.4 66.3 66.1 65.8 65.0 65.4
Smoking marijuana  18 50.6 55.9 57.4 59.9 62.9 64.2 64.4 67.0 72.1 71.1 76.4 75.8 79.2 73.8 69.1 65.4 63.1 59.9 60.4
  occasionally 19–22 50.9 49.2 54.0 57.9 59.4 64.6 64.4 65.1 69.8 71.5 74.1 73.9 74.3 73.1 73.0 66.6 71.3 65.1 65.1
23–26 — — — — 54.3 56.4 57.1 63.1 68.1 73.2 71.8 72.5 75.3 73.5 72.2 70.7 70.8 68.5 73.6
27–30 — — — — — — — — 67.8 69.4 71.9 73.7 76.0 75.1 76.4 73.8 75.6 72.4 74.9
 
Smoking marijuana  18 72.0 75.0 74.7 77.6 79.2 81.0 82.3 82.9 85.5 84.9 86.7 85.9 88.0 83.5 80.6 78.9 76.1 74.1 74.7
  regularly 19–22 70.3 75.2 75.7 79.5 80.0 82.7 83.5 84.8 86.9 87.5 89.1 88.4 89.1 87.6 85.9 83.9 84.5 83.3 81.1
23–26 — — — — 77.8 78.4 80.9 82.0 85.8 89.2 88.1 87.9 90.3 89.1 88.8 84.9 89.5 85.6 87.1
27–30 — — — — — — — — 85.4 86.0 88.4 89.2 88.7 88.2 88.9 89.7 89.6 87.8 90.8
Trying LSD once or 18 87.4 86.5 87.8 87.8 87.6 88.6 89.0 87.9 89.5 88.4 87.9 87.9 87.3 83.5 83.4 82.6 80.8 79.3 81.7
  twice 19–22 87.4 90.5 88.0 89.3 89.3 91.1 90.5 91.8 90.8 91.2 89.1 89.9 87.2 87.7 87.9 84.6 85.3 83.6 81.7
23–26 — — — — 87.4 90.8 88.6 89.8 88.9 91.0 90.1 92.4 88.9 87.7 86.3 85.3 88.5 85.4 87.6
27–30 — — — — — — — — 88.8 89.7 92.3 91.1 91.4 89.9 91.2 89.7 89.3 88.5 88.7
Trying cocaine once or 18 — — — — — — 79.6 83.9 88.1 88.9 90.5 91.8 92.2 91.1 91.4 91.1 89.2 87.3 88.8
  twice 19–22 — — — — — — 76.4 — 84.8 87.7 89.2 92.3 91.9 92.4 94.7 91.7 91.5 91.8 90.0
23–26 — — — — — — 70.8 — 81.4 84.5 84.1 86.7 87.4 87.7 87.9 90.4 90.0 91.1 92.0
27–30 — — — — — — — — 81.8 81.1 83.7 83.5 84.4 86.1 87.8 87.5 88.7 89.4 89.3
Taking cocaine 18 — — — — — — 87.3 89.7 92.1 92.1 94.2 94.7 94.4 93.7 93.9 93.8 92.5 90.8 92.2
  occasionally 19–22 — — — — — — 84.9 — 91.0 93.8 94.2 95.6 95.9 95.6 97.5 95.6 95.7 96.6 93.1
23–26 — — — — — — 81.7 — 88.2 91.5 92.4 94.1 93.8 93.5 94.3 94.6 95.4 95.1 95.2
27–30 — — — — — — — — 87.7 89.5 90.0 92.2 92.3 92.8 94.6 94.1 94.6 94.2 96.1
Trying an amphetamine  18 78.9 74.4 75.7 76.8 77.0 77.0 79.4 80.0 82.3 84.1 84.2 85.3 85.7 83.2 84.5 81.9 80.6 80.4 82.6
  once or twice 19–22 75.8 76.7 75.3 74.3 77.0 79.7 81.5 81.3 83.0 83.5 84.5 86.5 83.8 85.0 87.2 83.1 86.0 84.5 84.0
23–26 — — — — 78.4 79.1 76.7 81.7 83.0 85.6 84.3 85.0 83.6 84.2 84.7 87.6 86.5 83.3 87.0
27–30 — — — — — — — — 82.7 84.1 84.9 84.6 84.7 84.1 85.9 85.5 85.6 85.9 85.8
Taking one or two 18 70.5 69.5 71.9 71.7 73.6 75.4 75.9 71.8 74.9 76.4 79.0 76.6 77.9 76.8 75.8 72.6 72.9 71.5 72.3
  drinks nearly 19–22 71.9 72.1 68.6 73.5 71.6 72.2 72.7 70.2 73.9 77.1 73.3 73.7 74.0 71.2 73.0 68.3 68.9 73.5 67.3
  every day 23–26 — — — — 63.6 66.8 67.7 68.3 69.2 70.8 72.7 72.5 72.1 67.6 71.5 68.2 72.8 68.1 66.9
27–30 — — — — — — — — 71.0 68.0 70.4 71.9 68.8 73.2 70.9 68.8 65.7 67.3 66.7
Taking four or five 18 87.9 86.4 86.6 86.0 86.1 88.2 87.4 85.6 87.1 87.2 88.2 86.4 87.4 87.2 85.2 84.1 82.6 82.5 82.8
  drinks nearly every 19–22 93.7 91.7 89.9 91.9 91.7 92.5 91.5 90.8 90.4 92.5 89.9 91.7 92.6 89.6 90.1 88.8 88.1 90.0 85.9
  day 23–26 — — — — 90.8 90.2 92.5 92.8 93.7 92.1 92.1 92.4 91.1 93.1 92.1 92.2 92.6 90.7 93.7
27–30 — — — — — — — — 92.8 92.0 92.9 92.7 92.7 93.9 94.0 92.9 91.9 93.8 92.1
Having five or more   18 50.6 50.3 51.2 50.6 51.3 55.9 54.9 52.4 54.0 56.4 59.0 58.1 60.8 58.5 59.1 58.0 57.8 56.4 55.5
  drinks once or twice 19–22 53.5 51.7 51.7 53.3 50.8 53.3 47.0 49.4 50.5 56.8 53.1 51.4 53.6 51.9 54.4 55.5 52.1 56.4 52.8
  each weekend 23–26 — — — — 53.8 57.3 61.0 57.2 58.8 57.5 55.1 56.8 58.4 57.6 61.4 58.9 58.4 55.6 60.0
27–30 — — — — — — — — 61.9 65.1 66.3 68.2 66.2 66.7 63.7 64.6 61.6 64.0 63.0
Smoking one or more 18 74.4 73.8 70.3 72.2 73.9 73.7 76.2 74.2 76.4 74.4 75.3 74.0 76.2 71.8 72.4 69.2 69.3 68.5 69.0
  packs of cigarettes 19–22 75.6 75.1 75.4 78.5 76.2 79.7 77.7 78.6 80.2 78.4 77.5 78.3 79.0 76.0 73.8 70.9 73.9 76.5 69.2
  per day 23–26 — — — — 73.9 77.3 80.3 80.5 79.5 80.5 78.5 83.3 82.3 77.4 80.1 78.8 78.3 75.8 76.5
27–30 — — — — — — — — 81.2 80.9 82.9 84.5 83.1 86.8 82.5 83.4 81.9 80.5 81.9
Approximate  18 2,766 3,120 3,024 2,722 2,721 2,688 2,639 2,815 2,778 2,400 2,184 2,160 2,229 2,220 2,149 2,177 2,030 2,095 2,037
Weighted  N = 19–22 569 597 580 577 582 556 577 595 584 555 559 537 520 510 470 480 471 466 436
23–26 510 548 549 540 510 513 516 516 507 481 463 445 436 419 425
27–30 483 518 479 480 451 451 457 439 439 422 440
(Table continued on next page.)
Age 
Group
TABLE 7-1
Trends in Proportions of Respondents Reporting Their Close Friends Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Percentage saying friends disapprove a
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Trying marijuana once  18 55.1 58.1 57.6 54.1 58.4 59.5 60.9 62.3 60.4 60.8 61.4 54.9 53.0 52.9 51.2 50.4 51.0 48.6 44.3 -4.3
  or twice 19–22 56.5 56.0 54.2 53.4 56.5 61.0 57.9 60.5 58.4 62.4 57.0 57.4 52.4 54.6 52.2 50.7 46.7 40.5 41.1 +0.6
23–26 62.6 64.6 55.2 53.8 51.4 57.7 55.9 60.7 55.8 62.1 57.1 58.0 55.5 59.3 50.2 50.1 43.7 44.7 40.0 -4.7
27–30 61.8 63.9 64.9 67.1 61.9 67.2 61.2 64.1 58.2 57.1 55.6 60.5 57.1 56.8 48.2 49.5 45.5 42.1 41.6 -0.5
Smoking marijuana  18 61.6 63.9 64.3 60.3 64.2 65.0 67.6 68.1 65.8 66.3 68.5 61.8 59.4 59.5 57.6 56.2 58.1 54.9 51.4 -3.5
  occasionally 19–22 64.6 61.8 61.0 62.6 63.3 70.1 67.2 68.8 70.6 67.5 65.9 67.1 60.6 60.9 59.0 59.5 54.1 48.0 48.4 +0.3
23–26 70.2 70.9 63.9 64.5 61.6 63.5 65.5 71.3 63.8 70.1 66.8 63.4 64.7 69.3 60.9 57.6 54.9 52.6 49.1 -3.6
27–30 74.5 75.0 74.2 72.9 71.4 76.9 70.4 74.9 66.4 67.0 64.6 68.3 64.9 67.1 59.7 60.1 57.8 51.5 48.4 -3.1
Smoking marijuana  18 74.5 76.1 77.8 75.3 77.0 77.3 79.5 79.8 78.3 78.0 79.1 73.8 73.3 72.7 71.2 70.1 70.9 68.4 65.2 -3.2
  regularly 19–22 78.2 78.5 80.0 80.5 79.1 84.4 82.2 84.1 83.7 81.4 81.9 81.1 76.3 74.5 75.2 77.1 74.3 67.1 71.4 +4.3
23–26 86.8 86.9 83.7 82.8 80.0 79.2 82.7 83.7 81.9 87.1 81.9 83.5 82.7 83.8 77.7 76.7 71.6 71.3 68.4 -2.9
27–30 89.2 91.6 90.1 87.9 87.2 88.0 87.7 88.2 84.3 84.5 83.4 87.5 83.4 86.1 80.8 81.5 76.2 74.8 68.1 -6.7
Trying LSD once or 18 83.2 84.7 85.5 84.9 87.5 87.3 88.4 89.5 88.4 86.3 87.2 84.5 85.6 85.0 84.9 84.6 81.9 83.3 81.3 -2.0
  twice b 19–22 82.0 82.1 85.2 86.9 86.9 88.6 90.5 90.4 90.0 90.0 87.1 — — — — — — — — —
23–26 84.5 85.3 82.8 83.6 79.3 82.4 85.6 89.3 90.4 88.4 88.3 — — — — — — — — —
27–30 88.4 85.6 87.4 86.3 87.1 87.7 86.9 88.5 83.5 85.3 84.6 — — — — — — — — —
Trying cocaine once or 18 88.7 90.2 89.3 89.1 91.2 87.9 89.0 88.7 89.6 88.7 90.2 89.7 89.7 89.2 89.2 88.6 87.0 89.1 88.5 -0.6
  twice b 19–22 91.2 89.4 89.1 91.7 90.6 90.3 90.3 91.2 93.3 90.2 91.2 — — — — — — — — —
23–26 89.6 90.5 88.0 88.5 83.6 84.2 84.6 88.7 91.7 91.0 91.0 — — — — — — — — —
27–30 90.5 90.4 89.3 88.8 89.9 91.8 89.5 92.0 86.4 88.0 84.5 — — — — — — — — —
Taking cocaine 18 91.8 92.8 92.2 92.2 93.0 91.0 92.3 92.4 93.1 92.0 92.7 91.8 92.9 92.8 92.5 91.4 90.6 91.5 91.7 +0.2
  occasionally b 19–22 95.7 94.7 94.5 95.6 95.1 96.0 95.3 96.1 97.1 95.5 95.6 — — — — — — — — —
23–26 95.2 96.7 94.7 93.2 91.2 90.1 93.0 94.9 95.9 96.6 95.6 — — — — — — — — —
27–30 95.4 95.9 94.2 94.0 95.1 96.3 94.5 95.4 93.2 94.3 94.3 — — — — — — — — —
Trying an amphetamine  18 83.0 84.1 83.8 83.3 85.9 84.7 86.1 86.7 87.3 87.1 87.0 85.8 84.6 83.7 83.5 83.2 83.2 83.2 83.7 +0.5
  once or twice b 19–22 85.8 81.6 84.5 87.6 87.6 89.4 88.9 89.4 89.1 90.2 87.4 — — — — — — — — —
23–26 85.9 85.1 83.1 83.9 81.5 82.7 86.2 89.9 89.3 89.6 87.2 — — — — — — — — —
27–30 87.2 87.8 86.4 86.0 87.9 88.9 87.5 88.5 82.9 85.3 85.6 — — — — — — — — —
Taking one or two 18 71.7 71.6 73.4 71.6 74.7 72.8 74.0 73.2 74.5 75.2 75.5 75.0 74.9 74.0 75.4 74.0 76.3 76.3 77.3 1.0
  drinks nearly 19–22 68.6 66.6 64.9 68.5 64.4 72.4 68.3 68.7 68.4 69.5 68.8 — — — — — — — — —
  every day b 23–26 66.1 65.4 64.4 61.6 62.1 61.8 62.3 66.1 62.5 63.4 59.4 — — — — — — — — —
27–30 64.3 67.3 67.1 64.0 64.5 65.0 62.8 64.9 59.4 58.9 59.8 — — — — — — — — —
Taking four or five 18 82.2 82.8 84.4 80.1 83.1 82.9 82.7 83.3 84.8 84.7 84.6 83.4 85.8 84.1 85.8 83.8 85.3 85.6 87.3 +1.7
  drinks nearly every 19–22 87.9 86.6 84.6 87.7 86.8 89.8 86.8 89.0 90.7 88.8 89.9 — — — — — — — — —
  day b 23–26 89.9 92.5 91.1 88.1 89.3 87.8 89.1 90.8 87.8 93.8 89.1 — — — — — — — — —
27–30 95.3 92.4 91.2 92.7 92.6 92.5 93.4 92.3 91.3 89.0 93.1 — — — — — — — — —
Having five or more   18 57.6 57.7 57.8 55.6 60.3 59.4 59.9 60.6 60.0 62.1 63.5 62.0 62.2 62.3 65.2 65.6 68.5 70.7 69.0 -1.8
  drinks once or twice 19–22 51.8 45.2 47.4 50.4 47.9 52.4 53.2 54.8 54.4 55.2 54.6 47.7 48.7 53.9 53.0 54.5 50.4 51.9 54.7 +2.7
  each weekend 23–26 54.5 56.6 56.9 52.9 49.5 49.5 51.9 56.0 51.3 55.3 51.0 51.2 50.7 53.4 48.5 52.3 49.7 51.1 52.1 +1.0
27–30 57.7 65.8 58.8 63.3 59.6 64.6 56.9 62.7 56.3 57.3 52.7 52.9 50.6 53.7 52.7 57.1 52.8 54.1 56.4 +2.3
Smoking one or more 18 71.2 72.6 74.5 75.7 79.2 78.6 81.1 81.2 81.4 82.5 81.6 81.4 81.6 83.2 84.4 84.0 85.1 87.1 85.3 -1.8
  packs of cigarettes 19–22 73.9 71.1 74.3 77.3 78.3 82.1 82.7 84.8 87.0 85.5 86.8 85.7 84.8 89.2 87.9 90.9 90.7 90.2 89.5 -0.7
  per day 23–26 78.0 79.9 77.0 75.4 78.3 77.6 77.4 84.4 82.6 88.2 88.1 88.0 88.2 90.6 85.5 89.6 88.5 90.0 90.5 +0.5
27–30 82.6 84.0 83.6 86.1 84.0 84.6 82.2 84.1 81.3 83.9 85.0 89.5 88.4 88.1 90.0 89.4 92.2 91.2 90.1 -1.1
Approximate  18 1,945 1,775 1,862 1,820 2,133 2,208 2,183 2,183 2,161 2,090 2,033 2,101 2,132 2,126 1,916 1,863 1,992 1,763 1,922
Weighted  N = 19–22 430 379 402 361 399 427 395 395 361 370 389 347 364 337 309 289 263 246 255
23–26 394 398 378 366 363 377 361 344 349 336 322 355 320 329 327 284 299 238 244
27–30 397 394 374 364 346 408 362 327 330 318 333 322 321 285 303 288 265 272 279
Source.  The Monitoring the Future study, the University of Michigan.
Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the 
change estimate and the prevalence estimates for the two most recent years is due to rounding. ' — ' indicates data not available.
aAnswer alternatives were: (1) Don’t disapprove, (2) Disapprove, and (3) Strongly disapprove. Percentages are shown for categories (2) and (3) combined.
bThese questions were dropped from the questionnaires beginning in 2010.
Percentage saying friends disapprove a
TABLE 7-1 (cont.)
Trends in Proportions of Respondents Reporting Their Close Friends Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Age  
Group
2016– 
2017 
change
Q. How do you think your close 
friends feel (or would feel) 
about you. . .
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Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take any illicit drug b
   % saying any 18 87.5 85.4 86.3 82.6 81.0 82.4 82.2 81.7 79.1 76.9 71.0 69.1 67.3 71.0 78.3 78.6 80.6 83.4 84.6
19–22 90.2 88.0 86.8 85.0 82.3 82.9 80.5 76.7 77.2 78.4 72.7 71.5 66.8 71.7 71.6 71.6 76.2 77.2 79.8
23–26 — — — — 83.6 82.7 80.3 80.9 74.4 73.8 65.8 63.0 67.3 64.6 66.7 65.3 64.6 67.0 67.6
27–30 — — — — — — — — 74.8 72.9 69.6 67.1 61.5 60.2 57.1 58.5 59.1 60.9 58.3  
35 — — — — — — — — — — — — — — 38.1 37.4 39.7 39.2 38.4
40 — — — — — — — — — — — — — — — — — — 39.2
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 32.5 29.8 26.5 23.8 20.9 22.7 21.5 18.6 15.8 15.7 11.6 11.7 12.0 15.5 20.3 21.7 23.8 23.7 25.9
19–22 34.9 32.8 28.1 22.4 21.9 18.2 16.2 14.0 13.5 10.9 10.5 8.8 9.0 10.4 14.9 13.1 17.3 16.2 16.8
23–26 — — — — 19.6 15.4 16.2 11.7 9.5 9.7 9.5 7.4 6.2 6.4 8.7 7.6 8.8 10.5 9.6
27–30 — — — — — — — — 8.6 6.4 5.9 2.9 5.8 5.0 5.6 6.1 3.6 4.5 5.3
35 — — — — — — — — — — — — — — 2.1 1.9 2.0 3.0 3.1
40 — — — — — — — — — — — — — — — — — — 2.3
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take any illicit drug 
 other than marijuana b 18 62.4 63.3 64.7 61.2 61.3 61.8 63.3 62.4 56.5 56.2 50.1 46.3 47.1 48.7 53.7 53.7 54.5 55.1 55.6
   % saying any 19–22 67.9 67.8 66.7 65.2 60.8 62.1 61.0 57.3 53.5 60.8 53.4 51.5 45.3 51.4 46.3 46.4 46.5 49.7 53.3
23–26 — — — — 63.7 64.0 59.0 61.1 55.1 54.2 47.8 41.8 46.1 42.3 39.4 40.3 32.8 35.1 35.4
27–30 — — — — — — — — 55.9 55.0 49.7 47.2 37.7 38.5 33.9 37.7 36.4 33.9 34.1
35 — — — — — — — — — — — — — — 21.4 21.6 22.1 19.2 19.3
40 — — — — — — — — — — — — — — — — — — 20.9
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 11.1 11.9 10.9 11.0 10.3 10.4 10.3 9.2 6.9 7.7 5.1 4.6 5.3 7.1 7.1 7.7 8.9 7.0 8.9
19–22 9.8 12.9 11.8 9.8 9.3 8.6 7.6 5.0 5.3 4.0 3.2 2.6 3.3 4.0 4.4 3.5 6.2 4.1 4.3
23–26 — — — — 10.6 6.6 8.6 5.2 3.9 4.2 3.4 1.6 1.8 2.8 2.5 1.9 1.9 2.6 2.8
27–30 — — — — — — — — 4.6 3.0 2.8 1.0 1.4 1.5 1.5 1.5 0.9 1.2 0.9
35 — — — — — — — — — — — — — — 0.8 0.5 0.7 0.5 0.7
40 — — — — — — — — — — — — — — — — — — 0.4
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Smoke marijuana  
   % saying any 18 86.4 83.0 84.4 80.3 77.7 79.5 79.2 78.4 75.3 72.5 68.3 65.8 63.1 67.4 75.6 76.1 78.0 81.4 83.2
19–22 88.8 86.4 85.2 83.8 81.6 81.1 78.5 75.3 75.1 73.8 67.6 68.0 63.5 67.6 67.4 68.8 74.9 74.7 77.2
23–26 — — — — 82.0 80.8 77.7 79.4 71.6 69.8 61.8 59.6 61.3 61.2 62.6 63.2 62.6 63.5 65.0
27–30 — — — — — — — — 71.8 68.2 65.1 62.6 58.0 57.4 52.3 55.7 55.1 58.3 55.5
35 — — — — — — — — — — — — — — 36.9 36.3 36.3 35.0 34.6
40 — — — — — — — — — — — — — — — — — — 34.6
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 31.3 27.7 23.8 21.7 18.3 19.8 18.2 15.8 13.6 13.4 10.1 10.0 10.3 13.9 18.9 20.7 22.2 22.5 23.8
19–22 34.1 30.6 25.6 20.6 19.4 16.0 13.3 12.5 12.2 9.0 9.2 8.3 8.2 8.5 13.0 12.5 16.3 16.2 16.4
23–26 — — — — 17.0 14.3 13.7 10.4 7.8 8.6 8.3 6.9 5.6 5.6 7.5 6.6 8.2 9.8 9.0
27–30 — — — — — — — — 6.8 4.4 4.0 2.8 5.1 5.2 5.0 5.6 3.5 3.9 4.8
35 — — — — — — — — — — — — — — 3.0 2.5 2.9 2.9 2.8
40 — — — — — — — — — — — — — — — — — — 2.1
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Percentage saying friends use a
Age 
Group
TABLE 7-2
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
(Table continued on next page.)
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Take any illicit drug b,g
   % saying any 18 82.0 82.0 82.8 81.8 80.7 81.2 79.8 78.8 77.7 80.1 79.2 80.4 81.7 78.9 80.8 80.8 78.2 79.9 79.6 -0.3
19–22 77.3 83.1 81.1 78.3 79.4 78.1 78.6 74.7 79.8 77.4 80.3 78.6 78.1 78.8 78.3 79.4 — 83.5 83.8 +0.4
23–26 67.9 67.8 66.9 73.4 70.8 70.8 74.2 72.2 71.3 72.2 74.5 75.7 80.3 74.2 76.9 78.5 — 80.2 79.1 -1.1
27–30 59.6 55.6 57.2 61.8 58.6 63.1 63.7 62.3 62.7 66.7 70.0 66.9 69.2 72.3 72.9 73.6 — 74.5 78.0 +3.5
35 36.3 37.7 39.1 40.9 37.5 37.9 40.0 40.4 42.1 44.9 44.4 45.0 50.8 49.0 52.7 55.3 55.9 60.9 62.9 +2.0
40 38.2 38.0 38.4 36.2 36.5 34.6 36.2 35.4 34.6 35.9 39.0 37.3 36.6 40.3 42.1 42.0 44.0 48.0 49.0 +1.0
 45 — — — — 37.8 38.3 34.3 36.7 38.5 35.9 36.1 37.7 36.2 39.2 39.5 41.3 39.6 42.8 43.8 +1.1
50 — — — — — — — — — 39.3 37.0 36.5 36.0 38.4 39.1 39.8 41.1 40.4 44.0 +3.6
55 — — — — — — — — — — — — — — 36.2 36.2 38.0 38.7 41.7 +3.0
   % saying most or all 18 25.5 24.5 25.2 23.1 23.5 23.0 20.2 20.9 21.7 21.3 22.4 25.4 29.1 26.4 26.7 24.6 28.0 24.9 26.1 +1.2
19–22 20.6 18.9 20.3 20.2 17.3 14.7 15.8 16.8 14.5 13.7 16.0 17.2 21.8 17.3 22.1 20.5 — 22.3 25.5 +3.2
23–26 8.4 9.7 10.4 10.3 10.3 11.7 9.7 11.1 8.1 8.9 12.7 13.9 10.5 9.1 13.6 15.3 — 14.0 18.3 +4.3
27–30 5.7 5.3 7.1 6.9 6.9 3.9 4.7 5.4 6.5 6.3 6.4 6.6 7.1 6.8 6.7 8.3 — 9.1 10.3 +1.3
35 2.8 3.1 3.2 2.9 3.2 2.8 2.5 2.1 2.2 2.2 2.5 3.7 4.5 3.3 4.7 5.1 6.4 6.3 6.5 +0.1
40 2.0 2.0 1.6 2.2 1.6 1.6 2.1 2.5 2.0 1.3 1.3 2.1 1.9 1.2 2.3 3.3 3.4 4.1 3.9 -0.2
45 — — — — 2.2 1.5 1.4 1.7 1.3 1.3 1.2 1.5 1.2 1.0 1.5 1.9 1.6 2.2 2.1 -0.1
50 — — — — — — — — — 1.4 1.4 1.4 1.8 1.8 1.0 1.4 1.9 2.0 1.4 -0.6
55 — — — — — — — — — — — — — — 2.0 0.9 2.2 1.3 2.0 +0.7
Take any illicit drug
 other than marijuana b 18 51.2 52.5 55.0 54.3 50.0 51.4 51.3 51.0 50.0 49.3 49.4 53.7 49.9 48.9 45.4 43.7 41.2 44.2 40.3 -3.9
   % saying any 19–22 54.8 56.1 60.0 57.2 50.8 53.4 54.9 49.5 52.5 46.4 47.5 52.0 52.0 49.3 52.4 50.3 — 46.2 51.2 +5.0
23–26 41.1 42.5 42.6 49.4 42.3 47.1 46.6 45.6 42.6 45.9 44.4 52.4 50.5 46.6 45.3 53.3 — 50.3 49.6 -0.8
27–30 35.2 31.7 33.5 36.0 34.7 35.8 33.1 36.2 34.2 36.4 41.6 40.1 40.9 50.1 44.6 48.2 — 45.1 50.7 +5.6
35 19.0 17.9 18.7 20.4 18.5 20.2 18.5 18.1 20.7 23.7 20.2 23.9 26.4 25.7 25.2 26.5 27.2 28.3 29.3 +1.1
40 21.0 21.9 21.4 21.0 20.2 18.5 21.0 20.3 20.3 19.8 20.6 18.8 17.4 20.2 18.7 17.9 21.3 23.5 20.3 -3.2
45 — — — — 23.4 25.1 20.8 22.7 25.0 21.2 20.7 20.9 21.5 22.6 20.9 19.7 18.3 18.3 19.8 +1.5
50 — — — — — — — — — 24.5 24.8 21.7 22.8 22.2 20.1 21.3 20.5 18.9 20.7 +1.8
55 — — — — — — — — — — — — — — 19.9 19.0 21.0 20.1 18.8 -1.3
   % saying most or all 18 7.4 7.4 7.0 6.1 6.7 7.3 6.7 5.3 6.5 5.3 5.6 7.1 6.5 5.5 4.3 5.1 6.0 4.6 4.6 +0.1
19–22 5.1 7.7 8.0 5.7 5.1 3.5 4.8 4.2 3.9 3.4 3.6 4.8 7.4 4.6 6.6 5.5 — 4.6 5.7 +1.1
23–26 2.2 3.8 3.7 2.8 3.7 3.1 3.2 3.2 1.0 1.5 2.9 3.2 3.1 3.2 3.3 5.3 — 3.5 4.6 +1.1
27–30 1.3 1.5 2.6 2.3 0.7 0.8 0.9 1.4 2.2 2.5 1.7 1.5 2.5 1.5 0.7 1.6 — 2.4 2.5 +0.1
35 0.9 1.0 0.9 0.6 0.6 0.4 0.5 0.5 0.6 0.5 0.5 1.0 0.7 0.8 1.3 0.9 1.2 0.9 0.7 -0.2
40 0.8 0.7 0.5 0.3 0.3 0.2 0.5 0.7 0.6 0.7 0.3 * 0.2 0.1 0.2 0.4 0.6 0.4 0.5 +0.2
45 — — — — 0.7 0.7 0.4 0.9 0.5 0.5 0.3 0.3 0.1 0.2 0.4 0.5 0.2 0.3 0.5 +0.2
50 — — — — — — — — — 0.5 0.4 0.3 0.8 0.4 0.2 0.3 0.3 0.5 0.2 -0.3
55 — — — — — — — — — — — — — — 0.4 0.4 0.4 0.3 0.2 -0.1
Smoke marijuana  
   % saying any 18 80.7 80.5 81.2 79.4 78.9 79.5 77.4 76.4 74.8 78.2 77.2 79.7 80.6 77.7 80.2 79.3 76.9 78.9 78.2 -0.7
19–22 73.9 81.2 78.4 77.2 76.5 75.6 75.8 72.0 76.6 74.7 77.7 75.6 74.7 76.8 76.2 77.5 78.4 82.9 82.8 -0.1
23–26 64.4 64.8 64.5 68.8 67.7 68.4 70.7 67.6 69.0 67.7 71.7 71.9 77.5 71.5 73.4 74.7 74.6 79.2 77.5 -1.7
27–30 57.0 51.7 56.5 59.0 55.8 60.4 60.8 61.0 60.2 64.2 65.2 62.3 65.9 66.6 69.2 69.4 76.2 72.2 76.2 4.0
35 33.3 34.9 35.6 37.4 32.9 34.7 37.2 37.3 38.6 42.1 40.6 41.3 47.4 45.1 48.8 54.0 53.4 57.0 60.7 +3.8
40 32.5 32.3 31.8 31.4 30.7 29.9 30.4 29.4 29.2 29.6 33.6 32.1 32.4 35.8 38.0 38.2 39.4 45.0 46.4 +1.3
45 — — — — 31.1 29.4 26.3 28.4 30.0 28.6 29.4 32.6 30.3 33.0 34.5 36.4 34.8 37.6 40.4 +2.8
50 — — — — — — — — — 30.1 26.9 28.0 27.9 31.3 33.0 34.0 36.2 36.1 39.4 +3.3
55 — — — — — — — — — — — — — — 29.5 28.9 31.6 31.9 37.0 +5.2 s
   % saying most or all 18 24.2 23.2 24.0 21.4 21.7 21.1 17.9 19.6 19.2 19.9 20.9 23.6 27.3 25.0 25.7 23.4 25.9 23.8 24.3 0.5
19–22 19.4 16.6 18.5 18.6 16.0 15.0 13.4 15.7 13.4 11.5 14.5 15.4 19.1 16.2 19.7 18.3 23.1 20.5 23.9 3.4
23–26 8.5 8.2 9.0 8.7 9.3 9.8 8.0 10.1 7.9 8.5 12.2 12.3 9.6 8.3 12.8 13.7 17.1 12.8 15.2 +2.5
27–30 5.5 4.9 6.3 6.2 6.7 3.5 4.3 5.0 6.6 5.0 5.8 6.3 5.8 5.6 6.6 7.8 7.4 8.0 9.4 +1.4
35 2.6 2.8 2.6 2.7 3.1 2.7 2.3 2.0 2.1 1.9 2.3 3.4 4.2 2.9 4.3 4.9 6.2 6.1 6.1 0.0
40 1.4 1.9 1.2 2.0 1.4 1.6 1.8 2.1 1.6 0.9 1.2 2.1 1.7 1.2 2.1 3.1 3.1 3.8 3.9 +0.1
45 — — — — 1.9 0.9 1.3 1.1 1.0 1.0 1.1 1.3 1.1 0.9 1.3 1.6 1.5 2.1 2.0 -0.1
50 — — — — — — — — — 1.2 1.2 1.2 1.3 1.5 1.0 1.2 1.6 1.6 1.4 -0.3
55 — — — — — — — — — — — — — — 1.8 0.7 1.9 1.1 1.9 0.8
↓
(List of drugs continued.)
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Percentage saying friends use a
Age 
Group
Q.  How many of your friends 
would you estimate. . .
2016– 
2017 
change
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 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Use inhalants
   % saying any 18 17.8 16.5 18.4 16.1 19.3 21.2 22.4 24.7 20.8 22.1 20.0 19.2 22.2 23.7 26.5 27.5 27.2 27.4 25.9
19–22 11.9 13.2 13.8 12.3 11.7 9.6 10.9 12.7 10.9 11.7 13.0 12.2 12.6 13.8 14.0 14.2 16.2 13.7 16.2
23–26 — — — — 7.7 6.7 7.2 6.1 6.2 5.9 6.1 4.4 5.1 6.3 7.0 9.3 5.6 7.5 6.2
27–30 — — — — — — — — 4.6 3.5 2.9 2.5 3.3 2.9 3.5 4.0 4.1 3.6 3.8
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.2 0.9 1.3 1.1 1.1 1.5 2.0 1.9 1.2 1.9 1.0 0.7 1.8 1.8 2.0 2.0 2.4 1.9 2.7
19–22 0.5 0.4 0.7 0.3 0.5 0.6 0.7 0.7 0.7 0.4 0.6 0.2 0.8 0.7 0.7 0.6 1.1 0.7 1.3
23–26 — — — — 0.6 0.2 0.6 0.1 0.2 0.4 0.4 0.1 * 0.1 0.2 0.7 0.5 0.8 *
27–30 — — — — — — — — 0.3 * 0.2 0.2 * 0.2 * * * * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Use nitrites
   % saying any 18 19.0 17.4 17.5 14.5 15.0 15.6 18.0 18.3 13.6 13.3 10.4 8.9 9.0 10.7 10.0 10.7 11.2 11.9 12.9
19–22 18.4 16.0 14.2 13.8 8.9 9.9 11.7 13.2 10.2 — — — — — — — — — —
23–26 — — — — 10.8 7.8 8.0 7.9 5.2 — — — — — — — — — —
27–30 — — — — — — — — 6.6 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.3 1.2 0.9 0.7 1.2 1.0 1.2 1.3 0.7 0.9 0.6 0.4 0.7 0.7 0.8 0.8 0.8 0.7 1.0
19–22 0.3 0.4 0.9 0.6 0.6 0.6 0.4 0.4 0.2 — — — — — — — — — —
23–26 — — — — 0.8 0.3 0.4 0.3 0.1 — — — — — — — — — —
27–30 — — — — — — — — 0.5 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take LSD
   % saying any 18 28.1 28.5 27.8 24.0 23.9 24.4 24.5 25.3 24.1 25.2 25.0 23.4 28.1 31.3 34.1 36.9 37.9 36.5 36.8
19–22 30.9 25.9 26.5 22.6 21.6 18.8 18.7 18.2 19.0 20.1 20.1 22.0 22.2 28.8 23.8 26.9 28.6 24.7 29.4
23–26 — — — — 21.5 17.2 15.4 15.9 13.3 14.1 12.3 12.5 15.0 17.2 17.3 21.5 15.3 18.2 15.2
27–30 — — — — — — — — 10.4 7.7 9.1 8.6 10.9 8.7 8.1 12.0 11.6 12.3 12.6
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.8 2.2 2.4 1.4 2.0 1.5 1.8 1.6 1.5 2.4 1.9 1.7 2.4 3.8 4.2 4.8 5.0 3.7 4.7
19–22 1.2 0.8 0.9 1.0 0.6 0.8 0.9 0.6 1.3 0.4 1.2 1.4 1.9 2.1 2.5 2.3 3.8 1.4 2.5
23–26 — — — — 0.8 0.5 1.0 0.2 0.6 0.5 0.6 0.2 0.4 0.7 1.1 0.7 0.7 0.6 1.0
27–30 — — — — — — — — 0.3 0.2 0.3 0.3 * 0.3 0.4 0.3 0.4 0.4 0.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
Percentage saying friends use a
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Q.  How many of your friends 
would you estimate. . .
322
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Use inhalants
   % saying any 18 21.6 23.5 22.2 21.0 17.5 17.9 18.1 18.9 17.9 18.0 18.0 19.0 16.4 12.3 12.1 9.4 8.7 8.8 7.2 -1.6
19–22 16.3 13.7 13.7 10.4 10.0 9.5 11.1 11.0 9.6 7.4 6.6 8.3 11.9 8.2 7.3 5.5 7.5 3.5 5.4 1.9
23–26 7.9 6.9 7.5 7.4 7.9 6.2 5.8 5.2 3.7 6.1 6.5 6.0 4.8 5.4 4.1 4.4 2.7 4.1 5.3 +1.2
27–30 4.2 3.6 6.0 4.5 3.2 2.6 3.2 3.3 2.8 2.7 3.6 1.7 3.2 3.8 2.9 5.4 1.7 3.7 4.2 +0.5
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.8 1.4 1.4 1.2 1.1 1.2 2.0 1.2 1.6 1.1 0.9 1.8 1.4 0.9 1.1 0.7 0.8 0.8 0.7 -0.1
19–22 0.8 0.6 1.2 0.4 0.6 * 0.1 0.5 0.3 0.6 * 0.6 0.6 0.1 0.9 * 0.5 * * 0.0
23–26 0.1 0.7 0.1 0.4 0.3 * 0.1 0.3 * * * 0.1 0.1 * 0.3 0.3 * * 0.4 +0.4
27–30 * * 0.3 0.3 * * * * * 0.3 0.3 * 0.3 * 0.1 0.5 * * 0.4 +0.4
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Use nitrites
   % saying any 18 10.9 11.0 11.9 11.2 8.5 9.4 9.1 8.1 7.7 7.3 7.7 — — — — — — — — —
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 0.7 1.0 0.6 0.8 1.0 1.2 1.0 0.5 0.7 0.5 0.2 — — — — — — — — —
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take LSD
   % saying any 18 32.2 31.9 32.2 28.6 21.9 23.5 19.5 18.7 18.3 20.9 21.3 22.3 22.5 21.3 17.7 18.0 18.9 22.7 20.1 -2.6
19–22 28.2 27.8 28.4 24.0 15.4 15.9 13.9 14.2 15.1 12.5 12.8 16.0 18.0 15.7 23.3 17.1 22.0 17.1 26.3 +9.2 s
23–26 18.1 19.3 16.8 15.8 16.1 14.4 12.0 11.7 11.2 9.2 11.0 11.9 10.2 11.5 13.4 16.7 16.8 17.0 22.7 +5.7
27–30 13.4 11.8 12.5 13.1 11.4 8.9 6.6 9.1 7.6 8.8 7.6 8.2 7.6 7.7 10.6 9.7 8.4 12.8 14.3 +1.5
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 3.9 3.1 2.9 1.7 1.9 1.5 1.5 0.8 1.2 1.1 1.1 1.5 1.4 1.3 1.2 1.2 1.6 1.0 1.5 +0.5
19–22 1.8 2.1 2.7 1.6 0.8 0.3 0.3 0.2 0.8 0.2 0.3 1.4 0.7 1.0 1.0 0.9 1.8 0.7 0.9 +0.2
23–26 1.5 0.9 0.3 0.4 0.8 0.4 0.2 0.3 * 0.1 0.5 0.1 0.6 0.4 0.3 0.6 0.4 0.4 1.0 +0.6
27–30 0.6 0.4 0.4 0.3 0.1 * 0.3 0.4 0.4 * 0.5 0.2 0.1 * * 0.3 * * 0.4 +0.4
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
↓
(List of drugs continued.)
Percentage saying friends use a
Age 
Group
2016– 
2017 
change
Q.  How many of your friends 
would you estimate. . .
TABLE 7-2 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
323
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1997 1998
(Years 
Cont.)
Take other
  hallucinogens c 18 28.2 26.3 25.6 22.1 21.3 22.0 22.3 21.7 17.8 18.1 15.9 15.1 17.0 19.3 21.4 23.8 26.4 26.3 26.3 27.4
   % saying any 19–22 33.4 25.5 25.1 21.0 20.2 16.6 15.8 15.0 16.1 13.9 15.3 14.2 12.0 15.0 13.8 14.9 17.2 17.2 17.2 19.1
23–26 — — — — 20.0 16.7 13.2 13.2 11.7 9.6 8.7 8.5 9.8 9.4 10.3 11.7 10.4 13.0 13.0 11.7
27–30 — — — — — — — — 10.6 7.4 7.1 6.8 7.9 7.1 6.6 7.9 7.5 6.8 6.8 7.8
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.2 2.1 1.9 1.6 1.9 1.4 1.3 1.2 0.9 1.4 1.0 0.8 1.0 1.7 2.2 2.2 2.3 2.6 2.6 3.1
19–22 1.5 0.9 1.1 1.2 0.7 1.0 0.7 0.6 0.9 0.2 0.5 0.8 0.7 0.9 1.6 1.5 1.0 1.1 1.1 1.7
23–26 — — — — 0.8 0.3 0.5 0.3 0.2 0.3 0.8 0.1 0.4 0.7 0.6 0.8 0.1 0.8 0.8 0.7
27–30 — — — — — — — — 0.2 0.1 0.3 0.2 * 0.2 0.3 0.1 0.2 0.3 0.3 0.2
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take PCP
   % saying any 18 22.2 17.2 17.3 14.2 14.2 15.9 16.1 15.5 13.5 14.7 13.0 12.0 12.7 15.6 15.5 18.3 20.3 19.7 19.7 20.2
19–22 24.1 15.3 15.3 12.6 9.5 8.9 10.1 9.7 10.1 — — — — — — — — — — —
23–26 — — — — 11.6 6.8 7.4 6.9 5.1 — — — — — — — — — — —
27–30 — — — — — — — — 6.7 — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.6 0.9 0.9 1.1 1.1 1.2 1.2 1.1 0.8 1.2 0.5 0.5 0.9 1.9 1.2 1.2 1.3 1.4 1.4 1.6
19–22 0.5 0.3 0.3 0.5 0.7 0.7 0.2 0.1 0.3 — — — — — — — — — — —
23–26 — — — — 0.6 * 0.4 * 0.2 — — — — — — — — — — —
27–30 — — — — — — — — 0.4 — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take ecstasy (MDMA)
   % saying any 18 — — — — — — — — — — 12.4 11.9 10.7 12.8 15.9 20.7 24.2 27.7 27.7 24.5
19–22 — — — — — — — — — 16.3 14.3 12.0 12.9 13.7 11.3 17.2 20.7 21.4 21.4 26.0
23–26 — — — — — — — — — 7.6 9.0 9.5 11.0 9.8 11.4 11.2 11.3 15.1 15.1 13.7
27–30 — — — — — — — — — 5.6 6.3 5.4 4.6 6.6 5.8 6.9 10.1 7.4 7.4 8.5
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — — — — 2.2 1.7 2.1 1.2 1.7 2.8 3.0 2.6 2.6 2.5
19–22 — — — — — — — — — 0.4 0.7 0.2 0.7 0.7 0.5 0.5 0.8 1.7 1.7 2.0
23–26 — — — — — — — — — 0.5 0.2 0.1 0.1 0.5 0.1 0.4 0.1 0.8 0.8 0.8
27–30 — — — — — — — — — 0.5 0.3 * 0.1 0.3 0.2 0.5 0.1 0.3 0.3 *
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
Age 
Group
Percentage saying friends use a
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
324
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Take other
 hallucinogens c 18 22.5 24.0 35.4 33.6 30.1 31.9 31.0 30.1 30.1 29.4 30.5 32.3 31.8 29.5 26.9 22.0 22.1 23.7 20.0 -3.7
   % saying any 19–22 18.9 20.9 33.6 33.5 24.8 26.8 25.1 27.8 26.7 21.9 21.8 26.4 26.4 22.6 28.3 19.9 27.1 23.2 26.8 +3.6
23–26 9.6 11.3 18.6 22.4 20.2 24.5 18.5 18.9 15.9 21.1 19.6 22.6 16.5 17.5 17.4 25.5 20.3 21.1 24.2 +3.1
27–30 9.4 8.0 14.6 14.9 13.5 12.4 9.4 14.9 10.6 16.9 12.1 14.9 13.9 17.1 16.5 15.6 18.8 17.3 19.4 +2.0
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.4 2.4 2.9 2.3 2.4 2.6 2.2 1.7 1.7 1.8 1.6 2.0 2.1 2.0 1.6 1.6 1.7 1.0 1.2 +0.2
19–22 0.8 2.0 2.3 2.2 1.5 1.1 0.6 0.9 1.0 1.3 0.6 0.9 0.7 0.8 1.0 1.0 1.3 0.7 0.9 +0.2
23–26 0.8 0.3 0.6 0.7 1.0 0.8 0.7 1.0 0.4 0.4 1.2 0.2 0.7 0.5 1.2 1.1 0.5 0.6 1.4 +0.8
27–30 0.2 0.4 0.6 1.0 0.1 * 0.4 0.4 0.4 0.4 0.6 0.7 0.5 0.3 0.4 0.1 * 0.3 0.4 0.0
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take PCP
   % saying any 18 16.8 17.5 19.1 17.2 13.6 11.8 10.1 10.6 9.4 9.4 9.3 — — — — — — — — —
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.5 1.7 1.3 1.0 1.5 1.1 1.0 0.5 0.8 0.5 0.5 — — — — — — — — —
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take ecstasy (MDMA)
   % saying any 18 26.7 37.3 41.9 38.0 34.2 28.9 23.1 23.0 23.6 24.7 23.5 25.9 27.5 26.8 25.6 24.3 26.3 24.4 22.4 -2.0
19–22 30.7 42.4 43.3 43.4 31.3 27.6 28.3 25.2 21.6 19.3 24.4 20.4 22.0 18.9 27.4 19.9 — 23.8 26.5 +2.8
23–26 15.2 25.9 29.4 36.8 27.0 31.2 25.3 23.4 16.5 20.8 19.7 20.7 19.5 18.8 19.1 22.7 — 24.9 29.0 +4.0
27–30 12.4 13.1 17.8 20.6 19.4 20.6 15.6 22.6 15.9 17.8 17.0 12.7 10.6 15.8 13.5 17.7 — 20.5 24.1 +3.6
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.7 4.8 5.2 3.7 2.7 3.2 2.5 1.9 2.1 2.4 2.2 2.1 2.7 2.7 1.8 2.3 2.0 1.0 1.2 +0.2
19–22 2.9 4.9 5.8 2.7 1.9 1.9 1.1 0.7 0.8 0.9 1.6 1.3 2.9 1.2 2.0 1.5 — 2.6 1.3 -1.3
23–26 0.4 2.9 1.7 1.2 2.0 1.1 1.3 0.9 0.3 0.4 0.7 0.6 0.4 1.7 1.0 2.2 — 0.6 0.4 -0.2
27–30 0.8 0.4 0.3 0.9 0.5 0.6 0.2 * 0.1 0.9 0.7 0.1 0.5 0.3 0.1 0.8 — 1.3 0.4 -0.9
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
↓
(List of drugs continued.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
Percentage saying friends use a
Age 
Group
2016– 
2017 
change
TABLE 7-2 (cont.)
Q.  How many of your friends 
would you estimate. . .
325
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take cocaine
   % saying any 18 41.6 40.1 40.7 37.6 38.9 43.8 45.6 43.7 37.7 37.4 31.7 26.8 26.3 24.5 26.1 24.8 28.1 28.2 31.2
19–22 51.0 48.9 49.8 46.5 47.6 45.9 48.3 45.7 42.0 42.7 33.2 29.7 22.8 24.3 21.5 22.0 19.4 22.2 26.8
23–26 — — — — 52.4 53.2 51.6 50.7 47.1 40.8 34.8 29.0 28.8 27.1 22.3 24.4 18.1 19.7 18.7
27–30 — — — — — — — — 47.9 43.3 38.3 35.7 29.9 27.6 22.6 26.2 20.8 21.5 18.6
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 6.1 6.3 4.9 5.1 5.1 5.8 6.2 5.1 3.4 3.7 2.1 1.5 1.5 2.1 1.5 2.0 2.2 2.0 3.2
 19–22 7.0 8.6 7.8 6.1 6.3 6.1 6.1 3.3 3.5 2.1 1.2 1.1 1.0 0.5 1.5 0.9 1.0 0.8 1.5
23–26 — — — — 9.1 5.3 7.0 4.1 3.1 2.7 2.1 0.6 0.9 0.8 1.0 0.3 0.4 1.1 0.9
27–30 — — — — — — — — 3.8 2.0 2.3 0.9 1.2 0.8 0.8 0.4 0.4 0.6 0.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take crack
   % saying any 18 — — — — — — — 27.4 25.4 26.1 19.2 17.6 17.8 17.9 20.0 19.2 21.6 22.2 24.4
19–22 — — — — — — — 23.8 21.8 20.6 14.6 14.3 11.8 13.6 13.8 14.0 9.4 13.1 16.4
23–26 — — — — — — — 26.4 22.4 19.8 14.4 10.8 10.8 8.8 8.8 11.1 8.2 8.3 8.3
27–30 — — — — — — — — 22.1 18.4 16.6 11.6 10.3 10.2 10.4 10.3 8.6 6.3 6.4
35 — — — — — — — — — — — — — — 4.5 5.1 4.4 3.1 2.8
40 — — — — — — — — — — — — — — — — — — 3.8
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — 2.2 1.1 2.1 0.6 0.6 0.7 0.9 1.0 1.1 0.9 1.1 1.7
19–22 — — — — — — — 0.7 0.8 1.0 0.6 0.2 0.1 0.3 0.4 0.3 0.5 0.3 0.9
23–26 — — — — — — — 0.8 0.9 0.8 0.5 0.1 0.1 0.5 0.2 * 0.3 0.5 0.4
27–30 — — — — — — — — 1.2 0.9 0.9 0.3 * 0.6 0.3 0.1 0.2 0.2 0.1
35 — — — — — — — — — — — — — — 0.6 0.3 0.4 * 0.1
40 — — — — — — — — — — — — — — — — — — *
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take cocaine powder
   % saying any 18 — — — — — — — — — 25.3 24.6 19.8 19.7 18.1 20.7 19.2 22.8 24.8 22.9
19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — 14.2 12.9 15.4 11.1 10.4
40 — — — — — — — — — — — — — — — — — — 10.8
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — — — 2.3 2.5 1.8 2.0 1.6 1.9 1.7 1.9 2.0 1.9
19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — 0.8 0.3 0.6 0.4 0.4
40 — — — — — — — — — — — — — — — — — — 0.2
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Percentage saying friends use a
Age 
Group
326
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Take cocaine
   % saying any 18 27.8 27.2 27.1 26.8 23.8 29.3 28.1 29.7 29.7 25.2 24.0 22.9 18.8 18.1 18.8 17.9 18.3 16.9 17.0 +0.1
19–22 25.7 24.8 27.4 28.2 25.5 26.2 27.2 26.6 29.4 21.8 21.2 21.8 22.3 15.9 19.5 20.5 21.4 18.2 24.6 +6.4
23–26 20.1 20.3 19.4 23.7 21.9 27.4 25.6 24.6 23.1 23.1 23.5 28.0 23.7 21.6 18.9 20.3 22.0 22.2 28.5 +6.3
27–30 20.7 16.5 19.7 16.0 17.0 17.0 17.9 19.5 18.6 20.7 22.1 19.2 16.1 21.6 18.4 20.8 24.7 22.4 23.4 +0.9
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.9 2.0 1.7 1.7 2.4 2.3 2.3 1.9 2.1 1.2 1.8 1.4 1.0 0.8 1.1 0.8 1.5 0.9 1.1 +0.3
 19–22 1.1 1.0 1.8 1.0 1.4 0.7 2.1 1.0 1.1 1.3 0.5 0.2 0.5 0.3 0.9 0.6 1.1 0.8 2.6 +1.8
23–26 0.5 0.8 1.6 1.0 1.6 1.0 1.5 1.4 0.8 0.6 1.7 0.9 0.4 0.6 0.9 1.1 1.0 0.6 2.0 +1.4
27–30 0.4 0.4 0.5 0.6 0.3 0.3 * * 1.4 0.9 0.7 0.2 0.5 0.6 0.5 0.4 0.4 0.5 0.8 +0.3
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take crack
   % saying any 18 19.0 21.4 23.4 21.5 18.7 22.5 22.9 22.3 21.8 19.1 18.8 15.2 12.1 10.4 10.3 9.0 10.1 8.0 8.0 0.0
19–22 15.7 16.5 17.4 18.0 11.8 16.0 14.9 14.5 16.0 12.2 11.3 7.2 8.3 5.1 8.3 6.9 — 5.9 4.9 -1.1
23–26 8.8 7.9 8.6 10.1 10.4 10.8 10.8 10.0 8.7 9.8 8.5 7.0 6.7 6.5 7.5 5.0 — 5.4 8.4 +3.0
27–30 8.7 6.0 7.1 6.4 6.5 5.2 8.5 9.1 6.9 5.8 9.5 3.6 4.2 3.6 4.6 4.2 — 4.8 5.2 +0.4
35 3.2 3.9 2.8 3.2 2.8 3.1 2.6 2.8 3.0 2.8 2.5 3.4 2.1 1.3 2.9 3.5 3.4 2.6 2.1 -0.5
40 3.0 2.9 3.5 2.6 2.7 2.6 2.8 2.3 3.1 1.9 1.2 1.5 1.2 1.2 1.2 2.1 1.9 1.1 1.2 0.0
45 — — — — 3.7 3.3 2.4 3.0 2.9 1.8 2.3 2.2 1.8 1.6 2.1 1.2 1.0 1.0 0.5 -0.5
50 — — — — — — — — — 2.0 1.6 1.8 1.4 1.1 1.2 1.9 1.3 0.9 0.9 0.0
55 — — — — — — — — — — — — — — 2.1 1.2 1.1 0.9 0.8 -0.1
   % saying most or all 18 1.5 1.4 0.8 0.8 1.4 1.6 1.6 1.0 1.3 1.1 1.1 1.5 0.9 0.8 0.9 0.8 1.0 0.7 1.0 0.3
19–22 0.9 0.5 0.3 0.2 0.4 0.1 1.0 0.8 0.3 0.4 0.3 * 0.3 0.3 0.6 0.1 — 0.4 * -0.4
23–26 * 0.5 0.3 * 0.3 0.5 0.2 0.7 0.1 0.3 * 0.4 0.1 * 0.3 0.1 — 1.2 0.9 -0.3
27–30 * * * 0.3 0.1 * 0.1 * 0.3 0.6 0.3 * * * 0.5 * — 0.2 0.4 +0.2
35 0.3 0.5 0.2 0.3 0.3 0.1 0.2 0.2 0.2 * 0.1 0.3 * 0.1 * * 0.3 0.2 0.1 -0.1
40 0.2 0.2 0.1 * * * 0.1 0.2 0.1 0.0 * * * * 0.1 * 0.3 * 0.1 0.1
45 — — — — 0.4 0.3 0.2 0.2 * * 0.1 * * 0.1 0.1 0.2 * 0.1 * -0.1
50 — — — — — — — — — 0.2 0.1 0.2 0.1 0.0 0.2 0.1 * 0.2 0.1 -0.1
55 — — — — — — — — — — — — — — 0.2 0.0 0.2 0.0 0.1 0.1
Take cocaine powder
   % saying any 18 22.0 21.3 20.1 22.4 23.2 25.4 23.2 22.8 22.3 22.6 19.1 17.6 15.9 17.4 15.6 15.4 14.7 16.0 17.1 +1.1
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 10.0 10.3 9.4 9.4 8.2 9.2 8.3 8.4 9.1 11.4 8.7 10.5 12.8 9.0 11.6 12.8 13.2 12.0 13.4 +1.5
40 8.9 8.8 8.8 8.5 7.6 7.6 8.9 7.3 6.7 6.2 6.5 4.9 4.8 5.2 6.6 6.6 6.2 8.1 7.3 -0.8
45 — — — — 8.3 8.0 7.0 7.4 8.0 6.7 6.4 5.9 5.8 6.0 6.0 5.2 4.6 4.8 4.8 0.0
50 — — — — — — — — — 6.0 5.4 5.3 4.9 4.9 4.4 4.6 5.1 4.3 4.5 +0.2
55 — — — — — — — — — — — — — — 4.1 3.0 3.8 3.5 3.9 0.4
   % saying most or all 18 1.9 1.8 1.5 1.9 1.9 3.3 1.7 1.7 1.8 1.5 1.5 1.0 1.6 1.5 1.2 1.8 1.2 2.2 2.2 * *
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 0.6 0.7 0.4 0.4 0.4 0.2 0.2 0.2 0.4 0.2 0.2 0.4 0.0 0.1 0.7 0.1 0.8 0.4 0.6 +0.2
40 0.2 * 0.2 0.1 0.1 0.1 0.2 0.5 0.2 0.2 0.1 * * * * * 0.3 * 0.2 +0.2
45 — — — — 0.5 0.5 0.2 0.4 0.1 0.1 * * * 0.1 0.3 0.2 * 0.1 0.3 +0.2
50 — — — — — — — — — 0.2 0.2 0.2 0.0 0.0 0.1 0.2 * 0.4 0.1 -0.3
55 — — — — — — — — — — — — — — 0.2 0.1 0.2 0.1 0.1 0.0
↓
(List of drugs continued.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
Percentage saying friends use a
Age 
Group
2016– 
2017 
change
Q.  How many of your friends 
would you estimate. . .
TABLE 7-2 (cont.)
327
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take heroin
   % saying any 18 13.0 12.5 13.2 12.0 13.0 14.5 15.3 13.9 12.4 14.0 11.4 11.4 13.2 13.3 14.3 14.5 15.6 15.6 16.5
19–22 11.0 8.1 9.4 7.5 7.1 6.5 8.5 8.5 7.8 6.8 6.5 6.1 4.7 7.0 8.1 10.4 6.7 7.4 9.4
23–26 — — — — 6.1 4.4 4.3 6.5 3.6 5.2 4.2 3.6 3.8 4.5 4.9 5.8 4.0 6.2 5.8
  27–30 — — — — — — — — 3.8 2.8 4.5 2.7 3.1 3.6 4.2 3.6 4.4 4.2 3.5
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.0 0.5 0.7 0.8 0.8 0.9 1.1 0.9 0.7 1.1 0.4 0.4 0.7 1.1 1.0 1.1 0.9 0.8 1.3
19–22 0.3 0.5 0.1 0.2 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.1 0.2 0.4 0.4 0.4 0.2 0.5
23–26 — — — — 0.4 0.2 0.2 * 0.2 0.4 0.2 0.3 0.4 0.1 0.2 0.2 * 0.7 *
27–30 — — — — — — — — 0.2 0.1 0.2 0.2 * 0.2 0.3 * * * 0.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take other narcotics d
   % saying any 18 22.4 23.1 23.9 20.8 21.4 22.8 21.8 23.2 19.2 19.2 17.2 13.7 14.9 16.1 18.5 19.5 21.8 22.2 24.8
19–22 22.8 20.4 21.9 17.9 17.4 16.9 14.6 15.4 14.1 15.0 12.9 14.1 10.8 13.2 10.5 15.9 13.4 13.2 15.2
23–26 — — — — 16.0 14.9 14.0 13.0 10.6 10.8 10.5 8.5 8.4 8.7 8.0 10.5 8.9 9.9 9.4
27–30 — — — — — — — — 12.1 8.6 9.1 9.3 7.5 8.2 8.0 7.7 9.5 7.9 8.3
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.7 1.5 1.4 1.4 1.6 1.4 1.8 1.4 1.2 1.4 0.9 0.5 1.1 1.2 1.0 1.6 1.5 1.4 2.9
19–22 0.9 0.7 0.6 0.5 0.8 1.0 0.5 0.4 0.9 0.1 0.6 0.4 0.5 0.6 0.6 0.6 0.4 0.4 0.8
23–26 — — — — 0.4 0.3 0.7 * 0.3 0.2 0.2 * * * 0.3 0.2 * 0.6 0.3
27–30 — — — — — — — — 0.3 * 0.2 0.2 0.1 0.2 0.2 * 0.2 * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take amphetamines e 
   % saying any 18 43.9 48.8 50.6 46.1 45.1 43.3 41.8 39.5 33.4 33.5 28.7 24.3 24.3 27.5 28.1 30.3 32.2 32.7 33.8
19–22 54.1 52.2 51.3 49.7 46.1 42.1 38.5 34.5 26.8 29.6 23.3 26.2 19.5 21.0 20.9 21.7 21.6 21.1 24.4
23–26 — — — — 45.6 40.1 33.5 32.1 28.4 23.1 20.6 17.1 15.1 16.8 16.2 18.2 12.5 14.4 14.1
27–30 — — — — — — — — 26.1 21.6 19.3 17.0 15.3 14.0 13.1 13.7 15.5 12.9 11.0
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 4.8 6.4 5.4 5.1 4.5 3.4 3.4 2.6 1.9 2.6 1.9 1.3 1.3 2.0 1.8 2.0 2.8 2.4 3.4
19–22 3.8 5.7 4.6 3.8 3.3 2.9 1.3 1.9 1.4 0.7 1.0 0.6 0.9 0.2 1.1 1.2 0.7 0.7 1.2
23–26 — — — — 1.9 1.8 1.7 1.2 0.3 0.6 0.7 0.8 0.4 1.5 0.9 0.5 0.2 0.8 0.5
27–30 — — — — — — — — 0.6 0.4 0.5 0.5 0.1 0.5 0.5 0.3 0.3 0.1 0.3
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
Percentage saying friends use a
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
TABLE 7-2 (cont.)
Age 
Group
328
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Take heroin
   % saying any 18 12.7 14.9 13.1 12.9 10.3 12.7 13.1 12.7 12.9 11.2 12.7 12.4 10.2 7.7 8.5 7.9 7.1 6.0 5.3 -0.8
19–22 9.7 7.7 8.7 8.9 5.3 7.0 6.4 7.5 9.0 6.4 3.9 5.3 6.2 6.4 4.8 4.6 5.6 6.6 3.6 -3.0
23–26 4.8 4.7 5.0 5.2 6.1 2.9 5.1 3.5 4.3 3.1 5.9 6.9 3.9 5.9 4.6 3.9 3.0 4.4 7.0 +2.6
  27–30 3.8 2.8 4.3 3.9 3.4 3.0 3.8 2.5 3.0 2.1 3.9 3.3 2.6 3.5 4.6 3.3 4.9 4.6 3.7 -0.9
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.0 1.1 0.9 0.7 0.9 0.9 1.1 0.8 1.4 0.7 0.9 1.3 0.6 0.6 0.6 0.5 0.7 0.7 0.9 +0.1
19–22 0.1 0.3 0.6 * 0.3 * 0.3 0.4 0.3 0.6 * * 0.5 0.1 0.6 * 0.6 * * 0.0
23–26 * 0.3 * 0.1 * * 0.3 0.3 * * 0.1 0.5 0.1 0.1 0.8 0.3 0.5 0.2 0.6 +0.4
27–30 * * * 0.3 * * * * * * 0.3 * 0.3 * 0.1 0.1 * 0.2 0.4 +0.2
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take other narcotics d
   % saying any 18 22.9 23.1 24.0 27.5 21.6 24.6 21.4 23.0 20.7 20.6 21.5 36.3 31.0 28.5 25.8 22.0 20.0 20.5 18.4 -2.1
19–22 19.8 23.2 23.0 21.8 21.9 22.6 19.9 17.6 23.7 16.8 15.3 31.4 31.3 25.7 29.5 20.9 21.7 17.1 19.1 +2.0
23–26 10.4 11.2 13.5 14.6 18.4 16.8 18.3 17.6 14.2 16.0 19.3 36.7 30.4 27.9 25.6 29.2 24.4 24.2 18.8 -5.4
27–30 7.2 8.4 11.2 11.8 11.0 12.0 12.5 13.1 10.6 14.3 14.2 28.4 29.8 32.9 30.4 29.6 28.7 25.5 26.8 +1.3
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.8 2.0 2.0 2.1 2.4 2.4 1.9 1.8 2.6 1.3 1.9 3.8 2.6 1.8 1.9 1.8 1.5 1.7 1.7 0.0
19–22 0.4 1.2 1.8 1.3 1.0 0.5 1.0 0.9 0.3 1.3 0.4 1.8 2.1 1.4 2.7 0.5 1.1 0.5 0.3 -0.1
23–26 * 0.4 0.5 0.6 0.6 0.5 0.8 0.5 0.3 0.1 0.9 1.6 1.1 1.0 1.6 1.2 1.0 0.6 1.0 +0.4
27–30 0.2 * * 0.3 0.1 * * 0.6 * 0.6 0.6 0.9 1.2 0.1 0.5 0.5 * 0.5 0.9 +0.4
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take amphetamines e 
   % saying any 18 30.8 32.9 33.2 34.4 28.1 31.4 28.8 29.0 27.4 27.3 30.0 31.1 31.3 30.5 25.7 25.0 24.2 27.3 21.4 -5.9
19–22 25.5 28.4 28.0 28.6 24.0 23.5 25.9 25.4 26.9 19.9 26.6 27.3 29.5 30.5 37.9 33.4 38.5 30.6 35.2 +4.6
23–26 14.2 14.5 17.5 18.4 18.0 18.8 18.4 19.7 17.6 17.9 21.3 23.8 27.7 26.1 27.0 31.5 28.5 30.5 32.4 +1.9
27–30 11.8 11.9 12.9 12.3 12.0 13.5 11.8 12.5 10.0 12.8 16.4 16.4 17.2 22.9 24.7 24.1 27.0 25.4 30.0 +4.6
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.8 3.1 2.2 2.4 2.1 2.9 2.2 2.0 2.4 1.8 2.0 2.9 2.2 2.4 2.2 2.9 2.5 2.4 1.7 -0.7
19–22 0.7 1.7 1.6 1.3 1.2 0.5 0.7 1.1 0.4 1.3 1.6 1.2 4.3 2.0 3.5 3.8 4.3 2.4 3.0 +0.7
23–26 0.6 0.3 0.5 0.3 0.7 0.1 0.3 0.7 * 0.1 0.3 0.8 1.3 1.5 1.9 2.2 1.3 1.9 2.4 +0.5
27–30 0.6 0.1 0.5 0.9 0.1 * 0.4 0.4 0.4 0.3 0.5 0.3 0.3 0.3 0.1 0.3 0.8 0.5 1.1 +0.6
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
↓
(List of drugs continued.)
Percentage saying friends use a
Trends in Friends’ Use of Drugs as Estimated by
TABLE 7-2 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Q.  How many of your friends 
would you estimate. . .
Age 
Group
2016– 
2017 
change
329
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take sedatives/
   barbiturates f
   % saying any 18 30.5 31.1 31.3 28.3 26.6 27.1 25.6 24.3 19.7 20.3 17.4 14.8 16.4 17.8 18.2 17.8 21.6 20.4 22.8
19–22 33.2 27.9 27.7 23.6 22.0 17.2 18.8 15.5 14.0 14.1 11.9 12.8 10.7 11.7 9.7 13.3 11.6 12.1 14.8
23–26 — — — — 22.2 18.7 16.3 14.1 11.2 10.4 8.9 8.3 8.7 8.2 7.6 9.6 6.9 8.4 7.9
27–30 — — — — — — — — 12.0 8.5 8.8 7.1 6.6 6.7 7.4 7.2 6.7 6.5 6.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.6 2.1 1.8 1.7 1.7 1.6 1.4 1.1 1.1 1.4 0.6 0.5 0.6 1.0 1.1 1.4 1.6 1.1 2.5
19–22 1.1 1.3 1.0 0.8 0.8 0.5 0.3 0.4 0.8 0.1 0.2 0.3 0.1 0.1 0.3 0.8 0.2 0.7 0.4
23–26 — — — — 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.2 * * 0.8 *
27–30 — — — — — — — — 0.2 * 0.4 0.2 0.2 0.2 * * 0.3 * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take quaaludes 
   % saying any 18 32.5 35.0 35.5 29.7 26.1 26.0 23.5 22.0 17.1 16.6 14.3 12.0 13.1 14.2 14.2 15.5 18.1 16.1 17.4
19–22 38.3 36.2 35.4 30.5 24.6 19.9 20.3 16.9 12.5 10.9 10.0 10.6 9.2 10.0 7.8 11.5 10.1 9.3 10.6
23–26 — — — — 25.7 21.0 17.4 15.0 12.1 10.3 8.6 5.9 6.4 7.6 7.7 9.0 6.3 6.5 6.6
27–30 — — — — — — — — 11.8 7.9 8.2 7.0 7.1 6.5 6.6 4.5 6.9 4.9 4.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 3.6 3.6 2.6 2.6 1.7 1.3 1.6 1.0 1.0 1.3 0.8 0.5 0.8 1.1 1.1 1.3 1.7 1.1 2.0
19–22 1.9 2.7 1.2 1.3 1.2 0.6 0.2 0.4 0.4 0.2 0.6 0.2 0.1 0.1 0.2 0.7 0.1 0.6 0.5
23–26 — — — — 0.6 0.3 0.7 0.2 0.2 0.4 0.2 0.1 0.2 0.6 0.2 0.2 * 0.8 *
27–30 — — — — — — — — 0.5 0.2 0.2 0.2 * 0.2 * * 0.2 * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Take tranquilizers 
   % saying any 18 29.7 29.5 29.9 26.7 26.6 25.8 24.2 23.3 19.9 18.0 14.9 13.5 14.6 15.5 16.5 15.8 18.1 17.9 19.7
19–22 37.5 33.9 28.7 22.9 22.0 19.7 20.6 18.0 16.4 14.8 13.4 13.0 11.3 11.9 9.5 13.6 10.5 11.7 13.7
23–26 — — — — 29.3 26.3 22.3 20.8 15.5 13.1 14.8 12.1 12.5 11.0 13.4 10.4 10.7 9.6 8.5
27–30 — — — — — — — — 20.1 16.6 16.9 14.9 12.0 12.5 13.9 11.9 11.0 10.8 12.6
35 — — — — — — — — — — — — — — 14.3 12.2 13.1 10.8 10.7
40 — — — — — — — — — — — — — — — — — — 13.7
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.9 1.4 1.1 1.2 1.5 1.2 1.3 1.0 0.7 1.5 0.5 0.4 0.7 0.9 0.9 1.1 1.4 0.8 2.3
19–22 0.7 0.9 0.5 0.8 0.3 0.7 0.3 0.6 0.4 0.1 0.4 0.5 0.1 0.1 0.2 0.7 0.7 0.8 0.6
23–26 — — — — 0.4 0.3 0.5 * 0.3 0.4 0.2 0.3 0.1 0.4 0.2 * * 1.1 0.1
27–30 — — — — — — — — 0.5 0.3 0.4 0.2 0.1 0.2 0.4 * 0.2 * *
35 — — — — — — — — — — — — — — 0.5 0.3 0.3 0.1 0.2
40 — — — — — — — — — — — — — — — — — — 0.0
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
TABLE 7-2 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
Percentage saying friends use a
Age 
Group
330
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Take sedatives/
barbiturates f
   % saying any 18 20.9 21.6 22.1 25.3 18.1 25.2 22.3 22.5 20.8 19.8 21.0 23.5 21.1 17.3 15.5 14.2 14.5 15.1 12.9 -2.2
19–22 16.0 15.2 18.6 17.1 14.4 18.8 19.6 18.7 20.1 17.8 16.4 19.1 14.5 13.7 19.0 13.6 18.2 12.0 14.9 +2.9
23–26 8.3 6.6 11.1 10.9 12.9 16.7 15.7 16.2 16.5 13.4 18.6 17.6 12.2 11.8 14.3 15.0 11.9 15.4 11.6 -3.8
27–30 5.7 6.4 7.9 7.4 7.3 11.5 10.5 13.5 12.5 15.2 12.7 15.3 13.7 14.5 16.5 13.0 13.1 13.0 14.8 +1.9
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.4 1.7 1.1 1.7 1.9 2.0 1.8 1.3 1.6 1.3 1.3 1.5 1.3 1.5 1.2 1.1 1.4 1.4 1.0 -0.4
19–22 0.4 1.0 0.9 0.8 0.7 0.3 0.3 0.2 0.6 0.5 1.0 0.6 0.6 0.3 1.2 0.7 1.3 * 0.2 +0.2
23–26 * 0.4 0.4 * 0.2 0.4 0.2 0.5 * 0.4 0.4 0.5 0.3 0.4 0.7 0.4 0.7 0.8 1.0 +0.2
27–30 0.2 * 0.3 0.6 0.1 * 0.5 0.4 0.6 0.1 0.9 0.4 0.2 * 0.1 0.1 0.4 0.6 0.4 -0.2
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take quaaludes 
   % saying any 18 15.5 16.2 17.8 18.0 14.2 16.6 13.6 13.4 13.6 11.2 14.3 — — — — — — — — —
19–22 11.4 13.1 14.6 13.0 10.3 8.3 8.2 8.6 8.8 5.9 5.3 — — — — — — — — —
23–26 6.4 4.9 7.7 8.5 8.9 6.5 7.7 5.6 5.6 4.1 8.0 — — — — — — — — —
27–30 5.1 5.0 4.9 6.6 4.3 4.4 3.6 4.9 4.3 5.8 4.5 — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.4 1.4 1.2 1.2 1.2 1.6 1.3 1.3 1.6 0.8 1.1 — — — — — — — — —
19–22 0.4 0.9 0.8 0.1 0.4 * 0.4 0.2 * 0.2 * — — — — — — — — —
23–26 0.2 0.3 0.3 0.1 0.2 0.1 0.2 0.3 0.3 * 0.1 — — — — — — — — —
27–30 0.2 0.3 * 0.3 * * 0.3 0.7 * 0.3 0.5 — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Take tranquilizers 
   % saying any 18 16.4 19.4 18.6 21.2 17.2 18.3 16.9 15.3 15.5 15.0 15.8 16.1 13.9 13.3 11.7 10.1 11.5 12.0 11.1 -0.9
19–22 16.2 16.7 21.3 18.1 14.5 12.3 11.5 13.0 17.2 11.6 11.1 11.6 8.2 10.2 12.7 8.6 10.8 7.2 7.9 +0.7
23–26 9.8 11.2 12.4 14.9 12.9 15.1 13.1 10.7 12.3 12.6 15.5 13.4 9.9 7.3 9.3 8.9 7.5 7.9 8.0 +0.1
27–30 10.4 10.6 9.6 10.6 10.4 9.9 9.7 8.5 9.1 12.3 10.3 9.5 9.4 12.6 12.3 8.7 11.6 7.1 9.3 +2.2
35 11.4 10.8 12.2 12.5 11.4 12.7 12.4 12.2 14.7 16.1 14.8 17.6 17.7 17.9 17.3 17.7 19.2 19.5 18.7 -0.8
40 14.8 15.2 15.1 15.6 15.0 13.6 14.1 16.1 16.0 15.0 15.1 13.6 12.9 15.8 14.5 13.2 14.5 17.1 14.7 -2.4
45 — — — — 17.3 19.8 15.4 18.3 20.7 17.3 17.5 16.3 16.7 18.8 16.7 15.8 14.5 14.2 13.7 -0.6
50 — — — — — — — — — 19.7 21.0 17.8 19.1 18.1 16.7 17.9 15.7 15.0 16.3 +1.3
55 — — — — — — — — — — — — — — 17.0 16.6 17.0 16.8 15.8 -1.0
   % saying most or all 18 1.3 2.1 1.3 1.6 1.5 1.7 1.6 1.2 1.8 1.2 1.5 1.4 0.8 0.8 1.0 1.3 1.5 1.1 1.0 -0.1
19–22 0.3 0.6 0.9 0.4 0.4 0.3 0.3 0.3 0.3 0.1 0.1 0.6 0.6 0.2 0.6 0.4 0.8 * 0.7 +0.7
23–26 * 0.5 0.8 0.1 * 0.5 0.7 0.4 * 0.1 0.3 0.2 0.1 0.3 0.3 0.3 0.2 0.4 0.4 0.0
27–30 0.4 * 0.4 0.6 0.1 * 0.2 0.2 * 0.1 0.5 * * * 0.1 0.1 0.6 0.4 0.4 0.0
35 0.6 0.6 0.2 0.1 0.2 0.3 0.5 0.3 0.5 0.3 0.4 0.6 0.3 0.4 0.4 0.5 0.4 0.4 0.1 -0.3
40 0.4 0.1 0.3 0.2 * 0.2 0.2 0.3 0.3 0.3 0.1 * * 0.1 * 0.2 * 0.1 0.4 +0.3
45 — — — — 0.3 0.2 0.2 0.1 0.3 * 0.2 0.1 0.1 * 0.2 0.2 0.1 0.1 0.1 0.0
50 — — — — — — — — — 0.3 0.1 0.1 0.4 0.2 0.1 0.2 0.2 0.2 0.2 -0.1
55 — — — — — — — — — — — — — — 0.3 0.4 0.2 0.2 0.1 -0.1
↓
(List of drugs continued.)
Percentage saying friends use a
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
Age 
Group
2016– 
2017 
change
TABLE 7-2 (cont.)
Q.  How many of your friends 
would you estimate. . .
331
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Drink alcoholic beverages
   % saying any 18 96.1 94.7 95.7 95.5 94.6 94.6 95.6 95.4 95.7 95.1 92.0 91.2 90.5 88.9 90.1 90.9 89.6 90.7 91.2
19–22 96.3 96.7 96.6 97.3 96.8 95.8 96.9 95.6 97.0 97.6 96.1 95.2 93.1 95.1 92.5 94.8 93.7 94.5 94.5
23–26 — — — — 96.8 96.8 96.2 95.9 95.3 95.4 94.7 93.9 95.1 94.4 94.0 94.1 92.7 95.4 95.5
27–30 — — — — — — — — 96.1 96.0 95.2 94.4 95.6 93.4 93.3 93.3 93.1 95.1 93.1
35 — — — — — — — — — — — — — — 89.6 89.9 90.3 89.5 88.1
40 — — — — — — — — — — — — — — — — — — 88.4
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 68.9 67.7 69.7 69.0 66.6 66.0 68.0 71.8 68.1 67.1 60.5 58.6 56.9 57.0 59.6 56.4 56.4 60.9 61.0
19–22 76.6 77.6 75.2 75.1 74.9 71.9 74.2 71.3 73.4 74.1 70.0 71.4 67.4 66.5 68.7 63.9 67.0 63.8 69.4
23–26 — — — — 73.2 74.4 69.5 74.9 68.9 69.8 67.1 69.3 68.8 68.7 70.7 67.0 68.9 66.6 67.4
27–30 — — — — — — — — 66.7 67.8 62.0 62.7 63.3 61.3 63.2 62.6 64.1 66.6 62.9
35 — — — — — — — — — — — — — — 43.8 45.1 49.5 46.6 47.1
40 — — — — — — — — — — — — — — — — — — 37.7
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Get drunk at least 
 once a week
   % saying any 18 83.1 81.8 83.1 83.9 81.5 82.5 84.7 85.6 84.4 82.8 79.2 79.8 79.9 79.2 81.4 78.9 78.5 82.4 81.1
19–22 80.9 79.9 80.0 80.4 79.8 76.7 82.0 81.1 80.6 80.4 80.1 80.8 76.5 81.1 79.6 83.2 80.9 79.2 82.3
23–26 — — — — 73.1 72.7 73.5 73.7 72.1 73.1 72.2 74.0 73.1 74.3 72.1 73.1 74.5 71.9 74.1
27–30 — — — — — — — — 66.3 61.8 65.4 65.2 65.5 64.5 62.7 67.1 66.7 65.4 65.5
35 — — — — — — — — — — — — — — 44.3 43.2 44.9 42.9 46.1
40 — — — — — — — — — — — — — — — — — — 41.6
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 30.1 29.4 29.9 31.0 29.6 29.9 31.8 31.3 29.6 31.1 27.5 29.7 28.6 27.6 28.4 27.4 29.0 30.9 31.7
19–22 21.9 23.3 22.0 20.2 22.7 21.7 20.8 21.3 24.0 22.6 23.6 24.9 22.6 28.8 26.3 28.2 26.0 26.6 29.8
23–26 — — — — 11.4 11.6 12.5 11.9 12.8 12.0 13.9 11.6 14.6 13.2 15.2 15.2 14.0 17.0 16.0
27–30 — — — — — — — — 5.2 6.3 6.7 6.6 5.9 6.7 6.4 7.9 8.6 7.7 9.3
35 — — — — — — — — — — — — — — 3.6 3.6 5.4 3.2 4.4
40 — — — — — — — — — — — — — — — — — — 2.8
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Smoke cigarettes
   % saying any 18 90.6 88.5 88.3 87.0 86.0 87.0 87.8 88.3 87.7 86.5 84.9 85.7 84.4 84.8 88.1 87.9 88.3 89.9 89.5
19–22 94.4 94.3 93.4 93.1 91.9 91.6 91.1 90.3 89.3 90.0 86.1 86.1 86.7 86.7 86.1 88.8 89.2 91.3 92.6
23–26 — — — — 93.9 95.0 91.6 92.1 89.8 90.1 88.7 89.6 85.6 88.3 86.4 86.8 85.3 85.4 88.7
27–30 — — — — — — — — 92.6 89.8 90.7 90.4 88.0 85.8 84.8 84.9 85.4 84.1 81.1
35 — — — — — — — — — — — — — — 72.7 71.7 71.7 72.4 71.8
40 — — — — — — — — — — — — — — — — — — 70.2
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 23.3 22.4 24.1 22.4 19.2 22.8 21.5 21.0 20.2 23.1 21.4 21.8 21.4 25.0 25.3 27.5 30.4 34.4 33.9
19–22 31.8 27.6 25.6 25.2 25.6 22.7 21.9 22.5 19.3 19.9 19.2 20.2 20.3 22.2 21.7 28.4 24.0 25.1 28.8
23–26 — — — — 25.6 22.7 19.7 18.5 16.5 20.5 16.9 18.1 16.0 15.5 16.6 13.9 17.6 17.0 16.8
27–30 — — — — — — — — 15.8 14.2 11.6 12.9 11.9 14.3 10.9 12.3 10.4 12.1 12.3
35 — — — — — — — — — — — — — — 7.9 7.2 9.3 7.2 8.0
40 — — — — — — — — — — — — — — — — — — 8.1
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
Percentage saying friends use a
Age 
Group
TABLE 7-2 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
332
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Drink alcoholic beverages
   % saying any 18 90.2 89.8 89.2 88.0 87.9 87.8 87.2 86.0 85.1 85.2 83.7 83.9 82.6 82.0 82.0 79.7 75.5 77.2 75.7 -1.4
19–22 92.8 95.2 93.4 94.5 92.5 90.4 95.0 91.9 94.0 92.6 93.2 90.9 88.9 93.3 92.0 91.0 — 87.7 86.8 -0.9
23–26 93.3 94.5 93.1 95.3 92.8 94.9 91.6 93.6 94.7 93.3 95.0 95.3 95.3 92.3 92.5 94.1 — 91.6 91.9 +0.3
27–30 94.4 92.7 91.4 92.8 90.5 94.4 93.7 95.6 92.4 91.7 93.9 93.0 92.5 93.4 91.6 95.1 — 94.7 92.5 -2.2
35 88.7 89.6 89.3 90.1 87.4 93.4 91.3 90.6 90.5 91.0 90.4 93.3 93.0 92.7 93.2 92.6 92.6 94.3 93.2 -1.1
40 88.9 90.7 89.6 90.5 89.2 90.5 92.1 90.8 93.0 89.3 92.6 92.1 92.4 91.3 91.9 90.8 91.2 91.4 91.2 -0.2
45 — — — — 87.9 90.3 89.8 90.1 89.8 90.5 89.5 90.6 90.8 90.1 91.4 92.4 92.5 91.3 90.0 -1.4
50 — — — — — — — — — 88.9 90.2 89.9 90.4 90.1 89.2 92.0 90.3 91.4 91.2 -0.2
55 — — — — — — — — — — — — — — 87.6 89.3 89.5 88.3 89.9 +1.6
   % saying most or all 18 58.2 57.2 59.2 53.7 53.1 53.9 55.3 52.4 52.0 51.6 50.5 51.4 50.3 49.4 46.9 46.2 42.3 39.2 39.7 +0.4
19–22 67.8 70.1 65.4 68.8 63.9 66.4 71.8 65.4 71.1 64.4 69.7 69.1 63.3 66.3 63.2 63.4 — 66.1 62.4 -3.8
23–26 63.6 70.8 65.7 73.4 66.0 71.3 69.3 69.2 70.2 76.3 76.9 75.5 79.7 74.3 73.7 76.5 — 66.5 65.4 -3.1
27–30 64.4 64.8 64.9 66.3 61.5 69.0 66.2 70.7 65.6 67.1 74.0 72.2 70.9 74.9 72.9 74.7 — 75.1 76.3 +1.2
35 46.0 49.1 48.4 52.9 51.6 53.7 55.5 55.2 56.1 55.7 53.2 56.9 61.9 58.7 62.1 66.1 64.2 66.5 65.4 -1.1
40 41.4 42.5 44.7 44.8 47.2 43.3 47.2 45.9 50.3 48.9 54.5 54.7 54.3 55.9 56.6 53.6 55.2 57.6 60.2 +2.6
45 — — — — 38.9 41.7 42.4 45.1 46.6 47.0 45.9 46.7 47.2 53.5 52.0 56.1 57.8 55.1 56.5 +1.4
50 — — — — — — — — — 37.7 39.3 41.9 43.5 45.8 48.2 48.6 48.8 50.0 50.7 +0.7
55 — — — — — — — — — — — — — — 39.1 41.0 42.4 46.9 47.7 +0.8
Get drunk at least 
 once a week
   % saying any 18 81.5 79.5 79.6 78.3 77.3 79.0 78.7 77.4 75.5 76.2 76.2 73.5 71.9 68.9 69.9 64.2 58.9 59.0 58.0 -0.9
19–22 82.8 82.2 81.9 81.5 81.5 80.5 85.1 81.7 84.4 81.3 82.8 81.2 78.3 83.6 77.7 78.2 — 75.6 76.5 +0.9
23–26 71.0 76.5 74.7 81.0 76.4 75.8 80.7 80.9 80.4 79.5 83.0 83.7 83.9 79.7 83.1 85.6 — 81.2 76.1 -5.1
27–30 65.9 64.3 64.7 68.9 66.5 73.8 72.4 74.6 72.0 71.7 78.7 78.2 78.3 80.1 74.4 77.2 — 77.9 79.2 +1.3
35 44.5 46.9 47.6 48.3 47.9 52.0 50.7 52.6 55.0 56.0 56.0 59.2 63.2 62.4 63.9 65.4 68.0 67.8 68.2 +0.4
40 40.6 42.2 41.3 42.6 42.9 43.2 48.4 47.2 46.3 48.2 53.7 49.6 48.5 54.9 54.7 53.4 58.0 57.4 58.9 +1.5
45 — — — — 41.6 42.2 41.6 40.0 42.7 45.7 45.4 49.1 45.9 50.0 50.5 52.1 52.8 52.3 54.3 +2.0
50 — — — — — — — — — 40.0 38.3 39.6 42.4 42.5 45.0 45.5 46.7 48.7 47.3 -1.4
55 — — — — — — — — — — — — — — 35.1 35.4 39.2 39.7 38.9 -0.9
   % saying most or all 18 30.1 32.4 32.7 28.3 27.1 27.6 28.5 27.7 27.0 25.2 24.4 23.7 23.8 21.2 20.7 18.5 15.5 11.5 12.4 +0.9
19–22 29.3 28.1 30.2 31.0 29.6 29.0 31.2 32.9 32.0 28.9 31.4 27.7 27.6 27.2 28.1 28.7 — 21.6 25.8 +4.2
23–26 16.8 17.4 19.1 19.2 18.3 24.0 24.0 20.3 22.8 23.1 23.2 24.0 22.6 20.0 23.4 20.2 — 23.5 20.1 -3.3
27–30 12.1 9.8 11.7 8.9 13.0 9.4 11.2 13.5 12.2 10.9 17.1 13.7 13.2 13.5 13.2 15.2 — 16.7 17.2 +0.5
35 4.9 4.6 4.8 4.5 5.2 5.3 5.3 5.6 6.1 7.3 5.9 7.4 8.4 6.8 8.3 10.7 10.8 8.6 10.2 +1.5
40 3.0 2.5 2.9 3.8 3.9 3.0 3.6 4.0 3.4 4.8 4.6 4.8 4.8 4.3 4.2 5.7 5.6 5.6 6.7 +1.1
45 — — — — 3.6 2.7 2.7 3.1 3.7 4.1 3.2 3.2 3.5 4.3 5.1 5.1 5.5 4.2 3.5 -0.7
50 — — — — — — — — — 3.2 2.7 2.0 2.9 2.5 3.6 4.1 3.6 4.0 3.0 -0.9
55 — — — — — — — — — — — — — — 2.0 1.9 3.2 3.1 2.9 -0.2
Smoke cigarettes
   % saying any 18 89.3 87.2 86.8 85.4 83.3 83.7 81.8 81.4 77.1 78.4 79.6 78.0 75.4 74.3 72.1 66.4 60.2 58.4 54.0 -4.4
19–22 91.0 90.9 90.9 89.7 86.5 89.7 89.3 85.8 86.8 84.4 88.3 81.8 79.4 78.2 77.4 76.5 76.0 70.8 63.9 -7.0
23–26 84.1 86.5 86.7 86.4 86.5 87.0 87.3 85.4 84.1 86.8 85.3 87.7 86.5 83.1 80.3 82.2 79.8 77.5 72.9 -4.5
27–30 86.3 85.1 84.9 87.0 82.8 83.5 81.0 84.4 81.7 82.1 84.1 84.6 83.8 85.2 81.6 84.4 78.6 74.5 77.5 +3.0
35 69.9 70.8 69.2 66.6 67.0 67.7 65.5 67.0 64.8 67.6 62.2 65.4 66.1 66.4 63.2 63.8 65.2 65.0 62.6 -2.4
40 70.0 67.8 64.3 65.5 65.1 62.4 63.8 64.6 59.2 59.7 60.5 57.4 57.4 56.7 59.1 56.2 54.5 54.8 52.4 -2.4
45 — — — — 66.1 67.0 62.9 60.9 58.5 56.1 57.7 60.6 58.0 57.4 54.3 56.0 49.7 52.1 50.4 -1.7
50 — — — — — — — — — 62.1 61.3 59.2 55.9 57.4 54.7 55.4 55.4 52.4 52.8 +0.4
55 — — — — — — — — — — — — — — 56.5 52.4 52.9 48.5 49.4 +0.9
   % saying most or all 18 31.1 28.2 25.0 23.0 19.6 20.6 16.7 15.8 16.4 13.9 14.1 14.9 14.1 12.2 11.0 8.1 6.5 5.9 6.6 +0.7
19–22 26.8 29.4 27.0 25.7 20.2 20.7 20.4 15.2 17.9 12.9 15.3 16.7 13.7 13.6 10.8 9.4 8.9 5.4 5.0 -0.4
23–26 17.5 17.0 15.5 15.1 18.3 19.8 19.6 13.9 14.7 15.0 13.4 15.0 11.1 10.6 13.5 11.4 9.5 5.6 7.9 +2.3
27–30 13.4 11.7 10.2 12.9 12.2 9.2 12.6 12.6 12.7 10.8 12.4 7.9 7.4 10.0 6.8 7.7 5.9 5.8 6.3 +0.5
35 9.0 6.7 8.8 6.6 6.3 6.9 6.0 6.8 5.7 5.9 6.4 6.8 6.2 5.5 4.9 5.8 6.0 4.0 4.5 +0.5
40 7.4 6.8 5.7 5.8 5.9 6.0 7.0 5.1 4.7 4.5 3.9 4.0 4.2 2.9 3.8 4.0 4.1 2.7 3.5 +0.9
45 — — — — 5.7 5.9 6.1 5.4 4.5 3.7 4.8 5.2 3.8 3.4 4.6 2.5 3.3 2.8 1.3 -1.4 s
50 — — — — — — — — — 4.0 4.3 4.2 3.6 2.6 2.3 4.4 3.4 2.6 2.5 -0.2 s
55 — — — — — — — — — — — — — — 3.3 2.2 2.7 1.9 1.7 -0.3
↓
(List of drugs continued.)
Trends in Friends’ Use of Drugs as Estimated by
Percentage saying friends use a
TABLE 7-2 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Age 
Group
Q.  How many of your friends 
would you estimate. . .
2016– 
2017 
change
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Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take steroids
   % saying any 18 — — — — — — — — — — 25.9 24.7 21.5 19.0 18.1 19.5 17.9 18.9 18.3
19–22 — — — — — — — — — 23.4 21.5 22.2 19.7 20.7 16.8 16.6 16.1 16.8 20.0
23–26 — — — — — — — — — 15.3 15.0 12.3 14.5 11.1 10.5 12.4 7.3 13.0 9.2
27–30 — — — — — — — — — 9.9 10.5 7.5 8.0 8.0 8.0 8.0 10.2 9.1 7.0
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — — — — 1.8 1.0 1.7 0.9 1.2 1.3 0.8 1.7 1.4
19–22 — — — — — — — — — 0.2 0.6 * 0.1 0.4 0.2 0.1 * 0.1 0.3
23–26 — — — — — — — — — 0.4 * * 0.2 0.1 0.1 * * 0.5 *
27–30 — — — — — — — — — 0.5 * * * 0.2 0.1 * * * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Approximate 18 2,987 3,307 3,303 3,095 2,945 2,971 2,798 2,948 2,961 2,587 2,361 2,339 2,373 2,410 2,337 2,379 2,156 2,292 2,313
Weighted N = 19–22 576 592 564 579 543 554 579 572 562 579 556 526 510 468 435 470 469 467 437
23–26 527 534 546 528 528 506 510 507 516 495 449 456 416 419 394
27–30 516 507 499 476 478 461 419 450 464 454 428
35 1,200 1,187 1,187 1,209 1,067
40 1,098
45
50
55
(Table continued on next page.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Percentage saying friends use a
Trends in Friends’ Use of Drugs as Estimated by
TABLE 7-2 (cont.)
Age 
Group
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Take steroids
   % saying any 18 20.0 19.8 21.7 21.6 21.1 22.8 19.1 19.8 20.1 19.4 19.3 16.4 16.0 18.7 17.4 15.7 12.8 15.5 13.7 -1.8
19–22 20.6 18.9 20.0 19.3 17.1 21.4 20.1 21.0 18.3 14.8 16.8 13.8 15.3 12.6 11.1 16.4 12.7 8.6 9.6 +1.0
23–26 15.0 12.2 13.6 14.3 12.9 12.4 11.6 13.4 13.8 13.3 12.8 11.7 13.9 10.0 11.6 12.7 8.7 11.9 10.6 -1.3
27–30 11.2 9.3 10.7 6.4 11.6 10.1 7.4 7.5 6.7 6.6 12.0 9.2 8.5 11.6 10.0 9.1 11.0 9.4 10.9 +1.4
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 0.9 1.9 1.2 1.5 1.5 2.6 1.5 0.9 1.2 1.3 1.5 1.7 1.1 1.8 1.5 1.7 1.0 1.9 1.7 -0.3
19–22 0.1 0.3 0.7 0.7 0.4 * 0.1 0.3 0.3 0.3 * 0.7 0.6 0.4 0.7 0.5 0.4 * * 0.0
23–26 0.1 0.3 0.2 0.1 * 0.1 0.3 0.3 * * 0.7 * 0.1 0.1 0.3 0.1 * 0.9 0.4 -0.5
27–30 * * * 0.3 * * 0.1 * * * 0.3 * * * * * 0.2 * 0.4 +0.4
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Approximate 18 2,060 1,838 1,923 1,968 2,233 2,271 2,266 2,266 2,253 2,125 2,110 2,195 2,208 2,144 1,973 1,920 2,055 1,795 1,955
Weighted N = 19–22 426 402 402 375 388 443 395 377 362 375 382 376 353 348 340 315 297 251 269
23–26 414 387 403 358 362 411 361 336 340 355 311 359 314 330 328 305 305 272 268
27–30 424 363 359 348 369 396 363 350 324 332 309 340 325 333 284 307 260 287 287
35 1,071 1,033 1,005 918 968 985 1,041 953 884 905 974 922 858 877 848 776 741 740 731
40 1,156 1,144 1,119 1,083 945 1,004 975 951 896 924 905 952 877 852 844 919 808 782 819
45 976 1,074 1,052 1,009 999 904 937 889 887 874 844 825 889 812 773
50 940 1,009 1,016 974 987 840 891 830 845 793
50 880 943 933 926 941
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001. Any apparent inconsistency between the change estimate and the 
prevalence estimates for the two most recent years is due to rounding.  ' — ' indicates data not available. ' * ' indicates a prevalence rate of less than 0.05%.
aAnswer alternatives were: (1) None, (2) A few, (3) Some, (4) Most, (5) All. The any percentage combines categories (2)–(5). The most or all percentage combines categories (4) and (5).
bFor the young adult sample, any illicit drug includes all of the drugs listed in this table except cigarettes and alcohol. For the 35-, 40-, 45-, and 50-year-olds, 
any illicit drug includes marijuana, tranquilizers, crack, cocaine powder, and other illicit drugs.
cIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples. These changes likely explain
the discontinuity in the 2001 results.
dIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc.  This change likely explains the 
discontinuity in the 2010 results.
eIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin.  This change likely explains the discontinuity in the 2011 results.
fIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc.
to just downers. These changes likely explain the discontinuity in the 2004 results.
gNo data reported in 2015 due to a printing error in the questionnaire in which this question is asked.
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Friends’ Use of Drugs as Estimated by
Percentage saying friends use a
TABLE 7-2 (cont.)
Age 
Group
2016– 
2017 
change
Q.  How many of your friends 
would you estimate. . .
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Any illicit drug b  
  % saying any 18 84.3 82.7 81.4 79.4 77.9 77.7 75.5 73.9 71.3 68.6 67.6 64.2 61.3 66.1 70.8 75.3 78.0 78.8
19–22 80.6 81.0 81.5 76.5 76.3 77.4 74.6 72.7 69.5 61.5 60.8 58.9 58.6 58.4 60.7 66.4 67.2 65.3
23–26 — — — — 68.9 70.2 68.0 62.4 62.7 58.3 54.6 52.1 48.2 49.9 47.1 54.2 50.3 55.4
27–30 — — — — — — — — 52.4 50.2 47.0 39.6 41.7 38.9 45.6 42.4 44.9 41.6
  % saying often exposed 18 36.3 36.1 31.4 29.8 28.3 27.2 26.3 23.3 20.8 22.0 20.7 18.2 18.0 24.0 29.3 32.3 33.8 34.7
19–22 34.6 34.0 32.1 24.4 24.4 23.7 21.1 18.9 19.9 16.2 16.4 17.6 21.4 16.1 18.1 23.7 20.4 25.3
23–26 — — — — 20.7 23.3 18.5 17.4 18.2 13.8 13.7 13.3 12.2 11.1 11.1 12.5 12.8 14.3
27–30 — — — — — — — — 13.7 12.0 10.8 8.2 10.5 9.0 12.5 8.5 10.1 10.3
  % saying any 18 58.5 62.6 62.5 59.4 59.8 59.3 55.3 51.7 47.8 47.1 45.4 40.0 41.6 42.6 45.3 47.2 49.7 47.9
19–22 56.9 58.4 61.6 54.9 57.1 53.3 53.4 48.5 46.4 36.5 39.4 33.8 37.1 29.4 33.9 36.8 36.5 39.4
23–26 — — — — 51.5 51.9 51.5 43.6 42.9 36.8 34.0 30.0 27.3 27.8 24.9 26.8 23.2 25.6
27–30 — — — — — — — — 35.8 33.7 31.5 25.8 26.6 24.2 25.8 21.1 21.8 21.4
  % saying often exposed 18 14.1 17.1 16.6 14.2 14.6 12.9 12.1 10.2 9.6 10.7 9.2 7.9 7.5 9.6 9.4 11.1 12.1 11.7
19–22 11.8 15.6 13.5 11.1 10.7 10.2 8.2 8.1 7.5 6.7 4.5 4.4 5.5 4.1 5.1 7.7 3.9 7.6
23–26 — — — — 9.0 10.4 9.3 8.5 6.7 5.0 5.1 3.5 2.6 3.0 2.2 3.5 3.4 3.1
27–30 — — — — — — — — 6.0 4.7 4.1 3.2 3.7 2.4 3.4 2.9 3.4 3.2
Marijuana 
  % saying any 18 82.0 80.2 77.9 76.2 74.4 73.5 72.0 70.4 67.0 64.8 63.4 59.6 56.8 61.0 67.2 72.7 75.6 76.8
19–22 79.8 79.8 78.7 72.7 74.1 75.5 72.4 70.5 66.3 59.3 57.5 55.0 56.4 55.4 56.8 64.0 64.8 63.4
23–26 — — — — 65.3 66.0 64.1 59.0 57.6 55.0 50.6 47.9 44.6 45.9 44.4 51.0 47.8 53.1
27–30 — — — — — — — — 49.1 47.4 42.1 36.0 38.2 35.3 41.9 38.3 41.8 39.1
  % saying often exposed 18 33.8 33.1 28.0 26.1 24.8 24.2 24.0 20.6 17.9 19.5 17.8 16.0 15.6 20.9 27.6 30.7 31.8 32.9
19–22 32.6 30.5 30.3 21.1 21.9 20.3 18.6 16.4 18.3 14.2 14.7 15.9 19.9 14.7 17.0 22.1 20.3 23.7
23–26 — — — — 17.5 20.6 14.6 14.8 15.6 11.6 11.2 11.6 10.9 10.4 10.4 11.1 11.5 12.9
27–30 — — — — — — — — 10.9 9.8 8.5 6.7 8.9 7.6 10.7 7.4 9.1 8.9
LSD
  % saying any 18 17.2 17.4 16.1 13.8 12.5 13.2 13.1 12.9 13.4 15.0 14.9 15.7 17.8 21.0 24.2 26.1 27.6 25.9
19–22 17.4 15.8 16.0 13.5 12.8 12.7 10.8 10.9 12.0 12.0 12.1 13.1 19.3 13.4 16.5 18.6 20.7 22.3
23–26 — — — — 8.3 9.3 8.8 7.3 6.3 6.7 8.4 8.6 8.8 7.8 8.4 9.9 8.6 7.6
27–30 — — — — — — — — 3.6 3.2 3.3 3.6 3.9 4.9 5.3 5.5 4.3 3.9
  % saying often exposed 18 1.4 2.0 1.9 1.4 1.5 1.3 1.6 1.8 1.6 2.2 2.6 2.9 3.0 3.9 4.2 6.1 4.7 5.1
19–22 1.4 1.5 1.4 0.6 0.8 0.7 0.5 1.2 0.6 1.1 1.2 1.0 2.0 1.1 0.4 3.6 1.4 1.8
23–26 — — — — 0.3 0.4 0.4 0.7 0.6 0.3 0.5 0.2 0.8 0.3 0.5 0.5 0.4 0.2
27–30 — — — — — — — — 0.3 0.2 0.5 0.2 0.2 0.5 0.5 0.2 0.2 *
Other hallucinogens c
  % saying any 18 20.4 17.6 16.8 13.1 12.7 12.5 11.8 10.0 9.0 8.8 9.4 9.4 9.7 12.1 14.0 15.8 16.6 17.8
19–22 18.3 16.3 16.3 12.5 10.5 11.0 9.2 9.1 7.7 8.4 8.3 8.9 10.6 6.7 8.3 12.8 13.1 15.0
23–26 — — — — 8.4 8.9 9.1 6.0 5.1 4.8 5.7 5.5 5.1 5.7 5.2 5.5 6.9 5.6
27–30 — — — — — — — — 5.0 3.4 3.4 3.4 2.1 3.7 3.4 4.2 3.2 2.9
  % saying often exposed 18 2.2 2.0 2.6 1.1 1.7 1.4 1.5 1.2 1.1 1.3 1.2 1.3 1.1 1.9 2.3 2.5 2.7 2.8
19–22 1.1 0.9 0.9 0.7 0.8 0.8 0.2 0.8 0.3 0.4 0.4 0.5 0.7 0.4 0.2 1.6 0.7 0.7
23–26 — — — — 0.1 0.3 0.5 0.6 0.8 0.1 0.4 0.4 * 0.2 0.4 0.3 0.3 0.2
27–30 — — — — — — — — 0.2 0.4 0.5 0.3 0.1 0.5 0.2 0.3 0.2 0.5
TABLE 7-3
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trends in Exposure to Drug Use
you been around people 
who were taking each of 
the following to get high or 
for “kicks”?
Q. During the LAST 12 
MONTHS how often have Percentage saying exposed to drug a
Age 
Group
(Years 
Cont.)
(Table continued on next page.)
Any illicit drug other than 
marijuana b
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1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Any illicit drug b  
  % saying any 18 77.2 77.9 76.0 76.5 76.5 73.6 74.3 73.0 73.7 70.8 71.9 74.1 76.0 76.6 76.4 75.4 75.2 75.4 75.1 74.8 -0.2
19–22 69.1 65.8 64.7 69.7 65.7 68.0 67.6 68.8 67.1 67.4 66.2 69.8 66.0 68.3 70.4 72.1 73.6 72.5 73.1 72.3 -0.8
23–26 50.6 50.5 55.1 56.4 56.5 57.0 53.5 53.9 56.7 58.3 56.3 57.7 56.3 62.6 67.0 65.2 65.1 68.2 68.9 73.9 +5.1
27–30 37.5 41.1 40.8 42.2 47.0 46.7 43.3 45.7 48.4 44.1 48.7 42.5 49.3 51.6 58.9 57.2 57.1 56.7 58.6 69.0 +10.3 s
  % saying often exposed 18 33.2 35.6 32.6 33.6 32.6 31.8 30.4 29.9 29.7 27.8 28.6 31.4 33.2 34.6 34.9 32.3 31.3 32.5 33.1 32.8 -0.3
19–22 24.2 24.0 21.3 26.1 25.2 26.5 26.8 25.2 24.2 22.8 20.1 23.7 26.5 24.8 27.3 24.6 29.8 26.2 32.1 28.0 -4.1
23–26 14.2 15.0 15.9 16.4 15.9 17.8 15.1 18.7 14.9 18.9 15.4 14.9 18.8 19.4 21.2 20.8 20.1 23.2 23.3 22.9 -0.4
27–30 8.5 9.6 9.4 10.4 13.8 13.9 10.3 14.5 13.2 9.7 9.7 12.1 13.2 13.6 15.7 18.5 16.1 18.9 19.8 21.1 +1.4
  % saying any 18 47.3 46.5 47.2 49.9 49.3 46.3 48.3 45.9 45.4 45.4 43.8 44.3 47.2 46.6 45.0 44.2 41.0 44.3 43.8 41.7 -2.1
19–22 40.0 36.4 38.1 39.2 38.0 40.2 40.9 41.1 38.5 42.7 38.2 37.1 38.5 38.5 41.8 38.9 44.0 42.3 49.3 44.2 -5.1
23–26 27.1 28.0 31.0 31.4 31.5 32.2 32.6 32.3 34.5 33.1 31.3 33.0 34.8 39.9 37.8 37.4 33.9 38.6 38.5 39.4 +0.9
27–30 15.4 19.5 17.2 22.2 23.1 26.1 23.2 27.1 27.4 24.8 27.7 22.8 29.3 33.4 35.2 34.4 30.1 35.9 31.6 37.1 +5.5
  % saying often exposed 18 9.9 11.7 10.5 11.9 12.6 10.8 11.4 10.6 11.4 10.8 8.2 9.4 10.2 11.5 11.6 9.3 9.7 9.2 10.3 10.7 +0.5
19–22 7.0 4.8 6.4 7.8 8.6 5.2 7.9 8.0 6.7 6.9 6.6 6.8 6.6 6.9 10.1 8.1 9.4 7.0 9.6 7.5 -2.1
23–26 3.1 4.3 3.5 3.4 5.0 5.4 5.4 4.0 5.4 6.7 5.4 3.8 6.4 6.3 7.6 5.8 7.0 5.8 8.1 6.6 -1.5
27–30 1.0 2.5 1.6 3.7 4.7 4.9 2.4 5.6 4.0 3.4 2.3 3.0 4.8 4.2 4.5 4.8 4.9 6.6 6.0 4.4 -1.6
Marijuana 
  % saying any 18 75.5 75.8 73.8 74.9 74.2 71.4 72.2 70.8 71.4 68.4 69.8 71.8 74.2 74.6 75.1 73.7 73.4 73.2 73.1 73.5 +0.4
19–22 67.1 63.5 63.9 68.0 64.6 64.8 65.1 66.8 65.4 66.3 64.3 67.5 64.9 65.7 67.6 69.0 71.1 70.3 71.9 70.6 -1.4
23–26 48.8 48.1 51.8 54.2 53.5 54.4 50.6 49.7 51.9 53.3 54.0 55.5 54.0 57.9 63.9 63.4 61.1 63.6 66.7 70.9 +4.2
27–30 35.7 38.7 38.8 37.0 44.6 44.1 40.4 42.4 44.1 40.7 44.8 39.8 43.5 46.1 56.0 52.3 54.4 53.3 58.1 67.4 +9.3 s
  % saying often exposed 18 31.4 34.4 30.3 30.8 30.7 30.4 28.0 27.0 27.8 25.1 27.0 29.3 31.3 32.3 32.2 30.6 29.2 30.5 31.2 30.4 -0.8
19–22 22.8 23.0 20.4 24.5 24.8 24.2 24.5 23.6 23.1 20.1 18.3 22.6 25.2 22.9 24.2 22.6 28.2 25.7 30.1 26.7 -3.4
23–26 13.6 13.2 15.2 15.6 14.9 16.2 13.7 17.8 12.5 16.2 13.7 13.5 17.0 18.0 19.7 18.3 18.8 21.2 21.5 21.0 -0.5
27–30 8.1 8.8 8.6 8.4 11.7 11.7 9.6 12.2 11.5 8.2 8.5 12.3 10.8 10.9 13.9 16.0 14.7 16.5 17.7 20.4 +2.6
LSD
  % saying any 18 23.1 23.6 22.0 21.6 17.2 14.2 12.4 10.8 11.6 12.4 12.1 11.9 14.1 13.5 13.0 13.8 12.9 15.7 15.5 17.4 +1.9
19–22 21.0 20.1 15.9 15.2 13.6 10.0 8.5 7.2 10.4 6.3 9.2 9.1 9.7 10.1 12.2 10.0 13.1 13.4 19.3 15.5 -3.8
23–26 9.8 9.4 9.8 11.1 9.3 5.5 4.4 4.7 5.6 4.5 4.8 3.7 5.7 8.9 9.6 8.3 7.6 6.1 10.3 11.4 +1.2
27–30 3.2 3.7 3.2 4.3 4.8 3.0 4.7 4.0 3.4 3.9 1.7 3.8 4.2 4.1 4.2 4.7 4.6 7.7 6.2 9.8 +3.5
  % saying often exposed 18 3.2 4.1 3.3 2.8 2.6 1.8 1.6 1.5 1.9 1.7 0.8 1.3 1.4 1.4 1.6 1.5 1.5 1.9 2.1 2.4 +0.3
19–22 2.0 1.7 1.4 2.4 0.9 0.2 0.1 0.7 0.7 0.3 0.7 0.3 0.1 0.2 0.6 0.9 0.4 0.9 1.0 0.7 -0.3
23–26 0.1 0.3 0.2 * 0.3 0.3 * 0.3 * 0.5 0.6 * 0.6 0.3 1.4 0.1 0.8 0.1 0.8 0.2 -0.6
27–30 * 0.1 * * * 0.3 0.3 0.6 * 0.1 * 0.3 0.5 0.5 0.6 1.0 0.3 0.9 0.2 0.6 +0.4
Other hallucinogens c
  % saying any 18 15.9 17.7 16.3 28.1 26.4 25.8 24.8 24.3 23.8 23.5 23.6 22.0 25.0 23.8 22.7 22.3 19.8 20.4 18.6 17.5 -1.1
19–22 15.0 12.4 11.8 22.8 23.4 18.9 18.7 19.5 17.8 20.2 17.5 17.5 19.6 17.5 17.0 14.6 19.1 17.1 18.7 13.1 -5.6
23–26 8.7 5.8 8.9 14.8 14.7 11.9 10.1 11.3 10.3 9.8 9.8 9.9 12.5 13.8 13.6 14.6 10.3 11.8 11.4 12.2 +0.8
27–30 2.6 3.0 3.0 6.4 7.7 6.3 7.9 8.8 7.8 6.8 5.2 7.5 5.0 8.1 7.8 7.2 8.3 12.0 5.9 13.4 +7.5 ss
  % saying often exposed 18 1.7 2.7 2.1 3.6 4.5 3.2 3.2 2.6 4.1 3.0 1.9 2.7 2.2 2.5 2.7 2.4 1.9 1.9 2.4 2.5 +0.1
19–22 0.5 0.6 0.8 2.6 2.4 0.4 0.7 1.2 0.7 0.7 0.9 0.9 1.1 1.3 0.8 * 0.9 0.6 0.6 1.1 +0.5
23–26 * * 0.4 0.2 0.4 * * 0.5 * 0.6 0.7 0.1 0.7 0.3 1.1 0.3 1.1 * 0.8 0.2 -0.6
27–30 * 0.1 * 0.4 * * 0.3 0.6 * 0.4 0.3 0.3 0.7 0.5 0.8 0.9 0.9 1.2 0.2 0.6 +0.4
↓
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Cocaine
  % saying any 18 37.7 36.3 34.9 33.3 35.6 38.3 37.4 34.9 30.2 30.2 27.7 21.3 19.8 19.2 18.8 21.6 25.0 25.6
19–22 37.6 42.3 43.6 36.6 38.9 39.4 41.5 37.0 36.2 26.6 24.0 18.5 19.8 13.5 14.7 14.1 19.3 18.8
23–26 — — — — 38.5 40.6 42.0 34.5 35.9 28.0 24.0 19.9 16.7 14.6 14.3 14.1 12.5 14.0
27–30 — — — — — — — — 28.9 28.3 24.2 18.6 19.4 16.6 14.3 11.4 12.1 11.4
  % saying often exposed 18 5.9 6.6 6.6 5.2 6.7 7.1 7.8 5.9 5.1 5.4 4.7 3.4 2.7 2.9 2.5 3.2 4.0 4.2
19–22 5.8 7.6 6.5 4.3 6.5 7.0 5.4 5.2 4.8 4.3 2.2 1.6 1.7 1.7 1.8 1.7 1.2 2.4
23–26 — — — — 5.3 8.5 7.0 6.0 5.4 3.5 2.5 1.7 1.4 1.7 1.0 1.7 1.3 1.8
27–30 — — — — — — — — 4.4 3.9 2.9 2.2 2.0 1.2 1.5 1.4 1.9 1.6
Heroin
  % saying any 18 7.4 6.6 7.1 5.1 6.0 5.5 6.0 5.8 5.7 6.5 5.4 5.1 5.4 5.7 7.3 7.9 8.6 9.1
19–22 4.4 3.3 4.1 2.9 3.1 4.8 2.9 2.9 2.9 2.9 2.5 3.0 2.7 2.0 3.7 3.8 3.6 3.7
23–26 — — — — 2.3 3.3 3.2 2.9 1.7 2.3 2.3 1.8 1.7 1.5 1.9 2.8 2.9 2.7
27–30 — — — — — — — — 2.1 1.4 1.5 0.9 1.0 2.0 2.0 1.7 1.5 1.3
  % saying often exposed 18 0.4 0.6 1.0 0.7 1.1 0.5 1.0 0.9 0.8 1.0 0.5 0.9 0.7 1.1 0.7 1.2 1.6 1.2
19–22 0.2 0.3 0.3 0.1 0.2 0.5 0.2 0.1 0.2 0.1 0.2 0.4 0.6 0.4 0.6 1.2 0.2 0.4
23–26 — — — — * 0.7 0.3 0.6 0.4 0.3 0.6 0.3 * * * 0.2 0.2 0.3
27–30 — — — — — — — — 0.3 0.3 0.5 0.2 0.2 0.9 0.3 0.6 0.6 *
Other narcotics d
  % saying any 18 19.6 17.5 18.5 17.3 18.0 18.4 15.6 14.4 14.8 13.8 14.2 11.3 11.1 12.4 14.9 15.5 18.5 20.4
19–22 14.4 14.4 15.2 10.9 12.4 13.7 9.8 12.2 11.2 9.0 9.4 9.2 8.5 6.8 10.1 12.1 11.5 14.5
23–26 — — — — 9.0 12.3 9.2 9.7 7.4 8.0 5.9 8.3 7.0 4.6 6.9 7.8 7.4 6.5
27–30 — — — — — — — — 6.5 6.5 5.8 5.5 3.7 5.6 5.9 5.7 4.7 4.9
  % saying often exposed 18 1.7 1.7 2.4 2.2 2.0 1.8 2.1 1.7 1.7 1.7 1.6 1.4 1.3 1.7 1.7 2.1 3.4 2.5
19–22 0.7 0.5 0.5 0.9 0.7 1.0 0.5 0.4 0.9 0.3 0.2 1.0 0.9 0.6 0.8 1.4 0.7 1.5
23–26 — — — — 0.4 0.5 1.3 0.8 0.8 0.5 1.6 0.7 0.1 0.3 0.1 0.1 0.3 0.7
27–30 — — — — — — — — 0.7 0.5 1.0 0.3 0.8 1.2 0.8 0.8 0.7 0.5
Amphetamines
  % saying any 18 40.8 49.5 50.2 46.1 45.0 41.0 36.5 31.7 27.9 27.4 28.3 23.6 24.5 24.7 28.2 28.1 31.5 31.0
19–22 42.3 48.6 48.4 39.7 41.3 35.9 31.3 26.7 21.2 18.5 19.5 17.4 21.3 15.1 20.3 21.0 22.3 24.6
23–26 — — — — 32.3 30.5 29.1 20.9 18.8 14.0 16.8 14.6 11.8 13.2 11.2 13.0 11.1 11.7
27–30 — — — — — — — — 15.6 14.3 13.5 10.7 11.4 11.3 11.0 10.6 7.6 9.1
  % saying often exposed 18 8.3 12.1 12.3 10.1 9.0 6.5 5.8 4.5 4.1 4.7 4.1 3.1 3.0 3.9 4.1 4.5 5.6 5.2
19–22 7.4 9.9 7.7 6.9 5.4 4.4 3.1 3.3 2.2 1.5 1.1 1.9 2.6 1.5 3.3 5.0 1.3 4.1
23–26 — — — — 3.9 3.2 2.2 3.3 1.9 0.7 2.0 1.3 0.2 0.8 0.9 1.6 1.3 1.4
27–30 — — — — — — — — 2.0 2.0 1.2 0.8 0.8 1.3 0.7 1.6 1.8 1.0
(Table continued on next page.)
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Age 
Group 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cocaine
  % saying any 18 26.6 25.8 24.2 24.5 24.9 24.8 24.4 25.7 28.2 25.2 24.1 20.0 20.0 19.3 17.4 16.7 17.6 18.0 18.2 17.6 -0.7
19–22 21.6 18.5 19.1 20.6 22.5 18.4 23.6 22.7 22.9 22.5 22.7 18.6 17.8 15.5 18.9 11.5 17.6 18.0 28.7 18.6 -10.1 ss
23–26 16.0 18.2 16.4 16.9 18.3 17.4 18.7 19.2 19.3 19.0 18.2 15.3 14.7 20.5 17.2 14.4 15.6 15.7 20.0 20.0 -0.1
27–30 8.6 11.6 10.2 11.6 12.2 12.6 13.0 15.8 16.0 14.1 14.8 13.2 11.4 13.1 14.2 15.0 12.1 17.8 15.4 19.3 +3.8
  % saying often exposed 18 3.7 4.6 4.6 4.5 5.3 5.0 4.7 4.2 5.3 4.6 3.6 2.6 2.1 2.3 2.8 2.1 2.2 2.3 3.0 3.0 0.0
19–22 3.2 1.4 3.8 3.0 4.1 1.6 2.6 4.0 2.6 1.8 2.6 2.6 0.7 1.2 3.2 1.7 2.4 1.2 1.8 1.5 -0.2
23–26 1.5 2.2 1.8 1.0 2.5 1.9 2.9 1.8 2.0 3.2 1.0 1.0 1.2 1.4 2.0 1.0 2.1 0.8 3.4 3.2 -0.1
27–30 0.8 1.5 0.3 1.6 2.4 1.7 0.7 2.4 0.8 0.7 1.4 0.8 0.1 1.4 0.8 1.6 1.8 2.0 2.2 1.9 -0.3
Heroin
  % saying any 18 8.7 8.1 9.1 8.7 8.3 7.3 6.6 7.3 9.0 8.6 6.8 7.3 8.3 6.4 6.0 6.6 5.2 5.6 5.3 6.4 +1.0
19–22 6.4 3.2 5.2 3.2 5.3 3.4 3.0 3.2 3.7 3.3 4.8 4.3 3.2 4.0 3.6 3.4 3.6 3.2 2.9 4.4 +1.5
23–26 3.1 2.9 2.6 2.4 3.8 2.0 3.1 2.6 3.5 3.6 1.8 1.8 4.1 4.8 2.4 2.3 2.4 3.9 5.1 5.2 +0.1
27–30 1.4 1.9 1.9 2.3 2.7 1.3 3.2 2.9 2.3 3.0 2.2 1.9 1.5 3.5 3.0 3.9 5.3 2.6 3.4 5.5 +2.1
  % saying often exposed 18 0.9 1.3 1.5 0.7 1.3 1.2 1.2 0.8 1.7 1.1 0.8 0.8 1.0 1.1 1.3 0.7 0.7 1.2 0.9 1.1 +0.2
19–22 0.7 0.8 0.7 0.8 0.6 0.2 * 0.8 0.1 * 0.6 * 0.4 0.7 1.0 1.0 0.9 * * 0.5 +0.5
23–26 0.5 1.0 * * 0.8 0.5 0.5 0.3 0.6 0.3 * * 1.2 0.3 0.2 * 0.3 1.1 0.8 0.6 -0.2
27–30 * 0.2 * * 0.7 0.3 * 0.4 0.3 0.4 0.3 0.6 * 1.2 0.7 1.3 0.5 1.0 0.9 1.0 0.0
Other narcotics d
  % saying any 18 20.7 21.9 21.1 21.6 22.5 21.8 20.3 19.0 18.9 18.9 16.3 16.3 30.3 27.5 27.1 22.9 20.9 21.0 21.0 19.9 -1.1
19–22 15.3 13.9 17.0 18.3 18.7 13.6 14.5 16.8 15.3 12.5 13.2 14.2 27.5 23.7 25.2 19.5 21.3 17.8 19.9 15.3 -4.6
23–26 8.1 9.4 10.9 12.2 12.0 12.6 12.6 12.4 13.0 14.4 11.2 13.2 25.9 25.3 24.1 22.5 17.8 19.6 20.4 16.7 -3.7
27–30 3.6 5.2 6.5 9.0 7.9 9.5 8.8 11.6 10.6 9.2 9.1 9.7 23.4 22.7 23.6 24.5 19.4 19.1 14.8 22.8 +8.0 s
  % saying often exposed 18 2.8 3.9 2.9 3.0 3.8 3.0 3.3 2.6 3.4 3.4 2.1 2.7 5.3 5.6 5.7 3.8 3.6 2.8 3.8 3.4 -0.4
19–22 1.7 1.1 2.4 1.6 3.0 1.2 0.8 2.4 1.9 1.7 1.9 1.6 3.3 2.1 1.6 2.2 2.0 1.7 0.4 0.7 +0.3
23–26 0.5 1.1 0.7 1.0 0.9 1.6 1.4 1.3 1.1 1.8 1.0 1.3 4.4 2.5 3.6 1.5 2.3 2.0 4.0 1.6 -2.4
27–30 * 0.2 1.1 1.0 0.7 1.2 0.1 1.7 0.7 0.8 0.4 1.4 3.0 3.1 2.3 3.1 2.6 2.3 2.6 1.4 -1.1
Amphetamines e
  % saying any 18 29.9 30.1 29.5 31.5 30.6 27.4 27.2 26.4 26.6 23.8 23.3 23.8 23.6 28.0 26.2 25.4 23.7 25.7 24.3 22.4 -1.9
19–22 24.8 21.2 24.8 23.3 25.5 21.6 23.7 22.2 22.7 22.8 17.6 18.0 19.4 26.0 27.4 26.2 30.4 30.3 34.2 26.3 -7.9
23–26 14.6 12.3 18.5 18.2 17.9 15.4 18.8 15.6 18.7 16.6 13.7 15.3 15.8 24.2 23.1 21.4 22.0 23.5 25.8 23.0 -2.9
27–30 6.6 10.4 7.4 11.1 11.5 12.2 11.4 12.2 14.1 10.0 10.3 10.3 12.6 16.4 19.0 19.1 17.7 23.1 19.9 20.3 +0.4
  % saying often exposed 18 4.7 6.3 4.4 6.0 6.4 4.9 5.3 4.1 5.6 4.3 3.0 4.3 3.3 6.1 5.7 5.3 5.7 5.2 5.0 5.0 0.0
19–22 2.9 2.2 2.4 2.6 5.6 1.7 4.1 3.1 2.9 2.3 2.1 3.0 3.9 3.3 5.5 3.7 6.8 5.4 8.2 4.9 -3.3
23–26 2.2 1.7 1.4 2.2 0.7 1.3 1.7 1.6 2.6 1.6 1.8 1.1 1.6 3.1 4.1 3.2 3.6 2.3 3.6 3.0 -0.5
27–30 0.2 1.1 0.4 0.6 1.5 1.0 1.2 1.0 0.8 1.1 0.3 0.7 0.6 1.7 3.0 2.7 2.0 3.5 2.7 1.8 -0.9
↓
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Sedatives/barbiturates e
  % saying any 18 25.2 25.9 25.7 22.5 21.2 18.9 15.8 13.1 12.4 11.8 13.3 10.0 10.2 11.9 13.0 14.5 15.5 16.1
19–22 25.6 23.1 21.8 18.3 15.7 14.7 12.8 12.0 8.2 8.3 6.5 7.9 7.3 7.2 7.4 10.1 8.8 11.7
23–26 — — — — 16.1 13.1 11.0 7.1 7.1 6.6 6.9 5.9 6.5 3.8 4.2 5.7 6.6 4.9
27–30 — — — — — — — — 8.0 6.8 5.9 5.4 5.2 5.7 4.5 5.2 3.5 3.8
  % saying often exposed 18 3.4 4.0 4.3 3.0 2.7 1.7 2.1 1.5 1.4 1.7 1.7 1.2 1.1 1.6 1.7 2.0 2.9 2.5
19–22 2.5 2.8 1.1 1.4 0.7 1.3 0.5 0.7 0.7 0.3 0.7 0.4 0.7 0.7 1.3 1.3 0.4 0.9
23–26 — — — — 0.7 0.9 1.7 0.8 0.6 0.3 1.1 0.3 0.3 * * 0.2 0.3 0.8
27–30 — — — — — — — — 0.7 0.4 0.6 0.2 0.4 1.2 0.2 0.6 0.5 0.2
Tranquilizers f
  % saying any 18 29.1 29.0 26.6 23.5 23.1 23.4 19.6 18.4 18.2 15.1 16.3 14.2 12.7 13.8 16.5 15.7 17.9 18.9
19–22 29.6 26.9 28.5 19.5 21.2 19.5 16.4 18.5 13.8 12.0 12.7 12.6 11.0 10.0 12.0 11.8 10.7 15.6
23–26 — — — — 23.1 21.0 16.9 15.9 13.4 12.9 12.0 10.4 9.7 10.9 9.8 10.3 10.1 9.4
27–30 — — — — — — — — 15.0 11.6 11.1 9.7 10.3 10.4 9.0 11.2 9.6 9.6
  % saying often exposed 18 3.2 4.2 3.5 2.9 2.9 2.2 2.5 2.6 2.2 2.1 1.9 1.4 1.9 1.7 1.8 2.3 3.5 3.2
19–22 3.2 2.6 1.8 2.1 1.5 1.7 0.9 1.1 1.8 1.0 1.1 1.1 1.5 1.1 1.3 1.5 0.5 1.3
23–26 — — — — 2.0 1.6 2.6 1.8 1.2 0.8 0.5 1.0 0.6 0.7 0.1 1.1 1.5 0.7
27–30 — — — — — — — — 1.4 0.3 1.7 0.8 1.3 1.3 1.0 1.1 0.8 1.2
Alcoholic beverages
  % saying any 18 94.7 94.0 94.0 94.0 94.0 94.0 94.1 93.9 93.1 92.3 93.6 91.7 90.6 91.8 90.0 91.2 91.5 91.4
19–22 94.3 93.8 94.5 93.4 94.2 92.7 93.6 94.4 92.5 91.8 92.4 94.0 93.3 92.9 93.7 93.1 93.7 93.1
23–26 — — — — 90.3 92.7 91.4 90.6 91.1 92.9 91.3 91.0 91.4 90.3 89.5 91.9 89.6 93.1
27–30 — — — — — — — — 87.1 88.4 86.2 87.7 87.3 86.6 86.2 89.3 89.2 86.4
  % saying often exposed 18 60.2 61.0 59.3 60.2 58.7 59.5 58.0 58.7 56.4 55.5 56.1 54.5 53.1 51.9 54.0 54.0 54.5 53.9
19–22 59.6 61.2 62.5 56.6 59.3 61.8 59.9 61.4 55.4 53.8 56.0 53.9 56.1 56.8 57.0 56.3 52.3 54.2
23–26 — — — — 52.1 54.8 51.4 53.0 48.1 50.9 49.7 48.4 45.4 45.4 43.3 47.5 44.8 49.8
27–30 — — — — — — — — 39.9 39.5 38.7 38.0 39.9 38.1 39.3 38.0 34.7 37.1
Approximate 18 3,259 3,608 3,645 3,334 3,238 3,252 3,078 3,296 3,300 2,795 2,556 2,525 2,630 2,730 2,581 2,608 2,407 2,595
Weighted  N = 19–22 582 574 601 569 578 549 591 582 556 567 567 532 528 489 460 464 485 471
23–26 533 532 557 529 531 514 523 494 532 513 471 467 447 424
27–30 522 507 506 478 502 457 425 452 432 455
Percentage saying exposed to drug a
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Cont.)
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1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Sedatives/barbiturates f
  % saying any 18 16.1 17.1 16.3 17.1 17.7 14.8 21.5 20.4 21.3 18.8 16.7 17.6 18.8 16.2 16.0 15.0 13.4 13.5 12.8 11.2 -1.6
19–22 13.4 11.6 13.1 13.1 16.0 11.9 17.2 17.8 16.0 16.1 15.2 17.3 16.1 12.2 14.8 10.7 14.2 13.1 16.9 9.3 -7.6 s
23–26 8.5 7.1 9.3 9.0 9.8 7.9 15.9 12.5 14.8 13.1 12.4 12.7 13.4 15.2 14.9 10.6 11.9 11.5 13.3 12.1 -1.3
27–30 2.7 4.1 2.9 5.3 6.0 6.1 9.2 12.4 11.9 10.3 10.1 9.9 11.6 10.4 11.7 10.1 11.8 12.1 10.5 13.1 +2.6
  % saying often exposed 18 2.7 3.8 2.7 2.7 4.6 2.8 4.1 3.7 3.9 3.9 2.1 3.4 2.5 3.1 2.9 2.5 2.3 1.8 2.5 2.3 -0.3
19–22 1.4 0.9 1.6 1.2 1.8 0.8 1.7 2.1 2.5 1.4 2.2 1.9 0.9 1.2 1.7 1.0 1.5 1.9 1.5 0.9 -0.6
23–26 0.5 0.9 0.7 0.2 0.3 0.4 0.7 1.1 1.1 1.6 1.7 0.7 1.0 1.0 1.5 0.8 1.3 0.5 1.4 0.8 -0.6
27–30 * 0.6 0.2 0.9 0.4 0.6 0.4 1.7 0.7 1.3 0.4 1.7 0.9 1.3 1.1 2.0 0.6 1.4 0.2 1.4 +1.2
Tranquilizers g
  % saying any 18 17.3 18.2 17.7 23.8 22.7 21.0 22.1 20.9 21.8 19.3 19.9 20.0 18.2 17.0 17.6 16.4 16.0 19.7 22.2 22.6 +0.4
19–22 16.9 14.3 18.5 21.3 23.6 20.0 21.9 20.6 23.1 21.4 20.0 19.6 18.1 16.6 19.0 13.3 18.3 16.8 24.4 18.1 -6.3
23–26 10.9 10.8 12.3 16.4 20.1 18.7 19.9 20.1 19.9 18.8 18.4 17.5 21.4 19.6 21.0 19.5 15.5 17.9 19.3 18.0 -1.3
27–30 6.1 8.8 7.6 12.6 13.6 15.3 14.6 18.1 19.2 16.7 16.8 13.5 18.6 16.5 19.5 17.5 16.3 17.4 13.8 23.5 +9.7 ss
  % saying often exposed 18 2.8 3.7 3.5 4.9 5.8 4.2 4.1 4.5 5.4 4.9 3.7 3.9 2.8 3.4 3.3 3.4 3.4 2.6 4.6 4.7 +0.1
19–22 1.6 1.5 1.7 3.1 3.6 2.3 2.7 2.7 3.2 3.0 3.2 2.1 1.7 2.9 2.0 1.7 2.3 2.0 2.7 1.8 -0.9
23–26 1.1 1.5 1.7 1.3 2.1 1.6 2.0 1.3 2.6 2.4 3.6 1.5 3.2 2.6 2.5 1.6 1.8 1.2 1.9 3.1 +1.2
27–30 0.2 0.9 0.4 1.6 1.6 1.9 0.8 3.5 2.9 2.6 1.0 2.0 1.7 2.0 2.3 1.8 1.9 3.6 2.0 1.9 0.0
Alcoholic beverages
  % saying any 18 92.2 91.8 90.7 90.8 89.5 88.3 87.6 87.4 87.6 86.5 85.7 86.5 85.2 85.0 85.3 84.8 82.1 80.5 80.4 78.9 -1.5
19–22 91.8 91.0 93.3 94.3 93.7 93.6 92.5 92.7 92.0 91.8 90.5 91.2 86.5 87.5 85.8 82.8 89.7 85.5 86.9 81.6 -5.3
23–26 89.1 91.5 92.1 90.1 91.9 91.8 92.2 90.0 94.0 94.5 92.0 93.0 91.1 94.2 88.7 88.7 82.7 87.2 86.9 90.2 +3.3
27–30 88.4 88.7 89.8 91.2 89.0 90.0 85.3 92.2 91.8 89.6 94.4 91.0 91.2 92.5 90.5 88.8 85.6 89.3 85.3 83.6 -1.7
  % saying often exposed 18 54.5 53.5 50.2 52.7 50.8 49.0 48.2 49.1 47.8 46.4 45.4 46.3 45.8 40.7 43.0 41.7 40.3 38.0 37.4 35.4 -2.0
19–22 57.9 54.7 54.3 53.4 54.9 55.7 54.3 58.9 55.0 60.7 53.9 53.4 48.5 46.0 50.6 45.3 49.5 51.1 53.2 43.2 -9.9 s
23–26 44.6 45.7 49.6 48.8 46.3 50.5 48.3 46.4 57.1 54.2 49.6 53.8 51.3 52.5 55.6 49.3 44.4 49.3 47.6 52.3 +4.7
27–30 36.6 38.3 34.4 40.0 39.6 40.6 36.8 43.6 47.3 44.3 47.8 45.2 43.0 49.3 50.4 48.1 47.7 47.4 48.7 46.5 -2.1
Approximate 18 2,541 2,312 2,153 2,147 2,162 2,454 2,456 2,469 2,469 2,448 2,332 2,274 2,434 2,372 2,299 2,150 2,075 2,177 2,018 2,086
Weighted  N = 19–22 445 450 415 412 403 396 432 377 378 333 365 368 364 340 356 281 316 264 251 228
23–26 400 398 389 406 345 385 404 374 363 327 333 328 347 308 334 311 308 286 271 237
27–30 449 430 395 369 359 347 370 370 330 356 339 324 336 306 312 301 303 263 259 276
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  Any apparent inconsistency between 
the change estimate and the prevalence estimates for the two most recent years is due to rounding. ' — ' indicates data not available.
' * ' indicates a prevalence rate of less than 0.05%.
aAnswer alternatives were: (1) Not at all, (2) Once or twice, (3) Occasionally, (4) Often. The “any” percentage combines categories (2)–(4).
bThese estimates were derived from responses to the question for the following drugs: marijuana, LSD, other hallucinogens, cocaine, heroin or other narcotics, amphetamines,
sedatives (barbiturates), and tranquilizers.
cIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the 
discontinuity in the 2001 results. 
dIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc. This change likely explains the discontinuity
in the 2010 results.
eIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin. This change likely explains the discontinuity in the 2011 results.
fIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just
downers. These changes likely explain the discontinuity in the 2004 results.
gIn 2001 Xanax was added to the list of examples. This change likely explains the discontinuity in the 2001 results. 
TABLE 7-3 (cont.)
Trends in Exposure to Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Age 
Group
2016– 
2017 
change
you been around people 
who were taking each of 
the following to get high or 
for “kicks”?
Q. During the LAST 12 
MONTHS how often have Percentage saying exposed to drug a
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Marijuana 18 89.0 89.2 88.5 86.2 84.6 85.5 85.2 84.8 85.0 84.3 84.4 83.3 82.7 83.0 85.5 88.5 88.7 89.6 90.4
19–22 95.6 91.1 92.4 89.7 88.3 89.5 87.2 85.9 87.1 87.1 86.2 86.0 87.8 85.6 87.2 87.9 89.3 90.6 89.9
23–26 — — — — 92.5 88.8 88.8 90.3 86.9 88.7 83.3 82.5 83.8 84.6 87.1 86.2 85.3 84.4 87.5
27–30 — — — — — — — — 89.3 86.0 83.1 83.8 80.7 82.8 80.3 83.3 82.6 84.5 82.1
35 — — — — — — — — — — — — — — 75.7 75.6 73.0 77.1 76.0
40 — — — — — — — — — — — — — — — — — — 73.4
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Amyl & butyl nitrites 18 — — — — — — — 23.9 25.9 26.8 24.4 22.7 25.9 25.9 26.7 26.0 23.9 23.8 25.1
19–22 — — — — — — — 22.8 26.0 — — — — — — — — — —
23–26 — — — — — — — 23.1 28.0 — — — — — — — — — —
27–30 — — — — — — — — 26.7 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
LSD 18 35.3 35.0 34.2 30.9 30.6 30.5 28.5 31.4 33.3 38.3 40.7 39.5 44.5 49.2 50.8 53.8 51.3 50.7 48.8
19–22 39.6 38.4 35.1 31.8 32.7 29.6 30.5 29.9 33.9 36.4 36.6 37.8 42.5 44.9 43.7 50.5 50.8 47.7 51.1
23–26 — — — — 32.7 29.1 30.0 27.5 32.7 32.6 30.2 32.8 33.5 33.4 40.1 41.0 43.6 39.2 40.4
27–30 — — — — — — — — 29.4 29.9 32.3 27.0 30.9 30.5 27.2 35.6 33.6 35.2 32.9
35 — — — — — — — — — — — — — — 33.8 32.4 28.4 32.9 31.2
40 — — — — — — — — — — — — — — — — — — 31.1
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Other 18 35.0 32.7 30.6 26.6 26.6 26.1 24.9 25.0 26.2 28.2 28.3 28.0 29.9 33.5 33.8 35.8 33.9 33.9 35.1
  hallucinogens b 19–22 42.1 37.7 33.5 31.0 28.9 28.7 26.3 27.5 28.7 28.1 28.9 26.6 28.3 29.5 28.6 31.5 31.5 33.4 34.1
23–26 — — — — 31.8 29.6 26.4 25.6 29.6 28.7 27.0 25.7 27.7 25.3 28.3 29.2 32.6 31.0 32.4
27–30 — — — — — — — — 28.6 29.6 30.8 24.9 24.8 25.4 24.7 29.3 25.9 28.0 25.2
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
PCP 18 — — — — — — — 22.8 24.9 28.9 27.7 27.6 31.7 31.7 31.4 31.0 30.5 30.0 30.7
19–22 — — — — — — — 21.7 24.6 — — — — — — — — — —
23–26 — — — — — — — 21.2 27.6 — — — — — — — — — —
27–30 — — — — — — — — 24.3 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Ecstasy (MDMA) 18 — — — — — — — — — 21.7 22.0 22.1 24.2 28.1 31.2 34.2 36.9 38.8 38.2
19–22 — — — — — — — — — — 26.6 24.9 27.1 23.9 27.0 29.3 33.4 35.6 39.4
23–26 — — — — — — — — — — 21.4 23.1 26.4 24.0 26.0 27.8 28.7 31.1 30.1
27–30 — — — — — — — — — — 27.1 20.8 22.2 22.8 21.9 27.1 29.3 24.3 26.4
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
Age 
Group
(Years 
Cont.)
TABLE 7-4
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Q. How difficult do you 
think it would be for you 
to get each of the 
following types of drugs, 
if you wanted some?
Percentage saying fairly easy or very easy to get a
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Marijuana 18 88.9 88.5 88.5 87.2 87.1 85.8 85.6 84.9 83.9 83.9 81.1 82.1 82.2 81.6 81.4 81.3 79.5 81.0 79.8 -1.1
19–22 87.4 89.6 91.7 88.1 87.7 87.3 88.0 86.8 88.4 87.5 83.0 84.2 82.9 85.4 83.9 85.7 88.7 86.5 90.1 +3.6
23–26 85.9 88.4 87.0 89.1 87.2 88.8 87.0 86.8 87.6 85.3 89.4 83.3 88.3 87.0 87.4 87.7 87.4 88.5 88.8 +0.2
27–30 83.0 81.5 84.8 83.6 81.8 86.0 84.6 87.6 87.8 86.4 88.9 84.6 85.6 85.1 86.8 86.4 91.5 86.8 87.0 +0.3
35 74.9 77.1 75.3 76.5 75.1 75.6 73.8 75.1 75.5 76.4 75.7 75.6 80.4 80.5 80.2 84.4 85.5 84.7 84.9 +0.2
40 71.7 73.1 70.4 72.1 72.3 68.9 73.6 69.7 71.2 72.5 72.9 73.6 74.6 74.6 78.8 76.0 77.3 80.7 82.3 +1.6
45 — — — — 68.5 69.9 70.1 67.9 70.1 68.1 67.9 73.4 69.8 71.8 73.6 76.9 77.2 81.1 82.6 +1.6
50 — — — — — — — — — 64.4 65.8 67.9 65.8 68.9 70.1 71.9 75.8 74.5 76.6 +2.1
55 — — — — — — — — — — — — — — 68.8 72.1 71.7 72.8 76.7 +3.9
Amyl & butyl nitrites 18 21.4 23.3 22.5 22.3 19.7 20.0 19.7 18.4 18.1 16.9 15.7 — — — — — — — — —
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
LSD 18 44.7 46.9 44.7 39.6 33.6 33.1 28.6 29.0 28.7 28.5 26.3 25.1 25.1 27.6 24.5 25.9 26.5 28.0 26.3 -1.7
19–22 43.8 47.1 42.5 37.9 34.1 30.3 27.7 29.0 23.0 19.7 24.2 26.1 24.8 23.2 26.2 22.3 25.8 24.6 33.3 +8.7 s
23–26 41.2 40.4 38.3 37.2 34.1 38.5 26.5 30.3 25.2 24.1 26.1 24.2 21.4 19.3 22.8 17.2 20.5 17.7 23.0 +5.3
27–30 35.7 35.6 38.3 32.3 33.5 30.0 29.3 29.7 26.8 28.1 22.5 25.2 26.6 19.1 21.7 21.1 15.5 20.4 17.9 -2.6
35 27.7 32.2 28.7 29.1 29.8 25.6 24.0 28.7 26.6 26.4 26.9 25.5 24.0 23.0 24.1 22.2 19.3 20.8 18.5 -2.3
40 31.0 28.5 25.7 27.4 25.0 24.4 24.3 23.9 21.5 25.1 22.2 23.3 22.6 21.6 20.1 23.0 20.6 21.4 18.8 -2.6
45 — — — — 24.2 27.0 25.4 23.7 23.6 21.1 19.4 23.6 21.3 18.9 23.4 21.2 17.9 19.7 21.6 +2.0
50 — — — — — — — — — 19.0 21.9 18.6 20.3 18.1 17.1 17.7 19.7 19.5 17.3 -2.2
55 — — — — — — — — — — — — — — — — — — — —
Other 18 29.5 34.5 48.5 47.7 47.2 49.4 45.0 43.9 43.7 42.8 40.5 39.5 38.3 37.8 36.6 33.6 31.4 32.5 28.4 -4.0
hallucinogens b 19–22 31.1 33.4 45.9 48.8 45.1 46.9 48.5 41.9 39.3 34.7 38.1 39.1 37.5 36.4 34.1 31.2 35.4 30.6 32.4 +1.7
23–26 31.5 28.5 38.3 39.7 39.2 44.4 39.2 41.5 36.8 39.3 39.2 32.3 35.0 32.7 31.8 27.5 31.1 29.6 30.1 +0.5
27–30 30.3 25.0 38.6 33.3 35.6 31.2 30.8 32.1 30.0 36.2 32.0 34.7 33.4 31.4 33.3 31.0 27.3 24.3 27.2 +2.9
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
PCP 18 26.7 28.8 27.2 25.8 21.9 24.2 23.2 23.1 21.0 20.6 19.2 18.5 17.2 14.2 15.3 11.0 13.8 12.6 10.6 -2.0
19–22 — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Ecstasy (MDMA) 18 40.1 51.4 61.5 59.1 57.5 47.9 40.3 40.3 40.9 41.9 35.1 36.4 37.1 35.9 35.1 36.1 37.1 32.5 29.3 -3.2
19–22 43.2 49.9 55.5 59.7 52.1 45.8 43.5 41.2 38.4 34.7 37.1 30.4 37.9 28.3 33.9 32.9 38.6 33.4 32.0 -1.4
23–26 34.9 41.8 51.5 52.9 49.3 51.3 46.4 44.6 42.2 41.5 36.8 35.2 34.0 32.2 35.7 30.9 36.3 30.8 35.0 +4.2
27–30 30.0 35.5 40.6 41.2 41.0 41.1 38.0 40.5 40.7 42.2 38.0 31.2 33.8 32.8 28.6 29.7 33.2 35.8 33.1 -2.7
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
↓
(List of drugs continued.)
Age 
Group
2016– 
2017 
change
TABLE 7-4 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
Trends in Availability of Drugs as Perceived by
Percentage saying fairly easy or very easy to get aQ. How difficult do you 
think it would be for you to 
get each of the following 
types of drugs, if you 
wanted some?
343
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Cocaine 18 47.9 47.5 47.4 43.1 45.0 48.9 51.5 54.2 55.0 58.7 54.5 51.0 52.7 48.5 46.6 47.7 48.1 48.5 51.3
19–22 56.2 57.1 55.2 56.2 56.9 60.4 65.0 64.9 66.8 61.7 54.3 54.5 49.2 49.9 49.4 44.4 49.7 47.7
23–26 — — — — 63.7 67.2 65.8 69.0 71.7 70.0 65.6 58.0 61.1 53.8 54.4 54.7 50.2 46.9 51.8
27–30 — — — — — — — — 68.6 68.2 64.0 60.0 63.1 56.8 53.1 57.0 53.0 50.4 46.9
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Crack 18 — — — — — — — 41.1 42.1 47.0 42.4 39.9 43.5 43.6 40.5 41.9 40.7 40.6 43.8
19–22 — — — — — — — 41.9 47.3 47.2 46.9 42.1 42.1 38.4 41.6 40.7 32.9 39.9 40.0
23–26 — — — — — — — 44.5 53.0 49.9 46.9 42.0 42.6 42.5 42.4 42.3 37.9 37.2 38.4
27–30 — — — — — — — — 46.5 46.8 46.8 43.1 45.2 45.8 41.1 44.7 39.9 36.5 33.3
35 — — — — — — — — — — — — — — 49.6 48.2 43.1 44.3 45.0
40 — — — — — — — — — — — — — — — — — — 43.3
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Cocaine powder 18 — — — — — — — 52.9 50.3 53.7 49.0 46.0 48.0 45.4 43.7 43.8 44.4 43.3 45.7
19–22 — — — — — — — 58.7 60.2 61.7 56.5 52.5 48.9 45.7 47.8 45.5 41.3 46.0 47.1
23–26 — — — — — — — 64.9 69.1 60.1 58.6 53.2 56.4 50.5 49.7 49.6 45.9 43.6 44.4
27–30 — — — — — — — — 63.5 62.8 57.9 55.8 56.8 55.0 48.9 52.9 48.4 45.1 43.9
35 — — — — — — — — — — — — — — 53.9 52.1 46.7 48.3 47.0
40 — — — — — — — — — — — — — — — — — — 46.0
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Heroin 18 21.2 19.2 20.8 19.3 19.9 21.0 22.0 23.7 28.0 31.4 31.9 30.6 34.9 33.7 34.1 35.1 32.2 33.8 35.6
19–22 18.9 19.4 19.3 16.4 17.2 20.8 21.2 24.4 28.5 31.6 30.7 25.3 30.2 30.0 33.2 35.2 29.1 31.4 32.1
23–26 — — — — 18.6 18.1 21.0 22.3 28.4 31.2 28.1 25.6 25.7 25.7 29.2 29.3 32.3 30.5 35.1
27–30 — — — — — — — — 23.6 27.4 29.5 22.1 25.6 28.5 24.4 30.7 29.5 30.0 28.3
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Some other narcotic c 18 29.4 29.6 30.4 30.0 32.1 33.1 32.2 33.0 35.8 38.3 38.1 34.6 37.1 37.5 38.0 39.8 40.0 38.9 42.8
19–22 32.7 32.4 30.8 31.0 28.7 34.3 32.6 33.8 37.9 37.9 35.6 35.4 35.2 33.5 35.1 38.7 37.3 38.3 38.9
23–26 — — — — 32.8 32.1 33.6 32.2 35.9 36.4 34.7 33.2 33.9 33.1 35.8 32.6 36.7 35.7 39.9
27–30 — — — — — — — — 31.6 36.2 36.1 29.0 31.8 33.0 34.8 36.9 37.2 35.2 32.2
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Amphetamines 18 61.3 69.5 70.8 68.5 68.2 66.4 64.3 64.5 63.9 64.3 59.7 57.3 58.8 61.5 62.0 62.8 59.4 59.8 60.8
19–22 71.7 72.6 73.5 69.7 69.1 69.1 63.1 61.8 61.3 62.2 57.7 58.3 56.3 56.0 56.6 60.3 56.9 55.5 56.3
23–26 — — — — 65.8 66.0 64.5 65.3 62.2 60.1 55.8 54.8 54.5 52.6 52.9 56.0 52.8 51.2 53.2
27–30 — — — — — — — — 54.3 58.6 55.3 54.4 50.4 52.9 48.3 53.7 51.7 48.1 41.4
35 — — — — — — — — — — — — — — 45.6 43.5 39.1 40.9 39.4
40 — — — — — — — — — — — — — — — — — — 41.0
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, and 55
TABLE 7-4 (cont.)
(Table continued on next page.)
Q. How difficult do you 
think it would be for you 
to get each of the 
following types of drugs, 
if you wanted some?
(Years 
Cont.)
Percentage saying fairly easy or very easy to get a
344
Age 
Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cocaine 18 47.6 47.8 46.2 44.6 43.3 47.8 44.7 46.5 47.1 42.4 39.4 35.5 30.5 29.8 30.5 29.2 29.1 28.6 27.3 -1.3
19–22 52.6 52.1 49.6 47.6 46.7 47.0 50.0 47.4 47.3 44.0 38.5 37.2 39.2 32.9 28.1 34.4 33.3 37.3 37.0 -0.3
23–26 45.7 45.0 44.6 47.8 40.8 50.7 48.4 51.2 47.4 45.5 44.0 41.1 37.8 37.4 36.8 36.8 36.2 36.8 38.0 +1.2
27–30 50.0 44.6 45.5 46.3 42.9 38.0 43.1 43.2 45.8 50.6 43.6 40.8 44.2 42.3 35.0 41.6 39.4 39.7 40.1 +0.4
35 — — — — — — — — — — — — — — — — — — — —
 40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Crack 18 41.1 42.6 40.2 38.5 35.3 39.2 39.3 38.8 37.5 35.2 31.9 26.1 24.0 22.0 24.6 20.1 22.0 19.8 18.1 -1.7
19–22 40.8 40.2 37.3 35.7 37.5 33.7 34.0 35.2 35.7 31.4 27.3 27.2 27.3 20.6 20.8 23.3 21.0 20.0 18.3 -1.7
23–26 35.0 31.9 37.1 33.9 32.8 36.5 35.1 34.0 31.4 33.1 27.4 27.1 25.3 27.6 24.2 26.7 21.9 19.4 23.6 +4.2
27–30 38.8 35.9 36.9 33.4 33.7 28.0 34.4 29.6 36.4 36.1 33.1 27.5 28.9 25.2 24.6 26.5 26.5 28.4 22.6 -5.8
35 41.6 45.0 41.2 38.9 40.5 36.1 34.2 37.1 35.1 33.2 31.6 30.0 30.4 27.3 28.7 25.7 26.1 26.3 24.3 -1.9
40 44.3 42.0 38.7 39.5 39.0 35.8 38.6 37.1 32.7 35.2 33.2 30.9 30.1 27.9 25.5 28.1 24.7 25.0 22.7 -2.2
45 — — — — 37.0 40.0 40.6 36.2 37.0 34.2 31.7 36.2 32.3 28.2 32.3 27.3 24.7 28.8 26.5 -2.3
50 — — — — — — — — — 32.8 36.3 32.4 29.5 30.5 30.0 27.2 29.9 28.6 24.2 -4.4 s
55 — — — — — — — — — — — — — — 30.2 34.6 28.7 28.0 28.6 +0.6
Cocaine powder 18 43.7 44.6 40.7 40.2 37.4 41.7 41.6 42.5 41.2 38.9 33.9 29.0 26.4 25.1 28.4 22.3 25.8 22.9 21.3 -1.6
19–22 45.2 45.2 43.3 43.9 45.5 43.2 44.3 44.2 44.5 39.0 36.1 35.6 35.4 26.0 25.1 31.8 33.0 29.2 29.2 0.0
23–26 44.3 41.8 44.4 40.7 43.4 48.5 45.1 46.4 45.0 41.4 41.6 40.3 37.5 37.0 35.1 34.0 34.3 32.4 34.5 +2.1
27–30 46.5 43.9 42.7 42.4 39.7 37.9 40.2 42.7 43.0 47.5 41.3 38.2 38.4 37.0 35.4 36.9 40.7 38.1 36.1 -2.0
35 43.4 47.9 43.1 41.7 42.0 39.6 35.8 39.5 37.4 38.6 34.9 35.5 35.3 31.4 35.2 31.9 34.2 35.3 33.7 -1.6
40 46.7 44.7 41.5 41.5 40.7 38.5 40.3 37.8 35.2 36.5 33.9 33.5 31.8 29.5 29.8 31.6 28.6 30.2 27.7 -2.5
45 — — — — 39.0 40.2 40.6 37.3 38.2 34.1 31.5 37.2 33.2 28.7 34.0 29.9 26.6 29.6 29.6 0.0
50 — — — — — — — — — 32.6 35.9 32.8 31.0 30.8 30.3 27.8 30.7 29.3 27.0 -2.2
55 — — — — — — — — — — — — — — 30.6 35.3 30.4 29.8 30.9 +1.1
Heroin 18 32.1 33.5 32.3 29.0 27.9 29.6 27.3 27.4 29.7 25.4 27.4 24.1 20.8 19.9 22.1 20.2 20.4 20.0 19.1 -0.9
19–22 32.7 29.4 30.2 26.4 26.9 22.6 25.4 25.3 26.5 24.2 19.4 22.0 21.2 19.3 16.0 20.2 21.1 24.5 20.0 -4.5
23–26 31.9 25.7 26.6 27.2 25.5 30.9 22.5 28.1 22.2 23.4 23.4 23.1 21.1 22.7 23.1 21.1 21.2 24.9 22.1 -2.8
27–30 33.0 29.3 29.9 27.0 27.5 22.0 27.8 25.4 27.5 26.3 25.2 25.2 28.0 23.3 20.9 25.5 26.9 28.7 28.9 +0.2
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Some other narcotic c 18 40.8 43.9 40.5 44.0 39.3 40.2 39.2 39.6 37.3 34.9 36.1 54.2 50.7 50.4 46.5 42.2 39.0 39.3 35.8 -3.5
19–22 39.5 41.1 44.1 40.4 40.6 39.4 41.4 38.5 38.3 38.0 35.3 55.2 53.8 52.2 53.5 49.7 47.5 46.8 40.1 -6.7
23–26 38.2 38.1 35.8 40.0 40.3 47.7 44.7 45.5 41.7 41.2 42.5 56.2 59.6 58.6 62.1 52.1 52.6 55.0 48.3 -6.7
27–30 36.9 32.4 39.4 38.5 38.9 35.8 37.7 39.8 41.3 39.4 43.5 62.3 65.2 59.8 64.4 56.2 60.9 55.2 57.6 +2.3
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Amphetamines d 18 58.1 57.1 57.1 57.4 55.0 55.4 51.2 52.9 49.6 47.9 47.1 44.1 47.0 45.4 42.7 44.5 41.9 41.1 38.0 -3.2
19–22 57.6 60.2 56.5 53.7 55.1 53.9 56.9 52.3 55.8 49.5 49.8 43.6 52.3 54.4 54.0 55.3 57.4 54.8 57.9 +3.1
23–26 49.1 51.1 49.4 48.2 50.3 51.8 51.9 58.0 53.7 46.9 51.0 45.5 55.5 55.6 59.4 54.3 54.7 52.5 52.7 +0.2
27–30 48.2 47.6 49.3 45.6 48.7 43.9 45.3 49.2 48.1 45.0 51.1 46.4 49.9 54.6 54.2 55.5 56.6 49.2 58.0 +8.8 s
35 38.5 42.2 39.6 39.2 39.2 35.4 35.4 40.3 40.4 40.6 39.2 37.1 40.4 37.5 40.7 38.9 37.3 38.9 36.2 -2.6
40 41.9 39.4 37.5 39.4 38.7 37.9 41.1 38.4 37.6 39.2 37.2 37.0 34.3 35.8 34.6 35.6 34.0 36.7 34.8 -1.9
45 — — — — 35.8 39.8 39.3 37.1 38.3 36.8 33.0 39.8 37.0 34.5 39.3 35.2 32.4 35.2 34.9 -0.3
50 — — — — — — — — — 32.8 38.0 34.4 33.9 32.3 33.0 31.1 33.5 34.9 32.7 -2.2
55 — — — — — — — — — — — — — — 36.8 39.6 35.3 35.2 34.8 -0.3
↓
(List of drugs continued.)
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TABLE 7-4 (cont.)
2016– 
2017 
change
Percentage saying fairly easy or very easy to get aQ. How difficult do you 
think it would be for you to 
get each of the following 
types of drugs, if you 
wanted some?
345
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Crystal 18 — — — — — — — — — — 24.0 24.3 26.0 26.6 25.6 27.0 26.9 27.6 29.8
  methamphetamine 19–22 — — — — — — — — — — 24.0 21.8 22.5 20.9 24.7 25.5 25.4 29.3 31.0
  (ice) 23–26 — — — — — — — — — — 22.3 20.0 21.3 22.9 24.5 24.7 24.7 25.8 30.2
27–30 — — — — — — — — — — 27.3 19.7 22.0 21.2 21.7 25.8 26.1 25.1 22.6
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Sedatives/ 18 49.1 54.9 55.2 52.5 51.9 51.3 48.3 48.2 47.8 48.4 45.9 42.4 44.0 44.5 43.3 42.3 41.4 40.0 40.7
  barbiturates d 19–22 59.5 61.1 56.8 54.2 48.1 52.7 46.8 44.6 45.5 47.7 44.2 41.7 43.4 41.9 40.6 42.9 41.1 39.8 39.2
23–26 — — — — 52.7 47.7 46.4 45.9 47.4 44.8 41.6 39.6 42.0 38.8 40.3 42.1 40.6 39.1 42.6
27–30 — — — — — — — — 43.2 44.5 44.2 38.5 37.8 39.7 37.4 39.9 41.2 39.1 33.9
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Tranquilizers 18 59.1 60.8 58.9 55.3 54.5 54.7 51.2 48.6 49.1 45.3 44.7 40.8 40.9 41.1 39.2 37.8 36.0 35.4 36.2
19–22 67.4 62.8 62.0 62.3 52.5 55.6 52.9 50.3 50.0 49.4 45.4 44.8 40.7 40.9 41.0 40.2 37.6 37.8 36.8
23–26 — — — — 60.2 54.3 54.1 56.3 52.8 51.4 47.8 45.1 48.1 43.2 45.9 44.3 42.3 36.4 39.4
27–30 — — — — — — — — 55.3 54.4 54.9 47.5 47.8 47.4 44.4 44.8 46.2 41.9 39.9
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Steroids 18 — — — — — — — — — — — 46.7 46.8 44.8 42.9 45.5 40.3 41.7 44.5
19–22 — — — — — — — — — — 44.1 44.8 46.3 41.7 40.9 41.8 40.8 39.2 39.2
23–26 — — — — — — — — — — 37.6 35.8 39.3 35.8 37.0 37.4 33.9 35.5 34.9
27–30 — — — — — — — — — — 36.4 30.6 35.0 31.6 30.5 33.1 35.6 32.5 30.5
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Approximate 18 3,240 3,578 3,602 3,385 3,269 3,274 3,077 3,271 3,231 2,806 2,549 2,476 2,586 2,670 2,526 2,552 2,340 2,517 2,520
Weighted N = 19–22 582 601 582 588 559 571 592 581 568 572 571 534 512 480 459 470 467 463 433
23–26 540 541 548 539 526 514 532 511 523 500 463 449 418 419 395
27–30 519 513 510 487 475 473 437 446 468 459 425
35 1,142 1,141 1,146 1,150 1,032
40 1,029
45
50
55
Age 
Group
(Table continued on next page.)
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Cont.)
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Crystal 18 27.6 27.8 28.3 28.3 26.1 26.7 27.2 26.7 25.1 23.3 22.3 18.3 17.1 14.5 17.2 13.7 15.3 14.5 13.6 -0.9
  methamphetamine 19–22 31.8 27.4 28.4 31.2 26.5 27.1 28.9 29.1 27.7 24.1 19.2 19.3 19.4 13.5 15.3 15.3 15.0 15.7 10.9 -4.8
  (ice) 23–26 28.5 25.8 26.4 25.1 26.4 32.3 27.8 32.3 27.8 27.7 23.1 26.1 18.2 23.5 16.3 16.0 15.1 14.0 16.2 +2.2
27–30 29.1 25.3 27.6 29.5 30.9 25.5 27.4 31.8 29.7 31.4 27.7 27.6 26.2 24.2 22.3 22.0 20.3 22.6 17.9 -4.7
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Sedatives/ 18 37.9 37.4 35.7 36.6 35.3 46.3 44.4 43.8 41.7 38.8 37.9 36.8 32.4 28.7 27.9 26.3 25.0 25.7 23.4 -2.3
  barbiturates e 19–22 42.3 40.6 39.3 40.8 38.4 43.8 47.8 42.6 47.5 43.2 42.6 39.6 38.1 31.6 32.1 32.6 35.3 31.1 30.3 -0.8
23–26 39.7 37.6 36.1 36.4 37.8 49.4 48.4 51.4 46.5 43.3 47.7 40.4 41.3 40.1 42.2 33.2 35.1 32.0 28.2 -3.8
27–30 38.4 36.1 38.1 34.8 35.6 40.5 42.9 43.3 46.4 44.7 48.5 43.1 42.9 42.3 44.8 39.9 42.9 35.9 36.5 +0.6
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Tranquilizers 18 32.7 33.8 33.1 32.9 29.8 30.1 25.7 24.4 23.6 22.4 21.2 18.4 16.8 14.9 15.0 14.4 14.9 15.2 14.9 -0.3
19–22 37.1 36.5 34.9 34.6 34.2 29.7 30.1 22.8 28.5 23.3 18.3 20.2 18.6 17.3 17.4 16.8 19.7 17.8 15.0 -2.8
23–26 38.3 37.6 38.7 33.7 32.5 36.6 32.9 33.0 31.7 30.3 27.7 21.8 23.0 22.1 18.5 17.5 16.6 13.3 15.9 +2.7
27–30 41.5 36.7 42.9 38.1 35.9 30.6 33.5 32.1 32.4 33.1 30.1 30.6 27.1 25.7 28.1 21.2 22.1 20.3 18.1 -2.2
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Steroids 18 44.6 44.8 44.4 45.5 40.7 42.6 39.7 41.1 40.1 35.2 30.3 27.3 26.1 25.0 28.5 22.0 23.7 21.3 20.1 -1.2
19–22 40.5 40.3 38.1 41.4 39.4 37.8 37.6 37.1 37.9 33.5 28.7 25.1 24.3 21.2 20.6 25.7 25.1 24.8 19.8 -4.9
23–26 37.1 34.0 34.7 33.1 31.1 34.7 31.2 34.2 33.3 30.2 28.6 22.2 29.2 25.6 23.6 24.1 18.3 18.7 18.5 -0.2
27–30 34.5 36.2 34.6 33.0 32.6 30.6 32.4 29.7 30.9 31.0 31.9 27.6 27.0 23.9 22.3 22.6 23.9 22.5 23.5 +0.9
35 — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — —
Approximate 18 2,215 2,095 1,850 2,138 2,391 2,169 2,161 2,161 2,420 2,276 2,243 2,395 2,337 2,280 2,092 2,066 2,181 1,966 1,882
Weighted N = 19–22 425 400 398 375 386 441 392 376 362 380 377 377 355 341 342 313 294 252 266
23–26 415 388 401 362 356 411 359 335 338 355 312 358 313 332 325 309 305 271 267
27–30 424 365 357 349 368 393 359 347 324 334 305 340 325 334 281 310 258 284 291
35 1,022 981 977 890 934 963 1,009 925 863 898 952 895 852 875 844 769 726 732 727
40 1,093 1,096 1,065 1,037 898 967 928 919 868 881 870 911 850 823 820 883 787 765 796
45 911 1,026 1,005 972 954 851 888 846 852 842 806 785 839 783 738
50 902 975 989 939 958 819 868 802 827 776
55 832 903 907 909 920
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
' — ' indicates data not available.
aAnswer alternatives were: (1) Probably impossible, (2) Very difficult, (3) Fairly difficult, (4) Fairly easy, and (5) Very easy.
bIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the discontinuity 
in the 2001 results.
cIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin,OxyContin, Percocet, etc.  This change likely explains the discontinuity  
in the 2010 results.
dIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin.  This change likely explains the discontinuity in the 2011 results.
eIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers.
These changes likely explain the discontinuity in the 2004 results.
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Source.  The Monitoring the Future study, the University of Michigan.
FIGURE 7-1
Trends in Exposure to Use of ANY ILLICIT DRUGS
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Often Exposed
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
FIGURE 7-2
Trends in Exposure to Use of ANY ILLICIT DRUGS
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Source.  The Monitoring the Future study, the University of Michigan.
aThese estimates were derived from responses to the question for the following drugs: marijuana, LSD, other hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), and tranquilizers.
FIGURE 7-3
Trends in Exposure to Use of ANY ILLICIT DRUG OTHER THAN MARIJUANAa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
% Saying Any Exposure
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 Source.  The Monitoring the Future study, the University of Michigan.
aThese estimates were derived from responses to the question for the following drugs: marijuana, LSD, other hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), and tranquilizers.
% Saying Often Exposed
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
FIGURE 7-4
Trends in Exposure to Use of ANY ILLICIT DRUG OTHER THAN MARIJUANAa
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 7-5
Trends in Exposure to Use of MARIJUANA
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.  
% Saying Often Exposed
FIGURE 7-6
Trends in Exposure to Use of MARIJUANA
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
FIGURE 7-7
Trends in Exposure to Use of LSD
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
FIGURE 7-8
% Saying Often Exposed
Trends in Exposure to Use of LSD
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the discontinuity in the 2001 results. 
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FIGURE 7-9
Trends in Exposure to Use of HALLUCINOGENS OTHER THAN LSDa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the discontinuity in the 2001 results. 
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FIGURE 7-10
Trends in Exposure to Use of HALLUCINOGENS OTHER THAN LSDa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Any Exposure
FIGURE 7-11
Trends in Exposure to Use of COCAINE
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
0
10
20
30
40
50
’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
18 23-26
19-22 27-30
358
Source.  The Monitoring the Future study, the University of Michigan.
% Saying Often Exposed
FIGURE 7-12
Trends in Exposure to Use of COCAINE
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
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FIGURE 7-13
Trends in Exposure to Use of HEROIN
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Often Exposed
FIGURE 7-14
Trends in Exposure to Use of HEROIN
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc. This change likely explains the discontinuity in the 2010 results.
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FIGURE 7-15
Trends in Exposure to Use of NARCOTICS OTHER THAN HEROINa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source.  The Monitoring the Future study, the University of Michigan.
aIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc. This change likely explains the discontinuity in the 2010 results.
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FIGURE 7-16
Trends in Exposure to Use of NARCOTICS OTHER THAN HEROINa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin. This change likely explains the discontinuity in the 2011 results.
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FIGURE 7-17
Trends in Exposure to Use of AMPHETAMINESa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin. This change likely explains the discontinuity in the 2011 results.
% Saying Often Exposed
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
FIGURE 7-18
Trends in Exposure to Use of AMPHETAMINESa
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Source.  The Monitoring the Future study, the University of Michigan.
a  In 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. These changes likely explain the 
discontinuity in the 2004 results.
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FIGURE 7-19
Trends in Exposure to Use of SEDATIVES (BARBITURATES)a
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source.  The Monitoring the Future study, the University of Michigan.
a  In 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. These changes likely explain the 
discontinuity in the 2004 results.
% Saying Often Exposed
FIGURE 7-20
Trends in Exposure to Use of SEDATIVES (BARBITURATES)a
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
0
5
10
15
20
25
30
’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
18 23-26
19-22 27-30
367
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2001 Xanax was added to the list of examples. This change likely explains the discontinuity in the 2001 results. 
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FIGURE 7-21
Trends in Exposure to Use of TRANQUILIZERSa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.  
aIn 2001 Xanax was added to the list of examples. This change likely explains the discontinuity in the 2001 results.  
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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FIGURE 7-22
Trends in Exposure to Use of TRANQUILIZERSa
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Any Exposure
FIGURE 7-23
Trends in Exposure to Use of ALCOHOL
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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FIGURE 7-24
Trends in Exposure to Use of ALCOHOL
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Chapter 8 
 
PREVALENCE OF DRUG USE AMONG COLLEGE STUDENTS AND 
THEIR NONCOLLEGE PEERS 
 
College students have often been the harbingers of social and political changes that eventually 
spread to other segments of the population up and down the age spectrum. The Monitoring the 
Future (MTF) study tracks multiple forms of substance use among U.S. college students and has 
done so for nearly four decades. In this process, MTF has documented the fluctuations in college 
substance use as well as some patterns of influence on or by other age groups. This chapter focuses 
on the prevalence of drug use in 2017 by college students and their age-peers not in college; the 
next chapter (Chapter 9) focuses on historical trends in drug use in these two groups. 
 
Definition of College Students 
College students are defined in this volume as those follow-up respondents one to four years past 
high school who report that they were taking courses as full-time students in a two- or four-year 
undergraduate college at the beginning of March of the year in question. Note that full-time 
students at two-year colleges, such as community colleges, are included.  
The definition excludes those who are currently enrolled in college part-time and those who 
previously may have been college students or may have graduated from college by March one to 
four years after high school. MTF has been able to generate an unparalleled national sample of 
college students and peers not in college every year since 1980 by following representative 
samples of sequential high school classes after they graduate. The graduating class of 1976 was 
the first such class followed after graduation, and by 1980 the survey included college students 
one to four years past high school.  
The absence of dropouts in the original high school senior samples has practically no effect on the 
representativeness of these college samples, because very few high school dropouts go on to 
college. One notable limitation of the present design for the purpose of characterizing college 
students is that it limits the age range of the college sample. For trend estimation purposes (covered 
primarily in Chapter 9), we decided to limit the age band to the most typical one for college 
attendance, that is, one to four years past high school, which corresponds to modal ages 19 through 
22. According to statistics available from the United States Census Bureau,1 this age band should 
encompass about 75% of all undergraduate college students enrolled full-time in 2014, down 
slightly from the 79% covered in 1989. Although expanding the age band to include an additional 
two years would cover 79% of all enrolled college students of any age, it would slightly reduce 
the homogeneity of the college experience by including older classmates, it would bring four-year 
college graduates into the noncollege group, and it would limit historical comparability. Special 
analyses conducted in 1985, and replicated in 1997, 2011, and 2017 indicated extremely small 
differences in the estimates of drug use prevalence under the two definitions for college students 
on noncollege youth. In all the years we evaluated this, the annual prevalence of all drugs shifted 
0.5 percentage points or less, with few exceptions. Based on the 2017 analyses, the difference was 
0.6 percentage points for hallucinogens other than LSD, and 0.7 percentage points for MDMA 
                                                 
1 U.S. Census Bureau, October 2014. Available at: http://www.census.gov/  
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 (ecstasy, molly). Thus, for purposes of estimating prevalence, the four- and six-year intervals are 
nearly interchangeable, suggesting that this limitation is negligible for our purposes of estimating 
current prevalence and historical trends (in Chapter 9). 
The MTF panels also include high school graduates one to four years past high school who were 
not attending college during March in the year in question. Having data for both groups is a rare 
and valuable feature of the MTF follow-up design and makes it possible to compare differences 
and changes in the use of various substances after high school for each group. Full-time college 
students as defined here now constitute almost two-thirds (63%) of the entire follow-up sample 
one to four years past high school. If data from the missing high school dropout segment—which 
has declined from around 15% to roughly 7% of a class cohort as summarized in Chapter 1—were 
available for inclusion as part of the noncollege segment, any difference between the two groups 
in terms of their substance use would likely be enlarged; therefore, any difference observed here 
is only an indication of the direction and relative size of difference between the college and the 
entire noncollege population, not an absolute estimate of the difference. 
 
PREVALENCE OF DRUG USE AMONG COLLEGE STUDENTS VERSUS THEIR 
NONCOLLEGE PEERS  
In 2017, prevalence of use for most illicit drugs among college students was lower compared with 
use among their noncollege peers, but the degree of difference varied considerably by drug, as 
Tables 8-1 through 8-4 show. 
 
• In 2017, annual prevalence of use of any illicit drug was 43% for college students as well 
as for noncollege respondents (Table 8-2). Similarly, annual prevalence of using any illicit 
drug other than marijuana was 18% among college students and also noncollege 
respondents. Thirty-day prevalence was lower among college than among noncollege 
youth for use of any illicit drug (24% vs. 27%, respectively) and use of any illicit other 
than marijuana (7.0% vs. 8.4%, respectively) (Table 8-3). 
• The annual prevalence of marijuana use was lower among college students than 
noncollege respondents in 2017 (38% vs. 41%, respectively) (Table 8-2); the same was 
true regarding 30-day marijuana prevalence (21% versus 28%, respectively) (Table 8-3). 
The rate of current daily marijuana use was three times higher for the noncollege group 
(13.2%) compared to the college students (4.4%) (Table 8-4). It is noteworthy that 
proportional differences between college and noncollege youth for marijuana use increase 
for measures of more frequent use. 
• With regard to vaping marijuana, based on new questions added to the surveys in 2017, 
prevalence was higher among noncollege youth than college students. For the two groups 
respectively, annual prevalence was 14% and 11% (Table 8-2); 30-day prevalence was 
7.8% and 5.2% (Table 8-3). 
• It is clear that use of a number of illicit drugs other than marijuana tended to be distinctly 
higher among those not in college. (As previously noted, such differences would likely be 
larger if the noncollege sample included high school dropouts.) In fact, several of the less 
commonly used drugs showed annual use rates for noncollege respondents in 2017 that 
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were two or more times the college student rates, including synthetic marijuana, salvia, 
crack cocaine, heroin, methamphetamine, crystal methamphetamine, and bath salts 
(synthetic stimulants). 
• In 2017, 4.1% of the noncollege group and 3.1% of the college group reported past-year
use of narcotics other than heroin without medical supervision (Table 8-2). With respect
to specific drugs in this class, Vicodin was used by 1.8% of the noncollege group vs. 1.1%
of college students; the corresponding numbers for OxyContin were 2.6% and 1.8%.
• By way of contrast, amphetamine use was somewhat higher among college students than
among their noncollege age-mates. Annual prevalence of amphetamine use among college
students was 8.6% in 2017, compared to 7.3% in the noncollege group. Specifically, annual
prevalence of Adderall use without medical supervision (Table 8-2) was higher for college
students (9.5%) than for noncollege respondents (6.7%), as has been the case for the last
several years. The higher use by college students is very likely because this amphetamine
drug, intended for the treatment of attention deficit hyperactivity disorder (ADHD), is
sometimes used by students to stay awake and alert in order to complete course work and
to study for exams. The nonmedical use of Ritalin, another but now less common stimulant
drug prescribed for ADHD, was similarly low in the college and noncollege groups in 2017
(annual prevalence of 1.5% vs. 1.4%, respectively).
• In addition, for most all measures of annual and current alcohol use, 2017 prevalence was
somewhat higher for the college group than the noncollege group. This was true for both
annual prevalence (76% vs. 72%) (Table 8-2) and 30-day prevalence (62% vs. 56%) (Table
8-3).
• College students also had a higher prevalence (33%) of occasions of heavy or binge 
drinking (five or more drinks in a row in the past two weeks) than their noncollege peers 
(28%) in 2017 (Table 8-4). Similarly, more college students (35%) reported having been 
drunk in the prior 30 days, compared to noncollege respondents (30%) (Table 8-3). Both 
groups had relatively low daily drinking prevalence, with it being lower in 2017 among 
college students (2.2%) than their noncollege peers (4.0%) (Table 8-4). In high school, 
college-bound students, especially in earlier grades, were far less likely to drink alcohol 
at any level compared to their noncollege-bound peers (see Volume I); thus, both relative 
and absolute increases in most indices of alcohol use among college students in the first 
few years following high school are quite striking.
• Beginning in 2005, we have given explicit attention to the problem of extreme binge
drinking (also referred to as high intensity drinking), introducing a set of questions on the
subject into one of the six questionnaire forms used with young adults, including college
students. The questions asked respondents about the frequency in the past two weeks of
having 10 or more drinks in a row and of having 15 or more drinks in a row. The low
numbers of cases that resulted from a single questionnaire form necessitate combining
multiple years of data (2005–2017), making 2,520 weighted cases available from the
college student segment and 1,467 for the noncollege segment of the same age. Across the
13 years from 2005 to 2017, about one in eight college students (12%) reported having 10
or more drinks in a row at least once in the prior two weeks, and one in twenty-five (4%)
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reported 15 or more drinks in a row at least once in the prior two weeks.2 The noncollege 
respondents had similar respective rates (11% and 5%). Clearly, this type of extreme binge 
drinking is worrisome among both college students and noncollege youth.3,4 Trends since 
2005 are considered in Chapter 9 (Tables 9-4, 9-5, and 9-6), where we document a general 
downward trend, especially for college students. As will be discussed below, there are 
dramatic gender differences in the prevalence of these behaviors. 
• In 2017, 60% of college students reported using flavored alcoholic beverages in the prior
year, similar to 61% for the noncollege group (Table 8-2).
• In 2017, prevalence of alcohol beverages containing caffeine was slightly higher for the
college than the noncollege group (32% versus 27% respectively) (Table 8-2).
• Among all substances studied, the largest differences for annual, 30-day, and daily
prevalence rates between college and noncollege groups occur for cigarette smoking. For
example, the prevalence of daily smoking for college students was 2.0% versus 14.4% for
noncollege respondents in 2017 (Table 8-4). Smoking at the rate of a half pack or more per
day stood at 0.2% versus 7.9% % for these two groups, respectively. The 12th grade data
show the college-bound to have much lower smoking rates in high school than the non-
college-bound; thus, in contrast to what was true for alcohol use, these substantial
differences observed at college age actually largely preceded college attendance.5 The
smoking differences would be even greater if dropouts were included in the noncollege
group, because dropouts have consistently shown an exceptionally high rate of smoking.6
• In 2017, we expanded the vaping questions to get at specific substances being vaped 
including nicotine, marijuana, and just flavoring. With regard to vaping nicotine, annual 
prevalence was lower for college youth (13%) than noncollege youth (21%) (Table 8-2); 
this was also true regarding 30-day prevalence (6.0% versus 7.9%, respectively) (Table 
8-3). Vaping just flavoring was similar for college students and noncollege youth; for the 
two groups, respectively, annual prevalence was 13% and 15% (Table 8-2) and 
30-day prevalence was 4.2% and 4.7% (Table 8-3).
In sum, as has been true for many years, the noncollege segment of the modal age 19-22 population 
was generally more drug-involved than the college student segment in 2017, especially regarding 
most forms of illicit drug and tobacco use. This pattern is a continuation of the high school pattern 
2 See Patrick & Terry-McElrath (2017) for differences in 5+, 10+, and 15+ drinking by non-attenders, part-time college attenders, 2-year college 
attenders, and 4-year college attenders. Patrick, M. E., & Terry-McElrath, Y. M. (2017). High-intensity drinking by underage young adults in the 
United States. Addiction, 112, 82-93. 
3 Patrick, M. E., Terry-McElrath, Y. M., Kloska, D. D., & Schulenberg, J. E. (2016). High-intensity drinking among young adults in the United 
States: Prevalence, frequency, and developmental change. Alcoholism: Clinical and Experimental Research, 40, 1905-1912.  
4 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O’Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence of 
binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41, 
1319-1328. 
5 See also Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in 
young adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
6 For an analysis showing much higher smoking rates among 8th graders who later dropped out before completing high school, see Bachman, J. G., 
O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use connection: How 
successes and failures in school relate to adolescent smoking, drug use, and delinquency. New York: Lawrence Erlbaum Associates/Taylor & 
Francis. 
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 in which those without college plans are more likely to use drugs. The only substances that college 
students were appreciably more likely to use than their noncollege peers were amphetamines 
(including Adderall in particular) and alcohol (particularly getting drunk and binge drinking). 
The higher rates of alcohol use among college students emerged only after high school; during 
high school alcohol use was lower among those who would later go on to college. 
 
GENDER DIFFERENCES IN PREVALENCE OF USE AMONG COLLEGE STUDENTS 
AND THEIR NONCOLLEGE PEERS 
Data stratified by gender (and college student status) are provided in Tables 8-1 to 8-4. 
 
• Most gender differences among college students and noncollege youth replicated those 
discussed in Chapter 4 for all young adults one to 12 years past high school, which in turn 
replicated gender differences among secondary school students. Thus among college 
students and noncollege youth, males had higher annual prevalence rates for most illicit 
drugs. 
• Among college students in 2017, annual prevalence of use of any illicit drug and any illicit 
drug other than marijuana was higher for males than females (46% vs. 40% for any illicit 
drug, and 20% vs. 17% for any illicit drug other than marijuana). Gender differences were 
similar in the noncollege group (Table 8-2).  
• Annual marijuana use was slightly higher among college males than females (41% vs. 
37%) in 2017, but the opposite was true for the noncollege group (40% vs. 42%) (Table 8-
2). Thirty-day marijuana use was higher among college males than females (24% vs. 
19%), as well as for noncollege males than females (29% vs. 27%) (Table 8-3). Daily 
marijuana use was about twice as high among male college students compared to female 
college students (6.4% vs. 3.1% respectively); and also higher for noncollege males than 
females (15% vs. 12%, respectively), although the rates of use for both genders were much 
higher for the noncollege than college group (Table 8-4).  
• With regard to vaping marijuana, based on new questions added to the surveys in 2017, 
annual prevalence was higher among college males than females (13% vs. 9.3%), as well 
as among noncollege males than females (16% vs. 12%) (Table 8-2). Among college 
students, 30-day prevalence was higher among males than females (8.7% vs. 2.9%); 
however, among noncollege youth the opposite was true (6.6% vs. 8.6%) (Table 8-3). 
• Among college students, annual prevalence of any hallucinogens in 2017 was twice as 
high for males than for females (6.0% vs. 2.9%), and the same was true for LSD specifically 
(4.1% vs. 2.1%); corresponding prevalence for hallucinogens other than LSD was 3.3% 
and 2.0%, and for MDMA (ecstasy, and more recently Molly) it was 3.1% and 2.2%. 
Among noncollege respondents, annual prevalence was about twice as high for males than 
for females for use of any hallucinogens (7.8% vs. 4.0%), for use of LSD specifically (5.7% 
vs. 2.9%), and for use of hallucinogens other than LSD (5.3% vs. 1.9%); however, annual 
prevalence was lower for males than for females for MDMA (ecstasy, and more recently 
Molly) (4.2% vs. 5.1%), as well as for rarely used salvia (1.4% vs. 3.2%) (Table 8-2). 
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 • Among college students, annual prevalence of narcotics other than heroin without 
medical supervision was slightly higher for males (3.7%) than for females (2.7%) in 2017, 
whereas in the noncollege group annual prevalence was similar for males (4.2%) and 
females (4.1%) (Table 8-2). For the specific narcotic Vicodin, use among college students 
was slightly higher for males than females (1.4% vs. 0.9%), as was the case in the 
noncollege group (2.1% vs. 1.6%). For OxyContin use, males were slightly higher than 
females among college students (2.6% vs. 1.2%), with the opposite being true for 
noncollege youth (1.9% vs. 3.0%).  
 
• Annual amphetamine use in 2017 was higher among college females (9.2%) than college 
males (7.7%), with it being similar among noncollege females and males (7.2% versus 
7.5%) (Table 8-2).  
• Annual Ritalin use without medical supervision in 2017 was similar among college males 
(1.4%) and females (1.5%), and in the noncollege segment use among males was lower 
than among females (0.8% vs. 1.8%, respectively) (Table 8-2). 
• The annual prevalence of Adderall use outside of medical supervision in 2017 was similar 
among male and female college students (9.8% and 9.2%, respectively), whereas use was 
higher among females than among males in the noncollege segment (7.4% vs. 5.7%, 
respectively) (Table 8-2). Again, the higher use of amphetamines among male and female 
college students compared with male and female noncollege respondents suggests that 
some college students of both genders could be using these drugs to try to enhance their 
academic performance.  
• Binge drinking (5+ drinks in a row in the past two weeks) was higher for males than for 
females among both college students (39% vs. 29%) and noncollege youth (32% vs. 26%) 
(Table 8-4). Similarly, among college students, males were more likely than females to 
report being drunk in the past 30 days (38% vs. 33%) in 2017; however, for the noncollege 
segment, males were lower than females (25% vs. 33%) (Table 8-3).  
• Extreme binge drinking (10+ or 15+ drinks in a row in the past two weeks) showed a large 
gender difference in both groups. For the years 2005–2017 combined (as discussed above), 
the prevalence of having 10 or more drinks in a row in the prior two weeks was about 
three times higher among college males (21%) than among college females (7%), and 
similarly higher among noncollege males (17%) than noncollege females (7%). Prevalence 
of 10+ extreme binge drinking for college males (21%) exceeded that for noncollege males 
(17%), whereas college and noncollege females were similar (at 7%). Regarding the 
prevalence of having 15 or more drinks in a row, gender differences were similar across 
college and noncollege respondents: it was 8.5% and 9.1% for college and noncollege 
males, respectively, and 1.6% and 2.1% for college and noncollege females, respectively. 
Put another way, about one in five college males and one in six noncollege males had 10 
or more drinks at least once during the prior two weeks, and one in eleven males regardless 
of college student status reported having 15 or more drinks at least once in the past two 
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 weeks; corresponding rates for females regardless of college student status were about one 
in fifteen and one in fifty, respectively.7 
• Flavored alcoholic beverages were more likely to be consumed by college females than 
college males (68% vs. 45% reporting past-year use), as was the case for the noncollege 
group (67% of females vs. 53% of males) in 2017 (Table 8-2).  
• Annual prevalence of alcoholic beverages containing caffeine in 2017 was higher among 
college males (36%) than college females (28%); it was also slightly higher among 
noncollege males (29%) than noncollege females (26%) (Table 8-2). These findings 
suggest that college males in particular are at risk for this potentially dangerous behavior. 
• Among college students, 30-day prevalence of cigarette smoking was higher for males 
(11%) than for females (6%) in 2017, and that was true to a lesser extent for the noncollege 
segment (24% and 20%, respectively) (Table 8-3); rates for both genders were much higher 
in the noncollege group. Daily smoking was also higher for males than females in the 
college segment (3.4% and 1.1%, respectively); the rates again were much higher in the 
noncollege segment (15% for males and 14% for females) (Table 8-4). Put another way, 
daily smoking was five times as high among males in the noncollege segment as among 
male college students (15% vs. 3%), and eight times as high among females in the 
noncollege segment as among female college students (8% vs. 1%). Rates of smoking a 
half pack or more per day among college students were 0.6% for males and <.01% for 
females, compared with 7.2% and 8.3% for the noncollege segment, respectively. 
• Prevalence of most other types of tobacco use was higher among males than females in 
both the college and noncollege groups in 2017 as shown in Tables 8-2 and 8-3.  
• With regard to vaping nicotine, annual prevalence was twice as high among college males 
compared to college females (19% versus 9.4%); among noncollege youth, it was also 
somewhat higher among males than females (25% versus 19%) (Table 8-2). Thirty-day 
prevalence was much higher for males than females among both college students (11% 
versus 3.2%) and noncollege youth (12% versus 4.9%) (Table 8-3).  
In sum, most licit and illicit drugs were used by a higher proportion of college males than college 
females, with the largest proportional differences occurring for daily marijuana use, two-week 
extreme binge drinking, 30-day vaping of marijuana and nicotine, and annual hallucinogen 
use. In general, gender differences in the college segment were similar to those in the noncollege 
segment, with noteworthy differences in 2017 regarding 30-day marijuana vaping and binge 
drinking. Compared with noncollege males, college males were more frequent users of alcohol 
and Adderall (outside of medical supervision), but considerably less likely to use marijuana daily, 
and this same pattern held for noncollege versus college females. The most impressive difference 
between the college and noncollege segments is for cigarette smoking, with noncollege males and 
females showing much higher use than college males and females. 
                                                 
7 For additional information on 10+ drinking by gender and college attendance, see Patrick, M. E., Terry-McElrath, Y. M., Kloska, D. D., & 
Schulenberg, J. E. (2016). High-intensity drinking among young adults in the United States: Prevalence, frequency, and developmental change. 
Alcoholism: Clinical and Experimental Research, 40, 1905-1912.  
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Any Illicit Drug a 55.5 63.3 57.8 61.7 54.1 64.4
Any Illicit Drug other than Marijuana a 26.3 31.3 27.0 33.8 25.8 29.5
Marijuana 50.6 59.6 52.6 60.2 49.3 59.2
Inhalants b 3.4 3.6 2.9 4.4 3.7 3.0
Hallucinogens c 7.3 12.1 9.2 14.7 6.1 10.3
     LSD c 5.3 8.5 6.1 10.1 4.7 7.4
     Hallucinogens other than LSD c   5.0 8.1 6.7 10.7 4.0 6.4
     Ecstasy (MDMA) d 5.3 11.3 4.6 11.6 5.8 11.1
Cocaine 6.6 9.8 8.5 10.5 5.3 9.4
     Crack c 0.6 1.4 1.0 0.4 0.3 2.0
     Other Cocaine d 6.1 9.8 7.3 12.1 5.4 8.2
Heroin 0.1 1.1 0.1 1.2 * 1.0
     With a Needle e . 0.7 . 0.8 . 0.6
     Without a Needle e 0.1 1.3 0.4 2.3 * 0.6
Narcotics other than Heroin f 6.9 10.5 7.2 11.8 6.7 9.7
Amphetamines, Adjusted f,g 12.7 14.2 11.9 16.2 13.2 12.9
     Methamphetamine e 0.6 4.8 1.1 5.3 0.3 4.6
     Crystal Methamphetamine (Ice) e 0.4 2.2 0.9 1.8 * 2.4
Sedatives (Barbiturates) f 3.9 4.8 4.8 5.4 3.3 4.5
Tranquilizers f 6.7 11.4 6.8 12.2 6.7 10.9
Alcohol 79.0 77.1 75.9 76.2 81.0 77.7
     Been Drunk b 64.8 63.7 67.2 64.8 63.1 63.1
     Flavored Alcoholic Beverages h 72.2 74.9 63.1 70.6 77.0 78.5
Cigarettes — — — — — —
Any Vaping e 36.1 37.0 37.5 43.4 35.2 32.9
     Vaping Marijuana e 14.3 18.8 14.9 22.2 14.0 16.6
     Vaping Nicotine e 22.5 29.2 26.5 32.4 20.0 27.2
     Vaping Just Flavoring e 26.7 32.5 22.3 36.3 29.4 30.1
Steroids e 1.2 1.2 2.7 2.7 0.2 0.4
Approximate Weighted N = 870 500 340 200 530 300
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
' — ' indicates data not available. 
See footnotes following Table 8-4.
TABLE 8-1
Lifetime Prevalence of Use for Various Types of Drugs, 2017:
Full-Time College Students vs. Others
by Gender
College Others
Full-Time
College
(Entries are percentages.)
among Respondents 1 to 4 Years beyond High School
Full-Time
College
Total
Others
Males Females
Others
Full-Time
379
Any Illicit Drug a 42.5 43.0 46.4 39.8 40.0 45.1
Any Illicit Drug other than Marijuana a 18.2 18.0 19.8 19.9 17.1 16.7
Marijuana 38.3 41.3 40.8 39.8 36.7 42.4
Synthetic Marijuana b 0.5 2.4 0.9 3.8 0.4 1.6
Inhalants b 1.7 0.6 2.3 1.5 1.4 *
Hallucinogens c 4.1 5.5 6.0 7.8 2.9 4.0
     LSD c 2.9 4.0 4.1 5.7 2.1 2.9
     Hallucinogens other than LSD c 2.5 3.2 3.3 5.3 2.0 1.9
     Ecstasy (MDMA) d 2.6 4.7 3.1 4.2 2.2 5.1
     Salvia b 0.3 2.5 0.9 1.4 * 3.2
Cocaine 4.8 5.2 6.6 3.9 3.6 6.0
     Crack c 0.2 0.7 0.5 0.4 * 0.9
     Other Cocaine d 4.5 4.8 5.2 3.9 4.0 5.3
Heroin * 0.3 * * * 0.4
     With a Needle e * * * * * *
     Without a Needle e * * * * * *
Narcotics other than Heroin f 3.1 4.1 3.7 4.2 2.7 4.1
     OxyContin b,f 1.8 2.6 2.6 1.9 1.2 3.0
     Vicodin b,f 1.1 1.8 1.4 2.1 0.9 1.6
Amphetamines, Adjusted f,g 8.6 7.3 7.7 7.5 9.2 7.2
     Ritalin b,f 1.5 1.4 1.4 0.8 1.5 1.8
     Adderall b,f 9.5 6.7 9.8 5.7 9.2 7.4
     Methamphetamine e 0.4 1.8 1.1 0.7 * 2.5
     Crystal Methamphetamine (Ice) e 0.4 1.1 0.9 * * 1.9
     Bath Salts (synthetic stimulants) b 0.2 1.5 0.6 2.4 * 1.0
Sedatives (Barbiturates) f 1.9 2.4 2.4 3.1 1.6 1.9
Tranquilizers f 3.7 4.5 4.0 4.8 3.4 4.4
GHB e * * * * * *
Ketamine e 0.3 0.5 0.9 1.4 * *
Alcohol 75.7 72.0 73.6 71.4 77.1 72.4
     Been Drunk b 58.4 52.2 62.8 51.2 55.4 52.8
     Flavored Alcoholic Beverages h 60.1 60.9 45.2 53.3 67.9 67.1
     Alcoholic Beverages containing Caffeine e,j 31.5 26.7 36.1 28.8 28.2 25.6
TABLE 8-2
Annual Prevalence of Use for Various Types of Drugs, 2017:
Full-Time College Students vs. Others
by Gender
OthersOthers
Full-Time
College Others
(Entries are percentages.)
Total Males Females
Full-Time
among Respondents 1 to 4 Years beyond High School
College
Full-Time
College
(Table continued on next page.)
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Cigarettes 16.6 30.4 20.0 35.5 14.4 26.9
     Tobacco using a Hookah b 10.1 16.8 12.9 17.7 8.3 16.2
     Small Cigars e 13.7 20.8 26.9 30.8 4.5 14.4
     Dissolvable Tobacco e 0.7 1.4 1.7 0.5 * 2.0
     Snus e 4.3 4.9 8.2 10.8 1.6 1.2
Any Vaping e 23.5 24.8 27.1 29.5 21.2 21.7
     Vaping Marijuana e 10.7 13.7 12.9 16.2 9.3 12.0
     Vaping Nicotine e 12.9 21.0 18.5 24.8 9.4 18.5
     Vaping Just Flavoring e 13.1 15.0 12.5 13.1 13.5 16.3
Steroids e 0.6 0.6 1.6 0.9 * 0.4
Approximate Weighted N = 870 500 340 200 530 300
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 8-4.
Males Females
TABLE 8-2 (cont.)
Annual Prevalence of Use for Various Types of Drugs, 2017:
Others
Full-Time Full-Time Full-Time
College Others College Others College
Full-Time College Students vs. Others
among Respondents 1 to 4 Years beyond High School
by Gender
(Entries are percentages.)
Total
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Any Illicit Drug a 23.5 27.2 26.4 27.7 21.5 27.0
Any Illicit Drug other than Marijuana a 7.0 8.4 7.2 9.4 6.9 7.8
Marijuana 21.3 27.6 24.4 28.8 19.3 26.8
Inhalantsb 0.9 * 0.6 * 1.0 *
Hallucinogens c 1.2 1.5 1.2 2.1 1.3 1.1
     LSD c 0.9 1.0 1.1 1.1 0.7 0.9
     Hallucinogens other than LSD c 0.6 0.5 0.3 0.9 0.8 0.2
     Ecstasy (MDMA) d 0.5 1.2 0.6 0.7 0.4 1.6
Cocaine 1.3 1.2 1.4 1.4 1.3 1.2
     Crack c * 0.4 * * * 0.7
     Other Cocaine d 1.1 0.7 1.1 1.6 1.1 *
Heroin * 0.3 * * * 0.4
Narcotics other than Heroin f 0.7 1.4 0.6 1.5 0.7 1.3
Amphetamines, Adjusted f,g 3.7 3.1 3.9 3.2 3.5 3.0
     Crystal Methamphetamine (Ice) e 0.4 0.9 0.9 * * 1.5
Sedatives (Barbiturates) f 0.5 0.9 0.7 1.2 0.4 0.8
Tranquilizers f 0.9 1.6 0.6 1.7 1.1 1.5
Alcohol 62.0 56.4 63.2 56.3 61.2 56.4
     Been Drunk b 35.0 29.9 37.5 25.3 33.3 32.5
     Flavored Alcoholic Beverages h 36.3 27.3 19.1 28.8 45.3 26.0
Cigarettes 7.9 21.7 11.3 24.4 5.8 19.9
Any Vaping e 11.2 13.7 16.6 15.9 7.8 12.3
     Vaping Marijuana e 5.2 7.8 8.7 6.6 2.9 8.6
     Vaping Nicotine e 6.0 7.9 10.6 12.4 3.2 4.9
     Vaping Just Flavoring e 4.2 4.7 5.6 7.4 3.3 3.0
Large Cigars h 1.7 5.5 5.1 2.2 * 7.9
Flavored Little Cigars h 4.9 10.4 8.1 9.1 3.1 11.3
Regular Little Cigars h 1.7 5.3 3.1 7.2 1.0 3.9
Steroids e 0.3 0.3 0.8 * * 0.4
Approximate Weighted N = 870 500 340 200 530 300
Source. The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 8-4.
Total Males Females
Full-Time Full-Time Full-Time
TABLE 8-3
Thirty-Day Prevalence of Use for Various Types of Drugs, 2017:
Full-Time College Students vs. Others
among Respondents 1 to 4 Years beyond High School
(Entries are percentages.)
by Gender
CollegeOthers Others OthersCollege College
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Marijuana 4.4 13.2 6.4 15.4 3.1 11.7
Cocaine * 0.1 * 0.2 * *
Amphetamines, Adjusted f,g 0.1 0.4 0.1 0.3 0.1 0.5
Alcohol
     Daily 2.2 4.0 3.7 8.2 1.1 1.1
     5+ Drinks in a Row in Last 2 Weeks 32.9 28.1 38.6 31.5 29.2 25.8
Cigarettes
     Daily 2.0 14.4 3.4 14.5 1.1 14.4
     1/2 Pack+/Day 0.2 7.9 0.6 7.2 * 8.3
Approximate Weighted N = 870 500 340 200 530 300
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes on the following page.
TABLE 8-4
(Entries are percentages.)
by Gender
among Respondents 1 to 4 Years beyond High School
 Full-Time College Students vs. Others 
Thirty-Day Prevalence of Daily i Use for Various Types of Drugs, 2017:
FemalesMalesTotal
Full-Time
College
Full-Time
College OthersOthers
Full-Time
College Others
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Marijuana 4.4 13.2 6.4 15.4 3.1 11.7
Cocaine * 0.1 * 0.2 * *
Amphetamines, Adjusted f,g 0.1 0.4 0.1 0.3 0.1 0.5
Alcohol
     Daily 2.2 4.0 3.7 8.2 1.1 1.1
     5+ Drinks in a Row in Last 2 Weeks 32.9 28.1 38.6 31.5 29.2 25.8
     10+ Drinks in a Row in Last 2 Weeks h 10.2 9.3 14.5 11.8 7.8 7.2
     15+ Drinks in a Row in Last 2 Weeks h 1.3 5.0 2.0 7.4 0.9 3.2
Cigarettes
     Daily 2.0 14.4 3.4 14.5 1.1 14.4
     1/2 Pack+/Day 0.2 7.9 0.6 7.2 * 8.3
Approximate Weighted N = 870 500 340 200 530 300
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes on the following page.
College Others College Others College Others
Total Males Females
Full-Time Full-Time Full-Time
(Entries are percentages.)
TABLE 8-4
Thirty-Day Prevalence of Daily i Use for Various Types of Drugs, 2017:
 Full-Time College Students vs. Others 
among Respondents 1 to 4 Years beyond High School
by Gender
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aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, 
amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders. 
bThis drug was asked about in three of the six questionnaire forms. Total N  in 2017 for college students 
is approximately 440. 
cThis drug was asked about in five of the six questionnaire forms. Total N  in 2017 for college students 
is approximately 730. 
dThis drug was asked about in four of the six questionnaire forms. Total N  in 2017 for college students 
is approximately 580. 
eThis drug was asked about in two of the six questionnaire forms. Total N  in 2017 for college students 
is approximately 290. 
fOnly drug use that was not under a doctor’s orders is included here. 
gBased on the data from the revised question, which attempts to exclude inappropriate reporting of  
nonprescription amphetamines. 
hThis drug was asked about in one of the six questionnaire forms. Total N  in 2017 for college students 
is approximately 150. 
iDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured
as actual daily use, and 5+ drinks, measured as having five or more drinks in a row in the last two weeks.
jIn 2012 the alcoholic beverage containing caffeine question text was changed to alcoholic beverage mixed with energy  
drink.  The data for 2011 and 2012 are not comparable due to this question change.
Footnotes for Tables 8-1 through 8-4
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Chapter 9 
 
TRENDS IN DRUG USE AMONG COLLEGE STUDENTS AND THEIR 
NONCOLLEGE PEERS 
 
In this chapter, we consider current and past trends in substance use among college students and 
their noncollege peers. To put current trends in historical context, we note that between about 2000 
and 2009, years college students and high school seniors showed simultaneous decreases and 
increases in marijuana use as well as in the index of any illicit drug use. This secular trend (where 
change occurs similarly regardless of age/cohort) differed from prior trends in which drug use 
increases among college students either preceded or followed those among younger students. 
During the 1960–70s drug epidemic, illicit drug use increased dramatically among U.S. college 
students, then spread quickly to their noncollege-attending peers and eventually down the age 
spectrum to high school and even middle school students. The diffusion process seemed to have 
reversed during the subsequent epidemic relapse in the 1990s, when drug use increased first among 
those in early adolescence and then radiated up the age spectrum as those cohorts grew older 
(reflecting a cohort effect). Use subsequently declined among adolescents; this decline, like the 
preceding increase, radiated up the age spectrum—again a sign of a cohort effect.  
  
There has been some evidence of a more recent cohort effect emerging particularly regarding 
marijuana: marijuana use first rose among high school seniors, particularly from 2009 through 
2012 (followed by a leveling that continued through 2015 and nonsignificant increases in 2016 
and 2017) and then rose among college students and their noncollege peers, starting in 2011 and 
continuing into 2016. In 2017, there was a nonsignificant decline among college students and 
leveling among noncollege youth who had a slightly higher annual prevalence. See Figure 9-3a. 
 
Again, we define college students as follow-up respondents (i.e., high school graduates) one to 
four years past high school who report that they were taking courses as full-time students in a two- 
or four-year undergraduate college at the beginning of March in the year in question. For more 
information, see the “Definition of College Students” subsection in Chapter 8. 
 
Trend data are also provided here on the other high school graduates, those follow-up respondents 
who are one to four years past high school but do not meet our definition of full-time college 
students (Figures 9-1 through 9-16c). These young people may be working full- or part-time, not 
working at all, and/or attending a two- or four-year college part-time. This is an important group 
by itself, given less is known about their substance use, as well as an important comparison group 
for the college students. 
 
The proportion of young adult high school graduates one to four years beyond high school who 
attend college full-time has increased considerably since the MTF follow-ups began. In 2017, 
about 63% of the weighted number of follow-up respondents one to four years past high school 
met our definition of college students, compared with only 38% in the 1980 survey—the first 
survey to provide the full sampling of college students. This means, of course, that the proportion 
of our annual follow-up samples that is in the noncollege group of the same age has diminished 
considerably. 
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The difference between the college group and the noncollege group provides an estimate of the 
degree to which college students’ usage levels for various substances are above or below other 
high school graduates in this age band. If we were able to include the high school dropout segment 
in the calculations for the noncollege group, many of the differences with the college-enrolled 
would be accentuated.1 
For each year, approximately 900–1,500 weighted respondents constitute the college student 
sample (see Table 9-7 for numbers [Ns] per year) and roughly 600–1,700 respondents constitute 
the noncollege group one to four years beyond high school. Trend comparisons for these two 
groups are provided in this chapter. The reported results begin with 1980, the first year that enough 
follow-up surveys had accrued to characterize young high school graduates one to four years past 
high school. The 2017 survey is thus the 38th in the annual series on college students and non-
college-attending youth 1 to 4 years out of high school. 
Throughout much of the chapter, trends for the 12th grade samples are included for comparison 
purposes. It is important to keep in mind that the total 12th grade samples are shown and that there 
are substantial differences in rates of substance use within those samples between the college-
bound and those who do not plan to complete college. As shown extensively in Volume I2 and in 
Occasional Paper 91,3 12th grade students expecting to complete college are far less likely to 
smoke cigarettes and also less likely to use most other substances. So when considering figures 
that show higher rates of use among all 12th graders (regardless of college expectations) than 
among college students, it should not be concluded that usage declined after college entrance; the 
college-bound were already lower in usage rates than other 12th graders for almost all substances. 
One additional point is relevant to interpreting differences over time for those attending college 
and those not attending college, both in terms of the differences between them and trends over 
time for either taken separately: the proportion of college students who are female has risen 
substantially since 1980. In 1980, females constituted about 50% of the college respondents, but 
by 2017 they constituted 61%. Females thus are a declining proportion of the noncollege group. 
As will be discussed below, we have charted the trends separately for male and female college 
students to permit an assessment of what effect these changing proportions may have on the overall 
rates observed for college students.  
TRENDS IN PREVALENCE, 1980–2017: COLLEGE STUDENTS VERSUS THOSE 
NOT ENROLLED IN COLLEGE AND 12TH GRADERS 
• Among college students, the annual prevalence of using any illicit drug rose gradually
from a recent low of 34% in 2006 to 43% in 2016, the highest it had been for three decades
1 Panel analyses of samples from the high school classes of 1995–1997, followed for an eight-year period beginning when they were in 8th grade, 
clearly show that those who dropped out of high school had distinctly higher rates of substance use both before and after they left school. See 
Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use 
connection: How successes and failures in school relate to adolescent smoking, drinking, drug use, and delinquency. New York: Lawrence Erlbaum 
Associates/Taylor & Francis. 
2 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2018). Monitoring the Future national 
survey results on drug use, 1975-2017: Volume I, secondary school students. Ann Arbor, MI: Institute for Social Research, The University of 
Michigan. 
3 Johnston, L. D., Schulenberg, J. E., O'Malley, P. M., Miech, R. A., & Bachman, J. G. (2018). Demographic subgroup trends among young adults 
in the use of various licit and illicit drugs, 1988-2017 (Monitoring the Future Occasional Paper No. 91). Ann Arbor, MI: Institute for Social 
Research, University of Michigan. 
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(Table 9-2 and Figure 9-1); this increase through 2016 was driven primarily by an increase 
in marijuana use. In 2017, however, there was a nonsignificant decrease in annual 
prevalence of any illicit drug (and of marijuana use, summarized below). This 
nonsignificant decline is in contrast to the nonsignificant increases that we found in 2017 
among 19-28 year olds overall, as summarized in Chapter 5; however, as we note in 
Chapter 5, the increases were greater among young adults in their mid- and late-20s. The 
evidence converges to suggest that while annual prevalence of any illicit drug use (and 
marijuana use in particular) has been rising among young adults age 19-28 through 2017, 
it appears to have leveled in 2017 among those aged 19-22 (college students and noncollege 
youth).  
 
Back during the first decade of MTF college student data, between 1980 and 1991, college 
student annual use of any illicit drug dropped fairly steadily—from 56% to 29%, a decrease 
of nearly half. After 1991, annual prevalence held fairly steady for a couple of years before 
beginning to rise, reaching 38% in 1998 and again in 2001 before leveling at between 34% 
and 37% through 2012; since 2013 it increased to 2016 prevalence of 43%, a recent high 
level (but still well below the 1980 peak of 56%); in 2017, annual prevalence of any illicit 
drug use dropped slightly to 42%. Annual use of any illicit drug among noncollege youth 
moved similarly until 2000, when their annual use exhibited a four-percentage-point 
increase due largely to their sharper increases in marijuana, amphetamine, and tranquilizer 
use. In recent years the noncollege annual prevalence has not differed much from the rate 
for college students, though in some of the past few years, it was higher for noncollege 
youth, reaching a recent high of 47% in 2016. In 2017, it dropped nonsignificantly to 43%, 
a level similar to college students. (We should mention that because of the diminishing 
sample sizes for the noncollege group, their estimates have become less stable in recent 
years, as is illustrated in Figure 9-1.)  
 
Twelfth-graders’ annual use of any illicit drug showed a declining trajectory parallel to the 
other two groups from 1980 through 1991, but then followed with a much steeper increase 
through 1997, leaving their prevalence considerably above the two older groups. Their use 
leveled after 1998 and then declined some after 1999 (by about six percentage points), 
whereas among college students there was a continued increase through 2001, followed by 
a leveling as use among 12th graders continued to decline. As a result, all three groups had 
quite similar prevalence rates by 2007. After 2009, use increased among the high school 
seniors but did so somewhat later among the college students, creating some new 
divergence before they converged in 2013. Between 2013 and 2016, annual prevalence 
remained fairly steady for 12th graders and increased for both the college and noncollege 
groups; in 2017, there was a nonsignificant increase for 12th graders and nonsignificant 
declines for college students and noncollege youth. 
 
The divergences and convergences over the years among the three groups likely reflect 
cohort effects. After 2007 (2006 for college students), all three groups showed some 
increase in the annual prevalence of any illicit drug use—due largely to a turnaround in 
their use of marijuana, as described below—but the increase was greater and longer from 
2007 to 2011 among the 12th graders, compared to college students, likely once again 
reflecting a cohort effect. The divergence we are now seeing between 12th graders and 
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college students may reflect another emerging cohort effect. Usage estimates for the 
noncollege segment have been rather unstable in recent years (see Figure 9-1), likely due 
to the smaller sample sizes that comprise that segment; but overall they show a rise in use 
since 2010. 
 
• Annual prevalence of any illicit drug other than marijuana has diverged among the three 
groups since 2012 (when it was 17% to 18% for all three groups), declining considerably 
for 12th graders (13% in 2017) and remaining fairly steady for college students (20% in 
2016 with a nonsignificant decline to 18% in 2017). For noncollege youth, it showed some 
uneven increase through 2016 (24%), and then decreased significantly in 2017 to 18%. 
Figure 9-2 shows that since 1980, of the three groups the noncollege segment has usually 
had the highest levels of use of any illicit drug other than marijuana. The exception was 
during most of the 1990s (the relapse phase in the epidemic), when use among 12th graders 
rose sharply and exceeded use in the noncollege segment. The noncollege group also 
showed an increase during that phase, though slightly lagged, and passed the 12th graders 
in the early 2000s.  
 
An increase in use of any illicit drug other than marijuana among college students also 
occurred after around 1994, but it lagged considerably behind the upturn among 12th 
graders, reflecting a cohort effect. From 1986 through 2009, college students exhibited the 
lowest rates of use. In the earlier period from 1980 to 1994, use of any illicit drug other 
than marijuana declined appreciably among college students, with their annual prevalence 
dropping by nearly two thirds from 32% to 12% (Table 9-2). This generally paralleled the 
trends for the noncollege group and the 12th graders, indicating a secular trend during that 
period. All three groups showed some increase in use during the early 1990s; however, the 
rise in use of illicit drugs other than marijuana was again not as sharp among college 
students as it was in the other two groups, and it began two years later than among the 12th 
graders and one year later than among the noncollege group (Figure 9-2). This pattern is 
more consistent with a cohort effect.  
 
After 1999, use among 12th graders leveled off, whereas the college students and 
noncollege segment showed a continuing increase. In fact, the college students and 
noncollege respondents continued to show an increase in their annual prevalence rate from 
1998 through 2004, before declining from 2005 through 2007 among the noncollege group 
and through 2008 among the college students. From 2008 to 2012 the rate increased among 
the college students and declined steadily among those in the noncollege group, closing the 
considerable gap between the noncollege group and both college students and 12th graders. 
Between 2009 and 2012, annual prevalence for college students and 12th graders 
converged. In 2012 all three groups had comparable annual prevalence rates at 17%–18%.  
 
As summarized above, starting in 2013, the three groups began diverging again. In 2013 
and again in 2014, college students and their noncollege peers showed increases in use 
while use among 12th graders remained unchanged in 2013 and declined after 2014. The 
increase in use of any illicit drug other than marijuana among college students, from 15% 
in 2008 to 21% in 2014, was significant (Table 9-1). Thus by 2014 annual use of any illicit 
drug other than marijuana by college students exceeded that by 12th graders, approached 
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that of the noncollege segment, and reached a new recent peak rate. This increase appeared 
attributable mostly to college students’ increased use of amphetamines (without a doctor’s 
orders) and of ecstasy. However, in 2015 all three groups showed a decline in their annual 
use of any illicit drug other than marijuana—the noncollege group declined by a significant 
5.3 percentage points and the college students by a nonsignificant 2.4%. The net effect was 
to essentially eliminate the difference between those two groups; but their use remained 
above that of 12th graders and has in the years since then. In 2016, annual prevalence 
showed a rebound, with increases for college and noncollege youth and continued decline 
for 12th graders. In 2017, there was again a decline for college and noncollege youth (with 
the decline for noncollege youth significant), resulting in similar prevalence across these 
two groups.  
 
• Annual prevalence of marijuana use among college students and noncollege youth rose 
from recent lows in 2006 (for college students at 30%) and 2007 (for noncollege youth at 
32%) through 2016, reaching the highest levels over the past three decades at 39% and 
41% respectively, both increasing about 5 percentage points in 2015 and 2016 (Figure 9-
3a); however, in 2017, both groups showed nonsignificant declines or leveling to 38% and 
41%, respectively. In contrast, prevalence for 12th graders increased from a recent low of 
32% in 2007 through 2011 (to 36%), leveled for several years, and then showed 
nonsignificant increases in 2016 (to 36%) and in 2017 (to 37%). Whereas there was little 
distinction among the three groups for most of the past decade, annual prevalence began to 
show some divergence in the past few years with use becoming higher for the young adult 
groups than for 12th graders. However, as a result of nonsignificant declines and leveling 
in 2017 for college students and noncollege youth, along with nonsignificant increases 
among 12th graders in 2016 and 2017, some convergence again appears among the three 
groups. As summarized in Chapter 5, annual marijuana use increased nonsignificantly in 
2017 among 19-28 year olds; however, as noted in that chapter this overall increase pertains 
primarily to those in their mid- to late-20s. As mentioned above, the evidence suggests that 
although marijuana use is continuing to rise through 2017 among older young adults, it 
appears to have leveled in 2017 among 19-22 year olds (including college students and 
noncollege youth). 
 
In an earlier period, from 1981 through 1991, annual prevalence of marijuana use dropped 
by nearly half from 51% to 27% among college students (Figure 9-3a). The noncollege 
group showed a comparable decline over the same time interval, as did the 12th graders; 
trends in annual prevalence for all three groups were fairly comparable across that interval, 
reflecting a secular trend. Use among 12th graders rose sharply after 1992, while use among 
college students and noncollege respondents rose more gradually. From 1991 through 
1998, annual prevalence rose by 14 percentage points among 12th graders, compared to 10 
percentage points among college students and 7 percentage points among the noncollege 
group. As a result, the 12th graders came to exhibit the highest rate of marijuana use in the 
last half of the 1990s, but they were the first to show a leveling off in marijuana use (in 
1998), followed by the college students in 1999 and the noncollege group in 2002. This 
suggests that a cohort effect was present during this period. All three groups had very 
similar rates of use by 2005 after use showed some decline, particularly among the 12th 
graders. The college students and 12th graders both showed some continuing decline in 
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2006, but they then both showed a gradual increase in their marijuana use from 2006 
through 2011, with the sharpest increase occurring among the 12th graders, indicating in 
both cases the end of the gradual decline in marijuana use seen earlier in the decade.  
• From 2007–2014, daily marijuana use among college students rose from 3.5% to 5.9%,
which was the highest rate observed since 1980 (Figure 9-3b). In 2015 they showed a
nonsignificant decline to 4.6%, and that was the year after 12th graders showed some
decline in daily use to 5.9%. Since 2015, daily use showed slight uneven changes for
college students, appearing to level (4.4% in 2017); similarly, for 12th graders, daily use
has leveled since 2014 (5.9% in 2017). In a rather dramatic contrast, daily marijuana use
has continued to rise for noncollege youth, reaching its highest levels in 2016 (12.8%) and
2017 (13.2%). As a result, daily marijuana use is now over twice as high among noncollege
youth as among college students and 12th graders.
Of the three groups, college students have had the lowest rate of daily marijuana use 
throughout, with the single exception of 2014, when the college and 12th graders converged 
The differences have been greatest in periods of relatively high use and diminished 
considerably when use was at its nadir at the beginning of the 1990s. Daily marijuana use 
has varied widely in all three groups since 1980. The period from 1980 through 1992 saw 
a large proportional decline in daily use in all three groups, with rates falling by half or 
more. Since 1992, the rates have climbed substantially in all three groups, though there 
were periods of leveling: among high school seniors from 1999 through 2009, among 
college students from roughly 2003 through 2006, and among the noncollege group from 
2003 through 2010.  
• Synthetic marijuana (Figure 9-4) was first included in the study in 2011 and had an annual
prevalence among college students of 8.5% at that time. Since then, use of this drug has
dropped precipitously, reaching 0.9% in 2014, including a significant 1.4 percentage point
decline between 2013 and 2014, followed by small rebounds in 2015 and 2016 (to 1.5%
and 1.3%, respectively); in 2017, it declined nonsignificantly to 0.5%. Annual use among
the noncollege and 12th grade segments also has declined sharply since 2011, reaching
2.4% and 3.7%, respectively, in 2017, still higher than among college students. Throughout
the past six years, the 12th graders have shown the highest annual prevalence and college
students the lowest.
• Use of salvia, another fairly recent arrival to the drug scene, was added to the MTF
questionnaires in 2009. It has likewise seen a sharp decline in popularity among college
students. Annual prevalence was 5.8% in 2009 but fell to 0.3% by 2017 (Table 9-2). Annual
prevalence was somewhat higher in the noncollege group in 2017, at 2.5% (Table 8-2 in
Chapter 8).
• Bath salts—containing cathinones, a synthetic stimulant—the use of which was first
measured in 2012, have shown only trace levels of use among college students in the years
since then (0.3% or less, and 0.2% in 2017; Table 9-2). Among the noncollege group, use
in 2017 was at 1.5% (Table 8.2).
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• In recent years annual amphetamine use without medical supervision rose substantially
among college students (Figure 9-12) from 2008 (5.7%) through 2012 (11.1%) but has
since declined (8.6% in 2017). Similarly, there has been a recent decline among 12th graders
since 2013, and among noncollege youth since 2014. The 1980s saw a dramatic decline of
annual prevalence among college students, from 22% in 1981 to 4% in 1991.
Proportionately, this was a larger drop than that among 12th graders, who also showed a
considerable decline, but fairly parallel to the overall change among the noncollege group.
These large declines in all three groups suggest a secular trend in that period. Amphetamine
use among college students and their noncollege peers began to increase during the relapse
phase in the drug epidemic after 1992 and 1993, respectively, through 2001, with a leveling
in 2002. Still, during the 1990s and early 2000s, the prevalence rates for amphetamine use
in all three groups remained well below the rates observed in the early 1980s. Since 2002,
there have been some divergence among the three groups, with amphetamine use among
college students (who consistently had the lowest rate of use from the mid-1980s through
the mid-2000s) holding steady through 2008, while use among 12th graders and the
noncollege group declined, nearly closing the gaps among the three groups. In 2009,
prevalence rates were similar for the college and noncollege groups (7.5% and 7.7%), and
slightly lower among 12th graders (6.6%). Despite the recent declines for college students,
their annual prevalence has remained the highest among the three groups since 2010. It
seems very likely that this is due to their higher interest in using these drugs to improve
academic performance.4 In 2017 Adderall was used by about six times as many college
students (9.5%) as was Ritalin (1.5%).
• Use of inhalants has been very low among both college and noncollege respondents since
1980, when rates were first measured (Figure 9-5). Although it dropped for college students
from a peak of 4.1% in 1997 to a low of 0.2% in 2016, it increased significantly in 2017 to
1.7%, the highest it has been since 2004; whether this constitutes a new upward trend will
await next year’s data. For noncollege youth, 2017 annual prevalence declined to 0.6%, the
lowest level since 1980 when MTF began tracking it; this is down from its peak of 3.5%
in 2006. Twelfth graders have consistently had considerably higher rates of inhalant use
than either of these segments of the young adult population – until 2017; and as is
documented in Volume I, the 8th and 10th graders have had still higher levels of use. With
the one exception of 2017, there has thus been a consistent age effect, with use of inhalants
declining considerably with increasing age. The college, noncollege, and 12th grade groups
have trended largely in parallel across the years, but the increase through the mid-1990s
and subsequent decline were substantially more pronounced among 12th graders, opening
and then shrinking the gap between them and the two young adult groups.
• Annual prevalence of LSD remained fairly low among college students in 2017 (2.8%),
compared with 3.9% in the noncollege group and 3.3% among 12th graders (Figure 9-7).
Annual prevalence for the three groups was similar in 2012 (at about 2%), with the
noncollege group showing a relatively large increase through 2016 and declining somewhat
4 Data from high school seniors in 2012 on their reasons for using amphetamines showed “To help me study” was the most frequently chosen reason 
among 17 reasons, and was mentioned by 59% of the college-bound vs. by only 18% of those not college bound. Bachman, J. G., Johnston, L. D., 
& O’Malley, P. M. (2014). Monitoring the Future: Questionnaire responses from the nation’s high school seniors, 2012. Ann Arbor, MI: Institute 
for Social Research, University of Michigan. 
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in 2017; a similar pattern is evident for annual prevalence of hallucinogens overall, of 
which LSD is one component (Figure 9-6). During the early 1980s, one of the largest 
proportional declines observed among college students occurred with LSD: annual 
prevalence fell from 6.3% in 1982 to 2.2% in 1985. After 1989, use in all three groups 
increased, with the prevalence among college students reaching 6.9% by 1995. After 1995, 
use fell gradually among college students, their noncollege peers, and 12th graders until 
2001, followed in 2002 by a particularly sharp decrease in all groups. As a result, there was 
a considerable convergence in usage rates, which remained for some years. College 
students maintained lower levels of use than the other two groups for most of the life of 
the study until 2007. Use rose some in all three groups between 2007 and 2012, with little 
consistent difference among them suggesting a secular trend. Beginning in 2013, 
noncollege use increased through 2016, while the other two groups remained fairly level. 
In 2017, the three groups converged somewhat again. 
• Among college students the annual prevalence for hallucinogens other than LSD was
2.5% in 2017, a nonsignificant decline but new low for the study; it also dropped
nonsignificantly for the noncollege group, while remaining steady for 12th graders. The
three groups converged in 2012 at about 3.9%, after which use showed a slow decline for
12th graders (to 2.9% in 2017) and an uneven increase then decrease for noncollege youth
(to 3.2% in 2017) (Figure 9-8); based on the 2017 prevalence, it appears the three groups
are again converging at recent lows. Use of hallucinogens other than LSD (which primarily
involves the use of psilocybin known as mushrooms or “shrooms”) followed a track
somewhat parallel to LSD use, at least up until about 2000. Other hallucinogen use declined
in all three groups from the early 1980s through the early 1990s, followed by rising use
during the relapse in drug use in the 1990s, and then some leveling. But the secular trends
for these other hallucinogens diverged from those for LSD after about 2000, with an
increase in their use, including among college students, just before and after the drop off
in LSD use in 2002. While overall annual prevalence of LSD across the three groups was
higher than that of the other hallucinogens in the first two decades of the study, overall
annual prevalence is now about the same for these two drugs.
• The use of MDMA (ecstasy and, more recently, Molly) by college students and noncollege
youth declined significantly in 2017 to 2.5% and 4.7%, respectively. This follows a
leveling in 2016 for college students (4.7%) and an increase in 2016 for noncollege youth
(8.6%). In contrast, use among 12th graders has continued to decline in the past three years
(Figure 9-9). Use by college students and their noncollege peers began to rise after 1994
and their rates tracked closely through about 2000 (Figure 9-9). Questions about ecstasy
use were added to the 12th grade survey in 1996 and usage rates tracked similarly with those
of the other two groups through about 2000. After 1997 there was a sharp increase in use
in all three groups. The annual prevalence for college students, for example, rose from
2.4% in 1997 to 9.2% in 2001 and rose considerably more among the noncollege group.
Use in all three groups declined sharply from 2001 to 2004, when annual rates were back
to 2.2% for college students, 2.7% for 12th graders, and 4.0% for the noncollege segment.
Both the college and noncollege groups showed some increase in use by 2012, after which
use by college students began a decline while use in the noncollege group began an uneven
increase. It is worth noting that “Molly”—which is a purer form of MDMA than ecstasy
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and has its own street name—was added as an example of MDMA in half of the 
questionnaires in 2014 and in all of them a year later. Figure 9-9 shows in 2014 the 
prevalence reported by respondents with and without Molly included. There is rather little 
difference in the level for the two older groups, but the 12th graders show a fair difference, 
with the inclusion of Molly leading to a higher prevalence. In 2015, even with Molly 
included, all three groups showed a decline in annual prevalence, a decline that continued 
into 2017 for 12th graders. In 2016, the college group and especially the noncollege group 
showed an increase, reaching levels that constituted a doubling of prevalence since 2007; 
2017 saw significant declines for all three groups.  
 
• Annual prevalence of nonmedical sedative (barbiturate) use declined nonsignificantly in 
2017 for college students (1.9%) and noncollege youth (2.4%), and showed a leveling for 
12th graders (Figure 9-13). Throughout the time data have been available in this study (1980 
through 2017), college students have had the lowest prevalence of use among the three 
groups. At that early date, sedative (barbiturate) use was already quite low among college 
students (at 2.9%), but it still fell by more than half to 1.3% by 1985. This proportional 
decline was sharper than among 12th graders and less sharp than among the noncollege 
respondents: both groups started at considerably higher levels of use than college students. 
Annual prevalence remained essentially unchanged between 1985 and 1993 for all three 
groups. A gradual increase in use occurred between 1994 and 2004 for college students and 
between 1993 and 2005 for the other two groups. After 2005, declines in use appeared in 
all three groups through 2011 (2012 for the noncollege stratum), before showing a rise in 
use through 2013 and 2014. In fact, among college students sedative (barbiturate) use rose 
from 1.7% in 2011 to 3.1% in 2014, before nonsignificant declines in use in the past three 
years; 12th graders have shown a similar recent trend, whereas noncollege youth have 
shown an uneven decline since 2014. 
 
• Similar to what was found for sedatives, annual prevalence of nonmedical tranquilizer use 
declined nonsignificantly in 2017 for college students (3.6%) and noncollege youth (4.5%), 
and showed a leveling (at 4.7%) for 12th graders (Figure 9-14). For a few years prior to 
2017, the annual prevalence of nonmedical tranquilizer use increased slightly among 
college students and noncollege youth, reaching 4.9% and 7.1% respectively in 2016, while 
12th grade prevalence remained level. For college and noncollege youth, the increases 
through 2016 reflected a reversal of a longer term downward trend that began in the early 
2000s; 12th graders have also shown a long-term decrease since early 2000s. In general, 
tranquilizer annual prevalence trends have been similar to those for sedatives. Between 
1980 and 1994, annual tranquilizer use among college students dropped by nearly three 
fourths from 6.9% to 1.8%—a period in which use declined in the other two groups as well. 
After this long period of decline, tranquilizer use by college students increased gradually, 
returning to 6.9% by 2003. Use by the noncollege segment and by 12th graders dropped 
more sharply from 1980 through 1992, eliminating the differences among the three groups. 
Use rose after 1992 for all, but the noncollege group showed the largest gain after 1999, 
again creating some differences. By 2002, tranquilizer use was once again at or near its 
recent high in all three groups, followed by a period of decline, until 2014, after which 
there was some slight increase in use through 2016 and decrease in 2017 among the college 
and noncollege groups.  
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• The nonmedical use of narcotics other than heroin5 (Figure 9-11a) has been declining for
all three groups in the past decade, dropping from peak levels in the mid-2000s. These
declines continued into 2017, with annual use declining nonsignificantly for college
students (3.1%), noncollege youth (4.1%), and 12th graders (4.2%); these declines resulted
in the lowest levels for all three groups since the late 1990s.The overall trends in use have
been quite parallel to those for sedatives (barbiturates) and tranquilizers. From 1980
through the mid-1990s, there was a slight decline for all groups, with little distinctions
among the groups. Annual prevalence then rose considerably after about the mid-1990s in
all three groups. Prior to then, the use of narcotics other than heroin by college students
was down to about half by 1994 from what it was in 1980 (2.4% in 1994 vs. 5.1% in 1980)
as a result of a fairly gradual decline over that 14-year interval. This trend closely paralleled
use among participants’ noncollege counterparts and 12th graders. As with a number of
other drugs, use among 12th graders began to rise after 1992, but use among college
students did not begin to increase until after 1994, likely due to a cohort effect. In 2003,
annual prevalence among college students reached a historic high point of 8.7% before
leveling for three years. It then declined from 8.8% in 2006 to the recent low of 3.1% in
2017. For the past decade, college students have shown the lowest prevalence among the
three groups. Use among 12th graders leveled after reaching a historic high of 9.5% in 2004,
but it then declined fairly steadily to a recent low of 4.2% in 2017. The noncollege group
emerged after 2000 as the most heavily using group for the first time, supplanting the high
school seniors, as their use kept increasing through 2005, reaching an all-time high of 13%.
After that, use in the noncollege group declined to recent low of 4.1% in 2017. It thus
appears that all three groups have shown fairly steady and parallel declines in the use of
these dangerous drugs since the early to mid-2000s, following a substantial increase in use
by all three in the 1990s and into the early 2000s. Although there was a nonsignificant
increase in 2016 for college and noncollege youth, the 2017 results suggest that the overall
declines for these two groups over the past decade are continuing.
• Although data about nonmedical use of the specific narcotic drugs, OxyContin and
Vicodin, were not collected until 2002 (Figures 9-11b and 9-11c and Table 8-2), these
drugs help to account for past differences between the college and noncollege segments in
use of narcotics other than heroin. The noncollege group had annual prevalence rates up to
twice that for college students in the use of both drugs when their use was first measured
in 2002, but the differences among the three groups have changed since then.
Annual prevalence of nonmedical OxyContin use among college students rose fairly 
steadily, from 1.5% in 2002 to 5.0% in 2009, before dropping significantly to 1.2% in 
2012; it has since shown an uneven increase to 1.7% in 2017 (Figure 9-11c). Use in the 
noncollege segment rose from 2002 (3.3%) to 2005 (6.2%) and then declined to 4% by 
2010 and remained fairly level through 2015; in 2016, it declined to 2.1% and then 
increased nonsignificantly to 2.6% in 2017. The trend line has been quite uneven, likely 
due to the limited numbers of cases in this segment. (Questions about OxyContin and 
Vicodin are in only three of the six questionnaire forms.) Among 12th graders, OxyContin 
5 As discussed in Chapters 4 and 5, because the questions about narcotics other than heroin were changed in 2002, the prevalence figures are 
adjusted estimates. See the earlier discussion for details. 
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use rose from 4.0% in 2002 to 5.1% in 2010 and then leveled for several years, before 
declining to 2.7% by 2017. It is clear that OxyContin use increased among college students 
between 2002 and 2009, closing the previously existing gaps among the three groups; 
however, use has declined sharply among the college students since then, again opening a 
sizeable gap between them and the other two groups until 2016 and 2017, with the evidence 
suggesting that the three groups are now converging again.  
 
Vicodin use without medical supervision (Figure 9-11b) showed a somewhat different 
pattern of change, with annual prevalence among all three groups remaining fairly level—
and substantially higher than use of OxyContin—from 2002 through about 2008. Since 
then, annual prevalence for all three groups declined sharply, reaching its lowest point in 
2017 for college students (1.1%), noncollege youth (1.8%), and 12th graders (2.0%). As 
with OxyContin, the noncollege segment has consistently had higher Vicodin use than the 
college students. Twelfth-grade levels of Vicodin use have fallen in between. The 2017 
data show a convergence among the three groups at historical lows. Because of the limited 
numbers of cases, as with OxyContin, trend data for use of Vicodin have generally been 
uneven in the young adult groups.  
 
• Over recent years, the rates of cocaine use among college students, noncollege peers, and 
12th graders (Figure 9-10) generally have declined to levels below those in the 1990s and 
far below those in the 1980s. The trend line for college students showed an increase in 
cocaine use in 2014 as annual prevalence among college students increased a significant 
1.7 percentage points to 4.4%. In 2017 this higher level of cocaine use among college 
students held at 4.8%. In the noncollege group there was also a bump up in cocaine use in 
2014, which has held for recent years, increasing to 6.5% in 2016 and then declining 
nonsignificantly to 4.1% in 2017, suggesting a leveling over the past five years. So cocaine 
use is no longer declining among these young adults, nor is it declining among 12th graders, 
who have the lowest prevalence of the three groups (2.7% in 2017).  
 
The early to mid-1980s saw a level period during which cocaine use was considerably 
greater among college students and their noncollege peers than among 12th graders. It was 
followed by a dramatic drop in annual prevalence among college students (nearly nine 
tenths, from 17.1% in 1986 to 2.0% by 1994) and noncollege counterparts (from 18.9% in 
1986 to 5.1% in 1994). A cohort effect emerged as cocaine use began to rise among 12th 
graders after 1992, among the college segment after 1994, and among the noncollege 
segment after 1995. Since 2000 the 12th graders and college students have had similar rates 
of use and parallel trends, while use in the noncollege stratum has been considerably 
higher. After around 2006 all three groups showed declines in use until 2012 among the 
noncollege group and 2013 among college students, after which use rose for a year and 
then leveled. All three groups now have rates of cocaine use below those attained in the 
relapse phase of the illicit drug epidemic in the 1990s, with the noncollege group showing 
the greatest decline but still the highest level of use. These patterns of change suggest that 
a secular trend was underway through most of the 1980s, combined with a considerable 
age effect. After 1992 a cohort effect emerged through most of the 1990s, and since 2000 
or so through 2012 a secular trend re-emerged with all three groups moving in parallel for 
the most part. After 2012 the three groups diverged. 
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• Despite different trend patterns among the three groups, college students have exhibited
the highest levels and greatest constancy in occasions of heavy drinking (also known as
binge drinking) since the first measurement in the MTF surveys in 1980 (Figure 9-15d).
Heavy or “binge” drinking is defined as having five or more drinks in a row at least once
during the prior two weeks. From 1980 through 2017, college students’ prevalence of such
drinking declined 11 percentage points (from 44% to 33%), while noncollege respondents’
prevalence declined 13 percentage points (41% to 28%) and high school seniors’
prevalence declined 24 percentage points (41% to 17%).
As can be seen in Figure 9-15d, both the noncollege segment and 12th graders showed fairly 
substantial declines in the prevalence of occasions of heavy drinking from 1981 through 
1990. In contrast, college students showed no decline from 1981 to 1986 and then only a 
modest decline of five percentage points from 1986 through 1993. Between 1981 (when 
all three populations were very close in use) and 1992, this measure of heavy drinking 
dropped by 14 percentage points among 12th graders, by 11 percentage points among the 
noncollege respondents, but by only two percentage points among college students. After 
1992, occasions of heavy drinking began to rise among 12th graders, while still declining 
some among college students—likely reflecting a cohort effect emerging during this 
period, similar to that observed for a number of illicit drugs—narrowing the gap somewhat. 
Drinking at that level subsequently began to increase among the noncollege segment after 
1995, and by less among college students after 1996—modest increases that continued into 
2001. Between 2001 and 2008, college students held fairly steady in their rates before 
showing some decline through 2015 and leveling since then, while the noncollege segment 
held steady from roughly 2003 to 2007, followed by some decline and then an uneven 
leveling through 2017. Meanwhile, among 12th graders, occasions of heavy drinking started 
a gradual decline after 1998 that continued into 2016 and leveled in 2017, enlarging the 
difference between them and the two older groups. Once again there is evidence of cohort 
effects since the early 1990s, with the inflection points occurring later for the older strata.  
Why did college students’ heavy drinking decline so little for a decade (1981–1991) 
compared to their noncollege peers and 12th graders? One possibility is that campuses 
provided some insulation from the effects of changes in the drinking age laws that took 
place in many states during that interval. Similarly, entrenched in many college campuses 
is a culture of binge drinking that has proven impervious to many societal trends and 
intervention attempts.6 Also, individuals who are under the legal drinking age in college 
are mixed in with peers who are of legal age to purchase alcohol; this was no longer true 
in high schools by the mid-1980s and was less true, perhaps, for many of those ages 19 to 
22 who were not in college. Finally, much alcohol advertising and promotion was and is 
directed specifically at the college student population.  
Starting in 2005, we included a set of questions concerning extreme binge drinking, also 
known as high-intensity drinking, in one of the six questionnaire forms used with young 
adults, including college students. The questions asked respondents about the frequency in 
6 Schulenberg, J. E., & Maggs, J. L. (2002). A developmental perspective on alcohol use and heavy drinking during adolescence and the transition 
to young adulthood. Journal of Studies on Alcohol, Supplement 14, 54–70. 
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the past two weeks of having 10 or more drinks in a row and also of having 15 or more 
drinks in a row. The low numbers of cases that result from a single questionnaire form 
necessitate combining multiple years of data. By combining data across 2005 through 2011 
and across 2012 through 2017, we find that extreme binge drinking has declined for college 
students and noncollege youth. As shown in Table 9-5, prevalence of 10 or more drinks in 
a row at least once in the prior two weeks decreased for college students from 13.6% in 
2005-2011 to 10.1% in 2012-2017; corresponding prevalence for noncollege youth 
declined from 11.8% to 10.3%. Prevalence of 15 or more drinks in a row at least once in 
the prior two weeks decreased for college students from 5.0% in 2005-2011 to 3.1% in 
2012-2017; corresponding prevalence for noncollege youth was level at 5.2% and 5.1%, 
respectively (Table 9-6). In table 9-4, extreme binge drinking prevalence levels (for both 
10 or more and 15 or more drinks) are shown for college students each year from 2005 
through 2017. These levels are based on small sample sizes and thus show uneven trend 
lines from year to year. Nonetheless, the overall downward trends are evident, with notable 
recent declines in 10 or more drinks after 2012, and notable recent declines in 15 or more 
drinks after 2014. These recent declines in prevalence of extreme binge drinking are 
consistent with declines in occasions of heavy drinking (at the 5+ drinks level) for college 
students and noncollege youth.7 As we summarize below (and also discuss in Chapter 8), 
extreme binge drinking is much higher among males than females in both college and 
noncollege youth. 
College students’ daily drinking estimates (Figure 9-15c) showed a significant decline in 
2017 to 2.2%, dropping by half (from 4.3% in 2016) and reaching a historic low. For 
noncollege youth, it remained level at 3.9% and for 12th graders, it continued on a long-
term decline to 1.6%. Earlier trend data for college students appeared a little less stable, 
perhaps due to smaller sample sizes at those times, going from around 6.5% in the early 
1980s to a considerable decline from 1984 through 1995 (to 3.0%), followed by a period 
of some increase during and after the relapse phase in the drug epidemic in the 1990s, 
reaching 5.0% in 2002. From 2002 through 2016, daily drinking among college students 
fluctuated at about 4% without a clear downward trend; however, 2017 showed a clear and 
significant downward trend. Twelfth graders showed a somewhat similar pattern of daily 
drinking with a long period of decline, followed by an earlier reversal beginning in 1994. 
After 1998, 12th grade daily drinking resumed its decline, reaching its lowest level of 1.3% 
in 2016, with a nonsignificant increase to 1.6% in 2017. Of the three groups, 12th graders 
have typically had the lowest rates of daily drinking. The noncollege respondents have 
generally had the highest rate of current daily drinking and have shown the most change in 
daily drinking trends. After a 2008 decline in daily use among noncollege respondents, 
daily drinking levels have been fairly comparable between the college students and their 
noncollege peers; and both of them showed some decline in daily use in 2015 and then a 
rebound in 2016 to 4.3% for college students and 3.8% for noncollege respondents. In 
2017, this rebound remained for the noncollege youth (3.9%), while daily drinking declined 
to 2.2% among college students, a level just above that for 12th graders. 
7 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O’Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence of 
binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41, 
1319-1328. 
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• The 30-day prevalence of cigarette smoking (Figure 9-16a) among college students has
declined dramatically for the past decade and a half, falling by nearly three-fourths from a
recent high of 31% in 1999 to an all-time low of 8% in 2017, and their daily smoking rate
has fallen by about nine-tenths over the same interval, from 19% to 2% (also to an all-time
low in 2017) (Figure 9-16b). In the early 1980s, cigarette smoking among U.S. college
students declined modestly, and by less than their noncollege peers. Thirty-day prevalence
for college students fell from 26% to 22% between 1980 and 1984, remained fairly stable
through 1990 (22%), then increased gradually but substantially, reaching 31% by 1999. In
2000 the first evidence of a new decline in smoking among college students began to
appear, two years after smoking had begun to decline among 12th graders—this lag
reflecting a cohort effect. The noncollege group, which has consistently had the highest
smoking rate of the three groups, showed a fairly consistent decline in 30-day prevalence
from 1980 through 1990, an offsetting increase from 1990 through 2001 (44%), and a
considerable decline since then to an all-time low of 19% in 2016; in 2017, it showed a
slight but nonsignificant increase to 22%. Over the past decade and a half, 30-day use has
declined in parallel form for noncollege and college youth, with smoking being about twice
as high among noncollege youth as among college students across the past seven years.
Across the same period, prevalence of daily smoking also decreased in parallel form; it was
three to four times as high among noncollege youth as among college students in recent
years (Figure 9-16b and Table 8-4).
While smoking rates have consistently been lower among college students than the 
noncollege segment, the trend lines for these two groups converged some after 1984, as 
smoking rates more or less stabilized among college students but continued to decline 
among young adults not in college (Figure 9-16a). In fact, between 1989 and 1991, use 
began to rise among college students while continuing to decline among noncollege 
respondents. Both groups showed fairly parallel increases in smoking between about 1991 
and 1999, after which use continued to increase among the noncollege segment but began 
to decline among college students, opening up a large difference between them. (Twelfth 
graders exhibited an increase from 1992 to 1997— peaking two to three years prior to the 
older groups—reflecting a cohort effect, and their use has declined significantly since 
then.) All three groups have seen very substantial declines since those peaks, and the rates 
for college students and 12th graders have largely converged, but use among the noncollege 
group remains far higher than the other two groups.  
The popularity of Camel cigarettes among the college-bound may have helped to explain 
some of the narrowing of the gap between college students and their noncollege-attending 
peers in the 1990s. The Joe Camel advertising and promotion campaign, which commenced 
in the late 1980s and ended in the late 1990s, may have succeeded in initiating more college 
and college-bound students (particularly males) to smoking than had been the case 
previously or has been the case since.8 
• In sum, quite a number of drugs have been fading in popularity on American college
campuses in recent years, and a similar pattern is found among noncollege youth. Two of
8 Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (1999). Cigarette brand preferences among adolescents (Monitoring the 
Future Occasional Paper No. 45). Ann Arbor, MI: Institute for Social Research, University of Michigan. 
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the newer drugs—synthetic marijuana and salvia—have shown steep declines in use. 
Other drugs have shown more gradual declines over the past several years, including 
narcotic drugs other than heroin, sedatives, and tranquilizers—all used nonmedically—
as well as inhalants, cocaine, hallucinogens, alcohol, and cigarettes. Evidence from the 
past few years, however, suggests that the declines in cocaine and hallucinogen use may 
have stopped; and against the historical downward trend, inhalant use showed a significant 
increase for college students in 2017. In addition, annual marijuana use increased from 
2006 through 2016 reaching its recent highest level in 2016 for college students (39%) and 
noncollege youth (41%); in 2017, it dropped slightly for college students (38%) and leveled 
for noncollege youth (41%). Daily marijuana use grew since 2007, reaching the highest 
level seen in the past 35 years in 2014 for college students (5.9%) before declining over 
the past few years to 4.4% in 2017; for noncollege youth daily marijuana use has increased 
sharply, reaching an all-time high of 13.2% in 2017. That is, as of 2017 over one in 
twenty-five college students and one in eight noncollege youth are daily marijuana 
users. Amphetamine use grew fairly sharply on campuses between 2008 and 2012, and 
it then stabilized and declined in 2017, though still at high levels not seen since the 
mid-1980s. MDMA (including ecstasy and, more recently, Molly) use had made 
somewhat of a rebound since the recent low observed among college students and 
noncollege youth in 2007, but then has shown some decline for college students in the 
past few years, including a significant decrease in 2017.  
The trend findings over the years concerning divergences and convergences among the 
three groups highlight the importance of cohort effects in determining the source of 
changes. The overall drug use trends among college students parallel the trends among 12th 
graders, though after the early 1990s they were generally lagged by a few years; still, 
declines in many drugs from 1980 to 1990 were proportionately larger among 19- to 22-
year-olds (both college and noncollege) than among 12th graders. Despite parallel trends in 
the early 1990s, 12th graders showed larger, and usually earlier, increases in the use of a 
number of drugs in the years since; as indicated in Volume I, 8th and 10th graders showed 
increases a year earlier than 12th graders. Clearly the upsurge, or what we have called a 
“relapse phase” in the illicit drug epidemic during the 1990s, did not originate on the 
nation’s college campuses, as did the earlier epidemic. The relapse originated among 
secondary school students—and the younger ones at that—and was carried up the age 
spectrum through generational replacement. In other words, it exhibited a cohort effect. 
GENDER DIFFERENCES IN TRENDS AMONG COLLEGE STUDENTS 
As mentioned earlier, recent decades have seen a gradual rise in the proportion of college students 
who are female. Females constituted 50% of the 1980 sample of college students compared to 61% 
of our 2017 sample. Given that substantial gender differences exist in the use of some drugs, we 
have been concerned that apparent long-term trends in the levels of drug use among college 
students (and/or among the noncollege group) might actually be attributable to changes in the 
gender composition of each population. For this reason, in particular, we present separate trend 
lines for college males and females in the lower panels of Figures 9-1 through 9-16c. We do not 
focus on noncollege youth in these figures or this subsection in large part due to the limited 
numbers of cases for subgroups.  
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In general, college student trends in use of the various drugs have been highly parallel for men and 
women, as an examination of the relevant figures will show. The most noteworthy exceptions are 
mentioned below.  
 
• Certain drug use measures showed a convergence between the genders as use rates declined 
to low levels in the early 1990s. This was true for annual use of any illicit drug and any 
illicit drug other than marijuana. After 1991 the genders diverged again, with a recent 
convergence especially for any illicit drug, due largely to a convergence for marijuana, 
discussed next. 
 
• Marijuana use has been consistently higher among college males than among college 
females. There was some gender convergence in annual prevalence of marijuana use 
between 1980 and 1991 as overall use declined, and then some gender divergence between 
1991 and 1999 as usage rates rose. After 2001, the two genders diverged further, with use 
among males remaining essentially unchanged through 2008 and use among females 
decreasing (Figure 9-3a). Since 2010, use among college males has remained fairly steady, 
whereas use among college females increased from 2010 through 2016, reaching a level 
not seen since the 1980s—narrowing the gap considerably; use decreased nonsignificantly 
for both genders in 2017, to 41% for males and 37% for females. 
 
• Daily marijuana use (Figure 9-3b) has generally been about twice as high among college 
males as their female counterparts throughout the study; since the mid-1990s, such use has 
risen more among males, especially since 2007, opening a wide difference. In 2017, after 
some recent decline in daily use by males, the rates for college males and females, 
respectively, were 6.4% and 3.1%. 
 
• From 1999 to 2005, LSD use dropped more steeply among males than among females, 
offsetting sizeable previous differences in which males had higher use and bringing the 
genders close together at very low prevalence rates (Figure 9-7). The small increases in use 
that have occurred since 2005 have been greater among males. 
 
• Use of hallucinogens other than LSD has dropped for both genders since 2002 or 2003, 
with percentages for males generally twice as high or more as those for females; in the past 
few years, as it dropped more for males than for females, there has been some convergence 
(Figure 9-8). 
 
• Until recently, annual prevalence of MDMA (ecstasy and, more recently, Molly) use have 
been quite similar for male and female college students since measures were first 
introduced in 1989, and changes in their usage levels have tracked closely (Figure 9-9). 
Between 2006-2007 and 2012-2013, males showed more increase than females; since then, 
both have showed some uneven declines, with a trend toward convergence in 2017 (3.1% 
for college males and 2.2% for college females). (Starting in 2014, Molly was included as 
an example of MDMA. See Figure 9-9.)  
 
• Trends in the nonmedical use of narcotics other than heroin have generally moved in 
parallel for both male and female college students, with males generally higher, except 
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during the nadir in use at the beginning of the 1990s when their rates were equivalent. 
(Figure 9-11a). Both genders have shown considerable declines in their use since about 
2005 or 2006, with the past few years showing some convergence. 
 
• After 1986, cocaine use, which had been substantially higher among males up until then, 
dropped more steeply for males than for females in general, and among male college 
students in particular, considerably narrowing the sizable gap between genders (Figure 9-
10). Since 1991, both genders have moved in parallel, with males reporting higher annual 
usage rates. Both genders showed small and nonsignificant upticks in use in 2014, which 
continued for males into 2017 (6.6% for males versus 3.6% for females). 
 
• Nonmedical amphetamine use (Figure 9-12) also showed some convergence in the 1980s 
due to a greater decline among males; the two genders showed virtually equivalent annual 
prevalence from 1986 through 1998. From 1998 through 2016 males have had higher 
annual prevalence rates generally, as use increased for both through 2012. Use continued 
to increase for males through 2015 while it declined for females; these trends reversed in 
2016 and 2017 and as a result college females showed higher annual prevalence than 
college males in 2017 (9.2% and 7.7%, respectively). 
 
• The gender differences for nonmedical sedative (barbiturate) and tranquilizer use have 
been modest through most of the life of the study, with college males usually having 
slightly higher rates than their female counterparts (Figures 9-13 and 9-14). After 1995, a 
somewhat larger gap emerged for tranquilizers, again with males being higher. Tranquilizer 
use by college females peaked in 2003, briefly closing the gender gap, but use by males 
has consistently been slightly higher since then, showing slight increases or leveling in the 
past few years. Both genders have shown declines in annual use of sedatives from the early 
2000s through 2011 and converging during this period; both then showed a slight rebound 
through 2014, declining or leveling since then. 
 
• Among college students, the annual prevalence of alcohol use has been virtually identical 
for the two genders since 1980, when use by college students and their noncollege peers 
was first reported (Figure 9-15a). Both college males and females have shown a very 
gradual and modest decline over the past 34 years. Prior to 2000, 30-day alcohol prevalence 
showed modest differences, with males slightly higher (Figure 9-15b); however, that 
difference largely disappeared by 2000. Since then, college males have had very slightly 
higher 30-day rates more years than not.  
 
College males have consistently had considerably higher rates of daily drinking than 
college females (Figures 9-15c and 9-15d). But since about 2004 or 2005 the gender gap 
in daily drinking has narrowed, with little change among college females but an overall 
decrease among college males. Both showed declines in 2017 to historic low levels. 
 
• Binge drinking (having one or more occasions of having five or more drinks in a row in 
the prior two weeks) has shown a considerable gender gap, but a gradual long-term decline 
among college males since about 1985 that continued into 2016, reducing the gap (Figure 
9-15d). As there has been less change among college females, whose use has been 
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consistently less than that of college males, the gender gap has narrowed. The gap in 2016 
was the lowest it had been, with males at 35% and females at 31%; however, in 2017 males 
showed a nonsignificant increase (39%) and females showed a nonsignificant decrease 
(29%), increasing the gap again. The gender gap in extreme binge drinking also shows 
signs of decreasing, though two-week prevalence remains much higher among males 
(Tables 9-5 and 9-6). Between 2005-2011 and 2012-2017, having ten or more drinks in a 
row dropped from 24% to 16% for college males, whereas it remained steady for college 
females at 7%; corresponding prevalence for having 15 or more drinks in a row dropped 
for males from 10.1% to 6.0%, and dropped from 2.0% to 1.3% for females. 
 
• For the interval between 1980 and 1988, the 30-day prevalence of cigarette smoking was 
higher among college females than males (Figure 9-16a). However, the gaps in 30-day 
prevalence narrowed because use by female college students declined considerably 
between 1980 and 1989, while use by male college students did not decline. After 1989, as 
prevalence for both genders increased considerably, the gaps remained quite small and the 
genders reversed position, with college males catching up to and passing females in their 
rate of smoking by 1994 and then generally remaining higher thereafter. (A similar reversal 
had occurred among 12th graders a few years earlier, so the reversal among college students 
probably reflected a cohort effect.) Both genders exhibited a considerable decrease in 30-
day smoking between 1999 and 2011, leaving only a modest difference between them 
(although the trend line for college males was irregular during this interval). Use then 
leveled for males through 2015 and continued to drop for females, widening the gap 
somewhat. In 2016 it dropped for males more than for females. In 2017 the 30-day 
prevalence levels were 11% and 6% for college males and females, respectively, at historic 
lows. Daily smoking and half-pack-a-day smoking (Figure 9-16b and c) also were initially 
higher among college females than among college males—this time up through 1994—
after which the two genders have tracked rather closely, both reaching historic lows in 
2017. It thus appears that college males in recent years have been more likely than college 
females to smoke at a less than daily rate but about equally likely as females to smoke at 
more frequent rates. 
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Any Illicit Drug a 69.4 66.8 64.6 66.9 62.7 65.2 61.8 60.0 58.4 55.6 54.0 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2
Any Illicit Drug other than Marijuana a 42.2 41.3 39.6 41.7 38.6 40.0 37.5 35.7 33.4 30.5 28.4 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5
Marijuana 65.0 63.3 60.5 63.1 59.0 60.6 57.9 55.8 54.3 51.3 49.1 46.3 44.1 42.0 42.2 41.7 45.1 46.1 49.9 50.8
Inhalants b 10.2 8.8 10.6 11.0 10.4 10.6 11.0 13.2 12.6 15.0 13.9 14.4 14.2 14.8 12.0 13.8 11.4 12.4 12.8 12.4
Hallucinogens c,x 15.0 12.0 15.0 12.2 12.9 11.4 11.2 10.9 10.2 10.7 11.2 11.3 12.0 11.8 10.0 13.0 12.6 13.8 15.2 14.8
     LSD x 10.3 8.5 11.5 8.8 9.4 7.4 7.7 8.0 7.5 7.8 9.1 9.6 10.6 10.6 9.2 11.5 10.8 11.7 13.1 12.7
     Hallucinogens other than LSD c,x 11.6 9.0 10.6 8.3 9.2 8.1 7.8 6.8 6.2 6.2 6.0 6.0 5.7 5.4 4.4 6.5 6.5 7.5 8.7 8.8
     Ecstasy (MDMA), original d,z — — — — — — — — — 3.8 3.9 2.0 2.9 2.3 2.1 3.1 4.3 4.6 6.8 8.4
     Ecstasy (MDMA), revised d,z — — — — — — — — — — — — — — — — — — — —
Cocaine 22.0 21.5 22.4 23.1 21.7 22.9 23.3 20.6 15.8 14.6 11.4 9.4 7.9 6.3 5.0 5.5 5.0 5.6 8.1 8.4
     Crack e — — — — — — — 3.3 3.4 2.4 1.4 1.5 1.7 1.3 1.0 1.8 1.2 1.4 2.2 2.4
     Other Cocaine f — — — — — — — 18.1 14.2 16.0 10.2 9.0 7.6 6.3 4.6 5.2 4.6 5.0 7.4 7.8
Heroin 0.9 0.6 0.5 0.3 0.5 0.4 0.4 0.6 0.3 0.7 0.3 0.5 0.5 0.6 0.1 0.6 0.7 0.9 1.7 0.9
Narcotics other than Heroin g,h 8.9 8.3 8.1 8.4 8.9 6.3 8.8 7.6 6.3 7.6 6.8 7.3 7.3 6.2 5.1 7.2 5.7 8.2 8.7 8.7
Amphetamines g,i 29.5 29.4 30.1 27.8 27.8 25.4 22.3 19.8 17.7 14.6 13.2 13.0 10.5 10.1 9.2 10.7 9.5 10.6 10.6 11.9
     Methamphetamine j — — — — — — — — — — — — — — — — — — — 7.1
     Crystal Methamphetamine (Ice) j — — — — — — — — — — 1.0 1.3 0.6 1.6 1.3 1.0 0.8 1.6 2.2 2.8
Sedatives (Barbiturates) g,t 8.1 7.8 8.2 6.6 6.4 4.9 5.4 3.5 3.6 3.2 3.8 3.5 3.8 3.5 3.2 4.0 4.6 5.2 5.7 6.7
    Sedatives, Adjusted g,k 13.7 14.2 14.1 12.2 10.8 9.3 8.0 6.1 4.7 4.1 — — — — — — — — — —
    Methaqualone g 10.3 10.4 11.1 9.2 9.0 7.2 5.8 4.1 2.2 2.4 — — — — — — — — — —
Tranquilizers g,l 15.2 11.4 11.7 10.8 10.8 9.8 10.7 8.7 8.0 8.0 7.1 6.8 6.9 6.3 4.4 5.4 5.4 6.9 7.7 8.2
Alcohol m 94.3 95.2 95.2 95.0 94.2 95.3 94.9 94.1 94.9 93.7 93.1 93.6 91.8 89.3 88.2 88.5 88.4 87.3 88.5 88.0
     Been Drunk n — — — — — — — — — — — 79.6 76.8 76.4 74.4 76.6 76.2 77.0 76.8 75.1
     Flavored Alcoholic Beverages o — — — — — — — — — — — — — — — — — — — —
Cigarettes — — — — — — — — — — — — — — — — — — — —
Any Vaping j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — — — —
Steroids p — — — — — — — — — 0.4 1.5 1.4 1.7 1.9 0.5 0.8 0.6 1.6 0.9 1.3
(Table continued on next page.)
TABLE 9-1
Trends in Lifetime Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Years 
cont.)
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880
Any Illicit Drug a 53.7 53.6 51.8 53.9 52.2 52.3 50.6 50.5 49.5 51.4 49.1 49.2 50.5 53.3 52.4 53.4 54.4 55.4 +1.0
Any Illicit Drug other than Marijuana a 25.8 26.3 26.9 27.6 28.0 26.5 26.3 25.3 22.6 25.6 24.8 24.3 23.8 28.3 29.0 26.4 26.5 26.1 -0.4
Marijuana 51.2 51.0 49.5 50.7 49.1 49.1 46.9 47.5 46.8 47.5 46.8 46.6 49.1 47.7 48.5 50.4 51.0 50.5 -0.5
Inhalants b 12.9 9.6 7.7 9.7 8.5 7.1 7.4 6.3 4.9 6.9 5.5 3.7 5.7 4.3 3.5 3.1 3.2 3.4 +0.2
Hallucinogens c,x 14.4 14.8 13.6 14.5 12.0 11.0 10.6 9.1 8.5 8.0 7.8 7.4 7.6 7.8 7.6 6.5 7.7 7.2 -0.4
     LSD x 11.8 12.2 8.6 8.7 5.6 3.7 3.5 3.3 4.3 3.3 4.0 3.7 3.1 4.4 4.5 4.8 5.1 5.3 +0.1
     Hallucinogens other than LSD c,x 8.2 10.7 11.0 12.8 10.1 10.6 10.1 8.5 8.2 7.8 7.1 6.9 7.2 6.8 6.8 5.1 6.6 5.0 -1.6
     Ecstasy (MDMA), original d,z 13.1 14.7 12.7 12.9 10.2 8.3 6.9 5.4 6.2 6.5 6.2 6.8 8.7 8.1 8.2 — — — —
     Ecstasy (MDMA), revised d,z — — — — — — — — — — — — — — 8.1 8.9 8.4 5.3 -3.2 s
Cocaine 9.1 8.6 8.2 9.2 9.5 8.8 7.7 8.5 7.2 8.1 6.6 5.5 5.2 5.1 6.2 6.1 5.3 6.5 +1.2
     Crack e 2.5 2.0 1.9 3.1 2.0 1.7 2.3 1.3 1.4 1.0 1.2 0.8 0.7 0.7 1.4 0.5 0.4 0.6 +0.2
     Other Cocaine f 8.1 8.3 8.6 8.5 9.3 8.1 6.2 8.0 7.1 7.9 6.7 5.4 5.1 5.2 6.2 6.4 6.5 6.1 -0.4
Heroin 1.7 1.2 1.0 1.0 0.9 0.5 0.7 0.5 0.7 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.5 0.1 -0.4
Narcotics other than Heroin g,h 8.9 11.0 12.2 14.2 13.8 14.4 14.6 14.1 12.4 14.0 12.2 12.4 10.3 10.8 9.9 6.6 7.4 6.8 -0.6
Amphetamines g,i 12.3 12.4 11.9 12.3 12.7 12.3 10.7 11.2 9.1 11.8 12.1 13.4 14.4 16.1 15.0 13.9 13.6 12.6 -1.0
     Methamphetamine j 5.1 5.3 5.0 5.8 5.2 4.1 2.9 1.9 1.9 1.0 1.1 0.6 0.3 0.9 0.7 0.8 0.6 0.6 +0.1
     Crystal Methamphetamine (Ice) j 1.3 2.3 2.0 2.9 2.2 2.4 1.7 1.3 1.1 0.7 0.8 0.2 0.6 0.0 0.3 0.3 0.6 0.4 -0.3
Sedatives (Barbiturates) g,t 6.9 6.0 5.9 5.7 7.2 8.5 6.3 5.9 6.4 6.0 5.3 3.6 3.5 5.4 5.9 4.4 3.3 3.9 +0.6
    Sedatives, Adjusted g,k — — — — — — — — — — — — — — — — — — —
    Methaqualone g — — — — — — — — — — — — — — — — — — —
Tranquilizers g,l 8.8 9.7 10.7 11.0 10.6 11.9 10.0 9.1 8.6 9.2 8.1 7.1 6.4 7.8 6.9 7.8 6.5 6.7 +0.2
Alcohol m 86.6 86.1 86.0 86.2 84.6 86.6 84.7 83.1 85.3 82.6 82.3 80.5 81.0 78.0 79.4 81.4 81.3 79.1 -2.2
     Been Drunk n 74.7 76.1 75.1 74.9 73.4 72.9 73.1 71.6 72.5 69.1 70.5 67.9 70.0 66.5 68.8 68.6 66.7 64.8 -1.9
     Flavored Alcoholic Beverages o — — — — 79.0 84.5 80.9 80.6 78.6 78.1 77.4 76.7 76.6 67.5 72.7 74.8 76.1 72.4 -3.7
Cigarettes — — — — — — — — — — — — — — — — — — —
Any Vaping j,aa — — — — — — — — — — — — — — — 26.0 26.8 36.0 —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — 14.4 —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — 22.5 —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — 26.7 —
Steroids p 0.6 1.5 1.2 1.2 1.6 1.0 1.9 0.6 1.6 1.3 0.7 1.1 0.4 0.8 0.9 0.6 0.8 1.2 +0.5
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
TABLE 9-1 (cont.)
Trends in Lifetime Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
2016– 
2017 
change
405
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Any Illicit Drug a 56.2 55.0 49.5 49.8 45.1 46.3 45.0 40.1 37.4 36.7 33.3 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9
Any Illicit Drug other than Marijuana a 32.3 31.7 29.9 29.9 27.2 26.7 25.0 21.3 19.2 16.4 15.2 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4
Synthetic Marijuana u — — — — — — — — — — — — — — — — — — — —
Marijuana 51.2 51.3 44.7 45.2 40.7 41.7 40.9 37.0 34.6 33.6 29.4 26.5 27.7 27.9 29.3 31.2 33.1 31.6 35.9 35.2
Inhalants b 3.0 2.5 2.5 2.8 2.4 3.1 3.9 3.7 4.1 3.7 3.9 3.5 3.1 3.8 3.0 3.9 3.6 4.1 3.0 3.2
Hallucinogens c,x 8.5 7.0 8.7 6.5 6.2 5.0 6.0 5.9 5.3 5.1 5.4 6.3 6.8 6.0 6.2 8.2 6.9 7.7 7.2 7.8
     LSD x 6.0 4.6 6.3 4.3 3.7 2.2 3.9 4.0 3.6 3.4 4.3 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4
     Hallucinogens other than LSD c,x 5.2 4.7 5.4 3.9 4.1 3.9 3.8 3.1 3.4 3.1 3.0 3.1 2.6 2.7 2.8 4.0 4.1 4.9 4.4 4.5
     Ecstasy (MDMA), original d,z — — — — — — — — — 2.3 2.3 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5
     Ecstasy (MDMA), revised d,z — — — — — — — — — — — — — — — — — — — —
     Salvia v — — — — — — — — — — — — — — — — — — — —
Cocaine 16.8 16.0 17.2 17.3 16.3 17.3 17.1 13.7 10.0 8.2 5.6 3.6 3.0 2.7 2.0 3.6 2.9 3.4 4.6 4.6
     Crack e — — — — — — — 2.0 1.4 1.5 0.6 0.5 0.4 0.6 0.5 1.1 0.6 0.4 1.0 0.9
     Other Cocaine f — — — — — — — 10.7 10.6 9.3 5.1 3.2 2.4 2.5 1.8 3.3 2.3 3.0 4.2 4.2
Heroin 0.4 0.2 0.1 * 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.2
Narcotics other than Heroin g,h 5.1 4.3 3.8 3.8 3.8 2.4 4.0 3.1 3.1 3.2 2.9 2.7 2.7 2.5 2.4 3.8 3.1 4.2 4.2 4.3
     OxyContin g,j — — — — — — — — — — — — — — — — — — — —
     Vicodin g,j — — — — — — — — — — — — — — — — — — — —
Amphetamines g,i 22.4 22.2 21.1 17.3 15.7 11.9 10.3 7.2 6.2 4.6 4.5 3.9 3.6 4.2 4.2 5.4 4.2 5.7 5.1 5.8
     Ritalin g,j — — — — — — — — — — — — — — — — — — — —
     Adderall g,j — — — — — — — — — — — — — — — — — — — —
     Methamphetamine j — — — — — — — — — — — — — — — — — — — 3.3
      Crystal Methamphetamine (Ice) j — — — — — — — — — — 0.1 0.1 0.2 0.7 0.8 1.1 0.4 0.8 1.0 0.5
     Bath Salts (synthetic stimulants) n — — — — — — — — — — — — — — — — — — — —
Sedatives (Barbiturates) g,t 2.9 2.8 3.2 2.2 1.9 1.3 2.0 1.2 1.1 1.0 1.4 1.2 1.4 1.5 1.2 2.0 2.3 3.0 2.5 3.2
    Sedatives, Adjusted g,k 8.3 8.0 8.0 4.5 3.5 2.5 2.6 1.7 1.5 1.0 — — — — — — — — — —
    Methaqualone g 7.2 6.5 6.6 3.1 2.5 1.4 1.2 0.8 0.5 0.2 — — — — — — — — — —
Tranquilizers g,l 6.9 4.8 4.7 4.6 3.5 3.6 4.4 3.8 3.1 2.6 3.0 2.4 2.9 2.4 1.8 2.9 2.8 3.8 3.9 3.8
Rohypnol j — — — — — — — — — — — — — — — — — — — —
GHB w — — — — — — — — — — — — — — — — — — — —
Ketamine w — — — — — — — — — — — — — — — — — — — —
Alcohol m 90.5 92.5 92.2 91.6 90.0 92.0 91.5 90.9 89.6 89.6 89.0 88.3 86.9 85.1 82.7 83.2 83.0 82.4 84.6 83.6
     Been Drunk n — — — — — — — — — — — 69.1 67.3 65.6 63.1 62.1 64.2 66.8 67.0 65.4
     Flavored Alcoholic Beverages o — — — — — — — — — — — — — — — — — — — —
     Alcoholic Beverages 
          containing Caffeine j,s — — — — — — — — — — — — — — — — — — — —
Cigarettes 36.2 37.6 34.3 36.1 33.2 35.0 35.3 38.0 36.6 34.2 35.5 35.6 37.3 38.8 37.6 39.3 41.4 43.6 44.3 44.5
Any Vaping j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — — — —
Tobacco Using a Hookah j — — — — — — — — — — — — — — — — — — — —
Small Cigars y — — — — — — — — — — — — — — — — — — — —
Snus j — — — — — — — — — — — — — — — — — — — —
Dissolvable Tobacco j — — — — — — — — — — — — — — — — — — — —
Steroids p — — — — — — — — — 0.4 0.5 0.6 0.2 0.9 0.2 0.4 0.2 0.7 0.2 0.9
(Table continued on next page.)
TABLE 9-2
Trends in Annual Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Years 
cont.)
406
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880
Any Illicit Drug a 36.1 37.9 37.0 36.5 36.2 36.6 33.9 35.0 35.2 36.0 35.0 36.3 37.3 40.5 38.6 41.4 42.8 42.4 -0.4
Any Illicit Drug other than Marijuana a 15.6 16.4 16.6 17.9 18.6 18.5 18.1 17.3 15.3 16.9 17.1 16.8 17.1 19.3 20.8 18.5 19.7 18.1 -1.6
Synthetic Marijuana u — — — — — — — — — — — 8.5 5.3 2.3 0.9 1.5 1.3 0.5 -0.8
Marijuana 34.0 35.6 34.7 33.7 33.3 33.3 30.2 31.8 32.3 32.8 32.7 33.2 34.9 35.5 34.4 37.9 39.3 38.3 -1.1
Inhalants b 2.9 2.8 2.0 1.8 2.7 1.8 1.5 1.5 1.1 1.2 1.7 0.9 1.5 0.5 1.3 0.6 0.2 1.7 +1.5 s
Hallucinogens c,x 6.7 7.5 6.3 7.4 5.9 5.0 5.6 4.9 5.1 4.7 4.9 4.1 4.5 4.5 4.0 4.3 4.5 4.1 -0.5
     LSD x 4.3 4.0 2.1 1.4 1.2 0.7 1.4 1.3 2.6 2.0 2.1 2.0 1.9 2.6 2.2 3.0 3.1 2.8 -0.2
     Hallucinogens other than LSD c,x 4.4 5.5 5.8 7.1 5.6 5.0 5.4 4.7 4.4 4.1 4.4 3.4 3.9 3.7 3.2 3.0 3.4 2.5 -0.9
     Ecstasy (MDMA), original d,z 9.1 9.2 6.8 4.4 2.2 2.9 2.6 2.2 3.7 3.1 4.3 4.2 5.8 5.3 5.0 — — — —
     Ecstasy (MDMA), revised d,z — — — — — — — — — — — — — — 4.9 4.2 4.7 2.5 -2.2 s
     Salvia v — — — — — — — — — 5.8 3.5 3.1 1.5 1.0 1.1 0.4 0.7 0.3 -0.4
Cocaine 4.8 4.7 4.8 5.4 6.6 5.7 5.1 5.4 4.4 4.2 3.5 3.3 3.1 2.7 4.4 4.3 4.0 4.8 +0.8
     Crack e 0.9 0.9 0.4 1.3 1.3 0.8 1.0 0.6 0.5 0.3 0.4 0.3 0.3 0.3 0.8 0.2 0.0 0.2 +0.2
     Other Cocaine f 4.1 4.1 5.0 5.1 6.3 5.0 3.8 5.3 4.2 4.2 4.0 3.0 3.0 2.8 4.1 4.2 4.7 4.4 -0.3
Heroin 0.5 0.4 0.1 0.2 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.1 0.1 0.3 0.0 0.1 0.2 * -0.2
Narcotics other than Heroin g,h 4.5 5.7 7.4 8.7 8.2 8.4 8.8 7.7 6.5 7.6 7.2 6.2 5.4 5.4 4.8 3.3 3.8 3.1 -0.8
     OxyContin g,q — — 1.5 2.2 2.5 2.1 3.0 2.8 3.6 5.0 2.3 2.4 1.2 2.3 1.3 1.5 1.9 1.7 -0.2
     Vicodin g,q — — 6.9 7.5 7.4 9.6 7.6 6.7 6.7 8.4 4.9 5.8 3.8 4.4 2.8 1.6 1.3 1.1 -0.2
Amphetamines g,i 6.6 7.2 7.0 7.1 7.0 6.7 6.0 6.9 5.7 7.5 9.0 9.3 11.1 9.6 10.1 9.7 9.8 8.6 -1.2
     Ritalin g,q — — 5.7 4.7 4.7 4.2 3.9 3.7 3.2 1.7 1.9 2.3 1.8 3.6 1.6 2.0 2.4 1.4 -0.9
     Adderall g,q — — — — — — — — — 10.2 9.0 9.8 9.0 10.7 9.6 10.7 9.9 9.4 -0.5
     Methamphetamine j 1.6 2.4 1.2 2.6 2.9 1.7 1.2 0.4 0.5 0.3 0.4 0.2 0.0 0.4 0.1 0.5 0.0 0.4 +0.4
     Crystal Methamphetamine (Ice) j 0.5 0.6 0.8 0.9 1.1 1.4 0.6 0.7 0.1 0.1 0.5 0.1 0.6 * * * * 0.4 +0.4
     Bath Salts (synthetic stimulants) n — — — — — — — — — — — — 0.3 0.1 0.2 0.1 0.0 0.2 +0.2
Sedatives (Barbiturates) g,t 3.7 3.8 3.7 4.1 4.2 3.9 3.4 3.6 3.7 3.1 2.5 1.7 2.2 2.7 3.1 2.3 2.1 1.9 -0.1
    Sedatives, Adjusted g,k — — — — — — — — — — — — — — — — — — —
    Methaqualone g — — — — — — — — — — — — — — — — — — —
Tranquilizers g,l 4.2 5.1 6.7 6.9 6.7 6.4 5.8 5.5 5.0 5.4 4.9 4.2 3.4 4.4 3.5 4.3 4.9 3.6 -1.2
Rohypnol j — — 0.7 0.4 0.3 0.1 0.2 0.1 0.3 * — — — — — — — — —
GHB w — — 0.6 0.3 0.7 0.4 * 0.1 0.2 * 0.1 0.1 * 0.1 0.2 * — — —
Ketamine w — — 1.3 1.0 1.5 0.5 0.9 0.2 0.4 0.1 0.7 0.6 0.4 0.9 0.1 0.6 0.5 0.3 -0.1
Alcohol m 83.2 83.0 82.9 81.7 81.2 83.0 82.1 80.9 82.1 79.4 78.6 77.4 79.2 75.6 76.1 79.0 78.9 75.8 -3.2
     Been Drunk n 64.7 68.8 66.0 64.7 67.1 64.2 66.2 64.8 66.8 61.5 63.8 60.1 61.5 57.9 60.5 61.6 60.7 58.0 -2.7
     Flavored Alcoholic Beverages o — — — — 63.2 67.0 63.5 62.6 65.0 66.1 60.3 63.0 58.1 57.6 64.2 64.5 68.5 60.3 -8.2
     Alcoholic Beverages 
          containing Caffeine j — — — — — — — — — — — 33.6 33.8 39.1 32.8 34.1 29.4 31.3 +1.9
Cigarettes 41.3 39.0 38.3 35.2 36.7 36.0 30.9 30.7 30.0 29.9 28.1 25.8 23.4 23.2 22.6 20.1 18.7 16.7 -1.9
Any Vaping j,aa — — — — — — — — — — — — — — — — — 23.5 —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — 10.7 —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — 13.0 —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — 13.1 —
Tobacco Using a Hookah j — — — — — — — — — — — 27.9 25.7 26.1 32.7 23.4 16.9 10.0 -6.8 ss
Small Cigars y — — — — — — — — — — — 23.6 20.3 19.0 24.2 19.6 17.6 14.0 -3.6
Snus j — — — — — — — — — — — 6.5 4.7 4.8 5.0 5.8 3.3 4.3 +1.0
Dissolvable Tobacco j — — — — — — — — — — — * 0.3 0.2 0.5 1.1 0.3 0.7 +0.4
Steroids p 0.1 0.6 0.5 0.3 0.6 0.5 0.8 0.6 0.1 0.7 0.3 0.2 0.3 0.8 0.5 0.3 0.0 0.6 +0.6
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
2016– 
2017 
change
TABLE 9-2 (cont.)
Trends in Annual Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
407
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Any Illicit Drug a 38.4 37.6 31.3 29.3 27.0 26.1 25.9 22.4 18.5 18.2 15.2 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6
Any Illicit Drug other than Marijuana a 20.7 18.6 17.1 13.9 13.8 11.8 11.6 8.8 8.5 6.9 4.4 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4
Marijuana 34.0 33.2 26.8 26.2 23.0 23.6 22.3 20.3 16.8 16.3 14.0 14.1 14.6 14.2 15.1 18.6 17.5 17.7 18.6 20.7
Inhalants b 1.5 0.9 0.8 0.7 0.7 1.0 1.1 0.9 1.3 0.8 1.0 0.9 1.1 1.3 0.6 1.6 0.8 0.7 0.6 1.5
Hallucinogens c,x 2.7 2.3 2.6 1.8 1.8 1.3 2.2 2.0 1.7 2.3 1.4 1.2 2.3 2.5 2.1 3.3 1.9 2.1 2.1 2.0
     LSD x 1.4 1.4 1.7 0.9 0.8 0.7 1.4 1.4 1.1 1.4 1.1 0.8 1.8 1.6 1.8 2.5 0.9 1.1 1.5 1.2
     Hallucinogens other than LSD c,x 1.9 1.2 1.4 1.0 1.2 0.7 1.2 0.8 0.8 1.1 0.8 0.6 0.7 1.1 0.8 1.6 1.2 1.2 0.7 1.2
     Ecstasy (MDMA), original d,z — — — — — — — — — 0.3 0.6 0.2 0.4 0.3 0.2 0.7 0.7 0.8 0.8 2.1
     Ecstasy (MDMA), revised d,z — — — — — — — — — — — — — — — — — — — —
Cocaine 6.9 7.3 7.9 6.5 7.6 6.9 7.0 4.6 4.2 2.8 1.2 1.0 1.0 0.7 0.6 0.7 0.8 1.6 1.6 1.2
     Crack e — — — — — — 1.3 0.4 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3
     Other Cocaine f — — — — — — — 3.5 3.2 3.2 1.0 1.0 0.9 0.6 0.3 0.8 0.6 1.3 1.5 1.0
Heroin 0.3 * * * * * * 0.1 0.1 0.1 * 0.1 * * * 0.1 * 0.2 0.1 0.1
Narcotics other than Heroin g,h 1.8 1.1 0.9 1.1 1.4 0.7 0.6 0.8 0.8 0.7 0.5 0.6 1.0 0.7 0.4 1.2 0.7 1.3 1.1 1.0
Amphetamines g,i 13.4 12.3 9.9 7.0 5.5 4.2 3.7 2.3 1.8 1.3 1.4 1.0 1.1 1.5 1.5 2.2 0.9 2.1 1.7 2.3
     Methamphetamine j — — — — — — — — — — — — — — — — — — — 1.2
     Crystal Methamphetamine (Ice) j — — — — — — — — — — * * * 0.3 0.5 0.3 0.1 0.2 0.3 *
Sedatives (Barbiturates) g,t 0.9 0.8 1.0 0.5 0.7 0.4 0.6 0.5 0.5 0.2 0.2 0.3 0.7 0.4 0.4 0.5 0.8 1.2 1.1 1.1
    Sedatives, Adjusted g,k 3.8 3.4 2.5 1.1 1.0 0.7 0.6 0.6 0.6 0.2 — — — — — — — — — —
    Methaqualone g 3.1 3.0 1.9 0.7 0.5 0.3 0.1 0.2 0.1 0.0 — — — — — — — — — —
Tranquilizers g,l 2.0 1.4 1.4 1.2 1.1 1.4 1.9 1.0 1.1 0.8 0.5 0.6 0.6 0.4 0.4 0.5 0.7 1.2 1.3 1.1
Alcohol m 81.8 81.9 82.8 80.3 79.1 80.3 79.7 78.4 77.0 76.2 74.5 74.7 71.4 70.1 67.8 67.5 67.0 65.8 68.1 69.6
     Been Drunk n — — — — — — — — — — — 45.0 45.0 43.8 42.8 37.9 40.3 46.4 44.3 44.6
     Flavored Alcoholic Beverages o — — — — — — — — — — — — — — — — — — — —
Cigarettes 25.8 25.9 24.4 24.7 21.5 22.4 22.4 24.0 22.6 21.1 21.5 23.2 23.5 24.5 23.5 26.8 27.9 28.3 30.0 30.6
Any Vaping j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — — — —
Large Cigars o — — — — — — — — — — — — — — — — — — — —
Flavored Little Cigars o — — — — — — — — — — — — — — — — — — — —
Regular Little Cigars o — — — — — — — — — — — — — — — — — — — —
Steroids p — — — — — — — — — * 0.2 0.3 0.2 0.2 0.2 0.1 * 0.2 0.2 0.4
TABLE 9-3
Trends in 30-Day Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Years 
cont.)
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880
Any Illicit Drug a 21.5 21.9 21.5 21.4 21.2 19.5 19.2 19.3 18.9 20.7 19.2 21.4 22.3 22.8 22.7 23.4 24.3 23.3 -0.9
Any Illicit Drug other than Marijuana a 6.9 7.5 7.8 8.2 9.1 8.2 8.2 8.1 7.3 8.4 8.1 8.2 7.8 8.8 10.0 9.2 8.4 7.0 -1.5
Marijuana 20.0 20.2 19.7 19.3 18.9 17.1 16.7 16.8 17.0 18.5 17.5 19.4 20.5 20.6 20.8 21.1 22.2 21.2 -1.0
Inhalants b 0.9 0.4 0.7 0.4 0.4 0.3 0.4 0.1 0.4 0.1 0.5 0.3 0.2 0.1 0.3 0.2 * 0.9 +0.9 s
Hallucinogens c,x 1.4 1.8 1.2 1.8 1.3 1.2 0.9 1.3 1.7 1.0 1.4 1.2 1.1 1.0 1.0 1.4 0.8 1.2 +0.4
     LSD x 0.9 1.0 0.2 0.2 0.2 0.1 0.3 0.3 0.8 0.3 0.7 0.5 0.4 0.4 0.5 0.7 0.4 0.8 +0.5
     Hallucinogens other than LSD c,x 0.8 0.8 1.1 1.7 1.2 1.1 0.7 1.1 1.3 0.8 1.2 0.8 0.7 0.8 0.7 0.9 0.5 0.6 +0.1
     Ecstasy (MDMA), original d,z 2.5 1.5 0.7 1.0 0.7 0.8 0.6 0.4 0.6 0.5 1.0 0.7 1.4 0.8 1.3 — — — —
     Ecstasy (MDMA), revised d,z — — — — — — — — — — — — — — 1.0 0.7 1.0 0.5 -0.5
Cocaine 1.4 1.9 1.6 1.9 2.4 1.8 1.8 1.7 1.2 1.3 1.0 1.2 1.1 0.9 1.8 1.5 1.4 1.3 -0.1
     Crack e 0.3 0.1 0.3 0.4 0.4 0.1 * 0.1 0.1 0.1 0.1 0.1 * 0.3 0.1 * * * 0.0
     Other Cocaine f 0.9 1.5 1.4 1.9 2.2 1.8 1.3 1.6 1.1 1.2 1.0 1.2 1.3 0.9 1.8 1.4 1.7 1.1 -0.6
Heroin 0.2 0.1 * * 0.1 0.1 0.2 0.1 * 0.1 * * 0.1 0.2 * * 0.2 * -0.2
Narcotics other than Heroin g,h 1.7 1.7 3.2 2.3 3.0 3.1 3.1 2.2 2.3 2.7 2.3 2.1 2.2 1.5 1.2 1.3 1.1 0.7 -0.5
Amphetamines g,i 2.9 3.3 3.0 3.1 3.2 2.9 2.5 3.1 2.8 3.4 4.1 4.5 4.6 5.0 4.8 4.2 3.8 3.6 -0.2
     Methamphetamine j 0.2 0.5 0.2 0.6 0.2 0.1 0.2 0.1 * 0.1 * * * * 0.1 * * * 0.0
     Crystal Methamphetamine (Ice) j * 0.1 * 0.3 0.1 0.2 * 0.1 * * 0.2 * 0.3 * * * * 0.4 +0.4
Sedatives (Barbiturates) g,t 1.1 1.5 1.7 1.7 1.5 1.3 1.3 1.4 1.4 1.2 0.6 0.8 0.8 0.9 0.7 1.0 0.9 0.5 -0.4
    Sedatives, Adjusted g,k — — — — — — — — — — — — — — — — — — —
    Methaqualone g — — — — — — — — — — — — — — — — — — —
Tranquilizers g,l 2.0 1.5 3.0 2.8 2.7 2.2 2.1 1.8 1.6 2.2 1.3 1.6 1.1 1.2 1.7 1.6 1.8 0.9 -0.9
Alcohol m 67.4 67.0 68.9 66.2 67.7 67.9 65.4 66.6 69.0 65.8 65.0 63.5 67.7 63.1 63.1 63.2 63.2 62.0 -1.2
     Been Drunk n 43.9 44.7 44.4 40.4 47.4 43.1 47.6 46.8 45.3 42.4 43.6 39.9 40.1 40.2 42.6 38.4 40.8 34.8 -6.0
     Flavored Alcoholic Beverages o — — — — 34.0 30.9 26.2 27.5 35.8 32.3 31.5 29.5 31.3 29.1 32.9 30.5 33.5 36.7 +3.2
Cigarettes 28.2 25.7 26.7 22.5 24.3 23.8 19.2 19.9 17.9 17.9 16.4 15.2 12.5 14.0 12.9 11.3 8.9 8.0 -0.9
Any Vaping j,aa — — — — — — — — — — — — — — — 8.8 6.9 11.3 —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — 5.2 —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — 6.1 —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — 4.3 —
Large Cigars o — — — — — — — — — — — — — — 8.4 4.9 4.4 1.7 -2.7
Flavored Little Cigars o — — — — — — — — — — — — — — 9.8 5.6 5.6 4.9 -0.8
Regular Little Cigars o — — — — — — — — — — — — — — 8.6 4.1 3.6 1.7 -2.0
Steroids p * 0.3 * 0.1 * * * 0.1 * 0.2 * 0.2 * * * 0.3 * 0.3 +0.3
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
TABLE 9-3 (cont.)
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Marijuana 7.2 5.6 4.2 3.8 3.6 3.1 2.1 2.3 1.8 2.6 1.7 1.8 1.6 1.9 1.8 3.7 2.8 3.7 4.0 4.0
Cocaine 0.2 * 0.3 0.1 0.4 0.1 0.1 0.1 0.1  * *  * * * 0.1 * * * * *
Amphetamines g 0.5 0.4 — — — — — — — — — — — — — — — — — —
Amphetamines, Adjusted g,i — — 0.3 0.2 0.2  * 0.1 0.1  *  * * 0.1 * 0.1 0.1 0.1  * 0.2 0.1 0.1
Alcohol m
     Daily 6.5 5.5 6.1 6.1 6.6 5.0 4.6 6.0 4.9 4.0 3.8 4.1 3.7 3.9 3.7 3.0 3.2 4.5 3.9 4.5
     Been Drunk n — — — — — — — — — — — 0.5 0.2 0.3 0.8 0.5 0.1 1.3 0.8 1.0
     5+ Drinks in a Row in Last 2 Weeks 43.9 43.6 44.0 43.1 45.4 44.6 45.0 42.8 43.2 41.7 41.0 42.8 41.4 40.2 40.2 38.6 38.3 40.7 38.9 40.0
     10+ Drinks in a Row in Last 2 Weeks o — — — — — — — — — — — — — — — — — — — —
     15+ Drinks in a Row in Last 2 Weeks o — — — — — — — — — — — — — — — — — — — —
Cigarettes
     Daily 18.3 17.1 16.2 15.3 14.7 14.2 12.7 13.9 12.4 12.2 12.1 13.8 14.1 15.2 13.2 15.8 15.9 15.2 18.0 19.3
     1/2 Pack+/Day 12.7 11.9 10.5 9.6 10.2 9.4 8.3 8.2 7.3 6.7 8.2 8.0 8.9 8.9 8.0 10.2 8.5 9.1 11.3 11.0
TABLE 9-4
Trends in 30-Day Prevalence of Daily r Use of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Table continued on next page.)
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880
Marijuana 4.6 4.5 4.1 4.7 4.5 4.0 4.3 3.5 3.9 4.9 4.4 4.7 4.8 5.1 5.9 4.6 4.9 4.4 -0.5
Cocaine * * * * * 0.1 0.1 * * * * * * * * * 0.1 * -0.1
Amphetamines g — — — — — — — — — — — — — — — — — — —
Amphetamines, Adjusted g,i 0.1 0.2 0.1 0.3 0.2 0.2 0.4 0.1 0.2 0.1 * 0.2 0.1 * 0.2 0.1 * 0.1 +0.1
Alcohol m
     Daily 3.6 4.7 5.0 4.3 3.7 4.6 4.8 4.3 4.0 4.3 3.6 3.8 3.9 3.6 4.3 3.1 4.3 2.2 -2.1 s
     Been Drunk n 0.7 0.5 0.8 1.1 0.8 0.5 0.6 0.7 0.5 0.7 0.3 1.3 0.4 0.5 0.4 0.7 0.4 0.0 -0.4
     5+ Drinks in a Row in Last 2 Weeks 39.3 40.9 40.1 38.5 41.7 40.1 40.2 41.1 40.0 36.9 37.0 36.1 37.4 35.2 35.4 31.9 32.4 32.7 +0.3
     10+ Drinks in a Row in Last 2 Weeks o — — — — — 12.5 13.7 13.9 13.0 15.8 11.6 14.6 13.7 10.4 9.1 7.3 9.0 10.5 +1.5
     15+ Drinks in a Row in Last 2 Weeks o — — — — — 5.1 4.2 5.1 4.7 6.4 4.0 5.4 4.7 3.6 5.1 1.2 2.1 1.3 -0.8
Cigarettes
     Daily 17.8 15.0 15.9 13.8 13.8 12.4 9.2 9.3 9.2 8.0 7.6 7.3 5.2 5.6 5.2 4.2 2.6 2.0 -0.6
     1/2 Pack+/Day 10.1 7.8 7.9 7.6 6.8 6.7 4.9 4.3 4.3 3.8 3.9 2.5 2.4 2.4 2.4 1.4 1.7 0.2 -1.4 ss
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
TABLE 9-4 (cont.)
Trends in 30-Day Prevalence of Daily r Use of Various Types of Drugs
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2016– 
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change
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Total 2005-2011 2012-2017 Change
Full-Time College 13.6 10.1 -3.5
Weighted N 1296 1021
Others 11.8 10.3 -1.5
Weighted N 884 584
Males
Full-Time College 23.6 16.2 -7.4
Weighted N 584 381
Others 17.9 16.8 -1.1
Weighted N 373 264
Females
Full-Time College 7.2 6.5 -0.7
Weighted N 915 640
Others 7.4 5.0 -2.4
Weighted N 510 320
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 9-7.
TABLE 9-5
Trends in Having 10+ Drinks in a Row in the Last Two Weeks:
 Full-Time College Students vs. Others 
among Respondents 1 to 4 Years beyond High School
by Gender
(Entries are percentages.)
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Total 2005-2011 2012-2017 Change
Full-Time College 5.0 3.1 -1.9
Weighted N 1267 1021
Others 5.2 5.1 -0.1
Weighted N 886 582
Males
Full-Time College 10.1 6.0 -4.1
Weighted N 585 381
Others 9.4 8.8 -0.7
Weighted N 373 262
Females
Full-Time College 1.8 1.3 -0.5
Weighted N 913 640
Others 2.1 2.0 0.0
Weighted N 512 320
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 9-7.
TABLE 9-6
Trends in Having 15+ Drinks in a Row in the Last Two Weeks:
 Full-Time College Students vs. Others 
among Respondents 1 to 4 Years beyond High School
by Gender
(Entries are percentages.)
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1980 i 1981 i 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Any Illicit Drug
     Total 69.4 66.8 64.6 66.9 62.7 65.2 61.8 60.0 58.4 55.6 54.0 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2
     Males 71.0 67.5 68.1 71.3 66.4 69.8 64.7 63.5 56.0 56.5 52.5 51.3 50.8 45.7 49.5 47.3 50.3 52.1 54.4 58.4
     Females 67.5 66.3 61.5 63.0 59.2 61.6 59.4 57.4 60.2 54.9 55.1 49.7 47.1 46.0 42.6 44.3 45.6 46.7 52.0 49.6
Any Illicit Drug other than Marijuana
     Total 42.2 41.3 39.6 41.7 38.6 40.0 37.5 35.7 33.4 30.5 28.4 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5
     Males 42.8 39.8 45.1 44.6 40.9 42.1 38.2 37.2 31.8 30.6 26.2 27.6 26.3 24.3 24.6 26.6 25.0 27.3 27.3 29.4
     Females 41.6 42.6 34.7 39.2 36.4 38.3 37.0 34.6 34.6 30.4 30.1 24.3 26.1 24.3 20.1 22.9 21.2 22.2 23.3 22.8
Any Illicit Drug
     Total 56.2 55.0 49.5 49.8 45.1 46.3 45.0 40.1 37.4 36.7 33.3 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9
     Males 58.9 56.2 54.6 53.4 48.4 50.9 49.8 43.3 37.0 38.2 34.2 30.2 32.8 32.6 33.9 36.1 36.6 38.3 40.1 42.5
     Females 53.3 54.0 44.9 46.7 41.9 42.7 41.1 37.7 37.6 35.4 32.5 28.4 28.7 29.1 29.5 31.7 32.7 31.1 36.4 33.2
Any Illicit Drug other than Marijuana
     Total 32.3 31.7 29.9 29.9 27.2 26.7 25.0 21.3 19.2 16.4 15.2 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4
     Males 33.7 32.8 33.4 33.5 29.2 29.7 28.6 23.5 19.4 18.7 15.7 14.4 13.8 15.0 14.9 19.5 15.1 18.1 17.0 19.0
     Females 31.1 30.8 26.9 26.8 25.2 24.4 22.1 19.6 19.0 14.6 14.8 12.1 12.6 10.5 10.2 13.3 11.3 14.1 12.1 12.8
Any Illicit Drug
     Total 38.4 37.6 31.3 29.3 27.0 26.1 25.9 22.4 18.5 18.2 15.2 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6
     Males 42.9 40.6 37.7 33.8 30.4 29.9 31.0 24.0 18.8 20.0 18.2 16.0 18.0 16.0 20.5 23.7 20.6 23.4 23.1 26.7
     Females 34.0 34.8 25.6 25.5 23.7 23.2 21.7 21.1 18.3 16.7 12.7 14.6 14.5 14.5 12.7 15.7 15.8 16.2 17.6 18.1
Any Illicit Drug other than Marijuana
     Total 20.7 18.6 17.1 13.9 13.8 11.8 11.6 8.8 8.5 6.9 4.4 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4
     Males 22.8 18.6 20.2 16.0 16.1 12.6 14.4 9.0 8.2 8.0 4.9 4.8 5.1 7.3 6.2 8.8 6.1 7.8 8.6 7.5
     Females 18.7 18.5 14.2 12.1 11.5 11.2 9.3 8.5 8.8 6.0 4.0 3.9 4.2 3.8 3.4 4.5 3.4 6.1 4.6 5.6
All Respondents
     Total 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
     Males 520 530 550 550 540 490 540 520 560 580 620 640 680 660 590 610 560 630 570 590
     Females 520 600 610 620 570 600 650 700 750 720 780 770 810 830 820 840 890 860 880 850
Percentage who used in lifetime
TABLE 9-7
Trends in Lifetime, Annual, and 30-Day Prevalence of an Illicit Drug Use Index a
among College Students 1 to 4 Years beyond High School, by Gender
(Years 
cont.)
(Table continued on next page.)
Percentage who used in last 12 months
Percentage who used in last 30 days
Approximate Weighted N
414
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Any Illicit Drug
    Total 53.7 53.6 51.8 53.9 52.2 52.3 50.6 50.5 49.5 51.4 49.1 49.2 50.5 53.3 52.4 53.4 54.4 55.5 +1.1
     Males 54.4 53.9 54.3 54.1 54.9 54.2 55.0 52.3 50.7 53.2 53.5 52.3 52.4 53.7 54.5 55.1 54.5 57.8 +3.3
     Females 53.2 53.5 50.2 53.7 50.6 51.3 47.8 49.4 48.8 50.2 46.2 47.3 49.2 53.0 50.9 52.5 54.3 54.1 -0.2
Any Illicit Drug other than Marijuana
     Total 25.8 26.3 26.9 27.6 28.0 26.5 26.3 25.3 22.6 25.6 24.8 24.3 23.8 28.3 29.0 26.4 26.5 26.3 -0.3
     Males 28.9 27.0 30.4 27.6 31.1 29.0 29.2 26.5 25.2 29.9 27.8 27.8 26.0 30.4 29.8 31.0 28.1 27.0 -1.1
     Females 23.5 25.9 24.6 27.5 26.2 25.1 24.4 24.6 21.0 22.7 22.8 22.1 22.2 26.8 28.3 23.8 25.6 25.8 +0.2
Any Illicit Drug
     Total 36.1 37.9 37.0 36.5 36.2 36.6 33.9 35.0 35.2 36.0 35.0 36.3 37.3 40.5 38.6 41.4 42.8 42.5 -0.3
     Males 38.0 38.8 39.5 39.2 40.9 40.7 39.2 38.0 38.7 37.6 40.3 41.2 39.5 41.3 39.2 45.2 44.9 46.4 +1.5
     Females 34.7 37.3 35.4 34.8 33.4 34.2 30.6 33.1 32.9 35.0 31.6 33.2 35.7 40.0 38.2 39.2 41.5 40.0 -1.5
Any Illicit Drug other than Marijuana
     Total 15.6 16.4 16.6 17.9 18.6 18.5 18.1 17.3 15.3 16.9 17.1 16.8 17.1 19.3 20.8 18.5 19.7 18.2 -1.5
     Males 18.6 17.2 19.2 19.3 22.1 21.1 22.6 19.0 17.8 19.7 20.3 20.1 19.6 22.0 21.8 24.6 22.7 19.8 -2.8
     Females 13.5 15.8 15.0 17.1 16.5 16.9 15.2 16.3 13.7 15.0 15.1 14.7 15.4 17.4 20.1 14.9 17.9 17.1 -0.8
Any Illicit Drug
     Total 21.5 21.9 21.5 21.4 21.2 19.5 19.2 19.3 18.9 20.7 19.2 21.4 22.3 22.8 22.7 23.4 24.3 23.5 -0.8
     Males 24.0 25.0 25.1 22.8 26.1 22.9 23.4 22.7 23.1 23.4 25.9 27.0 27.0 27.8 25.9 27.4 25.4 26.4 +1.0
     Females 19.6 19.8 19.3 20.5 18.4 17.5 16.6 17.1 16.2 19.0 15.0 17.9 19.1 19.3 20.2 21.1 23.6 21.5 -2.0
Any Illicit Drug other than Marijuana
     Total 6.9 7.5 7.8 8.2 8.2 8.2 8.1 7.3 8.4 8.1 8.2 7.8 8.8 10.0 9.2 8.4 7.0 -1.4
     Males 8.2 9.0 8.4 8.1 11.3 10.3 10.3 9.5 9.6 9.0 10.4 10.6 9.2 11.2 12.4 12.9 11.8 7.2 -4.6
     Females 6.0 6.4 7.4 8.3 7.8 7.0 6.9 7.2 5.8 8.0 6.7 6.7 6.8 7.2 8.3 7.1 6.4 6.9 +0.5
All Respondents
     Total 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 870
     Males 560 540 490 480 520 500 500 470 510 530 500 480 480 430 440 380 340 340
     Females 790 800 770 790 880 860 780 770 760 790 760 750 670 660 590 640 540 530
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes on the following page.
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Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001. Any apparent inconsistency between the change estimate and the 
prevalence estimates for the two most recent years is due to rounding. ' — ' indicates data not available. ' * ' indicates a prevalence rate of less than 0.05%.
aAny illicit drug includes use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone (until 1990), or tranquilizers not 
under a doctor ʾs orders.  
bThis drug was asked about in four of the five questionnaire forms in 1980–1989, in five of the six forms in 1990–1998, and in three of the six forms beginning in 1999.
cIn 2001 the question text was changed on three of the six questionnaire forms. Other psychedelics was changed to other hallucinogens, and shrooms was added to the list of examples. 
Beginning in 2002 the remaining forms were changed to the new wording.
dThis drug was asked about in two of the five questionnaire forms in 1989, in two of the six questionnaire forms in 1990–2001, in three of the six questionnaire forms in 2002–2015, and 
in four of six questionnaire forms beginning in 2015.  
eThis drug was asked about in one of the five questionnaire forms for annual use only in 1986, two of the five questionnaire forms in 1987–1989, in all six questionnaire forms in 1990–2001, and 
in five of the six questionnaire forms beginning in 2002.. 
fThis drug was asked about in one of the five questionnaire forms in 1987–1989 and in four of six questionnaire forms beginning in 1990.
gOnly drug use that was not under a doctor ʾs orders is included here.
hIn 2002 the question text was changed on three of the six questionnaire forms. The list of examples of narcotics other than heroin was updated: Talwin, laudanum, and paregoric—all 
of which had negligible rates of use by 2001—were replaced by Vicodin, OxyContin, and Percocet. The 2002 data presented here are based on the changed forms only; 
N  is three sixths of N  indicated. In 2003 the remaining forms were changed to the new wording. The data are based on all forms in 2003 and beyond.
iRevised questions about amphetamine use were introduced in 1982 to more completely exclude inappropriate reporting of nonprescription amphetamines.  In 2013 the question wording was changed 
slightly in thee of the six questionnaire forms.  2013 data are based on the changed forms only; N is one half of N indicated.
jThis drug was asked about in two of the six questionnaire forms.  Questions about Rohypnol use were dropped from the questionnaires beginning in 2010.
kSedatives, adjusted data are a combination of barbiturate and methaqualone data.
lIn 2001 the question text was changed on three of the six questionnaire forms. Miltown was replaced with Xanax in the list of examples. Beginning in 2002 the remaining forms 
were changed to the new wording.
mIn 1993 and 1994, the question text was changed slightly in three of the six questionnaire forms to indicate that a drink meant more than just a few sips. Because this revision resulted in rather 
little change in reported prevalence in the surveys of high school graduates, the data for all forms combined are used in order to provide the most reliable estimate of change. 
After 1994 the new question text was used in all six of the questionnaire forms.
nThis drug was asked about in three of the six questionnaire forms. 
oThis drug was asked about in one of the six questionnaire forms. 
pThis drug was asked about in one of the five questionnaire forms in 1989 and in two of the six questionnaire forms beginning in 1990.
qThis drug was asked about in two of the six questionnaire forms through 2010 and in three of the six questionnaire forms beginning in 2011. 
rDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, and 5+ drinks, 
measured as having five or more drinks in a row in the last two weeks.
sIn 2012 the alcoholic beverage containing caffeine question text was changed to alcoholic beverage mixed with an energy drink.  The data in 2011 and 2012
are not comparable due to this question change.
tIn 2013 the question text was changed on all forms: Tuinal, Nembutal, and Seconal were replaced with Ambien, Lunesta, and Sonata.  The data in 2012 and
2013 are not comparable due to this question change.
uThis drug was asked about in two of the six questionnaire forms in 2011-2012; N is two sixths of N indicated.  Data were based on three of the six 
questionaire forms beginning in 2013; N is three sixths of N indicated.
vThis drug was asked about in one of the six questionnaire forms in 2009; N is one sixth of N indicated; Data were based on two of the six questionnaire
forms in 2010-2011; N is two sixths of N indicated.  Data were based on three of the six questionnaire forms beginning in 2012; N is three sixths of N indicated.
wThis drug was asked about in two of the six questionnaire forms in 2002-2009; N is two sixths of N indicated; Data were based on three of the six questionnaire
forms in 2010-2011; N is three sixths of N indicated.  Data were based on two of the six questionnaire forms in 2012-2015; N is two sixths of N indicated.
xThis drug was asked about in all six questionaire forms from 1980-2013.  Data based on five of six forms beginning in 2014; N is five sixths of N indicated.
yThis drug asked about in three of six questionnaire forms from 2011-2013; N is one half of N indicated.  Beginning in 2014, data based on two of six questionnaire forms; N is two sixths of N indicated.
z  In 2014 a revised question on use of ecstasy (MDMA) including "Molly" was added to one form at each level. The 2013 and 2014 "Original wording" data reported here are for only the 
 questionnaires using the original question wording. The 2014 and 2015 "Revised wording" data reported here are for only the questionnaires using the version which includes "Molly."
aaIn 2017, the surveys switched from asking about vaping in general to asking separately about vaping nicotine, marijuana, and just flavoring.  
Beginning in 2017, data presented for any vaping are based on these new questions.
Footnotes for Tables 9-1 through 9-7
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
Trends in Annual Prevalence 
among Male vs. Female College Students 
FIGURE 9-2
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 Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
MARIJUANA
Trends in Annual Prevalence 
among Male vs. Female College Students 
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
MARIJUANA
Trends in 30-Day Prevalence of Daily Use
among Male vs. Female College Students 
FIGURE 9-3b
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-4
SYNTHETIC MARIJUANA
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aUnadjusted for the possible underreporting of amyl and butyl nitrites.
INHALANTS a 
among Male vs. Female College Students 
Trends in Annual Prevalence
FIGURE 9-5
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aUnadjusted for the possible underreporting of PCP.
HALLUCINOGENS a 
Trends in Annual Prevalence
among Male vs. Female College Students 
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
LSD
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-7
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
HALLUCINOGENS OTHER THAN LSD
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-8
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aIn 2014, a version of the question was added to an additional form that included "molly" in the description.  In 2015, the
remaining forms were changed to this updated wording.  Data for both versions of the question are included here. 
ECSTASY (MDMA, Molly) a
Trends in Annual Prevalence
among Male vs. Female College Students 
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
COCAINE
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-10
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aIn 2002 the question text was changed on half of the questionnaire forms. The list of examples of narcotics other than heroin 
was updated: Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—were replaced by Vicodin,
OxyContin, and Percocet. The 2002 data presented here are based on the changed forms only. In 2003 the remaining forms
were changed to the new wording.  
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
FIGURE 9-11b
VICODIN
Trends in Annual Prevalence among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
FIGURE 9-11c
OXYCONTIN
Trends in Annual Prevalence among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
0
2
4
6
8
10
’80’81’82’83’84’85’86’87’88’89’90’91’92’93’94’95’96’97’98’99’00’01’02’03’04’05’06’07’08’09’10’11’12’13’14’15’16’17
PE
R
C
EN
T
YEAR OF ADMINISTRATION
Full-Time College Students
Others
12th Graders
430
Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
AMPHETAMINES
Trends in Annual Prevalence 
among Male vs. Female College Students 
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 Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
SEDATIVES (BARBITURATES)
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-13
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
TRANQUILIZERS
Trends in Annual Prevalence 
among Male vs. Female College Students 
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
ALCOHOL
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-15a
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
ALCOHOL
Trends in 30-Day Prevalence
among Male vs. Female College Students 
FIGURE 9-15b
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(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
ALCOHOL
Trends in 30-Day Prevalence of Daily Use
among Male vs. Female College Students 
FIGURE 9-15c
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
ALCOHOL
Trends in 2-Week Prevalence of 5 or More Drinks in a Row
among Male vs. Female College Students 
(Twelfth graders included for comparison.)
FIGURE 9-15d
ALCOHOL
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
CIGARETTES
Trends in 30-Day Prevalence
among Male vs. Female College Students 
FIGURE 9-16a
CIGARETTES
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1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
0
5
10
15
20
25
30
35
40
45
’80’81’82’83’84’85’86’87’88’89’90’91’92’93’94’95’96’97’98’99’00’01’02’03’04’05’06’07’08’09’10’11’12’13’14’15’16’17
PE
R
C
EN
T
YEAR OF ADMINISTRATION
Full-Time College Students
Others
12th Graders
0
5
10
15
20
25
30
35
40
45
’80’81’82’83’84’85’86’87’88’89’90’91’92’93’94’95’96’97’98’99’00’01’02’03’04’05’06’07’08’09’10’11’12’13’14’15’16’17
PE
R
C
EN
T
YEAR OF ADMINISTRATION
Male College Students
Female College Students
438
Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
(Twelfth graders included for comparison.)
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Chapter 10 
 
STUDY PUBLICATIONS 
 
MTF results are reported in a number of other types of publications, in particular peer-reviewed 
journals. Selected articles published in the past year or in press as of this writing are summarized 
below. Further details, as well as a more complete listing, may be found on the MTF website. In 
this chapter, we include summaries of publications that used MTF 8th, 10th, and 12th grade samples, 
as well as the panel data. 
 
Adolescents’ prescription stimulant use and adult functional outcomes: A national 
prospective study1  
The objective was to assess the prospective 17-year relationship between the medical and 
nonmedical use of prescription stimulants during adolescence (age 18 years) and educational 
attainment and substance use disorder (SUD) symptoms in adulthood (age 35 years). MTF 
nationally representative probability samples of US high school seniors from the Monitoring the 
Future study were surveyed (1976-1996); 8,362 of these individuals were followed longitudinally 
to adulthood (age 35, 1993-2013). We found that an estimated 8.1% reported medical use of 
prescription stimulants, and 16.7% reported nonmedical use of prescription stimulants by age 18 
years. Approximately 43% of adolescent medical users of prescription stimulants had also engaged 
in nonmedical use of prescription stimulants during adolescence. Among past-year adolescent 
nonmedical users of prescription stimulants, 97.3% had used at least one other substance during 
the past year. Medical users of prescription stimulants without any history of nonmedical use 
during adolescence did not differ significantly from population controls (i.e., non-attention-
deficit/hyperactivity disorder [ADHD] and non-stimulant-medicated ADHD during adolescence) 
in educational attainment and SUD symptoms in adulthood. In contrast, adolescent nonmedical 
users of prescription stimulants (with or without medical use) had lower educational attainment 
and more SUD symptoms in adulthood, compared to population controls and medical users of 
prescription stimulants without nonmedical use during adolescence. In conclusion, nonmedical use 
of prescription stimulants is common among adolescents prescribed these medications. The 
findings indicate youth should be carefully monitored for nonmedical use because this behavior is 
associated with lower educational attainment and more SUD symptoms in adulthood. 
 
Age-related changes in associations between reasons for alcohol use and high-
intensity drinking across young adulthood2 
Objective Analyses focus on whether self-reported reasons for drinking alcohol change in their 
associations with high-intensity drinking across the transition to adulthood. Method Self-report 
data on high-intensity drinking (10+ drinks) collected from the national Monitoring the Future 
study in 2005 to 2014 from those ages 18–26 were used (N = 2,664 [60% women] for all drinkers 
and 1,377 for heavy episodic [5+] drinkers; up to 6,541 person-waves). Time-varying effect 
modeling examined changes in the direction and magnitude of associations between eight reasons 
                                                 
1 McCabe, S. E., Veliz, P., Wilens, T. E., & Schulenberg, J. E. (2017). Adolescents’ prescription stimulant use and adult functional outcomes: A 
national prospective study. Journal of American Academy of Child Adolescent Psychiatry, 56(3), 226-233.  
2 Patrick, M. E., Evans-Polce, R. J., Kloska, D. D., Maggs, J. L., & Lanza, S. T. (2017). Age-related changes in associations between reasons for 
alcohol use and high-intensity drinking across young adulthood. Journal of Studies on Alcohol and Drugs, 78(4), 558-570. 
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for drinking and high-intensity alcohol use across continuous age. Results Four reasons to drink 
showed quite stable associations with high-intensity drinking across age: drinking to get away 
from problems, to get high, to relax, and to sleep. Associations between two reasons and high-
intensity drinking decreased with age: anger/frustration and to have a good time. The association 
between drinking because of boredom and high-intensity drinking increased with age. Drinking 
because it tastes good had a weak association with high-intensity drinking. Among heavy episodic 
drinkers, reasons for use also differentiated high-intensity drinking, with two exceptions: drinking 
to have a good time and to relax did not distinguish drinking 10+ drinks from drinking 5–9 drinks. 
Conclusions Reasons for drinking are differentially associated with high-intensity drinking, 
compared with any other drinking and compared with lower intensity heavy drinking, across age 
during the transition to adulthood. Intervention programs seeking to mitigate alcohol-related harms 
should focus on reasons for use when they are the most developmentally salient. 
 
Age-specific prevalence of binge and high-intensity drinking among U.S. young adults: 
Changes from 2005 to 20153 
Background This study examined changes during the past decade, from 2005 to 2015, in binge 
and high‐intensity drinking in 7 separate age groups of U.S. 12th graders and young adults. 
Methods National longitudinal data (N = 6,711) from Monitoring the Future were used to examine 
trends in consuming 5+, 10+, and 15+ drinks on the same occasion in the past 2 weeks from ages 
18 to 29/30 overall and by gender. Results were compared with trends in past 12‐month and 30‐
day alcohol use for the same age groups. Results Between 2005 and 2015, binge (5+) and high‐
intensity drinking (10+, 15+) generally decreased for individuals in their early 20s, remained 
somewhat stable for individuals in their mid‐20s, and increased for individuals at the end of young 
adulthood (age 29/30). The observed historical trends in binge and high‐intensity drinking were 
similar to those for past 12‐month and past 30‐day alcohol use for those aged 18 to 20, but diverged 
for most other age groups in young adulthood. Trends were generally similar for men and women, 
except that the increase in prevalence began earlier in young adulthood for women than for men. 
Conclusions Binge and high‐intensity drinking among U.S. 12th graders and young adults are 
dynamic phenomena. Prevention and intervention efforts aimed at reducing the harms resulting 
from 5+, 10+, and 15+ drinking should acknowledge and focus on differences in trends in these 
behaviors by age and gender. 
 
Alcohol mixed with energy drink use during young adulthood4 
Aims Alcohol mixed with energy drink (AmED) use is associated with negative consequences 
including hazardous alcohol use and driving under the influence. While many studies have focused 
on correlates of AmED use among college samples, very few have examined patterns of AmED 
use during adolescence and young adulthood within the general population. Accordingly, the 
purpose of this study is to assess age differences in AmED use among a national sample of 
respondents aged 18 to 30. Methods The data for this study come from the Monitoring the Future 
panel study from 2012 to 2015. The sample consists of 2222 respondents between the ages of 18 
and 30. Multiple logistic regression using generalized estimating equations (GEE) was used to 
                                                 
3 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O'Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence of 
binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41(7), 
1319-1328. 
4 Patrick, M. E., Veliz, P., Linden-Carmichael, A., & Terry-McElrath, Y. M. (2018). Alcohol mixed with energy drink use during young adulthood. 
Addictive Behaviors, 84, 224-230.  
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model past-year AmED prevalence across age and other covariates. Results Nearly half (45.0%) 
of respondents indicated past-year AmED use at some point during the study period. The lowest 
prevalence rates were found at age 18 (25.9%) and the highest prevalence rates at age 21/22 
(43.5%). GEE analyses indicated a statistically significant positive linear and negative quadratic 
trend with respect to the association between age of respondent and past-year AmED use. Namely, 
peak use occurred in early young adulthood (age 21/22 and 23/24) and then declined, reaching 
32.0% by age 29/30. College attendance and several substance use behaviors at age 18 moderated 
these linear and quadratic age trends. Conclusions AmED use peaked rapidly in early young 
adulthood and declined into later young adulthood. Substance use during adolescence was 
associated with a higher incidence of AmED use across all young adult ages and a slower decline 
of AmED use after age 21/22. Several sociodemographic factors were associated with AmED use, 
particularly college attendance at the age of 21/22. 
 
Competitive sports participation in high school and subsequent substance use in 
young adulthood: Assessing differences based on level of contact5 
The objective of this study is to examine how participation in different types of competitive sports 
(based on level of contact) during high school is associated with substance use 1 to 4 years after 
the 12th grade. The analysis uses nationally representative samples of 12th graders from the 
Monitoring the Future Study, who were followed 1 to 4 years after the 12th grade. The longitudinal 
sample consisted of 970 12th graders from six recent cohorts (2006–2011). The analyses, which 
controlled for 12th grade substance use, school difficulties, time with friends, and socio-
demographic characteristics, found that respondents who participated in at least one competitive 
sport during the 12th grade had greater odds of binge drinking during the past two weeks (AOR = 
2.04; 95% CI = 1.43, 2.90) 1 to 4 years after the 12th grade, when compared to their peers who did 
not participate in sports during their 12th grade year. Moreover, respondents who participated in 
high-contact sports (i.e. football, ice hockey, lacrosse, and wrestling) had greater odds of binge 
drinking (AOR = 1.80; 95% CI = 1.18, 2.72), and engaging in marijuana use during the past 30 
days (AOR = 1.81; 95% CI = 1.12, 2.93) 1 to 4 years after the 12th grade when compared to their 
peers who did not participate in these types of sports during their 12th grade year. Accordingly, the 
findings indicate important distinctions in sport participation experiences on long-term substance 
use risk that can help inform potential interventions among young athletes. 
 
Current high-intensity drinking among 8th and 10th grade students in the United States6 
Introduction This study assessed the prevalence of current high-intensity drinking (i.e., having 
ten or more drinks in a row in the past 2 weeks) among national samples of U.S. eighth and tenth 
grade students (at modal ages 14 and 16 years, respectively). Methods Data on high-intensity 
drinking were provided by 10,210 students participating in the nationally representative 
Monitoring the Future study in 2016, and analyzed in 2016–2017. Prevalence levels and 
interactions between grade and key covariates were estimated using procedures that adjusted for 
the Monitoring the Future study’s complex sampling design. Results Approximately 2% of 
adolescents reported current high-intensity drinking, with significant differences by grade (1.2% 
                                                 
5 Veliz, P., Schulenberg, J. E., Patrick, M. E., Kloska, D. D., McCabe, S. E., & Zarrett, N. (2017). Competitive sports participation in high school 
and subsequent substance use in young adulthood: Assessing differences based on level of contact. International Review for the Sociology of Sport, 
52(2), 240-259.  
6 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., O'Malley, P. M., Schulenberg, J. E., & Johnston, L. D. (2017). Current high-intensity 
drinking among 8th and 10th grade students in the United States. American Journal of Preventive Medicine, 53(6), 904-908. 
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of eighth graders; 3.1% of tenth graders) and gender (1.7% female; 2.3% male). High-intensity 
drinking was significantly higher among eighth and tenth grade students who reported any 
cigarette or marijuana use than among students who reported never using either substance. 
Conclusions A meaningful percentage of young adolescents in the U.S. engage in high-intensity 
drinking. 
 
The developmental course of community service across the transition to adulthood in 
a national U.S. sample7 
Despite the importance of community service for the well-being of individuals and communities, 
relatively little is known about the developmental course of community service during the 
transition to adulthood (TTA). This study tested competing hypotheses about change in community 
service across the TTA by estimating latent growth models from Ages 18 to 26 in a national U.S. 
sample. Analyses tested for cohort differences in community service and for individual differences 
in developmental trajectories by socioeconomic status, gender, grades, religiosity, race/ethnicity, 
college expectations, and college degree attainment. Using Monitoring the Future data from 1976 
to 2011, the best-fitting latent growth model for community service was quadratic: Community 
service declined from Ages 18 to 24 and leveled off thereafter. Cohort differences in intercepts 
indicated that Age 18 community service increased over historical time; developmental declines 
in community service were consistent over 4 decades. Parent education predicted higher Age 18 
community service but not growth parameters. Community service trajectories varied by gender, 
high school grades, religiosity, college expectations, and educational attainment, although all 
groups declined. Findings contribute to civic developmental theory by clarifying age and cohort 
effects in community service. Rising levels of community service at Age 18 may reflect heightened 
focus on service in high schools or the role of other socialization forces, yet these increases do not 
mitigate the decline across the TTA. We highlight the need for rethinking the ways in which 
institutions and communities can better support youth community service during the TTA. 
 
Do alcohol use reasons and contexts differentiate adolescent high-intensity drinking? 
Data for U.S. high school seniors, 2005-20168 
The purpose of this study was to examine associations between (a) self-reported reasons for and 
contexts of alcohol use and (b) high-intensity drinking (i.e., having 10+ drinks in a row in the past 
2 weeks) among national samples of U.S. 12th grade students. Data were obtained from 16,902 
students who reported any past 12-month alcohol use from nationally representative annual 12th 
grade student samples from 2005–2016. When asked about drinking behavior during the past 2 
weeks, 72% reported consuming less than 5 drinks at most during 1 drinking occasion; 14% 
reported 5–9 drinks, 7% reported 10–14 drinks, and 7% reported 15+ drinks. Adolescent drinkers 
in all categories (<5, 5–9, 10–14, and 15+ drinks) endorsed “to have a good time” as the most 
prevalent reason for alcohol use, and “at a party” as the most prevalent context of alcohol use. 
However, high-intensity drinking was particularly likely among adolescents drinking for coping, 
compulsive use, and drug effect reasons, as well as those who enjoyed the taste. Having 15+ drinks 
(vs. 10–14 drinks) was particularly associated with compulsive use and enjoying the taste. The 
relative risk of any high-intensity drinking, and of higher levels of high-intensity drinking 
                                                 
7 Wray-Lake, L., Schulenberg, J. E., Keyes, K. M., & Shubert, J. (2017). The developmental course of community service across the transition to 
adulthood in a national U.S. sample. Developmental Psychology, 53(12), 2397-2408.  
8 Terry-McElrath, Y. M., Stern, S. A., & Patrick, M. E. (2017). Do alcohol use reasons and contexts differentiate adolescent high-intensity drinking? 
Data from U.S. High school seniors, 2005-2016. Psychology of Addictive Behaviors, 31(7), 775-785. 
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involvement, increased with the total number of reasons and contexts endorsed. Alcohol appears 
to serve a larger number of functions for high-intensity drinking adolescents than non-high-
intensity drinking youth. 
 
Frequent binge drinking among U.S. adolescents, 1991-20159 
Background and Objectives Scientific understanding of the forces involved in the decades-long 
decline of adolescent alcohol use in the United States is limited. This study examines specific 
changes in US adolescent frequent binge drinking (FBD) by age (variation due to maturation), 
period (variation across time that does not covary across age), and cohort (variation common to 
adolescents born around the same time). Methods We analyzed nationally representative, 
multicohort data from 8th, 10th, and 12th grade students sampled between 1991 and 2015 from 
Monitoring the Future (n = 1 065 022) to estimate age, period, and cohort effects on adolescents’ 
FBD (defined as ≥2 occasions of ≥5 drinks in a row during the past 2 weeks). Age-Period-Cohort 
analyses were stratified by sex, race/ethnicity, and socioeconomic status (SES). Trends in the 
associations between demographics and FBD across historical time were examined. 
Results Decreases in FBD during adolescence were attributable to period and cohort effects 
independent of age variations. Birth cohorts between 1985 and 1990 showed the greatest decline 
in FBD. The Age-Period-Cohort results were consistent across sex, race/ethnicity, and SES, with 
the exception of slower declines seen among African American adolescents compared with white 
adolescents since 2007. We also found convergence in FBD by sex and divergence by SES. 
Conclusions Recent declines in adolescent FBD have been driven by period and cohort effects. 
Attention is warranted for the slower declines in FBD seen among African American adolescents 
since 2007, a narrowing difference by sex, and a growing gap by SES. 
 
Gender- and age-varying associations of sensation seeking and substance use across 
young adulthood10 
Introduction Sensation seeking is associated with elevated risk for substance use among 
adolescents and young adults. However, whether these associations vary across age for young men 
and women is not well characterized. Methods Using data from the Monitoring the Future (MTF) 
panel study, we examine the age-varying associations of sensation seeking and three types of 
substance use behavior (binge drinking, cigarette use, and marijuana use) across ages 18 to 30 
using time-varying effect modeling. Analyses include participants in the eleven most recent MTF 
cohorts (12th-graders in 1994–2004), who are eligible to respond through age 29/30 (N = 6338 
people; 30,237 observations). Results While sensation seeking levels and substance use are lower 
among women, the magnitude of the association of sensation seeking with binge drinking and with 
marijuana use among women exceeds that of men in the later 20s. Differential age trends were 
observed; among men, the associations generally decreased or remained constant with age. Yet 
among women, the associations decayed more slowly or even increased with age. Specifically, the 
association of sensation seeking with marijuana use among women increased during the late 20s, 
such that the association at age 30 exceeded that in the early 20s. Conclusions The significantly 
stronger associations of sensation seeking with binge drinking and marijuana use observed among 
women compared to men during the mid- to late-20s suggests divergent risk factors across genders 
                                                 
9 Jang, B., Patrick, M. E., Keyes, K. M., Hamilton, A. D., & Schulenberg, J. E. (2017). Frequent binge drinking among U.S. adolescents, 1991-
2015. Pediatrics, 139(6). 
10 Evans-Polce, R. J., Schuler, M. S., Schulenberg, J. E., & Patrick, M. E. (2018). Gender- and age-varying associations of sensation seeking and 
substance use across young adulthood. Addictive Behaviors, 84, 271-277.  
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for substance use during young adulthood, with sensation seeking remaining a strong risk factor 
for women but not men. 
 
High-intensity and simultaneous alcohol and marijuana use among high school 
seniors in the U.S.11 
Background Simultaneous alcohol and marijuana (SAM) use poses threats to health, particularly 
among adolescents. These risks would be exacerbated to the extent that high-intensity drinking 
(e.g., 10+ drinks in a row) and marijuana use (e.g., 1+ joints per day) are associated with a higher 
likelihood of SAM use. The current study examines the extent to which the intensity of alcohol 
use and of marijuana use are associated with adolescent SAM use prevalence, and whether 
associations remain after controlling for key covariates known to associate with both alcohol and 
marijuana use; it identifies alcohol and marijuana use intensity levels associated with the highest 
risk of adolescent SAM use. Methods Data come from nationally representative samples of US 
12th graders who participated in the Monitoring the Future study from 2005 to 2014 (N = 24,203 
respondents; 48.4% boys, 51.6% girls). Results SAM use during the past year was reported by 
20% of 12th graders overall. SAM use prevalence was strongly and positively associated with 
alcohol and marijuana use intensity even after controlling for covariates. High school seniors at 
highest risk for engaging in SAM use were those who reported 10+ drinks and those smoking at 
least 1 joint/day. Approximately 60% of those who had 10–14 or 15+ drinks in a row during the 
past 2 weeks and 76%–80% of those who had 1 or 2+ joints per day on average during the past 
30 days reported SAM use. Conclusions Results suggest that high school seniors who consume 
high quantities of alcohol and marijuana are very likely to consume these substances so that their 
effects overlap. 
 
High-intensity drinking and nonmedical use of prescription drugs: Results from a 
national survey of 12th grade students12 
Background Nearly 10% of U.S. 12th graders report high-intensity drinking (10+ or 15+ drinks in 
a row), but the extent to which these drinkers also engage in nonmedical use of prescription drugs 
(NMUPD) is largely unknown. This study examined the associations between different thresholds 
of past two-week high-intensity drinking and past-month NMUPD among U.S. 12th graders. 
Methods The sample consisted of eleven nationally representative cross-sections of 12th graders 
in the Monitoring the Future study (2005–2015) who answered questions on past two-
week drinking behaviors and past-month nonmedical use of prescription opioids, sedative, 
stimulants, and tranquilizers (N = 26,502 respondents). Results High-intensity drinking during the 
past two-weeks was associated with an increased risk of past-month NMUPD. The odds of 
NMUPD were four times larger among 12th graders who indicated drinking 15 or more drinks on 
at least one occasion (AOR = 4.43, 95% CI = 3.18, 5.01) relative to those who had 0–4 drinks 
during the past two-weeks, after adjusting for relevant covariates. These associations were similar 
across different classes of prescription drugs and tended to be stronger among non-white 
respondents. A sub-analysis revealed simultaneous co-ingestion of alcohol and NMUPD was more 
prevalent among high-intensity drinkers. Conclusions More than 1 in every 4 U.S 12th graders 
who engage in high-intensity drinking (15+ drinks in a row) also report NMUPD. Given the greater 
                                                 
11 Patrick, M. E., Veliz, P., & Terry-McElrath, Y. M. (2017). High-intensity and simultaneous alcohol and marijuana use among high school seniors 
in the U.S. Substance Abuse, 38(4), 498-503. 
12 McCabe, S. E., Veliz, P., & Patrick, M. E. (2017). High-intensity drinking and nonmedical use of prescription drugs: Results from a national 
survey of 12th grade students. Drug and Alcohol Dependence, 178, 372-379.  
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likelihood of simultaneous co-ingestion of alcohol and prescription drugs among high-intensity 
drinkers, adolescent substance use interventions need to address the risks associated with mixing 
alcohol and prescription drugs. 
How collegiate fraternity and sorority involvement relates to substance use during 
young adulthood and substance use disorders in early midlife: A national longitudinal 
study13
The purpose of this study was to assess how social fraternity involvement (i.e., membership and 
residence) in college relates to substance use behaviors and substance use disorder symptoms 
during young adulthood and early midlife, using the MTF national panel data. National multi-
cohort probability samples of U.S. high school seniors from MTF were assessed at baseline (age 
18) and followed longitudinally via self-administered surveys across seven follow-up waves to age
35. The longitudinal sample consisted of 7019 males and 8661 females, of which 10% of males
and 10% of females were active members of fraternities or sororities during college. Results show 
that male fraternity members who lived in fraternity houses during college had the highest levels 
of binge drinking and marijuana use relative to non-members and non-students in young adulthood 
that continued through age 35, controlling for adolescent sociodemographic and other 
characteristics. At age 35, 45% of the residential fraternity members reported alcohol use disorder 
(AUD) symptoms reflecting mild to severe AUDs; their adjusted odds of experiencing 
AUD symptoms at age 35 were higher than all other college and noncollege groups except 
non-residential fraternity members. Residential sorority members had higher odds of AUD 
symptoms at age 35 when compared to their noncollege female peers. In conclusion, national 
longitudinal data confirm binge drinking and marijuana use are most prevalent among male 
fraternity residents relative to non-members and non-students. The increased risk for substance-
related consequences associated with fraternity involvement was not developmentally 
limited to college and is associated with higher levels of long-term AUD symptoms during 
early midlife. 
Inverse propensity score weighting with a latent class exposure: Estimating the causal 
effect of reported reasons for alcohol use on problem alcohol use 15 years later14
Latent class analysis (LCA) has proven to be a useful tool for identifying qualitatively different 
population subgroups who may be at varying levels of risk for negative outcomes. Recent 
methodological work has improved techniques for linking latent class membership to distal 
outcomes; however, these techniques do not adjust for potential confounding variables that may 
provide alternative explanations for observed relations. Inverse propensity score weighting 
provides a way to account for many confounders simultaneously, thereby strengthening causal 
inference of the effects of predictors on outcomes. Although propensity score weighting has been 
adapted to LCA with covariates, there has been limited work adapting it to LCA with distal 
outcomes. The current study proposes a step-by-step approach for using inverse propensity score 
weighting together with the “Bolck, Croon, and Hagenaars” approach to LCA with distal outcomes 
(i.e., the BCH approach), in order to estimate the causal effects of reasons for alcohol use latent 
class membership during the year after high school (at age 19) on later problem alcohol use (at age 
35) with data from the longitudinal sample in the Monitoring the Future study. A supplementary
13 McCabe, S. E., Veliz, P., & Schulenberg, J. E. (2018). How collegiate fraternity and sorority involvement relates to substance use during young 
adulthood and substance use disorders in early midlife: A national longitudinal study. Journal of Adolescent Health, 62(3S), S35-S43. 
14 Bray, B. C., Dziak, J. J., Patrick, M. E., & Lanza, S. T. (2018). Inverse propensity score weighting with a latent class exposure: Estimating the 
causal effect of reported reasons for alcohol use on problem alcohol use 16 years later. Prevention Science. 
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appendix provides evidence for the accuracy of the proposed approach via a small-scale simulation 
study, as well as sample programming code to conduct the step-by-step approach. 
 
Joint effects of age, period, and cohort on conduct problems among American 
adolescents from 1991 through 201515 
Although arrest rates among juveniles have substantially decreased since the 1990s, US national 
trends in conduct problems are unknown. Population variation in conduct problems would imply 
changes in the social environment, which would include emergent or receding risk factors. In the 
present study, we separated age, period, and cohort effects on conduct problems using nationally 
representative surveys of 375,879 US students conducted annually (1991–2015). The summed 
score of 7 items measuring the frequency of conduct problems was the outcome. Conduct problems 
have decreased during the past 25 years among boys; the total amount of the decrease was 
approximately 0.4 standard deviations (P < 0.01), and by item prevalence, the total amount of the 
decrease was 8%–11%. Declines are best explained by period effects beginning approximately in 
2008, and a declining cohort effect beginning among those born after 1992, which suggests not 
only declines in population levels, but more rapid declines among younger cohorts of boys. Trends 
were also consistent with age-period-cohort effects on evenings spent out, which suggest a possible 
mechanism. Conduct problems among girls were lower than boys and did not demonstrate trends 
across time. These changes may reflect the changing nature of adolescence toward less 
unsupervised interaction. 
 
Marital status as a partial mediator of the associations between young adult substance 
use and subsequent substance use disorder: Application of causal inference 
methods16 
Objectives Young adult substance use is linked with risk of substance use disorders [SUDs] later 
in adulthood. Marriage may be part of this pathway both due to selection effects (early substance 
use reducing marriage) and socialization effects (marriage reducing later substance use and 
disorder). We examine whether marital status mediates the association between young adult 
substance use and subsequent SUDs, employing causal mediation methods to strengthen 
inferences. Methods Using panel data from high school seniors in 1990-1998, we examined 
whether the effects of two exposures (level of alcohol/marijuana use at age 19/20) on the outcomes 
(alcohol use disorder [AUD]/marijuana use disorder [MUD], non-disordered use, or abstinence at 
age 35) were mediated by marital status at age 29/30. Propensity score weights adjusted for 
potential confounding regarding both the exposures and the mediator. Results Moderate and heavy 
alcohol/marijuana use at age 19/20 were associated with higher odds of AUD/MUD and lower 
odds of abstinence, each relative to non-disordered use, at age 35. The association between heavy 
alcohol use at age 19/20 and subsequent AUD was partially mediated by being unmarried at age 
29/30; the associations between moderate and heavy marijuana use at age 19/20 and subsequent 
marijuana abstinence were partially mediated by being unmarried at age 29/30. Conclusions Both 
selection and socialization effects related to marriage help explain the perpetuation of substance 
use behaviors across adulthood. Of note, selection effects on marriage seem to occur at different 
thresholds for young adult alcohol and marijuana use. 
                                                 
15 Keyes, K. M., Gary, D. S., Beardslee, J., Prins, S. J., O'Malley, P. M., Rutherford, C., & Schulenberg, J. E. (2018). Joint effects of age, period, 
and cohort on conduct problems among American adolescents from 1991 through 2015. American Journal of Epidemiology, 187(3), 548-557.  
16 Jang, B., Schuler, M. S., Evans-Polce, R. J., & Patrick, M. E. (in press). Marital status as a partial mediator of the associations between young 
adult substance use and subsequent substance use disorder: Application of causal inference methods. Journal of Studies on Alcohol and Drugs.  
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Passing on pot: High school seniors' reasons for not using marijuana as predictors of 
future use17 
As MTF has shown, marijuana use is relatively common among youth and increases during the 
transition to adulthood. Yet, a substantial number of adolescents and young adults do not use 
marijuana. The purpose of this study was to examine how high school seniors’ reasons for 
intending not to use marijuana within the next 12 months were prospectively associated with 
marijuana use reported one year later. Data were drawn from the MTF national longitudinal 
samples of U.S. high school seniors (n = 3,044; 50% female; 65% White). Bivariate and 
multivariable logistic regression analyses were conducted to examine associations between 
reasons seniors indicated for intending not to use marijuana within the next 12 months and 
marijuana use reported one year later in the follow-up survey, controlling for sociodemographic 
characteristics and high school risk factors. Analyses were conducted separately among youth with 
and without lifetime marijuana use in high school. In multivariable models, reasons associated 
with marijuana abstinence one year later among prior marijuana use abstainers were concerns 
about becoming addicted, being against ones’ beliefs, not liking marijuana users, and not having 
friends who use marijuana. Among prior marijuana users, not enjoying marijuana was a significant 
predictor of marijuana abstinence one year later. In conclusion, reasons for abstaining from 
marijuana have predictive utility in relation to later use, but these associations differ between those 
with and without prior marijuana use. Understanding the underlying reasons for stopping 
marijuana use or maintaining abstinence informs youth substance use prevention and intervention 
programs. 
 
Patterns of high-intensity drinking among young adults in the United States: A 
repeated measures latent class analysis18 
Objective Using a national sample of young adults, this study identified latent classes of alcohol 
use including high-intensity drinking (10+ drinks) from ages 18 to 25/26, and explored 
associations between time-invariant covariates measured at age 18 and class membership. Method 
Longitudinal data from the national Monitoring the Future study were available for 1078 
individuals (51% female) first surveyed as 12th grade students in 2005–2008, and followed through 
modal age 25/26. Repeated measures latent class analysis was used to identify latent classes based 
on self-reported alcohol use: no past 30-day drinking, 1–9 drinks per occasion in the past 2 weeks, 
and 10+ drinks per occasion. Results Four latent classes of alcohol use from ages 18 to 25/26 were 
identified: (1) Non-Drinkers (21%); (2) Legal Non-High-Intensity Drinkers (23%); (3) Persistent 
Non-High-Intensity Drinkers (40%); and (4) High-Intensity Drinkers (16%). Membership in the 
High-Intensity Drinkers class was characterized by higher than average probabilities of high-
intensity drinking at all ages, with the probability of high-intensity drinking increasing between 
ages 18 and 21/22. Both gender and race/ethnicity significantly differentiated class membership, 
whereas neither parental education (a proxy for socioeconomic status) nor college plans at 12th 
grade showed significant associations. Conclusions More than one in seven individuals who were 
seniors in high school experienced a long-term pattern of high-intensity drinking lasting into 
middle young adulthood. Young adult high-intensity drinking is often preceded by high-intensity 
drinking in high school, suggesting the importance of screening and prevention for high-intensity 
                                                 
17 Martz, M. E., Schulenberg, J. E., & Patrick, M. E. (in press). Passing on pot: High school seniors' reasons for not using marijuana as predictors 
of future use. Journal of Studies on Alcohol and Drugs.  
18 Patrick, M. E., Terry-McElrath, Y. M., Schulenberg, J. E., & Bray, B. C. (2017). Patterns of high-intensity drinking among young adults in the 
United States: A repeated measures latent class analysis. Addictive Behaviors, 74, 134-139.  
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drinking during adolescence. 
 
Patterns of simultaneous and concurrent alcohol and marijuana use among 
adolescents19 
Background Alcohol and marijuana are the most commonly used substances among adolescents 
but little is known about patterns of co-use. Objectives This study examined patterns of concurrent 
(not overlapping) and simultaneous (overlapping) use of alcohol and marijuana among 
adolescents. Methods Data from US-national samples of 12th graders (N = 84,805, 48.4% female) 
who participated in the Monitoring the Future study from 1976 to 2016 and who used alcohol 
and/or marijuana in the past 12 months were used to identify latent classes of alcohol use, 
marijuana use, and simultaneous alcohol and marijuana (SAM) use. Results A four-class solution 
indicated four patterns of use among adolescents: (1) Simultaneous alcohol and marijuana (SAM) 
use with binge drinking and recent marijuana use (SAM-Heavier Use; 11.2%); (2) SAM use 
without binge drinking and with recent marijuana use (SAM-Lighter Use; 21.6%); (3) Marijuana 
use and alcohol use but no SAM use (Concurrent Use; 10.7%); and (4) Alcohol use but no 
marijuana or SAM use (Alcohol-Only Use; 56.4%). Membership in either SAM use class was 
associated with a higher likelihood of truancy, evenings out, and use of illicit drugs other than 
marijuana. SAM-Heavier Use, compared to SAM-Lighter Use, class members were more likely to 
report these behaviors and be male, and less likely to have college plans. Conclusions Among 12th 
graders who use both alcohol and marijuana, the majority use simultaneously, although not all use 
heavily. Given the recognized increased public health risks associated with simultaneous use, 
adolescent prevention programming should include focus on particular risks of simultaneous use. 
 
Prevalence and attitudes regarding marijuana use among adolescents over the past 
decade20 
Adolescent marijuana prevalence has not increased since 2005 despite a substantial decrease in the 
percentage of adolescents who believe marijuana use leads to great risk of harm. This finding calls 
into question the long-standing, inverse connection between marijuana prevalence and perceived 
risk of use, a connection central to many arguments opposing marijuana legalization. We tested 
two hypotheses for why marijuana prevalence did not increase after 2005: (1) decreases in 
adolescent use of cigarettes and alcohol reduced risk for marijuana use and counteracted the 
expected risk in marijuana prevalence, and/or (2) perceived risk of harm now plays a smaller role 
in marijuana use. To test these hypotheses the entire sample was stratified into three mutually 
exclusive and exhaustive groups on the basis of cigarette and alcohol use. Within each of the three 
groups, marijuana prevalence increased from 2005 to 2016. Paradoxically, when the three groups 
were combined into one analysis pool, overall marijuana prevalence did not increase. The seeming 
paradox results from a decline in the percentage of adolescents who used cigarettes; as this group 
grew smaller, so too did its disproportionately large contribution to overall marijuana prevalence. 
Perceived risk of harm from marijuana remained a strong indicator of use throughout 2005 to 2016. 
The paper concludes that perceived risk of marijuana remains tightly associated with use, and 
adolescent marijuana prevalence today would be at or near record highs if cigarette use had not 
declined since 2005, according to study projections. 
                                                 
19 Patrick, M. E., Kloska, D. D., Terry-McElrath, Y. M., Lee, C. M., O'Malley, P. M., & Johnston, L. D. (2018). Patterns of simultaneous and 
concurrent alcohol and marijuana use among adolescents. The American Journal of Drug and Alcohol Abuse, 44(4), 441-451. 
20 Miech, R. A., Johnson, L. D., & O’Malley, P. M (2017). Prevalence and attitudes regarding marijuana use among adolescents over the past 
decade. Pediatrics, 140(6). 
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Prevalence of concussion among U.S. adolescents and correlated factors21 
Concern with concussion among teens and adults has increased in recent years; however little is 
known about the prevalence of concussions among youth in the U.S. Using the 2016 MTF 8th, 10th, 
and 12th grade nationally representative data (N=13,088), we examined the prevalence and 
correlates of self-reported diagnosed concussion. We found that one out of five (19.5%) teens 
reported at least one concussion diagnosis during their lifetime, and 5.5 percent have had more 
than one concussion. Several factors were associated with higher lifetime prevalence of reporting 
a diagnosed concussion: being male, white, in a higher grade, and participating in competitive 
sports. Future research should consider associations with substance use as well as more detailed 
consideration of characteristics of sports most associated with concussions. 
 
Prospective associations of 12th grade drinking intensity and age 19/20 driving-related 
consequences in a national sample22 
Purpose The purpose of this study is to examine driving-related consequences associated with 
levels of drinking intensity among a national sample of young adult drinkers. Methods Data come 
from a nationally representative sample of 12th graders sampled annually in 2005–2014 with 
subsamples surveyed at age 19/20 years. Multivariable logistic regressions examined associations 
of 12th-grade drinking intensity (0–4, 5–9, 10–14, and 15+ drinks in a row) with driving 
consequences at age 19/20 years. Results Twelfth-grade binge drinkers (compared with nonbinge 
drinkers) were more likely to experience negative driving consequences at age 19/20 years. Among 
binge drinkers, 15+ drinkers (compared with 5–9 drinkers) in 12th grade had increased the risk of 
negative drinking consequences at age 19/20 years. Conclusions These results suggest that while 
underage binge drinkers are at an increased risk for having driving consequences, those who 
engage in higher intensity drinking are at even greater risk for these consequences. High-intensity 
drinkers may require additional screening or intervention to reduce future driving-related 
consequences. 
 
Reasons for vaping among U.S. 12th graders: A latent class analysis23 
Introduction Vaping has recently increased in popularity among adolescents. Little is known 
about heterogeneity of vapers, particularly in terms of why they vape. Identifying major subgroups 
of adolescent vapers by reasons for vaping is important to understand adolescent vaping behavior 
and to identify those most at risk for other substance use. Methods Monitoring Future data from 
2015 and 2016 were used in a latent class analysis to identify subgroups of 12th graders based on 
their endorsement of 10 potential reasons for vaping. Multinomial regression with a latent class 
outcome was used to predict class membership. Results Three distinct classes of vapers were 
identified: adolescents who were (1) Vaping to Experiment (29.4%), (2) Vaping to Replace 
Cigarettes (7.3%), and (3) Vaping for Taste + Entertainment (63.4%). Vaping only flavors was 
associated with lower odds of membership and cigarette use was associated with higher odds of 
membership in the Vaping to Replace Cigarettes subgroup, and marijuana was associated with 
                                                 
21 Veliz, P., McCabe, S. E., Eckner, J. T., & Schulenberg, J. E. (2017). Prevalence of concussion among U.S. adolescents and correlated factors. 
JAMA, 318(12), 1180-1182. 
22 Evans-Polce, R. J., Patrick, M. E., & O'Malley, P. M. (2017). Prospective associations of 12th-grade drinking intensity and age 19/20 driving-
related consequences. Journal of Adolescent Health, 61(3), 389-391. 
23 Evans-Polce, R. J., Patrick, M. E., Lanza, S. T., Miech, R. A., O'Malley, P. M., & Johnston, L. D. (2018). Reasons for vaping among U.S. 12th 
graders. Journal of Adolescent Health, 62(4), 457-462.  
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lower odds of membership in the Vaping to Experiment subgroup, compared with the Vaping for 
Taste + Entertainment subgroup. Conclusions This study identified multiple subgroups of vapers 
based on reasons for vaping. Whereas a small subgroup vaped for reasons related to cigarette use, 
most adolescent vapers reported vaping for reasons unrelated to cigarette use. There were 
considerable differences in primary reasons for vaping and risk for traditional cigarette and other 
substance use, suggesting different intervention strategies may be needed for different subgroups 
of vapers. 
 
Risk is still relevant: Time-varying associations between perceived risk and marijuana 
use among U.S. 12th grade students from 1991-201624 
Background: Perceived risk of harm has long been a key preventive factor for adolescent 
marijuana use. However, in recent years, perceived risk has decreased markedly and marijuana use 
has increased only slightly, leading to new questions about their association. This study 
investigates the magnitude and stability of the US adolescent marijuana risk/use association from 
1991 to 2016, overall and by gender and race/ethnicity. Methods: Self-reported data on past 12-
month marijuana use, perceived risk of regular marijuana use, gender, and race/ethnicity were 
obtained from 275,768 US 12th grade students participating in the nationally representative 
Monitoring the Future study. Time-varying effect modeling (TVEM) was used to examine the 
marijuana risk/use association over time. Results: Both before and after controlling for gender and 
race/ethnicity, perceived risk was a strong protective factor against adolescent marijuana use. The 
magnitude of the great risk/use association strengthened for Hispanic students; remained generally 
stable over time for 12th graders overall, males, females, and White students; and weakened for 
Black students. The magnitude of the moderate risk/use association strengthened for 12th graders 
overall, males, females, White and Hispanic students, but did not continue to strengthen for Black 
students from 2005 onwards. In general, marijuana use prevalence decreased over time within all 
levels of perceived risk. Conclusions: Perceived risk remains a strong protective factor for 
adolescent marijuana use, and the protective association for moderate risk (vs. no/slight risk) is 
actually increasing over time. Results suggest that accurate and credible information on the risks 
associated with marijuana use should remain a key component of prevention efforts. 
 
A sequential mixed-mode experiment in the U.S. national Monitoring the Future study25 
The national Monitoring the Future (MTF) study examines substance use among adolescents and 
adults in the United States and has used paper questionnaires since it began in 1975. The current 
experiment tested three conditions as compared to the standard MTF follow-up protocol (i.e., MTF 
Control) for the first MTF follow-up survey at ages 19/20 years (i.e., one or two years after high 
school graduation). The MTF Control group included participants who completed in-school 
baseline surveys in the 12th grade in 2012–2013 and who were selected to participate in the first 
follow-up survey in 2014 (n = 2,451). A supplementary sample of participants who completed the 
12th grade baseline survey in 2012 or 2013 but were not selected to participate in the main MTF 
follow-up (n = 4,950) were recruited and randomly assigned to one of three experimental 
conditions: (1) Mail Push, (2) Web Push, (3) Web Push + E-mail. Results indicated that the overall 
response rate was lower in Condition 2 compared to MTF Control and to Condition 1; there were 
                                                 
24 Terry-McElrath, Y. M., O'Malley, P. M., Patrick, M. E., & Miech, R. A. (2017). Risk is still relevant: Time-varying associations between 
perceived risk and marijuana use among U.S. 12th grade students from 1991-2016. Addictive Behaviors, 74, 13-19. 
25 Patrick, M. E., Couper, M. P., Laetz, V. B., Schulenberg, J. E., O’Malley, P. M., Johnston, L. D., & Miech, R. A. (2018). A sequential mixed 
mode experiment in the U.S. national Monitoring the Future study. Journal of Survey Statistics and Methodology, 6(1), 72-97.  
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no differences between Condition 3 and other conditions. Web response was highest in Condition 
3; among web responders, smartphone response was also highest in Condition 3. Subgroup 
differences also emerged such that, for example, compared to white participants, Hispanics had 
greater odds of web (versus paper) response and blacks had greater odds of smartphone (versus 
computer or tablet) response. Item nonresponse was lowest in the Web Push conditions (compared 
to MTF Control) and on the web survey (compared to paper). Compared to MTF Control, 
Condition 3 respondents reported higher rates of alcohol use in the past 30 days. The total cost was 
lowest for Condition 3. Overall, the Condition 3 Web Push + E-mail design is promising. Future 
research is needed to continue to examine the implications of web and mobile response in large, 
national surveys. 
 
Substance use behaviors and the timing of family formation during young adulthood26 
The impact of substance use on the life course of young adults can be substantial, yet few studies 
have examined to what extent early adult substance use behaviors are related to the timing of 
family formation, independent of confounding factors from adolescence. Using panel data from 
the Monitoring the Future study (N~20,000), the current study examined the associations between 
three substance use behaviors (i.e., cigarette use, binge drinking, and marijuana use) and the timing 
of family formation events in young adulthood. Survival analysis and propensity score weighting 
addressed preexisting differences between substance users and nonusers in the estimation of the 
timing of union formation (i.e., marriage, cohabitation) and parenthood. Results for young adult 
substance users showed general patterns of reduced rates of marriage and parenthood and increased 
cohabitation during young adulthood. Variations were evident by substance and sex. 
 
Technology and interactive social media use among 8th and 10th graders in the U.S. and 
associations with homework and school grades27 
This study examined differences by age, gender, and race/ethnicity in the use of technology and 
interactive social media from 2013-2016 using data from nationally-representative samples of U.S. 
8th and 10th graders (N=40,389). Results indicated that 8th graders watch TV and play video games 
more than 10th graders; boys play more video games and use interactive social media less than 
girls; and Black adolescents use most forms of media more often than those from other 
race/ethnicity groups, with the exception of using the computer for school reported most often by 
Asian adolescents. Mean differences showed that adolescents who spend more time on homework 
spend more time using the computer for school, and spend less time watching weekday TV, 
playing video games, and talking on the phone. Adolescents with higher grades spend more time 
using the computer for school and spend less time on all other types of technology and interactive 
social media, except for watching weekend TV. Multivariable logistic regression results indicate 
that watching TV on a weekday was consistently negatively associated with academic outcomes 
and using the computer for school was consistently positively associated with academic outcomes. 
 
 
 
 
                                                 
26 Jang, B., Patrick, M. E., & Schuler, M. S. (2017). Substance use behaviors and the timing of family formation during young adulthood. Journal 
of Family Issues, 39(5), 1396-1418. 
27 Tang, S., & Patrick, M. E. (2018). Technology and interactive social media use among 8th and 10th graders in the U.S. and associations with 
homework and school grades. Computers in Human Behavior, 86, 34-44.  
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U.S. adolescent alcohol use by race/ethnicity: Consumption and perceived need to 
reduce/stop use28 
Understanding racial/ethnic drinking patterns and service provision preferences is critical for 
deciding how best to use limited alcohol prevention, intervention, and treatment resources. We 
used nationally representative data from 150,727 U.S. high school seniors from 2005 to 2016 to 
examine differences in a range of alcohol use behaviors and the felt need to reduce or stop alcohol 
use based on detailed racial/ethnic categories, both before and after controlling for key 
risk/protective factors. Native students reported particularly high use but corresponding high felt 
need to reduce/stop use. White and dual-endorsement students reported high use but low felt need 
to stop/reduce alcohol use. 
 
OTHER DATA ON CORRELATES AND TRENDS 
Drug use correlates and trends not presented in this monograph or in the papers above can be 
calculated using the publicly available MTF data archive at the Inter-university Consortium of 
Political and Social Research. In addition, interested users can use the online interface at the 
National Addiction and HIV Data Archive Program (sponsored in part by the National Institute on 
Drug Abuse) to produce cross-tabulations for variables of interest, also available at the Inter-
university Consortium of Political and Social Research website.  
 
These online resources allow users to calculate hundreds of correlates of drug use. For data 
previous to 2013, MTF published bivariate correlates without accompanying interpretation in a 
series of annual volumes entitled Monitoring the Future: Questionnaire Responses from the 
Nation’s High School Seniors. For each year between 1975 and 2012, a separate volume presents 
univariate and selected bivariate distributions on all questions asked of 12th graders. A host of 
variables dealing explicitly with drugs—many of them not covered here—are contained in that 
series. Bivariate tables are provided for all questions asked of high school seniors each year 
distributed against an index of lifetime illicit drug involvement, making it possible to examine the 
relationships between hundreds of potential risk factors and illicit drug use. These reference 
volumes are available on the MTF website and include MTF data up to 2012. They were 
discontinued thereafter as the online resources make it possible for interested readers to themselves 
calculate these statistics and any combination thereof, for 8th and 10th grade as well as for 12th 
grade respondents.  
 
An annual occasional paper on subgroups29 presents trends in both graphic and tabular form for 
the various subgroups for each of the many drug classes. It covers all years for all three grades in 
which data have been collected. It is available on the MTF website. 
 
WEBSITE 
Any reader wishing to obtain more information on the study, or to check for recent findings and 
publications, may visit the MTF website.  
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